Citrus Sinensis ID: 006402
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 646 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LZM4 | 657 | Wall-associated receptor | yes | no | 0.907 | 0.891 | 0.496 | 1e-162 | |
| Q9M342 | 639 | Wall-associated receptor | no | no | 0.907 | 0.917 | 0.452 | 1e-137 | |
| Q8RY67 | 708 | Wall-associated receptor | no | no | 0.597 | 0.545 | 0.433 | 3e-81 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.591 | 0.521 | 0.424 | 2e-79 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.611 | 0.535 | 0.397 | 1e-78 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.578 | 0.504 | 0.407 | 1e-78 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.580 | 0.510 | 0.400 | 3e-78 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.600 | 0.529 | 0.401 | 1e-76 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.450 | 0.387 | 0.474 | 1e-76 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.602 | 0.625 | 0.405 | 2e-76 |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 572 bits (1475), Expect = e-162, Method: Compositional matrix adjust.
Identities = 310/624 (49%), Positives = 416/624 (66%), Gaps = 38/624 (6%)
Query: 34 CPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRIVMQ 93
CP+CGP+ VPYPLST P CGD Y + C KLYF AL+GSSY++ + +QRIV++
Sbjct: 43 CPNCGPMVVPYPLSTGPTCGDQAYRINC--VGGKLYFGALHGSSYVITSINSVTQRIVLR 100
Query: 94 PASWIND-SCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNCSSSSLCH 152
P + SC++ D V+ +GL L+ LPF++TSSNTI L NCS +L +P++CS +SLC+
Sbjct: 101 PPGLASSVSCISAD-VSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCY 159
Query: 153 NFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILHLDPNK-- 210
+++ K A C S+ CCTF G +AY IR++ GC A++S + L+PNK
Sbjct: 160 SYI-------KNNASPC-SKAPLCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEV 211
Query: 211 --PANQW-EEGLEIQWAPPPEPVCKTQLDCS---GASKCLSAGRN-GVYRCLCIKGYYWD 263
P +W + GLE+QWA P EPVCKT +DC+ G SKCL + G+ RC C KG WD
Sbjct: 212 PPPGKKWPDTGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWD 271
Query: 264 HVLGTCQRKRRNRR-----SGLSLKISIGVISVLSLAIAVAAIKIICSRKLAKQ---AKL 315
V C + R + + + + ++LAIAVA I S + K+ +
Sbjct: 272 PVNAICGKCRHGKHCKKKKKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNI 331
Query: 316 AKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAV 375
KERE+ML S+N GK +RIF +E+ KATN FSK+ ++G+GGFGEV+K L+DGT+ A+
Sbjct: 332 VKEREEML-SANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAI 390
Query: 376 KSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG 435
K AK+ N K T Q+LNEV IL QVNH++LVRLLGCCV+ E PLLIYE+I NGTL +HLHG
Sbjct: 391 KRAKLNNTKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHG 450
Query: 436 KYSSF--NLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493
LTW RL+IA QTAE LAYLHSAA PIYHRDVKS+NILLD+ N+KV+DFG
Sbjct: 451 SSDRTWKPLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFG 510
Query: 494 LSRLAK-----PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKA 548
LSRL SH+ T AQGTLGYLDPEYYRN+QLTDKSDVYS+GVVLLE++TS+KA
Sbjct: 511 LSRLVDLTETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKA 570
Query: 549 IDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREK 608
IDF+R+ +DVNL +Y+++ + E +DP L+ ++ + +++ LA ACL E+
Sbjct: 571 IDFTREEEDVNLVMYINKMMDQERLTECIDPLLKKTANKID-MQTIQQLGNLASACLNER 629
Query: 609 KSERPSMTDVVHELQRIIEIVNQE 632
+ RPSM +V E++ II I++QE
Sbjct: 630 RQNRPSMKEVADEIEYIINILSQE 653
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 280/619 (45%), Positives = 377/619 (60%), Gaps = 33/619 (5%)
Query: 32 KICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRIV 91
K CP+CG +VPYPLST CGDP Y +RCD + L+FD LNGS+ + S QR V
Sbjct: 27 KRCPNCGSTRVPYPLSTGLDCGDPGYRIRCDNYG-SLWFDTLNGSTNPIKTIDPSGQRFV 85
Query: 92 MQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLIS----PLNCSS 147
++P + + CV+ D + G+ L+ +LPFNV+ SNT+ + NC+ L + NCS
Sbjct: 86 LRPPGFEQNKCVSVD-IKYHGIQLDLNLPFNVSCSNTVIIMNCTKDGLDAYSSQGFNCSD 144
Query: 148 SSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKI-RLHSSGCKAFRSILHL 206
+SLCH FL + A + CC + G + YK+ R C A++S ++L
Sbjct: 145 NSLCHKFLNA-----NLEARGNCRGVTSCCWYKTGASVNTYKVYRARPDMCSAYQSFMNL 199
Query: 207 DPNKPANQW-EEGLEIQWAPPPEPVCKTQLDCSGA--SKCLSAGRN-GVYRCLCIKGYYW 262
D P ++W E +EI W P EPVCK+Q DC S C + N G RC C KG+ W
Sbjct: 200 DLTIPVSKWGEPAVEILWEAPREPVCKSQGDCRDLLNSVCSNDSTNLGQKRCFCKKGFQW 259
Query: 263 DHVLGTCQRKRRNRRSGLS-----LKISIGVISVLSLAIAVAAIKIICS---RKLAKQAK 314
D V C+ R ++R + V ++ IA K I S R++A
Sbjct: 260 DSVNAVCEVNRCSKRKSCKRWSNLPLLGGLAGGVGAILIAGFITKTIVSKQNRRIAGNQS 319
Query: 315 LAKERE--DMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTV 372
A R+ L S N G RIF KE+ KAT+ F+K +LG GGFGEV+KG L DGT
Sbjct: 320 WASVRKLHRNLLSINSTGLD-RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTT 378
Query: 373 VAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDH 432
VAVK AK+GN KS Q++NEV IL QV+HKNLV+LLGCC+E E P+L+YE++ NGTL +H
Sbjct: 379 VAVKRAKLGNEKSIYQIVNEVQILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEH 438
Query: 433 LHGKYSSF-----NLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487
++G +L RL IA QTA+ L YLHS++ PIYHRDVKS+NILLD++ +
Sbjct: 439 IYGGGGGGGGLYDHLPLRRRLMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDV 498
Query: 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
KVADFGLSRL +SHV+TCAQGTLGYLDPEYY N+QLTDKSDVYS+GVVL ELLT +K
Sbjct: 499 KVADFGLSRLGVSDVSHVTTCAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKK 558
Query: 548 AIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLRE 607
AIDF+R+ +DVNL ++V + G +M+V+DP + G A+ + S+K LA C++E
Sbjct: 559 AIDFNREEEDVNLVVFVRKALKEGRLMDVIDPVI-GIGATEKEIESMKALGVLAELCVKE 617
Query: 608 KKSERPSMTDVVHELQRII 626
+ RP+M E++ I+
Sbjct: 618 TRQCRPTMQVAAKEIENIL 636
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 177/408 (43%), Positives = 245/408 (60%), Gaps = 22/408 (5%)
Query: 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRK----------RRNRRSG 279
C DC+ G G +RC C+ G++ D CQR R+ RS
Sbjct: 226 TCAANTDCTDVET--PHGYAG-HRCSCLDGFHGDGYTNPCQRALPECRGSKLVWRHCRSN 282
Query: 280 LSLKISIGVISVLSLAIAVAAIKIICSRKLAK--QAKLAKEREDMLKSSNIAGKPARIFH 337
L + I G + L A+A C R+ + ++ L+ +R L S F
Sbjct: 283 L-ITIVGGTVGGAFLLAALAFFFF-CKRRRSTPLRSHLSAKR---LLSEAAGNSSVAFFP 337
Query: 338 LKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILS 397
KE++KAT+GFS+++ LG G +G VY+G+LQ+ VA+K + + +S QV+NE+ +LS
Sbjct: 338 YKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKLLS 397
Query: 398 QVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEA 457
V+H NLVRLLGCC+E P+L+YEY+ NGTL +HL S L W+ RL +A QTA+A
Sbjct: 398 SVSHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGS-GLPWTLRLTVATQTAKA 456
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
+AYLHS+ PIYHRD+KSTNILLD DFNSKVADFGLSRL SH+ST QGT GYLD
Sbjct: 457 IAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTPGYLD 516
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577
P+Y++ + L+DKSDVYS+GVVL E++T K +DF+R ++NLA + +G I E++
Sbjct: 517 PQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDEII 576
Query: 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
DP L + L S+ +ELA CL RP+MT+V EL++I
Sbjct: 577 DPILD-LDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQI 623
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 169/398 (42%), Positives = 235/398 (59%), Gaps = 16/398 (4%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRN---RRSGLSLKISIGVISVL 292
+CS S C + G + C C GY D L +C RK R R + + L +IG SV+
Sbjct: 288 NCSEHSTCENT--KGSFNCNCPSGYRKDS-LNSCTRKVRPEYFRWTQIFLGTTIG-FSVI 343
Query: 293 SLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGK-----PARIFHLKELKKATNG 347
L I+ KI + + K ++ + ++G +IF K +K+ATNG
Sbjct: 344 MLGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNG 403
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + RILG GG G VYKG L D ++VA+K A++GN +Q +NEV +LSQ+NH+N+V++
Sbjct: 404 YHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKV 463
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
LGCC+E E PLL+YE+I +GTL DHLHG +LTW RLRIA + A +LAYLHS+A
Sbjct: 464 LGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAYLHSSASI 523
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
PI HRD+K+ NILLD + +KVADFG SRL ++T QGTLGYLDPEYY L
Sbjct: 524 PIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLN 583
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
+KSDVYS+GVVL+ELL+ QKA+ F R NL + N E++D ++ +
Sbjct: 584 EKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIIDGQVMNEDNQ 643
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
I + ++ +E C R ERP M +V EL+ +
Sbjct: 644 REIQEAARIAAE----CTRLMGEERPRMKEVAAELEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 163/410 (39%), Positives = 243/410 (59%), Gaps = 15/410 (3%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRR---SGLSLKISIGVISVL 292
+CSG S C + G +RC C Y + TC+ K + + L +IG + +L
Sbjct: 293 NCSGDSTC--ENKLGHFRCNCRSRYELNTTTNTCKPKGNPEYVEWTTIVLGTTIGFLVIL 350
Query: 293 SLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGK-----PARIFHLKELKKATNG 347
LAI+ K+ ++ + + ++ + ++G +IF + +K+AT+G
Sbjct: 351 -LAISCIEHKMKNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDG 409
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + RILG GG G VYKG L D ++VA+K A++G+ +Q +NEV +LSQ+NH+N+V+L
Sbjct: 410 YDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKL 469
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
LGCC+E E PLL+YE+I++GTL DHLHG +LTW RLR+A++ A LAYLHS+A
Sbjct: 470 LGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASI 529
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
PI HRD+K+ NILLD++ +KVADFG SRL ++T QGTLGYLDPEYY L
Sbjct: 530 PIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLN 589
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
+KSDVYS+GVVL+ELL+ QKA+ F R ++ Y + + E++D G +
Sbjct: 590 EKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIID----GQVMN 645
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSND 637
N ++ + +AV C R ERP M +V EL+ + + K S++
Sbjct: 646 ENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKTKHKWSDE 695
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 164/402 (40%), Positives = 235/402 (58%), Gaps = 28/402 (6%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVISVLSLA 295
+CS C + R+G + C C GY + + +C R +R+ + L I IGV+ +L A
Sbjct: 303 NCSDPKTCRN--RDGGFDCKCPSGYDLNSSM-SCTRPEY-KRTRIFLVIIIGVLVLLLAA 358
Query: 296 IAVAAIKIICSRKLAKQAKLAKEREDM------------LKSSNIAGKPARIFHLKELKK 343
I C + KQ K K R L + ++ +IF + +K+
Sbjct: 359 I--------CIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKE 410
Query: 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN 403
ATNG+ + RILG GG G VYKG L D T+VA+K A++ + + Q ++EV +LSQ+NH+N
Sbjct: 411 ATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRN 470
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+V++LGCC+E E PLL+YE+I NGTL DHLHG +LTW RLRIA++ A LAYLHS
Sbjct: 471 VVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYLHS 530
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+A PI HRD+K+ NILLD++ +KVADFG S+L ++T QGTLGYLDPEYY
Sbjct: 531 SASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTT 590
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
L +KSDVYS+GVVL+ELL+ QKA+ F R +L Y + E++D ++
Sbjct: 591 GLLNEKSDVYSFGVVLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQVLN 650
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+ L ++ + +A C R ERP M +V +L+ +
Sbjct: 651 EDN----LKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 161/402 (40%), Positives = 231/402 (57%), Gaps = 27/402 (6%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVISVLSLA 295
+CS C + + G + C C GY D +C+RK + ++ V ++
Sbjct: 296 NCSDPKTCRN--KVGGFYCKCQSGYRLDTTTMSCKRKEFAWTT---------ILLVTTIG 344
Query: 296 IAVAAIKIICSRKLAKQAKLAKEREDMLK-------SSNIAGK-----PARIFHLKELKK 343
V + + C ++ K K K RE + + ++G +IF +KK
Sbjct: 345 FLVILLGVACIQQRMKHLKDTKLREQFFEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKK 404
Query: 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN 403
ATNG+++ RILG GG G VYKG L D ++VA+K A++G+ +Q +NEV +LSQ+NH+N
Sbjct: 405 ATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRN 464
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+V+LLGCC+E E PLL+YE+I NGTL DHLHG +LTW RL+IA++ A LAYLHS
Sbjct: 465 VVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAYLHS 524
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+A PI HRD+K+ NILLD + +KVADFG SRL + T QGTLGYLDPEYY
Sbjct: 525 SASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNT 584
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
L +KSDVYS+GVVL+ELL+ QKA+ F R +L Y + + E++ G
Sbjct: 585 GLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEIIG----G 640
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+ + L ++ + +A C R ERP M +V +L+ +
Sbjct: 641 EVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 163/406 (40%), Positives = 236/406 (58%), Gaps = 18/406 (4%)
Query: 231 CKTQL-DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLS-----LKI 284
C T++ +CS S C + G + C C G + +C + L L
Sbjct: 283 CTTRIHNCSDTSTCENT--LGSFHCQCPSGSDLNTTTMSCIDTPKEEPKYLGWTTVLLGT 340
Query: 285 SIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGK-----PARIFHLK 339
+IG + +L L I+ K+ + + + ++ + ++G +IF +
Sbjct: 341 TIGFLIIL-LTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEE 399
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV 399
+K+AT+G+++ RILG GG G VYKG LQD ++VA+K A++G+ +Q +NEV +LSQ+
Sbjct: 400 GMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQI 459
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
NH+N+V+LLGCC+E E PLL+YE+I++GTL DHLHG +LTW RLRIA++ A LA
Sbjct: 460 NHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLA 519
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLHS A PI HRDVK+ NILLD++ +KVADFG SRL ++T QGTLGYLDPE
Sbjct: 520 YLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPE 579
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579
YY L +KSDVYS+GVVL+ELL+ +KA+ F R +L Y + E++D
Sbjct: 580 YYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDG 639
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
++ I S + +AV C R ERPSM +V EL+ +
Sbjct: 640 QVMNEYNQREIQESAR----IAVECTRIMGEERPSMKEVAAELEAL 681
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 140/295 (47%), Positives = 199/295 (67%), Gaps = 4/295 (1%)
Query: 331 KPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVL 390
+ ++IF KEL+KAT+ F+ R+LG GG G VYKG L DG +VAVK +KV + ++ +
Sbjct: 404 QSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFI 463
Query: 391 NEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI 450
NEVG+LSQ+NH+N+V+L+GCC+E E P+L+YE+I NG L LH + +TW RLRI
Sbjct: 464 NEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRI 523
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
+++ A ALAYLHSAA TP+YHRDVK+TNILLD+ + +KV+DFG SR +H++T
Sbjct: 524 SVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVA 583
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
GT GYLDPEY++ Q TDKSDVYS+GVVL+EL+T +K R ++ L + ++
Sbjct: 584 GTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQ 643
Query: 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
++++VD R++ +L K LA CL K +RP+M +V EL+RI
Sbjct: 644 NRVLDIVDSRIKEGCTLEQVLAVAK----LARRCLSLKGKKRPNMREVSVELERI 694
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 287 bits (735), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 164/404 (40%), Positives = 241/404 (59%), Gaps = 15/404 (3%)
Query: 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDH--VLGTCQRKRRNRRSGLSLKISIG 287
C DC+ L G G +RC C +G+ V G C R R+ GL + +G
Sbjct: 197 TCSENADCAKVK--LDDGGLG-HRCTCREGFSGKAFTVPGGCHRLVYKRK-GLHKLVVLG 252
Query: 288 VISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKS--SNIAGKPARIFH-LKELKKA 344
+ L + + +I + + + ER + +AG + F+ KE++KA
Sbjct: 253 --TAGILVGVLVIVVLIATYFFRNKQSASSERASIANRLLCELAGNSSVPFYTYKEIEKA 310
Query: 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
T+ FS + +LG+G +G VY GE + + VA+K K + S QV+NE+ +LS V+H NL
Sbjct: 311 TDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKLLSSVSHPNL 370
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
VRLLGCC +P L+YE++ NGTL+ HL + L+W RL IA QTA A+A+LHS+
Sbjct: 371 VRLLGCCFADGEPFLVYEFMPNGTLYQHLQHERGQPPLSWQLRLAIACQTANAIAHLHSS 430
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG---LSHVSTCAQGTLGYLDPEYY 521
PIYHRD+KS+NILLD +FNSK++DFGLSRL SH+ST QGT GYLDP+Y+
Sbjct: 431 VNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTAPQGTPGYLDPQYH 490
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
+++QL+DKSDVYS+GVVL+E+++ K IDF+R +VNLA R G +++++DP L
Sbjct: 491 QDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIGRGRVVDIIDPCL 550
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
E + + S+ +ELA CL ++ RP+M ++ +L RI
Sbjct: 551 N-KEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRI 593
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 646 | ||||||
| 359481950 | 639 | PREDICTED: wall-associated receptor kina | 0.948 | 0.959 | 0.762 | 0.0 | |
| 255556762 | 669 | serine-threonine protein kinase, plant-t | 0.982 | 0.949 | 0.737 | 0.0 | |
| 147828025 | 1303 | hypothetical protein VITISV_022322 [Viti | 0.945 | 0.468 | 0.754 | 0.0 | |
| 297740021 | 605 | unnamed protein product [Vitis vinifera] | 0.896 | 0.957 | 0.712 | 0.0 | |
| 356570800 | 633 | PREDICTED: wall-associated receptor kina | 0.964 | 0.984 | 0.688 | 0.0 | |
| 449501079 | 635 | PREDICTED: wall-associated receptor kina | 0.944 | 0.960 | 0.700 | 0.0 | |
| 449440453 | 641 | PREDICTED: wall-associated receptor kina | 0.927 | 0.934 | 0.709 | 0.0 | |
| 356503766 | 627 | PREDICTED: wall-associated receptor kina | 0.956 | 0.985 | 0.684 | 0.0 | |
| 125551810 | 654 | hypothetical protein OsI_19447 [Oryza sa | 0.941 | 0.929 | 0.501 | 1e-173 | |
| 326528875 | 652 | predicted protein [Hordeum vulgare subsp | 0.910 | 0.901 | 0.513 | 1e-173 |
| >gi|359481950|ref|XP_002264481.2| PREDICTED: wall-associated receptor kinase-like 20-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 990 bits (2560), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/615 (76%), Positives = 536/615 (87%), Gaps = 2/615 (0%)
Query: 26 HYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMA 85
H+ SQK CP+CG IQVPYPLSTNP CGDP+Y LRCD S KLYFD LNGSSYLVLR MA
Sbjct: 24 HHSSSQKDCPNCGSIQVPYPLSTNPNCGDPDYSLRCDGDSQKLYFDGLNGSSYLVLRIMA 83
Query: 86 SSQRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNC 145
SSQR+V+QP+ W+ +CVT DM SEGLWLNQ+ PF +TSSNTIFLFNCSPRLL+SPLNC
Sbjct: 84 SSQRMVVQPSPWLPGTCVTQDMPVSEGLWLNQTRPFKITSSNTIFLFNCSPRLLVSPLNC 143
Query: 146 SSSSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILH 205
+ SSLCH++LES HVD+KRALQCAS L+PCCTF+AGGMPSAYKIRLHSSGC+AFRSIL
Sbjct: 144 TPSSLCHHYLESSGHVDRKRALQCASGLDPCCTFVAGGMPSAYKIRLHSSGCRAFRSILG 203
Query: 206 LDPNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHV 265
LDP KP +QWEEGLEIQWAP PEPVCKTQLDC+ SKC AG G+ RCLC +GYYWD
Sbjct: 204 LDPEKPPSQWEEGLEIQWAPAPEPVCKTQLDCTRDSKCSPAGGKGLLRCLCNRGYYWDLA 263
Query: 266 LGTCQRKRRNRRSGLSLKISIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKS 325
GTC +K +N + +SLK+SIGV+S SLA+A+AA+ + S K + Q KL K RE+MLKS
Sbjct: 264 RGTCLKKEKNSKLAISLKVSIGVVSFFSLAVAIAAVTVRRSGKFSNQEKLVKAREEMLKS 323
Query: 326 SNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS 385
S + GK AR+F LKE+KKATNGFSK+R+LGSGGFGEVYKGEL DGT+VAVKSAKVGN+KS
Sbjct: 324 S-MGGKSARMFSLKEVKKATNGFSKDRVLGSGGFGEVYKGELHDGTIVAVKSAKVGNLKS 382
Query: 386 TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWS 445
TQQVLNEVGILSQVNHKNLV+LLGCCVEAEQPL+IY YI NGTLH+HLHGK S+F L W
Sbjct: 383 TQQVLNEVGILSQVNHKNLVKLLGCCVEAEQPLMIYNYIPNGTLHEHLHGKRSTF-LKWD 441
Query: 446 TRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505
TRLRIALQTAEALAYLHSAA+TPIYHRDVKSTNILLD+DFN+KVADFGLSRLA+PGLSHV
Sbjct: 442 TRLRIALQTAEALAYLHSAAHTPIYHRDVKSTNILLDEDFNAKVADFGLSRLAEPGLSHV 501
Query: 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565
STCAQGTLGYLDPEYYRNYQLTDKSDVYSYG+V+LELLTSQKAIDFSR+PDD+NLAIYVS
Sbjct: 502 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGIVMLELLTSQKAIDFSREPDDINLAIYVS 561
Query: 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
QRAS+GA+M VVD RL GH SV ++ S++LFSELA+ACLREKK ERPSM VV ELQRI
Sbjct: 562 QRASDGAVMGVVDQRLLGHNPSVEVITSIRLFSELALACLREKKGERPSMKAVVQELQRI 621
Query: 626 IEIVNQEKVSNDVNV 640
I+ V++E+V ++V+
Sbjct: 622 IKFVDKEEVFSEVSA 636
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556762|ref|XP_002519414.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223541277|gb|EEF42828.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/644 (73%), Positives = 543/644 (84%), Gaps = 9/644 (1%)
Query: 2 ITTTNPNNKPELFLYINISFLLILHYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRC 61
+ T+ KP YI L H+ SQK CP+CG ++VPYPLSTNP CGDPNY LRC
Sbjct: 31 MITSKSTAKPPFLSYI-FFLLFFSHHSSSQKTCPNCGFMEVPYPLSTNPSCGDPNYHLRC 89
Query: 62 DLHSHKLYFDALNGSSYLVLRTMASSQRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPF 121
D HS KLYFDA+NGSSYLVLR MAS R+V++P+ W++ +CVT DM+ S GLWLNQ+LPF
Sbjct: 90 DSHSQKLYFDAMNGSSYLVLRIMASFHRMVVKPSPWVSSTCVTQDMLVSGGLWLNQTLPF 149
Query: 122 NVTSSNTIFLFNCSPRLLISPLNCSSSSLCHNFLESPEHVDKKRALQCASELEPCCTFIA 181
NVTSSNT+FLFNCSPRLL+SPLNC+ SSLCH++LES VDK R+LQCAS L+PCCTFIA
Sbjct: 150 NVTSSNTVFLFNCSPRLLVSPLNCTPSSLCHSYLESSGLVDKNRSLQCASSLKPCCTFIA 209
Query: 182 GGMPSAYKIRLHSSGCKAFRSILHLDPNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGAS 241
GGMPSAYKIRLHSSGCKAFRSIL+LDP +PA+QWEEGLEIQW+ PPEP+C+TQLDCSGAS
Sbjct: 210 GGMPSAYKIRLHSSGCKAFRSILNLDPKRPASQWEEGLEIQWSSPPEPICRTQLDCSGAS 269
Query: 242 KCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVISVLSLAIAVAAI 301
KCL GRNG +RCLC +GY WDH G+C+RK+ NR++ LSLK+SI VIS +SLA A I
Sbjct: 270 KCLPTGRNGPFRCLCNRGYLWDHTRGSCKRKKCNRKASLSLKVSIAVISFVSLA---AVI 326
Query: 302 KIICSRKL---AKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGG 358
II +RK A QAKLAK RED+LKS N GK AR+F LKE+KKATN FSK+R+LGSGG
Sbjct: 327 GIIIARKSSAHANQAKLAKAREDLLKSRN-GGKAARMFQLKEVKKATNSFSKDRVLGSGG 385
Query: 359 FGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418
FGEVYKGELQDGTVVAVKSAKVGN+KSTQQVLNEVGILSQVNHK LVRLLGCCVE EQPL
Sbjct: 386 FGEVYKGELQDGTVVAVKSAKVGNVKSTQQVLNEVGILSQVNHKYLVRLLGCCVEGEQPL 445
Query: 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTN 478
+IYEYI+NGTL DHLHGK +F L W TRLRIALQTAEALAYLHS A+TPIYHRDVK+TN
Sbjct: 446 MIYEYISNGTLQDHLHGKACTF-LDWRTRLRIALQTAEALAYLHSEAHTPIYHRDVKTTN 504
Query: 479 ILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVV 538
ILLD+DFN KVADFGLSRLA PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVV
Sbjct: 505 ILLDEDFNVKVADFGLSRLACPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVV 564
Query: 539 LLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFS 598
LLELLTSQKAIDFSR+ DDVNL IYVSQ+A N AIMEV+D RL S NIL S+KL S
Sbjct: 565 LLELLTSQKAIDFSRNQDDVNLVIYVSQQAKNDAIMEVIDQRLLIKHPSGNILRSMKLLS 624
Query: 599 ELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSNDVNVET 642
ELA ACL+E+K +RPSM +VV +L+ I++I++QEKV +VN ++
Sbjct: 625 ELAFACLQERKVDRPSMKNVVQQLECIVQIIDQEKVLGEVNTDS 668
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147828025|emb|CAN72920.1| hypothetical protein VITISV_022322 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2510), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/615 (75%), Positives = 529/615 (86%), Gaps = 4/615 (0%)
Query: 31 QKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRI 90
Q+I P+ I+VPYPLSTNP CGDP+Y LRCD S KLYFD LNGSSYLVLR MASSQR+
Sbjct: 631 QEIPPN-ATIEVPYPLSTNPNCGDPDYSLRCDGDSQKLYFDGLNGSSYLVLRIMASSQRM 689
Query: 91 VMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNCSSSSL 150
V+QP+ W+ +CVT DM SEGLWLNQ+ PF +TSSNTIFLFNCSPRLL+SPLNC+ SSL
Sbjct: 690 VVQPSPWLPGTCVTQDMPVSEGLWLNQTRPFKITSSNTIFLFNCSPRLLVSPLNCTPSSL 749
Query: 151 CHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILHLDPNK 210
CH++LES HVD+KRALQCAS L+PCCTF+AGGMPSAYKIRLHSSGC+AFRSIL LDP K
Sbjct: 750 CHHYLESSGHVDRKRALQCASGLDPCCTFVAGGMPSAYKIRLHSSGCRAFRSILGLDPEK 809
Query: 211 PANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQ 270
P +QWEEGLEIQWAP PEPVCKTQLDC+ SKC AG G+ RCLC +GYYWD GTC
Sbjct: 810 PPSQWEEGLEIQWAPAPEPVCKTQLDCTRDSKCSPAGGKGLLRCLCNRGYYWDLARGTCL 869
Query: 271 RKRRNRRSGLSLKISIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAG 330
+K +N + +SLK+SIGV+S SLA+A+AA+ + S K + Q KL K RE+MLKSS + G
Sbjct: 870 KKEKNSKLAISLKVSIGVVSFFSLAVAIAAVTVRRSGKFSNQEKLVKAREEMLKSS-MGG 928
Query: 331 KPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVL 390
K AR+F LKE+KKATNGFSK+R+LGSGGFGEVYKGEL DGT+VAVKSAKVGN+KSTQQVL
Sbjct: 929 KSARMFSLKEVKKATNGFSKDRVLGSGGFGEVYKGELHDGTIVAVKSAKVGNLKSTQQVL 988
Query: 391 NEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI 450
NEVGILSQVNHKNLV+LLGCCVEAEQPL+IY YI NGTLH+HLHGK S+F L W TRLRI
Sbjct: 989 NEVGILSQVNHKNLVKLLGCCVEAEQPLMIYNYIPNGTLHEHLHGKRSTF-LKWDTRLRI 1047
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
ALQTAEALAYLHSAA+TPIYHRDVKSTNILLD+DFN+KVADFGLSRLA+PGLSHVSTCAQ
Sbjct: 1048 ALQTAEALAYLHSAAHTPIYHRDVKSTNILLDEDFNAKVADFGLSRLAEPGLSHVSTCAQ 1107
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
GTLGYLDPEYYRNYQLTDKSDVYSYG+V+LELLTSQKAIDFSR+PDD+NLAIYVSQRAS+
Sbjct: 1108 GTLGYLDPEYYRNYQLTDKSDVYSYGIVMLELLTSQKAIDFSREPDDINLAIYVSQRASD 1167
Query: 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630
GA+M VVD RL G SV ++ S++LFSELA+ACLREKK ERPSM VV ELQRII+ V+
Sbjct: 1168 GAVMGVVDQRLLGXNPSVEVITSIRLFSELALACLREKKGERPSMKAVVQELQRIIKXVD 1227
Query: 631 QEKV-SNDVNVETAP 644
+E+V S D P
Sbjct: 1228 KEEVFSEDTEAXVIP 1242
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740021|emb|CBI30203.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2355), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/615 (71%), Positives = 503/615 (81%), Gaps = 36/615 (5%)
Query: 26 HYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMA 85
H+ SQK CP+CG IQVPYPLSTNP CGDP+Y LRCD S KLYFD LNGSSYLVLR MA
Sbjct: 24 HHSSSQKDCPNCGSIQVPYPLSTNPNCGDPDYSLRCDGDSQKLYFDGLNGSSYLVLRIMA 83
Query: 86 SSQRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNC 145
SSQR+V+QP+ W+ +CVT DM SEGLWLNQ+ PF +TSSNTIFLFNCSPRLL+SPLNC
Sbjct: 84 SSQRMVVQPSPWLPGTCVTQDMPVSEGLWLNQTRPFKITSSNTIFLFNCSPRLLVSPLNC 143
Query: 146 SSSSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILH 205
+ SSLCH++LES HVD+KRALQCAS L+PCCTF+AGGMPSAYKIRLHSSGC+AFRSIL
Sbjct: 144 TPSSLCHHYLESSGHVDRKRALQCASGLDPCCTFVAGGMPSAYKIRLHSSGCRAFRSILG 203
Query: 206 LDPNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHV 265
LDP KP +QWEEGLEIQWAP PEPVCKTQLDC+ SKC AG G+ RCLC +GYYWD
Sbjct: 204 LDPEKPPSQWEEGLEIQWAPAPEPVCKTQLDCTRDSKCSPAGGKGLLRCLCNRGYYWDLA 263
Query: 266 LGTCQRKRRNRRSGLSLKISIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKS 325
GTC +K +N + +SLK+SIGV+S SLA+A+AA+ + S K + Q KL K RE+MLKS
Sbjct: 264 RGTCLKKEKNSKLAISLKVSIGVVSFFSLAVAIAAVTVRRSGKFSNQEKLVKAREEMLKS 323
Query: 326 SNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS 385
S + GK AR+F LKE+KKATNGFSK+R+LGSGGFGEVYK
Sbjct: 324 S-MGGKSARMFSLKEVKKATNGFSKDRVLGSGGFGEVYK--------------------- 361
Query: 386 TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWS 445
VNHKNLV+LLGCCVEAEQPL+IY YI NGTLH+HLHGK S+F L W
Sbjct: 362 -------------VNHKNLVKLLGCCVEAEQPLMIYNYIPNGTLHEHLHGKRSTF-LKWD 407
Query: 446 TRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505
TRLRIALQTAEALAYLHSAA+TPIYHRDVKSTNILLD+DFN+KVADFGLSRLA+PGLSHV
Sbjct: 408 TRLRIALQTAEALAYLHSAAHTPIYHRDVKSTNILLDEDFNAKVADFGLSRLAEPGLSHV 467
Query: 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565
STCAQGTLGYLDPEYYRNYQLTDKSDVYSYG+V+LELLTSQKAIDFSR+PDD+NLAIYVS
Sbjct: 468 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGIVMLELLTSQKAIDFSREPDDINLAIYVS 527
Query: 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
QRAS+GA+M VVD RL GH SV ++ S++LFSELA+ACLREKK ERPSM VV ELQRI
Sbjct: 528 QRASDGAVMGVVDQRLLGHNPSVEVITSIRLFSELALACLREKKGERPSMKAVVQELQRI 587
Query: 626 IEIVNQEKVSNDVNV 640
I+ V++E+V ++V+
Sbjct: 588 IKFVDKEEVFSEVSA 602
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570800|ref|XP_003553572.1| PREDICTED: wall-associated receptor kinase-like 20-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/630 (68%), Positives = 511/630 (81%), Gaps = 7/630 (1%)
Query: 8 NNKPEL-FLYINISFLLILHYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSH 66
N +P F Y + L++ H+ SQK C +CG +QVPYPLST+ CGDP+Y LRCD HS
Sbjct: 6 NMRPNFHFCYAFLLILVLGHHTSSQKTCTNCGSMQVPYPLSTDSTCGDPHYKLRCDPHSQ 65
Query: 67 KLYFDALNGSSYLVLRTMASSQRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSS 126
+L+FD LNGSSYLVLR M+S+QR+V++P+ W+ SCVT DM S G+WLNQSLPFN+TSS
Sbjct: 66 RLFFDTLNGSSYLVLRIMSSNQRMVVEPSPWLPGSCVTQDMPRSNGIWLNQSLPFNITSS 125
Query: 127 NTIFLFNCSPRLLISPLNCSSSSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPS 186
NT+FLFNCSPRLL+SPLNC+SSS+CH +LE+ HVD KRAL+CA++L PCCTF+AGG+PS
Sbjct: 126 NTVFLFNCSPRLLVSPLNCTSSSICHRYLENSGHVDTKRALECANDLHPCCTFLAGGIPS 185
Query: 187 AYKIRLHSSGCKAFRSILHLDPNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCLSA 246
AY+IRLH SGCKAFRSI+HL+ +KP NQWEEGLEIQWAPPPEPVCKTQ DCS SKC
Sbjct: 186 AYRIRLHDSGCKAFRSIIHLNQDKPPNQWEEGLEIQWAPPPEPVCKTQRDCSEDSKCSPT 245
Query: 247 GRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVI-SVLSLAIAVAAIKIIC 305
RNG++RCLC G+ W+ TC R R + SL +SIGV+ + SLA+ + I C
Sbjct: 246 SRNGLFRCLCNGGHIWNPFEATCVRYERKSKWKTSLVVSIGVVVTFFSLAVVLTIITKSC 305
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
K+ + AKERED LKSS + KP R+F LKE+K+ATNGFS ER LGSGGFGEV+KG
Sbjct: 306 KLSTYKENQ-AKEREDKLKSSAVE-KPCRMFQLKEVKRATNGFSHERFLGSGGFGEVFKG 363
Query: 366 ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425
ELQDGT+VAVK A+VGN+KSTQQVLNEV ILSQVNHKNLVRLLGCCVE+E PL+IYEYI+
Sbjct: 364 ELQDGTLVAVKKARVGNLKSTQQVLNEVAILSQVNHKNLVRLLGCCVESELPLMIYEYIS 423
Query: 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485
NGTL+DHLHG+Y S L W TRL++A QTAEALAYLHSAA+TPIYHRD+KSTNILLDD+F
Sbjct: 424 NGTLYDHLHGRYCSNFLDWKTRLKVAFQTAEALAYLHSAAHTPIYHRDIKSTNILLDDEF 483
Query: 486 NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS 545
N+KV+DFGLSRLA PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS
Sbjct: 484 NAKVSDFGLSRLASPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS 543
Query: 546 QKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASV---NILMSLKLFSELAV 602
QKAIDF+RD DDVNLAI+V+Q ASNG IMEVVD RL ++ + S+KLF ELA+
Sbjct: 544 QKAIDFNRDQDDVNLAIHVNQHASNGTIMEVVDQRLLISVETLLGDKMFTSIKLFLELAL 603
Query: 603 ACLREKKSERPSMTDVVHELQRIIEIVNQE 632
CLREKK ERP+M D+V L II IV QE
Sbjct: 604 ECLREKKGERPNMRDIVQRLLCIIRIVEQE 633
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449501079|ref|XP_004161272.1| PREDICTED: wall-associated receptor kinase-like 20-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/614 (70%), Positives = 503/614 (81%), Gaps = 4/614 (0%)
Query: 28 CYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASS 87
CYSQK CP CG +VPYPLSTNP CGD +Y LRCD HS KLYFDALNGSSY +L+ ASS
Sbjct: 23 CYSQKTCPRCGSFEVPYPLSTNPNCGDLDYALRCDSHSKKLYFDALNGSSYPILKINASS 82
Query: 88 QRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNCSS 147
QR+V+ P+ W+ SCVT DM+ SEGLWLNQSLPFN+TSSNTIFL NCSPRLL+SPLNC+
Sbjct: 83 QRLVILPSPWVAGSCVTQDMLVSEGLWLNQSLPFNITSSNTIFLLNCSPRLLVSPLNCTP 142
Query: 148 SSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILHLD 207
SSLCH++L + VD +RA QCAS L+PCCTFI GGMPSAYKIRLH+SGC+AFRSILHLD
Sbjct: 143 SSLCHHYLANSGRVDGERAFQCASVLDPCCTFIPGGMPSAYKIRLHNSGCRAFRSILHLD 202
Query: 208 PNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCL-SAGRNGVYRCLCIKGYYWDHVL 266
KP NQWEEGLEIQWA PPEP+C+TQ DC+G S CL + G N RCLC YYWDH L
Sbjct: 203 VEKPPNQWEEGLEIQWATPPEPICRTQSDCTGESDCLPTGGSNNRSRCLCRMSYYWDHNL 262
Query: 267 GTCQRKRRNRRSGLSLKISIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSS 326
GTC R + LS+K+S+ ++S LA +A I + S+ +KQ KL KERE+ L S
Sbjct: 263 GTCLRTNKKSLVRLSIKLSVCLVSFFVLAAVIAFITVRKSKTFSKQEKLYKEREEKLNLS 322
Query: 327 NIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST 386
+ G+PAR+FHLKE+KKATN FSK+R+LGSGGFGEVYKGELQDGTVVAVKSAKVGN+KST
Sbjct: 323 H-GGRPARMFHLKEMKKATNEFSKDRVLGSGGFGEVYKGELQDGTVVAVKSAKVGNLKST 381
Query: 387 QQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWST 446
+Q+LNEVGILSQVNH+NLV+L+GCCVE EQPL++YEYI+NGTLHDHLHGK +F L W
Sbjct: 382 EQILNEVGILSQVNHRNLVKLIGCCVETEQPLMVYEYISNGTLHDHLHGKVPTF-LDWRK 440
Query: 447 RLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506
RL+IA QTAEALAYLHSAAY PIYHRDVKSTNILLDD+FN+KV+DFGLSRLA PG+SHVS
Sbjct: 441 RLKIASQTAEALAYLHSAAYPPIYHRDVKSTNILLDDNFNAKVSDFGLSRLALPGISHVS 500
Query: 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566
TCAQGTLGYLDPEYYRNYQLTDKSDVYS+GVVLLELLTS+KAIDF+RD D VNLAIYV Q
Sbjct: 501 TCAQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSKKAIDFTRDEDGVNLAIYVIQ 560
Query: 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
+ NGA ++ +D +L S IL+SLK F ELA++CLREKK ERP M DV+ EL+ I
Sbjct: 561 QVQNGACIDAIDKQLISDNPSSKILISLKHFMELALSCLREKKVERPCMKDVLQELEYIT 620
Query: 627 EIV-NQEKVSNDVN 639
+I+ N E ++ + N
Sbjct: 621 QILDNPETIAEEGN 634
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440453|ref|XP_004137999.1| PREDICTED: wall-associated receptor kinase-like 20-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2311), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/602 (70%), Positives = 496/602 (82%), Gaps = 3/602 (0%)
Query: 28 CYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASS 87
CYSQK CP CG +VPYPLSTNP CGD +Y LRCD HS KLYFDALNGSSY +L+ ASS
Sbjct: 23 CYSQKTCPRCGSFEVPYPLSTNPNCGDLDYALRCDSHSKKLYFDALNGSSYPILKINASS 82
Query: 88 QRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNCSS 147
QR+V+ P+ W+ SCVT DM+ SEGLWLNQSLPFN+TSSNTIFL NCSPRLL+SPLNC+
Sbjct: 83 QRLVILPSPWVAGSCVTQDMLVSEGLWLNQSLPFNITSSNTIFLLNCSPRLLVSPLNCTP 142
Query: 148 SSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILHLD 207
SSLCH++L + VD +RA QCAS L+PCCTFI GGMPSAYKIRLH+SGC+AFRSILHLD
Sbjct: 143 SSLCHHYLANSGRVDGERAFQCASVLDPCCTFIPGGMPSAYKIRLHNSGCRAFRSILHLD 202
Query: 208 PNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCL-SAGRNGVYRCLCIKGYYWDHVL 266
KP NQWEEGLEIQWA PPEP+C+TQ DC+G S CL + G N RCLC YYWDH L
Sbjct: 203 VEKPPNQWEEGLEIQWATPPEPICRTQSDCTGESDCLPTGGSNNRSRCLCRMSYYWDHNL 262
Query: 267 GTCQRKRRNRRSGLSLKISIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSS 326
GTC R + LS+K+S+ ++S LA +A I + S+ +KQ KL KERE+ L S
Sbjct: 263 GTCLRTNKKSLVRLSIKLSVCLVSFFVLAAVIAFITVRKSKTFSKQEKLYKEREEKLNLS 322
Query: 327 NIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST 386
+ G+PAR+FHLKE+KKATN FSK+R+LGSGGFGEVYKGELQDGTVVAVKSAKVGN+KST
Sbjct: 323 H-GGRPARMFHLKEMKKATNEFSKDRVLGSGGFGEVYKGELQDGTVVAVKSAKVGNLKST 381
Query: 387 QQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWST 446
+Q+LNEVGILSQVNH+NLV+L+GCCVE EQPL++YEYI+NGTLHDHLHGK +F L W
Sbjct: 382 EQILNEVGILSQVNHRNLVKLIGCCVETEQPLMVYEYISNGTLHDHLHGKVPTF-LDWRK 440
Query: 447 RLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506
RL+IA QTAEALAYLHSAAY PIYHRDVKSTNILLDD+FN+KV+DFGLSRLA PG+SHVS
Sbjct: 441 RLKIASQTAEALAYLHSAAYPPIYHRDVKSTNILLDDNFNAKVSDFGLSRLALPGISHVS 500
Query: 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566
TCAQGTLGYLDPEYYRNYQLTDKSDVYS+GVVLLELLTS+KAIDF+RD D VNLAIYV Q
Sbjct: 501 TCAQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSKKAIDFTRDEDGVNLAIYVIQ 560
Query: 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
+ NGA ++ +D +L S IL+SLK F ELA++CLREKK ERP M DV+ EL+ I
Sbjct: 561 QVQNGACIDAIDKQLISDNPSSKILISLKHFMELALSCLREKKVERPCMKDVLQELEYIT 620
Query: 627 EI 628
+I
Sbjct: 621 QI 622
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503766|ref|XP_003520675.1| PREDICTED: wall-associated receptor kinase-like 20-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/622 (68%), Positives = 498/622 (80%), Gaps = 4/622 (0%)
Query: 14 FLYINISFLLILHYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDAL 73
F Y + L++ + S K CP+CG IQVPYPLST+ CGD NY LRCD HS +L FD L
Sbjct: 7 FWYAFLLILVLGRHISSLKTCPNCGTIQVPYPLSTDSTCGDQNYKLRCDPHSQRLLFDIL 66
Query: 74 NGSSYLVLRTMASSQRIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFN 133
NGSSYLVLR M+S+QR+V+QP+ W+ SCVT DM S G+WLNQSLPFN+TSSNT+FLFN
Sbjct: 67 NGSSYLVLRIMSSNQRMVVQPSPWLPGSCVTQDMPRSNGIWLNQSLPFNITSSNTVFLFN 126
Query: 134 CSPRLLISPLNCSSSSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLH 193
CSPRLL+SPLNC+SSS+CH +LE+ HVD K +L+CAS L PCCTF+AGG+PSAY+IRLH
Sbjct: 127 CSPRLLVSPLNCTSSSICHRYLENSGHVDTKLSLECASGLHPCCTFLAGGIPSAYRIRLH 186
Query: 194 SSGCKAFRSILHLDPNKPANQWEEGLEIQWAPPPEPVCKTQLDCSGASKCLSAGRNGVYR 253
SGCKAFRSI+HL+ +KP NQWEE LEIQW+PPPEPVC Q DCS SKC RNG++R
Sbjct: 187 DSGCKAFRSIIHLNQDKPPNQWEEVLEIQWSPPPEPVCNNQRDCSEDSKCSPTNRNGLFR 246
Query: 254 CLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVI-SVLSLAIAVAAIKIICSRKLAKQ 312
CLC G+ W+ TC R R + SL +SIGV+ + SLA+ + IK C K+
Sbjct: 247 CLCNGGHVWNPFEATCVRYERKSKWKTSLVVSIGVVVTFFSLAVVLTIIKKSCKLSNYKE 306
Query: 313 AKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTV 372
+ ERE+ LKSS + KP R+F LKE+KKATNGFS ER LGSGGFGEV+KGELQDGT+
Sbjct: 307 NQAKDEREEKLKSSAME-KPCRMFQLKEVKKATNGFSHERFLGSGGFGEVFKGELQDGTL 365
Query: 373 VAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDH 432
VAVK A+VGN+KSTQQVLNE ILSQVNHKNLVRLLGCCVE+E PL+IYEYI+NGTL+DH
Sbjct: 366 VAVKKARVGNLKSTQQVLNEAAILSQVNHKNLVRLLGCCVESELPLMIYEYISNGTLYDH 425
Query: 433 LHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492
LHG+Y S L W TRL++A QTAEALAYLHSAA+TPIYHRDVKSTNILLDD+FN+KV+DF
Sbjct: 426 LHGRYCSNFLDWKTRLKVAFQTAEALAYLHSAAHTPIYHRDVKSTNILLDDEFNAKVSDF 485
Query: 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552
GLSRLA PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDF+
Sbjct: 486 GLSRLASPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFN 545
Query: 553 RDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN--ILMSLKLFSELAVACLREKKS 610
RD DDVNLAI+V+Q ASNG IMEV+D RL ++ + S+KLF ELA+ CLREKK
Sbjct: 546 RDQDDVNLAIHVNQHASNGTIMEVMDQRLLISLETLGDKMFTSIKLFLELALECLREKKG 605
Query: 611 ERPSMTDVVHELQRIIEIVNQE 632
ERP+M D+V L II IV QE
Sbjct: 606 ERPNMRDIVQRLLCIIRIVEQE 627
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125551810|gb|EAY97519.1| hypothetical protein OsI_19447 [Oryza sativa Indica Group] gi|222631101|gb|EEE63233.1| hypothetical protein OsJ_18043 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1587), Expect = e-173, Method: Compositional matrix adjust.
Identities = 319/636 (50%), Positives = 428/636 (67%), Gaps = 28/636 (4%)
Query: 13 LFLYINISFLLILHYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSH-----K 67
FL + ++ L+L ++ ++CP CG +VPYPLST CGDP Y +RC +
Sbjct: 14 FFLEVAVAMALLLPGGHA-RVCPPCGSTEVPYPLSTADGCGDPEYKVRCAAAAAGGTAPT 72
Query: 68 LYFDALNGSSYLVLRTMASSQRIVMQPASWIN-DSCVTHDMVTSEGLWLNQSLPFNVTSS 126
L FDALNG+SY + +SQR+V+ PA +++ +CV+ S G+ L+ S PFNV+SS
Sbjct: 73 LLFDALNGTSYPITSISPASQRLVVSPAPFVSPGACVSVGAAASRGVQLDPSRPFNVSSS 132
Query: 127 NTIFLFNCSPRLLISPLNCSSSSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPS 186
NT+ L NC+ LL SPLNCSS+SLCH + + A CA L CCTF+AGG +
Sbjct: 133 NTVMLLNCTELLLRSPLNCSSNSLCHAYAGA----AGSTASACA-PLPLCCTFVAGGSST 187
Query: 187 AYKIRLHSSGCKAFRSILHLDPNKPANQWEE--GLEIQWAPPPEPVCKTQLDC--SGASK 242
+Y+IRL C A+RS + LDP++P W GLE+QWA P EP+C+TQ DC A+
Sbjct: 188 SYRIRLGPQSCSAYRSFVGLDPSQPPATWGSRLGLELQWATPREPLCRTQADCEDGAAAT 247
Query: 243 CL-----SAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVISVLSLAIA 297
C + G V RCLC+ G W+ + G CQ++ + G++ L A+
Sbjct: 248 CADDPSATGGAGTVRRCLCVSGLVWNPIAGACQQQNLTDSGSNHAPLIAGIVCGLGGALL 307
Query: 298 VAAIKIICSRK-----LAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKER 352
VA + R+ LAK+ KLAKERE++L ++N +G+ A+ F +EL++AT FS++
Sbjct: 308 VATAGLFAYRRQQRIRLAKE-KLAKEREEILNANNSSGRTAKNFSGRELRRATANFSRDN 366
Query: 353 ILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+LG+GG+GEVY+G L DGTVVAVK AK+GN KST+QVLNEV +LSQVNH++LVRLLGCCV
Sbjct: 367 LLGAGGYGEVYRGVLADGTVVAVKCAKLGNTKSTEQVLNEVRVLSQVNHRSLVRLLGCCV 426
Query: 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHR 472
+ EQPL++YE+I NGTL DHL+G S L W RL IA TA+ +AYLH +A PIYHR
Sbjct: 427 DLEQPLMVYEFIPNGTLADHLYGPLSHPPLPWRRRLAIAHHTAQGIAYLHFSAVPPIYHR 486
Query: 473 DVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDV 532
D+KS+NILLD+ + KV+DFGLSRLA+ GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDV
Sbjct: 487 DIKSSNILLDERMDGKVSDFGLSRLAEQGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDV 546
Query: 533 YSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILM 592
YS+GVVLLELLT ++AIDF R DDVNLA++V + A +M+VVDP L+ + +
Sbjct: 547 YSFGVVLLELLTCKRAIDFGRGADDVNLAVHVQRAAEEERLMDVVDPVLKDNATQLQC-D 605
Query: 593 SLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628
++K LA+ CL E++ RPSM +V E++ I+ I
Sbjct: 606 TIKALGFLALGCLEERRQNRPSMKEVAEEIEYIMNI 641
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326528875|dbj|BAJ97459.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 315/614 (51%), Positives = 412/614 (67%), Gaps = 26/614 (4%)
Query: 32 KICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRIV 91
++CP CG VPYPLST CGDP Y +RC + L+FDALNG+SY + + QR+V
Sbjct: 34 RVCPPCGSTAVPYPLSTAAGCGDPAYKVRCAAGTSALFFDALNGTSYPITSVSPAEQRLV 93
Query: 92 MQPASWI-NDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNCSSSSL 150
+ PA + ND+CV+ G+ L+ SLPFNV+SSNTI L NC+ LL SPLNCSSSSL
Sbjct: 94 VSPAPLVSNDTCVSVGAAAGRGVQLDPSLPFNVSSSNTIMLLNCTSALLRSPLNCSSSSL 153
Query: 151 CHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILHLDPNK 210
CH + ++ A CA L CCTF+AGG ++++IR C A+ S + LDP +
Sbjct: 154 CHAYADA-------TASPCA-PLPLCCTFVAGGSSTSHRIRASPELCSAYTSFVGLDPAQ 205
Query: 211 PANQWEE--GLEIQWAPPPEPVCKTQLDCSGASKCLSAG----RNGVYRCLCIKGYYWDH 264
P W GLE+QWA P EP C+TQ DC ++ AG V RCLC+ G WD
Sbjct: 206 PPATWGGRLGLELQWATPREPACQTQADCEDSANATCAGDPVAAGAVRRCLCVPGLAWDP 265
Query: 265 VLGTCQRKRRN-RRSGL-----SLKISIGVISVLSLAIAVAAIKIIC----SRKLAKQAK 314
V G CQ+ + RSG I G++ L A+ + A + R + +
Sbjct: 266 VAGACQQIPSDCERSGDCEGSNRAPIIAGIVCGLGGALLLIAAGLFLYRRQRRIRLARER 325
Query: 315 LAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVA 374
L KERED+L ++N +G+ A+ F +ELK+AT FS++ +LG GG+GEVYKG L DGT+VA
Sbjct: 326 LIKEREDILNANNSSGRTAKNFTARELKRATANFSRDNLLGVGGYGEVYKGALADGTLVA 385
Query: 375 VKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH 434
VK AK+GN KST Q+LNEV +LSQVNH++LVRLLGCCV+ +QPL++YE+I NGTL DHL+
Sbjct: 386 VKCAKLGNTKSTDQILNEVRVLSQVNHRSLVRLLGCCVDLQQPLMVYEFIPNGTLSDHLY 445
Query: 435 GKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494
G S L W RL IA QTAE ++YLH +A PIYHRD+KS+NILLD+ + KV+DFGL
Sbjct: 446 GAMSQPPLPWRRRLAIARQTAEGISYLHFSASPPIYHRDIKSSNILLDEQLDGKVSDFGL 505
Query: 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554
SRLA+PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYS+GVVLLELLT+++AIDF R
Sbjct: 506 SRLAEPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTAKRAIDFGRG 565
Query: 555 PDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS 614
DDVNLA++V + A +++VVDP ++ + L ++K LA+ CL +++ RPS
Sbjct: 566 EDDVNLAVHVQRAADEERLLDVVDPAMKNRATQLE-LDTMKALGFLALGCLEDRRHNRPS 624
Query: 615 MTDVVHELQRIIEI 628
M +V E++ II I
Sbjct: 625 MKEVADEIEYIINI 638
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 646 | ||||||
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.905 | 0.890 | 0.500 | 5.8e-153 | |
| TAIR|locus:2084425 | 639 | AT3G53840 [Arabidopsis thalian | 0.907 | 0.917 | 0.455 | 3.1e-131 | |
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.591 | 0.521 | 0.427 | 2.2e-86 | |
| TAIR|locus:2046728 | 708 | AT2G23450 [Arabidopsis thalian | 0.597 | 0.545 | 0.435 | 5.8e-84 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.586 | 0.511 | 0.415 | 2.5e-83 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.611 | 0.535 | 0.4 | 1.3e-82 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.586 | 0.478 | 0.405 | 4.5e-80 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.591 | 0.519 | 0.417 | 1.1e-78 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.600 | 0.529 | 0.406 | 9.5e-78 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.492 | 0.423 | 0.452 | 1.2e-77 |
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1492 (530.3 bits), Expect = 5.8e-153, P = 5.8e-153
Identities = 313/625 (50%), Positives = 418/625 (66%)
Query: 34 CPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRIVMQ 93
CP+CGP+ VPYPLST P CGD Y + C KLYF AL+GSSY++ + +QRIV++
Sbjct: 43 CPNCGPMVVPYPLSTGPTCGDQAYRINCV--GGKLYFGALHGSSYVITSINSVTQRIVLR 100
Query: 94 PASWIND-SCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLISPLNCSSSSLCH 152
P + SC++ D V+ +GL L+ LPF++TSSNTI L NCS +L +P++CS +SLC+
Sbjct: 101 PPGLASSVSCISAD-VSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCY 159
Query: 153 NFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCKAFRSILHLDPNK-- 210
+++ K A C S+ CCTF G +AY IR++ GC A++S + L+PNK
Sbjct: 160 SYI-------KNNASPC-SKAPLCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEV 211
Query: 211 --PANQWEE-GLEIQWAPPPEPVCKTQLDCS---GASKCLSAGRN-GVYRCLCIKGYYWD 263
P +W + GLE+QWA P EPVCKT +DC+ G SKCL + G+ RC C KG WD
Sbjct: 212 PPPGKKWPDTGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWD 271
Query: 264 HVLGTCQRKRRNRRSGLSLKI------SIGVISVLSLAIAVAAIKIICSRKLAKQ---AK 314
V C + R + K ++ V+ V +LAIAVA I S + K+
Sbjct: 272 PVNAICGKCRHGKHCKKKKKTVVFAGAAVAVVGV-TLAIAVAVIGTKHSHQKVKKDIHKN 330
Query: 315 LAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVA 374
+ KERE+ML S+N GK +RIF +E+ KATN FSK+ ++G+GGFGEV+K L+DGT+ A
Sbjct: 331 IVKEREEML-SANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITA 389
Query: 375 VKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH 434
+K AK+ N K T Q+LNEV IL QVNH++LVRLLGCCV+ E PLLIYE+I NGTL +HLH
Sbjct: 390 IKRAKLNNTKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLH 449
Query: 435 GKYSSF--NLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492
G LTW RL+IA QTAE LAYLHSAA PIYHRDVKS+NILLD+ N+KV+DF
Sbjct: 450 GSSDRTWKPLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDF 509
Query: 493 GLSRLAK-----PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
GLSRL SH+ T AQGTLGYLDPEYYRN+QLTDKSDVYS+GVVLLE++TS+K
Sbjct: 510 GLSRLVDLTETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKK 569
Query: 548 AIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLRE 607
AIDF+R+ +DVNL +Y+++ + E +DP L+ ++ + +++ LA ACL E
Sbjct: 570 AIDFTREEEDVNLVMYINKMMDQERLTECIDPLLKKTANKID-MQTIQQLGNLASACLNE 628
Query: 608 KKSERPSMTDVVHELQRIIEIVNQE 632
++ RPSM +V E++ II I++QE
Sbjct: 629 RRQNRPSMKEVADEIEYIINILSQE 653
|
|
| TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1287 (458.1 bits), Expect = 3.1e-131, P = 3.1e-131
Identities = 282/619 (45%), Positives = 383/619 (61%)
Query: 32 KICPSCGPIQVPYPLSTNPKCGDPNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRIV 91
K CP+CG +VPYPLST CGDP Y +RCD + L+FD LNGS+ + S QR V
Sbjct: 27 KRCPNCGSTRVPYPLSTGLDCGDPGYRIRCDNYG-SLWFDTLNGSTNPIKTIDPSGQRFV 85
Query: 92 MQPASWINDSCVTHDMVTSEGLWLNQSLPFNVTSSNTIFLFNCSPRLLIS----PLNCSS 147
++P + + CV+ D + G+ L+ +LPFNV+ SNT+ + NC+ L + NCS
Sbjct: 86 LRPPGFEQNKCVSVD-IKYHGIQLDLNLPFNVSCSNTVIIMNCTKDGLDAYSSQGFNCSD 144
Query: 148 SSLCHNFLESPEHVDKKRALQCASELEPCCTFIAGGMPSAYKI-RLHSSGCKAFRSILHL 206
+SLCH FL + +++ + C + CC + G + YK+ R C A++S ++L
Sbjct: 145 NSLCHKFLNA--NLEARG--NCRG-VTSCCWYKTGASVNTYKVYRARPDMCSAYQSFMNL 199
Query: 207 DPNKPANQW-EEGLEIQWAPPPEPVCKTQLDCSGA--SKCLSAGRN-GVYRCLCIKGYYW 262
D P ++W E +EI W P EPVCK+Q DC S C + N G RC C KG+ W
Sbjct: 200 DLTIPVSKWGEPAVEILWEAPREPVCKSQGDCRDLLNSVCSNDSTNLGQKRCFCKKGFQW 259
Query: 263 DHVLGTCQ------RKRRNRRSGLSLK--ISIGVISVLSLAIAVAAIKIICSRKLAKQAK 314
D V C+ RK R S L L ++ GV ++L I +R++A
Sbjct: 260 DSVNAVCEVNRCSKRKSCKRWSNLPLLGGLAGGVGAILIAGFITKTIVSKQNRRIAGNQS 319
Query: 315 LAKERE--DMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTV 372
A R+ L S N G RIF KE+ KAT+ F+K +LG GGFGEV+KG L DGT
Sbjct: 320 WASVRKLHRNLLSINSTGLD-RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTT 378
Query: 373 VAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDH 432
VAVK AK+GN KS Q++NEV IL QV+HKNLV+LLGCC+E E P+L+YE++ NGTL +H
Sbjct: 379 VAVKRAKLGNEKSIYQIVNEVQILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEH 438
Query: 433 LHGKYSSF-----NLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487
++G +L RL IA QTA+ L YLHS++ PIYHRDVKS+NILLD++ +
Sbjct: 439 IYGGGGGGGGLYDHLPLRRRLMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDV 498
Query: 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
KVADFGLSRL +SHV+TCAQGTLGYLDPEYY N+QLTDKSDVYS+GVVL ELLT +K
Sbjct: 499 KVADFGLSRLGVSDVSHVTTCAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKK 558
Query: 548 AIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLRE 607
AIDF+R+ +DVNL ++V + G +M+V+DP + G A+ + S+K LA C++E
Sbjct: 559 AIDFNREEEDVNLVVFVRKALKEGRLMDVIDPVI-GIGATEKEIESMKALGVLAELCVKE 617
Query: 608 KKSERPSMTDVVHELQRII 626
+ RP+M E++ I+
Sbjct: 618 TRQCRPTMQVAAKEIENIL 636
|
|
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 2.2e-86, Sum P(3) = 2.2e-86
Identities = 170/398 (42%), Positives = 237/398 (59%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRN---RRSGLSLKISIGVISVL 292
+CS S C + G + C C GY D L +C RK R R + + L +IG SV+
Sbjct: 288 NCSEHSTCENT--KGSFNCNCPSGYRKDS-LNSCTRKVRPEYFRWTQIFLGTTIG-FSVI 343
Query: 293 SLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGK-PA----RIFHLKELKKATNG 347
L I+ KI + + K ++ + ++G P+ +IF K +K+ATNG
Sbjct: 344 MLGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNG 403
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + RILG GG G VYKG L D ++VA+K A++GN +Q +NEV +LSQ+NH+N+V++
Sbjct: 404 YHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKV 463
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
LGCC+E E PLL+YE+I +GTL DHLHG +LTW RLRIA + A +LAYLHS+A
Sbjct: 464 LGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAYLHSSASI 523
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
PI HRD+K+ NILLD + +KVADFG SRL ++T QGTLGYLDPEYY L
Sbjct: 524 PIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLN 583
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
+KSDVYS+GVVL+ELL+ QKA+ F R NL + N E++D ++ +
Sbjct: 584 EKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIIDGQVMNEDNQ 643
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
I + ++ +E C R ERP M +V EL+ +
Sbjct: 644 REIQEAARIAAE----CTRLMGEERPRMKEVAAELEAL 677
|
|
| TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 5.8e-84, Sum P(3) = 5.8e-84
Identities = 177/406 (43%), Positives = 245/406 (60%)
Query: 231 CKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKR----------RNRRSGL 280
C DC+ G G +RC C+ G++ D CQR R+ RS L
Sbjct: 227 CAANTDCTDVET--PHGYAG-HRCSCLDGFHGDGYTNPCQRALPECRGSKLVWRHCRSNL 283
Query: 281 SLKISIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGKPA-RIFHLK 339
+ I G + L +A A C R+ + + + +L S AG + F K
Sbjct: 284 -ITIVGGTVGGAFL-LAALAFFFFCKRRRSTPLRSHLSAKRLL--SEAAGNSSVAFFPYK 339
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV 399
E++KAT+GFS+++ LG G +G VY+G+LQ+ VA+K + + +S QV+NE+ +LS V
Sbjct: 340 EIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKLLSSV 399
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
+H NLVRLLGCC+E P+L+YEY+ NGTL +HL S L W+ RL +A QTA+A+A
Sbjct: 400 SHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGS-GLPWTLRLTVATQTAKAIA 458
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLHS+ PIYHRD+KSTNILLD DFNSKVADFGLSRL SH+ST QGT GYLDP+
Sbjct: 459 YLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQ 518
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579
Y++ + L+DKSDVYS+GVVL E++T K +DF+R ++NLA + +G I E++DP
Sbjct: 519 YHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDEIIDP 578
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
L + L S+ +ELA CL RP+MT+V EL++I
Sbjct: 579 ILD-LDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQI 623
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 2.5e-83, Sum P(3) = 2.5e-83
Identities = 165/397 (41%), Positives = 238/397 (59%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIGVISVLSLA 295
+CS C + R+G + C C GY + + +C R +R+ + L I IGV+ +L A
Sbjct: 303 NCSDPKTCRN--RDGGFDCKCPSGYDLNSSM-SCTRPEY-KRTRIFLVIIIGVLVLLLAA 358
Query: 296 IAVA-AIKIICSRKLAKQAKLAKERE------DMLKSSNIAGKPARIFHLKELKKATNGF 348
I + A K RK K + E+ L + ++ +IF + +K+ATNG+
Sbjct: 359 ICIQHATK---QRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGY 415
Query: 349 SKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+ RILG GG G VYKG L D T+VA+K A++ + + Q ++EV +LSQ+NH+N+V++L
Sbjct: 416 DESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKIL 475
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
GCC+E E PLL+YE+I NGTL DHLHG +LTW RLRIA++ A LAYLHS+A P
Sbjct: 476 GCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASIP 535
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD 528
I HRD+K+ NILLD++ +KVADFG S+L ++T QGTLGYLDPEYY L +
Sbjct: 536 IIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNE 595
Query: 529 KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASV 588
KSDVYS+GVVL+ELL+ QKA+ F R +L Y + E++D ++ +
Sbjct: 596 KSDVYSFGVVLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQVLNED--- 652
Query: 589 NILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
N L ++ + +A C R ERP M +V +L+ +
Sbjct: 653 N-LKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 1.3e-82, Sum P(2) = 1.3e-82
Identities = 164/410 (40%), Positives = 245/410 (59%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRR---SGLSLKISIGVISVL 292
+CSG S C + G +RC C Y + TC+ K + + L +IG + +L
Sbjct: 293 NCSGDSTC--ENKLGHFRCNCRSRYELNTTTNTCKPKGNPEYVEWTTIVLGTTIGFLVIL 350
Query: 293 SLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGK-PA----RIFHLKELKKATNG 347
LAI+ K+ ++ + + ++ + ++G P+ +IF + +K+AT+G
Sbjct: 351 -LAISCIEHKMKNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDG 409
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + RILG GG G VYKG L D ++VA+K A++G+ +Q +NEV +LSQ+NH+N+V+L
Sbjct: 410 YDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKL 469
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
LGCC+E E PLL+YE+I++GTL DHLHG +LTW RLR+A++ A LAYLHS+A
Sbjct: 470 LGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASI 529
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
PI HRD+K+ NILLD++ +KVADFG SRL ++T QGTLGYLDPEYY L
Sbjct: 530 PIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLN 589
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
+KSDVYS+GVVL+ELL+ QKA+ F R ++ Y + + E++D G +
Sbjct: 590 EKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIID----GQVMN 645
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSND 637
N ++ + +AV C R ERP M +V EL+ + + K S++
Sbjct: 646 ENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKTKHKWSDE 695
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 733 (263.1 bits), Expect = 4.5e-80, Sum P(3) = 4.5e-80
Identities = 163/402 (40%), Positives = 241/402 (59%)
Query: 231 CKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIG-VI 289
CK +C G N +C+ ++G++ C +R + L S G +I
Sbjct: 336 CKDINECKEEEGMTYCGTN---KCVNLQGHF------KCVYNN-HRPLAIGLGASFGSLI 385
Query: 290 SVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNI---AGKPAR--IFHLKELKKA 344
V+ + + IK RKL ++ K K +L + G + +F +EL+KA
Sbjct: 386 FVVGIYLLYKFIKK--QRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKA 443
Query: 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
T FS RILG GG G VYKG L DG +VAVK +KV + ++ +NEV ILSQ+NH+N+
Sbjct: 444 TENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNI 503
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYS-SFNLTWSTRLRIALQTAEALAYLHS 463
V+LLGCC+E + P+L+YE+I NG L +HLH ++ + TW+ RLRIA+ A AL+YLHS
Sbjct: 504 VKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHS 563
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+A +PIYHRDVKSTNI+LD+ + +KV+DFG SR +H++T GT+GY+DPEY+++
Sbjct: 564 SASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQS 623
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
Q TDKSDVYS+GVVL+EL+T +K+I F R ++ LA Y + +++D R++
Sbjct: 624 SQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRD 683
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+L + +++A CL K +RPSM +V EL I
Sbjct: 684 G----CMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSI 721
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 1.1e-78, Sum P(2) = 1.1e-78
Identities = 165/395 (41%), Positives = 233/395 (58%)
Query: 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGLSLKISIG-VISVLSL 294
+CS C + + G + C C GY D +C+RK + L L +IG ++ +L +
Sbjct: 296 NCSDPKTCRN--KVGGFYCKCQSGYRLDTTTMSCKRKEFAWTTIL-LVTTIGFLVILLGV 352
Query: 295 AIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGKPA----RIFHLKELKKATNGFSK 350
A +K + KL +Q + ML P+ +IF +KKATNG+++
Sbjct: 353 ACIQQRMKHLKDTKLREQF-FEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAE 411
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
RILG GG G VYKG L D ++VA+K A++G+ +Q +NEV +LSQ+NH+N+V+LLGC
Sbjct: 412 SRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGC 471
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
C+E E PLL+YE+I NGTL DHLHG +LTW RL+IA++ A LAYLHS+A PI
Sbjct: 472 CLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAYLHSSASIPII 531
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKS 530
HRD+K+ NILLD + +KVADFG SRL + T QGTLGYLDPEYY L +KS
Sbjct: 532 HRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTGLLNEKS 591
Query: 531 DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNI 590
DVYS+GVVL+ELL+ QKA+ F R +L Y + + E++ + + N
Sbjct: 592 DVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEIIGGEVMNED---N- 647
Query: 591 LMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
L ++ + +A C R ERP M +V +L+ +
Sbjct: 648 LKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 682
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 736 (264.1 bits), Expect = 9.5e-78, Sum P(2) = 9.5e-78
Identities = 165/406 (40%), Positives = 240/406 (59%)
Query: 231 CKTQL-DCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTC--QRKRRNRRSGLS---LKI 284
C T++ +CS S C + G + C C G + +C K + G + L
Sbjct: 283 CTTRIHNCSDTSTCENT--LGSFHCQCPSGSDLNTTTMSCIDTPKEEPKYLGWTTVLLGT 340
Query: 285 SIGVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGK-PA----RIFHLK 339
+IG + +L L I+ K+ + + + ++ + ++G P+ +IF +
Sbjct: 341 TIGFLIIL-LTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEE 399
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV 399
+K+AT+G+++ RILG GG G VYKG LQD ++VA+K A++G+ +Q +NEV +LSQ+
Sbjct: 400 GMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQI 459
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
NH+N+V+LLGCC+E E PLL+YE+I++GTL DHLHG +LTW RLRIA++ A LA
Sbjct: 460 NHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLA 519
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLHS A PI HRDVK+ NILLD++ +KVADFG SRL ++T QGTLGYLDPE
Sbjct: 520 YLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPE 579
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579
YY L +KSDVYS+GVVL+ELL+ +KA+ F R +L Y + E++D
Sbjct: 580 YYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDG 639
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
++ I S ++ AV C R ERPSM +V EL+ +
Sbjct: 640 QVMNEYNQREIQESARI----AVECTRIMGEERPSMKEVAAELEAL 681
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 1.2e-77, Sum P(2) = 1.2e-77
Identities = 147/325 (45%), Positives = 214/325 (65%)
Query: 302 KIICSRKLAKQ-AKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFG 360
KII R K+ L +++ + N+ + ++IF KEL+KAT+ F+ R+LG GG G
Sbjct: 376 KIIRKRMFFKRNGGLLLKQQLTTRGGNV--QSSKIFSSKELEKATDNFNMNRVLGQGGQG 433
Query: 361 EVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420
VYKG L DG +VAVK +KV + ++ +NEVG+LSQ+NH+N+V+L+GCC+E E P+L+
Sbjct: 434 TVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILV 493
Query: 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNIL 480
YE+I NG L LH + +TW RLRI+++ A ALAYLHSAA TP+YHRDVK+TNIL
Sbjct: 494 YEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNIL 553
Query: 481 LDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLL 540
LD+ + +KV+DFG SR +H++T GT GYLDPEY++ Q TDKSDVYS+GVVL+
Sbjct: 554 LDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLV 613
Query: 541 ELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSEL 600
EL+T +K R ++ L + ++ ++++VD R++ E L + ++L
Sbjct: 614 ELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIK--EGCT--LEQVLAVAKL 669
Query: 601 AVACLREKKSERPSMTDVVHELQRI 625
A CL K +RP+M +V EL+RI
Sbjct: 670 ARRCLSLKGKKRPNMREVSVELERI 694
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LZM4 | WAKLQ_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4967 | 0.9071 | 0.8919 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00000553001 | SubName- Full=Chromosome chr8 scaffold_106, whole genome shotgun sequence; (1433 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 646 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 29/280 (10%)
Query: 349 SKERILGSGGFGEVYKGELQDG-----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHK 402
+ + LG G FGEVYKG L+ VAVK+ K + + ++ L E I+ +++H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V+LLG C E E +++ EY+ G L D+L K L+ S L ALQ A + YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
S HRD+ + N L+ ++ K++DFGLSR + + + ++ PE +
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ T KSDV+S+GV+L E+ T +P V + G + +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT------LGEEPYPGMSNAEVLEYLKKGYRLP------K 225
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
+ +L + C E +RP+ +++V L
Sbjct: 226 PPNCPPELY-------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-51
Identities = 81/210 (38%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST-QQVLNEVGILSQVNHKNLVRLLGCC 411
LG GGFG VY + G VA+K K + S +++L E+ IL ++NH N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
+ L+ EY G+L D L L+ LRI LQ E L YLHS I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 472 RDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ-LTDK 529
RD+K NILLD D K+ADFGLS+L S + T GT Y+ PE ++K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEK 174
Query: 530 SDVYSYGVVLLELLTSQKAID--FSRDPDD 557
SD++S GV+L EL + I +DP+
Sbjct: 175 SDIWSLGVILYELPELKDLIRKMLQKDPEK 204
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 8e-51
Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 30/280 (10%)
Query: 349 SKERILGSGGFGEVYKGELQD-----GTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHK 402
+ + LG G FGEVYKG+L+ VAVK+ K + + ++ L E I+ +++H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V+LLG C E E ++ EY+ G L +L + + L+ S L ALQ A + YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
S HRD+ + N L+ ++ K++DFGLSR + + + ++ PE +
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ T KSDV+S+GV+L E+ T + ++ V + NG + Q
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT-----LGEQPYPGMS-NEEVLEYLKNGYRLP------Q 224
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
+ +L + C E +RP+ +++V L
Sbjct: 225 PPNCPPELY-------DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 85/291 (29%), Positives = 132/291 (45%), Gaps = 49/291 (16%)
Query: 348 FSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKSTQQ-VLNEVGILSQVNH 401
+ LG G FGEVYKG L T VAVK+ K G + ++ L E I+ +++H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
N+VRLLG C + E ++ EY+ G L D L LT L++ALQ A+ + YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEYL 118
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG---YLDP 518
S + HRD+ + N L+ ++ K++DFGLSR + G ++ P
Sbjct: 119 ESKNFV---HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAP 173
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY-------VSQRASNG 571
E ++ + T KSDV+S+GV+L E+ T P Y V + +G
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFT------LGEQP-------YPGMSNEEVLELLEDG 220
Query: 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
+ PR + + LM C +RP+ +++V +L
Sbjct: 221 YRL----PRPENCPDELYELMLQ---------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 48/291 (16%)
Query: 352 RILGSGGFGEVYKGELQDG----TVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNL 404
+ LG G FGEVYKG+L+ T VAVK+ K S ++ L E ++ ++ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK--EDASEEERKDFLKEARVMKKLGHPNV 58
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF------NLTWSTRLRIALQTAEAL 458
VRLLG C E E L+ EY+ G L D+L F L+ L A+Q A+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG---- 514
YL S HRD+ + N L+ +D K++DFGLSR + T G
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPI 171
Query: 515 -YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLAIYVSQRASNGA 572
++ PE ++ T KSDV+S+GV+L E+ T P ++ V + G
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLS-NEEVLEYLRKGY 224
Query: 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
+ P +L+ EL ++C + +RP+ +++V L+
Sbjct: 225 RLP--KP----------EYCPDELY-ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 91/279 (32%), Positives = 133/279 (47%), Gaps = 29/279 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
+ R LGSG FG VYK + + G +VAVK K + KS Q E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
VRL+ + + L+ EY G L D+L L+ +IALQ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE---YY 521
I HRD+K NILLD++ K+ADFGL++ S ++T GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGG 173
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
Y K DV+S GV+L ELLT + FS + L + ++ P L
Sbjct: 174 NGY--GPKVDVWSLGVILYELLTGK--PPFSGENILDQLQLIR----------RILGPPL 219
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620
+ E + +L CL + S+RP+ +++
Sbjct: 220 EFDEPKWSSGSE--EAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 1e-45
Identities = 72/199 (36%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST-QQVLNEVGILSQVNHKNLV 405
+ LG G FG+VY + + G +VA+K K IK +++L E+ IL ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
RL + ++ L+ EY G L D L K + Q AL YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSE--DEARFYLRQILSALEYLHSK- 116
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I HRD+K NILLD+D + K+ADFGL+R PG + GT Y+ PE
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKG 172
Query: 526 LTDKSDVYSYGVVLLELLT 544
D++S GV+L ELLT
Sbjct: 173 YGKAVDIWSLGVILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQ--QVLNEVGILSQVNHKNL 404
+++ +LG G FG VY +D G ++AVKS ++ + + E+ ILS + H N+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 405 VRLLGCCVEAEQP-LLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYL 461
VR G + E+ L I+ EY++ G+L L K+ +R Q E LAYL
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEP---VIRKYTRQILEGLAYL 117
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEY 520
HS I HRD+K NIL+D D K+ADFG ++ L + +GT ++ PE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 521 YRNYQLTDKSDVYSYGVVLLELLTSQ 546
R + +D++S G ++E+ T +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
F +G GGFGEVYK + G VA+K K+ + + ++++NE+ IL + H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTW-STRLRIALQTAEALAYLHSAA 465
G ++ ++ ++ E+ + G+L D L + + + + + + L YLHS
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYLHSNG 118
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I HRD+K+ NILL D K+ DFGLS + + GT ++ PE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKP 173
Query: 526 LTDKSDVYSYGVVLLELLT 544
K+D++S G+ +EL
Sbjct: 174 YDYKADIWSLGITAIELAE 192
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNL 404
+ + +G G FG+VY DG + +K + N K + LNEV IL ++NH N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLH-GKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++ E + ++ EY G L + K L +Q AL YLHS
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ---GTLGYLDPEY 520
I HRD+K NI L + K+ DFG+S++ LS A+ GT YL PE
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGTPYYLSPEL 174
Query: 521 YRNYQLTDKSDVYSYGVVLLELLTSQKA 548
+N KSD++S G VL EL T +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 85/269 (31%), Positives = 129/269 (47%), Gaps = 34/269 (12%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
ER LG+G FGEV+ G T VAVK+ K G + S + L E I+ ++ H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
C E E ++ EY++ G+L D L L + +A Q AE +AYL S Y
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRNYI--- 125
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKS 530
HRD+ + NIL+ ++ K+ADFGL+RL + A+ + + PE + T KS
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 531 DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGHE 585
DV+S+G++L E++T + R P Y +N ++E V+ PR
Sbjct: 186 DVWSFGILLTEIVT------YGRVP-------YPGM--TNREVLEQVERGYRMPRPPNCP 230
Query: 586 ASVNILMSLKLFSELAVACLREKKSERPS 614
+ LM + C + ERP+
Sbjct: 231 EELYDLM---------LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 3e-33
Identities = 92/312 (29%), Positives = 138/312 (44%), Gaps = 27/312 (8%)
Query: 347 GFSKERILGSGGFGEVYKGELQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNH-K 402
+ R LG G FGEVY +D +VA+K K ++ L E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V+L + L+ EY+ G+L D L L+ S L I Q AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 463 SAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQ-----GTLGYL 516
S I HRD+K NILLD D K+ DFGL++L S S A GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 517 DPEYYRNYQL---TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573
PE L + SD++S G+ L ELLT + ++ + + + I
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI--------I 227
Query: 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV-HELQRIIEIVNQE 632
+E+ P L + N + K S+L L + R S + + H+L +++ +
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
Query: 633 KVSNDVNVETAP 644
++AP
Sbjct: 288 LSDLLKPDDSAP 299
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413
+G G FG+V G+ + G VAVK K + + Q L E +++ + H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRD 473
++ EY+A G+L D+L + + +T + +L AL E + YL HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127
Query: 474 VKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVY 533
+ + N+L+ +D +KV+DFGL++ A G + + + PE R + + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 534 SYGVVLLELLTSQKAIDFSRDP 555
S+G++L E+ + F R P
Sbjct: 184 SFGILLWEIYS------FGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 353 ILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQ--QVLNEVGILSQVNHKNLVRLLG 409
++G G FG VYKG L+ G VA+K + IK ++ E+ +L + H N+V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
++ +I EY NG+L + K+ F + + Q + LAYLH +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVY-VY-QVLQGLAYLHEQG---V 120
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD 528
HRD+K+ NIL D K+ADFG++ +L +S GT ++ PE +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 529 KSDVYSYGVVLLELLTSQ 546
SD++S G ++ELLT
Sbjct: 179 ASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 81/296 (27%), Positives = 147/296 (49%), Gaps = 47/296 (15%)
Query: 346 NGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVN 400
+ +K++++G+G FGEV++G L+ VA+K+ K G K Q L+E I+ Q +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH---GKYSSFNLTWSTRLRIALQTAEA 457
H N++RL G + + ++I EY+ NG L +L G++SS+ L R A
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAG 119
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK--PGLSHVSTCAQGTLGY 515
+ YL Y HRD+ + NIL++ + KV+DFGLSR+ + P ++ ++ + + +
Sbjct: 120 MKYLSDMNYV---HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
PE + T SDV+S+G+V+ E+++ F P SN +M+
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS------FGERP---------YWDMSNHEVMK 221
Query: 576 VVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
++ P ++V LM + C ++ ++ RP D+V+ L +++
Sbjct: 222 AINDGFRLPAPMDCPSAVYQLM---------LQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCC 411
R LG+G FGEV++G + T VAVK+ K G + + L E I+ ++ H L++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
E ++ E + G+L ++L G L + +A Q A +AYL + Y H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSD 531
RD+ + N+L+ ++ KVADFGL+R+ K + A+ + + PE + + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 532 VYSYGVVLLELLT 544
V+S+G++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 352 RILGSGGFGEVYKGE---LQDGT--VVAVKSAKV-GNIKSTQQVLNEVGILSQVNHKNLV 405
+ LG G FG+V L D T VAVKS G + E+ IL ++H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 406 RLLGCCVEAEQ--PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+ G C + LI EY+ +G+L D+L NL L + Q + + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KRLLLFSSQICKGMDYLGS 127
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA--KPGLSHVSTCAQGTLGYLDPEYY 521
Y HRD+ + NIL++ + K++DFGL+++ +V + + + PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 522 RNYQLTDKSDVYSYGVVLLELLT 544
R + + SDV+S+GV L EL T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLLGC 410
+G G FG+VYKG L+ T VAVK+ + ++ L E IL Q +H N+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
CV+ + ++ E + G+L L K LT L+++L A + YL S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRNYQLTDK 529
HRD+ + N L+ ++ K++DFG+SR + G+ VS Q + + PE + T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 530 SDVYSYGVVLLELLT 544
SDV+SYG++L E +
Sbjct: 176 SDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 73/224 (32%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 352 RILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQ-VLNEVGILSQVNHKNL 404
R LG G FG+V+ GE D +VAVK+ K ++ E +L+ H+N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL--HG---------KYSSFNLTWSTRLRIALQ 453
V+ G C E + P++++EY+ +G L+ L HG LT S L+IA+Q
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
A + YL S + HRD+ + N L+ D K+ DFG+SR V T +
Sbjct: 131 IASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRV 180
Query: 514 G--------YLDPE--YYRNYQLTDKSDVYSYGVVLLELLTSQK 547
G ++ PE YR + T +SDV+S+GVVL E+ T K
Sbjct: 181 GGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 69/200 (34%), Positives = 108/200 (54%), Gaps = 11/200 (5%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
F+ ER LGSG FGEV++G ++ VA+K K ++ Q EV L ++ HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL---HGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
C E +I E + G+L L G+ L ++ + +A Q AE +AYL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEGMAYLEEQ 123
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
HRD+ + NIL+ +D KVADFGL+RL K + ++S+ + + PE +
Sbjct: 124 NSI---HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHG 179
Query: 525 QLTDKSDVYSYGVVLLELLT 544
+ KSDV+S+G++L E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 25/269 (9%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413
+GSG FG V+ G + VA+K+ + G + S + + E ++ +++H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRD 473
L++E++ +G L D+L + F + T L + L E +AYL S+ + HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 474 VKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVY 533
+ + N L+ ++ KV+DFG++R ST + + + PE + + + KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 534 SYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMS 593
S+GV++ E+ + K +R SN EVV+ G L S
Sbjct: 186 SFGVLMWEVFSEGKTPYENR---------------SNS---EVVETINAGFRLYKPRLAS 227
Query: 594 LKLFSELAVACLREKKSERPSMTDVVHEL 622
++ EL C +E+ +RPS + ++H+L
Sbjct: 228 QSVY-ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKV--GNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+G G FG+VY L G ++AVK ++ + K+ +++ +E+ +L + H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 411 CVEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
V E+ + EY + GTL + L HG+ ++ LQ E LAYLHS I
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI----RVYTLQLLEGLAYLHSHG---I 120
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG---YLDPEYYRNYQL 526
HRD+K NI LD + K+ DFG + K + + Q G Y+ PE +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 527 TDK---SDVYSYGVVLLELLT 544
+D++S G V+LE+ T
Sbjct: 181 KGHGRAADIWSLGCVVLEMAT 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 69/195 (35%), Positives = 107/195 (54%), Gaps = 8/195 (4%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ LG+G FGEV+ G T VA+KS K G++ S + L E ++ Q+ H LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYA- 68
Query: 411 CVEAEQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
V ++P+ I EY+ NG+L D L LT + + +A Q AE +A++ Y
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYI-- 124
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+++ NIL+ + K+ADFGL+RL + A+ + + PE T K
Sbjct: 125 -HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 530 SDVYSYGVVLLELLT 544
SDV+S+G++L E++T
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 78/263 (29%), Positives = 122/263 (46%), Gaps = 24/263 (9%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCC 411
+ LG+G FGEV+ G + T VAVK+ K G + S Q L E ++ + H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
+ E +I EY+A G+L D L + + + Q AE +AY+ Y H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSD 531
RD+++ N+L+ + K+ADFGL+R+ + A+ + + PE T KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 532 VYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNIL 591
V+S+G++L E++T K DV A+ R PR++ + +
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------PRMENCPDELYDI 236
Query: 592 MSLKLFSELAVACLREKKSERPS 614
M C +EK ERP+
Sbjct: 237 MKT---------CWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 80/278 (28%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
LG G +GEVY+G + VAVK+ K ++ ++ L E ++ ++ H NLV+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHR 472
+I E++ G L D+L + L +A Q + A+ YL + HR
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---HR 128
Query: 473 DVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDV 532
D+ + N L+ ++ KVADFGLSRL A+ + + PE + + KSDV
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 533 YSYGVVLLELLT----SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASV 588
+++GV+L E+ T ID S+ V + G ME R +G V
Sbjct: 189 WAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKGYRME----RPEGCPPKV 234
Query: 589 NILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
LM AC + S+RPS ++ + +
Sbjct: 235 YELMR---------ACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQ--VLNEVGILSQVNHKNLVRLLGC 410
+G G FG V+K + D V A+K + + ++ ++E +L++++ ++R
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 411 CVEAEQPLLIYEYIANGTLHDHLH---GKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
++ + ++ EY NG LH L G+ + W R +Q LA+LHS
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHS---K 120
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
I HRD+KS N+ LD N K+ D G+++L + +T GT YL PE +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYN 179
Query: 528 DKSDVYSYGVVLLELLTSQKAID 550
+KSDV++ GVVL E T + D
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 85/276 (30%), Positives = 132/276 (47%), Gaps = 31/276 (11%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ +G G FG+V G+ + G VAVK K N + Q L E +++Q+ H NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 411 CVEAEQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
VE + L I EY+A G+L D+L + S L L+ +L EA+ YL + +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV-- 124
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+ + N+L+ +D +KV+DFGL++ A S + + + PE R + + K
Sbjct: 125 -HRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589
SDV+S+G++L E+ + F R P V R G M+ D G V
Sbjct: 180 SDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPD----GCPPVVY 229
Query: 590 ILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+M C + RPS + +L+ I
Sbjct: 230 DVMK---------QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 33/269 (12%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
F KE LGSG FG V+ G+ + VA+K + G + S + E ++ +++H NLV+L
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQL 64
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G C + ++ EY+ANG L ++L + W L + EA+ YL S +
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGFI 122
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT---LGYLDPEYYRNY 524
HRD+ + N L+ +D KV+DFGL+R L T +QGT + + PE +
Sbjct: 123 ---HRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYS 176
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584
+ + KSDV+S+GV++ E+ + K P + R SN EVV+ G+
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKM------PYE---------RFSNS---EVVESVSAGY 218
Query: 585 EASVNILMSLKLFSELAVACLREKKSERP 613
L +++ + +C EK +RP
Sbjct: 219 RLYRPKLAPTEVY-TIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 27/262 (10%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413
LG G FGEV+ G T VA+K+ K G + S + L E ++ ++ H+ LV+L V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYA--VV 70
Query: 414 AEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHR 472
+E+P+ ++ EY++ G+L D L G+ + L + +A Q A +AY+ Y HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HR 126
Query: 473 DVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDV 532
D+++ NIL+ ++ KVADFGL+RL + A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 533 YSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILM 592
+S+G++L EL T + P VN EV+D +G+
Sbjct: 187 WSFGILLTELTTKGRV----PYPGMVN--------------REVLDQVERGYRMPCPPEC 228
Query: 593 SLKLFSELAVACLREKKSERPS 614
L +L C R++ ERP+
Sbjct: 229 PESL-HDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 71/227 (31%), Positives = 109/227 (48%), Gaps = 32/227 (14%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQ-VLNE 392
E+ + F +E LG G FG+VYKGEL T VA+K+ K QQ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 393 VGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTR--- 447
++S + H N+V LLG C + + +++EY+A+G LH+ L + +S
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 448 --------LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499
L IA+Q A + YL S + HRD+ + N L+ + K++DFGLSR
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFV---HRDLAARNCLVGEGLTVKISDFGLSRD-- 173
Query: 500 PGLSHVSTCAQGT----LGYLDPEYYRNYQLTDKSDVYSYGVVLLEL 542
S Q + ++ PE + T +SD++S+GVVL E+
Sbjct: 174 -IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 30/221 (13%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVN-HK 402
F +I+G G F V E + A+K ++ K + V E +L+++N H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+++L + E + EY NG L ++ KY S + TR A + AL YLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKC-TRF-YAAEILLALEYLH 119
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ------------ 510
S I HRD+K NILLD D + K+ DFG +++ P S S
Sbjct: 120 SKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 511 -------GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
GT Y+ PE SD+++ G ++ ++LT
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 90/291 (30%), Positives = 143/291 (49%), Gaps = 43/291 (14%)
Query: 338 LKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK---STQQVLNEVG 394
L L+K T G I+G G FG V +GE G VAVK NIK + Q L E
Sbjct: 2 LLNLQKLTLG----EIIGEGEFGAVLQGEYT-GQKVAVK-----NIKCDVTAQAFLEETA 51
Query: 395 ILSQVNHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
++++++HKNLVRLLG V L ++ E ++ G L + L + ++ L+ +L
Sbjct: 52 VMTKLHHKNLVRLLG--VILHNGLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLD 108
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
AE + YL S + HRD+ + NIL+ +D +KV+DFGL+R+ G+ + + T
Sbjct: 109 VAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA 165
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573
PE ++ + + KSDV+SYGV+L E+ + + R P V + G
Sbjct: 166 ----PEALKHKKFSSKSDVWSYGVLLWEVFS------YGRAPYPKMSLKEVKECVEKGYR 215
Query: 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
ME + G A V +LM+ +C + +RPS + +L++
Sbjct: 216 MEPPE----GCPADVYVLMT---------SCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 73/198 (36%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 354 LGSGGFGEVYK-GELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLG 409
LG G FG+V + G + A+K K I ++V L E ILS++NH +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 410 CCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
+ E+ L L+ EY G L HL K F+ R A + AL YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEER-ARFYAA-EIVLALEYLHSLG--- 113
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRNYQL 526
I +RD+K NILLD D + K+ DFG LAK S S GT YL PE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFG---LAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 527 TDKSDVYSYGVVLLELLT 544
D +S GV+L E+LT
Sbjct: 171 GKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 78/286 (27%), Positives = 137/286 (47%), Gaps = 37/286 (12%)
Query: 351 ERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLV 405
E+++G+G FGEV G L+ VA+K+ K G K + L+E I+ Q +H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLH---GKYSSFNLTWSTRLRIALQTAEALAYLH 462
L G +++ +++ EY+ NG+L L G+++ L R A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYLS 123
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK--PGLSHVSTCAQGTLGYLDPEY 520
Y HRD+ + NIL++ + KV+DFGLSR+ + P ++ + + + + PE
Sbjct: 124 DMGYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 521 YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580
+ T SDV+SYG+V+ E+++ + + DV AI R P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------PA 230
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
A+++ LM + C ++ ++ERP +V L ++I
Sbjct: 231 PMDCPAALHQLM---------LDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 42/293 (14%)
Query: 352 RILGSGGFGEVYKGEL-QDGTV---VAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLV 405
+ILG G FG V +G+L QD VAVK+ K+ + ++ L+E + +H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 406 RLLGCCVEAEQ------PLLIYEYIANGTLHDHLHGKYS-----SFNLTWSTRLRIALQT 454
+L+G C EA P++I ++ +G LH L YS L T L+ +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL--YSRLGGLPEKLPLQTLLKFMVDI 122
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTC-AQGTL 513
A + YL + + HRD+ + N +L +D VADFGLS+ G + A+ +
Sbjct: 123 ALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573
++ E + T KSDV+++GV + E+ T + + P N IY R N
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ----TPYPGVENHEIYDYLRHGN--- 232
Query: 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
RL+ E ++ L +L +C R +RP+ T + L+ I+
Sbjct: 233 ------RLKQPEDCLDELY------DLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 86/283 (30%), Positives = 142/283 (50%), Gaps = 33/283 (11%)
Query: 352 RILGSGGFGEVYKGELQDG----TVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
R++G G FG VY G L D AVKS ++ +++ +Q L E I+ +H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 407 LLGCCVEAE-QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
LLG C+ +E PL++ Y+ +G L + + + + N T + LQ A+ + YL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSR--LAKPGLS-HVSTCAQGTLGYLDPEYYR 522
+ HRD+ + N +LD+ F KVADFGL+R K S H T A+ + ++ E +
Sbjct: 119 FV---HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ T KSDV+S+GV+L EL+T + D D ++ +Y+ Q RL
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQ-----------GRRLL 222
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
E + L + L +C K RP+ +++V +++I
Sbjct: 223 QPEYCPDPLYEVML------SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 354 LGSGGFGEVYKGELQ--DGTV--VAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLL 408
LG G FG V KG G VAVK+ K +I + ++ L E +++Q++H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
G C + E +L+ E G L +L + + S +A Q A +AYL S +
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFV- 117
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT--LGYLDPEYYRNYQL 526
HRD+ + N+LL + +K++DFG+SR G + G L + PE +
Sbjct: 118 --HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 527 TDKSDVYSYGVVLLELLT 544
+ KSDV+SYGV L E +
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 78/304 (25%), Positives = 139/304 (45%), Gaps = 49/304 (16%)
Query: 333 ARIFHLKELKKATNGFSKERILGSGGFGEVYKG----ELQDGTV-VAVKSAKVGN-IKST 386
RI EL+K ++LGSG FG VYKG E + + VA+K + K+
Sbjct: 1 LRILKETELEKI-------KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN 53
Query: 387 QQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN----L 442
+++L+E +++ V+H ++VRLLG C+ + Q LI + + G L D++ + L
Sbjct: 54 KEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL 112
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
W Q A+ ++YL + HRD+ + N+L+ + K+ DFGL++L
Sbjct: 113 NWCV------QIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
Query: 503 SHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNL 560
+ + + ++ E + T KSDV+SYGV + EL+T F P + +
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT------FGAKPYEGIP- 216
Query: 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620
A+ + G + Q ++++ M L V C RP+ ++++
Sbjct: 217 AVEIPDLLEKGERLP------QPPICTIDVYMVL-------VKCWMIDAESRPTFKELIN 263
Query: 621 ELQR 624
E +
Sbjct: 264 EFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 46/290 (15%)
Query: 351 ERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIKSTQQ---VLNEVGILSQVNHKN 403
E+++G G FGEV +G L+ VA+K+ K G+ S +Q L E I+ Q +H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPN 66
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++RL G ++ ++I EY+ NG+L L F T + + A + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSE 124
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQG---TLGYLDPEY 520
Y HRD+ + NIL++ + KV+DFGLSR + + +T +G + + PE
Sbjct: 125 MNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIRWTAPEA 179
Query: 521 --YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578
YR + T SDV+S+G+V+ E+++ + P Y SN +++ V+
Sbjct: 180 IAYRKF--TSASDVWSFGIVMWEVMS------YGERP-------YWDM--SNQDVIKAVE 222
Query: 579 P--RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
RL + L +L + C ++ ++ERP+ + +V L ++I
Sbjct: 223 DGYRLPPPMDCPSALY------QLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 79/219 (36%), Positives = 113/219 (51%), Gaps = 24/219 (10%)
Query: 336 FHLKELKKATNGFSKERILGSGGFGEV--YKGE-LQDGT--VVAVKSAKVGN-IKSTQQV 389
FH + LKK R+LG G FG+V Y + DGT +VAVK+ K ++T
Sbjct: 1 FHKRYLKK-------IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW 53
Query: 390 LNEVGILSQVNHKNLVRLLGCCVE-AEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTR 447
E+ IL + H+N+V+ GCC E + L LI EY+ G+L D+L L +
Sbjct: 54 KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQL 109
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH--V 505
L A Q E +AYLHS Y HRD+ + N+LLD+D K+ DFGL++ G + V
Sbjct: 110 LLFAQQICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166
Query: 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ + E + + + SDV+S+GV L ELLT
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 32/275 (11%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKV-GNIKSTQQVLNEVGILSQVNHKNLVRLLGCC 411
LG G G VYK + G + A+K V G+ + +Q+L E+ L +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 412 VEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
+ + ++ EY+ G+L D L GK L IA Q + L YLH+ + I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRH--I 121
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+K +N+L++ K+ADFG+S++ + L +T GT+ Y+ PE + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGESYSYA 180
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589
+D++S G+ LLE + P L + P L E S
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---------PSLPAEEFSPE 231
Query: 590 ILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
F + ACL++ +RPS EL +
Sbjct: 232 -------FRDFISACLQKDPKKRPS----AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 31/278 (11%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
F KE LG+G FG V G+ + VA+K K G++ S + + E ++ +++H+ LV+L
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQL 64
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
G C + ++ EY++NG L ++L HGK S L + E +AYL S
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
+ HRD+ + N L+DD KV+DFGLSR S ++ + + PE +
Sbjct: 121 FI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585
+ KSDV+++GV++ E+ + K P + R +N E V+ QG
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKM------PYE---------RFNNS---ETVEKVSQGLR 219
Query: 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
L S K+++ + +C EK ERP+ ++ ++
Sbjct: 220 LYRPHLASEKVYA-IMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 316 AKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVA 374
+E + LK G P ++ K L+K +G G GEVYK + G VA
Sbjct: 1 EEELKAALKDIVSEGDPRELY--KNLEK----------IGEGASGEVYKATDRATGKEVA 48
Query: 375 VKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH 434
+K ++ ++ + ++NE+ I+ H N+V + ++ ++ EY+ G+L D +
Sbjct: 49 IKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII- 106
Query: 435 GKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494
+ + + + + L YLHS + HRD+KS NILL D + K+ADFG
Sbjct: 107 -TQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGF 162
Query: 495 S-RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
+ +L K S GT ++ PE + K D++S G++ +E+
Sbjct: 163 AAQLTKEKSKRNSVV--GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 6/193 (3%)
Query: 353 ILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKNLVRLLGCC 411
+LG G FGEV+KG L+D T VAVK+ K + + + L+E IL Q +H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
+ + ++ E + G L K L ++ AL A +AYL S H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIH 116
Query: 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSD 531
RD+ + N L+ ++ K++DFG+SR G+ S Q + + PE + + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 532 VYSYGVVLLELLT 544
V+SYG++L E +
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 8/195 (4%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ LG+G FGEV+ G T VAVK+ K G + S + L E I+ ++ H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYA- 68
Query: 411 CVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
V +E+P+ ++ EY++ G+L D L L + +A Q A +AY+ Y
Sbjct: 69 -VVSEEPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYI-- 124
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD++S NIL+ D K+ADFGL+RL + A+ + + PE + T K
Sbjct: 125 -HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 530 SDVYSYGVVLLELLT 544
SDV+S+G++L EL+T
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 352 RILGSGGFGE--VYKGELQDGTVVAVKSAKVGNIKSTQQ--VLNEVGILSQVNHKNLVRL 407
R+LG G FGE +Y+ +D ++V K + + ++ LNE+ ILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 408 LGCCVEAEQPLLI-YEYIANGTLHDHL-HGKYSSFNLTWSTRLRIAL--QTAEALAYLHS 463
++ + LLI EY GTL+D + K F + + Q A++Y+H
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQIVSAVSYIHK 119
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
A I HRD+K+ NI L K+ DFG+S++ S T GT Y+ PE +
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQG 175
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
+ KSD+++ G VL ELLT ++ D A+N + +V +QG
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFD-----------------ATN--PLNLVVKIVQG 216
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619
+ V + S +L S L + L++ +RP+ +V+
Sbjct: 217 NYTPVVSVYSSELIS-LVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
+ K LG G +G VYK + + G +VA+K ++ N I ST L E+ +L ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--ALREISLLKELKHP 58
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V+LL + L++EY L +L + + + I Q LAY H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCH 115
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR---LAKPGLSHVSTCAQGTLGYLDPE 519
S I HRD+K NIL++ D K+ADFGL+R + +H TL Y PE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPE 168
Query: 520 Y---YRNYQLTDKSDVYSYGVVLLELLTSQ 546
++Y D++S G + E++T +
Sbjct: 169 ILLGSKHYSTA--VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 70/239 (29%), Positives = 101/239 (42%), Gaps = 15/239 (6%)
Query: 347 GFSKERILGSGGFGEVYKGELQD-GTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHK 402
F R++G G FG+V + +D + A+K K S + VLNE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
LV L + E L+ + + G L HL + F+ + I + AL YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEE-QVKFWIC-EIVLALEYLH 117
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
S I HRD+K NILLD+ + + DF ++ P ST GT GY+ PE
Sbjct: 118 SKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLC 172
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDF-SRDPDDVNLAIYVSQR--ASNGAIMEVVD 578
+ D +S GV E L ++ SR D A + E +D
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST-----QQVLNEVGILSQVNHKN 403
K +LGSG FG VY+G L DG AVK + + T +Q+ E+ +LS++ H N
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 404 LVRLLGCCVEAEQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALA 459
+V+ LG E E L I+ E + G+L L KY SF I L T + L
Sbjct: 64 IVQYLGTERE-EDNLYIFLELVPGGSLAK-LLKKYGSF-----PEPVIRLYTRQILLGLE 116
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLH HRD+K NIL+D + K+ADFG+++ S + +G+ ++ PE
Sbjct: 117 YLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPE 171
Query: 520 YYRNYQLTD-KSDVYSYGVVLLELLTSQ 546
+D++S G +LE+ T +
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 85/265 (32%), Positives = 131/265 (49%), Gaps = 33/265 (12%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413
LG G FGEV+ G T VA+K+ K G + + L E I+ ++ H LV L V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYA--VV 70
Query: 414 AEQPL-LIYEYIANGTLHDHLH---GKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
+E+P+ ++ E++ G+L D L GKY L + +A Q A+ +AY+ Y
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKY----LKLPQLVDMAAQIADGMAYIERMNYI-- 124
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+++ NIL+ D+ K+ADFGL+RL + A+ + + PE + T K
Sbjct: 125 -HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589
SDV+S+G++L EL+T + P VN V ++ G M P QG S++
Sbjct: 184 SDVWSFGILLTELVTKGRV----PYPGMVNRE--VLEQVERGYRM----PCPQGCPESLH 233
Query: 590 ILMSLKLFSELAVACLREKKSERPS 614
LM L C ++ ERP+
Sbjct: 234 ELMKL---------CWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 347 GFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKN 403
F + LG G +G VYK + L D A+K +G++ K + +NE+ IL+ VNH N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLH 462
++ ++ + ++ EY G L + K + RI +Q L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRD+KS NILL + K+ D G+S++ K ++ GT Y+ PE ++
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ KSD++S G +L E+ T + +R D+ + QR I + LQ
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLRYKV---QRGKYPPIPPIYSQDLQ 230
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
N + S L+ K RP+ +
Sbjct: 231 ------NFIRS----------MLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNL 404
+ K +G G +G+VYK + G +VA+K ++ N K + E+ +L ++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 405 VRLLGCCVEAEQP--LLIYEYIA---NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
VRL + +++EY+ G L T S Q E L
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP------EVKFTESQIKCYMKQLLEGLQ 114
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLHS I HRD+K +NIL+++D K+ADFGL+R S T TL Y PE
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 520 YY---RNYQLTDKSDVYSYGVVLLELLT 544
Y + D++S G +L EL
Sbjct: 172 LLLGATRY--GPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/200 (31%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 353 ILGSGGFGEVYK-GELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLVRLLG 409
+G G FG V K DG ++ K GN+ QQ+++EV IL ++ H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 410 CCV-EAEQPLLIY-EYIANGTLHDHLHGKYSSFN-LTWSTRLRIALQTAEALAYLH--SA 464
+ + Q L I EY G L + + RI Q AL H S
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
+ HRD+K NI LD + N K+ DFGL+++ S T GT Y+ PE +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 525 QLTDKSDVYSYGVVLLELLT 544
+KSD++S G ++ EL
Sbjct: 186 SYDEKSDIWSLGCLIYELCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 59/300 (19%)
Query: 351 ERILGSGGFGEVYKGELQD------GTVVAVKSAKV-GNIKSTQQVLNEVGILSQVNHKN 403
R LG G FG VY+G + T VA+K+ +++ + LNE ++ + N +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN-------LTWSTRLRIALQTAE 456
+VRLLG + L++ E +A G L +L + T +++A + A+
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA------KPGLSHVSTCAQ 510
+AYL + + HRD+ + N ++ +D K+ DFG++R + G +
Sbjct: 131 GMAYLAAKKFV---HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG-------GK 180
Query: 511 GTLG--YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568
G L ++ PE ++ T KSDV+S+GVVL E+ T LA Q
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGL 225
Query: 569 SNGAIMEVVDPRLQGH----EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
SN +++ V GH E + L+ EL C + RP+ ++V L+
Sbjct: 226 SNEEVLKFVIDG--GHLDLPENCPDKLL------ELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 354 LGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
LG G FG+V+ E QD +VAVK+ K + + Q E +L+ + H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSF----------NLTWSTRLRIALQTA 455
G C E L+++EY+ +G L+ L HG + LT L IA Q A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLG 514
+ YL S + HRD+ + N L+ K+ DFG+SR + V +
Sbjct: 133 SGMVYLASLHFV---HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 515 YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
++ PE + T +SD++S+GVVL E+ T K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 78/280 (27%), Positives = 114/280 (40%), Gaps = 38/280 (13%)
Query: 354 LGSGGFGEVYKGELQD--GTV--VAVKSAKVGNIKSTQQ-VLNEVGILSQVNHKNLVRLL 408
LG G FG V +GE G V VAVK K + L E I+ ++H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 409 GCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G V PL ++ E G+L D L ST A+Q A + YL S
Sbjct: 63 G--VVLTHPLMMVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLESKR-- 117
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL--GYLDPEYYRNYQ 525
HRD+ + NILL D K+ DFGL R H + + PE R
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP---RLQ 582
+ SDV+ +GV L E+ T + +P + S I++ +D RL+
Sbjct: 177 FSHASDVWMFGVTLWEMFT------YGEEP-------WAGLSGSQ--ILKKIDKEGERLE 221
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
EA ++ + + C ++RP+ + L
Sbjct: 222 RPEAC-----PQDIY-NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
F LG G +G VYK + G VVA+K V Q+++ E+ IL Q + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
G + ++ EY G++ D + K ++ LT I QT + L YLHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNK- 119
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
HRD+K+ NILL+++ +K+ADFG+S ++ +T GT ++ PE +
Sbjct: 120 --KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 527 TDKSDVYSYGVVLLEL 542
+K+D++S G+ +E+
Sbjct: 177 NNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 351 ERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLV 405
E ++G+G FGEV +G L+ VA+K+ K G K + L+E I+ Q +H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLH---GKYSSFNLTWSTRLRIALQTAEALAYLH 462
L G ++ ++I E++ NG L L G+++ L R A + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS 123
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS-TCAQG---TLGYLDP 518
Y HRD+ + NIL++ + KV+DFGLSR + S + T + G + + P
Sbjct: 124 EMNYV---HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLT 544
E + T SDV+SYG+V+ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 63/215 (29%), Positives = 112/215 (52%), Gaps = 26/215 (12%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAKV-----GNIKSTQQVL-----NEVGILSQ 398
K ++G G +G VY + G ++AVK ++ G S Q+ + +E+ L
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 399 VNHKNLVRLLGCCVEAEQPLLIY-EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTA 455
++H N+V+ LG E+ L I+ EY+ G++ L +G++ + + T Q
Sbjct: 65 LDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVL 118
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA-QGTLG 514
E LAYLHS I HRD+K+ N+L+D D K++DFG+S+ + + + QG++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 515 YLDPEYYRNYQ--LTDKSDVYSYGVVLLELLTSQK 547
++ PE +Y + K D++S G V+LE+ ++
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 80/310 (25%), Positives = 133/310 (42%), Gaps = 57/310 (18%)
Query: 348 FSKERI-----LGSGGFGEVYKGELQD------GTVVAVKSAKV-GNIKSTQQVLNEVGI 395
++R+ LG G FG+V K E + VAVK K K +++E+ +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM 68
Query: 396 LSQV-NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH-----GKYSSFNLTWSTRLR 449
+ + HKN++ LLG C + ++ EY A+G L D L G+Y+S +
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 450 I--------ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
+ A Q A + +L S HRD+ + N+L+ +D K+ADFGL+R
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR----D 181
Query: 502 LSHVS---TCAQGTLGY--LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD 556
+ H+ G L + PE + T +SDV+S+GV+L E+ T P
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSP- 234
Query: 557 DVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMT 616
Y + E+ +G+ + +L+ L C E S+RP+
Sbjct: 235 ------YPGI-----PVEELFKLLKEGYRMEKPQNCTQELYH-LMRDCWHEVPSQRPTFK 282
Query: 617 DVVHELQRII 626
+V +L R++
Sbjct: 283 QLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 84/319 (26%), Positives = 130/319 (40%), Gaps = 85/319 (26%)
Query: 351 ERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKN 403
R +G G FG V++ + T+VAVK K Q E ++++ +H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL-----HGKYSSFNLTWSTR----------- 447
+V+LLG C + L++EY+A G L++ L + S + T S R
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 448 ---LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLS 503
L IA Q A +AYL + HRD+ + N L+ ++ K+ADFGLSR +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 504 HVSTCAQGTLGYLDPE--YYRNYQLTDKSDVYSYGVVLLEL----------LTSQKAIDF 551
S + ++ PE +Y Y T +SDV++YGVVL E+ + ++ I +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244
Query: 552 SRD------PDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACL 605
RD PD+ L +Y L C
Sbjct: 245 VRDGNVLSCPDNCPLELY-----------------------------------NLMRLCW 269
Query: 606 REKKSERPSMTDVVHELQR 624
+ S+RPS + LQR
Sbjct: 270 SKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 351 ERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+R LG G FG+V+ E QD +VAVK+ K + + + E +L+ + H+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSF--------NLTWSTRLRIALQT 454
V+ G CVE + ++++EY+ +G L+ L HG + LT S L IA Q
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTL 513
A + YL S + HRD+ + N L+ ++ K+ DFG+SR + V +
Sbjct: 130 AAGMVYLASQHFV---HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
++ PE + T +SDV+S GVVL E+ T K
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 352 RILGSGGFGEVYKGE------LQDGTVVAVKSAKVGNIKST-QQVLNEVGILSQVNHKNL 404
+ LG G FG+V K T VAVK K S + +L+E +L QVNH ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLH----------GKYSSFN-----------LT 443
++L G C + LLI EY G+L L G + N LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 444 WSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503
+ A Q + + YL A + HRD+ + N+L+ + K++DFGLSR S
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 504 HVSTCAQGTL--GYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+V ++G + ++ E ++ T +SDV+S+GV+L E++T
Sbjct: 183 YVKR-SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 352 RILGSGGFGEVYK------GELQDGTVVAVKSAK-VGNIKSTQQVLNEVGILSQV-NHKN 403
+ LG+G FG+V + + VAVK K + + +++E+ I+S + NH+N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+V LLG C L+I EY G L + L K SF LT L + Q A+ +A+L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL-- 157
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYR 522
A HRD+ + N+LL K+ DFGL+R ++V A+ + ++ PE
Sbjct: 158 -ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 523 NYQLTDKSDVYSYGVVLLELLT 544
N T +SDV+SYG++L E+ +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 23/228 (10%)
Query: 351 ERILGSGGFGEVYKGE------LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+R LG G FG+V+ E +D +VAVK+ K + + + E +L+ + H+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL--HG-----------KYSSFNLTWSTRLRIA 451
V+ G C + + ++++EY+ +G L+ L HG + + L S L IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQ 510
Q A + YL S + HRD+ + N L+ + K+ DFG+SR + V
Sbjct: 130 SQIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558
+ ++ PE + T +SDV+S+GV+L E+ T K F +V
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 86/292 (29%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 352 RILGSGGFGEVYKG----ELQDGT---VVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKN 403
LGSG FGEVY+G L G+ VAVK+ + G + + L E ++S NH N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG----KYSSFNLTWSTRLRIALQTAEALA 459
+V+LLG C+ E +I E + G L +L ++ LT L I L A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 460 YLHSAAYTPIYHRDVKSTNILL-----DDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTL 513
YL + HRD+ + N L+ D D K+ DFGL+R + K +G L
Sbjct: 121 YLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE--GEGLL 175
Query: 514 G--YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571
++ PE + + T +SDV+S+GV++ E+LT + P V Q + G
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT------LGQQPYPALNNQEVLQHVTAG 229
Query: 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
RLQ E + + L C + SERP+ + LQ
Sbjct: 230 G-------RLQKPENCPDKIYQLMT------NCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
E+ LG+G FGEV+ T VAVK+ K G++ S + L E ++ + H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
V E +I E++A G+L D L S + + Q AE +A++ Y
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKS 530
HRD+++ NIL+ K+ADFGL+R+ + A+ + + PE T KS
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 531 DVYSYGVVLLELLT 544
DV+S+G++L+E++T
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 353 ILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIKSTQQVLN-EVGILSQVNHKNLV 405
LG G FGEV+ + + T+V VK+ + ++ Q E+ + +++HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHL------HGKYSSFNLTWSTRLRIALQTAEALA 459
RLLG C EAE +I EY G L L K L+ ++ + Q A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
+L +A + HRD+ + N L+ KV+ LS+ + A L +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579
+ + KSDV+S+GV++ E+ T + + F D+ V R G
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGE-LPFYGLSDE-----EVLNRLQAG------KL 236
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
L E + L +L C +RPS +++V L
Sbjct: 237 ELPVPEGCPSRL------YKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 70/275 (25%), Positives = 134/275 (48%), Gaps = 27/275 (9%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
F KE LGSG FG V+ G+ + VA+K+ G + S + + E ++ +++H LV+L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQL 64
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G C + + ++ E++ NG L ++L + + L + E + YL ++
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK--DMLLSMCQDVCEGMEYLERNSFI 122
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
HRD+ + N L+ KV+DFG++R S+ A+ + + PE + + +
Sbjct: 123 ---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
KSDV+S+GV++ E+ T K + F ++ SN ++E++ +G
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK-MPF--------------EKKSNYEVVEMIS---RGFRLY 221
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
L S+ ++ E+ +C EK RP+ +++ +
Sbjct: 222 RPKLASMTVY-EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 84/317 (26%), Positives = 130/317 (41%), Gaps = 79/317 (24%)
Query: 354 LGSGGFGEVYKGE---LQDGTV--------------VAVKSAKVGNIKST-QQVLNEVGI 395
LG G FGEV+ E LQD + VAVK + + + L EV I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 396 LSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH--------GKYSSFNLTWSTR 447
LS+++ N+ RLLG C +I EY+ NG L+ L +S +L++ST
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
L +A Q A + YL S + HRD+ + N L+ ++ K+ADFG+SR
Sbjct: 133 LYMATQIASGMRYLESLNFV---HRDLATRNCLVGKNYTIKIADFGMSRNLYSS------ 183
Query: 508 CAQGTLGYLDPEYYR------------------NYQLTDKSDVYSYGVVLLELLTSQKAI 549
+YYR + T KSDV+++GV L E+LT +
Sbjct: 184 -----------DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
Query: 550 DFSRDPDD--VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLRE 607
+ D + A + + ++ PR + EL + C R
Sbjct: 233 PYEHLTDQQVIENAGHFFRDDG----RQIYLPRPPNCPKDI---------YELMLECWRR 279
Query: 608 KKSERPSMTDVVHELQR 624
+ +RP+ ++ LQR
Sbjct: 280 DEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 36/249 (14%)
Query: 346 NGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI-----KSTQQVLNEVGILSQV 399
+ + ++LG G FG VY ++ G +AVK K + E+ +L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEA 457
H+ +V+ GC + E + EY+ G++ D L +G LT + + Q E
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILEG 116
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS------RLAKPGLSHVSTCAQG 511
+ YLHS I HRD+K NIL D N K+ DFG S + G+ V+ G
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT----G 169
Query: 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK--------AIDF--SRDPDDVNLA 561
T ++ PE K+DV+S G ++E+LT + A F + P + L
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229
Query: 562 IYVSQRASN 570
+VS A N
Sbjct: 230 SHVSPDARN 238
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 349 SKERI-LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ ER+ LG G +G VY +L +A+K + + Q + E+ + S + H+N+V+
Sbjct: 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
LG E + E + G+L L K+ T + Q E L YLH
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD--- 126
Query: 467 TPIYHRDVKSTNILLDDDFNS-----KVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEY 520
I HRD+K N+L+ N+ K++DFG S RLA G++ + GTL Y+ PE
Sbjct: 127 NQIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEV 180
Query: 521 Y----RNYQLTDKSDVYSYGVVLLELLTSQ 546
R Y +D++S G ++E+ T +
Sbjct: 181 IDKGPRGY--GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 352 RILGSGGFGEVYKGELQD----GTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVR 406
R +G G FG+VY+G VAVK+ K S ++ L E I+ Q +H ++V+
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 407 LLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
L+G E P+ ++ E G L +L + + ++L ++ + + Q + ALAYL S
Sbjct: 72 LIGVITE--NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
+ HRD+ + N+L+ K+ DFGLSR + + ++ + + ++ PE +
Sbjct: 128 FV---HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 526 LTDKSDVYSYGVVLLELL 543
T SDV+ +GV + E+L
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 43/279 (15%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQ----VLNEVGILSQVNHK 402
F+ +G G FGEVYK + + VVA+K V +++ + + E+ LSQ
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTW-STRLRIALQTAEALAYL 461
+ + G ++ + +I EY G+ D L K + T+ + LR + L YL
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILR---EVLLGLEYL 114
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
H HRD+K+ NILL ++ + K+ADFG+S +S +T GT ++ PE
Sbjct: 115 HEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVI 170
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD--- 578
+ +K+D++S G+ +EL +P L+ R + +
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG--------EPP---LSDLHPMR----VLFLIPKNNP 215
Query: 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTD 617
P L+G++ S K F + CL + ERPS +
Sbjct: 216 PSLEGNKFS-------KPFKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 17/208 (8%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAK-VGNIKSTQQ-----VLNEVGILSQVNHK 402
K + LG+G F Y+ +++ GT++AVK V N S Q+ + E+ +++++NH
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+++R+LG E L E++A G++ L KY +F + + Q L+YLH
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE--AVIINYTEQLLRGLSYLH 120
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLS-RLAKPGLSHVSTCAQ--GTLGYLDP 518
I HRDVK N+L+D ++ADFG + RLA G Q GT+ ++ P
Sbjct: 121 E---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
E R Q DV+S G V++E+ T++
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 352 RILGSGGFGEVY----KGELQDG--TVVAVKSA-KVGNIKSTQQVLNEVGILSQVNHKNL 404
R LG G FG VY KG ++D T VA+K+ + +++ + LNE ++ + N ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL-------HGKYSSFNLTWSTRLRIALQTAEA 457
VRLLG + + L+I E + G L +L + +++A + A+
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG--- 514
+AYL++ + HRD+ + N ++ +DF K+ DFG++R + +G G
Sbjct: 132 MAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 515 --YLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
++ PE ++ T SDV+S+GVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI--------KSTQQVL-NEVGILSQV 399
K ++GSG FG VY G G ++AVK ++ ++ +S L E+ +L ++
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR-IALQTAEAL 458
H+N+V+ LG ++A+ + EY+ G++ L+ Y +F T +R Q + L
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFE---ETLVRNFVRQILKGL 119
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-----CAQGTL 513
YLH+ I HRD+K NIL+D+ K++DFG+S+ + T QG++
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS 545
++ PE + T K+D++S G +++E+LT
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 345 TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVN 400
F E+ +G G F VYK L DG VVA+K ++ + K+ Q L E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALA 459
H N+++ L +E + ++ E G L + H K + T + +Q AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ---GTLGYL 516
++HS I HRD+K N+ + K+ D GL R S +T A GT Y+
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYM 173
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLEL 542
PE KSD++S G +L E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 10/194 (5%)
Query: 354 LGSGGFGEVYK-GELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGC 410
+G G G V+K + + G VA+K + + Q L E+ L H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
+L+ EY+ L + L + L + + +AY+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKS 530
HRD+K N+L+ D K+ADFGL+RL + + T Y PE + D
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 531 -DVYSYGVVLLELL 543
D+++ G + ELL
Sbjct: 182 VDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 50/297 (16%)
Query: 354 LGSGGFGEVYK---GELQDGT--VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
LG G FG V LQD T VVAVK + + + E+ IL + H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 409 GCCVEAEQP--LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
G C A + L+ EY+ G+L D+L + L A Q + + YL S Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD--HRKLLLYASQICKGMEYLGSKRY 129
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRL----------AKPGLSHVSTCAQGTLGYL 516
HRD+ + NIL++ + K+ DFGL+++ +PG S + A
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA------- 179
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
PE + + SDV+S+GVVL EL T D S P + + + + + +
Sbjct: 180 -PESLTESKFSVASDVWSFGVVLYELFTY---SDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 577 VD--------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
++ P G A + +M C S+RPS +++ +++ I
Sbjct: 236 IELLKNNGRLPAPPGCPAEIYAIMKE---------CWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 354 LGSGGFGEVYKG--ELQDGTV-VAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLLG 409
LGSG FG V KG +++ + VA+K K N KS +++ E I+ Q+++ +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
C EAE +L+ E + G L+ L GK +T S + + Q + + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKNFV-- 117
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRL--AKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
HRD+ + N+LL + +K++DFGLS+ A + + L + PE + +
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 528 DKSDVYSYGVVLLELLT 544
+SDV+SYG+ + E +
Sbjct: 177 SRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 36/273 (13%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCC 411
+G G VY L + VA+K + + S ++ EV +SQ NH N+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
V ++ L+ Y++ G+L D + Y L + + + + L YLHS H
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI---H 125
Query: 472 RDVKSTNILLDDDFNSKVADFGLSR-LAKPG--LSHVSTCAQGTLGYLDPEYY---RNYQ 525
RD+K+ NILL +D + K+ADFG+S LA G V GT ++ PE Y
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY- 184
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585
K+D++S+G+ +EL T A +S+ P M+V+ LQ
Sbjct: 185 -DFKADIWSFGITAIELATG--AAPYSKYPP-----------------MKVLMLTLQNDP 224
Query: 586 ASVNILMSLKLFS----ELAVACLREKKSERPS 614
S+ K +S ++ CL++ S+RP+
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVK------SAKVGNIKSTQQVLNEVGILSQVNH 401
++K +LG G +G VY G G ++AVK S + K +++ EV +L + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALA 459
N+V+ LG C++ + E++ G++ L+ G T+ Q + +A
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVA 116
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGL----SHVSTCAQGTLG 514
YLH+ + HRD+K N++L + K+ DFG + RLA GL S++ GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 515 YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574
++ PE KSD++S G + E+ T + + S D I GA
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRLAAMFYI--------GAHR 224
Query: 575 EVVDPRLQGHEASVNILMSLKLFSELAV----ACLREKKSERPS 614
++ PRL FS A+ +CL + ERPS
Sbjct: 225 GLM-PRLPDS------------FSAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 354 LGSGGFGEVYKGELQDG--TVVAVKSAKVGNI----------KSTQQVLNEVGIL-SQVN 400
LGSG FG VYK ++ ++A+K V N KS +++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG-KYSSFNLTWSTRLRIALQTAEALA 459
H N+VR +E ++ ++ + I L +H + K T I +Q AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLH I HRD+ NI+L +D + DFGL++ +P T GT+ Y PE
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESKLTSVVGTILYSCPE 183
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQ 546
+N +K+DV+++G +L ++ T Q
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIK---STQQVLNEVGILSQVNHKNLVRLLG 409
+ G +G V+ + G + A+K K ++ QVL E ILSQ +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 410 CCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
+ ++ L L+ EY+ G L L S + R+ IA + AL YLHS
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLHSNG--- 113
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ----------GTLGYLDP 518
I HRD+K NIL+D + + K+ DFGLS++ GL GT Y+ P
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKV---GLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLT 544
E + D +S G +L E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 69/218 (31%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNLVRLLGC 410
LG G FGEVYK +++ G VVA+K + N K + L E+ IL ++ H N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 411 CVE-----AEQPLLIY---EYIA---NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
VE + +Y Y+ +G L + S LT S LQ E +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN------PSVKLTESQIKCYMLQLLEGIN 129
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL---AKPGLSHVSTCAQG----- 511
YLH I HRD+K+ NIL+D+ K+ADFGL+R P
Sbjct: 130 YLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 512 --TLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLT 544
T Y PE R Y T D++ G V E+ T
Sbjct: 187 VVTRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 67/197 (34%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ LG+G FG V + G A+K AK+ +K + VLNE IL + H LV L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G + L+ EY+ G L HL K F R A Q AL YLHS
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLHSLDI- 122
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
+Y RD+K N+LLD D K+ DFG ++ K + C GT YL PE + +
Sbjct: 123 -VY-RDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLC--GTPEYLAPEIILS-KGY 175
Query: 528 DKS-DVYSYGVVLLELL 543
K+ D ++ G+++ E+L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+GSG +G+VYK ++ G +VA+K K+ + + E+ +L + H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL---AYLHSAAYTPI 469
++ ++ EY G+L D + L+IA E L AYLH T
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPL-----SELQIAYVCRETLKGLAYLHE---TGK 122
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY---RNYQL 526
HRD+K NILL +D + K+ADFG+S ++ + GT ++ PE R
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 527 TDKSDVYSYGVVLLEL 542
K D+++ G+ +EL
Sbjct: 182 DGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 352 RILGSGGFGEVYKGEL--QDGTV----VAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNL 404
R LG G FGEVY+G +DG VAVK+ + + + L E I+S+ NH+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL-HGK---YSSFNLTWSTRLRIALQTAEALAY 460
VRL+G E ++ E +A G L L + +LT L A A+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 461 LHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYL 516
L + HRD+ + N LL +K+ADFG++R + + A + ++
Sbjct: 132 LEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLT 544
PE + + T K+DV+S+GV+L E+ +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 84/281 (29%), Positives = 120/281 (42%), Gaps = 51/281 (18%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKN 403
F+ R +G G FG VY +++ VVA+K +S Q ++ EV L Q+ H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
+ GC + L+ EY G+ D L H K L I + LAYL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAYL 131
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY- 520
HS + I HRD+K+ NILL + K+ADFG + L P S V GT ++ PE
Sbjct: 132 HS--HERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
Query: 521 --YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL----AIY-VSQRASNGAI 573
Q K DV+S G+ +EL R P N+ A+Y ++Q S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNDS---- 231
Query: 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS 614
P L ++ S F +CL++ +RPS
Sbjct: 232 -----PTLSSNDWS-------DYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 78/274 (28%), Positives = 118/274 (43%), Gaps = 45/274 (16%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLVRLLGC 410
LG+G G V K + G ++AVK+ ++ I +Q+L E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL-EINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
+ EY+ G+L L K + +IA+ + L YLH I
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ---GTLGYLDPEYYRNYQLT 527
HRDVK +NIL++ K+ DFG+S V++ A+ GT Y+ PE + +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG------QLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME----VVD---PR 580
KSD++S G+ L+EL T + DP D I E +V+ PR
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPD--------------GIFELLQYIVNEPPPR 223
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPS 614
L + S F + CL + ERPS
Sbjct: 224 LPSGKFS-------PDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVR 406
ERI G G FGEV+ G L+ D T VAVKS + ++K+ + L E IL Q +H N+VR
Sbjct: 1 ERI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIVR 57
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L+G C + + ++ E + G L + L +++ A + YL S
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH- 114
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL-SHVSTCAQGTLGYLDPEYYRNYQ 525
HRD+ + N L+ + K++DFG+SR + G+ + Q + + PE +
Sbjct: 115 --CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 526 LTDKSDVYSYGVVLLE 541
+ +SDV+S+G++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 79/290 (27%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 352 RILGSGGFGEVYKGEL-QDGTV--VAVKSAKVGNIKSTQ--QVLNEVGILSQVNHKNLVR 406
+ LG G FG V +G+L QD ++ VAVK+ K+ ++ L+E + + +H N++R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 407 LLGCCVEAEQ------PLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQT--AEA 457
L+G C++ + P++I ++ +G LH L + + T++ + T A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG-LSHVSTCAQGTLGYL 516
+ YL S ++ HRD+ + N +L+++ N VADFGLS+ G A+ + ++
Sbjct: 125 MEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
E + T KSDV+S+GV + E+ T + + P N IY R N
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQ----TPYPGVENSEIYDYLRQGN------ 231
Query: 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
RL+ ++ L SL + S C +RPS + EL++ +
Sbjct: 232 ---RLKQPPDCLDGLYSL-MSS-----CWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 55/288 (19%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKS----TQQVLNEVGILSQVNH- 401
+ + ++G G +G VY+G + G VVA+K + N+ + + EV +LSQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK---IINLDTPDDDVSDIQREVALLSQLRQS 59
Query: 402 --KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG-----KYSSFNLTWSTRLRIALQT 454
N+ + G ++ + +I EY G++ + KY S I +
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV---------IIREV 110
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG 514
AL Y+H + HRD+K+ NIL+ + N K+ DFG++ L S ST GT
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPY 166
Query: 515 YLDPEYYRNYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573
++ PE + D K+D++S G+ + E+ T S + A+
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY---------------SDVDAFRAM 211
Query: 574 MEVVD---PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
M + PRL+ + S KL E ACL E+ ER S ++
Sbjct: 212 MLIPKSKPPRLEDNGYS-------KLLREFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 333 ARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSA-KVGNIKSTQQVL 390
ARI EL+K ++LGSG FG V+KG + +G + + A K +S +Q
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 391 NEVG----ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN----L 442
E+ + ++H +VRLLG C A L+ + G+L DH+ S + L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP-G 501
W +Q A+ + YL + HR++ + NILL D ++ADFG++ L P
Sbjct: 113 NW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
Query: 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ + + + ++ E + T +SDV+SYGV + E+++
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 30/229 (13%)
Query: 350 KERILGSGGFGEVYKGEL-------------QDG--TVVAVKSAKVGNIKSTQQ-VLNEV 393
KE+ LG G FGEV+ E DG +VAVK + K+ + L E+
Sbjct: 10 KEK-LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGK--YSSF-------NLTW 444
I+S++ + N++RLLG CV + +I EY+ NG L+ L + S+F +++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLS 503
+ L +A+Q A + YL S + HRD+ + N L+ + + K+ADFG+SR L
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFV---HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552
+ A + ++ E + T SDV+++GV L E+ T K +S
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
+ K +G G +G VYK + G +VA+K K+ + L E+ +L ++NH N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHG-KYSSFNLTWSTRLRIALQTAEALAYLHS 463
++LL L++E++ D K L S Q + LA+ HS
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YYR 522
I HRD+K N+L++ + K+ADFGL+R T T Y PE
Sbjct: 117 HG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP-VRPYTHYVVTRWYRAPELLLG 172
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQ 546
+ + D++S G + ELL+ +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQ---VLNEVGILSQVNHKNLVRLLG 409
LG GGFG V +++ A+K K +I T Q + +E IL + NH +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
+ + ++ EY G L L G + ++ R IA A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIA-CVVLAFEYLHNRG-- 113
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
I +RD+K N+LLD + K+ DFG ++ K G + C GT Y+ PE N
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEIILNKGYD 170
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563
D +S G++L ELLT + F D D+ + IY
Sbjct: 171 FSVDYWSLGILLYELLTGR--PPFGED-DEDPMEIY 203
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 30/215 (13%)
Query: 354 LGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKSTQQ---VLNEVGILSQVNHKNLV 405
LG FG++YKG L +VA+K+ K +I + QQ E ++++++H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 406 RLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTR--------------LRI 450
LLG V EQP+ +++EY+ G LH+ L + ++ S+ L I
Sbjct: 71 CLLGV-VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCA 509
A+Q A + YL S + H+D+ + NIL+ + + K++D GLSR + V +
Sbjct: 130 AIQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ ++ PE + + SD++S+GVVL E+ +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 348 FSKERILGSGGFGEVYKGEL--QDGTV--VAVKSAKVGNIKST--QQVLNEVGILSQVNH 401
F+ R+LG G FG V + +L +DG+ VAVK K S+ ++ L E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 402 KNLVRLLGCCVEAEQ------PLLIYEYIANGTLHDHLHGKY---SSFNLTWSTRLRIAL 452
N+++L+G + + P++I ++ +G LH L F L T +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQG- 511
A + YL S + HRD+ + N +L+++ VADFGLS+ G + CA
Sbjct: 121 DIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ +L E + T SDV+++GV + E++T
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 80/301 (26%), Positives = 123/301 (40%), Gaps = 30/301 (9%)
Query: 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKN 403
+ LG G G V K L G + A+K+ N +Q+L E+ I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 404 LVRLLGCCVEAEQPLLIY---EYIANGTLHDHLHGKYSSFNLTWSTR--LRIALQTAEAL 458
+V+ G ++ E I EY G+L D ++ K + +IA + L
Sbjct: 61 IVKYYGAFLD-ESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
+YLHS I HRD+K +NILL K+ DFG+S + S T GT Y+ P
Sbjct: 119 SYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLAGTFT-GTSFYMAP 172
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578
E + + SDV+S G+ LLE+ +Q F + + I + N E+ D
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV--AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV-HELQRIIEIVNQEKVSND 637
E I S + F + CL + + RP+ D++ H I Q K +
Sbjct: 231 ------EPGNGIKWS-EEFKDFIKQCLEKDPTRRPTPWDMLEHP-----WIKAQMKKKVN 278
Query: 638 V 638
+
Sbjct: 279 M 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNL 404
+ K R++G G FG V+ D +V +K V + NE +L ++H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ +E + +++ EY GTL +++ + +S L T L +Q AL ++H+
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTK 120
Query: 465 AYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
I HRD+K+ NILLD K+ DFG+S++ S T GT Y+ PE
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVV-GTPCYISPELCEG 175
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555
KSD+++ G VL EL + ++A + + P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKNLVRLLGCC 411
LG+G G V K + + GTV+A K +G S + Q+L E+ I+ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
+ + E++ G+L D ++ K + +IA+ E L YL++ I H
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPG--LSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
RD+K +NIL++ K+ DFG+S G ++ ++ GT Y+ PE + + T K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA 561
SDV+S G+ ++EL + FS DD
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 60/212 (28%), Positives = 108/212 (50%), Gaps = 26/212 (12%)
Query: 352 RILGSGGFGEVYKGELQD------GTVVAVKSA-KVGNIKSTQQVLNEVGILSQVNHKNL 404
R LG G FG VY+G +D T VAVK+ + +++ + LNE ++ ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHG-KYSSFN------LTWSTRLRIALQTAEA 457
VRLLG + + L++ E +A+G L +L + + N T +++A + A+
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG--- 514
+AYL++ + HRD+ + N ++ DF K+ DFG++R + +G G
Sbjct: 132 MAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 515 --YLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
++ PE ++ T SD++S+GVVL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 34/225 (15%)
Query: 334 RIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSA-KVGN----IKSTQ 387
RI ELK+ ++LGSG FG VYKG + +G V + A K+ N K+
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 388 QVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL----HDHLHGKYSSFNLT 443
+ ++E I++ ++H +LVRLLG C+ + L+ + + +G L H+H S L
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN 113
Query: 444 WSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503
W +Q A+ + YL + HRD+ + N+L+ + K+ DFGL+RL + G
Sbjct: 114 W------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDE 163
Query: 504 HVSTCAQGTLGY----LDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
G + L+ +YR + T +SDV+SYGV + EL+T
Sbjct: 164 KEYNADGGKMPIKWMALECIHYRKF--THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLN-----EVGILSQVNH 401
+ K + LG G + VYK + G +VA+K K+G K + +N E+ +L ++ H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
N++ LL L++E++ L + K S LT + L T L YL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYL 118
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEY 520
HS I HRD+K N+L+ D K+ADFGL+R P T T Y PE
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPEL 173
Query: 521 Y---RNYQLTDKSDVYSYGVVLLELL 543
R+Y D++S G + ELL
Sbjct: 174 LFGARHY--GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 352 RILGSGGFGEV----YKGELQD-GTVVAVKSAKVGNIKSTQQVL-NEVGILSQVNHKNLV 405
R LG G FG+V Y E + G VAVKS K + + L E+ IL + H+N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 406 RLLGCCVE--AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+ G C E LI E++ +G+L ++L + NL +L+ A+Q + + YL S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGS 127
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK--PGLSHVSTCAQGTLGYLDPEYY 521
Y HRD+ + N+L++ + K+ DFGL++ + V + + PE
Sbjct: 128 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 522 RNYQLTDKSDVYSYGVVLLELLT 544
+ SDV+S+GV L ELLT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 82/313 (26%), Positives = 134/313 (42%), Gaps = 66/313 (21%)
Query: 350 KERILGSGGFGEVYKGELQ-----------------DGTVVAVKSAKV-GNIKSTQQVLN 391
KE+ LG G FGEV+ E + +VAVK + N + L
Sbjct: 10 KEK-LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 392 EVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH--------GKYSSFNLT 443
E+ I+S++ N++RLL C+ ++ +I EY+ NG L+ L K ++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 444 WSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGL 502
+ST + +A Q A + YL S + HRD+ + N L+ ++ K+ADFG+SR L
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFV---HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD------ 556
+ A + ++ E + T SDV+++GV L E+LT K +S+ D
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
Query: 557 ------DVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKS 610
D +Y+ + A + P S+ LM ++C R
Sbjct: 246 TGEFFRDQGRQVYLPKPA--------LCPD------SLYKLM---------LSCWRRNAK 282
Query: 611 ERPSMTDVVHELQ 623
ERPS ++ L
Sbjct: 283 ERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 354 LGSGGFGEVYKGELQDGTVVA---VKSAKV-GNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+G+G FG+V GE G A VK + L EV ++NH N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEALAYLHSAAYT 467
C+E+ LL+ E+ G L ++L + R+A + A L +LH A +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRNYQ- 525
H D+ N L D + K+ D+GL+ P +++ C L +L PE
Sbjct: 123 ---HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 526 ------LTDKSDVYSYGVVLLELLT 544
T KS+++S GV + EL T
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
++LG G FG+V EL+ + AVK K I V + E +L+ H L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L C ++ + EY+ G L H+ + F+ + A + L +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFY--AAEIVLGLQFLHERG- 116
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRNY 524
I +RD+K N+LLD + + K+ADFG+ K G+ T + GT Y+ PE Y
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILS-Y 170
Query: 525 QLTDKS-DVYSYGVVLLELLTSQKAIDFSRDPDDV 558
Q + D ++ GV+L E+L Q + D D++
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSA-----KVGNIKSTQQVLNEVGILSQVNH 401
F K ++LGSG FG VYKG + +G V + A + + K+ +++L+E +++ V++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ RLLG C+ + LI + + G L D++ + + L +Q A+ + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQG---TLGYLDP 518
+ HRD+ + N+L+ + K+ DFGL++L G A+G + ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIKWMAL 180
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLT 544
E + T +SDV+SYGV + EL+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 35/221 (15%)
Query: 349 SKERILGS-----GGFGEVYKGELQDGTVVAVKSAKVGNIK---STQQV---LNEVGILS 397
S++R+ S G FG ++ G L D + V +K S QV L E +L
Sbjct: 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLY 63
Query: 398 QVNHKNLVRLLGCCVE-AEQPLLIYEYIANGTLHDHLH-GKYSSFNL--TWSTR--LRIA 451
++H+N++ +L C+E E P ++Y Y+ G L L + N ST+ + +A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQG 511
+Q A ++YLH + H+D+ + N ++D++ K+ D LSR P H C
Sbjct: 124 IQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH---C--- 174
Query: 512 TLG--------YLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
LG ++ E N + + SDV+S+GV+L EL+T
Sbjct: 175 -LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 49/304 (16%)
Query: 334 RIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSA-KV----GNIKSTQ 387
RI ELKK ++LGSG FG VYKG + DG V + A KV + K+ +
Sbjct: 2 RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54
Query: 388 QVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH---GKYSSFNLTW 444
++L+E +++ V + RLLG C+ + L + + + G L D++ + S +L
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-- 111
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
L +Q A+ ++YL + HRD+ + N+L+ + K+ DFGL+RL +
Sbjct: 112 ---LNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDE 163
Query: 505 VSTCAQG---TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA 561
A G + ++ E + + T +SDV+SYGV + EL+T F P D A
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT------FGAKPYDGIPA 217
Query: 562 IYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621
+ G + Q ++++ M + V C RP ++V E
Sbjct: 218 REIPDLLEKGERLP------QPPICTIDVYM-------IMVKCWMIDSECRPRFRELVDE 264
Query: 622 LQRI 625
R+
Sbjct: 265 FSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 43/228 (18%)
Query: 341 LKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQ--VLNEVGILS 397
L T F ++G G +G+VYK + G +VA+K + +I ++ + E IL
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILR 57
Query: 398 QV-NHKNLVRLLGC------CVEAEQPLLIYEYIANGTLHD-----HLHGKYSSFNLTWS 445
+ NH N+ G +Q L+ E G++ D GK
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--------- 108
Query: 446 TRLR------IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499
RL+ I +T LAYLH + HRD+K NILL + K+ DFG+S
Sbjct: 109 -RLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
Query: 500 PGLSHVSTCAQGTLGYLDPE-----YYRNYQLTDKSDVYSYGVVLLEL 542
L +T GT ++ PE + +SDV+S G+ +EL
Sbjct: 165 STLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 354 LGSGGFGEVYKGELQ---DGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLVRLL 408
LGSG FG V KG + VAVK K N ++L E ++ Q+++ +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
G C EAE +L+ E G L+ L + ++T + Q + + YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT--LGYLDPEYYRNYQL 526
HRD+ + N+LL +K++DFGLS+ ++ G + + PE Y+
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 527 TDKSDVYSYGVVLLE 541
+ KSDV+S+GV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 73/243 (30%), Positives = 115/243 (47%), Gaps = 39/243 (16%)
Query: 350 KERILGSGGFGEVYKGELQD-----------------GTVVAVKSAKVGNIKSTQQ-VLN 391
KE+ LG G FGEV+ E+ + +VAVK + K+ + L
Sbjct: 10 KEK-LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 392 EVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL-----HDHLHGKYSSFN----- 441
EV ILS++ N++RLLG CV+ + +I EY+ NG L HL K + N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 442 ------LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495
+++S+ L +ALQ A + YL S + HRD+ + N L+ ++ K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFV---HRDLATRNCLVGENLTIKIADFGMS 185
Query: 496 R-LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554
R L + A + ++ E + T SDV+++GV L E+L K +
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 555 PDD 557
D+
Sbjct: 246 TDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 350 KERILGSGGFGEVYKGELQDGTV--VAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+E ++ G G YKG+ + V + V +I S +E+ + ++ H N+V+L
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-----SEIADMGKLQHPNIVKL 748
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
+G C + LI+EYI L + L NL+W R +IA+ A+AL +LH
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
+ ++ I++D D RL+ PGL T + Y+ PE +T
Sbjct: 803 AVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856
Query: 528 DKSDVYSYGVVLLELLTSQKAID--FSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585
+KSD+Y +G++L+ELLT + D F V A Y S+ + +DP ++G
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY---SDCHLDMWIDPSIRGD- 912
Query: 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
SVN +++ + LA+ C + RP DV+ L+
Sbjct: 913 VSVNQNEIVEVMN-LALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVG-----NIKSTQQVLNEVGILSQVNHKNLV 405
++LG G FG VY ++ G +A K + K + E+ +L + H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 406 RLLGCCVE-AEQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+ GC + AE+ L I+ EY+ G++ D L Y + LT S + Q E ++YLHS
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGA--LTESVTRKYTRQILEGMSYLHS 124
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR------LAKPGLSHVSTCAQGTLGYLD 517
I HRD+K NIL D N K+ DFG S+ ++ G+ V+ GT ++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMS 177
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
PE K+DV+S G ++E+LT +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLN--EVGILSQVN-HKNLVRLLG 409
LG G FG VY + G +VA+K K S ++ +N EV L ++N H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
E ++ ++EY+ G L+ L + S I Q + LA++H +
Sbjct: 66 VFRENDELYFVFEYM-EGNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF--- 120
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSR--LAKPGL-SHVST 507
+HRD+K N+L+ K+ADFGL+R ++P +VST
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST 161
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 353 ILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNLVRLLG 409
+G G +G+VYK +D G +VA+K ++ N K + + E+ IL Q+NH+N+V L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 410 CCVEAEQPL----------LIYEYIANGTLHDH-LHGKYSSFNLTWSTRLRIAL--QTAE 456
+ + L L++EY+ DH L G S + +S + Q E
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
L Y H + HRD+K +NILL++ K+ADFGL+RL S T TL Y
Sbjct: 128 GLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 517 DPEYYRNYQLTDKS-DVYSYGVVLLELLT 544
PE + + DV+S G +L EL T
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+GSG +G+VYK L G + AVK K+ + E+ ++ + H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 413 EAEQPLLIYEYIANGTLHD--HLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
E+ + EY G+L D H+ G S + + R +T + LAYLHS
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKM--- 128
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY---RNYQLT 527
HRD+K NILL D+ + K+ADFG++ ++ + GT ++ PE +N
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 528 DKSDVYSYGVVLLEL 542
D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKN 403
F E+ +G G F EVY+ L DG VA+K ++ ++ K+ + E+ +L Q+NH N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+++ +E + ++ E G L + H K + T + +Q AL ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG---YLDPE 519
S + HRD+K N+ + K+ D GL R S +T A +G Y+ PE
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQ 546
KSD++S G +L E+ Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNL 404
F K +G G +G VY+ + G +VA+K ++ N + + L E+ +L + H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 405 VRLLGCCV--EAEQPLLIYEYIAN--GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
V L V + L+ EY +L D++ +S S + LQ L Y
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-----SQVKCLMLQLLRGLQY 123
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
LH I HRD+K +N+LL D K+ADFGL+R ++ TL Y PE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPEL 179
Query: 521 Y---RNYQLTDKSDVYSYGVVLLELLT 544
Y T D+++ G +L ELL
Sbjct: 180 LLGCTTY--TTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 345 TNGFSK-ERI--LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQV--LNEVGILSQ 398
+ SK E++ +G G FGEV+K + +VA+K + N K + L E+ IL
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67
Query: 399 VNHKNLVRLLGCCVEAEQP--------LLIYEYIANGTLHD---HLHGKYSSFNLTWSTR 447
+ H+N+V L+ C P L++E+ HD L K F L S
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTL--SEI 121
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR---LAKPGLSH 504
++ L Y+H I HRD+K+ NIL+ D K+ADFGL+R L+K +
Sbjct: 122 KKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 505 VSTCAQGTLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQ 546
T TL Y PE R+Y D++ G ++ E+ T
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDY--GPPIDMWGAGCIMAEMWTRS 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 34/205 (16%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAK---VGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+G GG+G+V+ + +D G +VA+K K + + + VL E IL+ + LV+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 410 CCVEAEQPLLIYEYI----------ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
+ E L EY+ G L + R +A + EA+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED------------HARFYMA-EMFEAVD 115
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
LH Y HRD+K N L+D + K+ DFGLS K +++ ++ G+ Y+ PE
Sbjct: 116 ALHELGYI---HRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANS-VVGSPDYMAPE 168
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLT 544
R D +S G +L E L
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 82/290 (28%), Positives = 125/290 (43%), Gaps = 53/290 (18%)
Query: 348 FSKERILGSGGFGEVY-KGELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKN 403
F+ R +G G FG VY +++ VVA+K +S Q ++ EV L ++ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQT---AEALAY 460
+ GC + L+ EY G+ D L + IA T + LAY
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ-----EVEIAAITHGALQGLAY 140
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
LHS + HRD+K+ NILL + K+ADFG + +A P S V GT ++ PE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 521 ---YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL----AIY-VSQRASNGA 572
Q K DV+S G+ +EL R P N+ A+Y ++Q S
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNES--- 241
Query: 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
P LQ +E S F +CL++ +RP+ +++ +
Sbjct: 242 ------PTLQSNEWS-------DYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 348 FSKERI-----LGSGGFGEVYKGEL-------QDGTV-VAVKSAK-VGNIKSTQQVLNEV 393
F ++R+ LG G FG+V + E D TV VAVK K K +++E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 394 GILSQVN-HKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHG-------------KYS 438
++ + HKN++ LLG C + E PL +I EY A G L + L K
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 439 SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498
L++ + A Q A + YL S HRD+ + N+L+ +D K+ADFGL+R
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR-- 182
Query: 499 KPGLSHVSTCAQGTLG-----YLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
G+ + + + G ++ PE + T +SDV+S+G+++ E+ T
Sbjct: 183 --GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 24/201 (11%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLGC 410
LG G FG+VYK + ++ + A +AK+ I+S +++ + E+ ILS+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFA--AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 411 CVEAEQPLLIYEYIANGTLHDHL----HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ ++ E+ G L + G LT + Q EAL +LHS
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERG------LTEPQIRYVCRQMLEALNFLHSHK- 123
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY-----Y 521
+ HRD+K+ NILL D + K+ADFG+S K L T GT ++ PE +
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETF 180
Query: 522 RNYQLTDKSDVYSYGVVLLEL 542
++ K+D++S G+ L+EL
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 354 LGSGGFGEVYKGEL--------QDGTVVAVKSAKV-GNIKSTQQVLNEVGILSQV-NHKN 403
LG G FG+V E VAVK K K +++E+ ++ + HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYS-----SFN--------LTWSTRLRI 450
++ LLG C + ++ EY + G L ++L + SF+ LT+ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
A Q A + YL S HRD+ + N+L+ +D K+ADFGL+R + +
Sbjct: 140 AYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVH-NIDYYKKTTN 195
Query: 511 GTL--GYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
G L ++ PE + T +SDV+S+GV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVG-NIKSTQQVLN----EVGILSQVNHKNLV 405
++LG G FGEVY + G +AVK + + T + +N E+ +L + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 406 RLLGCCVEAEQPLL--IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+ GC + E+ L EY+ G++ D L Y + LT + R Q + ++YLHS
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-YGA--LTENVTRRYTRQILQGVSYLHS 124
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR------LAKPGLSHVSTCAQGTLGYLD 517
I HRD+K NIL D N K+ DFG S+ ++ G+ V+ GT ++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMS 177
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
PE K+DV+S ++E+LT +
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 20/202 (9%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKV----GNIKSTQQVLNEVGILSQVNHK 402
F+K +G G FGEV+KG + + VVA+K + I+ QQ E+ +LSQ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSP 62
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH-GKYSSFNLTWSTRLRIALQTAEALAYL 461
+ + G ++ + +I EY+ G+ D L G + F + +T L+ L+ L YL
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI--ATMLKEILK---GLDYL 117
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEY 520
HS HRD+K+ N+LL + + K+ADFG++ +L + + GT ++ PE
Sbjct: 118 HSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEV 172
Query: 521 YRNYQLTDKSDVYSYGVVLLEL 542
+ K+D++S G+ +EL
Sbjct: 173 IQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 352 RILGSGGFGEVY---KGELQD-GTVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNLV 405
++LG G FG+V+ K D G + A+K K +K +V E IL++VNH +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 406 RLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYL 461
+L + E L LI +++ G L L K F T + AE AL +L
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMF-----TEEDVKFYLAELALALDHL 114
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV-STCAQGTLGYLDPEY 520
HS I +RD+K NILLD++ + K+ DFGLS+ + S C GT+ Y+ PE
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEV 169
Query: 521 YRNYQLTDKSDVYSYGVVLLELLT 544
T +D +S+GV++ E+LT
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 73/276 (26%), Positives = 128/276 (46%), Gaps = 34/276 (12%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLV 405
F+K +G G FGEVYKG + + VVA+K + + + + E+ +LSQ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTW-STRLRIALQTAEALAYLHSA 464
R G ++ + +I EY+ G+ D L K T+ +T LR L+ L YLHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILK---GLDYLHSE 120
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
HRD+K+ N+LL + + K+ADFG++ +L + + GT ++ PE +
Sbjct: 121 RKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQ 175
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
K+D++S G+ +EL + + D + + + + + P L+G
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP---NSDLHPMRVLFLIPKNSP---------PTLEG 223
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619
+ K F E ACL + RP+ +++
Sbjct: 224 QYS--------KPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVG-----NIKSTQQVLNEVGILSQVNHKNLV 405
++LG G FG VY + G +AVK + K + E+ +L + H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 406 RLLGCCVEA-EQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+ GC + E+ L I+ E++ G++ D L Y + LT + + Q E ++YLHS
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YGA--LTENVTRKYTRQILEGVSYLHS 124
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR------LAKPGLSHVSTCAQGTLGYLD 517
I HRD+K NIL D N K+ DFG S+ L+ G+ V+ GT ++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMS 177
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
PE K+D++S G ++E+LT +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 353 ILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKS--TQQVLNEVGILSQV---NHKNLVR 406
+G G +G VYK +L G VA+K +V + L E+ +L Q+ H N+VR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 407 LLGCC----VEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
LL C + E L L++E++ + L +L K L T + Q + +L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLS-KCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497
HS I HRD+K NIL+ D K+ADFGL+R+
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 57/309 (18%)
Query: 354 LGSGGFGEVYKGEL--------QDGTVVAVKSAKV-GNIKSTQQVLNEVGILSQV-NHKN 403
LG G FG+V E T VAVK K K +++E+ ++ + HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLH-----GKYSSFN--------LTWSTRLRI 450
++ LLG C + +I EY + G L ++L G +N L++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
A Q A + YL S HRD+ + N+L+ +D K+ADFGL+R + H+ +
Sbjct: 146 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 511 GTLG-----YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565
T G ++ PE + T +SDV+S+GV+L E+ T + S P
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYP---------- 244
Query: 566 QRASNGAIMEVVDPRL-QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
G +E + L +GH + +L+ + C S+RP+ +V +L R
Sbjct: 245 -----GVPVEELFKLLKEGHRMDKPSNCTNELYMMMR-DCWHAVPSQRPTFKQLVEDLDR 298
Query: 625 IIEIV-NQE 632
I+ + NQE
Sbjct: 299 ILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 24/199 (12%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAK---VGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+G+G FG V+ + A+K V +K Q V NE +L +V+H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 410 CCVEAEQPLL--IYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
E +Q L + EY+ G L +L G++S+ ST L A + AL YLHS
Sbjct: 68 -WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN-----STGLFYASEIVCALEYLHSKE 121
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRNY 524
I +RD+K NILLD + + K+ DFG AK T C GT YL PE ++
Sbjct: 122 ---IVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWTLC--GTPEYLAPEVIQSK 173
Query: 525 QLTDKSDVYSYGVVLLELL 543
D ++ G+++ E+L
Sbjct: 174 GHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLGC 410
LG G FG+VYK + ++ V+A +AKV + KS +++ + E+ IL+ +H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA--AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
++ E+ A G + D + + LT + QT EAL YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAV-DAVMLELER-PLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY-------RN 523
HRD+K+ NIL D + K+ADFG+S + + GT ++ PE R
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 524 YQLTDKSDVYSYGVVLLEL 542
Y K+DV+S G+ L+E+
Sbjct: 185 YDY--KADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 87/288 (30%), Positives = 123/288 (42%), Gaps = 56/288 (19%)
Query: 354 LGSGGFGEVY-KGELQDGTVVAVK----SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+G G FG VY VVAVK S K N K Q ++ EV L Q+ H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK-WQDIIKEVKFLQQLKHPNTIEYK 87
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL---AYLHSAA 465
GC ++ L+ EY G+ D L + IA T AL AYLHS
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQ-----EVEIAAITHGALQGLAYLHSHN 141
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY---YR 522
+ HRD+K+ NILL + K+ADFG + + P S V GT ++ PE
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMD 193
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL----AIY-VSQRASNGAIMEVV 577
Q K DV+S G+ +EL R P N+ A+Y ++Q S
Sbjct: 194 EGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNDS-------- 237
Query: 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV-HELQR 624
P LQ +E + + F CL++ ERP+ +++ H+ R
Sbjct: 238 -PTLQSNEWTDS-------FRGFVDYCLQKIPQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 52/300 (17%)
Query: 351 ERILGSGGFGEVYKGEL-QDGTVV--AVKSAK-VGNIKSTQQVLNEVGILSQVN-HKNLV 405
+ ++G G FG+V K + +DG + A+K K + + E+ +L ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGK--------YSSFNLTWSTR-----LRIAL 452
LLG C L EY +G L D L ++ N T ST L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
A + YL + HRD+ + NIL+ +++ +K+ADFGLSR + + T
Sbjct: 132 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 513 LGYLDPEYYR----NYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567
+G L + NY + T SDV+SYGV+L E+ + P Y
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTP-------YCGMT 228
Query: 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ E+ + QG+ + +++ +L C REK ERPS ++ L R++E
Sbjct: 229 CA-----ELYEKLPQGYRLEKPLNCDDEVY-DLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 352 RILGSGGFGEVY--KGELQDG-TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+ +G G FG++Y K + V+ +K + EV +L+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHL---HGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
E + ++ EY G L + G S + S ++I+L L ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLKHIHD-- 119
Query: 466 YTPIYHRDVKSTNILLDDD-FNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I HRD+KS NI L + +K+ DFG++R + TC GT YL PE +N
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNR 177
Query: 525 QLTDKSDVYSYGVVLLELLT 544
+K+D++S G VL EL T
Sbjct: 178 PYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 348 FSKERILGSGGFGE-VYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNL 404
+ K + +G G FG+ + +DG +K + + K ++ EV +LS + H N+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN-----LTWSTRLRIALQTAEALA 459
V+ E ++ +Y G L+ ++ + L W ++ +AL+
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------ 115
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
++H I HRD+KS NI L D K+ DFG++R+ + TC GT YL PE
Sbjct: 116 HVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAID 550
N +KSD+++ G VL E+ T + A +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKN 403
F E+ +G G F EVY+ L D VA+K ++ + K+ Q + E+ +L Q+NH N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+++ L +E + ++ E G L + + K + T + +Q A+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG---YLDPE 519
S + HRD+K N+ + K+ D GL R S +T A +G Y+ PE
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQ 546
KSD++S G +L E+ Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLGC 410
LG G FG+VYK + ++ +A +AKV KS +++ + E+ IL+ NH +V+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALA--AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
+ ++ E+ G + D + + LT I Q EAL YLHS I
Sbjct: 78 FYWDGKLWIMIEFCPGGAV-DAIMLELDR-GLTEPQIQVICRQMLEALQYLHSMK---II 132
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD-- 528
HRD+K+ N+LL D + K+ADFG+S L + GT ++ PE + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 529 ---KSDVYSYGVVLLEL 542
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 354 LGSGGFGEVYKG---ELQDG-----TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLV 405
LG G F +++KG E+ D T V +K + ++ ++SQ++HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
G CV ++ +++ EY+ G+L +L + N++W +L +A Q A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL----GYLDPEYY 521
T H +V + N+LL + + K + +L+ PG+S ++ + L ++ PE
Sbjct: 121 LT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPPECI 176
Query: 522 RNYQ-LTDKSDVYSYGVVLLEL----------LTSQKAIDFSRD 554
N Q L+ +D +S+G L E+ L SQK + F D
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 56/302 (18%)
Query: 351 ERILGSGGFGEVYKGELQ-DGTVV--AVKSAK-VGNIKSTQQVLNEVGILSQV-NHKNLV 405
E ++G G FG+V + ++ DG + A+K K + + E+ +L ++ +H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHL---------------HGKYSSFNLTWSTRLRI 450
LLG C + EY G L D L HG S+ LT L+
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQF 124
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
A A + YL + HRD+ + N+L+ ++ SK+ADFGLSR + +
Sbjct: 125 ASDVATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEE-------VYVK 174
Query: 511 GTLGYLDPEYYR----NYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565
T+G L + NY + T KSDV+S+GV+L E+ + P +
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI------VSLGGTPYCGMTCAELY 228
Query: 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
++ G ME PR E EL C R++ ERP + +L R+
Sbjct: 229 EKLPQGYRME--KPRNCDDEV-----------YELMRQCWRDRPYERPPFAQISVQLSRM 275
Query: 626 IE 627
+E
Sbjct: 276 LE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVG----NIKSTQQVLNEVGILSQVNHKNLVRLL 408
+G G +G V K + G +VA+K K ++K T L EV +L Q+ H+N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT--ALREVKVLRQLRHENIVNLK 66
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
+ L++EY+ TL + L + S L Q +A+AY HS
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCHSHN--- 120
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
I HRD+K NIL+ + K+ DFG +R L S ++ Y+ +YR +L
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYRAPELL 173
Query: 528 DKS-------DVYSYGVVLLELLTSQ 546
DV++ G ++ ELL +
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+++ +G G G VY ++ G VA+K + + ++NE+ ++ + H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L + ++ ++ EY+A G+L D + + + + + +AL +LHS
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS--- 133
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
+ HRD+KS NILL D + K+ DFG P S ST GT ++ PE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 527 TDKSDVYSYGVVLLELL 543
K D++S G++ +E++
Sbjct: 193 GPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 34/227 (14%)
Query: 348 FSKERI-----LGSGGFGEVYKGEL--------QDGTVVAVKSAK-VGNIKSTQQVLNEV 393
FS++++ LG G FG+V E ++ VAVK K K +++E+
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71
Query: 394 GILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYS-----SFN------ 441
++ + HKN++ LLG C + +I EY + G L ++L + S++
Sbjct: 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 442 --LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499
+T+ + Q A + YL S HRD+ + N+L+ ++ K+ADFGL+R
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 500 PGLSHVSTCAQGTL--GYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ + G L ++ PE + T +SDV+S+GV++ E+ T
Sbjct: 189 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+GSG +G+VYK + G + A+K K+ + V E+ ++ H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 413 EAEQPLLIYEYIANGTLHD--HLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
++ + E+ G+L D H+ G S + + +R +T + L YLHS
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLHSKGKM--- 128
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY---RNYQLT 527
HRD+K NILL D+ + K+ADFG+S ++ + GT ++ PE R
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 528 DKSDVYSYGVVLLEL 542
D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 351 ERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIKSTQQ-VLNEVGILSQVNHKNLV 405
ERILG+G FGE+ +G L+ VA+ + + G ++ L E L Q +H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
RL G +++ EY++NG L L + L + + A + YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL--DPEYYRN 523
Y H+ + + +L++ D K++ F RL + + T G L PE +
Sbjct: 128 YV---HKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 524 YQLTDKSDVYSYGVVLLELLT 544
+ + SDV+S+G+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-15
Identities = 56/172 (32%), Positives = 85/172 (49%), Gaps = 24/172 (13%)
Query: 392 EVGILSQVNHKNLVRLL--GCCVEAEQPLL--IYEYIANGTLHDHLHGKYSSFNLTWSTR 447
E + +++ H N+V LL G EA LL ++EY+ TL + L + L
Sbjct: 28 ETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVLAADGA---LPAGET 81
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSH 504
R+ LQ +ALA H+ I HRD+K NI++ ++KV DFG+ L PG+
Sbjct: 82 GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRD 137
Query: 505 V-------STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAI 549
+T GT Y PE R +T SD+Y++G++ LE LT Q+ +
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ---QVLNEVGILSQVNHKN 403
F + R+LG GGFGEV +++ G + A K + IK + LNE IL +VN +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+V L + L+ + G L H+ H + F R AE L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGLE 116
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I +RD+K NILLDD + +++D GL+ G + GT+GY+ PE +
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVK 174
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQ 546
N + T D ++ G +L E++ Q
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 353 ILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVN---HKNLV 405
+LG G FG+V E + G + A+K+ K G+I + +V + E I N H LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLH 462
L C + + EY A G L H+H S R A L YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFYAACVVLGLQYLH 118
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEY 520
I +RD+K N+LLD + K+ADFG L K G+ + GT +L PE
Sbjct: 119 ENK---IVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 521 YRNYQLTDKS-----DVYSYGVVLLELLTSQ 546
LT+ S D + GV++ E+L +
Sbjct: 173 -----LTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 56/223 (25%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVR 406
+ +GSG +G V + G VA+K K+ N+ +++L E+ +L + H+N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 407 LLGCCVEAEQPL------LIYEY--------IANGTLHDHLHGKYSSFNLTWSTRLRIAL 452
LL + P ++ E I + H +Y
Sbjct: 64 LLDI-LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY------------FLY 110
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
Q L YLHSA + HRD+K +NIL++ + + K+ DFGL+R P +G
Sbjct: 111 QILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE-----KGF 162
Query: 513 L-GYLDPEYYR---------NYQLTDKS-DVYSYGVVLLELLT 544
L Y+ +YR Y K+ D++S G + ELLT
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRY---TKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 43/259 (16%)
Query: 325 SSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI 383
SS P+ L EL++ +GSG G VYK G + A+K GN
Sbjct: 60 SSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNH 111
Query: 384 KST--QQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDH--LHGKYSS 439
+ T +Q+ E+ IL VNH N+V+ + ++ E++ G+L ++ +
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA 171
Query: 440 FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LA 498
+A Q +AYLH I HRD+K +N+L++ N K+ADFG+SR LA
Sbjct: 172 ---------DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219
Query: 499 K---PGLSHVSTCAQGTLGYLDPEYYRNYQLTD------KSDVYSYGVVLLELLTSQKAI 549
+ P S V GT+ Y+ PE N L D++S GV +LE +
Sbjct: 220 QTMDPCNSSV-----GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
Query: 550 DFSRDPDDVNL--AIYVSQ 566
R D +L AI +SQ
Sbjct: 274 GVGRQGDWASLMCAICMSQ 292
|
Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 10/203 (4%)
Query: 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ---QVLNEVGILSQVNHKN 403
F + R+LG GGFGEV +++ G + A K + IK + LNE IL +VN +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+V L + L+ + G L H+ Y+ N + R AE L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEE-RALFYAAEILCGLED 117
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+RD+K NILLDD + +++D GL+ G S GT+GY+ PE N
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNN 175
Query: 524 YQLTDKSDVYSYGVVLLELLTSQ 546
+ T D + G ++ E++ Q
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 335 IFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEV 393
I + + KK F K +G G G VY ++ G VA+K + + ++NE+
Sbjct: 11 IVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
++ + + N+V L + ++ ++ EY+A G+L D + + + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRE 123
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
+AL +LHS + HRD+KS NILL D + K+ DFG P S ST GT
Sbjct: 124 CLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
++ PE K D++S G++ +E++ +
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 352 RILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
R+LG G FG+V L + G + AVK K I V + E ILS NH L +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
L C ++ + E++ G L H+ K F+ R R A + AL +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLHDKG 116
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRN 523
I +RD+K N+LLD + + K+ADFG + K G+ + T + GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562
D ++ GV+L E+L + + + DD+ AI
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 79/300 (26%), Positives = 127/300 (42%), Gaps = 56/300 (18%)
Query: 353 ILGSGGFGEVYKGELQ-DGTVV--AVKSAK-VGNIKSTQQVLNEVGILSQV-NHKNLVRL 407
++G G FG+V K ++ DG + A+K K + + E+ +L ++ +H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL---------------HGKYSSFNLTWSTRLRIAL 452
LG C L EY +G L D L + S+ L+ L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAA 119
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
A + YL + HRD+ + NIL+ +++ +K+ADFGLSR + + T
Sbjct: 120 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 169
Query: 513 LGYLDPEYYR----NYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567
+G L + NY + T SDV+SYGV+L E+ + P + ++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAELYEK 223
Query: 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
G +E P E +L C REK ERPS ++ L R++E
Sbjct: 224 LPQGYRLE--KPLNCDDEV-----------YDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRL 407
++LG G FG+V EL+ G AVK+ K + V + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 408 LGCCVEAEQPLL-IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L C + ++ L + E++ G L H+ K F+L +T A + L +LHS
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFY--AAEIVCGLQFLHSKG- 116
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRNYQ 525
I +RD+K N++LD D + K+ADFG+ + G + ST C GT Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC--GTPDYIAPEILQGLK 172
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557
T D +S+GV+L E+L Q F D +D
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP--FHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 54/160 (33%), Positives = 79/160 (49%), Gaps = 36/160 (22%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKV----GNIKSTQQVLNEVGILSQV-NHKNLVRL 407
LG G +G V+K + + VVA+K K+ N Q+ E+ L ++ +H N+V+L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 408 LGCCVEAEQPLLIY---EY--------IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE 456
L ++AE IY EY I L D +H +Y I Q +
Sbjct: 73 LNV-IKAENDKDIYLVFEYMETDLHAVIRANILED-VHKRY------------IMYQLLK 118
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
AL Y+HS + HRD+K +NILL+ D K+ADFGL+R
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK----SAKVGNIKSTQQVLNEVGILSQVNHK 402
FS R +G G FG VY ++++ VVA+K S K N K Q ++ EV L ++ H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-WQDIIKEVRFLQKLRHP 75
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQT---AEALA 459
N ++ GC + L+ EY G+ D L + IA T + LA
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ-----EVEIAAVTHGALQGLA 129
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
YLHS + HRDVK+ NILL + K+ DFG + + P V GT ++ PE
Sbjct: 130 YLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPE 181
Query: 520 Y---YRNYQLTDKSDVYSYGVVLLEL 542
Q K DV+S G+ +EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 46/216 (21%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNH-KNLVRLLGC 410
+GSG G+VYK + G V+AVK + GN + +++L ++ ++ + + +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 411 CVEAEQPLLIYEYIA----------NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
+ + E ++ G + + + GK + + +AL Y
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK-------------MTVAIVKALHY 129
Query: 461 L---HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYL 516
L H + HRDVK +NILLD N K+ DFG+S RL S T + G Y+
Sbjct: 130 LKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYM 181
Query: 517 DPE------YYRNYQLTDKSDVYSYGVVLLELLTSQ 546
PE Y + ++DV+S G+ L+EL T Q
Sbjct: 182 APERIDPPDPNPKYDI--RADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
++LG G FG+V+ EL+ A+K+ K + V + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L E + EY+ G L H+ + F+L +T A + L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFY--AAEIICGLQFLHSKG- 116
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRNYQ 525
I +RD+K NILLD D + K+ADFG+ + G + T C GT Y+ PE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEILLGQK 172
Query: 526 LTDKSDVYSYGVVLLELLTSQ 546
D +S+GV+L E+L Q
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 352 RILGSGGFGEVY----KGELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKN 403
R+LG+G +G+V+ G G + A+K K I K+ + E +L V
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 404 LVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWS-TRLRIALQTAEALAYL 461
+ L + + L LI +Y+ G L HL Y + T S R+ IA + AL +L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHL---YQREHFTESEVRVYIA-EIVLALDHL 121
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
H I +RD+K NILLD + + + DFGLS+ + GT+ Y+ PE
Sbjct: 122 HQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 522 RNYQL--TDKSDVYSYGVVLLELLT 544
R D +S GV+ ELLT
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 68/201 (33%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQ-VNHKNLVR 406
+++G G FG+V + DG AVK + K + ++ E +L + V H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
L A++ + +Y+ G L HL + SF R R A + A AL YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHSLN 116
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRN 523
I +RD+K NILLD + + DFG L K G+ H T + GT YL PE R
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 524 YQLTDKS-DVYSYGVVLLELL 543
Q D++ D + G VL E+L
Sbjct: 171 -QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 49/200 (24%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+++ +G G G V+ ++ G VA+K + + ++NE+ ++ ++ + N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L + ++ ++ EY+A G+L D + + + + + + +AL +LH+
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHA--- 133
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
+ HRD+KS N+LL D + K+ DFG P S ST GT ++ PE
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 527 TDKSDVYSYGVVLLELLTSQ 546
K D++S G++ +E++ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 354 LGSGGFGEVY----KGELQDGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRL 407
LG G FG VY K + + + +K VG + T Q E +LS+++H +V+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHG-KYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+E + +I EY L L K++ L+ + +Q + Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR- 126
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
I HRD+K+ NI L ++ K+ DFG+SRL G ++T GT Y+ PE ++
Sbjct: 127 --ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 527 TDKSDVYSYGVVLLEL 542
KSD++S G +L E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 335 IFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEV 393
I + + KK F K +G G G VY ++ G VA++ + + ++NE+
Sbjct: 12 IVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
++ + + N+V L + ++ ++ EY+A G+L D + + + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRE 124
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
+AL +LHS + HRD+KS NILL D + K+ DFG P S ST GT
Sbjct: 125 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 180
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
++ PE K D++S G++ +E++ +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 44/262 (16%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAK-VGNIKSTQQVLNE 392
E+ +T F +E LG FG+VYKG L + VA+K+ K ++ +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 393 VGILSQVNHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHL-----HGKYSSFN----- 441
+ S++ H N+V LLG V EQPL +I+ Y ++ LH+ L H S +
Sbjct: 59 AMMRSRLQHPNIVCLLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 442 ---LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-L 497
L + + I Q A + +L S + H+D+ + N+L+ D N K++D GL R +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL----------TSQK 547
+ + + ++ PE + + SD++SYGVVL E+ ++Q
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
Query: 548 AIDFSRD------PDDVNLAIY 563
I+ R+ PDD +Y
Sbjct: 235 VIEMIRNRQVLPCPDDCPAWVY 256
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 45/273 (16%)
Query: 353 ILGSGGFGEVYKG-ELQDGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
ILG G G VYK L ++AVK + ++ +Q+++E+ IL + + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
+ + E++ G+L ++ K L RIA+ + L YL S I
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---IL 117
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKS 530
HRDVK +N+L++ K+ DFG+S ++ ++ GT Y+ PE Q S
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 531 DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME------VVD---PRL 581
DV+S G+ +EL R P Y + + G++M +VD P L
Sbjct: 175 DVWSLGISFMELA-------LGRFP-------YPQIQKNQGSLMPLQLLQCIVDEDPPVL 220
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPS 614
+ S + F C+R++ ERP+
Sbjct: 221 PVGQFS-------EKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLV 405
F+K +G G FGEV+KG + + VVA+K + + + + E+ +LSQ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLH-GKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ G ++ + +I EY+ G+ D L G + +T LR L+ L YLHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI--ATILREILK---GLDYLHSE 120
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
HRD+K+ N+LL + K+ADFG++ +L + GT ++ PE +
Sbjct: 121 KKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQ 175
Query: 524 YQLTDKSDVYSYGVVLLEL 542
K+D++S G+ +EL
Sbjct: 176 SAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHKNLV 405
E+I G G +G VYK + G +VA+K ++ + ST + E+ +L ++NH N+V
Sbjct: 5 EKI-GEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPST--AIREISLLKELNHPNIV 61
Query: 406 RLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKY----SSFNLTWSTRLRIALQTAEALAY 460
RLL V +E L L++E++ D KY L Q + +AY
Sbjct: 62 RLLDV-VHSENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
HS + HRD+K N+L+D + K+ADFGL+R
Sbjct: 115 CHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 351 ERI--LGSGGFGEVYKGELQD-GTVVAVK----SAKVGNIKSTQQVLNEVGILSQVNHKN 403
E++ +G G +G V+K ++ G +VA+K S IK L E+ +L Q+ H N
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI--ALREIRMLKQLKHPN 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHD---HLHG--KYSSFNLTWSTRLRIALQTAEAL 458
LV L+ + L++EY + L++ + G ++ + W QT +A+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW--------QTLQAV 113
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
+ H HRDVK NIL+ K+ DFG +R+ + T Y P
Sbjct: 114 NFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAP 169
Query: 519 EYY-RNYQLTDKSDVYSYGVVLLELLTSQ 546
E + Q DV++ G V ELLT Q
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 354 LGSGGFGEVYKGELQDGT-VVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLG 409
+G G FG+V + +D + A+K+ + +I S +V L E +L+QVN +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLHSAAY 466
E+ L+ +I G L HL + F+L+ R TAE AL LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLS-----RARFYTAELLCALENLHK--F 112
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRNYQ 525
IY RD+K NILLD + + DFGL +L +T C GT YL PE +
Sbjct: 113 NVIY-RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYLAPELLLGHG 169
Query: 526 LTDKSDVYSYGVVLLELLT 544
T D ++ GV+L E+LT
Sbjct: 170 YTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVG----NIKSTQQVLNEVGILSQVNHK 402
F K +G G +G VYK G VVA+K ++ + ST + E+ +L ++NH
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST--AIREISLLKELNHP 59
Query: 403 NLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL------QTA 455
N+V+LL + E L L++E+ LH L K+ + + + + + L Q
Sbjct: 60 NIVKLLDV-IHTENKLYLVFEF-----LHQDLK-KF--MDASPLSGIPLPLIKSYLFQLL 110
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLG 514
+ LA+ HS + HRD+K N+L++ + K+ADFGL+R P ++ TL
Sbjct: 111 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 165
Query: 515 YLDPE------YYRNYQLTDKSDVYSYGVVLLELLT 544
Y PE YY + D++S G + E++T
Sbjct: 166 YRAPEILLGCKYY-----STAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
++K +G G +G VYKG + G +VA+K ++ + + ST + E+ +L ++ H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPST--AIREISLLKELQHP 59
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHL----HGKYSSFNLTWSTRLRIALQTAEAL 458
N+V L ++ + LI+E+++ L +L G+Y L S Q + +
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKS----YLYQILQGI 114
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLD 517
+ HS + HRD+K N+L+D+ K+ADFGL+R P V T TL Y
Sbjct: 115 LFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRA 169
Query: 518 PEYYRNYQL-TDKSDVYSYGVVLLELLT 544
PE + D++S G + E+ T
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 10/197 (5%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKNLVRLLG 409
LG GGFGEV +++ G + A K +K Q LNE IL +V+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
+ L+ + G L H++ + + A Q L +LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
+RD+K N+LLDD N +++D GL+ K G GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 530 SDVYSYGVVLLELLTSQ 546
D ++ G L E++ +
Sbjct: 175 VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 354 LGSGGFGEV----YKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
LG+G FG V +KG + + +K ++ +K Q V E IL +++H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLH--GKY----SSFNLTWSTRLRIALQTAEALAYLHS 463
+ + + E++ G L HL G++ + F + L +A + YLHS
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF---YHAELVLAFE------YLHS 136
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
I +RD+K N+LLD+ + KV DFG ++ K + C GT YL PE ++
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLC--GTPEYLAPEVIQS 189
Query: 524 YQLTDKSDVYSYGVVLLELL 543
D ++ GV+L E +
Sbjct: 190 KGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 362 VYKGELQDGTVVAVKSAK---VGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418
+YKG + V +++ K G+ NE+ L +++ N++++ G ++ L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 419 ----LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV 474
LI EY G L + L +L++ T+L +A+ + L L+ P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 475 KSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEYYRNY--QLTDKSD 531
S + L+ +++ K+ GL + L+ P +V+ Y + + + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDD 204
Query: 532 VYSYGVVLLELLT 544
+YS GVVL E+ T
Sbjct: 205 IYSLGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 68/262 (25%), Positives = 105/262 (40%), Gaps = 72/262 (27%)
Query: 352 RILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQVL-NEVGILSQV-NHKN 403
++LG G FG+V + VAVK K G S + L +E+ IL + NH N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 404 LVRLLGCCVEAEQPLL-IYEYIANGTLHDHLHGK-------------------------- 436
+V LLG C + PL+ I E+ G L + L K
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 437 -------------YSSFNLT--------------WSTRLRI------ALQTAEALAYLHS 463
+S F + W + L + + Q A + +L S
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYR 522
HRD+ + NILL ++ K+ DFGL+R +V A+ L ++ PE
Sbjct: 193 ---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249
Query: 523 NYQLTDKSDVYSYGVVLLELLT 544
+ T +SDV+S+GV+L E+ +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ---QVLNEVGILSQVNHKN 403
F R+LG GGFGEV +++ G + A K + IK + LNE IL +VN +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+V L E + L + I NG L H+ Y+ N + + R AE L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQ-RAIFYAAELCCGLE 116
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I +RD+K NILLDD + +++D GL+ G + GT+GY+ PE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVIN 174
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQ 546
N + T D + G ++ E++ Q
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 84/316 (26%), Positives = 128/316 (40%), Gaps = 32/316 (10%)
Query: 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAK---VGNIKSTQQVLNEVGIL-SQVNHKNLVR 406
+++G G FG+V + + DG AVK + V N K + ++ E +L V H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
L E+ + +++ G L HL + SF R R A + A AL YLHS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHS-- 114
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRN 523
I +RD+K NILLD + + DFG L K G++ T GT YL PE R
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD---------VNLAIYVSQRASN--GA 572
+ D + G VL E+L + RD + + L S A +
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNILHKPLVLRPGASLTAWSILEE 229
Query: 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV--HELQRIIEIVN 630
++E R G + + F L+ L +KK P +V ++ +
Sbjct: 230 LLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFT 289
Query: 631 QEKVSNDVNVETAPEV 646
+E V V + +
Sbjct: 290 EETVPYSVCFSSDYSI 305
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 40/231 (17%)
Query: 346 NGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAK---VGNIKSTQQVLNEVGILSQVNH 401
+ F +++G G FGEV+ + G V A+K + + V E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 402 KNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
+V+L + E+ L L+ EY+ G L + L + F R IA + AL
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI-RKDVFPEET-ARFYIA-ELVLALDS 116
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS------------------------- 495
+H + HRD+K NIL+D D + K+ADFGL
Sbjct: 117 VHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 496 ---RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
R + GT Y+ PE R + D +S GV+L E+L
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 352 RILGSGGFGEVYKGELQDGT----VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
++LG G FG+V EL+ + A+K V + + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 408 LGCCVEAEQPLL-IYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
L C + ++ L + EY+ G L H+ G++ + A + L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFLHKK 115
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRN 523
I +RD+K N+LLD D + K+ADFG+ + G ST C GT Y+ PE +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEILKG 170
Query: 524 YQLTDKSDVYSYGVVLLELLTSQ 546
+ + D +S+GV+L E+L Q
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKST----QQVLNEVGILSQV 399
TN + + +G G FG V Q G VA+K K+ ST ++ E+ +L +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
H+N++ L + + + Y L LH +S L Q L
Sbjct: 67 RHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
Y+HSA + HRD+K +NIL++++ + K+ DFGL+R+ P ++ GY+
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVSTR 169
Query: 520 YYR------NYQLTD-KSDVYSYGVVLLELL 543
YYR +Q D + D++S G + E+L
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQDGT--VVAVKSAKVGNI---KSTQQVLNEVGILSQVNHK 402
F+ +LG G FG+V E + GT + A+K K I + + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 403 NLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALA 459
+ L C + L + EY+ G L H+ GK+ + + A + A L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAIGLF 115
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL-AKPGLSHVSTCAQGTLGYLDP 518
+LHS I +RD+K N++LD + + K+ADFG+ + G + + C GT Y+ P
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAP 170
Query: 519 EYYRNYQLTDKS-DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562
E YQ KS D +++GV+L E+L Q D D D++ +I
Sbjct: 171 EIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 45/221 (20%)
Query: 355 GSGGFGEVYKG---ELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKNLVRLL 408
G G +G VYK +DG A+K K + T Q E+ +L ++ H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 409 GCCVE-AEQPL-LIYEYIAN---GTLHDHLHGKYSSFN------LTWSTRLRIALQTAEA 457
+E A++ + L+++Y + + H K S L W Q
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW--------QILNG 120
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNS----KVADFGLSRLAKPGLSHVSTCAQG-- 511
+ YLHS + HRD+K NIL+ + K+ D GL+RL L A
Sbjct: 121 VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL---KPLADLDP 174
Query: 512 ---TLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQ 546
T+ Y PE R+Y T D+++ G + ELLT +
Sbjct: 175 VVVTIWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 14/221 (6%)
Query: 352 RILGSGGFGEVYKGELQDGTVV----AVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
R++G G + +V L+ + VK V + + V E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 408 LGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L C + L L+ EY+ G L H+ + L A + AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG- 116
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLA-KPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I +RD+K N+LLD D + K+ D+G+ + PG + + C GT Y+ PE R +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC--GTPNYIAPEILRGEE 172
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566
D ++ GV++ E++ + D D D+N Y+ Q
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 351 ERILGSGGFGEVYK-GELQDGTVVAVKSAK--VGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+R +G G FG V+ + +DG VA+K N+ S ++V E+ +L H N++
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 408 LGCCVEAEQPLLI--YE--YIANGTLHDHLHGKYSSFNLTWSTRLRIAL-QTAEALAYLH 462
L + QP I +E Y+ + LH S S +++ L Q L YLH
Sbjct: 65 L----DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY- 521
SA I HRD+K N+L++ + K+ DFGL+R+ +P S T T Y PE
Sbjct: 121 SAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 522 --RNYQLTDKSDVYSYGVVLLELL 543
R+Y T D++S G + ELL
Sbjct: 178 GSRHY--TSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
R LG G G V+ D VAVK + + +S + L E+ I+ +++H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 411 CVEAEQPLLIYEYIA-NGTLHDHLHGKYSSFNLTW------STRLRIAL----------- 452
+YE + +G+ G + N + T L L
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 453 ----QTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVST 507
Q L Y+HSA + HRD+K N+ ++ +D K+ DFGL+R+ P SH
Sbjct: 118 LFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 508 CAQGTLG--YLDPEYY---RNYQLTDKSDVYSYGVVLLELLT 544
++G + Y P NY T D+++ G + E+LT
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 44/192 (22%)
Query: 370 GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429
G VAVK + + + + NEV I+ H N+V + + ++ ++ E++ G L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 430 HDHLHGKYSSFNLTWSTRLR------IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD 483
D + TR+ + L +AL++LH+ + HRD+KS +ILL
Sbjct: 104 TD----------IVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTS 150
Query: 484 DFNSKVADFGLSRLAKPGLSHVSTCAQ------------GTLGYLDPEYYRNYQLTDKSD 531
D K++DFG CAQ GT ++ PE + D
Sbjct: 151 DGRVKLSDFGF-------------CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197
Query: 532 VYSYGVVLLELL 543
++S G++++E++
Sbjct: 198 IWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 67/211 (31%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGIL-SQVNHKNLVR 406
+++G G FG+V + + DG+ AVK + I K ++ E +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
L AE+ + +Y+ G L HL + F R R A + A A+ YLHS
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFL---EPRARFYAAEVASAIGYLHSLN 116
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRN 523
I +RD+K NILLD + + DFG L K G+ T + GT YL PE R
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFG---LCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554
D + G VL E+L +SRD
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPF-YSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 354 LGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+G G G V E G VAVK + + + + NEV I+ H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHR 472
E+ ++ E++ G L D + S L + +AL YLHS + HR
Sbjct: 89 VGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIHR 141
Query: 473 DVKSTNILLDDDFNSKVADFGL-SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSD 531
D+KS +ILL D K++DFG ++++K S GT ++ PE + D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVD 199
Query: 532 VYSYGVVLLELLTSQKAIDFSRDP 555
++S G++++E++ + FS P
Sbjct: 200 IWSLGIMVIEMVDGEPPY-FSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKN 403
+ +G G +G V G VA+K K+ + Q+ L E+ IL + H+N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 404 LVRLLGCCVEAEQPLLIYE----YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
++ +L + +P YI + L+ + +L+ Q L
Sbjct: 65 IIGIL----DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLD 517
Y+HSA + HRD+K +N+LL+ + + K+ DFGL+R+A P H + T Y
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 518 PEYYRNYQLTDKS-DVYSYGVVLLELLT 544
PE N + K+ D++S G +L E+L+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 31/275 (11%)
Query: 352 RILGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQ--VLNEVGILSQVNHKNLVRLL 408
R++G G +GEV DG +K + N ++ E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 409 GCCVEAEQPLL--IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
E E LL + + G L+ L + L + + +Q A AL YLH
Sbjct: 66 ESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
I HRD+K+ N+ L KV D G++R+ + ST GT Y+ PE + N
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPY 179
Query: 527 TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586
KSDV++ G + E+ T + A + D+N +Y + + P L
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEGKLPPMPKDYSPEL----- 230
Query: 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621
EL L ++ +RPS+ ++ +
Sbjct: 231 -----------GELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 75/299 (25%), Positives = 131/299 (43%), Gaps = 55/299 (18%)
Query: 353 ILGSGGFGEVYKGELQD-GTVVAVK-------SAKVGNIKSTQQVLNEVGILSQVNHKNL 404
++G G +G V K + ++ G +VA+K V I + E+ +L Q+ H+NL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI-----AMREIRMLKQLRHENL 62
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
V L+ ++ L++E++ + T+ D L KY + L S + Q + + HS
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDH-TVLDDLE-KYPN-GLDESRVRKYLFQILRGIEFCHS- 118
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEYYRN 523
I HRD+K NIL+ K+ DFG +R LA PG + Y+ +YR
Sbjct: 119 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--------YVATRWYRA 168
Query: 524 YQLTDKS-------DVYSYGVVLLELLTSQKAIDFSRDPDDV--------NLAIY---VS 565
+L D+++ G ++ E+LT + D D + NL +
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
Query: 566 QRASNGAIMEVVDPR----LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620
Q+ A M + + + L+ ++ L+ +LA CLR +RPS + ++H
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV-----LDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 9/196 (4%)
Query: 352 RILGSGGFGE--VYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
R++G G FG + + D + + + + E +L+++ H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 410 CCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
EA+ L ++ EY G L + + T L+ +Q + ++H
Sbjct: 66 S-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEKR--- 120
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD 528
+ HRD+KS NI L + K+ DFG +RL ++ T GT Y+ PE + N +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNN 179
Query: 529 KSDVYSYGVVLLELLT 544
KSD++S G +L EL T
Sbjct: 180 KSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 26/235 (11%)
Query: 352 RILGSGGFGEVYKGELQDGT--VVAVKSAKVGNIKSTQQV---LNEVGILS-QVNHKNLV 405
++LG G FG+V EL+ GT V A+K K I V + E IL+ H L
Sbjct: 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSA 464
L C ++ + EY+ G L + + F+ R R A + AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFD---EPRSRFYAAEVTLALMFLHRH 115
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA-KPGLSHVSTCAQGTLGYLDPEYYRN 523
+ +RD+K NILLD + + K+ADFG+ + G++ + C GT Y+ PE +
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDYIAPEILQE 170
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP--------DDVNLAIYVSQRASN 570
+ D ++ GV++ E++ Q + + DDV +++S+ A +
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVS 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIK-----STQQVLNEVGILSQVNHKNLVRL 407
+G G +G VYK + G VA+KS +V + ST + + + L +H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 408 LGCCVEAE-----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+ C + + L++E++ + L +L K L T + Q L +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
+ I HRD+K NIL+ K+ADFGL+R+ ++ TL Y PE
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLL 180
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555
D++S G + E+ F R P
Sbjct: 181 QSTYATPVDMWSVGCIFAEM--------FRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 352 RILGSGGFGEVYKGELQDGTVV----AVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVR 406
R++G G + +V L+ + VK V + + V E + Q NH LV
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHL---------HGKYSSFNLTWSTRLRIALQTAEA 457
L C + + EY+ G L H+ H ++ S ++ A
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------------A 108
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA-KPGLSHVSTCAQGTLGYL 516
L YLH I +RD+K N+LLD + + K+ D+G+ + +PG + + C GT Y+
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYI 163
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDF--SRDPDDVNLAIYVSQ 566
PE R D ++ GV++ E++ + D S D D N Y+ Q
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 338 LKELKKATNGFSKERILGSGGFGEVYKGELQDG-TVVAVKS-AKVGNIKSTQQVL--NEV 393
+ +L+ F +++G G FGEV + V A+K +K IK + E
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLT--WSTRLRI 450
I++ N + +V+L + ++ L ++ EY+ G L + + S++++ W R
Sbjct: 95 DIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKW-ARFYT 148
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCA 509
A + AL +HS + HRDVK N+LLD + K+ADFG ++ G+ T A
Sbjct: 149 A-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-A 203
Query: 510 QGTLGYLDPEYYRNY----QLTDKSDVYSYGVVLLELL 543
GT Y+ PE ++ + D +S GV L E+L
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 348 FSKERILGSGGFGEVY---KGELQD-GTVVAVKSAKVGNI----KSTQQVLNEVGILSQV 399
F ++LG+G +G+V+ K D G + A+K K I K+T+ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 400 NHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE-- 456
+ L + + L LI +YI G L HL S R R Q +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-----------SQRERFKEQEVQIY 110
Query: 457 ------ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR--LAKPGLSHVSTC 508
AL +LH I +RD+K NILLD + + + DFGLS+ S C
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 509 AQGTLGYLDPEYYRNYQLT-DKS-DVYSYGVVLLELLT 544
GT+ Y+ P+ R DK+ D +S GV++ ELLT
Sbjct: 168 --GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 348 FSKERILGSGGFGEVY---------KGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQ 398
F ++LG+G +G+V+ G+L V+ K+A V K+ + E +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQ-KAALVQKAKTVEHTRTERNVLEH 60
Query: 399 VNHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEA 457
V + L + E L LI +Y++ G + HL Y N + + + A
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL---YQRDNFSEDEVRFYSGEIILA 117
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR--LAKPGLSHVSTCAQGTLGY 515
L +LH I +RD+K NILLD + + + DFGLS+ L++ S C GT+ Y
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC--GTIEY 172
Query: 516 LDPEYYRNYQLTDKS-DVYSYGVVLLELLT 544
+ PE R K+ D +S G+++ ELLT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 354 LGSGGFGEVYKGELQDG---TVVAVKSAKV-GNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+G+G FG+V GE+ G V VK +V +++ + L E + H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEALAYLHSAAYT 467
C E LL+ E+ G L +L + +T R+A + A L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRL 497
H D+ N LL D K+ D+GLS
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 353 ILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQ---VLNEVGILSQVNHKNLVRLL 408
I+G GGFGEVY D G + A+K IK Q LNE +LS V+ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 409 GCCVEAEQP---LLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
P I + + G LH HL HG +S + + A + L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHN 115
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+ +RD+K NILLD+ + +++D GL+ H S GT GY+ PE +
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 524 YQLTDKS-DVYSYGVVLLELL 543
D S D +S G +L +LL
Sbjct: 170 GTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/199 (30%), Positives = 88/199 (44%), Gaps = 17/199 (8%)
Query: 352 RILGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRL 407
++LG G FG+V E G A+K K I + +V L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAAY 466
++ + EY+ G L HL S + R R + AL YLHS
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRNY 524
I +RD+K N++LD D + K+ DFG L K G++ +T GT YL PE +
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFG---LCKEGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 525 QLTDKSDVYSYGVVLLELL 543
D + GVV+ E++
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 47/213 (22%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLN--EVGILSQVN-HKNLVRLLG 409
+G G F EV K + G A+K K + KS +QV N E+ L +++ H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 410 CCVEAEQPLL----------IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
+ + L +YE I + L Q ++L
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKG-------RKRP----LPEKRVKSYMYQLLKSLD 114
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG-YLDP 518
++H I+HRD+K NIL+ DD K+ADFG R ++ Y+
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR---------GIYSKPPYTEYIST 161
Query: 519 EYYRNYQ--LTD-----KSDVYSYGVVLLELLT 544
+YR + LTD K D+++ G V E+L+
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVG----NIKSTQQVLNEVGILSQVNHK 402
+ K +G G +G+VYK + G +VA+K ++ I T L E+ +L ++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT--ALREISLLQMLSES 60
Query: 403 N-LVRLLGCCVE-----AEQPLL--IYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIAL 452
+VRLL VE +P L ++EY+ + L + +G+ L T
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSR-LAKPGLSHVSTCAQ 510
Q + +A+ H + HRD+K N+L+D K+AD GL R + P S+
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173
Query: 511 GTLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQ 546
TL Y PE +Y + D++S G + E+ Q
Sbjct: 174 -TLWYRAPEVLLGSTHY--STPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 352 RILGSGGFGEVYKGELQDGT--------VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN 403
++LG GG+G+V++ G V K+ V N K T E IL V H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLH--GKY----SSFNLTWSTRLRIALQTAEA 457
+V L+ + LI EY++ G L HL G + + F L+ I+L A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISL----A 112
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR--LAKPGLSHVSTCAQGTLGY 515
L +LH I +RD+K NILLD + K+ DFGL + + + ++H + C GT+ Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH-TFC--GTIEY 166
Query: 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
+ PE D +S G ++ ++LT
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 77/291 (26%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 352 RILGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRL 407
++LG G FG+V E G A+K K I + +V L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLHSA 464
++ + EY G L HL + F + R AE AL YLHS
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL-SRERVF-----SEDRARFYGAEIVSALGYLHSC 114
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYR 522
+ +RD+K N++LD D + K+ DFG L K G+S +T GT YL PE
Sbjct: 115 D---VVYRDLKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD---------DVNLAIYVSQRASN--- 570
+ D + GVV+ E++ + +++D + ++ +S A +
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLSPEAKSLLA 227
Query: 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621
G + + RL G +M + F+ + + +KK E P V E
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSE 278
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 354 LGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+G G G V E G VAVK + + + + NEV I+ +H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 413 EAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
++ ++ E++ G L D + H + + + + L AL+YLH+ + H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VIH 141
Query: 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSD 531
RD+KS +ILL D K++DFG + + GT ++ PE + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 532 VYSYGVVLLELLTSQ 546
++S G++++E++ +
Sbjct: 201 IWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 354 LGSGGFGEVYKGELQDGTVVA---VKSAKV-GNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+G+G FG+V E+ T VA VK K + K + L + + H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL-RIALQTAEALAYLHSAAYTP 468
CVEA LL++EY G L +L + + L R+A + A + ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL- 121
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGL--SRLAKPGLSHVST----CAQGTLGYLDPEYYR 522
H D+ N L D KV D+G+ SR + ++ T C L +L PE
Sbjct: 122 --HSDLALRNCFLTSDLTVKVGDYGIGPSRYKE---DYIETEDDKCV--PLRWLAPELVG 174
Query: 523 NYQ-------LTDKSDVYSYGVVLLELL 543
+ T S+V++ GV L EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKN 403
+ + K LG G + VYKG+ + +G +VA+K ++ + T + E +L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGT---LHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
+V L E L++EY+ + H G + + +L + Q L+Y
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE-----NVKLFL-FQLLRGLSY 118
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE- 519
+H I HRD+K N+L+ D K+ADFGL+R AK SH + TL Y P+
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557
+ + + D++ G + +E++ A +D D
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKV----GNIKSTQQVLNEVGI----------LSQ 398
LG G +G+V K G +VA+K K+ ++ +Q++ GI +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 399 VNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
+ H+N++ L+ VE + L+ + +A L + K LT S I LQ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGL 132
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS-TCAQG------ 511
LH HRD+ NI ++ K+ADFGL+R + G S T ++
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR--RYGYPPYSDTLSKDETMQRR 187
Query: 512 --------TLGYLDPE-YYRNYQLTDKSDVYSYGVVLLELLTSQKAI 549
TL Y PE + D++S G + ELLT K +
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPL 233
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVG-NIKSTQQVLNEVGI-LSQVNHKNLVRLLGC 410
LG G +G V K + GT++AVK + N + +++L ++ I + V+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEALAYLHSAAYTP 468
E + I + + +L D + K LT + +IA+ +AL YLHS
Sbjct: 69 LFR-EGDVWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LS 124
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLS-----RLAKPGLSHVSTCAQGTLGYLDPEYY-- 521
+ HRDVK +N+L++ + K+ DFG+S +AK T G Y+ PE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-------TIDAGCKPYMAPERINP 177
Query: 522 -RNYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDP 555
N + D KSDV+S G+ ++EL T + D + P
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ---QVLNEVGILSQVNHKN 403
F R+LG GGFGEV +++ G + A K + IK + LNE IL +VN +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALA 459
+V L E + L + + NG L H+ Y+ N + R AE L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEE-RAVFYAAEITCGLE 116
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
LH I +RD+K NILLDD + +++D GL+ G GT+GY+ PE
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPE 171
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQ 546
+N + T D + G ++ E++ +
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
LG GGFGEV +++ G + A K ++ K + + E IL++V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWST----RLRIALQTAEALAYLHSAA 465
+ + L + I NG +Y +N+ R TA+ ++ L
Sbjct: 60 YAFQTKTDLCLVMTIMNGG-----DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I +RD+K N+LLD+D N +++D GL+ K G S A GT G++ PE + +
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEE 173
Query: 526 LTDKSDVYSYGVVLLELLTSQ 546
D ++ GV L E++ ++
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 33/225 (14%)
Query: 332 PARIFHLKELKKATNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVL 390
PA IF L EL +G+G +G+VYKG ++ G + A+K V +++
Sbjct: 4 PAGIFELVEL------------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIK 50
Query: 391 NEVGILSQVNH-KNLVRLLGCCVEAEQP------LLIYEYIANGTLHDHL-HGKYSSFNL 442
E+ +L + +H +N+ G ++ P L+ E+ G++ D + + K ++
Sbjct: 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
W I + L++LH + HRD+K N+LL ++ K+ DFG+S +
Sbjct: 111 EWIAY--ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165
Query: 503 SHVSTCAQGTLGYLDPEYYRNYQLTD-----KSDVYSYGVVLLEL 542
+T GT ++ PE + D KSD++S G+ +E+
Sbjct: 166 GRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
+G G G V ++ G +VAVK + + + + NEV I+ H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 413 EAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
++ ++ E++ G L D + H + + + + L +AL+ LH+ + H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VIH 139
Query: 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSD 531
RD+KS +ILL D K++DFG + + GT ++ PE + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 532 VYSYGVVLLELLTSQ 546
++S G++++E++ +
Sbjct: 199 IWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 72/303 (23%), Positives = 115/303 (37%), Gaps = 57/303 (18%)
Query: 348 FSKERILGSGGFGEVYK-GELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
F K LG+G G V K G ++A K + IK Q++ E+ +L + N +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSPYI 61
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALAYL- 461
V G + + E++ G+L L G+ L +I++ L YL
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLR 116
Query: 462 --HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLD 517
H I HRDVK +NIL++ K+ DFG+S G S GT Y+
Sbjct: 117 EKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMS 166
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLT----------SQKAIDFSRDPDDVNLAIYVSQR 567
PE + T +SD++S G+ L+E+ + F R +
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226
Query: 568 ASNG-------AIMEVVD-------PRLQGHEASVNILMSLKLFSELAVACLREKKSERP 613
+ + AI E++D P+L S F + CL++ ER
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS-------DEFQDFVDKCLKKNPKERA 279
Query: 614 SMT 616
+
Sbjct: 280 DLK 282
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 353 ILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQ---VLNEVGILSQVNHKNLVRLL 408
I+G GGFGEVY D G + A+K IK Q LNE +LS V+ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 409 GCCVEA----EQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLH 462
C A ++ I + + G LH HL HG +S + + A + L ++H
Sbjct: 61 -CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-----YAAEIILGLEHMH 114
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
+ + +RD+K NILLD+ + +++D GL+ H S GT GY+ PE +
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 523 NYQLTDKS-DVYSYGVVLLELL 543
D S D +S G +L +LL
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNE-----------VGILSQVNHK 402
LG G F +YKG L+ + + + + +VL ++SQ++HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVG-PGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+LV+L G CV E +++ EY+ G L LH + ++ +L W +L +A Q A AL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 463 SAAYTPIYHRDVKSTNILL--DDDFNSKVADFGLSRLAKPGLSHVSTCA------QGTLG 514
+ H +V NIL+ V LS PG + +
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLS---DPG---IPITVLSREERVERIP 169
Query: 515 YLDPEYYRNYQ--LTDKSDVYSYGVVLLEL 542
++ PE RN Q LT +D +S+G LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/225 (25%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 332 PARIFHLKELKKATNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVL 390
PA IF L E ++G+G +G+VYKG ++ G + A+K V +++
Sbjct: 14 PAGIFELVE------------VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIK 60
Query: 391 NEVGILSQVNH-KNLVRLLGCCVEAEQP------LLIYEYIANGTLHDHL-HGKYSSFNL 442
E+ +L + +H +N+ G ++ P L+ E+ G++ D + + K ++
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
W I + LA+LH+ + HRD+K N+LL ++ K+ DFG+S +
Sbjct: 121 DWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 503 SHVSTCAQGTLGYLDPEYYRNYQLTD-----KSDVYSYGVVLLEL 542
+T GT ++ PE + D +SD++S G+ +E+
Sbjct: 176 GRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 21/219 (9%)
Query: 353 ILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLL 408
+LG G FG+V E + + A+K K + V + E +L+ + + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 409 GCCVEAEQPL-LIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
C + L + EY+ G L H+ GK+ + A + + L +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-----YAAEISVGLFFLHRRG 121
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK-PGLSHVSTCAQGTLGYLDPEYYRNY 524
I +RD+K N++LD + + K+ADFG+ + G++ + C GT Y+ PE Y
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--GTPDYIAPEIIA-Y 175
Query: 525 QLTDKS-DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562
Q KS D ++YGV+L E+L Q D D D++ +I
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHKNLVRLL 408
+G G +G V+K + ++ +VA+K ++ + + S+ L E+ +L ++ HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--ALREICLLKELKHKNIVRLY 65
Query: 409 GCCVEAEQPLLIYEYIANG--TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
++ L++EY D +G + Q + LA+ HS
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGD-----IDPEIVKSFMFQLLKGLAFCHSHN- 119
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ-GTLGYLDPEYYRNYQ 525
+ HRD+K N+L++ + K+ADFGL+R G+ A+ TL Y P+ +
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 526 LTDKS-DVYSYGVVLLEL 542
L S D++S G + EL
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 16/220 (7%)
Query: 336 FHLKELKKAT----NGFSKERILGSGGFGEVYKGELQD-GTVVAVK--SAKVGNIKSTQQ 388
F+ +EL K + + +GSG +G+V G VA+K S + ++
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60
Query: 389 VLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE-YIANGTLHDHLHGKYSSFNLTWSTR 447
E+ +L ++H+N++ LL A + Y+ + L+ L+
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
+ Q L Y+HSA I HRD+K +NI +++D K+ DFGL+R T
Sbjct: 121 QFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMT 173
Query: 508 CAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQ 546
T Y PE N+ D++S G ++ ELLT +
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 35/205 (17%)
Query: 357 GGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNLVRLLGCCVE 413
G +G VY+ + + G +VA+K K+ K + L E+ IL ++ H N+V + V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 414 A--EQPLLIYEYIANG--TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
+ ++ ++ EY+ + +L + + + S + LQ +A+LH I
Sbjct: 76 SNLDKIYMVMEYVEHDLKSLMETMKQPFLQ-----SEVKCLMLQLLSGVAHLHDNW---I 127
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRL----AKPGLSHVSTCAQGTLGYLDPE------ 519
HRD+K++N+LL++ K+ DFGL+R KP V TL Y PE
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYRAPELLLGAK 182
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLT 544
Y + D++S G + ELLT
Sbjct: 183 EY-----STAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 347 GFSKERILGSGGFGEVY--KGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
G++ + L G G V+ Q VV K+G +T L E +L VNH ++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVL----KIGQKGTT---LIEAMLLQNVNHPSV 119
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+R+ V ++ + + L+ +L + S L L I Q E L YLH+
Sbjct: 120 IRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSR--LAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRDVK+ NI ++D + D G ++ + P ++ GT+ PE
Sbjct: 177 R---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVETNAPEVLA 229
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAI--DFSRDPDD 557
+ K+D++S G+VL E+L I D P++
Sbjct: 230 RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/200 (31%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGIL-SQVNHKNLVR 406
+++G G FG+V + + AVK + I K + +++E +L V H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
L A++ + +YI G L HL + R R A + A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL----EPRARFYAAEIASALGYLHSLN 116
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRN 523
I +RD+K NILLD + + DFG L K + H T + GT YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 524 YQLTDKSDVYSYGVVLLELL 543
D + G VL E+L
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 354 LGSGGFGEVYKG-ELQDG-TVVAVKSAKVGNIKSTQ--QVLNEVGILSQVN---HKNLVR 406
+G G +G+V+K +L++G VA+K +V + + EV +L + H N+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 407 LLGCCV----EAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
L C + E L L++E++ + L +L K + T + Q L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
HS + HRD+K NIL+ K+ADFGL+R+ T TL Y PE
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVL 181
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558
D++S G + E+ + S D D +
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 51/218 (23%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI-KSTQQVLNEV-GILSQVNHKNLVRLLG- 409
+G G FG V K GT++AVK + K +++L ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 410 ------C--CVEAEQPLL--IYEYI---ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE 456
C C+E L Y+Y+ + + + GK IA+ T +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK-------------IAVATVK 118
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-----RLAKPGLSHVSTCAQG 511
AL YL I HRDVK +NILLD + N K+ DFG+S +AK T G
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-------TRDAG 169
Query: 512 TLGY-----LDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
Y +DP Y + +SDV+S G+ L E+ T
Sbjct: 170 CRPYMAPERIDPSARDGYDV--RSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 354 LGSGGFGEVYKG---ELQDGTVVAVKSAKVGNIKS----TQQVLNEVGILSQV-NHKNLV 405
LG G +G V E + VA+K K+ N+ S ++ L E+ +L HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 406 RLLGCCVEAEQP-------LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
C + + L +YE + LH + S LT + Q L
Sbjct: 66 ----CLYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPLTDAHFQSFIYQILCGL 118
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS---TCAQGTLGY 515
Y+HSA + HRD+K N+L++ D K+ DFGL+R + T T Y
Sbjct: 119 KYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 516 LDPEYYRNYQLTDKS-DVYSYGVVLLELL 543
PE ++Q K+ DV+S G +L ELL
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 53/195 (27%), Positives = 76/195 (38%), Gaps = 20/195 (10%)
Query: 357 GGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLN---EVGIL-SQVNHKNLVRLLGCC 411
G FG VY + + G A+K K ++ + QV N E I+ Q + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471
+ L+ EY+ G L W+ + + + LH I H
Sbjct: 67 QSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIH 120
Query: 472 RDVKSTNILLDDDFNSKVADFGLSR--LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
RD+K N+L+D + K+ DFGLSR L GT YL PE
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILGVGDDKM 173
Query: 530 SDVYSYGVVLLELLT 544
SD +S G V+ E L
Sbjct: 174 SDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 37/100 (37%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS-HVSTCAQ 510
+Q A+ ++HS + HRD+KS NILL + K+ DFG S++ +S V
Sbjct: 150 IQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAID 550
GT Y+ PE +R + K+D++S GV+L ELLT ++ D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 15/210 (7%)
Query: 339 KELKKATNGFSKERILGSGGFGEVYKGELQDGTV--VAVK---SAKVGNIKSTQQVLNEV 393
++ K F+ R LG+G FG V ++ VA+K +K+ K V +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
IL+ +NH V L G + L+ E++ G L N A Q
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---DVGCFYAAQ 139
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
YL S I +RD+K N+LLD D K+ DFG +++ + C GT
Sbjct: 140 IVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYTLC--GTP 192
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
Y+ PE N +D ++ G+ + E+L
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
++ N ++L + +LI +YI +G L D L + L+ + +I Q EAL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALN 123
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKV--ADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
LH H D+K N+L D ++ D+GL ++ +C GTL Y
Sbjct: 124 DLHKHNII---HNDIKLENVLY-DRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFS 174
Query: 518 PEYYR--NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558
PE + NY ++ D ++ GV+ ELLT + F D D+
Sbjct: 175 PEKIKGHNYDVS--FDWWAVGVLTYELLTGKHP--FKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 354 LGSGGFGEVY---KGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+G+G FGEV+ Q+ S + + Q++ EV ++ ++ HKN+VR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 411 CV-EAEQPLLI-YEYIANGTLHDHLHGKYSSF-NLTWSTRLRIALQTAEALAYLHSAAYT 467
+ +A Q L I E+ G L ++ Y F + + I Q ALAY H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 468 P----IYHRDVKSTNILLD-------------DDFN----SKVADFGLSRLAKPGLSHVS 506
P + HRD+K NI L ++ N +K+ DFGLS+ G+ ++
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESMA 198
Query: 507 TCAQGTLGYLDPE--YYRNYQLTDKSDVYSYGVVLLELLTSQ----KAIDFSR 553
GT Y PE + DKSD+++ G ++ EL + + KA +FS+
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+GSG +G V + + G VAVK S +I ++ E+ +L + H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 82
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR------IALQTAEALAYLHSA 464
+ P E + L HL G + N+ +L + Q L Y+HSA
Sbjct: 83 --DVFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I HRD+K +N+ +++D K+ DFGL+R + T T Y PE N+
Sbjct: 140 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNW 192
Query: 525 QLTDKS-DVYSYGVVLLELLTSQ 546
+++ D++S G ++ ELLT +
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/199 (29%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 352 RILGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRL 407
++LG G FG+V E G A+K + I + +V + E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAAY 466
++ + EY G L HL S + R R + AL YLHS
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS--- 113
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRNY 524
+ +RD+K N++LD D + K+ DFG L K G+S +T GT YL PE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 525 QLTDKSDVYSYGVVLLELL 543
D + GVV+ E++
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 352 RILGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRL 407
++LG G FG+V E G A+K K I + +V L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAAY 466
++ + EY G L HL S + R R + AL YLHS
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLA-KPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
+ +RD+K N++LD D + K+ DFGL + K G + + C GT YL PE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 526 LTDKSDVYSYGVVLLELL 543
D + GVV+ E++
Sbjct: 173 YGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 352 RILGSGGFGEVYKGELQDGTVV----AVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVR 406
R++G G + +V EL+ + +K V + + V E + NH LV
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHL---------HGKYSSFNLTWSTRLRIALQTAEA 457
L C + + E+++ G L H+ H ++ S I+L A
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS--------AEISL----A 108
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA-KPGLSHVSTCAQGTLGYL 516
L +LH I +RD+K N+LLD + + K+ D+G+ + +PG + + C GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYI 163
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDF--SRDPDDVNLAIYVSQ 566
PE R D ++ GV++ E++ + D D D N Y+ Q
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQDGT--VVAVKSAKVGNIKSTQQV---LNEVGILSQVNHK 402
F+ +LG G FG+V E + GT + A+K K + V + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 403 NLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALA 459
+ L C + L + EY+ G L + G++ + + A + A L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAIGLF 115
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK-PGLSHVSTCAQGTLGYLDP 518
+LHS I +RD+K N++LD + + K+ADFG+ + G++ + C GT Y+ P
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--GTPDYIAP 170
Query: 519 EYYRNYQLTDKS-DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562
E YQ KS D +++GV+L E+L Q + D D++ +I
Sbjct: 171 EIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
+ K +G G +G VYK + +A+K ++ + ST + E+ +L ++ H
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPST--AIREISLLKEMQHG 61
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEALAY 460
N+VRL ++ L++EY+ + L H+ SS + + RL Q +AY
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMD---SSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSR-LAKPGLSHVSTCAQGTLGYLDP 518
HS + HRD+K N+L+D N+ K+ADFGL+R P + TL Y P
Sbjct: 118 CHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAP 172
Query: 519 EYY---RNYQLTDKSDVYSYGVVLLELLTSQ 546
E R+Y + D++S G + E++ +
Sbjct: 173 EILLGSRHY--STPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 346 NGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLN---EVGILSQVNH 401
+ F +++G G FGEV + +D G + A+K + + +QV + E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 402 KNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
+V+L + E L LI EY+ G + L K +F TR IA +T A+
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEE-ETRFYIA-ETILAIDS 116
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL--SHVSTCAQGTLGYLDP 518
+H Y HRD+K N+LLD + K++DFGL GL SH
Sbjct: 117 IHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSH------------RT 157
Query: 519 EYYRNY 524
E+YR
Sbjct: 158 EFYRIL 163
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 56/188 (29%), Positives = 83/188 (44%), Gaps = 17/188 (9%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKNLVRLLG 409
LG GGFGEV ++++ G + A K +K + L E IL +VN +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
L+ + G L H++ L + + Q + +LHS I
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
+RD+K N+LLDD N +++D GL+ K G + T GT GY+ PE K
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEIL-------K 167
Query: 530 SDVYSYGV 537
+ YSY V
Sbjct: 168 EEPYSYPV 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 31/222 (13%)
Query: 338 LKELKKATNGFSKERILGSGGFGEV----YKGELQDGTVVAVKS-AKVGNIKSTQQVL-- 390
+++L+ + +++G G FGEV +K + V A+K +K IK +
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK---VYAMKLLSKFEMIKRSDSAFFW 91
Query: 391 NEVGILSQVNHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNL--TWSTR 447
E I++ N +V+L C + ++ L ++ EY+ G L + + S++++ W+
Sbjct: 92 EERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAK- 145
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVS 506
TAE + L + + HRDVK N+LLD + K+ADFG ++ + G+
Sbjct: 146 ----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 507 TCAQGTLGYLDPEYYRNYQLTD-----KSDVYSYGVVLLELL 543
T A GT Y+ PE ++ Q D + D +S GV L E+L
Sbjct: 202 T-AVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKST-QQVLNEVGILSQVNHKNLVRLLGCC 411
LG G +G VYK + G +A+K ++ +S Q++ E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL-RIALQTAEALAYLHSAAYTPIY 470
+ EY+ G+L D L+ + L RI + L +L I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD-- 528
HRDVK TN+L++ + K+ DFG+S L+ + Q Y+ PE ++
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ---SYMAPERIKSGGPNQNP 182
Query: 529 ----KSDVYSYGVVLLEL 542
+SDV+S G+ +LE+
Sbjct: 183 TYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 22/201 (10%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKST-QQVLNEVGILSQVNHKNLVRLLGCC 411
LG G + VYKG + G +VA+K + + T + E+ ++ ++ H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 412 VEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
+ +L++EY+ + L ++ HG + + +T Q + +A+ H +
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDP--NTVKSFTYQLLKGIAFCHE---NRV 121
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQG--TLGYLDPEYY---RN 523
HRD+K N+L++ K+ADFGL+R P V+T + TL Y P+ R
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIP----VNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 524 YQLTDKSDVYSYGVVLLELLT 544
Y + D++S G ++ E++T
Sbjct: 178 Y--STSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVG---ILSQVNHKNLVRLLG 409
+G G FG+VY+ +D + A+K I + ++V + +G IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 410 CCVEAEQP---LLIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ L+ +Y++ G L HL G++S + IA + AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIA-ELVLALEHLHK- 114
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYR 522
I +RD+K NILLD + + DFGLS K L+ T GT YL PE
Sbjct: 115 --YDIVYRDLKPENILLDATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 523 NYQ-LTDKSDVYSYGVVLLEL 542
+ + T D +S GV++ E+
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-08
Identities = 27/108 (25%), Positives = 41/108 (37%), Gaps = 12/108 (11%)
Query: 34 CP-SCGPIQVPYPLSTNPKCG-DPNYLLRCD--LHSHKLYFDALNGSSYLVLR-TMASSQ 88
CP CG + +PYP P C DP + L C+ +L L +Y VL ++A+
Sbjct: 4 CPDRCGNVSIPYPFGIGPGCARDPGFELTCNNTTSPPRLL---LGNGNYEVLSISLANGT 60
Query: 89 RIVMQPASWINDSCVTHDMVTSEGLWLNQSLPFNV-TSSNTIFLFNCS 135
V+ P S + PF +S N + C+
Sbjct: 61 VRVLDPISSNCYNSSGKRTDNGSLSL---GGPFFFSSSRNKFVVVGCN 105
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+ + + +GSG G V + G VAVK S N ++ E+ +L VNHKN+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 405 VRLLGC-----CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
+ LL +E Q + + + + L +H + +++ + Q +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-----LLYQMLCGIK 137
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
+LHSA I HRD+K +NI++ D K+ DFGL+R A + T T Y PE
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPE 192
Query: 520 YYRNYQLTDKSDVYSYGVVLLELL 543
+ D++S G ++ EL+
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
+ +GSG +G V + + G VA+K K+ + ++ L E+ IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 403 NLVRLLGCCVEAEQPLLIYEYIA----NGTLHDHLHGKYSSFNLTWSTRLRIAL-QTAEA 457
N++ + + Y+ LH +H S LT +R L Q
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMESDLHHIIH---SDQPLT-EEHIRYFLYQLLRG 119
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQ--GTLG 514
L Y+HSA + HRD+K +N+L+++D ++ DFG++R L+ H + T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 515 YLDPE-YYRNYQLTDKSDVYSYGVVLLELL 543
Y PE + T D++S G + E+L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 391 NEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH--------DHLHGKYSSFNL 442
+E+ L+ +H +V+ ++ LLI EY + G L+ +HL + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
+ Q AL +HS + HRD+KS NI L K+ DFG S+ +
Sbjct: 174 LF-------YQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 503 S-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
S V++ GT YL PE + + + K+D++S GV+L ELLT
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 338 LKELKKATNGFSKERILGSGGFGEVYK-GELQDGTVVAVKSAK-VGNIKSTQQVLNEVGI 395
L+ L T+ + +G G +G+VYK +DG++ AVK + ++ +++ E I
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD--EEIEAEYNI 71
Query: 396 LSQV-NHKNLVRLLGCCVEAE-----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR 449
L + NH N+V+ G +A+ Q L+ E G++ + + G L RL
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-----LICGQRLD 126
Query: 450 ---IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHV 505
I+ AL L I HRDVK NILL + K+ DFG+S +L L
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 506 STCAQGTLGYLDPEYYRNYQLTDKS-----DVYSYGVVLLEL 542
++ GT ++ PE Q D S DV+S G+ +EL
Sbjct: 187 TSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 335 IFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGT-VVAVKS-AKVGNIKSTQQVL-- 390
I +++L+ + +++G G FGEV + V A+K +K IK +
Sbjct: 32 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 391 NEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH-----GKYSSFNLTWS 445
E I++ N +V+L + ++ EY+ G L + + K++ F ++
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF---YT 148
Query: 446 TRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSH 504
+ +AL ++ ++H RDVK N+LLD + K+ADFG ++ K G+
Sbjct: 149 AEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199
Query: 505 VSTCAQGTLGYLDPEYYRNYQLTD-----KSDVYSYGVVLLELL 543
T A GT Y+ PE ++ Q D + D +S GV L E+L
Sbjct: 200 CDT-AVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 336 FHLKELKKAT----NGFSKERILGSGGFGEV---YKGELQDGTVVAVKSAKVGNIKSTQQ 388
F+ +EL K + +GSG +G V Y L+ V S ++ ++
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR 60
Query: 389 VLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE-YIANGTLHDHLHGKYSSFNLTWSTR 447
E+ +L + H+N++ LL A E Y+ + L+ L+
Sbjct: 61 TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
+ Q L Y+HSA I HRD+K +N+ +++D ++ DFGL+R A + T
Sbjct: 121 QFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----T 173
Query: 508 CAQGTLGYLDPEYYRNYQLTDKS-DVYSYGVVLLELL 543
T Y PE N+ +++ D++S G ++ ELL
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 351 ERI--LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLVR 406
ERI LG+G G V K + + ++ + IK Q++ E+ +L + N +V
Sbjct: 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
G + + E++ G+L L + + ++++ LAYL
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH- 123
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
I HRDVK +NIL++ K+ DFG+S + ++ GT Y+ PE +
Sbjct: 124 -QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTHY 179
Query: 527 TDKSDVYSYGVVLLELLTSQKAI 549
+ +SD++S G+ L+EL + I
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 346 NGFSKERILGSGGFGEV-YKGELQDGTVVAVKS-AKVGNIKSTQ--QVLNEVGILSQVNH 401
F +++G G FGEV + G + A+K+ K K Q V E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
+V L +A+ LI E++ G L L KY +F+ TR +A + A+ +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSED-VTRFYMA-ECVLAIEAV 117
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495
H + HRD+K NIL+D + K++DFGLS
Sbjct: 118 HKLGFI---HRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQV----LNEVGILSQVNHKNLVRLL 408
LG G + VYKG + +G +VA+K V ++K+ + V + E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK---VISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 409 GCCVEAEQPLLIYEYIAN----------GTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
E ++EY+ G LH + + RL Q L
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY------------NVRL-FMFQLLRGL 116
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
AY+H I HRD+K N+L+ K+ADFGL+R AK S + TL Y P
Sbjct: 117 AYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPP 172
Query: 519 EYYRNYQLTDKS---DVYSYGVVLLELLTSQKA 548
+ TD S D++ G + +E+L Q A
Sbjct: 173 DVLLGA--TDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 18/198 (9%)
Query: 354 LGSGGFGEV---YKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+GSG G V Y L+ + S N ++ E+ ++ VNHKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 411 -----CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+E Q + I + + L + + +++ + Q + +LHSA
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 146
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I HRD+K +NI++ D K+ DFGL+R A G S + T T Y PE
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 526 LTDKSDVYSYGVVLLELL 543
+ D++S G ++ E++
Sbjct: 202 YKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 19/245 (7%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST--QQVLNEVGILS 397
ELK + F K LG+G G V+K + ++ + IK Q++ E+ +L
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 398 QVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH--GKYSSFNLTWSTRLRIALQTA 455
+ N +V G + + E++ G+L L G+ L ++++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 113
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515
+ L YL I HRDVK +NIL++ K+ DFG+S + ++ GT Y
Sbjct: 114 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSY 168
Query: 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
+ PE + + +SD++S G+ L+E+ + I PD L +
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP---PPDAKELELMFGCPVEGDPAES 225
Query: 576 VVDPR 580
PR
Sbjct: 226 ETSPR 230
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 23/205 (11%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+ + K + T+VAVK + + + + + E+ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 410 CCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
+ + ++ +A G+ D L H L + L+ L AL Y+HS +
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLN---ALDYIHSKGFI 123
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLS--------RLAKPGLSHVSTCAQGTLGYLDPE 519
HR VK+++ILL D ++ S R S + L +L PE
Sbjct: 124 ---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS--SVKNLPWLSPE 178
Query: 520 -YYRNYQ-LTDKSDVYSYGVVLLEL 542
+N Q +KSD+YS G+ EL
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 354 LGSGGFGEVYKG--ELQDGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKNLVRLLGC 410
LG G + VYKG +L D +VA+K ++ + + + EV +L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
+ L++EY+ + L +L +S N+ + +L + Q L Y H +
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFL-FQLLRGLNYCHRRK---VL 126
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YYRNYQLTDK 529
HRD+K N+L+++ K+ADFGL+R AK + + TL Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 530 SDVYSYGVVLLELLTSQ 546
D++ G + E+ T +
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-08
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 44/228 (19%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAK---VGNIKSTQQVLNEVGILSQVNHKNLVRL 407
R++G GG GEVY + VA+K + N ++ L E I + + H +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNL--------TWSTRLRIALQTAEALA 459
C + + YI TL L + +L + L I + +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 460 YLHSAAYTPIYHRDVKSTNILL---------------------DDDFNSKVADFGL--SR 496
Y+HS + HRD+K NILL +D + V + + S
Sbjct: 128 YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ PG GT Y+ PE ++ +D+Y+ GV+L ++LT
Sbjct: 185 MTIPGK------IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 354 LGSGGFGEV---YKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+GSG G V Y L + S N ++ E+ ++ VNHKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 411 -----CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+E Q + + + + L + + +++ + Q + +LHSA
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 139
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I HRD+K +NI++ D K+ DFGL+R A G S + T T Y PE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 526 LTDKSDVYSYGVVLLELL 543
+ D++S G ++ E++
Sbjct: 195 YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKNLVRLLGCC 411
LG G + V+KG + +VA+K ++ + + + EV +L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 412 VEAEQPL-LIYEYIANGTLH--DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
+ E+ L L++EY+ + D+ S N+ Q L+Y H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-----FMFQLLRGLSYCHKRK--- 123
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-NYQLT 527
I HRD+K N+L+++ K+ADFGL+R AK + + TL Y P+ + + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 528 DKSDVYSYGVVLLELLTSQ 546
D++ G +L E+ T +
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 354 LGSGGFGEVYKG-ELQDGTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+GSG +G V + + G VA+K S + ++ E+ +L + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 411 CVEAEQPLLIYE-YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
A + Y+ + L K L+ + Q L Y+HSA I
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ-KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---I 138
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+K N+ +++D K+ DFGL+R A ++ T Y PE N+ ++
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILNWMHYNQ 194
Query: 530 S-DVYSYGVVLLELLTSQ 546
+ D++S G ++ E+LT +
Sbjct: 195 TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 39/114 (34%), Positives = 52/114 (45%), Gaps = 11/114 (9%)
Query: 351 ERILGSGGFGEVYK------GELQDGTVVAVKSAKVGNIKSTQQVL-NEVGILSQV-NHK 402
+ LG G FG+V + + VAVK K G S + L E+ IL + +H
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71
Query: 403 NLVRLLGCCVEAEQPLL-IYEYIANGTLHDHLHGKYSSF--NLTWSTRLRIALQ 453
N+V LLG C + PL+ I EY G L ++L K F STR R Q
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQ 125
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 17/212 (8%)
Query: 346 NGFSKERILGSGGFGEVY-KGELQDGTVVAVKSAK---VGNIKSTQQVLNEVGILSQVNH 401
F + ++G G FGEV E G + A+K K + ++ E ILS N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
+ +L + + L+ EY G L L+ F+ + + +A + A+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA-QFYLA-ELVLAIHSV 118
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEY 520
H Y HRD+K N+L+D + K+ADFG + RL + S GT Y+ PE
Sbjct: 119 HQMGYV---HRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEV 174
Query: 521 YRNYQLTDKS------DVYSYGVVLLELLTSQ 546
K D +S GV+ E++ +
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKNLVRLLGCC 411
LG G + VYKG + G +VA+K ++ + + + E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHDI 71
Query: 412 VEAEQPL-LIYEYIANGTLHDHL------HGKYSSFNLTWSTRLRIAL-QTAEALAYLHS 463
+ ++ L L++EY L L G S + +R+ L Q LAY H
Sbjct: 72 IHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMH-----NVRLFLFQLLRGLAYCHQ 121
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY-- 521
+ HRD+K N+L+ + K+ADFGL+R AK S + TL Y P+
Sbjct: 122 RR---VLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 522 -RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557
Y + D++ G + E+ T + S D +D
Sbjct: 178 STEY--STSLDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKN 403
F K ++LG G G V+ L+ G + A+K ++ ++VL E IL+ ++H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLH---GKYSSFNLTWSTRLRIALQTAEALAY 460
L L L+ +Y G L L GK S R A AL Y
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE---VARFYAAEVLL-ALEY 118
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500
LH +Y RD+K NILL + + ++DF LS+ +
Sbjct: 119 LHLLGI--VY-RDLKPENILLHESGHIMLSDFDLSKQSDV 155
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+ +GSG G V + G VA+K S N+ ++ E+ ++ VNHKN++ LL
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 409 GC-----CVEAEQPLLIYEYIANGTLH-------DHLHGKYSSFNLTWSTRLRIAL-QTA 455
+E Q + + + + L DH R+ L Q
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH-------------ERMSYLLYQML 128
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515
+ +LHSA I HRD+K +NI++ D K+ DFGL+R A G S + T T Y
Sbjct: 129 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYY 183
Query: 516 LDPEYYRNYQLTDKSDVYSYGVVLLELL 543
PE + D++S G ++ E++
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 59/245 (24%), Positives = 97/245 (39%), Gaps = 52/245 (21%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVV-AVKSAKVGNIKSTQQVLN---EVGILSQVNHKN 403
F K + +G G FGEV D + A+K+ + ++ Q + E IL++ +++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+V+L + + + +YI G + L + F + R IA + A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLA-RFYIA-ELTCAIESVHK 119
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGL---------SRLAKPG------------- 501
+ HRD+K NIL+D D + K+ DFGL S+ + G
Sbjct: 120 MGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 502 LSHVSTCAQ--------------------GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLE 541
S + C GT Y+ PE T D +S GV+L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 542 LLTSQ 546
+L Q
Sbjct: 237 MLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 39/216 (18%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLV 405
+ ++G G +G V + G VA+K K+ ++ ++L E+ +L + H ++V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 406 RLLGCCV-----EAEQPLLIYEYIANGTLH------DHLHGKYSSFNLTWSTRLRIALQT 454
+ + E + +++E + LH D L ++ F L Q
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL---------YQL 112
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA--KPGLSHVSTCAQGT 512
AL Y+H+A ++HRD+K NIL + D K+ DFGL+R+A + T T
Sbjct: 113 LRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 513 LGYLDPE----YYRNYQLTDKSDVYSYGVVLLELLT 544
Y PE ++ Y T D++S G + E+LT
Sbjct: 170 RWYRAPELCGSFFSKY--TPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 354 LGSGGFGEVYK-GELQDGTVVAVKSAK-VGNIKSTQQVLNEVGILSQV-NHKNLVRLLGC 410
+G G +G+V+K ++G+ AVK + +I +++ E IL + +H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGM 83
Query: 411 -----CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR---IALQTAEALAYLH 462
+Q L+ E G++ D + G L R+ IA EAL L
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGF-----LKRGERMEEPIIAYILHEALMGLQ 138
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
HRDVK NILL + K+ DFG+S + GT ++ PE
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIA 197
Query: 523 NYQLTDKS-----DVYSYGVVLLEL 542
Q D + DV+S G+ +EL
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 50/199 (25%)
Query: 373 VAVKSAKVG----NIKSTQQVLNEVGILSQVNHKNLVRLLGC----CVEA-EQPLLIYEY 423
VA+K K+ N ++ L E+ +L ++H+N++ + EA ++YE
Sbjct: 33 VAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90
Query: 424 I---------ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV 474
+ ++ TL D H +Y + L LR L Y+HSA + HRD+
Sbjct: 91 MDTDLHQIIRSSQTLSDD-HCQYFLYQL-----LR-------GLKYIHSAN---VLHRDL 134
Query: 475 KSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL-------T 527
K +N+LL+ + + K+ DFGL+R S Y+ +YR +L T
Sbjct: 135 KPSNLLLNANCDLKICDFGLARTT-------SEKGDFMTEYVVTRWYRAPELLLNCSEYT 187
Query: 528 DKSDVYSYGVVLLELLTSQ 546
DV+S G + ELL +
Sbjct: 188 TAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 354 LGSGGFGEVYKG--ELQDGTVVAVKSAKVGNIKSTQ-QVLNEVGILSQVNHKNLVRLLGC 410
LG G + V+KG +L + +VA+K ++ + + + EV +L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL-QTAEALAYLHSAAYTPI 469
+ L++EY+ + L ++ N+ ++I L Q LAY H +
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHRRK---V 125
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-NYQLTD 528
HRD+K N+L+++ K+ADFGL+R AK + + TL Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 529 KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
+ D++ G + E+ + + S D+++L
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 38/211 (18%)
Query: 353 ILGSGGFGEVYKGELQDGT-VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL---- 407
I+G+G FG VY+ D + VA+K ++ Q E+ I+ +NH N++ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 408 -LGCCVEAEQPL---LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL---QTAEALAY 460
C + E+ + ++ E+I T+H ++ K+ + N + L Q ALAY
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYM--KHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
+HS I HRD+K N+L+D + ++ K+ DFG ++ G Q ++ Y+
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--------QRSVSYICSR 234
Query: 520 YYRNYQL-------TDKSDVYSYGVVLLELL 543
+YR +L T D++S G ++ E++
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 4/98 (4%)
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-VS 506
LR + Q A+ + +L A+ I HRDV + N+LL D +K+ DFGL+R ++ V
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
A+ + ++ PE + T +SDV+SYG++L E+ +
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 395 ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQT 454
++ QV+HK++V L G CV + +++ E++ G L +H K W + ++A Q
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQL 114
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILL-DDDFNSKVADFGLSRLAKPGLSHVSTCAQ--- 510
A AL+YL + H +V + NILL + + + F +L+ PG+ Q
Sbjct: 115 ASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECV 169
Query: 511 GTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLEL 542
+ ++ PE + + L+ +D +S+G L E+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 22/187 (11%)
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
LT + + Q A + +L S HRD+ + NILL ++ K+ DFGL+R
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD 226
Query: 502 LSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
+V A+ L ++ PE + T +SDV+S+GV+L E+ + + S P V +
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYP-GVQI 281
Query: 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620
+R G R++ E + + S+ L C +RP+ +++V
Sbjct: 282 DEEFCRRLKEGT-------RMRAPEYATPEIYSIML------DCWHNNPEDRPTFSELVE 328
Query: 621 ELQRIIE 627
L +++
Sbjct: 329 ILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 9/204 (4%)
Query: 346 NGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAK--VGNIKSTQQVLNEVGILSQVNHK 402
N F ++G G +G V K ++ +VA+K K N + + L E+ +L + +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V L + L++EY+ L L + + R I Q +A+ + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYI-YQLIKAIHWCH 117
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRD+K N+L+ + K+ DFG +R G + T T Y PE
Sbjct: 118 K---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQ 546
D++S G +L EL Q
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 352 RILGSGGFGEVYK------GELQDGTVVAVKSAKVGNIKSTQQVL-NEVGILSQV-NHKN 403
+ LG+G FG+V + G+ + VAVK K ++ L +E+ ILS + HKN
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKN 103
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN 441
+V LLG C L+I EY G L + L K +F
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 357 GGFGEVYKGELQDGT----VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412
G FG+VY G ++ + V VK A + N QV E L+ +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHR 472
A L+ EY+ G + LH Y F+ ++ + A AL YLH I HR
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLH-IYGYFD--EEMAVKYISEVALALDYLHRHG---IIHR 128
Query: 473 DVKSTNILLDDDFNSKVADFGLSRL 497
D+K N+L+ ++ + K+ DFGLS++
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 352 RILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQVL-NEVGILSQVN-HKN 403
RILGSG FG+V +G Q VAVK K S +Q L +E+ I++ + H N
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF 440
+V LLG C ++ +I EY G L ++LH +F
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 24/172 (13%)
Query: 395 ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQT 454
++SQV+H +L + G CV + +++ E++ +G L L + + W ++ +A Q
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-------RLAKPGLSHVST 507
A AL+YL + H +V + NILL A GL+ +L+ PG+S +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 508 CAQ---GTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555
+ + ++ PE L+ +D +S+G LLE+ + R P
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 352 RILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVN-HKN 403
R LGSG FG V + Q VAVK K S Q +++E+ I+S + H N
Sbjct: 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF 440
+V LLG C + +I EY G L D+LH +F
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKNLVRLLGC 410
+G G +G VYK + +DG K + I+ T E+ +L ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 411 CVEA--EQPLLIYEYIANGTLHDHLHGKYSSFN-----LTWSTRLRIALQTAEALAYLHS 463
+ + L+++Y + H + S N L S + Q + + YLH+
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 464 AAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTC--AQGTLGYLD 517
+ HRD+K NIL+ + K+AD G +RL L ++ T Y
Sbjct: 127 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 518 PEYY---RNYQLTDKSDVYSYGVVLLELLTSQ 546
PE R+Y T D+++ G + ELLTS+
Sbjct: 184 PELLLGARHY--TKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 46/235 (19%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLN---EVGILSQVNHKN 403
F +++G G FGEV + +D G V A+K + ++ +QV + E IL + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTW-STRLRIALQTAEALAYLH 462
+V++ + LI E++ G + L K + LT T+ IA +T A+ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIA-ETVLAIDSIH 118
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG--------LSH---------- 504
+ HRD+K N+LLD + K++DFGL K L+H
Sbjct: 119 QLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 505 ----------------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
++ GT Y+ PE + D +S GV++ E+L
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 46/235 (19%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLN---EVGILSQVNHKN 403
F +++G G FGEV + +D G + A+K + ++ +QV + E IL + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTW-STRLRIALQTAEALAYLH 462
+V++ + LI E++ G + L K + L+ +T+ IA +T A+ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIA-ETVLAIDAIH 118
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG--------LSH---------- 504
+ HRD+K N+LLD + K++DFGL K L+H
Sbjct: 119 QLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 505 ----------------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
++ GT Y+ PE + D +S GV++ E+L
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 58/250 (23%)
Query: 348 FSKERILGSGGFGEV-YKGELQDGTVVAVKSAKVGNIKSTQQVLN---EVGILSQVNHKN 403
F K + LG G FGEV ++ + A+K+ + ++ + QV + E IL++ +++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+V+L + + + +YI G + L + F + R IA T A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMEVFPEVLA-RFYIAELTL-AIESVHK 119
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGL---------SRLAKPGLSH---------- 504
+ HRD+K NIL+D D + K+ DFGL S+ + G SH
Sbjct: 120 MGFI---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSD 175
Query: 505 ----VSTCA------------------------QGTLGYLDPEYYRNYQLTDKSDVYSYG 536
VS C GT Y+ PE T D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 537 VVLLELLTSQ 546
V+L E+L Q
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 38/205 (18%)
Query: 354 LGSGGFGEVY---KGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
L G GEV+ K + V VK+ G E+ IL ++H+ ++ L
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINL--- 151
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR-IALQTA--------EALAYL 461
I+ Y + + KY T+ R + L+ A EALAYL
Sbjct: 152 ---------IHAY-RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD---P 518
H I HRDVK+ NI LD+ N+ + DFG + K + G G L+ P
Sbjct: 202 HGRG---IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQCYGWSGTLETNSP 256
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELL 543
E K+D++S G+VL E+
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
Q + L Y+H+A I HRD+K N+ +++D K+ DFGL+R ++ T
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----T 178
Query: 513 LGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQ 546
Y PE N+ T D++S G ++ E+LT +
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 45/187 (24%), Positives = 76/187 (40%), Gaps = 26/187 (13%)
Query: 383 IKSTQQ--VLNEVGILSQVNHKNLVRLLG--------CCVEAEQPLLIYEYIANGTLHDH 432
IK+ Q+ E IL +NH ++++L G C + +Y Y+A
Sbjct: 122 IKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA------- 174
Query: 433 LHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492
+ N+ L I A+ YLH I HRD+K+ NI ++ + + DF
Sbjct: 175 -----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226
Query: 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552
G + ++ GT+ PE D++S G+VL E+ T ++ F
Sbjct: 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL-FE 285
Query: 553 RDPDDVN 559
+D D +
Sbjct: 286 KDGLDGD 292
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 352 RILGSGGFGEVYK----GELQDGTV--VAVKSAK-VGNIKSTQQVLNEVGILSQV-NHKN 403
+ LG+G FG+V + G + VAVK K ++ + +++E+ +LS + NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF 440
+V LLG C L+I EY G L + L K SF
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-VS 506
L + Q A+ +++L S HRD+ + NILL +K+ DFGL+R + ++ V
Sbjct: 217 LSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
A+ + ++ PE N T +SDV+SYG++L E+ +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKNLVRLLGC 410
+G G +G VYK + +DG + + I+ T E+ +L ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 411 CV-EAEQPL-LIYEYIANGTLHDHLHGKYSSFN-----LTWSTRLRIALQTAEALAYLHS 463
+ A++ + L+++Y + H + S N L + Q + + YLH+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 464 AAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTC--AQGTLGYLD 517
+ HRD+K NIL+ + K+AD G +RL L ++ T Y
Sbjct: 127 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 518 PEYY---RNYQLTDKSDVYSYGVVLLELLTSQ 546
PE R+Y T D+++ G + ELLTS+
Sbjct: 184 PELLLGARHY--TKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 388 QVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI--------YEYIANGTLHDHLHGKYSS 439
Q+ NE+ L ++NH+N++++ +I Y ++ + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKD 262
Query: 440 FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499
L TR I Q A+ Y+H + HRD+K NI L+ D + DFG + +
Sbjct: 263 RPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
GT+ PE + +D++S G++LL++L+
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 36/149 (24%), Positives = 56/149 (37%), Gaps = 15/149 (10%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLV--RLLG 409
++L G VY +D V +K + + EV IL + K L ++L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYV-LK--INPSREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
L+ E+I TL ++ + IA Q AE LA LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLA 498
H D+ NIL+DD + D+ +
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 346 NGFSKERILGSGGFGEVY----KGELQDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQ 398
F +++ +G +G VY K Q A+K N+ QQV E IL+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQR---FAMKKINKQNLILRNQIQQVFVERDILTF 57
Query: 399 VNHKNLVRLLGCCVEAEQPL-LIYEYIANG---TLHDHLHGKYSSFNLTWSTRLRIALQT 454
+ +V + C E ++ L ++ EY+ G TL ++ R+ A +T
Sbjct: 58 AENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-----ARMYFA-ET 110
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS------HVSTC 508
AL YLH+ I HRD+K N+L+ + K+ DFGLS++ L+ H+
Sbjct: 111 VLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 509 AQ--------GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
+ GT Y+ PE D ++ G++L E L
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLN---EVGILSQVNHKN 403
F K + LG G FGEV D + A+K+ + ++ QV + E IL++ +++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKY-SSFNLTWSTRLRIALQTAEALAY 460
+VRL + + + +YI G + L G + + L A+++ + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494
+H RD+K NIL+D D + K+ DFGL
Sbjct: 123 IH---------RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTC-A 509
+ Q A+ + +L S HRD+ + NILL ++ K+ DFGL+R +V A
Sbjct: 185 SFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ L ++ PE + T +SDV+S+GV+L E+ +
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 348 FSKERI-----LGSGGFGEVYKGE------LQDGTVVAVKSAKVGNIKSTQQVL-NEVGI 395
F ++R+ LG G FG+V + + VAVK K G S + L +E+ I
Sbjct: 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 63
Query: 396 LSQVNHK-NLVRLLGCCVEAEQPLL-IYEYIANGTLHDHLHGKYSSF 440
L + H N+V LLG C + PL+ I E+ G L ++L K F
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
L++ + + Q A + +L S HRD+ + N+L+ + K+ DFGL+R
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 502 LSHVSTCAQGT----LGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+++S +G+ L ++ PE N T SDV+S+G++L E+ T
Sbjct: 293 SNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 348 FSKERILGSGGFGEVYKGELQDG-TVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKN 403
F +++G G FGEV +L++ V A+K + T E +L +++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTL-------HDHLHGKYSSFNLTWSTRLRIALQTAE 456
+ L + L+ +Y G L D L + F L + IA+ +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVIAIDSVH 119
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGY 515
L Y+H RD+K NIL+D + + ++ADFG +L + G S+ A GT Y
Sbjct: 120 QLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDY 169
Query: 516 LDPEYYRNYQ-----LTDKSDVYSYGVVLLELL 543
+ PE + + + D +S GV + E+L
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGY 515
A+ +H Y HRD+K N+LLD + + ++ADFG RL G + S A GT Y
Sbjct: 114 AIDSVHQLGYV---HRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDY 169
Query: 516 LDPEYYRNYQ-----LTDKSDVYSYGVVLLELL 543
+ PE + + + D +S GV + E+L
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTL 513
AE + +HS HRD+K N+LLD + + ++ADFG ++ + G S+ A GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAVGTP 167
Query: 514 GYLDPEYYRNYQ-----LTDKSDVYSYGVVLLELL 543
Y+ PE + + + D +S GV + E+L
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
LT L Q A + +L S HRD+ + N+LL K+ DFGL+R
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 502 LSHVSTCAQG-TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
++VS + + ++ PE + T SDV+SYG++L E+ +
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 39/143 (27%), Positives = 58/143 (40%), Gaps = 12/143 (8%)
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V L V + L+ ++ G L H+ K+ N+ R A + AL LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKF--LNIPEECVKRWAAEMVVALDALH 102
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLG-YLDPEYY 521
I RD+ NILLDD + ++ F + S + Y PE
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCAPEVG 154
Query: 522 RNYQLTDKSDVYSYGVVLLELLT 544
+ T+ D +S G +L ELLT
Sbjct: 155 GISEETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 646 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.35 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.07 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 97.05 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 96.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.74 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.18 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.17 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.46 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.18 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.45 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=475.70 Aligned_cols=293 Identities=51% Similarity=0.841 Sum_probs=257.9
Q ss_pred CcccccHHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeE
Q 006402 332 PARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCC 411 (646)
Q Consensus 332 ~~~~~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 411 (646)
+.+.|+++||++||++|+..++||+|+||.||+|.+.+|+.||||++........++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred EeCCc-CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 412 VEAEQ-PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 412 ~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
.+.+. ++||||||++|+|.++|+..... .|+|.+|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99994 99999999999999999986543 79999999999999999999999998899999999999999999999999
Q ss_pred ecCCCccCCC-CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 491 DFGLSRLAKP-GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 491 DfGl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
|||+++.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|+...+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999976655 32222211 699999999999999999999999999999999999999987665556668999999999
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
++.+.+++|+.+...... ......++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~--~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYP--DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCC--hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999998743322 115667789999999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=394.06 Aligned_cols=262 Identities=36% Similarity=0.529 Sum_probs=213.6
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCccc--HHHHHHHHHHHhhCCCCcccccceeEEeCC-cCeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS--TQQVLNEVGILSQVNHKNLVRLLGCCVEAE-QPLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~g 427 (646)
.+.||+|+||+||+|.+++...||||++....... .++|.+|+.+|.+++|||||+++|++.+.. ...+||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45599999999999999866669999987654322 569999999999999999999999999988 799999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccCCCCCCccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~~~~~~~~~ 506 (646)
+|.+++++. ....+++..+++||.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 999999875 34579999999999999999999999984 99999999999999997 99999999998776432 223
Q ss_pred cccCccccccCccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 507 TCAQGTLGYLDPEYYR--NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~--~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... ......+ ...+.... +..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v---~~~~~Rp~-----~p~- 269 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAV---VVGGLRPP-----IPK- 269 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HhcCCCCC-----CCc-
Confidence 3356999999999999 56899999999999999999999999973322 1111111 11111111 110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcccc
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVS 635 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~ 635 (646)
.....+..|+.+||+.||++||++.|++..|+.+..........
T Consensus 270 -------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~ 313 (362)
T KOG0192|consen 270 -------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE 313 (362)
T ss_pred -------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence 13345778999999999999999999999999998876654333
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=385.75 Aligned_cols=253 Identities=33% Similarity=0.467 Sum_probs=213.3
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
..+.||+|.||.||.|.++....||+|.++... ...++|.+|+.+|++|+|+|||+++|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 347799999999999999888899999998653 4568899999999999999999999999999899999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+||+.. .+..+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+||||++...++........
T Consensus 289 l~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 289 LDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 9999873 4456899999999999999999999999 99999999999999999999999999997777666666666
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASV 588 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 588 (646)
.-...|.|||.+....++.|||||||||+||||+| |+.|+.... ... +...+..+-- |..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~e-v~~~le~GyR-------lp~----- 425 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEE-VLELLERGYR-------LPR----- 425 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHH-HHHHHhccCc-------CCC-----
Confidence 77889999999999999999999999999999999 555554222 222 1222222211 110
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 589 NILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 589 ~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
...++..+.+|+..||+.+|++|||++.+...|+.+..
T Consensus 426 -P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 -PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 22355678899999999999999999988888887754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=366.73 Aligned_cols=248 Identities=28% Similarity=0.403 Sum_probs=204.4
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-CeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ-PLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~e~~~~g 427 (646)
.+.||+|..|+|||+.++ +++.+|+|++... +....+++.+|++++++.+|||||+++|.|..... ..|+||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 477999999999999887 6899999999544 44557889999999999999999999999999985 99999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
+|++++... +.+++....+|+.++++||.|||+ .+ |+||||||+|||++..|.+||+|||.++..... ..
T Consensus 164 SLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 164 SLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999753 358999999999999999999996 66 999999999999999999999999999887654 33
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||..|||||.+.+..|+.++||||||+.++|+.+|+.|+......... ..........+ -.|.+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-~~~Ll~~Iv~~------ppP~lP~~-- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-IFELLCAIVDE------PPPRLPEG-- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-HHHHHHHHhcC------CCCCCCcc--
Confidence 4456999999999999999999999999999999999999998765221111 11111111110 11222221
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
...+++.+++..||+.||.+|||++|+++.
T Consensus 306 -----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 245668899999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=378.87 Aligned_cols=246 Identities=28% Similarity=0.405 Sum_probs=207.9
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..|...++||+|+|++||.++. ..|+.||+|++.+. +....+.+.+|++|.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 78999999998753 3345678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
|++++++|..++++ +.++++.+++.++.||+.||.|||+.+ |+|||||..|+||+++.++||+|||||.....+
T Consensus 98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999973 457999999999999999999999999 999999999999999999999999999998865
Q ss_pred -CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 -LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 -~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
..+.+ ..|||.|+|||++.....+..+||||+||+||-||.|++||+...- ......+.... ..+..
T Consensus 172 ~Erk~T--lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------kety~~Ik~~~--Y~~P~- 239 (592)
T KOG0575|consen 172 GERKKT--LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------KETYNKIKLNE--YSMPS- 239 (592)
T ss_pred ccccce--ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------HHHHHHHHhcC--ccccc-
Confidence 33333 3499999999999988999999999999999999999999973311 11111221111 01111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....+..+||.++|+.+|.+|||+++|+.
T Consensus 240 -----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 -----------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12234568999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=361.09 Aligned_cols=200 Identities=36% Similarity=0.544 Sum_probs=179.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..+|...+.||+|+||+||+|+++ ++..||||.+... ..+..+....|+++|+.++|||||.+++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999876 6899999998766 4556777899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC------CCEEEeecCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD------FNSKVADFGLS 495 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~------~~~ki~DfGl~ 495 (646)
||+.+|+|.+||+.+. .+++.....++.|||.||++||+++ |+||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998653 5899999999999999999999999 9999999999999764 56899999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
+...++.-. ....|++-|||||++...+|+.|+|+||+|++||+|++|+.||+..
T Consensus 163 R~L~~~~~a--~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPGSMA--ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCchhHH--HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 998865433 3355999999999999999999999999999999999999999733
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=364.15 Aligned_cols=253 Identities=27% Similarity=0.363 Sum_probs=201.7
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcc-------cHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIK-------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||+++..... ....+.+|+++|++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35677889999999999999954 58999999998754321 23345799999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCEEEeecC
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD---FNSKVADFG 493 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~---~~~ki~DfG 493 (646)
.|+||||++||+|.+.+-.+. .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999997543 3666777889999999999999999 9999999999999765 789999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ---LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
+|+...... ......|||.|.|||++.+.. +..|.|+||+||+||-+++|..||...... ..+...+. .
T Consensus 325 lAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~----~ 396 (475)
T KOG0615|consen 325 LAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQIL----K 396 (475)
T ss_pred hhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHh----c
Confidence 999887432 333456999999999997653 344889999999999999999999744332 22333222 2
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
++... .+..-....++..+||.+||..||++|||+.|+++.
T Consensus 397 G~y~f----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYAF----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Ccccc----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 22111 011123345667799999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.69 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=208.6
Q ss_pred CCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccce-eEEeCCc-CeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLG-CCVEAEQ-PLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV~ 421 (646)
+|.++++||+|.||+|||+. +.+|..+|.|.++-. +.+..++...|+.+|++|+|||||+.++ -+.++.. .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 47778899999999999995 458999999987643 4456778999999999999999999999 4555544 88999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAY-TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|++..|+|...++.-+ ....+++..+++++.|++.||..+|+.-. ..|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999996432 34568999999999999999999999331 239999999999999999999999999999887
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..... .....|||.||+||.+...+|+.||||||+||++|||..-+.||... ++. .....+..+....+-
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~~p-- 249 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPPLP-- 249 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCCCc--
Confidence 65433 34567999999999999999999999999999999999999999743 222 233344444322211
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
..-...++.+||..|+..||+.||+...+++.++.
T Consensus 250 ----------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 ----------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 23355678899999999999999997665555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=382.09 Aligned_cols=261 Identities=29% Similarity=0.429 Sum_probs=214.7
Q ss_pred CCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
+....+.||+|+||+||+|+.. +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3445578999999999999753 3568999999877665 68899999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEE
Q 006402 420 IYEYIANGTLHDHLHGKY-------S----SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSK 488 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~k 488 (646)
|+|||..|+|.+||.... . ..+|+..+.+.||.|||.|+.||-++. ++||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 999999999999996331 1 233889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHH
Q 006402 489 VADFGLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 566 (646)
|+||||++......... .....-.++||+||.+..++||.+||||||||+|||+++ |+-|+....+. .+..
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVIe 716 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVIE 716 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHHH
Confidence 99999999765433322 223345789999999999999999999999999999999 77776533322 2333
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.+..+.+-+. ....+.++.+|+..||+.+|.+||+++||-..|+...+.-.
T Consensus 717 ~i~~g~lL~~-------------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 717 CIRAGQLLSC-------------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHcCCcccC-------------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 3444433211 22356678999999999999999999999999998866443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=343.88 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=198.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.+.|++.++||+|+||+||.++.+ +++.+|+|++++... +..+...+|..+|.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999665 689999999876533 3467788999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+||+.||.|..+|++. ..+++..+.-++.+|+.||.|||+++ |+||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999754 35888989999999999999999999 99999999999999999999999999996544
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... +....||+.|||||++.+..|+..+|.||+|+++|||++|.+||...... .+... +..++.. ..+.
T Consensus 178 ~~~~-t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~-I~~~k~~--~~p~ 247 (357)
T KOG0598|consen 178 DGDA-TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDK-ILKGKLP--LPPG 247 (357)
T ss_pred CCCc-cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHH-HhcCcCC--CCCc
Confidence 3222 23356999999999999999999999999999999999999999743221 11111 1111100 0000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERP 613 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 613 (646)
-...+..+++.+.|+.+|++|-
T Consensus 248 -----------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 -----------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----------cCCHHHHHHHHHHhccCHHHhc
Confidence 1223456899999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.18 Aligned_cols=269 Identities=24% Similarity=0.346 Sum_probs=209.4
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 420 (646)
+.|+.+++||+|.||.||||+. .+|+.||+|++.... ........+|+.||++|.||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3455667899999999999954 579999999987665 34466778999999999999999999998886 689999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+|||+. +|.-++.. ....++..++..++.|++.||.|+|+++ |+|||||.+|||||++|.+||+|||||+.+..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999966 77777764 3456899999999999999999999999 99999999999999999999999999998887
Q ss_pred CCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc-----
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM----- 574 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 574 (646)
......+..+-|..|+|||++.+. .|+.+.|+||.||||.||++|++.|....+.+.......+.-.+.+.-+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 776667777789999999998765 79999999999999999999999887665544333322221111111111
Q ss_pred --cccccccc-CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 --EVVDPRLQ-GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 --~~~d~~l~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+.+.-. .....+..........+|+..+|..||.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111110 00011111223355678999999999999999999884
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=327.23 Aligned_cols=283 Identities=25% Similarity=0.302 Sum_probs=210.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
+.|+...++|+|++|+|||.+.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777789999999999999887 599999999975533 234567899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|++..-|++ |... ...++...+.+++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||.|+.....
T Consensus 82 ~~dhTvL~e-Le~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY--PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHH-HHhc--cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 998765555 4332 234889999999999999999999999 999999999999999999999999999988742
Q ss_pred CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH--------HHhc-CCc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS--------QRAS-NGA 572 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~-~~~ 572 (646)
....+....|..|+|||.+.+ .+|...+||||+||++.||++|.+-|....+.+......... .... +..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 223344558999999999876 689999999999999999999998887554433322211110 0000 111
Q ss_pred ccccccccccCCc-hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHHHHhhcccc
Q 006402 573 IMEVVDPRLQGHE-ASVNILMSLKLFSELAVACLREKKSERPSMTDVVH--ELQRIIEIVNQEKVS 635 (646)
Q Consensus 573 ~~~~~d~~l~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~--~L~~~~~~~~~~~~~ 635 (646)
...+--|.....+ .+.-......-+++++..||+.||++|++-++++. .++++++...+.+..
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~~k~~ 300 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELKAKKP 300 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHHHHhcc
Confidence 1111111111100 00001122345789999999999999999999984 356666654444433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.32 Aligned_cols=266 Identities=27% Similarity=0.446 Sum_probs=221.0
Q ss_pred CCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
..++++||.|.||.|++|+++- ...||||.++... ++.+.+|+.|+.||.+..||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3567999999999999998862 4579999998764 3457889999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
||+||+|+.||+.+. .++++.++..++++||.|+.||.+++ ++||||..+|||++.+...|++|||+++..+++.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999998763 45899999999999999999999999 9999999999999999999999999999887665
Q ss_pred Cccccc--cCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 503 SHVSTC--AQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 503 ~~~~~~--~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
....+. .+-...|.|||.+...++|.+|||||||++|||.++ |.+|+-...+.+- .+.+.+ +.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-------IkaIe~-------gy 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-------IKAIEQ-------GY 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-------HHHHHh-------cc
Confidence 333332 234578999999999999999999999999999777 8888753322211 111110 11
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccccccc
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSNDV 638 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 638 (646)
+|. ..++++..+.+|++.|||.|-.+||++.+++..|++++.+.+..++..+.
T Consensus 852 RLP------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~ 904 (996)
T KOG0196|consen 852 RLP------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPE 904 (996)
T ss_pred CCC------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCC
Confidence 111 13456667889999999999999999999999999999888877776654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=356.97 Aligned_cols=273 Identities=29% Similarity=0.463 Sum_probs=215.5
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
+++....+.+.+...||+|.||+||+|+|.+ .||||+++.... +..+.|.+|+.++++.+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4555555667778899999999999999874 499999987644 457889999999999999999999999998877
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.||+.+++|.+|+.+||..+ ..++..+.++||.|||+|+.|||.++ |||||||+.||||.++++|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999999754 45888999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCC-CccccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 497 LAKPGL-SHVSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
....-. ........|...|||||+++. .+|+..+||||||+++|||+||..||. ....+... .....|-
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi------fmVGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII------FMVGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE------EEecccc
Confidence 543211 111122348889999999863 478999999999999999999999997 22222111 1111111
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcccc
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVS 635 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~ 635 (646)
++ .|... ......++|.+|+..||..++++||++.+|+..|+.++..+-+...+
T Consensus 610 l~--pd~s~-------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS 663 (678)
T KOG0193|consen 610 LM--PDLSK-------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRS 663 (678)
T ss_pred cC--ccchh-------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccC
Confidence 11 11111 12234567889999999999999999999999999988765444443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=350.41 Aligned_cols=269 Identities=23% Similarity=0.310 Sum_probs=207.7
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHH--HHHHHHHhhCC-CCcccccceeEEeCC-cCe
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQV--LNEVGILSQVN-HKNLVRLLGCCVEAE-QPL 418 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 418 (646)
..++|...++||.|.||.||+|+.+ +|+.||||+++..-.. .++. ++|+..|++|+ |||||+|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4467888899999999999999655 7899999998765433 3333 68999999999 999999999999988 899
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||| ..+|++.++++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+..
T Consensus 87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999999 56999999875 567999999999999999999999999 999999999999998889999999999987
Q ss_pred CCCCCccccccCccccccCcccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc--
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYY-RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME-- 575 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 575 (646)
..... .+....|..|+|||++ +.+.|+.+.|+|++||+++|+.+-++.|.+..+-+.....-.+.-......+.+
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 65433 3445589999999986 567899999999999999999999988875544332221111111111111110
Q ss_pred -------cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 576 -------VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 576 -------~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+--|...+.....-......+.++++.+|+.+||.+|||+.|+++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0011111111111112244667899999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=352.23 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=210.1
Q ss_pred CCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 347 GFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
.|....+||+|+.|.||.+. ..+++.||||++........+-+++|+.+|+..+|+|||++++.|..++.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 46666789999999999995 45789999999998887788889999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|+|.+.+... .+++.++..|.+++++||+|||..+ |+|||||.+||||+.+|.+||+|||++..........
T Consensus 354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999998654 3899999999999999999999999 9999999999999999999999999998887666543
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
. ...|||.|||||+.....|..|.||||||++++||+-|.+||-.... ..+.|.. ..++ . +.+..
T Consensus 427 ~-TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLI--a~ng-~-----P~lk~-- 491 (550)
T KOG0578|consen 427 S-TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLI--ATNG-T-----PKLKN-- 491 (550)
T ss_pred c-cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHH--hhcC-C-----CCcCC--
Confidence 3 35699999999999999999999999999999999999999864221 1111111 1111 1 12221
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.......+.+++.+||+.|+++||+++|+|+.
T Consensus 492 ----~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 ----PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12234567899999999999999999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=343.24 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=202.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC--cCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE--QPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 421 (646)
..++...+.||+|+||+||++... +|+..|||.+...+....+.+.+|+.+|++++|||||+.+|...... .+.+.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345677799999999999999776 48999999887654444677899999999999999999999855544 588999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~~~ 500 (646)
||+++|+|.+++.+... .|++..+.++..||++||+|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999986532 6999999999999999999999999 999999999999999 79999999999987763
Q ss_pred --CCCccccccCccccccCccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 --GLSHVSTCAQGTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 --~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.........+||+.|||||++..+. ...++|||||||+++||+||+.||... .....+........... .+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P-~i 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP-EI 244 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-CC
Confidence 2222334567999999999998633 335999999999999999999998743 11111111111111111 11
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
... ...+..+++.+|++.+|++|||++|+++.-
T Consensus 245 p~~------------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 245 PDS------------LSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred Ccc------------cCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111 234466899999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.53 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=205.4
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCccc--HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKS--TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.+|...++||+|.||.||+|+. ++|+.||||+++..+.++ ....++|++.|+.++|+||+.|+++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999965 479999999998775442 4567899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
||+ .+|+..++++ ...++..++..++.++++||+|+|.+. |+||||||.|+|++.+|.+||+|||+++......
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 994 5899999875 346889999999999999999999999 9999999999999999999999999999987654
Q ss_pred CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc---ccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME---VVD 578 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d 578 (646)
..... ..-|..|+|||.+.+ ..|+...|+||.||++.||+.|.+-|....+-+.......+.-.+.+..+.+ +-|
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 44332 257999999998765 4799999999999999999988766554433322222221111111111111 111
Q ss_pred cc-cc---CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 579 PR-LQ---GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 579 ~~-l~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. +. ......-.........+|+.+++..||.+|+|++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10 00 000000011233456799999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=337.75 Aligned_cols=274 Identities=26% Similarity=0.416 Sum_probs=207.2
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhC--CCCcccccceeEEeCC----cCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV--NHKNLVRLLGCCVEAE----QPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lV 420 (646)
.....++||+|.||.||||+++ ++.||||++.. +..+.|.+|..|.+.. +|+||+++++.-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445578999999999999996 48999999865 5677888998888765 7999999999866555 78999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA------YTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
+||.++|+|.+||+.+ .++|....+|+..+++||+|||+.. .++|+|||||++||||.+|++..|+|||+
T Consensus 287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999754 5899999999999999999999754 36899999999999999999999999999
Q ss_pred CccCCCCCCccc-cccCccccccCccccccC-CCC-----chhhHHHHHHHHHHHHcCCCCCCC-CCCCCCccHHHHHHH
Q 006402 495 SRLAKPGLSHVS-TCAQGTLGYLDPEYYRNY-QLT-----DKSDVYSYGVVLLELLTSQKAIDF-SRDPDDVNLAIYVSQ 566 (646)
Q Consensus 495 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~-~~~-----~ksDv~s~G~ll~elltg~~p~~~-~~~~~~~~~~~~~~~ 566 (646)
|..+.++..... ....||.+|||||++.+. .+. .+.||||+|.|||||+++.+-++. ...+....+...+..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 998876655433 335699999999999764 333 268999999999999998766542 111112222212222
Q ss_pred HhcCCccccc-----ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 567 RASNGAIMEV-----VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 567 ~~~~~~~~~~-----~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
++.-+.+.+. ..|.+...-. ....++.+.+.+..||+.|++-|.|+.-|.+++.++....+.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111111111 1111211111 112345678999999999999999999999999988876653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.45 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=204.0
Q ss_pred hcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeCC-
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE- 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 415 (646)
.++|.+.++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999964 2356899999875432 3356789999999999 8999999999887654
Q ss_pred cCeEEEEEccCCCccccccCCcC---------------------------------------------------------
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYS--------------------------------------------------------- 438 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 438 (646)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864311
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc-ccccCccccc
Q 006402 439 --SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV-STCAQGTLGY 515 (646)
Q Consensus 439 --~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y 515 (646)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788999999999999999999999 9999999999999999999999999998654332221 1223467889
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHH
Q 006402 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSL 594 (646)
Q Consensus 516 ~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 594 (646)
+|||++.+..++.++||||||++||||++ |..||......+ . .......+.... ... ...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~~-----~~~--------~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRMR-----APE--------NAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCCC-----CCC--------CCC
Confidence 99999988889999999999999999997 999986432211 1 111111111110 000 122
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 595 KLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 595 ~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
..+.+|+.+||+.+|++|||+.|+++.|+++..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 346789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=375.92 Aligned_cols=269 Identities=29% Similarity=0.445 Sum_probs=217.6
Q ss_pred cCCCcccEecccCcEEEEEEEEcC--Cc----EEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD--GT----VVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
.+.+..+.||+|+||.||.|...+ |. .||||.++.. +.+...+|++|..+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345567889999999999997753 43 4999988765 5567889999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 419 LIYEYIANGTLHDHLHGKY----SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
|++|||++|+|..||++.+ ....|+....+.++.|||+|+.||++++ .|||||..+|+||+....+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998653 2346899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccc-cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 495 SRLAKPGLSHVS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 495 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
|+.......... ....-...|||||.+..+.++.|+|||||||+|||++| |..||......+ + .......++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v---~~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---V---LLDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---H---HHHHHhCCc
Confidence 995543332222 22235578999999999999999999999999999999 667765322211 1 111122221
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcccccc
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSND 637 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~ 637 (646)
+. . ...+.+.+.+|+.+||+.+|++||++..+++.++.+.+........+.
T Consensus 923 L~---~-----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~ 973 (1025)
T KOG1095|consen 923 LD---P-----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPL 973 (1025)
T ss_pred cC---C-----------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccc
Confidence 11 1 123456678999999999999999999999999999988877765554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.14 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=208.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.+.|+..++||.|..++||+|... .++.||||++...+-. ..+.+.+|+..|+.++||||++.+..|..++.+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467899999999999999999654 6799999999865443 35889999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
||.+|++.+.++..... .+++..+..|.+++++||.|||.+| -||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999876533 4999999999999999999999999 8999999999999999999999999876654433
Q ss_pred Cccc---cccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 503 SHVS---TCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 503 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.+.. ....||+.|||||++.. ..|+.|+||||||++..||.+|..||..... .......+.+.. ...
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~p-p~~- 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDP-PTL- 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCC-CCc-
Confidence 2211 34579999999999643 3699999999999999999999999862211 111111121111 000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+ .+...........+.+.+++..||+.||++|||++++++
T Consensus 253 ~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 L---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred c---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 111122224455667899999999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.04 Aligned_cols=234 Identities=25% Similarity=0.359 Sum_probs=196.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|+..+.||.|+||+|.+++.+ +|..+|+|+++.... +..+...+|..+|+.+.||.++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34777899999999999999876 689999999976544 34566789999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||++||.|.+++++. ..+++..+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||.|+.....
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999853 35899999999999999999999999 999999999999999999999999999987543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc--ccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA--IMEVVDP 579 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~ 579 (646)
+....|||.|+|||.++...+..++|.|||||++|||+.|..||..... .. +...+-++. ....
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~--iY~KI~~~~v~fP~~--- 263 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQ--IYEKILEGKVKFPSY--- 263 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HH--HHHHHHhCcccCCcc---
Confidence 3445699999999999999999999999999999999999999974332 12 222222221 1111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCC
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSER 612 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 612 (646)
....+.+|+...|+.|-.+|
T Consensus 264 -------------fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 -------------FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------------cCHHHHHHHHHHHhhhhHhh
Confidence 12335578899999998888
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.46 Aligned_cols=246 Identities=19% Similarity=0.296 Sum_probs=198.0
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCccc---HHHHHHHHHHHhhCCCCcccccceeEEe----CCcCeEEEEEc
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS---TQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQPLLIYEYI 424 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~ 424 (646)
..||+|+++.||+|.+ +|+.||||+++...... .+.|.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 68899999987654333 5778899999999999999999999987 34678999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++|+|.+++... ..+++...++++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999753 3589999999999999999999985 6 7899999999999999999999999988654321
Q ss_pred ccccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...... .+.. .....+. . +.+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~-~----~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNN-S----LKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCC-C----CCC
Confidence 12347899999999976 67899999999999999999999999733211 1111 1111110 0 001
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
. ......+.+++.+||+.||++|||++|+++.|+++..
T Consensus 244 ~--------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 P--------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred C--------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0 0123457789999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=343.55 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=205.4
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
++..++|...+.||+|+|++|++++.+ .++.+|||++.+. .++..+-+..|-.+|.+| .||.|++|+-.|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 334567888999999999999999655 6899999998654 233445677899999999 79999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
+|+|+||+++|+|.++|++. +.+++.-...++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.++
T Consensus 149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999864 35888899999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCc----------cc--cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHH
Q 006402 497 LAKPGLSH----------VS--TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV 564 (646)
Q Consensus 497 ~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~ 564 (646)
.+.+.... .. ...+||..|.+||++.....+..+|+|+|||+||.|+.|.+||....+- .....+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI 299 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKI 299 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHH
Confidence 87543221 11 2356999999999999999999999999999999999999999743221 111111
Q ss_pred HHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 565 SQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 565 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. +|-.+.. ...+.+.+|+.+.|..||.+|+|.+++-+.
T Consensus 300 ~~----------l~y~fp~--------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QA----------LDYEFPE--------GFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH----------hcccCCC--------CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 10 1111111 122456789999999999999999887654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.69 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=208.7
Q ss_pred cCCCcccEecccCcEEEEEEEEcC--C--cE-EEEEEccc---CCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD--G--TV-VAVKSAKV---GNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
++....++||+|+||.||+|+++. + .. ||||..+. .......+|++|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999997763 2 23 89998875 2356678999999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|||+++||+|.+||+.... .++..++++++.+.|.||+|||+++ ++||||-.+|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999986532 5999999999999999999999999 99999999999999999999999999886
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
...... ......-...|+|||.+..+.++.++|||||||++||+++ |..|+...... .+..++ ..++.....
T Consensus 312 ~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~~r~~~ 384 (474)
T KOG0194|consen 312 GSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNGYRMPI 384 (474)
T ss_pred Ccceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcCccCCC
Confidence 641111 1112245788999999999999999999999999999999 77787633221 111111 111111110
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
. ...+..+..++.+||..+|++||||.++.+.|+.+......
T Consensus 385 -~------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 -P------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -C------------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 0 02334566788999999999999999999999999887664
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.66 Aligned_cols=258 Identities=28% Similarity=0.389 Sum_probs=213.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.. .+..+.+.+|++|+++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888889999999999999765 68999999887653 3456789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+.| +|..+|... ..++++.+..|+.++..||.|||+.+ |+|||+||+||||+.++.+|++|||+++.+...
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9976 999999754 45999999999999999999999999 999999999999999999999999999987664
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
....+..+|||-|||||+..+++|+..+|.||+||+||||++|++||... .+...+.....+ +...
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~v~~ 219 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------PVKP 219 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------CCCC
Confidence 34556678999999999999999999999999999999999999998621 111111111111 1000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHHHHhhc
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRIIEIVNQE 632 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~~~~~~~ 632 (646)
.......+..++...|+.||.+|.|..+++.. .++-.+..+.+
T Consensus 220 -------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~ 264 (808)
T KOG0597|consen 220 -------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELP 264 (808)
T ss_pred -------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccc
Confidence 11344557789999999999999999999843 45555544444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=385.27 Aligned_cols=266 Identities=25% Similarity=0.410 Sum_probs=213.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
....|...++||+|+||.||+|+.. ++..||||+++..... ...|++++++++|||||+++|++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456778899999999999999874 7899999998654322 2356889999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.++++. ++|..+.+|+.|+|+||+|||+...++|+||||||+||+++.++.+++. ||........
T Consensus 764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 9999999999952 7999999999999999999997655569999999999999999888876 6665443221
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
....+++.|+|||++.+..++.|+|||||||++|||+||+.||+.... .......|.............+|+.+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 122478999999999988999999999999999999999999853322 233455555544444455566676664
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
..... ......++.+++.+||+.+|++||||.||+++|+++...
T Consensus 911 ~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 911 GDVSV--NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCCc--cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 43221 223445678999999999999999999999999988653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.80 Aligned_cols=247 Identities=29% Similarity=0.390 Sum_probs=201.9
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC----Cc-ccHHHHHHHHHHHhhCC-CCcccccceeEEeCC
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG----NI-KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAE 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 415 (646)
....+|...+.||+|+||+|+.|... +++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999654 6899999976653 11 23455668999999999 999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFGL 494 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfGl 494 (646)
..++||||+.+|+|.+++..+ ..+.+.....++.|++.|++|+|+.+ |+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999863 35888999999999999999999999 9999999999999999 9999999999
Q ss_pred CccCC-CCCCccccccCccccccCccccccCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 495 SRLAK-PGLSHVSTCAQGTLGYLDPEYYRNYQ-LT-DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 495 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
+.... .+. ......||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. +....... +..+
T Consensus 168 s~~~~~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~k-i~~~ 238 (370)
T KOG0583|consen 168 SAISPGEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRK-IRKG 238 (370)
T ss_pred ccccCCCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHH-HhcC
Confidence 99884 322 233445999999999999877 75 6899999999999999999999741 11111111 1111
Q ss_pred --cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 572 --AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 572 --~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
.+...++ ..++..|+.+||+.+|.+|+|+.|++
T Consensus 239 ~~~~p~~~~---------------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFKIPSYLL---------------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CccCCCCcC---------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111110 34467899999999999999999998
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.00 Aligned_cols=261 Identities=29% Similarity=0.417 Sum_probs=199.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-----------------CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCccccc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-----------------GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRL 407 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 407 (646)
++|.+.++||+|+||.||++.+++ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 3469999887643 2345679999999999999999999
Q ss_pred ceeEEeCCcCeEEEEEccCCCccccccCCc----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 006402 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKY----------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYH 471 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H 471 (646)
++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1134788999999999999999999999 999
Q ss_pred ccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcC--CCC
Q 006402 472 RDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS--QKA 548 (646)
Q Consensus 472 ~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg--~~p 548 (646)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 11223357889999999888899999999999999999975 445
Q ss_pred CCCCCCCCCccHHHHHHHHhcCCc-ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 549 IDFSRDPDDVNLAIYVSQRASNGA-IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
|..... ......+........ ......+ ......+.+|+.+||+.+|++|||+.||.+.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQVYLFRP-----------PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccccccccCC-----------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 542211 111111111111110 0000000 012245778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=307.86 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=211.8
Q ss_pred hcCCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cCe
Q 006402 345 TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QPL 418 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (646)
.++|++.+.||+|||+.||.++ ..++..+|+|++.-...++.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999996 5578999999998887788899999999999999999999999887544 489
Q ss_pred EEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 419 LIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
|+++|...|+|.+.+.... .+..+++.+.++|+.+|++||++||+.. +|+.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999997654 3446999999999999999999999988 6799999999999999999999999999876
Q ss_pred CCCCCCccc--------cccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHH
Q 006402 498 AKPGLSHVS--------TCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 498 ~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 566 (646)
......... ....-|..|+|||.+. +...++++|||||||+||+|+.|..||+......+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--------- 249 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--------- 249 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC---------
Confidence 542211111 1223789999999985 44678999999999999999999999974333211
Q ss_pred HhcCCcccccc-cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 567 RASNGAIMEVV-DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 567 ~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
.+.-.+ .+.+.-... ....+.+.+|+.+|++.||.+||++.+++..++.+.
T Consensus 250 -----SlaLAv~n~q~s~P~~----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 -----SLALAVQNAQISIPNS----SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----eEEEeeeccccccCCC----CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 111111111 114456779999999999999999999999988764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.91 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.++||+|+||.||+|.++ .+..||+|.++.... ...+.|.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999764 356899999876532 3346789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999999754 235899999999999999999999999 99999999999999999999999998765433
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~----~~~~~~~~~~~---- 228 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DV----IKAVEDGFRLP---- 228 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHCCCCCC----
Confidence 22111122335678999999998899999999999999999775 99998633211 11 11111111100
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.. ......+.+++.+||+.+|++||+++++++.|+++
T Consensus 229 -~~--------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -AP--------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CC--------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 11234577899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.86 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=199.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.|+..+.||+|+||+||++... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999764 789999998864322 234567899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888643 2335899999999999999999999999 9999999999999999999999999998754332
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............. . +.
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~-~-~~---- 225 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE-E-YS---- 225 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc-c-CC----
Confidence 2 1234589999999999988999999999999999999999999974432211 1111111111000 0 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
......+.+|+.+||+.+|++||+ ++|+++
T Consensus 226 --------~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 --------EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --------ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 012345678999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=345.04 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=202.9
Q ss_pred hcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
.++|++.+.||+|+||+||+++. +++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999964 245689999987543 23456788999999999 89999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcC----------------------------------------------------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS---------------------------------------------------------- 438 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 438 (646)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 439 --------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 439 --------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124789999999999999999999999 999999999999999999999999999866443221
Q ss_pred c-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 505 V-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 505 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... .....+.... .+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~~~--~~~-- 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYRML--SPE-- 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCccCC--CCC--
Confidence 1 112235678999999998899999999999999999998 78887532211 1111 1111111000 000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
....++.+|+.+||+.+|++|||+.||++.|++.
T Consensus 341 ---------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ---------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1123577999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=324.28 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=202.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.+.||+|+||.||+++++++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999888899999876432 345788999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999987542 25899999999999999999999999 9999999999999999999999999988654332222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ...+.. ...+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~--~~~~~~--- 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFR--LYRPKL--- 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCC--CCCCCC---
Confidence 222335678999999988889999999999999999999 8888853221 111111 111110 001111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
....+.+++.+||+.+|++||+++|+++.|
T Consensus 226 --------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 --------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123467999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.77 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=206.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4688889999999999999998888899999876543 346789999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.++++.. ....+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999754 2345889999999999999999999998 9999999999999999999999999998765433222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||++....++.++||||||+++|||+| |+.||...... ..... ....... +...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~----~~~~-- 227 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQRGYRM----PRME-- 227 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCCC----CCCC--
Confidence 223346778999999988889999999999999999998 88888532111 11111 1111100 0000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.....+.+++.+||+.+|++||+++++.+.|+++
T Consensus 228 -------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 -------NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1223467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.85 Aligned_cols=269 Identities=21% Similarity=0.246 Sum_probs=201.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.+.||+|+||+||+++.+ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999876 58899999987542 2345678899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|++++.+..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998877655432 235899999999999999999999999 9999999999999999999999999998765433
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHH---------HHHhcCCcc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV---------SQRASNGAI 573 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~ 573 (646)
........|++.|+|||++.+..++.++||||||+++|||++|+.||......+........ .........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 22223345899999999998888999999999999999999999998743221111000000 000000000
Q ss_pred cccccccccCCch--hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEA--SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+....... ..........+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000010000000 0000113356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.32 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=198.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||++..+ +++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999876 68999999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999999753 35889999999999999999999999 999999999999999999999999999866432
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
. ....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .. .......+.. .+
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~-~~~~i~~~~~------~~ 217 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FG-IYEKILAGKL------EF 217 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHHhCCc------CC
Confidence 2 123489999999999988899999999999999999999999863321 11 1111111110 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~~ 621 (646)
.. .....+.+|+.+||+.||.+||+ ++|+++.
T Consensus 218 ~~--------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PR--------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred Cc--------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 01234668999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.19 Aligned_cols=260 Identities=29% Similarity=0.443 Sum_probs=203.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
.++|.+.+.||+|+||.||++... ++..||+|+++... ....+.+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 346888999999999999998642 34579999987543 23356788999999999 89999999999999999
Q ss_pred CeEEEEEccCCCccccccCCc-----------------------------------------------------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKY----------------------------------------------------------- 437 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 437 (646)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc-ccc
Q 006402 438 --------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV-STC 508 (646)
Q Consensus 438 --------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~-~~~ 508 (646)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1124788999999999999999999999 9999999999999999999999999997654332211 112
Q ss_pred cCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 509 AQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||....... .. ......+... ..+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~~~--~~~~------- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGYQM--SRPD------- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHcccCc--cCCC-------
Confidence 235678999999988889999999999999999997 999986432211 11 1111111000 0000
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
....++.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 339 ----~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 ----FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01245678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.83 Aligned_cols=255 Identities=28% Similarity=0.399 Sum_probs=204.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+|...+.||+|++|.||+|..+ .++.||+|.+... ....+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777789999999999999765 5889999988643 344678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999996542 345899999999999999999999999 999999999999999999999999999876543322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .. ......... +...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~-~~~~~~~~~-----~~~~- 227 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QV-YELLEKGYR-----MERP- 227 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCCCC-----CCCC-
Confidence 2222234678999999988899999999999999999998 88887532111 11 111111100 0000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
......+.+++.+||+.+|++|||+.+++++|+++
T Consensus 228 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 -------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01224577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.25 Aligned_cols=241 Identities=29% Similarity=0.412 Sum_probs=196.5
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCcc
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
++-||.|+.|.||.|+++ ++.||||+++..++ .+++-|++|+|+||+.+.|+|...--++|||||++.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 477999999999999996 57899998764332 4688899999999999999999999999999999999999
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccC
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~ 510 (646)
..|+.. ..++......|..+||.|+.|||.+. |||||||+-||||..+..+||+|||.++......+.+. ..
T Consensus 201 ~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS--Fa 272 (904)
T KOG4721|consen 201 EVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS--FA 272 (904)
T ss_pred HHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh--hh
Confidence 999854 46788889999999999999999999 99999999999999999999999999988765533333 34
Q ss_pred ccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHH
Q 006402 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNI 590 (646)
Q Consensus 511 gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 590 (646)
||..|||||++++.+.++|+|||||||||||||||..||....... . ++ ......+.- .+ .
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I--Iw-GVGsNsL~L----pv--------P 333 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I--IW-GVGSNSLHL----PV--------P 333 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e--EE-eccCCcccc----cC--------c
Confidence 9999999999999999999999999999999999999986222111 0 00 000111100 00 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 591 LMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 591 ~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
..+++-+.-|+++||+..|.+||++.+++..|+-..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 123344667999999999999999999999886543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.21 Aligned_cols=249 Identities=35% Similarity=0.554 Sum_probs=192.6
Q ss_pred cccEecccCcEEEEEEEEc-----CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 350 KERILGSGGFGEVYKGELQ-----DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999887 25789999996543 33478899999999999999999999999988889999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.++|+.. ....+++..++.|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999875 2346899999999999999999999998 99999999999999999999999999987732222
Q ss_pred -ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 504 -HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
...........|+|||.+....++.++||||||+++|||++ |+.|+... ....... ....+..... +.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~-~~~~~~~~~~-~~-- 228 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIE-KLKQGQRLPI-PD-- 228 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHH-HHHTTEETTS-BT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-ccccccccee-cc--
Confidence 22233447789999999998889999999999999999999 66776422 1111111 1122221111 10
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.....+.+++.+||..+|++|||+.++++.|
T Consensus 229 ----------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 ----------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1234467899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=324.41 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=209.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
..+|+..++||+|+||.||+|...+++.+|+|.+........+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688889999999999999998889999999998776656778999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.++++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999997653 346899999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+. ..... ...
T Consensus 161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~~~~~------~~~- 226 (261)
T cd05148 161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT---AGYRM------PCP- 226 (261)
T ss_pred c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH---hCCcC------CCC-
Confidence 1 23346778999999988889999999999999999998 78888533211 1111111 10000 000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
......+.+++.+||+.+|++|||++++++.|+++
T Consensus 227 -------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 -------AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11224467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=326.99 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=206.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..|+..+.||+|.||.||||... .++.||+|++..... ...+++.+|+.+|.+++++||.+.++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999654 689999999986543 4578899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+.+|++.+.|+.. ..+++..+..|+++++.||.|||.++ .+|||||+.|||+..+|.+|++|||.+........
T Consensus 93 ~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999743 33478888889999999999999999 99999999999999999999999999988776554
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.. ....||+.|||||+++...|+.|+||||||++.+||.+|.+|+...... .. . -.+.+-..|.+.+
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-rv--l---------flIpk~~PP~L~~ 233 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-RV--L---------FLIPKSAPPRLDG 233 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-eE--E---------EeccCCCCCcccc
Confidence 44 4456999999999999889999999999999999999999998622110 00 0 0111222334433
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+.+.+++..||+.+|+.|||++++++
T Consensus 234 --------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 --------DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 23345779999999999999999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=336.94 Aligned_cols=198 Identities=26% Similarity=0.377 Sum_probs=174.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||.||+++.+ ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67899999999999999999876 68899999887542 23456799999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... ..+++..+..++.|++.||+|||+.+. |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999753 358899999999999999999998532 9999999999999999999999999987654322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDF 551 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~ 551 (646)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 1234589999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.60 Aligned_cols=247 Identities=27% Similarity=0.368 Sum_probs=206.1
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCccc---HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKS---TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.+|++.+.||+|.||+|-++.. ..|+.||||.+++...++ .-.+.+|++||+.|+||||+.++.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999954 679999999987765444 456789999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||..+|.|++|+.+. ..|++.....+++||..|+.|.|.++ ++|||||.+|||||+|+++||+|||++.++..+
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999754 46999999999999999999999999 999999999999999999999999999988766
Q ss_pred CCccccccCccccccCccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLT-DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
....+ ..|+|-|.+||...+.+|. +..|-||||++||-|+.|..||+..+. ..++.. +..+...+ |.
T Consensus 207 kfLqT--FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQ----Is~GaYrE---P~ 274 (668)
T KOG0611|consen 207 KFLQT--FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQ----ISRGAYRE---PE 274 (668)
T ss_pred cHHHH--hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHH----hhcccccC---CC
Confidence 54433 4499999999999998874 689999999999999999999984432 122222 22222222 11
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.+....-||+|||..+|++|.|+.+|....
T Consensus 275 ------------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 ------------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111233699999999999999999998764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.50 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=205.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999988778889999987543 34577999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999997643 345899999999999999999999999 999999999999999999999999999876533222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+. ......... + ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~---~--~~- 226 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL----QQVDQGYRM---P--CP- 226 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCCCC---C--CC-
Confidence 2222223468999999988889999999999999999999 8888753211 1111 111111000 0 00
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
......+.+++.+||+.+|++||+++++++.|+.+
T Consensus 227 -------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 -------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01224577899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=337.48 Aligned_cols=243 Identities=27% Similarity=0.368 Sum_probs=200.5
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCe
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 418 (646)
..++|...++||+|.||+|+++..+ +++.+|||++++... ++.+..+.|.+|+.... ||.+++|+.+|+..++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467999999999999999999887 588999999987643 45677888999998885 999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+.||++..+.+. ..+++..+.-+|..|+.||.|||+++ |||||||.+|||||.+|++||+||||++..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999996666543 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
-.... .+....|||.|||||++.+..|+..+|.|||||+||||+.|..||....+.+..+ ... ..+..-
T Consensus 519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~----~d~~~y 587 (694)
T KOG0694|consen 519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIV----NDEVRY 587 (694)
T ss_pred CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHh----cCCCCC
Confidence 42222 3344569999999999999999999999999999999999999998554332111 000 011111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
......+.+.+++++|..+|++|.-+
T Consensus 588 -----------P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 -----------PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----------CCcccHHHHHHHHHHhccCcccccCC
Confidence 12234556789999999999999877
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.32 Aligned_cols=268 Identities=21% Similarity=0.285 Sum_probs=198.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|...++||+|+||+||+|..+ +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999775 688999998865432 2345678999999999999999999999999899999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++ +|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 974 899888643 234789999999999999999999999 99999999999999999999999999976543221
Q ss_pred ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc---------c
Q 006402 504 HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA---------I 573 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 573 (646)
. .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+................ .
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1 123357999999998865 5689999999999999999999999864332211111110000000000 0
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+................+..+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111000000000112345679999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.90 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=199.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||.||+++.+ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999876 58999999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999753 35788999999999999999999999 999999999999999999999999999866433
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ...||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. .......+... ++ ..
T Consensus 172 ~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~--~~~~i~~~~~~--~p-~~ 237 (329)
T PTZ00263 172 TF----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FR--IYEKILAGRLK--FP-NW 237 (329)
T ss_pred cc----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HH--HHHHHhcCCcC--CC-CC
Confidence 21 23589999999999988899999999999999999999999863211 11 11111111110 00 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~~ 621 (646)
....+.+|+.+||+.||.+||+ +++++..
T Consensus 238 -----------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 -----------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234668999999999999997 6777643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.48 Aligned_cols=262 Identities=28% Similarity=0.384 Sum_probs=209.1
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCccc-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+...+.++||+|.||.|.......+..||||+++....+. .++|.+|+++|.+++|||||+|+|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456678999999999999999888999999998776554 589999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.+|+..+... .+.-....+|+.|||.|++||.+.+ ++||||.++|+|+|.++++||+|||+++.+..+..+
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999866322 2455667789999999999999999 999999999999999999999999999976554443
Q ss_pred cc-cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCCCccHHHHHHHHhcCCccc-cccccc
Q 006402 505 VS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT--SQKAIDFSRDPDDVNLAIYVSQRASNGAIM-EVVDPR 580 (646)
Q Consensus 505 ~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d~~ 580 (646)
.. ....-.+.|||||.+..++++.+||||+||++|||+++ ...||....++ ....-.......+... -...
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l~~-- 768 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVLSR-- 768 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceeccC--
Confidence 32 23345789999999999999999999999999999876 56676522111 1111111111111111 1111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
...+...+.+++.+||..+.++|||++++...|++.
T Consensus 769 ---------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 ---------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 123455678999999999999999999999988765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.45 Aligned_cols=261 Identities=22% Similarity=0.266 Sum_probs=197.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+|++.+.||+|+||.||++... +++.||+|+.. .+.+.+|+.++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56999999999999999999765 68999999643 245779999999999999999999999999999999998
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 4 7888888643 35899999999999999999999999 999999999999999999999999999754332222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC-----ccHHHHHHHHhcCCc-------
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD-----VNLAIYVSQRASNGA------- 572 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~------- 572 (646)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ..+.. +........
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcch
Confidence 22334699999999999888899999999999999999999988753322110 01111 111000000
Q ss_pred ---ccccc----c--ccccCCc-hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 ---IMEVV----D--PRLQGHE-ASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ---~~~~~----d--~~l~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+.. . ....... ...........+.+|+.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0 0000000 00112233456889999999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=335.42 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=202.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 58999999987542 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999643 35889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+. ... .... .+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~-~~~-~~~~---~~~~ 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLK-YWK-ETLQ---RPVY 222 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHH-hcc-cccc---CCCC
Confidence 1223458999999999998899999999999999999999999986432111 101000 000 0000 0000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
... ......++.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~-----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDP-----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred Ccc-----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 01123456789999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.83 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=202.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.+.||+|+||+||+|+.+++..+|+|.++... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577788999999999999988877789999887543 345779999999999999999999999999989999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999997542 25899999999999999999999999 9999999999999999999999999988665433222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.... .+.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~~--~~~---- 224 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE----KVSQGLRLY--RPH---- 224 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHhcCCCCC--CCC----
Confidence 222335678999999988889999999999999999999 88887533211 1111 111111000 000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
.....+.+++.+||+.+|++||++.++++.|+
T Consensus 225 -------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 -------LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01245678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=335.72 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=206.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.-|+.++.||+|+.|.|-.|++. +|+.+|||++..... .....+.+|+.+|+.+.|||++++++++.+...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45778899999999999999765 799999999865521 22456789999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|.|++++..+ +++++..+.+++.||+.|+.|.|..+ |+||||||+|+|||...++||+|||+|.+..++
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999754 46899999999999999999999999 999999999999999999999999999988776
Q ss_pred CCccccccCccccccCccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLT-DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.-..+.+ |.|.|.|||++.+.+|. .++||||.||+||.||||+.||+ +.++.....+. ..|...
T Consensus 166 klLeTSC--GSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlKV-~~G~f~------ 230 (786)
T KOG0588|consen 166 KLLETSC--GSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLKV-QRGVFE------ 230 (786)
T ss_pred ccccccC--CCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHHH-HcCccc------
Confidence 5555554 99999999999999875 68999999999999999999997 33333333222 222110
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+. .....++.+|+++||..||++|.|+.||++.
T Consensus 231 MP--------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 MP--------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CC--------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 00 1122346689999999999999999999865
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=341.34 Aligned_cols=261 Identities=28% Similarity=0.388 Sum_probs=204.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCC-CCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 416 (646)
.++|.+.++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999753 234799999875433 33567999999999996 9999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcC----------------------------------------------------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS---------------------------------------------------------- 438 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 438 (646)
.++||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864310
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 006402 439 -----------------------------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 439 -----------------------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~ 483 (646)
...+++..++.++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788899999999999999999999 999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHH
Q 006402 484 DFNSKVADFGLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLA 561 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~ 561 (646)
++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----- 347 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence 9999999999998654332221 122346788999999988889999999999999999997 888886332111
Q ss_pred HHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 562 IYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
........+.... .. ......+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 348 -~~~~~~~~~~~~~-----~~--------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 -TFYNKIKSGYRMA-----KP--------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHHHHHhcCCCCC-----CC--------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111111000 00 1123457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=319.77 Aligned_cols=255 Identities=26% Similarity=0.465 Sum_probs=204.4
Q ss_pred cCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.+.||+|+||+||+|.++. ...||+|.++... .....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998742 4579999887543 23456789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++.... ..+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999997542 35899999999999999999999998 99999999999999999999999999987752
Q ss_pred CCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 501 GLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .. ...........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCCC---
Confidence 2221 1222335678999999988889999999999999999998 98887532111 11 11111111000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
. .......+.+++.+||+.+|++||++.||++.|+++
T Consensus 229 -~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -P---------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 001224467999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.32 Aligned_cols=247 Identities=23% Similarity=0.293 Sum_probs=197.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
..++|+.++.||+|+||.||+++-+ +|..+|+|++++... ...+.+..|..+|....+|+||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4577999999999999999999665 699999999987643 346778899999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||++||++..+|... ..|++..+..++.+++.||.-||+.| +|||||||+|+|||..|++||+||||+....
T Consensus 219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999754 46999999999999999999999999 9999999999999999999999999985321
Q ss_pred C-----------------------CCCc----c-------------------ccccCccccccCccccccCCCCchhhHH
Q 006402 500 P-----------------------GLSH----V-------------------STCAQGTLGYLDPEYYRNYQLTDKSDVY 533 (646)
Q Consensus 500 ~-----------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDv~ 533 (646)
. +... . .....|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0 0112499999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC
Q 006402 534 SYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP 613 (646)
Q Consensus 534 s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 613 (646)
|+|||+||||.|.+||......+ .+..+...+..-.... ......+..+||.+|+. ||++|-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~-------T~rkI~nwr~~l~fP~----------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQE-------TYRKIVNWRETLKFPE----------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhhhccCCC----------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999997443221 1111111110000000 01122456789999998 999996
Q ss_pred C
Q 006402 614 S 614 (646)
Q Consensus 614 s 614 (646)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.57 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=207.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999742 346799999876665567789999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 420 IYEYIANGTLHDHLHGKY----------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHH
Q 006402 490 ADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 490 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~-~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHH
Confidence 99999986543221 11122335778999999988889999999999999999998 88887533211 1 1111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+.... ... .....+.+|+.+||+.+|.+|||+.|+++.|+++...
T Consensus 235 i~~~~~~~-----~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQ-----RPR--------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCC-----CCC--------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111 000 1123477999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.71 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=203.7
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-C-----cEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-G-----TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.+.||+|+||.||+|.... + ..||+|.++.... ...+.|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999997643 2 5799998875432 33567899999999999999999999999988999
Q ss_pred EEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 006402 419 LIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~ 485 (646)
++|||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965321 145889999999999999999999999 99999999999999999
Q ss_pred CEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHH
Q 006402 486 NSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIY 563 (646)
Q Consensus 486 ~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~ 563 (646)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~--- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV--- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence 999999999986543221 12223346788999999988889999999999999999998 99898633221 11
Q ss_pred HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
...+........ .......+.+|+.+||+.+|.+||++.||++.|+.
T Consensus 236 -~~~i~~~~~~~~-------------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -IEMIRSRQLLPC-------------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCCC-------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111111110 01233557799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=327.84 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=202.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.+|+..+.||+|+||+||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888999999999999999764 343 48999987543 34467899999999999999999999998765 5789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|+||+++|+|.++++... ..+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999997642 34889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccc-cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSHVS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~-- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERLP-- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCCC--
Confidence 4333221 22234678999999998899999999999999999998 89888632111 11 11111110000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.+. .....+.+++.+||+.+|++||++.+++..|.++....
T Consensus 232 ~~~-----------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 232 QPP-----------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCC-----------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 000 01234668999999999999999999999988886443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.28 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=193.8
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
++||+|+||.||+++.+ +|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 68999999987532 234466889999999999999999999999999999999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~ 507 (646)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 999998643 35899999999999999999999999 99999999999999999999999999875432211 122
Q ss_pred ccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... .... .... .+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~---~~~~-~~~~------~~p~---- 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELIL-MEEI------RFPR---- 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH---HHHH-cCCC------CCCC----
Confidence 345899999999999889999999999999999999999998632111 111 1111 1100 0100
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 ----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1223467899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.78 Aligned_cols=198 Identities=25% Similarity=0.384 Sum_probs=173.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.++||+|+||.||++..+ ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 67899999999999999999876 68899999876542 23456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++... ..+++..+..++.|+++||.|||+. + |+|+||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 85 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999743 3588999999999999999999985 5 9999999999999999999999999987653321
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12235899999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.33 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=207.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||.||+|+.. +++.||||.+... +......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999765 7899999987542 2334567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345889999999999999999999999 99999999999999999999999999887654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ...... ........ +.
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~-~~~~~~~~-----~~ 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLC-QKIEQCDY-----PP 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHH-HHHhcCCC-----CC
Confidence 3221 1223588899999999888899999999999999999999999853221 111111 11111111 11
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
.. .......+.+++.+||+.+|++||++.||++.|++++
T Consensus 228 ~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LP-------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC-------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 10 1123355779999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.30 Aligned_cols=272 Identities=23% Similarity=0.312 Sum_probs=206.2
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcc--cCCcccHHHHHHHHHHHhhCCCCcccccceeEEe-----C
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAK--VGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-----A 414 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 414 (646)
.....|...+.||+|++|.|.++..+ +|+.||||++. -.+....++..+|+.+|+.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556666788999999999999765 78999999987 3444566788999999999999999999999876 3
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
+..|+|+|+| ..+|...++.. ..|+..+...++.||++||.|+|+.+ |+||||||+|+|++.+...||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 4689999999 77999999753 34899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCC-CCccccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC--
Q 006402 495 SRLAKPG-LSHVSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN-- 570 (646)
Q Consensus 495 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 570 (646)
|+..... .....+....|..|+|||++. ...|+...||||.||+|.||++|+.-|.+....+...+.......+.+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9988543 112235566899999999874 457999999999999999999999998866544333332221111111
Q ss_pred ------Cccccccc--ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 571 ------GAIMEVVD--PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 571 ------~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+. +.........-.........+|+.+||..||.+|+|++|.++.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111110 0000000010011223456799999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=321.76 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=196.7
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--------------cHHHHHHHHHHHhhCCCCccccc
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--------------STQQVLNEVGILSQVNHKNLVRL 407 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l 407 (646)
+..++|++.+.||+|.||.|-+|... +++.||||++.+.... ..+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999765 7999999998653221 24578999999999999999999
Q ss_pred ceeEEeC--CcCeEEEEEccCCCccccccCCcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC
Q 006402 408 LGCCVEA--EQPLLIYEYIANGTLHDHLHGKYSSFN-LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD 484 (646)
Q Consensus 408 ~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~ 484 (646)
+.+..+. +..|||+||+..|.+...-. ..+ ++..+++++++++..||+|||.++ |+||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998764 58899999999888766432 223 899999999999999999999999 9999999999999999
Q ss_pred CCEEEeecCCCccCCCCCC----ccccccCccccccCccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 006402 485 FNSKVADFGLSRLAKPGLS----HVSTCAQGTLGYLDPEYYRNY----QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD 556 (646)
Q Consensus 485 ~~~ki~DfGl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~ 556 (646)
|++||+|||.+........ .......|||.|+|||...+. ..+.+.||||+||+||-|+.|+.||.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 9999999999986633211 111224699999999988653 235688999999999999999999962211
Q ss_pred CccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 557 DVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
+. ....+.+ ..|.-.. ..+.-+++.+||.++|+.||++|.++.+|....
T Consensus 325 ---~~--l~~KIvn--------~pL~fP~----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 ---LE--LFDKIVN--------DPLEFPE----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---HH--HHHHHhc--------CcccCCC----cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 1111111 1111111 112334567899999999999999999987544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.10 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=215.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+.....+||.|.||.||.|.|+. .-.||||.++.. ....++|+.|..+|+.++|||+|+|+|+|.....+|||+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3445566889999999999999874 678999999754 35678999999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
|.+|+|.+||++. .+..++....+.+|.||+.|+.||..++ +|||||..+|.|+.++..+||+|||+++++..+..
T Consensus 345 M~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999876 4445788888999999999999999999 99999999999999999999999999999987665
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.........+.|.|||-+....++.|+|||+|||+||||.| |..|+.. .++. .++..+..+- ++.
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlS-qVY~LLEkgy-------RM~ 486 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLS-QVYGLLEKGY-------RMD 486 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHH-HHHHHHhccc-------ccc
Confidence 55555567889999999999999999999999999999998 5566542 2222 2222332221 121
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
+ ...+...+.+|+++||+++|.+||++.|+-+.++.+.
T Consensus 487 ~------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 487 G------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred C------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1 2245677899999999999999999999999998775
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.17 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=202.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeC-Cc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA-EQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 416 (646)
++|++.++||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999542 24789999987543 23346788999999999 799999999988764 46
Q ss_pred CeEEEEEccCCCccccccCCcC----------------------------------------------------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS---------------------------------------------------------- 438 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 438 (646)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998854311
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc-ccccCccccccC
Q 006402 439 SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV-STCAQGTLGYLD 517 (646)
Q Consensus 439 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~a 517 (646)
...++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 125899999999999999999999999 9999999999999999999999999998764332221 223346778999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHH
Q 006402 518 PEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKL 596 (646)
Q Consensus 518 PE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 596 (646)
||++.+..++.++||||||++||||++ |..||......+ .+ ......+... ..+ ......
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~-~~~------------~~~~~~ 304 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTRM-RAP------------EYATPE 304 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCCC-CCC------------ccCCHH
Confidence 999999899999999999999999998 988886432211 11 1111111110 000 012245
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 597 FSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 597 ~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
+.+++.+||+.+|++||++.|+++.|++++.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.03 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=200.5
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
+|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477788999999999999988877889999886433 3456788999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999997542 25899999999999999999999999 99999999999999999999999999986643322222
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ....... .....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~-----~~~~~--- 223 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVV----ESVSAGY-----RLYRP--- 223 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHH----HHHHcCC-----cCCCC---
Confidence 22224568999999988889999999999999999999 78887633221 111 1111110 00000
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
......+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 -----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 -----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01234577999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=318.45 Aligned_cols=254 Identities=29% Similarity=0.428 Sum_probs=202.5
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.++||+|+||.||+|+..+...||+|+++... ...+.+.+|+.++++++|+||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999988777789999987533 34567899999999999999999999874 456899999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++.... ...+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||.++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999997542 335799999999999999999999999 9999999999999999999999999998665433222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||+..+..++.++||||||+++|||+| |+.||...... . .......... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~----~~~~~~~~~~-----~~~--- 224 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---E----VLDQVERGYR-----MPC--- 224 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---H----HHHHHhcCCC-----CCC---
Confidence 223346778999999988889999999999999999999 77777532211 0 1111111100 000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.......+.+++.+||+.+|++||++.++++.|+..
T Consensus 225 -----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 012234577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.44 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=203.7
Q ss_pred cCCCcccEecccCcEEEEEEEEcC------CcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD------GTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|.+.+.||+|+||.||+|+..+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999997643 478999998765444 4578999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 419 LIYEYIANGTLHDHLHGKY-----------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
+||||+++++|.++++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997532 1245889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHH
Q 006402 488 KVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 565 (646)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~--- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE--- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---
Confidence 9999999976533221 11122335788999999999899999999999999999998 99998533221 1111
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
....+..... . ......+.+++.+||+.+|++||++.||++.|+
T Consensus 236 -~~~~~~~~~~-~------------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 -CITQGRLLQR-P------------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHcCCcCCC-C------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111110 0 012345778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=296.91 Aligned_cols=248 Identities=28% Similarity=0.366 Sum_probs=205.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|.||.||.|+.+ ++-.||+|++.+... +..+++.+|++|.+.|+||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 46889999999999999999765 688999999865432 33567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||.++|+|...|.+.. ...+++.....++.|+|.||.|+|..+ |+||||||+|+|++..+..||+|||-+...+..
T Consensus 102 Eya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 9999999999998653 345888899999999999999999999 999999999999999999999999999877633
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. . ...||..|.+||...+...+.+.|+|++|++.||++.|.+||...... ...+.+.. .++.+|..
T Consensus 178 kR-~--tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k---~~~~~p~~ 244 (281)
T KOG0580|consen 178 KR-K--TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRK---VDLKFPST 244 (281)
T ss_pred Cc-e--eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHH---ccccCCcc
Confidence 22 2 244999999999999999999999999999999999999999743311 11111211 11122211
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....+.++|.+|+..+|.+|.+..|+++.
T Consensus 245 -----------is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 -----------ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----------cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22346689999999999999999999854
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.53 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=194.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc--CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhC---CCCcccccceeEEe-----
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ--DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQV---NHKNLVRLLGCCVE----- 413 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 413 (646)
++|++.+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999763 468899998865432 2334566788777766 69999999999863
Q ss_pred CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
....++||||+. ++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 6899988654 2335899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc---C
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS---N 570 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 570 (646)
+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..... .
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCCh
Confidence 998664332 2233458999999999988889999999999999999999999987443221 1111111110 0
Q ss_pred Cccccc--cc-ccccC---CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 GAIMEV--VD-PRLQG---HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 ~~~~~~--~d-~~l~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...... ++ ..+.. .............+.+|+.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00 00000 0000000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=321.80 Aligned_cols=260 Identities=25% Similarity=0.438 Sum_probs=208.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.+|...+.||+|+||.||+++.. ++..+++|.++.......+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34777789999999999999742 356799999876665566789999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 420 IYEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1234899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHH
Q 006402 487 SKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYV 564 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 564 (646)
+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 11223346788999999988889999999999999999999 998875332111 1
Q ss_pred HHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 565 SQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 565 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
......+...... ......+.+++.+||+.+|++|||+.+|+++|+++...
T Consensus 235 ~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLERP-------------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCCC-------------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111111100 01234577999999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=323.41 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=201.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-----CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-----DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 418 (646)
++|++.+.||+|+||+||++..+ +++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999743 5789999998876666677899999999999999999999987543 4678
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+|+||+++++|.+++.+. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999999653 235899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccc--cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------C---ccHHHHHHHH
Q 006402 499 KPGLSHVS--TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD------D---VNLAIYVSQR 567 (646)
Q Consensus 499 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~------~---~~~~~~~~~~ 567 (646)
........ ....++..|+|||.+.+..++.++||||||+++|||++|..++....... . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 54332211 11224456999999988889999999999999999999877654221100 0 0000000000
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
..... .+.. .......+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~-------~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG-------RLPA------PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC-------cCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000 0000 011234577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=332.13 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=191.2
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
|+..++||+|+||+||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445578999999999999775 689999999865432 335678999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 99987643 2467788899999999999999999 99999999999999999999999999987643321 1
Q ss_pred ccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 506 STCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.....||..|+|||.+.. ...+.++||||||+++|||++|+.||......+ ............. +.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~------~~ 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQP------PE 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccCC------CC
Confidence 223458999999998743 234568999999999999999999997332221 1111111000000 00
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. .......+.+|+.+||+.+|++|||+.|+++.
T Consensus 296 ~--------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 A--------PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C--------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01123457789999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.04 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=198.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcC--CcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD--GTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|.+.+.||+|+||.||+|+.++ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999997653 368999988643 223456788999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. .......+.. .+++.
T Consensus 184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~--~~~~i~~~~~--~~p~~ 250 (340)
T PTZ00426 184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LL--IYQKILEGII--YFPKF 250 (340)
T ss_pred Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HH--HHHHHhcCCC--CCCCC
Confidence 22 234589999999999888899999999999999999999999963211 11 1111111110 01111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
....+.+++.+||+.+|++|+ +++|+++.
T Consensus 251 ------------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 ------------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 123356899999999999995 88888754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.04 Aligned_cols=253 Identities=30% Similarity=0.435 Sum_probs=201.5
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.++||+|++|.||++...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999888888899999875433 4567999999999999999999999875 456899999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.++++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999997542 345899999999999999999999999 9999999999999999999999999998765432222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ....... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~-----~~~-- 225 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ----VERGYRM-----PCP-- 225 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCCC-----CCC--
Confidence 222235678999999988889999999999999999999 8888753211 111111 1111000 000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
......+.+|+.+||+.+|++|||+.++.+.|++
T Consensus 226 ------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 ------QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0122347789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.04 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=201.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
..++|+..+.||+|+||.||+|..+ .+..||+|++.... .....++.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 35679999886432 2345678999999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS-------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
.++||||+++++|.++++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 224688999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHH
Q 006402 490 ADFGLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~-~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVL-RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HH
Confidence 9999987654322211 112235788999999988889999999999999999999 67777532211 111 11
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
......... .. .....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~~~~~~-----~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLDK-----PD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCCC-----CC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111110 00 11234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=328.36 Aligned_cols=241 Identities=24% Similarity=0.304 Sum_probs=193.2
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
++||+|+||.||+++.+ +|+.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999765 6899999998653 2234566788999999999999999999999999999999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~ 507 (646)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 999888643 35899999999999999999999999 99999999999999999999999999875432211 112
Q ss_pred ccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..... ... .+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~~~~~-~~~------~~p~---- 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELILM-EEI------RFPR---- 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHhc-CCC------CCCC----
Confidence 345899999999999889999999999999999999999998633211 111 11110 000 0100
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 217 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 ----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1223466899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.78 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=202.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-Cc--EEEEEEcccC-CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-GT--VVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.++||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998753 33 4788887743 333456789999999999 699999999999999999999
Q ss_pred EEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 421 YEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
+||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1124889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHH
Q 006402 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 566 (646)
||+|||++........ ......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEK 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 9999999864322111 111223567999999988889999999999999999998 9999853221 111111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
...+... ... ......+.+|+.+||+.+|.+|||+.++++.|+++.+..
T Consensus 231 -~~~~~~~-----~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 -LPQGYRM-----EKP--------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -HhcCCCC-----CCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111000 000 012244678999999999999999999999999888655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.39 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=194.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cCe
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (646)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999765 6899999988643 2234457889999999999999999999886533 468
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6898888643 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc--cccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh------
Q 006402 499 KPGLSH--VSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA------ 568 (646)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 568 (646)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 322211 1123458999999999865 5789999999999999999999999864322110 00000000
Q ss_pred -----cCCcccccc---cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 569 -----SNGAIMEVV---DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 569 -----~~~~~~~~~---d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+ .+... .............+.+++.+||+.+|++|||++|+++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQP-VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCC-CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 00000 00000001122456789999999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=324.41 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=198.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|.+.+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999876 688999999875432 234567899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+. ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 6788877643 235888999999999999999999999 9999999999999999999999999987543222
Q ss_pred CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---ccc----
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---AIM---- 574 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 574 (646)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+. .+....... ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLE-RIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHH-HHHHHhCCCChhhccchhh
Confidence 11223458999999998865 4588899999999999999999999974322111 011 111100000 000
Q ss_pred -ccccc-ccc--CCchhH---HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 -EVVDP-RLQ--GHEASV---NILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 -~~~d~-~l~--~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...++ .+. ...... ........+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 000 000000 00011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.53 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=202.1
Q ss_pred CCCcccEecccCcEEEEEEEEc-C-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-D-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.|.+.+.||+|++|.||++... + ++.||+|.+...+......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999654 4 6789999876665555667888999999999999999999999999999999999
Q ss_pred cCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 425 ANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 425 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++|+|.+++++.. ...++++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886432 3446899999999999999999999999 99999999999999999999999999987654322
Q ss_pred -ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 -HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .+... + ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~~----~-~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKYD----P-FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCC----C-CC
Confidence 122334589999999999988999999999999999999999999863211 11111111 11110 0 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|++||++.+++.
T Consensus 293 --------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 --------CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --------ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 012234678999999999999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.12 Aligned_cols=239 Identities=24% Similarity=0.296 Sum_probs=191.3
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|+||+||+++.. +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999776 5889999988643 233456788999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 9999753 35899999999999999999999999 99999999999999999999999999986433221 22234
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
.||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... ... .+..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~------~~~~------ 214 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL------RFPD------ 214 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC------CCCC------
Confidence 589999999999988999999999999999999999999863211 111111111 100 0000
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPS---MTDVVH 620 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs---~~evl~ 620 (646)
.....+.+++.+||+.+|++||+ +.|++.
T Consensus 215 --~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 --GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 12234678999999999999985 556553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=329.57 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=210.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-CeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ-PLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 421 (646)
++|...+++|+|+||.++..+.+ ++..+++|.+.... ....+...+|+.++++++|||||...+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999998765 67899999887553 3345578899999999999999999999999998 89999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
+|++||+|.+.|.+.+ +..++++.+.+++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+...++
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998764 567899999999999999999999888 999999999999999999999999999999876
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
... ...+.||+.|+.||.+.+.+|..|+|||||||++|||.+-+++|...... .+...+.... .+| +
T Consensus 160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~--------~~P-l 226 (426)
T KOG0589|consen 160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGL--------YSP-L 226 (426)
T ss_pred hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhcc--------CCC-C
Confidence 533 33456999999999999999999999999999999999999998733221 1221111111 111 1
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......++..++..||+.+|+.||++.+++.+
T Consensus 227 --------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 --------PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --------CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12234557789999999999999999999987
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=329.39 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=197.5
Q ss_pred CCCcccEecccCcEEEEEEEE----cCCcEEEEEEcccC----CcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcC
Q 006402 347 GFSKERILGSGGFGEVYKGEL----QDGTVVAVKSAKVG----NIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 417 (646)
+|++.+.||+|+||+||+++. .+++.||+|++... .....+.+.+|+.++.+++ |+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999865 35789999988643 2233456888999999995 99999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998643 35899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.............||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ..+.......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC----- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC-----
Confidence 544333333344589999999998765 4788999999999999999999999643322211 1111111110
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
++.+.. .....+.+++.+||+.+|++|| +++++++
T Consensus 227 -~~~~~~--------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 -DPPFPS--------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCC--------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 1123466899999999999999 7778775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.08 Aligned_cols=242 Identities=23% Similarity=0.290 Sum_probs=194.4
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
++||+|+||.||++..+ +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 6899999998653 2234567889999999999999999999999999999999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~ 507 (646)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 999988643 35899999999999999999999999 99999999999999999999999999875432211 122
Q ss_pred ccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ .. ..+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~-~~------~~~p~---- 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-ED------IKFPR---- 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhcc-CC------ccCCC----
Confidence 345899999999999888999999999999999999999998632211 11111110 00 00100
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
.....+.+|+.+||+.+|++|| ++.|+++.
T Consensus 217 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 ----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223466899999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.26 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=207.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC-----CcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEe-CCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD-----GTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-AEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 417 (646)
.++|.+.++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999998765 688999988644 23346778999999999999999999998776 4678
Q ss_pred eEEEEEccCCCccccccCCcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 418 LLIYEYIANGTLHDHLHGKYSS-----FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 46899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 493 GLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 493 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
|+++......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+.. ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA----YLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHc
Confidence 9998664432221 122346778999999988889999999999999999999 9998863211 11111 1111
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
+.. .... ......+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 235 ~~~-----~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 GYR-----LAQP--------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCC-----CCCC--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 100 0000 01223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=316.87 Aligned_cols=269 Identities=25% Similarity=0.309 Sum_probs=199.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 419 (646)
-.|...+++|.|+||.||+|++. +++.||||+......-. -+|+.+|+++.|||||+|+-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34666799999999999999876 57899999886543211 26899999999999999999987643 2348
Q ss_pred EEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCcc
Q 006402 420 IYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRL 497 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~ 497 (646)
|||||+. +|.++++... .+..++...+.-+..||++||+|||+.+ |+||||||+|+|+|. .|.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999965 8888887421 2345777888889999999999999999 999999999999995 59999999999999
Q ss_pred CCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC------
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN------ 570 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 570 (646)
...+....+ ..-|..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|......+.. .. +.+.+..
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~e-Iik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VE-IIKVLGTPTREDI 250 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HH-HHHHhCCCCHHHH
Confidence 887766543 3368899999998665 7999999999999999999999888754332222 21 1111111
Q ss_pred ----CcccccccccccCCchhH-HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 006402 571 ----GAIMEVVDPRLQGHEASV-NILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRIIE 627 (646)
Q Consensus 571 ----~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~~ 627 (646)
....+.-.+.+....... .......+..+|+.++|+.+|.+|.++.|++.. .+.+++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111122223333222111 122234567799999999999999999999843 444443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.14 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=208.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcCC-cEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccce-eEEeC------Cc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDG-TVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLG-CCVEA------EQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~------~~ 416 (646)
.+++++++|.+|||+.||.+....+ ..+|+|++-..++...+.+.+|+.+|++|+ |+|||.++| ..... -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 5677889999999999999988765 999999998888889999999999999997 999999999 33221 25
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+|.||||.+|.|-+++..+... .|++.++++|+.|+++|+++||... +||||||||-+||||+.++..||+|||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 67999999999999999865433 3999999999999999999999998 889999999999999999999999999986
Q ss_pred cCCCCCC--ccc------cccCccccccCcccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 497 LAKPGLS--HVS------TCAQGTLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 497 ~~~~~~~--~~~------~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
-.-.... ... -...-|+.|+|||.+ .+..+++|+|||+|||+||-|.....||+......
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------- 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------- 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence 4322211 000 012369999999976 57789999999999999999999999997432211
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
+++....-.. .......|.+||+.||+.+|.+||++-+|+..+-++++.
T Consensus 266 ----------Ilng~Y~~P~----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 ----------ILNGNYSFPP----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----------EEeccccCCC----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111000 123566788999999999999999999999888877643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.62 Aligned_cols=271 Identities=24% Similarity=0.296 Sum_probs=202.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCc-ccccceeEEeCC------
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKN-LVRLLGCCVEAE------ 415 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 415 (646)
..|...++||+|+||+||+|+.+ +|+.||+|+++....+ -.....+|+.+|++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555677999999999999765 7899999998866442 3455689999999999999 999999999877
Q ss_pred cCeEEEEEccCCCccccccCCcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSS-FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 56999999765321 35777899999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
|+........ .+...+|..|+|||++.+. .|+...||||+||++.||++++..|....+.+...........+.+..+
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9977644332 3345689999999998766 7999999999999999999998888755442211111111111111111
Q ss_pred cccc---ccc-----ccCC-chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 574 MEVV---DPR-----LQGH-EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 574 ~~~~---d~~-----l~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.... +-. .... ..............+++.+||+.+|.+|.|++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 111 0000 0000001111356799999999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.33 Aligned_cols=263 Identities=26% Similarity=0.420 Sum_probs=206.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 414 (646)
..+|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999641 34579999886432 34457789999999999 799999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
...++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975421 235889999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVN 559 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~ 559 (646)
++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 99999999999999876543222 1222346778999999988889999999999999999998 677764221
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
...... .......... + ......+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 245 ~~~~~~-~~~~~~~~~~--~-----------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 245 VEELFK-LLKEGHRMDK--P-----------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHH-HHHcCCcCCC--C-----------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111111 1111111000 0 0123456789999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.36 Aligned_cols=254 Identities=31% Similarity=0.459 Sum_probs=203.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+.|.+.++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 35688889999999999999998889999999987543 3457899999999999999999999986 455789999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999987543 346899999999999999999999999 999999999999999999999999999876533222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......++..|+|||++....++.++||||||+++|||++ |+.||...... .... ........+ ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~-----~~~ 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ----NLERGYRMP-----RPD 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH----HHHcCCCCC-----CCC
Confidence 2222346778999999988889999999999999999999 99998633211 1111 111110000 000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
....++.+++.+||+.+|++|||++++++.|+.
T Consensus 227 --------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 --------NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.17 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=206.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.+|++.+.||+|++|.||++... +++.+|||.+...+ ....+++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778899999999999999764 78999999876432 234567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345899999999999999999999999 99999999999999999999999999876643
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....++..|+|||++.+..++.++|+||||+++|||++|..||...... ... ........ ..+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~-----~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQC-----DYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHH-HhhhhhcC-----CCCC
Confidence 3221 12234888999999998888999999999999999999999998632211 111 11111111 1111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
+.. ......+.+++.+||+.+|++||||.+|++.++++.
T Consensus 228 ~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LPS-------DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCc-------ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 110 113345778999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=311.39 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=201.1
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|.+.+.||+|++|.||++..+++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999988877789999876543 34567899999999999999999999875 456899999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.++++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999997542 335899999999999999999999999 9999999999999999999999999998664332222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||...+..++.++||||||+++|||++ |+.||...... .... ........ ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~-----~~~-- 225 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE----QVERGYRM-----PCP-- 225 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-----CCC--
Confidence 222346778999999988889999999999999999999 88887632211 1111 11111000 000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
......+.+++.+||+.+|++||++++|++.|++
T Consensus 226 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 ------QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0123457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=324.27 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=206.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
++|.+.+.||+|+||.||+++.. +...+|+|.++... ....+++.+|+.+++++ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999753 23579999987542 33456788999999999 7999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
..++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999975421 235899999999999999999999998 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNL 560 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~ 560 (646)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------H
Confidence 9999999999998765432111 1122234578999999988889999999999999999998 777775221 1
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.. ...........+. . .....++.+++.+||+.+|++|||+.||++.|+++......
T Consensus 249 ~~-~~~~~~~~~~~~~-~------------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 249 EE-LFKLLKEGHRMDK-P------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HH-HHHHHHcCCCCCC-C------------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 11 1111111111110 0 01224567899999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.84 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=208.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|++|.||+|... +++.||+|.++.. +....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999877 7899999987643 2233567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
||+++++|.+++.... ....+++.+++.++.++++||+|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986432 2345899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........ ....+....
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~~~~~~~~~----- 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCK-KIEKCDYPP----- 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHh-hhhcCCCCC-----
Confidence 3211 122347889999999988889999999999999999999999985332 11111111 111111100
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
+. .......+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 228 ~~-------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LP-------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC-------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 1123345778999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.29 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=200.6
Q ss_pred cCCCcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
..|+..+.||+|+||+||+|+. .++..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577779999999999999975 246789999987433 3345678999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 006402 420 IYEYIANGTLHDHLHGKY--------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~ 485 (646)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1234789999999999999999999999 99999999999999999
Q ss_pred CEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHH
Q 006402 486 NSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIY 563 (646)
Q Consensus 486 ~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~ 563 (646)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~--- 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEV--- 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHH---
Confidence 999999999986543321 11222335778999999988889999999999999999998 8888753211 111
Q ss_pred HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
........... .. ......+.+++.+||+.+|++||++.++++.|..
T Consensus 236 -~~~~~~~~~~~-----~~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKRQLLP-----CS--------EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCC-----CC--------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111110 00 0122346789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.59 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=197.8
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCcc
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
++||+|+||.||+|...+++.+|+|.++.... .....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875533 33457899999999999999999999999999999999999999999
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccC
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~ 510 (646)
+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9986542 35789999999999999999999999 999999999999999999999999998765433222222223
Q ss_pred ccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 511 gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
+++.|+|||++.+..++.++||||||+++|||++ |..||...... .. ............ .
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~~~-----~------- 216 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QA----REQVEKGYRMSC-----P------- 216 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcCCCCCC-----C-------
Confidence 5678999999988889999999999999999998 88888532111 11 111111110000 0
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
......+.+++.+||+.+|++||++.|++++|.
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 -QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 012245778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=345.10 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=204.4
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCC-
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE- 415 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 415 (646)
+.+...++|.+.++||+|+||+||+++.. +++.||||++.... ......+.+|+.++..++|+|++++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34455679999999999999999999754 78999999986543 344567889999999999999999988776433
Q ss_pred -------cCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 416 -------QPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 416 -------~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2579999999999999997532 3346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHH
Q 006402 488 KVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 566 (646)
||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||.... .......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHH
Confidence 99999999876433221 2233458999999999999899999999999999999999999986321 1111111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. .+.... +.+ .....+.+++.+||+.+|.+||++.++++.
T Consensus 257 ~~-~~~~~~-~~~------------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-AGRYDP-LPP------------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-cCCCCC-CCC------------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 111110 111 123457789999999999999999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.33 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=199.8
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
+|+..++||+|+||+||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999765 689999999865322 223567889999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888643 2335899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.. ....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ...+........ ..+.
T Consensus 157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~--~~~~---- 225 (285)
T cd05605 157 TI--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ--EEYS---- 225 (285)
T ss_pred cc--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc--cccC----
Confidence 21 223589999999999888899999999999999999999999974322111 111111111100 0000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
......+.+|+.+||+.||.+|| +++++++.
T Consensus 226 --------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 --------EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --------cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11234567899999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.80 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=205.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
..++|+..+.||+|+||.||++... +...+|+|.+.... .+...++.+|+.++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999764 23689999887542 23456788999999999 7999999999999999
Q ss_pred cCeEEEEEccCCCccccccCC-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 416 QPLLIYEYIANGTLHDHLHGK-------------YSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
..++||||+++++|.++++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998643 12346899999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNL 560 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~ 560 (646)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 9999999999999876543221 1222335678999999988889999999999999999998 88887532111
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
. .......+...+. . ......+.+|+.+||+.+|++|||+.|+++.|+++.
T Consensus 242 -~-~~~~~~~~~~~~~-~------------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 -E-LFKLLKEGYRMEK-P------------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -H-HHHHHHcCCcCCC-C------------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 1111111111000 0 012234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.00 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=198.0
Q ss_pred cCCCcccEecccCcEEEEEEEEcC---------------CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccce
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD---------------GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLG 409 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 409 (646)
++|++.+.||+|+||.||++...+ ...||+|.++... ....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999986532 2358999987542 234567999999999999999999999
Q ss_pred eEEeCCcCeEEEEEccCCCccccccCCc---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 006402 410 CCVEAEQPLLIYEYIANGTLHDHLHGKY---------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNIL 480 (646)
Q Consensus 410 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIl 480 (646)
++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986432 1124789999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcC--CCCCCCCCCCCC
Q 006402 481 LDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS--QKAIDFSRDPDD 557 (646)
Q Consensus 481 l~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg--~~p~~~~~~~~~ 557 (646)
+++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+++ ..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 999999999999999765433221 11223357789999999888899999999999999999984 4455422111
Q ss_pred ccHHHHHHHHhcCC-cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 558 VNLAIYVSQRASNG-AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 558 ~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
............. .......+. .....+.+|+.+||+.+|++|||+.+|++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGRQIYLSQTP-----------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhccccccCCCCC-----------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111100 000000000 01245779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.80 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=193.4
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|+||+||+++.+ +|+.+|+|++..... ...+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 689999998864321 2234566799999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888654 2345899999999999999999999999 99999999999999999999999999876654322 2234
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
.|++.|+|||++.+..++.++||||||+++|||++|+.||....... .... +........ +.. .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~-~~~~~~~~~----~~~--~------- 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEE-LKRRTLEDE----VKF--E------- 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHH-HHHHhhccc----ccc--c-------
Confidence 58999999999988889999999999999999999999986432211 1111 111111110 000 0
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
......++.+|+.+||+.+|++||++.|+++.+
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 001234467899999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.29 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=203.1
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|++|.||+++.+ +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 6899999987643 334567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.++++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999764 2346899999999999999999999998 99999999999999999999999999887654322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. .....+++.|+|||++.+..++.++|+||||++++||++|+.||..... .. .......+.... +.
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~----~~~~~~~~~~~~-----~~- 222 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GA----LILKIIRGVFPP-----VS- 222 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HH----HHHHHHcCCCCC-----Cc-
Confidence 2 2233578999999999988899999999999999999999999863321 11 111111111111 00
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 -------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=319.47 Aligned_cols=266 Identities=29% Similarity=0.396 Sum_probs=200.5
Q ss_pred CcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCC--cCeEE
Q 006402 349 SKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE--QPLLI 420 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 420 (646)
...+.||+|+||+||++.. .+++.||+|.++.... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988643 3578899999875432 34567889999999999999999999887643 57899
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998643 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 501 GLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ................+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence 3221 11122356679999999888899999999999999999999999764322100 00000000000001111111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
....... .......+.+++.+||+.+|++|||++++++.|+++.
T Consensus 239 ~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPC----PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCC----CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111000 0112356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=311.89 Aligned_cols=255 Identities=30% Similarity=0.443 Sum_probs=205.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++|.+.++||+|++|.||++..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998888899999987543 34578999999999999999999999999888999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999997642 345899999999999999999999999 999999999999999999999999998876543222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.......+..|+|||.+.+..++.++||||||++++||++ |+.||..... ..... ........ ..+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~---~~~~~~~~--~~~----- 226 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLE---QVERGYRM--PRP----- 226 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHcCCCC--CCC-----
Confidence 2222235678999999988889999999999999999998 8888853211 11111 11110000 000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
......+.+++.+||+.+|++||+++++.+.|+.
T Consensus 227 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0113457789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.24 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=196.9
Q ss_pred CCcccEecccCcEEEEEEEEcC-Cc--EEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeC------Cc
Q 006402 348 FSKERILGSGGFGEVYKGELQD-GT--VVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA------EQ 416 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 416 (646)
|.+.++||+|+||.||+|++.+ ++ .+|+|.++.. .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999998764 33 6899987654 234467789999999999999999999987542 24
Q ss_pred CeEEEEEccCCCccccccCCc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 417 PLLIYEYIANGTLHDHLHGKY---SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
.++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874221 2335899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 494 LSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 494 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+ ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEI----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHcC
Confidence 99876543221 1122336778999999998889999999999999999999 7888753211 111 1111111
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
..... . ......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 ~~~~~-~------------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQ-P------------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC-C------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110 0 01223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=310.60 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=194.8
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
+.||+|+||.||+|+.. +++.+|+|.+.... .+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 68999999876432 33456799999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc-cc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS-TC 508 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~-~~ 508 (646)
.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9999653 235899999999999999999999999 99999999999999999999999999876543221111 11
Q ss_pred cCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 509 AQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... .. ........... ..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~~~~~~-----~~----- 218 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQGVRLP-----CP----- 218 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCCCCC-----Cc-----
Confidence 123567999999988889999999999999999998 77777522111 11 11111100000 00
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
......+.+++.+||+.+|++|||+.||+++|+
T Consensus 219 ---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ---ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 012345778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.19 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=202.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CC---cEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DG---TVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.++... ....+.+.+|++++++++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999875 33 379999887542 33457799999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++..+. ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999997542 35899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCccc--cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLSHVS--TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....++.|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~----i~~~~~---- 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKA----INDGFR---- 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHH----HhcCCC----
Confidence 322211 11223567999999988889999999999999999998 9999853221 111111 111100
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.+.. ......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ~~~~---------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LPAP---------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 01234567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.41 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=197.1
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+|+..++||+|+||.||+|... +++.||+|++... .....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777899999999999999764 6889999988654 2334567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999997653 3678899999999999999999999 9999999999999999999999999997654322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....................... .+.+...
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 223 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPVG 223 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCCC
Confidence 1223589999999999988899999999999999999999999864332221111111111111000 1111110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....++.+++.+||+.+|++||+++|+++.
T Consensus 224 -------~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 -------QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -------cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 122346789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.85 Aligned_cols=258 Identities=27% Similarity=0.404 Sum_probs=202.6
Q ss_pred CCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
+|.+.+.||+|+||.||+|+.. ....+++|.+..... ...+++.+|+.++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999753 235789998865432 345678999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 006402 420 IYEYIANGTLHDHLHGKY---------------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTN 478 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~N 478 (646)
|+||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1235889999999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 006402 479 ILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPD 556 (646)
Q Consensus 479 Ill~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~ 556 (646)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999865433221 1122335678999999988889999999999999999998 88888532211
Q ss_pred CccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 557 DVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
. ........... ... ......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 237 --~----~~~~~~~~~~~-----~~~--------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --R----LFNLLKTGYRM-----ERP--------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --H----HHHHHhCCCCC-----CCC--------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111111000 000 0122457789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=330.74 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=202.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+++.. +++.||+|+++... ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999876 68999999986532 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999754 35899999999999999999999999 999999999999999999999999999866543
Q ss_pred C----------------------------CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 502 L----------------------------SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 502 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
. ........||+.|+|||.+.+..++.++||||||++||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 111223458999999999999899999999999999999999999986432
Q ss_pred CCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 006402 554 DPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-MTDVVHE 621 (646)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-~~evl~~ 621 (646)
.. .. ........ ....-+.. ......+.+|+.+|++ +|.+||+ ++|+++.
T Consensus 235 ~~------~~-~~~i~~~~-~~~~~p~~---------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ------ET-YNKIINWK-ESLRFPPD---------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH------HH-HHHHhccC-CcccCCCC---------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11 11111100 00000000 0023456789999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=333.53 Aligned_cols=254 Identities=22% Similarity=0.266 Sum_probs=199.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
..++|++.++||+|+||+||+++.+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467899999999999999999775 6889999998642 22334567899999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998643 4788889999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccCccccccCccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNY----QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
...........||+.|+|||++.+. .++.++||||||++||||++|+.||..... ...............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcCC
Confidence 4332222345699999999998643 478899999999999999999999863321 111111111000000
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVHE 621 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~~ 621 (646)
++. .......+.+++.+||+.+|.+ |||+.|+++.
T Consensus 268 -~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -FPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -CCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0012345668999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.11 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=198.3
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
+|++.+.||+|+||+||+|++. +++ .+++|.+..... ...+++..|+.++++++||||+++++++. ....+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 4677789999999999999864 344 477887754322 23467888999999999999999999875 4567899
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+||+++|+|.++++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 87 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999754 235899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 501 GLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~--~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EV----PDLLEKGERLA--Q 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCCcCC--C
Confidence 3221 2223447788999999988889999999999999999998 88888532111 11 11111111110 1
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
+.. ....+.+++.+||..+|.+|||+.|+++.|+.+..
T Consensus 233 ~~~-----------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQI-----------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC-----------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 11235679999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.55 Aligned_cols=261 Identities=28% Similarity=0.401 Sum_probs=204.0
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCC-CCcccccceeEEeCC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAE 415 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 415 (646)
..++|.+.++||+|+||.||+|+++ .++.||+|+++.... ...+.+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999864 346899999975432 23457899999999997 999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcC---------------------------------------------------------
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYS--------------------------------------------------------- 438 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 438 (646)
..++|+||+++|+|.+++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999965321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 006402 439 --------------------------------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNIL 480 (646)
Q Consensus 439 --------------------------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIl 480 (646)
...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 124678889999999999999999998 999999999999
Q ss_pred EcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCc
Q 006402 481 LDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDV 558 (646)
Q Consensus 481 l~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~ 558 (646)
+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 999999999999999865332211 1122346788999999988889999999999999999998 888875332111
Q ss_pred cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
........+.... .+ .....++.+|+.+||+.+|.+||+++||++.|+++.
T Consensus 350 ----~~~~~~~~~~~~~--~p-----------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ----QFYNAIKRGYRMA--KP-----------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----HHHHHHHcCCCCC--CC-----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111000 00 012245778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.70 Aligned_cols=250 Identities=28% Similarity=0.474 Sum_probs=203.4
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|+..+.||+|++|.||++... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46788899999999999999875 78899999876543 56789999999999999999999999999899999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999997542 235899999999999999999999999 99999999999999999999999999987643222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....+..|+|||.+....++.++||||||++++||++ |+.||...... . ...........+. .
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~~-----~-- 221 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D----VVPHVEKGYRMEA-----P-- 221 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCCCCC-----c--
Confidence 2235678999999988889999999999999999997 88887532111 1 1111111110000 0
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
......+.+++.+||+.+|++|||+.|++++|+++
T Consensus 222 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 ------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 01234567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.83 Aligned_cols=241 Identities=27% Similarity=0.359 Sum_probs=192.4
Q ss_pred cEecccCcEEEEEEEE----cCCcEEEEEEcccCC----cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGEL----QDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999986432 23345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999998643 34788899999999999999999999 99999999999999999999999999875432222
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ...+.. .+++.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~-~~~~~~--~~~~~--- 222 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDK-ILKGKL--NLPPY--- 222 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHH-HHcCCC--CCCCC---
Confidence 122345899999999998888999999999999999999999998633211 11111 111110 01111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
....+.+++.+||+.+|++|| ++.++++
T Consensus 223 ---------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 ---------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 123467899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.60 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=173.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|+..+.||+|+||+||++... +++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999765 58999999986532 223456788999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC----------------------------------ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 006402 502 LS----------------------------------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547 (646)
Q Consensus 502 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~ 547 (646)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00122459999999999998899999999999999999999999
Q ss_pred CCCC
Q 006402 548 AIDF 551 (646)
Q Consensus 548 p~~~ 551 (646)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.91 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=201.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc--EEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT--VVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.+.||+|+||.||+|.++ ++. .+|+|.++... ....+.+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999865 444 46777765432 33456788999999999 899999999999999999999
Q ss_pred EEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 421 YEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
+||+++++|.++++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996432 1235889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHH
Q 006402 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 566 (646)
||+|||+++...... .......+..|+|||++.+..++.++||||||+++|||+| |..||...... ....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~- 234 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE- 234 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHH-
Confidence 999999986432111 1111224668999999988888999999999999999998 99988532211 1111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
........+ .. ......+.+|+.+||+.+|++||++.++++.|+++.+...
T Consensus 235 ~~~~~~~~~-----~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 KLPQGYRLE-----KP--------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHhcCCcCC-----CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111110000 00 0112346789999999999999999999999988865544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.01 Aligned_cols=252 Identities=21% Similarity=0.230 Sum_probs=200.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999765 68999999987542 234566889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999754 235899999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccCccccccCccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYR------NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccC
Confidence 333333346899999999986 446788999999999999999999998633211 11111111111000
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+ .......+.+|+.+||+ +|.+|||+.++++
T Consensus 230 ~~~-----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 FPE-----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 00123446789999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=331.58 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=197.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||+||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999875 68999999986532 233456789999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999998754321
Q ss_pred CCc-------------------------------------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc
Q 006402 502 LSH-------------------------------------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544 (646)
Q Consensus 502 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt 544 (646)
... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112358999999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 006402 545 SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS---MTDVVH 620 (646)
Q Consensus 545 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs---~~evl~ 620 (646)
|+.||...... ..... .......-.+.... ...+.+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~------~~~~~-i~~~~~~~~~~~~~----------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQ------ETYRK-IINWKETLQFPDEV----------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHH------HHHHH-HHcCCCccCCCCCC----------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99998633211 11111 11110000000000 122346688999996 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.54 Aligned_cols=255 Identities=28% Similarity=0.462 Sum_probs=199.6
Q ss_pred CCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-----
Q 006402 348 FSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ----- 416 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 416 (646)
|.+.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|+..+++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5667899999999999997642 3679999987543 2345678999999999999999999998876554
Q ss_pred -CeEEEEEccCCCccccccCCc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 417 -PLLIYEYIANGTLHDHLHGKY---SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 417 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
.++|+||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2245899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 493 GLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 493 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~----~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY----LRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHc
Confidence 9998765432221 112235678999999988889999999999999999999 8888753221 111111 111
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
+.... .. ......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 ~~~~~-----~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK-----QP--------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC-----CC--------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 00 01234577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=331.35 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=198.0
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
...++|++.++||+|+||.||+++.+ +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34567999999999999999999876 5889999988642 2233456889999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999998643 4788999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccCccccccCccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNY----QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
............||+.|+|||++.+. .++.++||||||++||||++|+.||..... ..............
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc
Confidence 43322222345699999999998653 378899999999999999999999963321 11111111110000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVHE 621 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~~ 621 (646)
. +.. .......+.+++.+||+.++.+ ||++.|+++.
T Consensus 267 ~-~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 N-FPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-CCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 000 1112344668899999755543 8999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.85 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=193.2
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+++.+ +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 6889999998753 223455678899988877 799999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 9999888643 35899999999999999999999999 99999999999999999999999999875432211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--CccHHHHHHHHhcCCcccccccccccCC
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD--DVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+.......... . ++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-~p~----- 226 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-IPR----- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-CCC-----
Confidence 23458999999999999899999999999999999999999996322211 11112222222221111 0 111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPS------MTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs------~~evl~ 620 (646)
.....+.+++.+||+.||++||+ +.++++
T Consensus 227 -------~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 227 -------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -------CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11234668999999999999998 456653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=312.23 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=194.9
Q ss_pred cEecccCcEEEEEEEEcC-Cc--EEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQD-GT--VVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||.||+|++++ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998753 43 57888886432 34456889999999999 799999999999999999999999999
Q ss_pred CCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 427 GTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 427 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
++|.++++... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1124789999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
++........ ......+..|+|||++....++.++||||||+++|||++ |..||..... ...... .....
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~-~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEK-LPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHH-HhCCC
Confidence 9864321111 111224567999999988889999999999999999997 9999853211 111111 11110
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
..+ .. ......+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 229 ~~~-----~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE-----KP--------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC-----CC--------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 00 012234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.16 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=194.3
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||.||+++.+ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999775 68899999987532 23456688899999998 699999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 9999888643 35899999999999999999999999 99999999999999999999999999875322111 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--CccHHHHHHHHhcCCcccccccccccCC
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD--DVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......+.......... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~- 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC-
Confidence 23458999999999998899999999999999999999999997432221 11111222222211111 0100
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPS------MTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs------~~evl~ 620 (646)
.....+.+++.+||+.+|.+||+ +.++++
T Consensus 227 -------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 -------SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11234678999999999999997 667763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=317.27 Aligned_cols=258 Identities=28% Similarity=0.391 Sum_probs=203.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
.++|...+.||+|+||.||+++.. ++..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888999999999999999642 35579999887543 23356789999999999 79999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++++|.++++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999997543 234899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 497 LAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .......+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcCCcC
Confidence 66433221 1112335778999999988889999999999999999998 888875322111 1 11111111100
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
. ... ....++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 264 ~-----~~~--------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 A-----QPE--------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C-----CCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 000 1124577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=302.52 Aligned_cols=268 Identities=24% Similarity=0.278 Sum_probs=200.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCccc--HHHHHHHHHHHhhCCCCcccccceeEEe--CCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKS--TQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 420 (646)
++|+..+.|++|.||.||+|+.+ +++.||+|+++...++. .=.-++|+.+|.+.+|||||.+..+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34777789999999999999765 78999999998764332 1235799999999999999999988765 4578999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||++. +|...++... .++...+..-+..|+++|++|||... |+|||||++|+|+++.|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999965 8888887542 46888899999999999999999999 99999999999999999999999999998876
Q ss_pred CCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... .+...-|..|+|||.+.+. .|+...|+||+||++.||+++++-|....+.+..+......-.+.+..+..+-..
T Consensus 230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 5333 3455679999999998765 6999999999999999999999888755443333222211111111111111100
Q ss_pred c-cc---CCchhHH-------HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 R-LQ---GHEASVN-------ILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~-l~---~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .. -...+.+ .....+.-.+|+...|..||.+|.|++|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 00 0000000 0002244568999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.54 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=201.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.+|...++||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677789999999999999642 356899999887666667889999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 420 IYEYIANGTLHDHLHGKYS------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
|+||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875421 134899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHH
Q 006402 488 KVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 565 (646)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--- 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE--- 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH---
Confidence 99999998765432211 1122235678999999988889999999999999999998 88887522111 1111
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
. ...+..... + ......+.+++.+||+.+|++||++.||++.|+
T Consensus 236 ~-~~~~~~~~~-~------------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 C-ITQGRELER-P------------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HHcCccCCC-C------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 111110000 0 011234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.78 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=200.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999864 68899999987655555667889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.++++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999998643 35899999999999999999999998 999999999999999999999999999866432211
Q ss_pred cccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||......+.. . ...... ...+.+
T Consensus 163 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~-~~~~~~---~~~~~~ 231 (267)
T cd06646 163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMSKSN---FQPPKL 231 (267)
T ss_pred -cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------e-eeecCC---CCCCCC
Confidence 12235888999999874 345788999999999999999999998532211100 0 000000 001111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. .......+.+++.+||+.+|++|||++++++.
T Consensus 232 ~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 KD------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cc------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 10 01123457799999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=311.62 Aligned_cols=255 Identities=27% Similarity=0.474 Sum_probs=202.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-C---CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-D---GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999764 2 3479999886543 23456889999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997542 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccc--ccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLSHVST--CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... ...++..|+|||++.+..++.++||||||+++||+++ |+.||......+ .... ...... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~~~---~ 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA----IEEGYR---L 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH----HhCCCc---C
Confidence 3322211 1223568999999998889999999999999999887 999986332211 1111 111100 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
+. . ......+.+++.+||+.+|++||+|.++++.|+++
T Consensus 229 -~~-~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PA-P--------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CC-C--------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 0 01223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=322.62 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=212.2
Q ss_pred CCcccEecccCcEEEEEEEEcC---C--cEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQD---G--TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
....++||.|.||.||+|...+ | -.||||.-+.. ..+..+.|+.|..+|++++|||||+|+|+|.+. ..+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 3456789999999999997642 2 36899988763 456688999999999999999999999998876 679999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
|.++-|.|..||+.+ ...|+......++.||..||+|||+.. .+||||..+|||+...-.+||+|||+++....+
T Consensus 470 EL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 999999999999875 345899999999999999999999999 999999999999999999999999999999887
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.....+...-.+.|||||.+.-..++.+||||.|||.+||++. |.+||.+-...+-. .++.+|. +
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe-------R 610 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE-------R 610 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC-------C
Confidence 7666666667889999999999999999999999999999886 89999866554311 0111111 1
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
+. -...++..+..|+.+||..+|.+||+++|+...|..+++
T Consensus 611 lP------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LP------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CC------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 122345567799999999999999999999999988876
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.85 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=194.4
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999765 68899999986542 2345678999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998753 35889999999999999999999999 9999999999999999999999999976431100
Q ss_pred C----------------------------------------------ccccccCccccccCccccccCCCCchhhHHHHH
Q 006402 503 S----------------------------------------------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYG 536 (646)
Q Consensus 503 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G 536 (646)
. .......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001124599999999999888899999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHH--hcccCCCCCCC
Q 006402 537 VVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVA--CLREKKSERPS 614 (646)
Q Consensus 537 ~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~--cl~~~p~~RPs 614 (646)
|++|||++|+.||......+ .. ........... +.+. .....++.+|+.+ |+..++..||+
T Consensus 236 ~il~elltG~~Pf~~~~~~~---~~---~~i~~~~~~~~-~~~~----------~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE---TQ---LKVINWENTLH-IPPQ----------VKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH---HH---HHHHccccccC-CCCC----------CCCCHHHHHHHHHHccCcccccCCCC
Confidence 99999999999996432211 00 01110000000 0000 0112345578877 45566667999
Q ss_pred HHHHHHH
Q 006402 615 MTDVVHE 621 (646)
Q Consensus 615 ~~evl~~ 621 (646)
+.|+++.
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.62 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=200.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC------CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD------GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|.+.+.||+|++|.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999997753 5689999876443 23356799999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CEEEe
Q 006402 418 LLIYEYIANGTLHDHLHGKYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF---NSKVA 490 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~---~~ki~ 490 (646)
++||||+++++|.++++.... ...+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999975431 125899999999999999999999999 99999999999998654 59999
Q ss_pred ecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHh
Q 006402 491 DFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 491 DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
|||+++........ .......+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+...+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~---~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV---T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---H
Confidence 99999876332111 1112223568999999988889999999999999999997 88888633221 111111 1
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
..... + .. ......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 236 ~~~~~-~-~~------------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL-D-PP------------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC-C-CC------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 0 00 012245678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.81 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=192.9
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
+.||+|+||+||++... +++.||+|+++.. .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 6899999998653 2234567788999999999999999999999999999999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~ 153 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-M 153 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-c
Confidence 999988643 358999999999999999999997 67 999999999999999999999999998754322211 2
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... ...... ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~----~i~~~~------~~~p~--- 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMEE------IRFPR--- 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHH----HHhcCC------CCCCC---
Confidence 2345899999999999889999999999999999999999998633211 1111 110000 00100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
.....+.+++.+||+.||++|+ ++.++++.
T Consensus 218 -----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 -----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1123466899999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.19 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=203.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++|+..+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35788899999999999999988788889999886542 345778999999999999999999999887 7789999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999997642 345889999999999999999999998 999999999999999999999999999766543222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......++..|+|||++....++.++|+||||+++|||++ |+.||..... ..+.. ....+..... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~~~~-----~- 225 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIR----ALERGYRMPR-----P- 225 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHhCCCCCCC-----c-
Confidence 2222345678999999988889999999999999999999 8888753211 11111 1111111000 0
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 -------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0122447789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.28 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=193.3
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|+||+||++... +++.||+|++..... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 688999998864322 2345678899999999999999999999999999999999999999
Q ss_pred cccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccc
Q 006402 430 HDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTC 508 (646)
Q Consensus 430 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~ 508 (646)
.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875422 3346899999999999999999999999 999999999999999999999999999766443222 223
Q ss_pred cCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhH
Q 006402 509 AQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASV 588 (646)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 588 (646)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... .......... ..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~------~~------- 220 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRILNDSV------TY------- 220 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-HHHhhcccCC------CC-------
Confidence 4589999999999998999999999999999999999999864322111 111 1111100000 00
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 589 NILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 589 ~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
.......+.+++.+||+.+|++|| +++++++
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 -PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 011234567899999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.73 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=191.0
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHH---hhCCCCcccccceeEEeCCcCeEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGIL---SQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
|++.+.||+|+||.||++..+ +++.||||+++... ....+.+.+|+.++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999765 68999999987432 22345566676655 566899999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|..+++. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988854 25899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...... ....
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~-i~~~~~--~~p~- 222 (324)
T cd05589 154 FGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDS-IVNDEV--RYPR- 222 (324)
T ss_pred CCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCC--CCCC-
Confidence 221 122345899999999999888999999999999999999999998633211 11111 111100 0000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
.....+.+++.+||+.+|.+||+ +.++++
T Consensus 223 -----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 -----------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11234668999999999999994 556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.32 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=188.5
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+|+.+ +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999986432 23345566777777654 799999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 9999998643 35899999999999999999999999 9999999999999999999999999997653322 122
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...... ..++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~-~i~~~~--~~~~~------- 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFD-SILNDR--PHFPR------- 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHH-HHHcCC--CCCCC-------
Confidence 234589999999999988899999999999999999999999863321 11111 111110 00111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMT-DVV 619 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-evl 619 (646)
....++.+++.+||+.+|++||++. +++
T Consensus 218 -----~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 -----WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1123456899999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.51 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=200.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||.||++... ++..+|+|.++... ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999765 58889999886542 23356788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999753 358899999999999999999998 46 9999999999999999999999999987653322
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc--------
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM-------- 574 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 574 (646)
. ....+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ................
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 A---NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred c---ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccC
Confidence 1 2235889999999998888999999999999999999999998643211 1111110000000000
Q ss_pred ------------ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 575 ------------EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 575 ------------~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+..+..................+.+++.+||+.+|++|||+.||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000123457899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=309.24 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=199.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-----ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-----KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|...+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999764 689999998764321 124578899999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998643 35788999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCccc--cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSHVS--TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... . .. ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~--~~-~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---M--AA-IFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---H--HH-HHHHhccCCC----
Confidence 3221111 223478899999999988899999999999999999999999853211 1 11 1111111000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.+. ......+.+++.+||+.+|++|||+.|+++.
T Consensus 226 -~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -PQLP--------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCC--------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111 0122346789999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.35 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=200.9
Q ss_pred cCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeC-Cc
Q 006402 346 NGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA-EQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 416 (646)
++|++.+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788899999999999999963 3578899999875432 3356788999999999 689999999988764 46
Q ss_pred CeEEEEEccCCCccccccCCcC----------------------------------------------------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS---------------------------------------------------------- 438 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 438 (646)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864310
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc-cccccCc
Q 006402 439 ------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQG 511 (646)
Q Consensus 439 ------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~g 511 (646)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123788899999999999999999999 999999999999999999999999998765332211 1112335
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHH
Q 006402 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNI 590 (646)
Q Consensus 512 t~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 590 (646)
++.|+|||.+.+..++.++||||||+++|||++ |..||....... . .......+..... +.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~--~~---------- 305 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA--PD---------- 305 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCCC--CC----------
Confidence 678999999988889999999999999999997 888875322111 1 1111111111100 00
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 591 LMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 591 ~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
.....+.+++.+||+.+|++|||+.||++.|+++.+
T Consensus 306 -~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 -YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 012346789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.95 Aligned_cols=268 Identities=21% Similarity=0.303 Sum_probs=198.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|...+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999776 678999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 888887643 234789999999999999999999999 99999999999999999999999999876543222
Q ss_pred ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc------
Q 006402 504 HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV------ 576 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 576 (646)
. .....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||......+...................+
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1 122347899999998864 46889999999999999999999998644332211111110000000000000
Q ss_pred cc---ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 VD---PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 ~d---~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+ +................++.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 000000000000112345679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=308.77 Aligned_cols=252 Identities=28% Similarity=0.505 Sum_probs=201.7
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
.+|+..+.||+|+||.||++.+.+++.+|+|.+.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3577789999999999999988778899999886443 345678999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999999987542 34789999999999999999999999 9999999999999999999999999987654332221
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... ....+. ....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~--~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVE-TINAGF--RLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHH-HHhCCC--CCCCCCC---
Confidence 222235678999999988889999999999999999998 8888753221 11111 111110 1111111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
..+.+.+|+.+||+.+|++|||+.|+++.|+
T Consensus 226 --------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 --------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=315.74 Aligned_cols=263 Identities=30% Similarity=0.399 Sum_probs=201.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC-----------------CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD-----------------GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVR 406 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 406 (646)
.++|++.+.||+|+||.||+++..+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987642 2468999887543 234678899999999999999999
Q ss_pred cceeEEeCCcCeEEEEEccCCCccccccCCc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 006402 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKY--------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTN 478 (646)
Q Consensus 407 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~N 478 (646)
+++++..++..++|+||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986542 1225899999999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 006402 479 ILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT--SQKAIDFSRDP 555 (646)
Q Consensus 479 Ill~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt--g~~p~~~~~~~ 555 (646)
|++++++.++|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999998765433221 2223346788999999988889999999999999999998 5566542211
Q ss_pred CCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 556 DDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
....................+. ......++.+++.+||+.+|++|||+.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLPR----------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccCCC----------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111111110000000 0012245779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.85 Aligned_cols=236 Identities=25% Similarity=0.372 Sum_probs=189.0
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+++.+ +++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5889999988643 223456778899998877 699999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 9999988643 35899999999999999999999999 99999999999999999999999999875432211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ......... ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~-~~~i~~~~~---~~~~------ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DL-FEAILNDEV---VYPT------ 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HH-HHHHhcCCC---CCCC------
Confidence 2345899999999999888999999999999999999999999633211 11 111111110 0010
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.....+.+++.+||+.||++||++
T Consensus 218 -----~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 -----WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -----CCCHHHHHHHHHHcccCHHHCCCC
Confidence 012346789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=308.00 Aligned_cols=245 Identities=29% Similarity=0.428 Sum_probs=193.9
Q ss_pred EecccCcEEEEEEEEc---CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 353 ILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
.||+|+||.||+|.++ ++..+|+|+++.... ...+++.+|+.+++++.|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 578899999865432 34567899999999999999999999875 45778999999999
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc--
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV-- 505 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~-- 505 (646)
+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999999643 35899999999999999999999999 9999999999999999999999999998765433221
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+++.|+|||.+....++.++||||||+++|||++ |+.||..... ... ......+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~i~~~~~~~-----~~~- 221 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEV----TQMIESGERME-----CPQ- 221 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHCCCCCC-----CCC-
Confidence 122234678999999988888999999999999999998 8989863211 111 11111211111 110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
....++.+++.+||+.+|++||++.+|.+.|++
T Consensus 222 -------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 -------RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -------CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 122446789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.15 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=197.3
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cCe
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (646)
+|+..++||+|+||+||++... +++.||+|++... +....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999764 7899999988643 2234567889999999999999999999998776 789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5787777532 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc--
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME-- 575 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 575 (646)
............+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ ...+..........+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence 54433333334578999999998764 578999999999999999999999964332111 111110000000000
Q ss_pred --------cccccccCCchhH----HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 576 --------VVDPRLQGHEASV----NILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 576 --------~~d~~l~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+........... ......+++.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 000113457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.15 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=202.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+|+..+.||+|++|.||+|... +++.||+|.+........+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999764 68899999988766666788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.+. .+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999998643 4789999999999999999999999 999999999999999999999999998865433221
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ....... .. .+..
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~-~~~~~~~-~~-----~~~~- 238 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----AL-YLIATNG-TP-----ELQN- 238 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hH-HHHhcCC-CC-----CCCC-
Confidence 122348899999999988888999999999999999999999986332111 11 1111111 00 0000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 239 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 -----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -----ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0112344678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.45 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=198.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe-CCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-AEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 424 (646)
++|.+.+.||+|+||.||++..+ +..+|+|.++.. ...+.+.+|+.++++++|+|++++++++.. .+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999765 778999987643 345678999999999999999999997654 45789999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999997542 334899999999999999999999999 9999999999999999999999999987654322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ....... ...+.... ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~-~~~~~~~~-----~~- 221 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPR-VEKGYKMD-----AP- 221 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH-HhcCCCCC-----CC-
Confidence 12235678999999988889999999999999999998 888875221 1111111 11111000 00
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 222 -------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 -------DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01234567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=315.44 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=199.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-----------------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCccccc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-----------------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRL 407 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 407 (646)
++|++.+.||+|+||+||++... ++..+|+|+++... ....+++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 24479999987543 3345789999999999999999999
Q ss_pred ceeEEeCCcCeEEEEEccCCCccccccCCcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 006402 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYS--------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNI 479 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NI 479 (646)
++++...+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999875321 124788899999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecCCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCC
Q 006402 480 LLDDDFNSKVADFGLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT--SQKAIDFSRDPD 556 (646)
Q Consensus 480 ll~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt--g~~p~~~~~~~~ 556 (646)
|+++++.+||+|||+++......... .....+++.|+|||......++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998654332211 112234678999999888889999999999999999998 556664222111
Q ss_pred CccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 557 DVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
.................. +.. ......+.+|+.+||+.+|++||++.||++.|++
T Consensus 242 ---~~~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQGRQVYL-PKP---------ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhccccccC-CCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111110000000 000 0122457789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=311.23 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=201.5
Q ss_pred HHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 341 LKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 341 l~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++.+++++....+||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4455667777789999999999999765 678899999877666667789999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCccC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLA 498 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~ 498 (646)
|+||+++++|.++++........++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999975422212378889999999999999999999 999999999999976 679999999998765
Q ss_pred CCCCCccccccCccccccCccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
..... ......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... ...+...... .
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~---~--- 229 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK---I--- 229 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc---c---
Confidence 43222 12223478999999998654 37889999999999999999999986432211 1111000000 0
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+. ....+++.+++.+||+.+|++|||+.|+++
T Consensus 230 -~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 -HPEIP--------ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -CCCCC--------cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01111 012344678999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=313.40 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=201.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
..++|++.++||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567899999999999999999654 245799998764432 334568899999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 417 PLLIYEYIANGTLHDHLHGKY-------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
.++||||+++|+|.++++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996432 1234677889999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHH
Q 006402 490 ADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-
Confidence 999998865432211 1122235678999999988889999999999999999998 67777532111 11111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
...+.... ... .....+.+++.+||+.+|++|||+.++++.|++..
T Consensus 234 ~~~~~~~~-----~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLD-----QPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCC-----CCC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111100 000 11245779999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.72 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=202.7
Q ss_pred cCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|.+.++||+|+||.||+|...+ ...||+|...... .+..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999997643 2468999886554 3456789999999999999999999998865 567899
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999997542 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..........++..|+|||.+....++.++||||||+++|||++ |+.||...... ..... ...+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~~~~---- 228 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGERLP---- 228 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCcCC----
Confidence 43222223335678999999988889999999999999999986 99998633221 11111 11111000
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
... .....+.+++.+|+..+|++|||+.++++.|+++.+
T Consensus 229 -~~~--------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 -MPP--------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 122357789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.65 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=192.4
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||.||+|+.+ +++.||+|+++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 5789999998653 223456678899999876 799999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 9999988643 35889999999999999999999999 99999999999999999999999999875432221 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ..... ...+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~-i~~~~---~~~p~~----- 218 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFES-ILHDD---VLYPVW----- 218 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHH-HHcCC---CCCCCC-----
Confidence 2345899999999999889999999999999999999999999633211 11111 11111 000100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERP-------SMTDVVHE 621 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RP-------s~~evl~~ 621 (646)
....+.+++.+||+.+|++|| ++.++++.
T Consensus 219 ------~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 ------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 123466899999999999999 77777743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=294.06 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=203.0
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-----c---cHHHHHHHHHHHhhCC-CCcccccceeE
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-----K---STQQVLNEVGILSQVN-HKNLVRLLGCC 411 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~---~~~~~~~E~~~l~~l~-h~niv~l~~~~ 411 (646)
+...+.|...++||+|..++|-+...+ +|...|+|++..... . -.+.-.+|+.||+++. ||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334566778889999999999887554 688899998764321 1 1345578999999985 99999999999
Q ss_pred EeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 412 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
+.+...++|+|.|+.|.|.|||... ..++++...+|+.|+.+|+.|||..+ |+||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999999754 46899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCCccccccCccccccCcccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 492 FGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 492 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
||.+...+++.... ...|||+|+|||.++. ..|+...|+|+.||++|.|+.|..||-... .....
T Consensus 167 FGFa~~l~~GekLr--elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlML 237 (411)
T KOG0599|consen 167 FGFACQLEPGEKLR--ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLML 237 (411)
T ss_pred cceeeccCCchhHH--HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHH
Confidence 99999998776543 3459999999998852 357889999999999999999999985211 11112
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
..+.++.. ++-.|.+ ......+.+||.+||+.||++|.|.+|+++.
T Consensus 238 R~ImeGky-qF~speW---------adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGKY-QFRSPEW---------ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhccc-ccCCcch---------hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 22222221 1111111 1234557799999999999999999999954
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=310.48 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=200.2
Q ss_pred CCCcccEecccCcEEEEEEEEcC-C---cEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQD-G---TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.|++.+.||+|+||.||+|.... + ..||+|.++.. .....++|.+|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998753 3 36999998754 3345678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999997542 35899999999999999999999999 999999999999999999999999998765433
Q ss_pred CCccc--ccc--CccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 502 LSHVS--TCA--QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 502 ~~~~~--~~~--~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
..... ... ..+..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~---~~~~~~-- 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIE---QDYRLP-- 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHH---cCCcCC--
Confidence 22111 111 12457999999998889999999999999999887 9888853221 11111111 100000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
. .......+.+++.+||+.+|++||++.+|+..|+++
T Consensus 232 ---~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ---P---------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---C---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 001223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.20 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=200.8
Q ss_pred HHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEe
Q 006402 338 LKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413 (646)
Q Consensus 338 ~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 413 (646)
+.++....++|++.+.||+|+||.||+++.+ +++.+|+|++... .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445555688999999999999999999876 6889999988542 22334567899999999999999999999999
Q ss_pred CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
.+..++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998643 4788889999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY----QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
+++..............||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .........
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHc
Confidence 9987654332223345699999999998653 378899999999999999999999963221 111111111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVHE 621 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~~ 621 (646)
........+ .......+.+++.+||+..+.+ ||++.|+++.
T Consensus 262 ~~~~~~~~~-----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLTFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCcccCCC-----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111100 0112344668999999844433 7899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.04 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=192.2
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+++.. +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999775 57899999987542 23456688999999888 599999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 9999888643 35899999999999999999999999 99999999999999999999999999875322111 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||++||||++|+.||.............+........... ++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~p~------- 224 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPR------- 224 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--CCC-------
Confidence 23458999999999998899999999999999999999999997543333322222222222211110 010
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.....+.+++.+||+.||.+|+++
T Consensus 225 -----~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 -----FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 012335689999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.97 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=201.0
Q ss_pred CCCcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCe
Q 006402 347 GFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 418 (646)
.|++.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|+.++++++|||++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999974 257889999987543 33456799999999999999999999998875 5678
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999986532 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------CCccHHHHHHHH
Q 006402 499 KPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP---------DDVNLAIYVSQR 567 (646)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~---------~~~~~~~~~~~~ 567 (646)
...... ......++..|+|||++.+..++.++||||||+++|||++++.|....... ......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HH
Confidence 543221 112234677899999998888999999999999999999987664321110 000111111 11
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
...+.... . .......+.+|+.+||+.+|++|||++++++.|+++
T Consensus 239 ~~~~~~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLP-----R--------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCC-----C--------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111000 0 001234577999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=309.69 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=193.4
Q ss_pred ecccCcEEEEEEEEc---CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ---DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 356799999875533 33567899999999999999999999875 4578999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc--cc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV--ST 507 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~--~~ 507 (646)
.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......... ..
T Consensus 82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9998753 235899999999999999999999999 9999999999999999999999999998654332211 12
Q ss_pred ccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
...++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ......+.... .++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~-~~~------- 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EV----MSFIEQGKRLD-CPA------- 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHCCCCCC-CCC-------
Confidence 2234678999999988889999999999999999996 99998633211 11 11111111100 110
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
....++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 222 -----~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 -----ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1234567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.61 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=191.3
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCC-cccccceeEEeCCcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHK-NLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 421 (646)
+|++.+.||+|+||.||+|+.+ +++.||+|+++.. .....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999776 5789999998643 223456788999999999764 5888999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999998643 35889999999999999999999999 999999999999999999999999998754322
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ........ .+
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~----~~i~~~~~------~~ 220 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF----QSIMEHNV------SY 220 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCCC------CC
Confidence 11 122345899999999999888999999999999999999999998633211 111 11111110 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.. .....+.+++.+||+.+|.+|++.
T Consensus 221 ~~--------~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PK--------SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC--------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 112346689999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.93 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=198.4
Q ss_pred CCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
|.+.+.||+|+||+||+|+.. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 556688999999999999763 2578999998754332 346788999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 421 YEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
+||+++++|.+++.... ....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 1234888999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHH
Q 006402 488 KVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 565 (646)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ... .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~-~ 236 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV-I 236 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHH-H
Confidence 9999999886543322 11222346789999999988889999999999999999998 7777653211 111 1
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
........... . ......+.+|+.+||+.+|++||+++||++.|+.
T Consensus 237 ~~i~~~~~~~~-----~--------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLPC-----P--------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCCC-----C--------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111100 0 0123446789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.35 Aligned_cols=198 Identities=28% Similarity=0.353 Sum_probs=168.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----- 415 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 415 (646)
..++|+..+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999765 6899999998643 2334567889999999999999999999987543
Q ss_pred -cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 416 -QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 416 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 56666542 3788999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97653322 122345899999999999889999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.42 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=205.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
.+|.+.+.||+|+||.||+++.. ....+|+|.++... ....+++.+|+.+++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999642 24579999887542 23456788999999999 5999999999999988
Q ss_pred cCeEEEEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 416 QPLLIYEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
..++||||+++|+|.+++.... ....+++.++++++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996532 1235899999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNL 560 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~ 560 (646)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------ 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence 9999999999999866432211 1112234567999999988889999999999999999999 7888752211
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.. .......+...+. .. .....+.+++.+||+.+|++|||+.|+++.|+++...+..
T Consensus 243 ~~-~~~~~~~~~~~~~-----~~--------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 243 EE-LFKLLREGHRMDK-----PS--------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HH-HHHHHHcCCCCCC-----CC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 11 1111111111110 00 1123466899999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=344.83 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=204.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||.||+|... +++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999775 58999999986532 223567999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 422 EYIANGTLHDHLHGKY--------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234677888999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCC-----------------ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 006402 494 LSRLAKPGLS-----------------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD 556 (646)
Q Consensus 494 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~ 556 (646)
+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 00112358999999999998899999999999999999999999986422111
Q ss_pred CccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHH
Q 006402 557 DVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-SMTDVVHELQRIIEI 628 (646)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~ 628 (646)
.. . .... .++.-... .......+.+++.+||+.+|++|| +++++++.|+...+.
T Consensus 239 ---i~-~-~~~i--------~~P~~~~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ---IS-Y-RDVI--------LSPIEVAP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ---hh-h-hhhc--------cChhhccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0 0000 00000000 112234567899999999999995 577888888877653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=313.64 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=198.2
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|+..++||+|+||+||++... +++.||+|.+..... ...+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999765 689999998865422 2235678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 2335899999999999999999999999 99999999999999999999999999876543322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. ....|+..|+|||++.+..++.++||||||+++|||++|+.||.................... . ...
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----~----~~~- 225 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-----E----EYS- 225 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-----h----hcC-
Confidence 1 223589999999999988899999999999999999999999974332111100000000000 0 000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
......+.+|+.+||+.+|++||| ++|+++
T Consensus 226 -------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 -------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011234668999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.97 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=200.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|+..++||+|+||+||+|++. +++ .||+|+++.... ...+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46788899999999999999754 444 489998865432 345678899999999999999999999875 45789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
++||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999997542 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..+... ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~- 232 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL----LEKGERLPQ- 232 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCcCCC-
Confidence 332221 112235678999999988889999999999999999998 8888753221 111111 111110000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
. ......+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 233 ~------------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 233 P------------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 01223467899999999999999999999988776443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=309.98 Aligned_cols=239 Identities=24% Similarity=0.364 Sum_probs=187.9
Q ss_pred cEecccCcEEEEEEEEcC-------------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 352 RILGSGGFGEVYKGELQD-------------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2358999887665555678899999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-------EEEee
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN-------SKVAD 491 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~-------~ki~D 491 (646)
+||||+++++|..+++.+ ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988653 235899999999999999999999999 999999999999987654 89999
Q ss_pred cCCCccCCCCCCccccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 492 FGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELL-TSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 492 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
||++....... ...++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+ . ....
T Consensus 156 ~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~----~~~~- 222 (262)
T cd05077 156 PGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---K----ERFY- 222 (262)
T ss_pred CCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---H----HHHH-
Confidence 99987653221 234788899999886 457899999999999999998 5777765321110 0 0000
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.... .... .....+.+|+.+||+.+|++||++.++++.|
T Consensus 223 ~~~~-~~~~-------------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-MLVT-------------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-cCCC-------------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0100 0000 0123467899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.06 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=201.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|+..+.||+|+||.||++... ++..||+|++.... ....+++.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 56888899999999999999763 46789999987543 234567999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 006402 419 LIYEYIANGTLHDHLHGKY-------------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNI 479 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NI 479 (646)
+|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 9999999999999996421 1234789999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 006402 480 LLDDDFNSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDD 557 (646)
Q Consensus 480 ll~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~ 557 (646)
|+++++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--- 238 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999876543221 11112234677999999988889999999999999999998 7777742211
Q ss_pred ccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 558 VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
... ......+..... . ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ---~~~-~~~~~~~~~~~~-----~--------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EEV-IYYVRDGNVLSC-----P--------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHH-HHHHhcCCCCCC-----C--------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 111111211110 0 0122457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.37 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=194.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999765 68999999886432 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998643 35889999999999999999999999 999999999999999999999999998632110
Q ss_pred CC------------c----------------------------------cccccCccccccCccccccCCCCchhhHHHH
Q 006402 502 LS------------H----------------------------------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSY 535 (646)
Q Consensus 502 ~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~ 535 (646)
.. . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012358999999999998889999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCC---
Q 006402 536 GVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSER--- 612 (646)
Q Consensus 536 G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R--- 612 (646)
||+||||++|+.||...... ... ........... +... .....++.+++.+||+ +|.+|
T Consensus 235 Gvil~elltG~~Pf~~~~~~---~~~---~~i~~~~~~~~-----~p~~------~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH---ETY---RKIINWRETLY-----FPDD------IHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH---HHH---HHHHccCCccC-----CCCC------CCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 99999999999998633211 110 11110000000 0000 0112346689999997 66665
Q ss_pred CCHHHHHHH
Q 006402 613 PSMTDVVHE 621 (646)
Q Consensus 613 Ps~~evl~~ 621 (646)
+++.|+++.
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 699998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=317.84 Aligned_cols=240 Identities=26% Similarity=0.360 Sum_probs=189.6
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
+.||+|+||+||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345677788888764 899999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 9999998643 35889999999999999999999999 99999999999999999999999999875432211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+. ....... ..++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~--~~~~~------- 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF----QSIRMDN--PCYPR------- 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC--CCCCc-------
Confidence 2345899999999999888999999999999999999999998633211 111 1111110 00111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMT-DVV 619 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-evl 619 (646)
.....+.+++.+||+.+|++||++. ++.
T Consensus 218 -----~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 -----WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -----cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0123466899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=312.02 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=202.1
Q ss_pred cCCCcccEecccCcEEEEEEEEcC------CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD------GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|.+.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 568888999999999999997642 3689999986543 234567899999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 419 LIYEYIANGTLHDHLHGKYS-------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
+||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 99999999999999965321 234789999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 492 FGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 492 fGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~----~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKF----VI 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHH----Hh
Confidence 999876543322 11223346789999999988889999999999999999998 8888753211 111111 11
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
.+..... .. .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~~-----~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLDL-----PE--------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCCC-----CC--------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 00 01345778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.30 Aligned_cols=251 Identities=30% Similarity=0.503 Sum_probs=192.8
Q ss_pred cEecccCcEEEEEEEEc----CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEe-CCcCeEEEEEcc
Q 006402 352 RILGSGGFGEVYKGELQ----DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-AEQPLLIYEYIA 425 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 425 (646)
+.||+|+||.||+|.+. ++..+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999764 2457999988543 33446788999999999999999999998764 556889999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc-
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH- 504 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~- 504 (646)
+++|.+++.+.. ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999997542 24678888999999999999999998 999999999999999999999999999765432111
Q ss_pred --cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 505 --VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK-AIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 505 --~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
......++..|+|||.+.+..++.++||||||+++|||++|.. ||... ....+.... . .+... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~---~-~~~~~-----~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYL---L-QGRRL-----LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH---h-cCCCC-----CC
Confidence 1112346778999999988889999999999999999999654 44321 111111111 1 11000 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
. ......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 224 ~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 P--------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 0112347789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=306.25 Aligned_cols=274 Identities=24% Similarity=0.351 Sum_probs=205.7
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhh--CCCCcccccceeEEeCC----
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQ--VNHKNLVRLLGCCVEAE---- 415 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 415 (646)
+....+....+.||+|.||.||+|.++ |+.||||++...+ .+.+.+|.+|.+. |+|+||+.+++.=..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 345567788899999999999999996 7899999997654 4556788888776 49999999998755433
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-----AAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
.++||++|.+.|||+|||.+ ..++....++++..+|.||++||. ++.|.|.|||||++|||+..++...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 67899999999999999965 368999999999999999999995 567889999999999999999999999
Q ss_pred ecCCCccCCCCCCc---cccccCccccccCccccccC------CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 006402 491 DFGLSRLAKPGLSH---VSTCAQGTLGYLDPEYYRNY------QLTDKSDVYSYGVVLLELLTS----------QKAIDF 551 (646)
Q Consensus 491 DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~ll~elltg----------~~p~~~ 551 (646)
|+|||......... ......||.+|||||++... ..-..+||||||.++||+..+ +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999866544222 22345699999999998542 112368999999999998763 234432
Q ss_pred CCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 552 SRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
....+ -.... ..+..--.++...++.++. ....+..+.++++.||..+|.-|-|+--+-+.|.++.+..++
T Consensus 439 ~Vp~D-Ps~ee-MrkVVCv~~~RP~ipnrW~-------s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 439 VVPSD-PSFEE-MRKVVCVQKLRPNIPNRWK-------SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCCC-CCHHH-HhcceeecccCCCCCcccc-------cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 11111 11111 1111111223333334443 335667788999999999999999999888888888765444
Q ss_pred c
Q 006402 632 E 632 (646)
Q Consensus 632 ~ 632 (646)
.
T Consensus 510 ~ 510 (513)
T KOG2052|consen 510 I 510 (513)
T ss_pred h
Confidence 3
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=318.55 Aligned_cols=240 Identities=25% Similarity=0.357 Sum_probs=189.4
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||.||+++.+ +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 68899999987532 23445677788888765 899999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 9999998643 35889999999999999999999999 99999999999999999999999999875322211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+. ....... +.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~~------~~~~~--- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVDT------PHYPR--- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------CCCCC---
Confidence 2345899999999999889999999999999999999999998633211 111 1111110 01100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMT-DVV 619 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-evl 619 (646)
....++.+++.+||+.||++||++. +++
T Consensus 218 -----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0123466899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.08 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=195.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999875 5899999998642 2234566889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999643 235889999999999999999999999 999999999999999999999999998765543
Q ss_pred CCccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.........||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ- 228 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc-
Confidence 3322233458999999999863 4578899999999999999999999863211 111111111110000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKK--SERPSMTDVVHE 621 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p--~~RPs~~evl~~ 621 (646)
+.+.. ......+.+++.+|+..++ ..||++.++++.
T Consensus 229 ~~~~~---------~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDV---------TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCcc---------CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01100 0123345678888775533 347899999865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.22 Aligned_cols=252 Identities=32% Similarity=0.469 Sum_probs=198.4
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHH--HHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQ--QVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
|+..+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999876 5678999999876554432 3456999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.. ...+++..++.++.|+++||++||+.+ |+|+||||+||++++++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999972 335899999999999999999999999 999999999999999999999999999764211 22
Q ss_pred cccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......++..|+|||++. +...+.++||||+|+++++|++|..||...... ............ .... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~-~~~~----~~~~ 225 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKR-PLPS----SSQQ 225 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHT-HHHH----HTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhcccc-cccc----cccc
Confidence 233455899999999998 778999999999999999999999998743111 111111111100 0000 0000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+++.+||+.+|++|||+.++++
T Consensus 226 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001256789999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.60 Aligned_cols=253 Identities=27% Similarity=0.371 Sum_probs=191.5
Q ss_pred cEecccCcEEEEEEEEcC---CcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 352 RILGSGGFGEVYKGELQD---GTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
+.||+|+||.||+|+..+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997653 45799998865432 33457889999999999999999999999999999999999999
Q ss_pred CccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 428 TLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 428 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|.++++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 2234678888899999999999999999 9999999999999999999999999987554322211
Q ss_pred -ccccCccccccCccccccC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 506 -STCAQGTLGYLDPEYYRNY-------QLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.....++..|+|||++.+. .++.++|+||||+++|||++ |+.||......+ ..... . .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---V-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---h-hcccCCC
Confidence 1223467889999998532 35789999999999999996 999986432211 11111 1 1111111
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
.++.+... ..+.+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~--------~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP--------LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC--------CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 1234667899998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.08 Aligned_cols=265 Identities=21% Similarity=0.247 Sum_probs=196.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999776 57899999632 23467899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+ .++|.+++... ...+++..++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 47888888643 235899999999999999999999999 99999999999999999999999999986543322
Q ss_pred c-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CCCCccHHHHHHHHhcCCcc--ccc---
Q 006402 504 H-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR-DPDDVNLAIYVSQRASNGAI--MEV--- 576 (646)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~--- 576 (646)
. ......||+.|+|||++.+..++.++|||||||+||||++|..++.... ..........+...+..... .+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 1223459999999999998899999999999999999999887654222 11111111111111111000 000
Q ss_pred cccccc------------C--CchhH-HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 577 VDPRLQ------------G--HEASV-NILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 577 ~d~~l~------------~--~~~~~-~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....+. . ..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 0 00000 001122357789999999999999999999863
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=318.50 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=192.3
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+++.+ +++.||+|+++.. .....+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5789999998753 223456678899999888 699999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 153 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-T 153 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-c
Confidence 9999988643 35899999999999999999999999 999999999999999999999999998753222111 1
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....|++.|+|||++.+..++.++||||||+++|||++|+.||..... ... ......... .+..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~----~~~i~~~~~--~~~~------- 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DEL----FQSILEDEV--RYPR------- 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHH----HHHHHcCCC--CCCC-------
Confidence 223589999999999998999999999999999999999999863321 111 111111110 0000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSM-----TDVVH 620 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~-----~evl~ 620 (646)
.....+.+|+.+||+.+|.+|||+ .++++
T Consensus 218 -----~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 -----WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112346789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=312.58 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=196.7
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|+..++||+|+||+||++... +++.+|+|.+..... ...+.+.+|+.++++++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999775 688999998865432 2345578899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999886542 335899999999999999999999999 99999999999999999999999999876543222
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. ....|+..|+|||++.+..++.++|+||||+++|||++|+.||........ ...+........ ..+.+
T Consensus 158 ~--~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~--~~~~~---- 226 (285)
T cd05632 158 I--RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE--EVYSA---- 226 (285)
T ss_pred c--cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc--cccCc----
Confidence 1 233589999999999888899999999999999999999999864322111 111111111110 00111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
.....+.+|+.+||+.+|++||+ +.++++
T Consensus 227 --------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 --------KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --------cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 12234568999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.45 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=198.0
Q ss_pred cEecccCcEEEEEEEEcC--C--cEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQD--G--TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999997643 3 3699999887665 556789999999999999999999999988 888999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc--
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-- 504 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~-- 504 (646)
++|.+++.+... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976532 46899999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........ .... +..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---~~~~-------~~~ 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK---EGER-------LER 222 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh---cCCc-------CCC
Confidence 1112347789999999998889999999999999999999 99998532111 11111111 0000 000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
. ......+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 ~------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 P------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 012345778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.58 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=197.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|++|.||+|+.+ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999875 68999999886542 22356788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++ ++|.+++........+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865444456899999999999999999999999 99999999999999999999999999876543321
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc--CC---------
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS--NG--------- 571 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~--------- 571 (646)
......+++.|+|||.+.+. .++.++||||||++++||+||+.||........ .......... +.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhH
Confidence 11223478899999988654 578899999999999999999999864321110 0000000000 00
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....++. ...............++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0000000000112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.24 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=200.8
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999775 6889999988643 2344677889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988653 2335789999999999999999999999 999999999999999999999999998766433221
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.... ........ ..+.... +..
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~-~~~~~~~-~~~----- 222 (255)
T cd08219 157 -ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKV-CQGSYKP-LPS----- 222 (255)
T ss_pred -cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHH-hcCCCCC-CCc-----
Confidence 122358889999999988889999999999999999999999986321 11111111 1111111 110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.....+.+++.+||+.+|++|||+.|++..
T Consensus 223 -------~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 -------HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.83 Aligned_cols=248 Identities=29% Similarity=0.467 Sum_probs=196.2
Q ss_pred cEecccCcEEEEEEEEcC----CcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQD----GTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999996542 26899999875543 24567899999999999999999999875 4567999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997542 5899999999999999999999999 99999999999999999999999999987654332211
Q ss_pred --cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 507 --TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 507 --~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+. ...... .+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~--~~---- 220 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLP--RP---- 220 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCC--CC----
Confidence 12224568999999988889999999999999999998 8998863321 11111111 111000 00
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 221 -------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 -------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 012245678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.89 Aligned_cols=253 Identities=23% Similarity=0.408 Sum_probs=197.8
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeC------
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA------ 414 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 414 (646)
.+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888899999999999999765 58899999986543 4456788999999998 699999999998763
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 35789999999999999987542 335899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
+........ ......|++.|+|||++. +..++.++||||||+++|||++|+.||..... ..... ....
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~~~~~-~~~~ 230 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALF-LIPR 230 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----HHHHH-HHhc
Confidence 986543222 122345899999999985 33578899999999999999999999852211 11111 1111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... +.+... .....+.+|+.+||+.+|.+|||+.|+++
T Consensus 231 -~~~-----~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -NPA-----PRLKSK-------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCC-----CCCCCC-------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 100 111100 12235678999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.60 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=197.8
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999876 5788999998776666678899999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|..++.+. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence 9999987643 235899999999999999999999999 99999999999999999999999999876543221 12
Q ss_pred cccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 507 TCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
....+++.|+|||++. +..++.++||||||+++|||++|+.||..... ......... ........+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~~-- 231 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SEPPTLAQP-- 231 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhh-cCCCCCCCc--
Confidence 2345889999999973 34578899999999999999999999863221 111111111 100000000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+++.+||+.+|++||++.++++.
T Consensus 232 ---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ---------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0122456789999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=313.45 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=192.5
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhC---CCCcccccceeEEeC-----C
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQV---NHKNLVRLLGCCVEA-----E 415 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 415 (646)
+|++.+.||+|+||+||+|..+ +++.||+|.++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999776 689999998865322 2234566777777665 699999999988753 3
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 4888888654 2345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh--cCCcc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA--SNGAI 573 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 573 (646)
+....... .....++..|+|||++.+..++.++||||||+++|||++|+.||......+ .+........ .....
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhC
Confidence 87643221 123457899999999988889999999999999999999999886332211 1111110000 00000
Q ss_pred cc-------cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 ME-------VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~-------~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. .+.+... ...........+.+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCC-CchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000 0000000122345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.40 Aligned_cols=238 Identities=26% Similarity=0.337 Sum_probs=190.3
Q ss_pred cEecccCcEEEEEEEE----cCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 352 RILGSGGFGEVYKGEL----QDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
+.||+|+||+||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3578999999875322 234567789999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 99999998643 35899999999999999999999999 99999999999999999999999999886543322 1
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .... .. ...... . ++.
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~---~~-i~~~~~-~-~p~------ 219 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETM---TM-ILKAKL-G-MPQ------ 219 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHH---HH-HHcCCC-C-CCC------
Confidence 2234589999999999888889999999999999999999999863321 1111 11 111110 0 000
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTD 617 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~e 617 (646)
.....+.+|+.+||+.+|++||++.+
T Consensus 220 ------~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 ------FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11234668999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=326.68 Aligned_cols=199 Identities=26% Similarity=0.331 Sum_probs=171.2
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.|+..++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888899999999999999765 68899999986532 2335678899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998653 35788999999999999999999999 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------CccccccCccccccCccccccCCCCchhhHHHHH
Q 006402 503 ----------------------------------------------SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYG 536 (646)
Q Consensus 503 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G 536 (646)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001123589999999999988999999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 006402 537 VVLLELLTSQKAIDF 551 (646)
Q Consensus 537 ~ll~elltg~~p~~~ 551 (646)
|+||||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=316.11 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=198.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|...+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999775 688999998865432 3345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 96 5898888653 235889999999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc---CCccccccc-
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS---NGAIMEVVD- 578 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d- 578 (646)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+. ...+..... ........+
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcc
Confidence 1 1223478899999988653 578899999999999999999999864322111 111111000 000000000
Q ss_pred --------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 --------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 --------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.................+.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000001112345779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=313.71 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=203.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-----CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCe
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-----DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 418 (646)
.|+..+.||+|+||.||++++. +++.+|+|+++..... ..+.|.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999764 3688999998765443 46789999999999999999999999887 55789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999997542 24899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCc--------cHHHHHHHHh
Q 006402 499 KPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV--------NLAIYVSQRA 568 (646)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~--------~~~~~~~~~~ 568 (646)
...... ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 633221 111223566799999998888999999999999999999999987543221100 0000001111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.... .... .......+.+|+.+||+.+|++|||+.||+++|+++
T Consensus 240 ~~~~---------~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE---------RLPR----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC---------cCCC----CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1100 0000 011224577899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.42 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=206.8
Q ss_pred CcccEecccCcEEEEEEEEc-CC----cEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 349 SKERILGSGGFGEVYKGELQ-DG----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
...++||+|+||+||||.+- .| -+||+|++... ..+...+++.|+-+|.+++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34588999999999999663 33 46899987654 3455788999999999999999999999999876 889999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
||+.|+|.+|++.+ +.++..+..+.|..|||+||.|||.++ ++||||-.+|||+..-..+||.|||+++....+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999875 345888999999999999999999999 9999999999999999999999999999988765
Q ss_pred Cccc-cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 503 SHVS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 503 ~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... ....-.+.|||-|.+....++.++|||||||++||++| |.+|++.....+ +...++.+.- +-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR--Lsq-- 921 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER--LSQ-- 921 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc--CCC--
Confidence 4433 33445778999999999999999999999999999998 778876433222 2222222211 111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
......++..++.+||..|++.||+++++...+.++....
T Consensus 922 ---------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 922 ---------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ---------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 1223445778999999999999999999999988776543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.28 Aligned_cols=238 Identities=24% Similarity=0.368 Sum_probs=186.2
Q ss_pred EecccCcEEEEEEEEcC-------------------------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCccccc
Q 006402 353 ILGSGGFGEVYKGELQD-------------------------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 407 (646)
.||+|+||.||+|++.. ...|++|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13589998876544455678999999999999999999
Q ss_pred ceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC--
Q 006402 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-- 485 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-- 485 (646)
++++.+....++||||+++++|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998653 235889999999999999999999998 99999999999997543
Q ss_pred -----CEEEeecCCCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHH-HcCCCCCCCCCCCCCc
Q 006402 486 -----NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLEL-LTSQKAIDFSRDPDDV 558 (646)
Q Consensus 486 -----~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~el-ltg~~p~~~~~~~~~~ 558 (646)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++||| ++|+.||......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 38999999886543221 1236788999998865 5689999999999999998 57888876332211
Q ss_pred cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
....... ... +... ....+.+++.+||+.+|++|||+.++++.|
T Consensus 230 -~~~~~~~---~~~--------~~~~--------~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KERFYEK---KHR--------LPEP--------SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHHHh---ccC--------CCCC--------CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111100 000 0000 113467899999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.93 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=194.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
+.|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 68999999986432 223566889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999999753 35788999999999999999999999 999999999999999999999999997532100
Q ss_pred ------------------------------------------CCccccccCccccccCccccccCCCCchhhHHHHHHHH
Q 006402 502 ------------------------------------------LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVL 539 (646)
Q Consensus 502 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll 539 (646)
.........||+.|+|||++.+..++.++|||||||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00001123589999999999988999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC---CHH
Q 006402 540 LELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP---SMT 616 (646)
Q Consensus 540 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP---s~~ 616 (646)
|||++|+.||......+ . ... .........+.. . ......+.+++.+|+ .+|.+|+ |+.
T Consensus 235 yell~G~~Pf~~~~~~~---~---~~~-i~~~~~~~~~~~-~---------~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 235 YEMLVGQPPFLADTPAE---T---QLK-VINWETTLHIPS-Q---------AKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred eehhhCCCCCCCCCHHH---H---HHH-HhccCccccCCC-C---------CCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 99999999996432211 0 011 111000000000 0 011233557788866 5999999 889
Q ss_pred HHHHH
Q 006402 617 DVVHE 621 (646)
Q Consensus 617 evl~~ 621 (646)
|+++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 98854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.75 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=201.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.+.||+|+||+||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 3467999988654433 4578999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 419 LIYEYIANGTLHDHLHGKYSS------FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
+||||+++++|.++++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754321 25899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
|+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||..... ... .. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~---~~-~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEV---LN-RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHH---HH-HHHcC
Confidence 9987553322222223346778999999988888999999999999999999 6777742211 111 11 11111
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
....... ......+.+++.+||+.+|++|||+.|+++.|.
T Consensus 235 ~~~~~~~------------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPVP------------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCCC------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110000 012235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.94 Aligned_cols=237 Identities=27% Similarity=0.362 Sum_probs=186.5
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHH-HHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVG-ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986432 122345555555 56789999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT 153 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence 9999998643 35889999999999999999999999 99999999999999999999999999875432211 22
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~------~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-NKPL------RLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cCCC------CCCC---
Confidence 234589999999999988999999999999999999999999863211 11111111 1110 0110
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMT 616 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 616 (646)
.....+.+++.+||+.+|.+||++.
T Consensus 218 -----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1123467899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.22 Aligned_cols=249 Identities=32% Similarity=0.498 Sum_probs=201.1
Q ss_pred cEecccCcEEEEEEEEcC----CcEEEEEEcccCCccc-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQD----GTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||.||++.... +..|++|.++...... .+.+.+|++++++++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997763 7889999987654433 67899999999999999999999999999999999999999
Q ss_pred CCccccccCCcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 427 GTLHDHLHGKYS------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 427 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976421 256899999999999999999999999 99999999999999999999999999987765
Q ss_pred CCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 501 GLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 501 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
... .......+++.|+|||.+....++.++||||+|+++|||++ |..||..... ... ......+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEV-LEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHH-HHHHHcCCCCC---
Confidence 431 11223457889999999988889999999999999999999 5888864311 111 11111111000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
. ......++.+++.+||+.+|++|||+.|+++.|+
T Consensus 228 --~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 --K--------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --C--------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0112345778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.59 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=191.4
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 421 (646)
+|.+.+.||+|+||+||+|+.. +++.||+|+++... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999776 57899999987532 22345677788888877 5899999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999988643 35889999999999999999999999 999999999999999999999999998754322
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+... ...... .+..
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~----i~~~~~--~~p~-- 222 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQS----IMEHNV--AYPK-- 222 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCCC--CCCC--
Confidence 21 12234589999999999998999999999999999999999999863321 111111 111110 0010
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
....++.+++.+||+.+|++|++.
T Consensus 223 ----------~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 ----------SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----------cCCHHHHHHHHHHcccCHHhcCCC
Confidence 122346789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.02 Aligned_cols=192 Identities=27% Similarity=0.371 Sum_probs=164.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+|.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.+....++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999876 5788999975332 235799999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+ .++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 139 ~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 139 Y-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred c-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 9 56888888643 345899999999999999999999999 99999999999999999999999999975432211
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAID 550 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~ 550 (646)
.....||+.|+|||++.+..++.++||||||+++|||+++..++.
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 123458999999999998899999999999999999999766653
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.21 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=199.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+.|++.++||+|+||.||+|+.. +++.+++|.+...+....+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999876 58899999998776667788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|..++.+. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999999887643 235899999999999999999999998 999999999999999999999999998764332211
Q ss_pred cccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ........ .........+
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~~ 238 (292)
T cd06644 167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLSQP 238 (292)
T ss_pred -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh-cCCCccCCCC
Confidence 12334788999999984 34578899999999999999999999853211 11111111 1111010000
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|++||++.|+++
T Consensus 239 -----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 239 -----------SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----------cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 012234678999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=332.35 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=192.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC--------C
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--------E 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 415 (646)
..+|++.++||+|+||+||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999775 68899999875432 2345799999999999999999987542 1
Q ss_pred cCeEEEEEccCCCccccccCC-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecC
Q 006402 416 QPLLIYEYIANGTLHDHLHGK-YSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFG 493 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfG 493 (646)
..++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 677666432 13346899999999999999999999999 9999999999999965 479999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
+++........ ....+|+.|+|||++.+. .++.++||||||++||||++|+.||......+. +.. +........
T Consensus 217 la~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGTPT 291 (440)
T ss_pred cchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCC
Confidence 99876543322 223589999999988654 689999999999999999999999864332111 111 111110000
Q ss_pred ----------ccccccccccCCchhH-HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 006402 573 ----------IMEVVDPRLQGHEASV-NILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRII 626 (646)
Q Consensus 573 ----------~~~~~d~~l~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~ 626 (646)
..++--+.+....... -......++.+|+.+||+.+|.+|||+.|+++. ++.+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000000000000000 000123467899999999999999999999843 44443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.91 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=168.7
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----- 415 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 415 (646)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999765 6889999998653 2334567889999999999999999999876433
Q ss_pred -cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 416 -QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 416 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999965 67776642 3788999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
++...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 98654322 122345899999999999989999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.42 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=202.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|+..+.||+|++|.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999998874 78999999865432 678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998643 345899999999999999999999999 99999999999999999999999999887654332
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......... .. ..... .+.+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~-----~~~~~~- 221 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKP-----PPTLSD- 221 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCC-----CCCCCc-
Confidence 122234788999999998888999999999999999999999998643221100 00 00000 000100
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+++.+||+.+|++|||++||++
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 -----PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -----hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112345778999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=323.91 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=196.7
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC----
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE---- 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 415 (646)
...++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999765 6889999988653 2234567889999999999999999999986543
Q ss_pred --cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 416 --QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 416 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
..++||||+++ +|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999965 66666642 3788999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH----------
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY---------- 563 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~---------- 563 (646)
+++...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||......+.......
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654322 12234589999999999988899999999999999999999999864321111000000
Q ss_pred ------HHHHhcC-Cccc-----ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 564 ------VSQRASN-GAIM-----EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 564 ------~~~~~~~-~~~~-----~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....... .... ......+..... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS-EHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhcccccccccc-ccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0000 000000000000 0001123457799999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.52 Aligned_cols=247 Identities=30% Similarity=0.488 Sum_probs=197.2
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCcc
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
++||+|++|.||++...+++.||+|.+...... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998877999999988765443 5678999999999999999999999999999999999999999999
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc-ccc
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS-TCA 509 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~-~~~ 509 (646)
+++.... ..+++..++.++.+++.||+|||+.+ ++||||||+|||++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9996542 35789999999999999999999999 99999999999999999999999999986543221111 112
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASV 588 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 588 (646)
..+..|+|||.+.+..++.++|+||||+++|||+| |..||...... ..... ..... ....+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~----~~~~~--~~~~~--------- 217 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRER----IESGY--RMPAP--------- 217 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHH----HhcCC--CCCCC---------
Confidence 24667999999988889999999999999999999 77777533211 11111 11110 00000
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 589 NILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 589 ~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 218 --~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 --QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 012345778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.09 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=204.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
.+|.+.+.||+|+||.||++... .+..||+|.++... ....+++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888899999999999999642 12368999887532 23467899999999999 7999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 416 QPLLIYEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
..++|+||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 2235889999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNL 560 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~ 560 (646)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 9999999999999865432211 1122334578999999988889999999999999999998 778775321 1
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
..... ........+. . ......+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 243 ~~~~~-~~~~~~~~~~-~------------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFK-LLKEGHRMDK-P------------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHH-HHHcCCCCCC-C------------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111 1111111110 0 012235778999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.19 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=198.2
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999876 6899999988653 3334578999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++++|.+++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999987543334689999999999999999999974 6 99999999999999999999999999876543221
Q ss_pred ccccccCccccccCccccccC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY------QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...... ........ ...+..
T Consensus 159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~-~~~~~~---- 227 (286)
T cd06622 159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSA-IVDGDP---- 227 (286)
T ss_pred ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHH-HhhcCC----
Confidence 223478899999998543 3578999999999999999999998633211 11111111 111110
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.+. ......+.+++.+||+.+|++||++.+++.
T Consensus 228 -~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 -PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CCCC--------cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0110 113345678999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.77 Aligned_cols=249 Identities=22% Similarity=0.398 Sum_probs=202.2
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+|+..+.||.|++|+||+|.. .+++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999975 478999999987666566778899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... .+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999988643 4899999999999999999999999 999999999999999999999999998865543222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .... .. ........+
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~---~~-~~~~~~~~~----- 238 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLI---AT-NGTPELQNP----- 238 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-cCCcccCCc-----
Confidence 1223588899999999888899999999999999999999999864322110 0111 10 000000000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|++|||+.++++
T Consensus 239 ------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 ------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 012234668999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.13 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=203.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+|+..+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367888999999999999999864 7899999998776666667889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++.+. .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999998642 4789999999999999999999999 99999999999999999999999999876544322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... .....+ .+.+..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~~~~~ 237 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPELQN 237 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CCCCCC
Confidence 2 122348889999999988889999999999999999999999986432211100 000000 000000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 ------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112344678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.52 Aligned_cols=238 Identities=26% Similarity=0.425 Sum_probs=187.9
Q ss_pred cEecccCcEEEEEEEEcCCc-----------EEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 352 RILGSGGFGEVYKGELQDGT-----------VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999876432 5788877654433 6789999999999999999999999988 788999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-------CEEEeecC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-------NSKVADFG 493 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-------~~ki~DfG 493 (646)
|||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999975422 5899999999999999999999999 99999999999999887 79999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccC--CCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTS-QKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
++...... ....++..|+|||++... .++.++||||||+++|||++| ..|+......+ ...+. . ..
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~-~--~~ 222 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY-Q--DQ 222 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH-h--cC
Confidence 98865431 122367789999998776 789999999999999999995 66654322110 00000 0 00
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
.. +... ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 223 ~~--------~~~~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR--------LPMP--------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--------CCCC--------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0000 0145678999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.92 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=198.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777788999999999999765 68899999987665555667889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ..+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 999999998643 35899999999999999999999999 99999999999999999999999999876543221
Q ss_pred cccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
......|+..|+|||++. ...++.++||||||+++|||++|+.||........ ......... ..+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~----~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNF----QPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCC----CCCcc
Confidence 122345899999999874 44688899999999999999999999853221110 000000000 00111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... ......+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 011234678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=302.98 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=198.4
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc------ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
+|...+.||+|+||+||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4777899999999999999888899999998764321 2235688999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999643 35789999999999999999999999 99999999999999999999999999876432
Q ss_pred C-----CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 501 G-----LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 501 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
. .........++..|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-- 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMFYIGAHRGLM-- 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHHHhhhccCCC--
Confidence 1 111122345889999999999888999999999999999999999998632211 1110000000111
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.+.. .....+.+++.+||+.+|++||++.|+++
T Consensus 228 ---~~~~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ---PRLPD--------SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCC--------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 12244678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.72 Aligned_cols=264 Identities=22% Similarity=0.218 Sum_probs=197.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc---CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.+|.+.+.||+|+||.||++... .++.||+|.+... +.+.+|+.++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46889999999999999999653 3578999987543 235689999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
++. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 985 688888842 346899999999999999999999999 9999999999999999999999999997654332
Q ss_pred Cc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc--c----
Q 006402 503 SH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM--E---- 575 (646)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~---- 575 (646)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......... .
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 2223458999999999998899999999999999999999999986544332111111111111100000 0
Q ss_pred ----c---ccccccCCchh---HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 576 ----V---VDPRLQGHEAS---VNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 576 ----~---~d~~l~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. +.......... .........+.+++.+||+.+|++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000000 0001122356789999999999999999999864
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=304.16 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=187.4
Q ss_pred EecccCcEEEEEEEEcC---CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCC
Q 006402 353 ILGSGGFGEVYKGELQD---GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3578888775443 2335678999999999999999999999999999999999999999
Q ss_pred ccccccCCcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc-c
Q 006402 429 LHDHLHGKYS--SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-V 505 (646)
Q Consensus 429 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~-~ 505 (646)
|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 223567888999999999999999999 999999999999999999999999998754332211 1
Q ss_pred ccccCccccccCcccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 506 STCAQGTLGYLDPEYYRN-------YQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.....+++.|+|||++.. ..++.++||||||+++|||++ |..||...... .. ........ .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhhcc-CccCC
Confidence 122335778999998742 356889999999999999999 67777533211 11 11111111 11111
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
++.+.. .....+.+++..|| .+|++|||++||++.|
T Consensus 232 ~~~~~~--------~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQLDL--------KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcccc--------cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 221111 12234557888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.97 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=201.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999876 68999999986543 34456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998753 5899999999999999999999999 99999999999999999999999999987754322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. .....+++.|+|||++.+..++.++||||||+++|||++|+.||...... .. ........ .+.+..
T Consensus 154 ~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~----~~~~~~~~-----~~~~~~ 220 (274)
T cd06609 154 K-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RV----LFLIPKNN-----PPSLEG 220 (274)
T ss_pred c-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HH----HHHhhhcC-----CCCCcc
Confidence 1 22234788999999998888999999999999999999999998633211 11 11111111 111111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .....+.+++.+||..+|++|||++++++
T Consensus 221 ~-------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N-------KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c-------ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 02334678999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.01 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=187.9
Q ss_pred cEecccCcEEEEEEEEcC--------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQD--------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+.||+|+||.||+|..+. ...+|+|.+........+.+.+|+.++++++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997642 234888887655555567889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--------EEEeecCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN--------SKVADFGLS 495 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~--------~ki~DfGl~ 495 (646)
+++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999997642 25899999999999999999999999 999999999999987665 699999998
Q ss_pred ccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
....... ...+++.|+|||++.+. .++.++||||||+++|||++|..++...... ...........
T Consensus 156 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~--- 222 (258)
T cd05078 156 ITVLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----QKKLQFYEDRH--- 222 (258)
T ss_pred cccCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----HHHHHHHHccc---
Confidence 7554321 23478899999999764 5789999999999999999995443211111 00000000000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
.+... ...++.+++.+||+.+|++|||++++++.|+
T Consensus 223 -----~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -----QLPAP--------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cCCCC--------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01100 1134678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.79 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=203.0
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|+||.||.++.. +++.+++|.+... +....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999998654 6889999987654 334567789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997643 345899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......+++.|+|||.+.+..++.++||||||++++||++|+.||..... ........ .+.....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~------- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV------- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC-------
Confidence 12234589999999999888889999999999999999999999863221 11111111 1111110
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......++.+++.+||+.+|++||+++|+++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.67 Aligned_cols=198 Identities=19% Similarity=0.258 Sum_probs=164.6
Q ss_pred cccEeccc--CcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 350 KERILGSG--GFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 350 ~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999765 78999999987542 233456778999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999996542 235899999999999999999999999 999999999999999999999999865433211110
Q ss_pred ------cccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006402 505 ------VSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDF 551 (646)
Q Consensus 505 ------~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~ 551 (646)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0111236778999999875 4688999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.79 Aligned_cols=241 Identities=25% Similarity=0.329 Sum_probs=186.8
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHH-HHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVG-ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
+.||+|+||+||+++.. +++.||+|++.... ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999986432 122334455544 56788999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 9999998753 34778888999999999999999999 99999999999999999999999999875432211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ... .+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~--~~~~------- 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN-KPL--QLKP------- 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHh-CCc--CCCC-------
Confidence 2345899999999999989999999999999999999999998632211 11111111 100 0111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+++.+||+.+|.+||++.+.+.
T Consensus 218 -----~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 -----NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -----CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11234668999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.90 Aligned_cols=240 Identities=27% Similarity=0.358 Sum_probs=187.6
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHH-HHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVG-ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+++.. +|+.+|+|++... .....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999765 6899999998643 2233445566655 46778999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 9999888643 35899999999999999999999999 99999999999999999999999999875432211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .... .+.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~-~~~~--~~~~~------ 218 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNIL-HKPL--VLRPG------ 218 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHH-cCCc--cCCCC------
Confidence 234589999999999998999999999999999999999999863321 11111111 1110 01111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
....+.+++.+||+.+|.+||++.+.+
T Consensus 219 ------~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 ------ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ------CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 123456899999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.48 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=203.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|...+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999775 57889999988766667788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999998653 235899999999999999999999999 999999999999999999999999998765432211
Q ss_pred cccccCccccccCccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYRNY---QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... . ........ ...+.+
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~---~~~~~~~~----~~~~~~ 226 (262)
T cd06613 158 -RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---A---LFLISKSN----FPPPKL 226 (262)
T ss_pred -cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhcc----CCCccc
Confidence 1223578899999998776 78899999999999999999999986322110 0 01111000 000111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. .......+.+++.+||+.+|.+|||+.+|+.
T Consensus 227 ~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KD------KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc------hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10 1123445789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.21 Aligned_cols=265 Identities=22% Similarity=0.262 Sum_probs=200.9
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|++.+.||+|++|.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999875 68999999987654 23356799999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+ +++|.+++.... ..+++.+++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986542 45899999999999999999999999 99999999999999999999999999987755432
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC-----------
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG----------- 571 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 571 (646)
.......++..|+|||.+.+. .++.++||||+|++++||++|+.+|...... .....+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCc
Confidence 223334589999999998654 4688999999999999999997776532211 1111111111000
Q ss_pred -cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 -AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 -~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....+..+.................+.+++.+||+.+|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000000000000112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.06 Aligned_cols=255 Identities=20% Similarity=0.223 Sum_probs=195.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||+||+++.+ +++.+|+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999876 5788999988542 1223455888999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999753 235899999999999999999999999 999999999999999999999999998765433
Q ss_pred CCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.........||+.|+|||++. ...++.++||||||++||||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc-
Confidence 332233345999999999985 34678899999999999999999999863211 111111111110000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVHE 621 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~~ 621 (646)
+.... ......+.+|+.+|+..++.+ |+++.|+++.
T Consensus 229 ~p~~~---------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQV---------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCcc---------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01100 112344668888988654444 6899999866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.69 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=201.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|++.+.||+|++|.||++... +++.+|+|.++.......+.+.+|++++++++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888889999999999999875 68999999988776667788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998653 235899999999999999999999999 999999999999999999999999998765432221
Q ss_pred cccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||...... .... ........
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~----- 226 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLL-KILKSEPP----- 226 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHH-HHhcCCCC-----
Confidence 12234889999999874 345778999999999999999999998632111 1111 11111110
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.. .......+.+++.+||+.+|++||++.++++.
T Consensus 227 ~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCC------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0100 01122356789999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=304.31 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=202.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.+|+..+.||+|+||+||+|.++ +|+ .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45777899999999999999765 333 589998865543 345778999999999999999999999887 78899
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999997642 34899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCccc-cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSHVS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... ....++..|+|||.+....++.++|+||||+++|||++ |+.||...... .+. .....+... -
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~--~ 231 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP----DLLEKGERL--P 231 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHhCCCCC--C
Confidence 4332211 12224568999999988889999999999999999999 99998633211 111 111111100 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
.+.. ....+.+++.+||..+|.+||++.++++.|+++..
T Consensus 232 ~~~~-----------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 QPPI-----------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCC-----------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0000 11236689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.09 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=200.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|+..+.||+|+||.||+|.+. +++ .||+|.+..... .....+.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677789999999999999764 444 578888765432 2345788999999999999999999998754 4679
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998754 235889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ...+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~-- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL----LEKGERLP-- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCC--
Confidence 332221 122335778999999988889999999999999999997 8888853211 111111 11111000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.+. .....+.+++.+||..+|++||++.++++.|+.+.+...
T Consensus 232 ~~~-----------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 232 QPP-----------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCC-----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 000 012346789999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=300.80 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=198.4
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCC-cCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-QPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e 422 (646)
+|++.+.||+|++|.||+++.+ +++.||+|++.... ....+.+.+|++++++++|+|++++++.+...+ ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999765 57899999986543 234567889999999999999999999876544 5789999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ....+++.+++.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999754 2345899999999999999999999999 9999999999999999999999999998664332
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||..... ........ .+.... +.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~-----~~ 223 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-EGKLPP-----MP 223 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hcCCCC-----Cc
Confidence 2 22234478999999999988899999999999999999999999863211 11111111 111110 10
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|++|||+.++++
T Consensus 224 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 --------KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --------cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=307.65 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=203.2
Q ss_pred ccHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEe
Q 006402 336 FHLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVE 413 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 413 (646)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455677788899999999999999999999775 58899999876432 2346688899999999 69999999998853
Q ss_pred -----CCcCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 414 -----AEQPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 414 -----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
++..++||||+++++|.++++... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 346799999999999999876321 2345889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH
Q 006402 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~ 562 (646)
||+|||+++........ .....|++.|+|||++.. ..++.++||||||+++|||++|+.||....... .
T Consensus 164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~ 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A 237 (286)
T ss_pred EEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H
Confidence 99999998866433221 223358999999998753 357889999999999999999999986332111 0
Q ss_pred HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 563 YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
... ..........++. .....+.+|+.+||+.+|++|||+.|+++.
T Consensus 238 -~~~-~~~~~~~~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 -LFK-IPRNPPPTLHQPE-----------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -Hhh-ccccCCCcccCCC-----------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 1111101111111 012346789999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.91 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=201.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777789999999999999765 68899999876543 33467889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999988643 358999999999999999999997 46 9999999999999999999999999986543221
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCc-----cHHHHHHHHhcCCcccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV-----NLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 577 (646)
. ....++..|+|||++.+..++.++||||||+++|||++|+.||......++. .+...........
T Consensus 159 ~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 A---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred c---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1 2245899999999998888999999999999999999999999744332111 0111111111100
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.+.+. .......+.+|+.+||+.+|++|||+.|+++..
T Consensus 230 ~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP-------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC-------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01111 011334577899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.14 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=194.8
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC-----
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA----- 414 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 414 (646)
...++|...+.||+|+||+||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999764 68899999886532 22345678999999999999999999988643
Q ss_pred -CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 415 -EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 415 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
...++++|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 7889887753 24899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ........... .
T Consensus 164 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~-~ 235 (343)
T cd07878 164 LARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGT-P 235 (343)
T ss_pred cceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCC-C
Confidence 998654322 22358999999999876 468899999999999999999999986432111 01101000000 0
Q ss_pred cccccc-----------ccc---cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 573 IMEVVD-----------PRL---QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 573 ~~~~~d-----------~~l---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
..+... ..+ ...............+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 0000000000112346789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.64 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=190.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 421 (646)
+|+..+.||+|+||+||++..+ +++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677799999999999999765 6899999988643 2234466788999998886 577888999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999998643 35899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...... ....... +..
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~----i~~~~~~--~p~-- 222 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQS----IMEHNVS--YPK-- 222 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCCCC--CCc--
Confidence 21 12234589999999999988899999999999999999999999863321 111111 1111100 000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.....+.+++.+||+.+|.+|++.
T Consensus 223 ----------~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ----------SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----------cCCHHHHHHHHHHcccCHhhCCCC
Confidence 112346689999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=302.11 Aligned_cols=248 Identities=24% Similarity=0.434 Sum_probs=197.4
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---------cHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
+|.+...||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999764 6889999988654322 12568899999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999643 35789999999999999999999999 9999999999999999999999999988
Q ss_pred cCCCCCCc-----cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 497 LAKPGLSH-----VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 497 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... . .+.. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~-~~~~-~~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----Q-AIFK-IGEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----H-HHHH-Hhcc
Confidence 76532111 111234788999999998888999999999999999999999998633211 1 0111 1010
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+.+. ......+.+++.+||+.+|.+||++.|+++
T Consensus 228 -----~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----ASPEIP--------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CCCcCC--------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111 012345678999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=301.19 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=198.5
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-----cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-----IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
+|+..+.||+|++|+||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999876 78999999886543 22456789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999643 35889999999999999999999999 99999999999999999999999999876644
Q ss_pred CCCccccccCccccccCccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ............... +.+
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~-~~~ 225 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP-IPD 225 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-cCC
Confidence 33 122345889999999987666 89999999999999999999999863321 111111111011100 111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+++.+||+.+|++||++.++++
T Consensus 226 ------------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 ------------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------------CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11244668999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.53 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=199.2
Q ss_pred CCCcccEecccCcEEEEEEEEcC--CcEEEEEEcccCC----------cccHHHHHHHHHHHhh-CCCCcccccceeEEe
Q 006402 347 GFSKERILGSGGFGEVYKGELQD--GTVVAVKSAKVGN----------IKSTQQVLNEVGILSQ-VNHKNLVRLLGCCVE 413 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 413 (646)
+|++.+.||+|+||.||+|..+. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998764 6889999875321 2234567889998875 789999999999999
Q ss_pred CCcCeEEEEEccCCCccccccCC-cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGK-YSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988532 133468999999999999999999996 56 99999999999999999999999
Q ss_pred cCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 492 FGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 492 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~-~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLAT-KIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHH-HHhhc
Confidence 99998765433 223345889999999998888999999999999999999999998532111 1111 11111
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
..... . .......+.+++.+||+.+|++||++.||..+++
T Consensus 229 ~~~~~-----~-------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPL-----P-------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcC-----C-------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11100 0 0012245678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.07 Aligned_cols=255 Identities=19% Similarity=0.220 Sum_probs=196.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+++.+ +++.||+|++... .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999876 6789999988642 2233456788999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999753 235889999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.........||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc-
Confidence 3332333459999999999865 4678899999999999999999999863221 111111111100000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVHE 621 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~~ 621 (646)
+++.+ ....+.+.+++.+|+...+.+ |++++++++.
T Consensus 229 ~p~~~---------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHI---------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcc---------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 012345668899998865544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=303.85 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=200.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|+||+||+++.. +++.||+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999765 6899999988643 233456889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++.... ...+++.++++++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999987542 235789999999999999999999999 99999999999999999999999999976644322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. .....+++.|+|||++.+..++.++|+||||+++++|++|+.||..... ......... +.... .
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~~-----~-- 221 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYPP-----V-- 221 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCCC-----C--
Confidence 1 1223478899999999888899999999999999999999999863211 111111111 11100 0
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+++.+||+.+|++||++.+|++
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ------cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.55 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=173.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|+..+.||+|+||+||++..+ +++.||+|+++... ....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999775 68999999986432 234567888999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998743 35899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC----------------------------------ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 006402 502 LS----------------------------------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547 (646)
Q Consensus 502 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~ 547 (646)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113458999999999999899999999999999999999999
Q ss_pred CCCC
Q 006402 548 AIDF 551 (646)
Q Consensus 548 p~~~ 551 (646)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=301.43 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=196.4
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3578889999999999999975 5778999988643 2346789999999999999999999998764 5799999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999999754 2345899999999999999999999998 99999999999999999999999999876533211
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||..... .... .....+...+ + .
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~-~~~~~~~~~~---~--~-- 219 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVK-ECVEKGYRME---P--P-- 219 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHH-HHHhCCCCCC---C--C--
Confidence 1224568999999988889999999999999999998 8888753221 1111 1111111000 0 0
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
......+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 ------EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0122456789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=310.50 Aligned_cols=197 Identities=24% Similarity=0.380 Sum_probs=160.4
Q ss_pred ccEecccCcEEEEEEEEc---CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCeEEEEEcc
Q 006402 351 ERILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPLLIYEYIA 425 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 425 (646)
.++||+|+||+||+|+.+ +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 367999999999999865 46789999886432 23557899999999999999999999865 345789999985
Q ss_pred CCCccccccCCc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCEEEeecCCC
Q 006402 426 NGTLHDHLHGKY------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLS 495 (646)
Q Consensus 426 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll----~~~~~~ki~DfGl~ 495 (646)
++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877764221 2235899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCCc--cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 496 RLAKPGLSH--VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 496 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
+........ ......+|+.|+|||++.+. .++.++||||+|+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876533221 12334589999999998764 58999999999999999999999997443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.23 Aligned_cols=265 Identities=25% Similarity=0.314 Sum_probs=199.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|+..+.||+|++|.||+|+.+ +++.||+|++..... ...+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 589999998864422 234668899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|..++... ..+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999888876532 35899999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC-----------
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN----------- 570 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 570 (646)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ..........
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhccc
Confidence 2 1122347889999999865 4578999999999999999999999864332111 1111100000
Q ss_pred Ccc-cccccccccCCch-hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 GAI-MEVVDPRLQGHEA-SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 ~~~-~~~~d~~l~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... .....+....... ..........+.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000000000000 0001122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.46 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=187.4
Q ss_pred EecccCcEEEEEEEEcCC---cEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCC
Q 006402 353 ILGSGGFGEVYKGELQDG---TVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
.||+|+||+||+|+..++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 346677665433 2346789999999999999999999999999999999999999999
Q ss_pred ccccccCCcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC-Cccc
Q 006402 429 LHDHLHGKYS-SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL-SHVS 506 (646)
Q Consensus 429 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~-~~~~ 506 (646)
|.+++++... ...+++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999975432 234677788899999999999999999 9999999999999999999999999986432211 1111
Q ss_pred cccCccccccCcccccc-------CCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 507 TCAQGTLGYLDPEYYRN-------YQLTDKSDVYSYGVVLLELLTS-QKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||..... . ........ +......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~---~~~~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---R---EVLNHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---H---HHHHHHHh-hcccccCC
Confidence 23347889999998743 2457899999999999999975 556642211 1 11111111 11222233
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
+.+... ....+.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~~~~--------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP--------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC--------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333211 2234667889999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.24 Aligned_cols=250 Identities=30% Similarity=0.440 Sum_probs=195.4
Q ss_pred cEecccCcEEEEEEEEcC-------CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQD-------GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2579999876543 23467889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-----CEEEeecCC
Q 006402 424 IANGTLHDHLHGKY----SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-----NSKVADFGL 494 (646)
Q Consensus 424 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-----~~ki~DfGl 494 (646)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2234789999999999999999999998 99999999999999877 899999999
Q ss_pred CccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 495 SRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 495 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----HhcCC
Confidence 8765432211 1112235778999999998899999999999999999998 9988863221 111111 11110
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
.. .. .......+.+++.+||+.+|++||+++++++.|++
T Consensus 231 ~~-------~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL-------QK------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc-------CC------cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 00 01123456789999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.17 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=200.2
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.|+..+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999875 58899999887543 344677899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999998642 4889999999999999999999998 99999999999999999999999999976644322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
......++..|+|||++.+..++.++|+||||+++|||++|+.||....... .. ....... .+.+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~----~~~~~~~-----~~~~--- 221 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VL----FLIPKNN-----PPTL--- 221 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hh----hhhhcCC-----CCCC---
Confidence 1223347889999999988889999999999999999999999986322110 00 0000000 0111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 -----TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11234557799999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.46 Aligned_cols=249 Identities=27% Similarity=0.312 Sum_probs=199.1
Q ss_pred CCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|+..+.||.|.-|+||++++++ +..+|+|++.+... +...+...|.+||+.+.||.++.|+..++.++..++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4445789999999999999875 68999999876533 3455677899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC---
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP--- 500 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~--- 500 (646)
++||+|...++++ ....+++..+..++.+++-||+|||-.| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 159 CpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999988766 4557999999999999999999999999 99999999999999999999999998753210
Q ss_pred ------------------------------C-CC---------------------ccccccCccccccCccccccCCCCc
Q 006402 501 ------------------------------G-LS---------------------HVSTCAQGTLGYLDPEYYRNYQLTD 528 (646)
Q Consensus 501 ------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 528 (646)
. .. ..+...+||-+|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 00 0011224999999999999999999
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccC
Q 006402 529 KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREK 608 (646)
Q Consensus 529 ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~ 608 (646)
++|.|+|||+||||+.|..||......+. +.. ++-..+.-.. .......+.+||++.|..|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~N-------------Iv~~~l~Fp~----~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRN-------------IVGQPLKFPE----EPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHH-------------HhcCCCcCCC----CCcchhHHHHHHHHHhccC
Confidence 99999999999999999999986554321 111 1111111111 1123345679999999999
Q ss_pred CCCCCC----HHHHH
Q 006402 609 KSERPS----MTDVV 619 (646)
Q Consensus 609 p~~RPs----~~evl 619 (646)
|++|.- +.||-
T Consensus 376 P~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhhccccchHHhh
Confidence 999987 66664
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.83 Aligned_cols=252 Identities=27% Similarity=0.355 Sum_probs=208.1
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---cHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCe
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---STQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 418 (646)
....|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999877 4999999998765443 4568999999999998 999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC----CCCEEEeecCC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD----DFNSKVADFGL 494 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~----~~~~ki~DfGl 494 (646)
+|||++.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 3899999999999999999999999 999999999999953 35899999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+..... ........||+.|+|||++....|+..+||||+|+++|.|++|..||.......... ....+..
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 998877 333445669999999999999999999999999999999999999997443322111 1111111
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
++-++.+ ......+.+++..++..||.+|+|+.++++.
T Consensus 256 ~f~~~~w---------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSEPW---------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCc---------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111111 1223456789999999999999999999983
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.44 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=197.4
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555677999999999999765 57899999886443 3345678999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........ .
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999998854 25889999999999999999999998 99999999999999999999999999876643321 1
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... ..... ..+.+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~-----~~~~~~~-- 223 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKN-----SPPTLEG-- 223 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcC-----CCCCCCc--
Confidence 122347889999999998889999999999999999999999975321110 010 01001 0111111
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 ------QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ------ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 123446789999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=302.71 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=198.8
Q ss_pred CCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCc------ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNI------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
+|+..+.||+|++|.||+++. .+++.||+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999976 4689999998864321 134678999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLA 498 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~ 498 (646)
|+||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 35889999999999999999999999 99999999999998765 5999999998776
Q ss_pred CCCCCc---cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 499 KPGLSH---VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 499 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
...... ......++..|+|||.+.+..++.++||||+|+++++|++|+.||......... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~--- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATT--- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCC---
Confidence 543211 112234788999999998888899999999999999999999998643322111 11111110000
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 229 --~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 --APSI--------PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCC--------chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001 1123345778999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=321.52 Aligned_cols=243 Identities=27% Similarity=0.452 Sum_probs=195.8
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEccc----CCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCc--CeEEEEE
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKV----GNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ--PLLIYEY 423 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~ 423 (646)
..+||+|+|-+||||... +|..||--.++. .+....+.|..|+.+|+.|+|||||++++++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999664 577777543332 233456889999999999999999999999988765 6789999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~~~~~ 502 (646)
+..|+|..|+++.+ .++.+.+..|++||++||.|||++. |||+|||||-+||||+ ..|.|||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999998653 4788999999999999999999987 8899999999999998 55899999999999876533
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. ..+.|||.|||||.+. ..|++..||||||+.++||+|+..||..-..+ -.++++...|.....+..-
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~kV-- 268 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALSKV-- 268 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhhcc--
Confidence 2 2367999999999998 58999999999999999999999998744332 2234444444333322211
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...++.++|.+||.. .++|||+.|+|.
T Consensus 269 ----------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 ----------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 123467899999999 999999999985
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.91 Aligned_cols=237 Identities=27% Similarity=0.365 Sum_probs=185.1
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHH-HHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVG-ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+++.. +++.||+|++.... ....+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 68899999986432 122344555654 67889999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT 153 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence 9999888643 35788999999999999999999999 99999999999999999999999999875422211 12
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....... ...... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~-i~~~~~------~~~~--- 217 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDN-ILHKPL------QLPG--- 217 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHH-HhcCCC------CCCC---
Confidence 23458999999999988889999999999999999999999986321 1111111 111110 0100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMT 616 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 616 (646)
.....+.+++.+||+.+|.+||+..
T Consensus 218 -----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 -----GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123466899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.27 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=198.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|+..++||+|+||.||++..+ +++.||+|++...... ..+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999876 5899999987654322 34678899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.++.... ..+++..++.++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876532 24899999999999999999999999 9999999999999999999999999988764433
Q ss_pred CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC--Ccccc----
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN--GAIME---- 575 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~---- 575 (646)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+...... ....+
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhcc
Confidence 2 2223347889999999865 357889999999999999999998886332111 00000000000 00000
Q ss_pred ------cccccccCCch-hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 ------VVDPRLQGHEA-SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ------~~d~~l~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+....... ..........+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000 0000122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.96 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=204.3
Q ss_pred cccHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEE
Q 006402 335 IFHLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCV 412 (646)
Q Consensus 335 ~~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 412 (646)
++...++.++.++|.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4566777788899999999999999999999775 68899999886432 2346678899999999 7999999999987
Q ss_pred eCC-----cCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 413 EAE-----QPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 413 ~~~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
..+ ..++|+||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 643 5789999999999999886422 2345899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCCccccccCccccccCccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHH
Q 006402 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-----QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA 561 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~ 561 (646)
+||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||......
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 999999998865432221 1223478899999997543 3688999999999999999999998632211
Q ss_pred HHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 562 IYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..... ..........++ ......+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~-~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFK-IPRNPPPTLLHP-----------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHH-HhcCCCCCCCcc-----------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10111 111111111111 012234778999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.99 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=196.9
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
...||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999765 6889999998766556677899999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++......... ....
T Consensus 107 ~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 9988532 4789999999999999999999999 999999999999999999999999998765433221 1223
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .... .+.+.+...
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~----~~~~-----~~~~~~~~~----- 241 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMR----RIRD-----NLPPRVKDS----- 241 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHh-----cCCCccccc-----
Confidence 4889999999998888999999999999999999999998632211 1111 1100 011111110
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+++.+||+.+|.+|||++|+++.
T Consensus 242 -~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 -HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122346689999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=302.31 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=203.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||.|++|+||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999765 68899999986543 23567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.++++.......+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433346899999999999999999999999 99999999999999999999999999876654332
Q ss_pred c---cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 504 H---VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 504 ~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
. ......++..|+|||.+... .++.++|+||||++++||++|+.||....... . ........ ++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~----~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--V----LMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--h----HHHHhcCC------CC
Confidence 2 12233588999999998776 78999999999999999999999986332211 0 11111110 01
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+..... .......+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGAD---YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccc---cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110000 0123455779999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=340.78 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=197.5
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcC
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQP 417 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (646)
...++|.+.+.||+|+||+||+++.. ++..+|+|.+.... ......|..|+.++++++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999775 57889999886542 23456789999999999999999999998654 467
Q ss_pred eEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeccCCCCCEEEcC---------
Q 006402 418 LLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAY----TPIYHRDVKSTNILLDD--------- 483 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~i~H~Dik~~NIll~~--------- 483 (646)
+|||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999997532 23469999999999999999999998542 23999999999999964
Q ss_pred --------CCCEEEeecCCCccCCCCCCccccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 484 --------DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 484 --------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23589999999986643221 223458999999999854 458899999999999999999999986332
Q ss_pred CCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 554 DPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ....+ ....... .+.. ......+.+|+.+||+.+|.+||++.|++.
T Consensus 248 ~-----~~qli-~~lk~~p-------~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-----FSQLI-SELKRGP-------DLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-----HHHHH-HHHhcCC-------CCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 11111 1111111 0100 011244678999999999999999999984
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.89 Aligned_cols=251 Identities=31% Similarity=0.483 Sum_probs=199.9
Q ss_pred CCcccEecccCcEEEEEEEEcC-----CcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQD-----GTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
|++.+.||+|+||.||+++..+ +..||+|+++..... ..+.+.+|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3556889999999999997763 388999998765433 5678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999975422 12899999999999999999999999 999999999999999999999999999877654
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.........+++.|+|||.+.+..++.++||||+|++++||++ |+.||.... ...... ..........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~-~~~~~~~~~~---- 225 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLE-YLKKGYRLPK---- 225 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHH-HHhcCCCCCC----
Confidence 3222222337789999999988889999999999999999998 677765311 111111 1111111100
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
. ......+.+++.+||+.+|++|||+.|+++.|
T Consensus 226 -~--------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -P--------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -C--------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 01234577899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=307.82 Aligned_cols=266 Identities=25% Similarity=0.328 Sum_probs=200.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|+..+.||+|++|.||+|..+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999876 5889999988653 23345788999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|++++.+..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777665543 234899999999999999999999999 9999999999999999999999999998776544
Q ss_pred CccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC--Cccccc--c
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN--GAIMEV--V 577 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~ 577 (646)
........++..|+|||++.+. .++.++||||||+++|||++|+.||......+ ........... ...... .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhccc
Confidence 3223334578899999999877 78999999999999999999999986432211 11000000000 000000 0
Q ss_pred cccccC-----Cchh-----HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQG-----HEAS-----VNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~-----~~~~-----~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
++.... .... ........++.+|+.+||+.+|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0000 000012466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=306.86 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=195.9
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|+||.||+|+.. +|+.+|+|+++.... .....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999875 689999998865322 2345678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 5788877643 235899999999999999999999999 99999999999999999999999999986543322
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc------cccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA------IMEV 576 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 576 (646)
. .....+++.|+|||.+.+. .++.++||||||+++|||+||+.|+........ .+ ..+........ ....
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhc
Confidence 1 1233478899999998664 478999999999999999999998653222110 00 00100000000 0000
Q ss_pred ccc----cccCCch-hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 VDP----RLQGHEA-SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 ~d~----~l~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+. ....... ..........+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 0000000 0001123456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.07 Aligned_cols=244 Identities=22% Similarity=0.343 Sum_probs=196.8
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCcc
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
..||+|+||.||++... +++.||+|++........+.+.+|+.++..++|||++++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999765 68999999987665556678899999999999999999999999999999999999999999
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccC
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~ 510 (646)
+++.. ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 107 ~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 178 (297)
T cd06659 107 DIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLV 178 (297)
T ss_pred HHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-cccee
Confidence 98754 24899999999999999999999999 999999999999999999999999998765433221 12345
Q ss_pred ccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHH
Q 006402 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNI 590 (646)
Q Consensus 511 gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 590 (646)
++..|+|||++.+..++.++||||||+++|||++|+.||...... .... ........ .... .
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~----~~~~~~~~-----~~~~------~ 240 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMK----RLRDSPPP-----KLKN------A 240 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhccCCC-----Cccc------c
Confidence 889999999998888999999999999999999999998632211 1111 11111000 0000 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 591 LMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 591 ~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+++.+||+.+|++||+++++++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112346789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=310.64 Aligned_cols=195 Identities=25% Similarity=0.388 Sum_probs=159.4
Q ss_pred cEecccCcEEEEEEEEc---CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 426 (646)
.+||+|+||+||+|+.+ ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 67999999999999865 35789999886442 33567899999999999999999999864 446789999986
Q ss_pred CCccccccCC------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCEEEeecCCCc
Q 006402 427 GTLHDHLHGK------YSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSR 496 (646)
Q Consensus 427 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll----~~~~~~ki~DfGl~~ 496 (646)
++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4777776422 12235889999999999999999999999 9999999999999 567799999999998
Q ss_pred cCCCCCCc--cccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 497 LAKPGLSH--VSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 497 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
........ ......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 1223458999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.60 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=200.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 421 (646)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999875 588999998875433 3456789999999999999999999998754 3678999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999875322 2345889999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... ...++..|+|||.+.+..++.++||||||+++|||++|+.||........... .... .......... ...
T Consensus 158 ~~~~---~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~-~~~~~~~~~~-~~~ 231 (287)
T cd06621 158 SLAG---TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLS-YIVNMPNPEL-KDE 231 (287)
T ss_pred cccc---cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHH-HHhcCCchhh-ccC
Confidence 2221 23478899999999888899999999999999999999999875533111111 1111 1111111111 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... .....+.+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGN------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCC------CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 0112355789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.58 Aligned_cols=264 Identities=25% Similarity=0.293 Sum_probs=197.8
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc-----cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK-----STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
+|+..+.||+|++|.||+|... +++.||+|+++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999875 6899999998755432 235577899999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+++ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997542 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC--------
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG-------- 571 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 571 (646)
.... .....+++.|+|||.+.+ ..++.++||||||++++||++|..+|...... .............
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhhc
Confidence 3221 122346788999998854 46789999999999999999997766532221 1111111100000
Q ss_pred -cccccccccccCCch-hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 -AIMEVVDPRLQGHEA-SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 -~~~~~~d~~l~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
............... ..........+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000 0000112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.83 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=196.8
Q ss_pred CCcccEecccCcEEEEEEEEc----CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 348 FSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
|.+.++||+|+||.||+|.+. +++.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999754 3688999988654 2334677899999999999999999999886543
Q ss_pred cCeEEEEEccCCCccccccCCc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 416 QPLLIYEYIANGTLHDHLHGKY---SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
..++++||+.+|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 2235789999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 493 GLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 493 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||..... ..+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence 999866433221 1122235678999999988889999999999999999999 7787753211 11111111 1
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
..... .. ......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 ~~~~~-----~~--------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK-----QP--------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC-----CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 00 01224577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.64 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=201.8
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+|+..+.||+|++|.||++..+ +++.+|+|++.... ....+++.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999876 68999999887653 344567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999997542 468899999999999999999999 88 99999999999999999999999999876543222
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.. ..++..|+|||.+.+..++.++||||||+++++|++|+.||......... .......... .. .+.+.
T Consensus 157 ~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-~~-----~~~~~- 225 (265)
T cd06605 157 KT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVN-EP-----PPRLP- 225 (265)
T ss_pred hc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhc-CC-----CCCCC-
Confidence 11 45888999999998888999999999999999999999998644321111 1111111111 10 00111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+++.+||..+|++|||+.+++.
T Consensus 226 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 ------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0013345779999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.35 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=196.5
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999775 68999999886443 22346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 68988886542 346899999999999999999999999 99999999999999999999999999876543322
Q ss_pred ccccccCccccccCccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc----
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD---- 578 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 578 (646)
. .....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||......+ ...... ...... ...+.
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~--~~~~~~~~~ 229 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTP--DEVVWPGVT 229 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCC--Chhhhhhhh
Confidence 1 12234688999999886644 6889999999999999999999986432211 111111 000000 00000
Q ss_pred ---------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 ---------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ---------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.................+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000112245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.09 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=198.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|++|.||++... +++.+|+|++.... ....+.+.+|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999764 68899999886542 23467889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997642 345899999999999999999999999 9999999999999854 468999999998765432
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... .. .......+
T Consensus 157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~~-~~~~~~~~---- 223 (256)
T cd08220 157 KA--YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---MS-GTFAPISD---- 223 (256)
T ss_pred cc--cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---Hh-cCCCCCCC----
Confidence 21 2234788999999998888899999999999999999999998633211 111111 11 11111000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ---------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ---------RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.18 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=196.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|+..+.||+|++|.||+|+.+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999876 6899999998654322 234577899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++ +|.+++.... ..+++.....++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 8999886542 35899999999999999999999999 99999999999999999999999999875432211
Q ss_pred ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Ccccc----
Q 006402 504 HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GAIME---- 575 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 575 (646)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+ ....+...... .....
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhc
Confidence 1 122246889999998865 4588999999999999999999999864331111 11111111000 00000
Q ss_pred --cccccccCCchhH---H--HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 --VVDPRLQGHEASV---N--ILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 --~~d~~l~~~~~~~---~--~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
............. . .......+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000 0 0011145678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.57 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=193.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-----ccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-----KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (646)
.+|+..+.||+|+||.||++... +++.||+|++..... +..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999765 688999998764321 2345688999999999999999999998763 467
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999999643 24789999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 498 AKPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 498 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC---
Confidence 5432111 11223478899999999888899999999999999999999999863211 111111111110
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+. ....+.+.+++ +||..+|++||+++||++
T Consensus 227 --~~~~~--------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 --NPQLP--------SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCc--------hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111 11223345566 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.69 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=196.9
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc----------ccHHHHHHHHHHHhhCCCCcccccceeEEeCC
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI----------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE 415 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 415 (646)
+|...+.||+|++|.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999764 689999998753211 01346788999999999999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999754 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccCccccccCccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 496 RLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQ--LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 496 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
+........ ......++..|+|||.+.... ++.++|+||||++++||++|..||..... .... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~-~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAM-FKLG-NKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHH-HHhh-ccc
Confidence 865432211 122345889999999987654 78999999999999999999999852211 1111 1100 111
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....++..+. ......+.+++.+||+.+|++|||+.+|++
T Consensus 229 ~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVS--------MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCcccc--------ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111110 122355778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.70 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=205.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+.++.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999876 589999999876544 4567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999753 458999999999999999999999 98 9999999999999999999999999998765433
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||..............+. .... +.+.
T Consensus 155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~~~ 224 (264)
T cd06623 155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----PSLP 224 (264)
T ss_pred Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----CCCC
Confidence 222 22347889999999988889999999999999999999999986443211111111111 1110 1111
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. .....+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~~-------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AE-------EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cc-------cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 023457789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.83 Aligned_cols=269 Identities=21% Similarity=0.326 Sum_probs=199.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+|+..+.||+|++|.||+|+.. +|+.||+|+++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999876 6899999998765332 3567789999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++ +|.+++........+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 75 88888865543456899999999999999999999999 999999999999999999999999999765432211
Q ss_pred cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc-----cccc
Q 006402 505 VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM-----EVVD 578 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~d 578 (646)
.....++..|++||.+.+. .++.++||||||+++|||++|+.||......+.................. ..+.
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1223468899999988653 57889999999999999999999986443221111000000000000000 0000
Q ss_pred ccccCCc-hhHH--HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQGHE-ASVN--ILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~~~-~~~~--~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....... .... .......+.+++.+||+.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0000 0122456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.20 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=200.0
Q ss_pred cEecccCcEEEEEEEEcC-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCcc
Q 006402 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
-+||+|.+|+||.|+..+ ...+|||.+...+....+-+..|+.+-++++|.|||+.+|.+.+++..-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 469999999999997764 6679999998887777888999999999999999999999999999888999999999999
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccCCCCCCcccccc
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
+.|+.+...-.=.+.++-.+..||++||.|||+.. |+|||||-+|||++ -.|.+||+|||.++....-.. .+...
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence 99987754322377888889999999999999999 99999999999996 678999999999987653222 22234
Q ss_pred CccccccCccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 510 QGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
.||..|||||++..+ .|..++|||||||++.||.||++||..-..+.. +++. . +. .+ .-|.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFk---V--Gm-yK-vHP~i------ 800 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFK---V--GM-YK-VHPPI------ 800 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhh---h--cc-ee-cCCCC------
Confidence 599999999999765 589999999999999999999999974433321 1110 0 00 00 01111
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+...+...+|.+|+.++|.+||+++++++
T Consensus 801 --Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 --PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2234556778999999999999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.96 Aligned_cols=255 Identities=23% Similarity=0.276 Sum_probs=198.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|...+.||+|+||.||++... .++.|++|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999876 578999998875432 33567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999653 35899999999999999999999998 999999999999999999999999998742111
Q ss_pred CC--------------ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 006402 502 LS--------------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 502 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
.. .......++..|+|||.+.+..++.++|+||||+++|||++|..||..... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 00 011123478899999999888899999999999999999999999863211 1111111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
.. +. ...+... ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~-~~---~~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 IS-DD---IEWPEGD--------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hh-cc---cCCCCcc--------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 10 0001100 0123446789999999999999997666555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=297.08 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=200.2
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|+||.||+|... +++.|++|.++..... ..+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999765 6899999998765443 567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998753 24788999999999999999999999 99999999999999999999999999887654332
Q ss_pred cccc---ccCccccccCccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 504 HVST---CAQGTLGYLDPEYYRNYQ---LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 504 ~~~~---~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.... ...+++.|+|||++.+.. .+.++||||||++++||++|+.||...... .... .... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~---~~~~-~~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIM---FHVG-AGH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHH---HHHh-cCC-----
Confidence 2111 245788999999987665 889999999999999999999998633211 1111 1111 010
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+... ......+.+++.+||+.+|++|||+.|++.
T Consensus 224 ~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDS------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcc------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111100 011334568999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.10 Aligned_cols=199 Identities=29% Similarity=0.367 Sum_probs=171.8
Q ss_pred CCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-C-----CcccccceeEEeCCcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-H-----KNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 419 (646)
+|.+.++||+|+||.|-++.. ++++.||||+++.. ....++...|+.+|..|+ | -|+|+++++|.-.++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 789999999999999999965 46999999999754 344566778999999997 4 489999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC--CCEEEeecCCCcc
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD--FNSKVADFGLSRL 497 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~--~~~ki~DfGl~~~ 497 (646)
|+|.+ ..+|.++|+.+. ...++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 669999998774 445999999999999999999999999 9999999999999643 3799999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~ 555 (646)
...... ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|....+.
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 754432 233677899999999999999999999999999999997777655443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.91 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=199.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|+..+.||+|++|+||++... +++.+|+|.+...... ..+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999776 4899999998765332 4567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998754 3346899999999999999999999999 999999999999999999999999998755322
Q ss_pred CCc----------------------------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 502 LSH----------------------------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 502 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0012247889999999988889999999999999999999999986332
Q ss_pred CCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 006402 554 DPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS----MTDVVH 620 (646)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~evl~ 620 (646)
... .+ ...... .. .... .......+.+++.+||+.+|++||| +.|++.
T Consensus 237 ~~~-----~~-~~~~~~-~~------~~~~------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE-----TF-SNILKK-EV------TFPG------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH-----HH-HHHhcC-Cc------cCCC------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 00 111100 00 0000 0113455779999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.64 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=198.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999775 68999999886432 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998754 35899999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
. ....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... .........+... +...
T Consensus 155 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~--~~~~- 220 (290)
T cd05580 155 T----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKVR--FPSF- 220 (290)
T ss_pred C----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcc--CCcc-
Confidence 1 223488999999999888889999999999999999999999863321 1111111111100 0110
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
....+.+++.+||+.+|.+|| +++|+++
T Consensus 221 -----------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 -----------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -----------CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 123466899999999999998 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.15 Aligned_cols=259 Identities=23% Similarity=0.394 Sum_probs=201.1
Q ss_pred cHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEe-
Q 006402 337 HLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVE- 413 (646)
Q Consensus 337 ~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 413 (646)
++.++....+.|+..+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45666667788999999999999999999775 68899999876543 3446788899999998 69999999999864
Q ss_pred -----CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEE
Q 006402 414 -----AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSK 488 (646)
Q Consensus 414 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~k 488 (646)
.+..+++|||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 346789999999999999987542 335888999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH
Q 006402 489 VADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~ 563 (646)
|+|||++......... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.........
T Consensus 162 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 9999998765322111 12234889999999875 346788999999999999999999998632211100
Q ss_pred HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 564 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. .... ..+.+.. ......+.+++.+||+.+|.+|||+.|+++
T Consensus 236 -~~-~~~~-----~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -FL-IPRN-----PPPKLKS-------KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hh-HhhC-----CCCCCcc-------cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000 0111110 112345778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=327.90 Aligned_cols=270 Identities=20% Similarity=0.254 Sum_probs=192.8
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC------CcccccceeE
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH------KNLVRLLGCC 411 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 411 (646)
+++....++|++.++||+|+||+||+|... .++.||||+++... ...+++..|+.++.+++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455688999999999999999999765 58899999986432 233455667777777654 4588899988
Q ss_pred EeC-CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCC----
Q 006402 412 VEA-EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDF---- 485 (646)
Q Consensus 412 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~---- 485 (646)
... ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 765 4678899987 77888888643 358999999999999999999998 47 99999999999998665
Q ss_pred ------------CEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 486 ------------NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 486 ------------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764322 1233458999999999999899999999999999999999999997543
Q ss_pred CCCCccHHHHHHHH----hcC----Cccccccc------ccccC-------CchhHHHHHHHHHHHHHHHHhcccCCCCC
Q 006402 554 DPDDVNLAIYVSQR----ASN----GAIMEVVD------PRLQG-------HEASVNILMSLKLFSELAVACLREKKSER 612 (646)
Q Consensus 554 ~~~~~~~~~~~~~~----~~~----~~~~~~~d------~~l~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~R 612 (646)
..+........... +.. ....++++ +.... .............+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 22111111100000 000 00000000 00000 00000011123457799999999999999
Q ss_pred CCHHHHHH
Q 006402 613 PSMTDVVH 620 (646)
Q Consensus 613 Ps~~evl~ 620 (646)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999996
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=296.37 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=193.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-----cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-----IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (646)
++|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999775 58999999875321 12346788999999999999999999998764 357
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||+++++|.+++... ..+++..+++++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999998643 24788999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCC--ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 498 AKPGLS--HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----H-HHHHHHhcCCC---
Confidence 542211 111223488899999999888899999999999999999999999863211 1 11111111100
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+ .......+.+++.+|+. +|++||+++|+++
T Consensus 227 --~~~~--------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 --NPVL--------PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCC--------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0101 11223456688999985 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.07 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=202.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+|...+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999764 68899999987655556678899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999998643 4789999999999999999999999 999999999999999999999999998765443222
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....+. +....
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~------~~~~~- 237 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------PELQN- 237 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC------CCCCC-
Confidence 122358889999999988889999999999999999999999996432211110 0000000 00000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.......+.+++.+||+.+|++||++.+++..
T Consensus 238 -----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 -----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123456789999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.15 Aligned_cols=268 Identities=22% Similarity=0.245 Sum_probs=195.4
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999765 688999999865432 22346789999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 6777776543 234788889999999999999999999 999999999999999999999999998765332
Q ss_pred CCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc--C--------
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS--N-------- 570 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~-------- 570 (646)
... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......... ......... .
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhh
Confidence 211 1223478899999998654 5788999999999999999999998643321110 000000000 0
Q ss_pred --CcccccccccccCCchh--HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 --GAIMEVVDPRLQGHEAS--VNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 --~~~~~~~d~~l~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....+...+........ .........+.+++.+|++.+|.+|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 000011245678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=295.53 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=199.3
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999876 58899999886542 23456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999997542 335799999999999999999999999 99999999999999875 46999999987765432
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.. .....|++.|+|||++.+..++.++|+||||++++||++|+.||.... .......... ...... .+
T Consensus 157 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~-~~--- 224 (257)
T cd08225 157 EL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAPI-SP--- 224 (257)
T ss_pred cc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCCC-CC---
Confidence 21 222358899999999988889999999999999999999999985321 1122222111 111110 11
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 225 ---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 ---------NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.19 Aligned_cols=249 Identities=26% Similarity=0.428 Sum_probs=202.3
Q ss_pred CcccEecccCcEEEEEEEEc--CCc--EEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 349 SKERILGSGGFGEVYKGELQ--DGT--VVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
...++||+|.||.|++|.|+ +|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999886 344 5899999876654 67899999999999999999999999888 678899999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++.|+|.+.|++. ....+.......++.|||.||.||.+++ +|||||..+|+||-..-.+||+||||.+.+.....
T Consensus 192 aplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999873 4556888899999999999999999999 99999999999999888999999999998875544
Q ss_pred ccc--cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 504 HVS--TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 504 ~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
... ....-...|.|||.++...++.+||||+|||++|||+| |..||..-... .+.+.+.++ + +
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------qIL~~iD~~---e----r 333 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------QILKNIDAG---E----R 333 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------HHHHhcccc---c----c
Confidence 322 22335668999999999999999999999999999999 56777533221 122222111 1 1
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
|.. ...+.+++.+++.+||..+|++|||+..+.+.+
T Consensus 334 LpR------Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 334 LPR------PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCC------CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111 123567789999999999999999999997544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.94 Aligned_cols=264 Identities=26% Similarity=0.312 Sum_probs=197.9
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLIYE 422 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 422 (646)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999876 58899999987653 33456788999999999999999999999988 78999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888886542 36899999999999999999999999 9999999999999999999999999998765543
Q ss_pred CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Cccccc--
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GAIMEV-- 576 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 576 (646)
....+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+...... ......
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccccc
Confidence 222233446888999998764 467899999999999999999999986433211 11111111000 000000
Q ss_pred ------ccccccCCch-hHHHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 ------VDPRLQGHEA-SVNILM-SLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 ------~d~~l~~~~~-~~~~~~-~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+....... ...... ....+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 000001 1456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.55 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=192.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHH-HhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGI-LSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.+.||+|+||.||+++.+ +|+.||+|+++.... +...++..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999876 689999998875432 334556667665 566789999999999999999999999
Q ss_pred EccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 423 YIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|++ ++|.+++.... ....+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 68888775432 234689999999999999999999997 7 99999999999999999999999999886543
Q ss_pred CCCccccccCccccccCcccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRN----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
... .+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ... ...... +.
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~~~-~~---- 224 (283)
T cd06617 157 SVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-LKQVVE-EP---- 224 (283)
T ss_pred ccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-HHHHHh-cC----
Confidence 221 122347889999998864 35688999999999999999999998532211 111 111111 10
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+.. ......+.+++.+||+.+|++||++.++++
T Consensus 225 -~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQLPA-------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCc-------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011110 012345778999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.24 Aligned_cols=273 Identities=19% Similarity=0.216 Sum_probs=189.5
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcC--CcEEEEEEc--------------c---cCCcccHHHHHHHHHHHhhCCCCcc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQD--GTVVAVKSA--------------K---VGNIKSTQQVLNEVGILSQVNHKNL 404 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~ni 404 (646)
..++|++.+.||+|+||+||++.++. +...++|.+ . .........+.+|+.+|++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986542 222222211 0 0111234568899999999999999
Q ss_pred cccceeEEeCCcCeEEEEEccCCCccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 405 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
+++++++...+..++|+|++ .++|.+++.... .........+..|+.||+.||+|||+.+ |+||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999999999999999998 457777765432 1122345677889999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-CccHH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD-DVNLA 561 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~-~~~~~ 561 (646)
.++.+||+|||+++..............||+.|+|||++.+..++.++||||||++||||++|..++....... ...+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998775443333334569999999999998899999999999999999999875433222111 11111
Q ss_pred HHHHHHhc--CCc-------cccccccc-ccC--Cc--hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 562 IYVSQRAS--NGA-------IMEVVDPR-LQG--HE--ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 562 ~~~~~~~~--~~~-------~~~~~d~~-l~~--~~--~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
..+. ... ... +.+.++.. +.. .. ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 382 ~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1110 000 000 00000000 000 00 000011122346788999999999999999999863
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.06 Aligned_cols=240 Identities=23% Similarity=0.283 Sum_probs=184.9
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC---CCCcccccceeEEeCCcCeEEEEEccC
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV---NHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
||+|+||+||+|+.+ +++.||+|++.... ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999775 68999999986432 12334556677777665 699999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 9999988643 35899999999999999999999999 99999999999999999999999999875432221 12
Q ss_pred cccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 507 TCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .. .......+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~-~~~~i~~~~~------~~~~~- 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQ-MYRNIAFGKV------RFPKN- 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HH-HHHHHHcCCC------CCCCc-
Confidence 234589999999998654 478999999999999999999999863221 11 1111111110 01100
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERP----SMTDVVH 620 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RP----s~~evl~ 620 (646)
.....+.+++.+||+.+|.+|| ++.++++
T Consensus 220 ------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123456899999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=294.92 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=198.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 421 (646)
+|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777899999999999999764 68899999886432 33456788999999999999999999987653 4578999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLH-----SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH-----~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
||+++++|.+++.... ....+++..++.++.||++||+||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999996532 2346899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
......... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||..... .. .......+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~- 228 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQ-LASKIKEGKFR- 228 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HH-HHHHHhcCCCC-
Confidence 877544321 2223589999999999888899999999999999999999999874321 11 11111111111
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+. ......+.+++.+||+.+|++||++.+|++
T Consensus 229 ----~~~--------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 ----RIP--------YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCc--------cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111 112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.08 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=198.5
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999764 6889999998766555667789999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++......... .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~ 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-R 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-c
Confidence 999999865 24889999999999999999999999 999999999999999999999999988765433221 1
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...... .+.+...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~-~~~~~~-----~~~~~~~-- 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMK-RIRDNL-----PPKLKNL-- 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHH-HHHhcC-----CCCCccc--
Confidence 223488999999999888899999999999999999999999863211 11111 111110 0111100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|++|||+.++++
T Consensus 239 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 ----HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 012245778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=297.16 Aligned_cols=261 Identities=23% Similarity=0.250 Sum_probs=192.9
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCC-CCcccccceeEEeC--CcCeEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEA--EQPLLIYE 422 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 422 (646)
|++.+.||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999765 68999999887542 222334568999999885 99999999999987 88999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 58888876532 35899999999999999999999999 999999999999999 999999999998764432
Q ss_pred CccccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH-----------hcC
Q 006402 503 SHVSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR-----------ASN 570 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 570 (646)
.. ....++..|+|||.+. +..++.++||||||+++|||++|+.||......+ ........ ...
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 22 1234788999999764 4457889999999999999999999986432211 11111110 000
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
........+.................+.+++.+||+.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11111101110000000001123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.34 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=198.4
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|++.+.||+|.|+.||+... .+|+.+|+|.+... ...+.+++.+|++|-+.|+||||++|.+...+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677778999999999999854 46889999977543 2335778899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeecCCCccC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRLA 498 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~DfGl~~~~ 498 (646)
|+|.|++|..-|-.+ .-.++..+-..++||+++|.|.|.++ |+|||+||+|+||- ..--+||+|||++...
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999998776543 34677788889999999999999999 99999999999994 4456999999999988
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
..+ .......|||+|||||+++..+|+..+|||+-||+||-|+.|..||..... ..+ .+.+..+.. ++-.
T Consensus 164 ~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rl----ye~I~~g~y-d~~~ 233 (355)
T KOG0033|consen 164 NDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YEQIKAGAY-DYPS 233 (355)
T ss_pred CCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHH----HHHHhcccc-CCCC
Confidence 733 233445699999999999999999999999999999999999999963211 111 112221211 1111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.+. ...+...+|+++||..||.+|.|+.|.+.
T Consensus 234 ~~w~---------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWD---------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cccC---------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1121 12234568999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.32 Aligned_cols=243 Identities=31% Similarity=0.437 Sum_probs=197.4
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|...+.||.|+||.||-+... +.++||||++.-... +.+++++.|+..|.+++|||+|...|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 556677999999999999654 788999999875544 3467899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+ -|+-.|.+.-. ..+|-+..+..|..+.+.||+|||+.+ .||||||..||||++.|.|||+|||.+....+..+
T Consensus 108 C-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 108 C-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred H-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 9 55777776432 235888999999999999999999999 99999999999999999999999999988765443
Q ss_pred ccccccCccccccCcccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
..|||.|||||++ ..+.|+.|+||||||++-.||.-+++|.... +.....+....+. .|.
T Consensus 182 -----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNe------sPt 244 (948)
T KOG0577|consen 182 -----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNE------SPT 244 (948)
T ss_pred -----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcC------CCC
Confidence 4599999999987 3568999999999999999999999887522 2222122211111 233
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
|... +....+..++..||+.-|.+|||..++++
T Consensus 245 Lqs~-------eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQSN-------EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCc-------hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3322 23455778999999999999999988764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.02 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=197.9
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCC---CCcccccceeEEeCCcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVN---HKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 421 (646)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999864 68999999886542 344567889999999997 999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... .+++..++.++.|+++||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998643 5899999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
... .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ... ..... ..+.
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~-----~~~~ 221 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKS-----KPPR 221 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccC-----CCCC
Confidence 322 2233588999999988654 57889999999999999999999986332111 110 00000 1111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+... .....+.+++.+||+.+|++||++.|+++
T Consensus 222 ~~~~-------~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN-------GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc-------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 12345778999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.92 Aligned_cols=246 Identities=29% Similarity=0.400 Sum_probs=194.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
+.|...+.||+|+||+||+|+.. +++.||+|++..... +..+++.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999775 689999998864332 33467889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5777766533 235899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
. ...+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ........ ...
T Consensus 169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~-~~~----- 231 (307)
T cd06607 169 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NDS----- 231 (307)
T ss_pred C-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhc-CCC-----
Confidence 2 234788999999874 456888999999999999999999998532111 11111110 000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.+. .......+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTLS-------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCC-------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111 11133457899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.88 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=195.6
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
|+..+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999765 799999998875432 23467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
+ ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 4 68999886542 235899999999999999999999998 999999999999999999999999999765432221
Q ss_pred cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC--------cccc
Q 006402 505 VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG--------AIME 575 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 575 (646)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+........... ...+
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence 1222468899999987654 57889999999999999999999986432111 0111000000000 0000
Q ss_pred ccc--ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVD--PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d--~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... +.................+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000000000001112245779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.81 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=198.2
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3666788999999999999764 68899999876443 234567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999998642 5899999999999999999999999 99999999999999999999999999876543221
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
......++..|+|||.+.+..++.++|+||||+++|||++|..||..... .... ........ +.+..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~~~~~-----~~~~~- 223 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVL-FLIPKNNP-----PTLEG- 223 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHH-HHHhcCCC-----CCCCc-
Confidence 11223578899999999888889999999999999999999999853211 1111 11111110 11110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 -------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 -------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122446789999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.80 Aligned_cols=247 Identities=26% Similarity=0.326 Sum_probs=200.5
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
+|++.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999876 589999998865432 346789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+.+++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999653 36899999999999999999999999 9999999999999999999999999988765432
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........... ......+
T Consensus 155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~~~~--- 223 (258)
T cd05578 155 L--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADVLYPA--- 223 (258)
T ss_pred c--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccccCcc---
Confidence 1 22345888999999998888999999999999999999999998744332 11111111110 0011111
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSM--TDVV 619 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~--~evl 619 (646)
.....+.+++.+||+.+|.+||++ +|++
T Consensus 224 ---------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 ---------TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---------cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122457789999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=301.12 Aligned_cols=267 Identities=23% Similarity=0.287 Sum_probs=195.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCC-CCcccccceeEEeCCc-----
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQ----- 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 416 (646)
++|+..+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999875 689999998765422 23467889999999995 6999999999987665
Q ss_pred CeEEEEEccCCCccccccCCcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecC
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS--SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFG 493 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfG 493 (646)
.++||||+++ +|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 78888864321 346899999999999999999999999 999999999999998 8999999999
Q ss_pred CCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....... ....+........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 98865432211 122346888999998865 457899999999999999999999986432211 1111111110000
Q ss_pred ---ccccc---c----ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 ---IMEVV---D----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ---~~~~~---d----~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..... + +.................+.+++.+||+.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0 000000000000123455789999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.78 Aligned_cols=262 Identities=24% Similarity=0.286 Sum_probs=196.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 420 (646)
++|+..+.||+|++|.||+|+.+ +++.+|+|.++..... ....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999876 5889999998754322 234677899999999999999999999887 789999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+|||+++++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58988886542 25899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc----------
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS---------- 569 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 569 (646)
.... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||....... ....+.....
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHHHh
Confidence 3221 1223478899999998654 46889999999999999999999986432211 1100000000
Q ss_pred -C------CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 -N------GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 -~------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ..........+..... .....+.+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFP---ALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhcccc---ccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000000000000 0002345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.12 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=199.3
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCC-----
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE----- 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 415 (646)
..+++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ .|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999875 578999998875543 456789999999999 6999999999997654
Q ss_pred -cCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 416 -QPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 416 -~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3789999999999999886532 2346899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
++......... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||..... . ..... .
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~~~~~-~ 230 (275)
T cd06608 159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---M---RALFK-I 230 (275)
T ss_pred cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---H---HHHHH-h
Confidence 98765432221 122348899999998753 3467899999999999999999999862211 1 11111 1
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.... .+.+.. .....+.+.+++.+||..+|++|||+.++++
T Consensus 231 ~~~~-----~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNP-----PPTLKS------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccC-----CCCCCc------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 111110 1123355779999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.17 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=208.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..-|..++.||+|.|+.|-++++- +|++||||++.+...+ ....+++|++.|+.++|||||+|+.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 455777789999999999999654 7999999999876544 4567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE-cCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL-DDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll-~~~~~~ki~DfGl~~~~~~ 500 (646)
|.=.+|+|++||.++.. .+.+....+++.||+.||.|.|+.. ++||||||+||.. ..-|-+||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976543 4889999999999999999999999 9999999999877 5678999999999999888
Q ss_pred CCCccccccCccccccCccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLT-DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
++...+.+ |...|-|||++.+..|+ ++.|||||||+||.|+.|+.||....+.+... .++|-
T Consensus 172 G~kL~TsC--GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC 234 (864)
T KOG4717|consen 172 GKKLTTSC--GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC 234 (864)
T ss_pred cchhhccc--chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence 77665554 99999999999888776 57899999999999999999998665544321 12222
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..-- ......++.+||..||+.||.+|.|.+|++.
T Consensus 235 KYtv------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KYTV------PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccC------chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1110 1124566889999999999999999999874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.32 Aligned_cols=269 Identities=26% Similarity=0.353 Sum_probs=198.2
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCC----
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE---- 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 415 (646)
...++|++.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999876 588999999875432 23456788999999999999999999987655
Q ss_pred ------cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 416 ------QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 416 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
..++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78899999976 677776543 235899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 490 ADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998765433222222346788999998864 35788999999999999999999998633211 1111111111
Q ss_pred cC---Ccccccc--------cccccC-CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 569 SN---GAIMEVV--------DPRLQG-HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 569 ~~---~~~~~~~--------d~~l~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. ....++. +..-.. .............+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000000 000000 0000000112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=291.49 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=204.0
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
|.+..+||+|++|.|||+.++ .|+++|||.+... .+.++++.|+.++++...|++|+.+|.+.....+++||||+..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566788999999999999665 6999999988654 5688999999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+..+.++.+ +.+|++..+..++...++||+|||... -+|||||..||||+.+|.+||+|||.+-.+.+.... .
T Consensus 113 GSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-R 186 (502)
T KOG0574|consen 113 GSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-R 186 (502)
T ss_pred CcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh-h
Confidence 9999999754 457999999999999999999999998 799999999999999999999999999776543322 2
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
..+.|||.|||||++..-.|+.++||||||++..||.-|++|+... +....+.. + .. --.|..+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI------HPMRAIFM-I-PT----~PPPTF~K--- 251 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI------HPMRAIFM-I-PT----KPPPTFKK--- 251 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc------cccceeEe-c-cC----CCCCCCCC---
Confidence 3456999999999999999999999999999999999999998511 10000000 0 00 00111111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
...-..++.+++++||-..|++|.|+.++++.
T Consensus 252 ---PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 ---PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22345668899999999999999999988753
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.89 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=202.6
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 677789999999999999876 6899999998776555678899999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99999987542 46899999999999999999999988 99999999999999999999999999987765432 2
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....++..|+|||.+.+..++.++||||||+++++|++|+.||..... ....... . .........+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~-~~~~~~~~~~------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKI---A-TNGPPGLRNP------- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHH---H-hcCCCCcCcc-------
Confidence 234588899999999888889999999999999999999999863221 1111111 1 0111111100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|++|||+.|+++
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011345778999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=308.17 Aligned_cols=267 Identities=23% Similarity=0.286 Sum_probs=197.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----- 415 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 415 (646)
..++|+..+.||+|+||.||++... +++.||+|++... +....+.+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999765 6899999988643 2334567889999999999999999999886543
Q ss_pred -cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 416 -QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 416 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
..++||||+. ++|.+++... +++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999995 5888877532 788999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccH------------HH
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL------------AI 562 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~------------~~ 562 (646)
++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ..
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 987644322 2223478899999999988999999999999999999999999864321110000 00
Q ss_pred H----HHHHhcCC------cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 563 Y----VSQRASNG------AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 563 ~----~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. ........ ...+.+...+...............+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000 00011111000000000011234557799999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.26 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=203.1
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.+++|+..+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888889999999999999876 688999999876544 56778999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997642 36899999999999999999999998 9999999999999999999999999987554332
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. ......++..|++||.+.+..++.++||||||+++|+|++|+.||...... .... .... ..... +.
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~---~~~~-~~~~~-----~~ 237 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALF---LITT-KGIPP-----LK 237 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-cCCCC-----Cc
Confidence 1 112234788999999998888999999999999999999999998532111 1111 1110 10000 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .......+.+++.+||+.+|.+|||+.++++
T Consensus 238 ~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 N------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred c------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 0112345778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=300.21 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=195.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|+..+.||+|++|+||+|+.+ +++.||+|.+..... ...+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999876 689999998865432 234678899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCccCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~~~~ 501 (646)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 57888775432 234688888999999999999999999 999999999999985 567999999999765433
Q ss_pred CCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc---
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV--- 577 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 577 (646)
.. ..+...+++.|+|||++.+ ..++.++||||||+++|+|+||+.||......+. .......... ......
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~-~~~~~~~~~ 231 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGT-PNEETWPGV 231 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCC-CChhhcccc
Confidence 21 1122347889999998865 3578999999999999999999999864322111 1001000000 000000
Q ss_pred ----c-----ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 ----D-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 ----d-----~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+ +.................+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000000000112345778999999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.57 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=199.5
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
|+..+.||+|++|.||++... +++.+++|++...... ....+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999775 6899999988754332 4567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++ +|.+++..+. ..+++..++.++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 65 8888876532 46899999999999999999999999 9999999999999999999999999998775543 1
Q ss_pred cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Cccccccc--
Q 006402 505 VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GAIMEVVD-- 578 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 578 (646)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ ........... .......+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhh
Confidence 12233478899999998776 78999999999999999999999886432211 11111111000 00000000
Q ss_pred -------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 -------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 -------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+................++.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000001111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.20 Aligned_cols=270 Identities=22% Similarity=0.281 Sum_probs=197.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 417 (646)
.++|++.++||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999765 68999999986432 234567889999999999999999999876543 47
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|+||+. ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 478777753 25899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCcc--ccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---C
Q 006402 498 AKPGLSHV--STCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---G 571 (646)
Q Consensus 498 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 571 (646)
........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 54322211 122357899999998754 468899999999999999999999986432111 11111111100 0
Q ss_pred cccccccccc-------cC-Cc--hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 006402 572 AIMEVVDPRL-------QG-HE--ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRI 625 (646)
Q Consensus 572 ~~~~~~d~~l-------~~-~~--~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~ 625 (646)
....+.+... .. .. ...........+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000000 00 00 000001123557899999999999999999999875 4443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.65 Aligned_cols=204 Identities=26% Similarity=0.388 Sum_probs=169.0
Q ss_pred CCCcccEecccCcEEEEEEEEc---CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCe
Q 006402 347 GFSKERILGSGGFGEVYKGELQ---DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 418 (646)
+|++.++||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999775 47899999987633 33456788999999999999999999999988 7899
Q ss_pred EEEEEccCCCccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC----CCCEEEeec
Q 006402 419 LIYEYIANGTLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD----DFNSKVADF 492 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~----~~~~ki~Df 492 (646)
+||||+++ +|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 6766664322 2236899999999999999999999999 999999999999999 999999999
Q ss_pred CCCccCCCCCCc--cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006402 493 GLSRLAKPGLSH--VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554 (646)
Q Consensus 493 Gl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~ 554 (646)
|++......... ......+++.|+|||.+.+. .++.++||||||++++||++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999876433221 12234578899999987654 578999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.77 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=189.7
Q ss_pred HHHHHhcCCCcccEe--cccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 340 ELKKATNGFSKERIL--GSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 340 el~~~~~~~~~~~~L--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
++....++|++.+.+ |+|+||.||++..+ +++.+|+|.+........ |+.....+ +|+||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445566666666 99999999999765 688899998765422211 22222222 6999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGL 494 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl 494 (646)
..++||||+++++|.+++... ..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999754 26899999999999999999999999 99999999999999888 999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.||..... +......+..... .. .
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--~~-~ 227 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQ--KK-L 227 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhc--cc-C
Confidence 87654322 23488999999999988899999999999999999999999973322 2222222211110 00 0
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-MTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-~~evl~ 620 (646)
.. . ......+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 ~~----~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 PF----I---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred Cc----c---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0 012344678999999999999996 688874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=301.97 Aligned_cols=266 Identities=25% Similarity=0.300 Sum_probs=195.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 419 (646)
.++|++.+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999875 6899999988654322 234567899999999999999999998765 46799
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+. ++|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4788887643 245899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC--Cccc-c
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN--GAIM-E 575 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~-~ 575 (646)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+...... .... .
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhchh
Confidence 43211 222335788999999865 46789999999999999999999998633221 111111111100 0000 0
Q ss_pred c--cc----ccccC---CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 V--VD----PRLQG---HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~--~d----~~l~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .+ ..+.. ...........+.+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00 00000 0000000112455678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.55 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=202.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 421 (646)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999876 689999999876543 4567889999999999999999999999988 8899999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987542 6899999999999999999999998 999999999999999999999999999877654
Q ss_pred CCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
... ......++..|+|||.+.+...+.++||||||+++++|++|+.||..... ................
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----- 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEPPE----- 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCCcC-----
Confidence 321 12234588999999999888899999999999999999999999874431 1111111110001000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+. ......+.+++.+|++.+|++||++.++++
T Consensus 225 ~~--------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IP--------EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CC--------cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 10 011345778999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.53 Aligned_cols=248 Identities=26% Similarity=0.319 Sum_probs=202.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.+.|+.-++||+|+||.||-.+.+ +|+.+|.|++.+... +.....++|-.+|.+++.+.||.+-..|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 355788899999999999998665 699999998864322 3345578999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+..|.||+|.-+|.... ...+++..++.+|.+|+-||++||..+ ||.||+||+|||||+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999998764 356999999999999999999999999 99999999999999999999999999998887
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
++.... ..||.+|||||++++..|+...|.||+||+||||+.|+.||......... +-+|.+
T Consensus 340 g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------eEvdrr 401 (591)
T KOG0986|consen 340 GKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------EEVDRR 401 (591)
T ss_pred CCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------------HHHHHH
Confidence 665543 35999999999999999999999999999999999999999633322110 111222
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
....... ......++..++.+..|+.||.+|.-.
T Consensus 402 ~~~~~~e-y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 402 TLEDPEE-YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred Hhcchhh-cccccCHHHHHHHHHHHccCHHHhccC
Confidence 1111110 012344567788999999999999643
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.42 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=191.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999765 58999999887543 234567889999999996 99999999999998899999999
Q ss_pred ccCCCccccc---cCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 424 IANGTLHDHL---HGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 424 ~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
+. ++|.++. ... ....+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 85 4554433 221 234689999999999999999999985 7 9999999999999999999999999987654
Q ss_pred CCCCccccccCccccccCccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNY---QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
..... ....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.... ........... +.
T Consensus 160 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~---- 227 (288)
T cd06616 160 DSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD---- 227 (288)
T ss_pred cCCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC----
Confidence 33221 223478899999998765 68899999999999999999999986332 11111111111 10
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.+.... .......+.+|+.+||+.+|++|||+.+|++.
T Consensus 228 -~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSE----EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111110 01133457799999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=292.70 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=201.7
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|++.++||+|++|.||+++.. +++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999765 68899999887543 23456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986532 2346899999999999999999999999 9999999999999999999999999998776542
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. ....+++.|++||.+.+..++.++|+||||++++||++|+.||...... .+.. ....+.....
T Consensus 158 ~---~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~~------ 221 (256)
T cd08530 158 A---KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKYPPI------ 221 (256)
T ss_pred c---ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCCCCC------
Confidence 2 2234788999999998888999999999999999999999998633211 1111 1111111110
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......++.+++.+||+.+|++||++.|+++
T Consensus 222 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 -------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0123355789999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=308.01 Aligned_cols=274 Identities=26% Similarity=0.375 Sum_probs=204.1
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeC------CcCeE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA------EQPLL 419 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 419 (646)
+...+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||+++++=.+. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344578999999999999854 79999999987643 34467788999999999999999999985543 35789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCC--CEEEeecCCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD--DDF--NSKVADFGLS 495 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~--~~~--~~ki~DfGl~ 495 (646)
||||+++|+|...|.+..+...|++.+.+.+..++..||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998877788999999999999999999999999 99999999999994 223 4799999999
Q ss_pred ccCCCCCCccccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+...++. ..+...||..|++||.+. .+.|+..+|.||||+++||..||..||.....+....-..|...........
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9887665 445567999999999998 4789999999999999999999999997655543322233322222221111
Q ss_pred ccccccccCC-----c---hhHHHHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHH
Q 006402 575 EVVDPRLQGH-----E---ASVNILMSLKLFSELAVACLREKKSERP--SMTDVVHELQRII 626 (646)
Q Consensus 575 ~~~d~~l~~~-----~---~~~~~~~~~~~~~~li~~cl~~~p~~RP--s~~evl~~L~~~~ 626 (646)
-..++...+. . ...........+...+..+|..+|.+|- ...+....+..|+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1111111110 0 0000112233455566677777888886 5555555555554
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.99 Aligned_cols=243 Identities=21% Similarity=0.356 Sum_probs=195.2
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCcc
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
.+||+|+||.||++..+ +++.||+|++........+.+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999775 68999999987655556677999999999999999999999999999999999999999999
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccC
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~ 510 (646)
+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 987532 4789999999999999999999999 99999999999999999999999999876543221 112334
Q ss_pred ccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHH
Q 006402 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNI 590 (646)
Q Consensus 511 gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 590 (646)
+++.|+|||.+.+..++.++|+||||+++|||++|..||...... ......... ..+.+...
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~---------~~~~~~~~------ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------LPPKLKNL------ 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh---------CCcccCCc------
Confidence 789999999998888899999999999999999999998632111 111111100 01111000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 591 LMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 591 ~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 011234668999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=305.99 Aligned_cols=271 Identities=21% Similarity=0.282 Sum_probs=199.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----c
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----Q 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 416 (646)
.++|.+.+.||+|+||+||+++.. +++.||||.++.. .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999765 6899999988653 2233556788999999999999999999887543 4
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 789999995 6888888643 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Cc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GA 572 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 572 (646)
....... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ........... ..
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHH
Confidence 7654321 1223347889999998764 468899999999999999999999986432111 01011100000 00
Q ss_pred ccccccccc-------c---CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 006402 573 IMEVVDPRL-------Q---GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRII 626 (646)
Q Consensus 573 ~~~~~d~~l-------~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~ 626 (646)
.....+... . .............++.+++.+||+.+|++|||++|+++. ++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 0 000000011234567899999999999999999999976 65553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.03 Aligned_cols=263 Identities=25% Similarity=0.301 Sum_probs=194.4
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhC---CCCcccccceeEEeCCc-----
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQV---NHKNLVRLLGCCVEAEQ----- 416 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 416 (646)
|++.+.||+|+||.||+|+.+ +++.+|+|+++..... ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999887 4899999998744222 234567788877666 59999999999998776
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 48988886542 235899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc--c-
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA--I- 573 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~- 573 (646)
........ ....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+ .+............ .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcC
Confidence 76433221 12237889999999988889999999999999999999988886332211 11111110000000 0
Q ss_pred ------cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 ------MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ------~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+..... .............+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTP-RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccc-cchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0001011223456779999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.41 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=193.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-----
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ----- 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 416 (646)
.++|+..++||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999775 689999998864432 223456789999999999999999999876543
Q ss_pred ---CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 417 ---PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 417 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
.++||||+. ++|.+++... ...+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 489999996 4788777543 235899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCc---cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 494 LSRLAKPGLSH---VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 494 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432221 11233478889999988654 478899999999999999999998864322111111111100000
Q ss_pred CCcccc-----cccc-cccCCchhHH-----HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 NGAIME-----VVDP-RLQGHEASVN-----ILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 ~~~~~~-----~~d~-~l~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...... ..+. .+........ .......+.+|+.+||+.+|++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 0000 0000000000 0001234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=287.75 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=201.0
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999765 678999999876654 4567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998653 46899999999999999999999999 99999999999999999999999999987765433
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. .....++..|+|||...+..++.++||||+|+++++|++|+.||..... ... ...... ... ..+..
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~-~~~-~~~~~---- 221 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAA-LFRIVQ-DDH-PPLPE---- 221 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHH-HHHHhc-cCC-CCCCC----
Confidence 2 2234588899999999877789999999999999999999999863221 111 111111 110 00111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+++.+||+.+|++|||+.+++.
T Consensus 222 --------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 --------GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --------CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11244668999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.23 Aligned_cols=242 Identities=26% Similarity=0.326 Sum_probs=192.9
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||.|++|.||+++.. +++.+|+|++..... ...+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999876 488999999865432 3456789999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--~~~~ 152 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTF 152 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc--cccc
Confidence 9999754 24899999999999999999999999 99999999999999999999999999987754321 1223
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
.+++.|++||.+.+..++.++|+||||+++|||++|..||...... . ......... +.....+.
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~~-~~~~~~~~----------- 216 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-P---MEIYNDILK-GNGKLEFP----------- 216 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-H---HHHHHHHhc-cCCCCCCC-----------
Confidence 4788999999998888999999999999999999999998744321 1 111111110 00000000
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 -NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011345779999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.66 Aligned_cols=267 Identities=22% Similarity=0.316 Sum_probs=195.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999865 68999999886432 223456889999999999999999999987653
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++|+||+.. +|.+++. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999854 6666542 24889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh------
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA------ 568 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 568 (646)
+...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+....
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 7653321 22347889999999866 468899999999999999999999997432111 011000000
Q ss_pred -----cCCccccccc--ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 006402 569 -----SNGAIMEVVD--PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRIIE 627 (646)
Q Consensus 569 -----~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~~ 627 (646)
........++ +.................+.+++.+||+.+|++||++.|++.. ++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000000 0000000000001123457799999999999999999999954 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.99 Aligned_cols=245 Identities=29% Similarity=0.441 Sum_probs=192.8
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|...+.||+|+||.||+++.. +++.||+|++..... +..+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999865 688999998864322 3345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+. |+|.+.+... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (317)
T cd06635 107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN- 179 (317)
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCcc-
Confidence 96 5777776543 335899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
...+++.|+|||++. ...++.++||||||+++|||++|+.||..... ... ......... +.
T Consensus 180 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~---~~~~~~~~~------~~ 243 (317)
T cd06635 180 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSA---LYHIAQNES------PT 243 (317)
T ss_pred ----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHH---HHHHHhccC------CC
Confidence 234788999999873 45688999999999999999999999853211 110 111111110 00
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.. .......+.+++.+||+.+|.+||++.++++.+
T Consensus 244 ~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 244 LQ-------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CC-------CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00 011234467899999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=298.57 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=198.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcc--cCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAK--VGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 421 (646)
...|++.++||+||.+.||++...+.+.+|+|++. ..+.+...-|.+|+..|.+|+ |.+||.|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35688999999999999999998888899998764 446667889999999999996 999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||= .-+|..+|+++.. ....| .+..+..|++.++.++|+++ |||.||||.|+|+-.+ .+||+|||+|.....+
T Consensus 440 E~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCcc
Confidence 974 6799999987643 22334 77789999999999999999 9999999999999775 8999999999988876
Q ss_pred CCccc-cccCccccccCccccccC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 502 LSHVS-TCAQGTLGYLDPEYYRNY-----------QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 502 ~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
..... ....||+.||+||.+... +.+.+|||||+||+||+|+.|+.||..... .|.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a----- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA----- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-----
Confidence 55433 345699999999998422 356799999999999999999999861110 111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
++..+.||.-.-+.. ..-...++.++++.||..||.+|||+.|+|+
T Consensus 581 --Kl~aI~~P~~~Iefp---~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFP---DIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCcccccc---CCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112223331110000 0001112678999999999999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.65 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=185.7
Q ss_pred EecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhh---CCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 353 ILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQ---VNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999775 689999998865322 122334455544443 479999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 99999998643 35899999999999999999999999 99999999999999999999999999875543222
Q ss_pred ccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ........ .+..+.
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~~~~-- 219 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNVELP-- 219 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCcCCc--
Confidence 12348999999999864 56889999999999999999999998643322111 11111100 011111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
......+.+++.+||+.+|++|| |++|+++.
T Consensus 220 ------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 ------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11234567899999999999999 59998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=293.96 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=193.4
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|+||.||+++.. +++.+++|++..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999887 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC------
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS------ 503 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~------ 503 (646)
.+++.+. ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999753 25899999999999999999999999 99999999999999999999999999876543321
Q ss_pred -ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 -HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.......++..|+|||.......+.++||||||++++||++|+.||..... ...... ...+... ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~------~~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQN-ILNGKIE------WP 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhcCCcC------CC
Confidence 112234478899999999888889999999999999999999999863321 111111 1111100 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
. .......+.+++.+||+.+|++|||+.++.+.|
T Consensus 222 ~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 222 E------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 000234567899999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=305.18 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=196.5
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCC--cC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE--QP 417 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~ 417 (646)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999876 6889999988542 233455678899999999 9999999999987543 57
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999996 5898888643 5789999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc----cccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH-----
Q 006402 498 AKPGLSH----VSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR----- 567 (646)
Q Consensus 498 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~----- 567 (646)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCH
Confidence 6433221 2223458899999998754 4578899999999999999999999863322111 00000000
Q ss_pred -----hcCCcccccccccccCCc---hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 568 -----ASNGAIMEVVDPRLQGHE---ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 568 -----~~~~~~~~~~d~~l~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
........+++ .+.... ...........+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 000000 000001123567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.24 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=191.9
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666654 6899999998754 33456789999999999999999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC-----
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS----- 503 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~----- 503 (646)
|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999997542 235889999999999999999999999 99999999999999999999999998865432111
Q ss_pred -ccccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc-----------
Q 006402 504 -HVSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS----------- 569 (646)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 569 (646)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... ...........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 11122347788999999865 358889999999999999999999986432111 01000000000
Q ss_pred CCcccc----cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 570 NGAIME----VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 570 ~~~~~~----~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
...... ..++................++.+++.+||+.+|++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0011100001111122334567899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=293.82 Aligned_cols=256 Identities=24% Similarity=0.283 Sum_probs=198.5
Q ss_pred CCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCC----cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcC
Q 006402 347 GFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGN----IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (646)
+|++.+.||+|++|.||+++.. +++.||||+++... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999998642 57889999886432 12345688999999999 599999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998643 35889999999999999999999998 99999999999999999999999999887
Q ss_pred CCCCCCccccccCccccccCccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQ--LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
.............++..|+|||.+.+.. .+.++||||||+++|||++|..||...... ............ .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~-~---- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILK-S---- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHc-c----
Confidence 6543332223345889999999987654 788999999999999999999998632211 111111111111 0
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.+... ......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 --~~~~~--------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KPPFP--------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCCCC--------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00010 01223467899999999999999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.60 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=195.0
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
|.+.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999876 578999998865422 22334567999999999 999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
+++|.+++.... ...+++..++.++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889999887543 245899999999999999999999999 999999999999999999999999999866443221
Q ss_pred cccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHH----------HHHHHHhcCCcc
Q 006402 505 VSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA----------IYVSQRASNGAI 573 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~ 573 (646)
....++..|+|||.+. ...++.++|+||||++++||++|+.||......+..... .|..........
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 2234788999999874 446789999999999999999999988644221110000 000000000000
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+..... .............+.+++.+||+.+|++|||++|++.
T Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAP-TSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccc-ccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 0000000011356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=292.81 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=190.7
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 68999999886432 22345678899999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence 99997543 235899999999999999999999999 99999999999999999999999999876543221 1223
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
.++..|+|||.+.+..++.++||||||+++++|++|+.||......... ..+....... .....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~------~~~~~------- 218 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEM------AVEYP------- 218 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccc------cccCC-------
Confidence 4788999999998888999999999999999999999998644321111 1111110000 00000
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
......+.+++.+||+.+|++|| ++.++++
T Consensus 219 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 -DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 01134467899999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.88 Aligned_cols=267 Identities=21% Similarity=0.272 Sum_probs=197.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEe----CCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 417 (646)
..+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999765 68999999987542 2345677889999999999999999998764 3457
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 6898888643 34899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCc---cccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc----
Q 006402 498 AKPGLSH---VSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS---- 569 (646)
Q Consensus 498 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 569 (646)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChh
Confidence 5432211 1123458889999998865 46889999999999999999999998643221110 00000000
Q ss_pred -------CCcccccccc--cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 570 -------NGAIMEVVDP--RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 570 -------~~~~~~~~d~--~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.....+.++. .................+.+++.+||+.+|++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 000000000011234568899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.19 Aligned_cols=256 Identities=17% Similarity=0.241 Sum_probs=182.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCCcccH-----------HHHHHHHHHHhhCCCCcccccce
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGNIKST-----------QQVLNEVGILSQVNHKNLVRLLG 409 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 409 (646)
.++|.+.++||+|+||+||+|...+ +..+|+|+......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999998754 45667775443322111 11233445566778999999999
Q ss_pred eEEeCC----cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 006402 410 CCVEAE----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485 (646)
Q Consensus 410 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~ 485 (646)
++.... ..++++|++. .++.+.+... ...++..+..|+.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876554 2356777653 3555555422 23578888999999999999999999 99999999999999999
Q ss_pred CEEEeecCCCccCCCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCcc
Q 006402 486 NSKVADFGLSRLAKPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVN 559 (646)
Q Consensus 486 ~~ki~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~ 559 (646)
.+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999866432111 1122359999999999999899999999999999999999999997442221110
Q ss_pred H-HH-HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 560 L-AI-YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 560 ~-~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
. .. ........+. +. .....+.+.+++..|++.+|++||++.++++.|
T Consensus 244 ~~~~~~~~~~~~~~~--------~~-------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGK--------IK-------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhh--------hc-------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 00 0111111111 00 011235577999999999999999999999876
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.75 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=198.8
Q ss_pred CCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
|.++..||.|+||+|||++.++ +-..|-|++........++|+-|++||....||+||+|++.|.-.+.++++.||+.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455679999999999998775 445567888877788899999999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|..+..+-.- ...|++.++.-+.+|++.||.|||+.. |||||||..|||++-+|.++|+|||.+........ ..
T Consensus 114 GAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-kR 187 (1187)
T KOG0579|consen 114 GAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-KR 187 (1187)
T ss_pred chHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh-hh
Confidence 9999887653 446999999999999999999999999 99999999999999999999999998765432211 12
Q ss_pred cccCccccccCcccc-----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 507 TCAQGTLGYLDPEYY-----RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~-----~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
....|||.|||||+. +..+|+.++||||||++|.||..+.+|-. +.+... +...+....-.-++.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnpMR-VllKiaKSePPTLlqP-- 258 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNPMR-VLLKIAKSEPPTLLQP-- 258 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccchHH-HHHHHhhcCCCcccCc--
Confidence 335699999999985 46689999999999999999999988843 222221 1111111111111111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+++.+||..||..||++.++++
T Consensus 259 ---------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 ---------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 112345778999999999999999999985
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=322.19 Aligned_cols=251 Identities=31% Similarity=0.452 Sum_probs=188.0
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----- 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 415 (646)
+...+|+..++||+||||.|||++.+ ||+.+|||++.... .+....+.+|+..|++|+|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45567888999999999999999887 89999999987653 334567889999999999999999876432100
Q ss_pred --------------------------------------------------------------------------------
Q 006402 416 -------------------------------------------------------------------------------- 415 (646)
Q Consensus 416 -------------------------------------------------------------------------------- 415 (646)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHH
Q 006402 416 ----------------------------------QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461 (646)
Q Consensus 416 ----------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL 461 (646)
.+||-||||+..+|.++++++.-.. .-...++++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 1256677777777777776542111 3567789999999999999
Q ss_pred HhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC----------------CCCCc-cccccCccccccCccccccC
Q 006402 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK----------------PGLSH-VSTCAQGTLGYLDPEYYRNY 524 (646)
Q Consensus 462 H~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~----------------~~~~~-~~~~~~gt~~y~aPE~~~~~ 524 (646)
|+++ ||||||||.|||||++..|||+|||++.... .+... ..+...||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998621 01111 23456799999999999654
Q ss_pred ---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc---ccccccCCchhHHHHHHHHHHH
Q 006402 525 ---QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV---VDPRLQGHEASVNILMSLKLFS 598 (646)
Q Consensus 525 ---~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~l~~~~~~~~~~~~~~~~~ 598 (646)
+|+.|+|+||+||||+||+. ||...++ ...+...++.+.+..- .++.. ..=+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR~g~iP~~~~f~~~~~-------------~~e~ 848 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTNLRKGSIPEPADFFDPEH-------------PEEA 848 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHhcccCCCCCCcccccccc-------------hHHH
Confidence 49999999999999999995 4543221 1223333444443332 22211 1123
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 006402 599 ELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 599 ~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+|+|+++.||.+|||+.|+|.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 7999999999999999999984
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.34 Aligned_cols=270 Identities=22% Similarity=0.276 Sum_probs=202.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cCe
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (646)
+|.+.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999876 48999999887543 344578999999999999999999999998875 789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||++ ++|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 5888888643 26899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCC--ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC-----
Q 006402 499 KPGLS--HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN----- 570 (646)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 570 (646)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+. ...+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhH
Confidence 54431 112233478899999999877 789999999999999999999999864432111 0011110000
Q ss_pred ------CcccccccccccCCchh--HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 006402 571 ------GAIMEVVDPRLQGHEAS--VNILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRII 626 (646)
Q Consensus 571 ------~~~~~~~d~~l~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~ 626 (646)
....+.+...-...... .........+.+++.+||+.+|++|||+.++++. ++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000000000 0001123557899999999999999999999964 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=291.83 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=195.0
Q ss_pred CCCcccEecccCcEEEEEEEE----cCCcEEEEEEcccCCc----ccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcC
Q 006402 347 GFSKERILGSGGFGEVYKGEL----QDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (646)
+|++.+.||+|+||.||+++. .+|+.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999976 3688999999865322 2346788999999999 599999999999999899
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999999753 35889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCccccccCccccccCccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
.............|+..|+|||.+... .++.++||||||+++|+|++|+.||....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC----
Confidence 654332222234588999999998653 46789999999999999999999986432211 1111111111100
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
+... ......+.+++.+||+.+|++|| ++.+++.
T Consensus 229 ---~~~~--------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ---PPYP--------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCC--------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 01223466899999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=285.04 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=202.8
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|...+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999775 688999999876533 4567789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++.... ....+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997542 2356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||..... ........ ...... +.
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~~ 224 (258)
T cd08215 158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQYPP-----IP 224 (258)
T ss_pred c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCCCCC-----CC
Confidence 1 22223588899999999888899999999999999999999999863321 11111111 111111 11
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .....+.+++.+||..+|++|||+.|+++
T Consensus 225 ~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 S--------QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C--------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 12245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.10 Aligned_cols=271 Identities=23% Similarity=0.318 Sum_probs=199.1
Q ss_pred ccHHHHHHHhcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEE
Q 006402 336 FHLKELKKATNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCV 412 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 412 (646)
....++..++++|.+.+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999975 478999999986532 223567889999999999999999999886
Q ss_pred eC------CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 413 EA------EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 413 ~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 43 2357788876 78998877532 4899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.. +.
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~-~~ 231 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKL-IL 231 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HH
Confidence 999999998765332 122347889999998866 468889999999999999999999985332211 1111 00
Q ss_pred HHhc--CCcccccccc-----------cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 566 QRAS--NGAIMEVVDP-----------RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 566 ~~~~--~~~~~~~~d~-----------~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.... .......+.. .................+.+++.+||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000000000 000000000000123457799999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=291.87 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=191.9
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCc-ccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNI-KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.+.||+|++|.||+|+.++ ++.||||.++.... .....+..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999998874 89999999875432 33456777888777775 9999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
|+. ++|.+++... ...+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 984 4677666442 2368999999999999999999997 46 999999999999999999999999998765433
Q ss_pred CCccccccCccccccCccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQ----LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ... ....... ....
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~---~~~~~~~-~~~~-- 238 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV---LTKILQE-EPPS-- 238 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH---HHHHhcC-CCCC--
Confidence 222 2224788999999986543 788999999999999999999998632111 111 1111111 1000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.... .....+.+++.+||+.+|++||++.++++.
T Consensus 239 ---~~~~~------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ---LPPNE------GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCCC------CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 123457789999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.23 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=194.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-----CcccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-----NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (646)
.+|.+.+.||+|+||.||+|... +++.||+|.+... ..+..+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57888999999999999999765 6899999987532 123456788999999999999999999998764 357
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|+||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998643 34789999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCC--ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 498 AKPGLS--HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
...... .......++..|+|||.+.+..++.++|+||||++++||++|+.||...... ..+..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~ 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIAT-QPTKP 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHc-CCCCC
Confidence 542111 1112345889999999998888899999999999999999999998632111 11111111 11111
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.++. ...+.+.+++.+||+ +|.+||+..+++.
T Consensus 229 ~~p~------------~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 MLPD------------GVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCc------------ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111 123457789999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.51 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=202.7
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
....|.+.+.||+|.|++|..+++. ++..||||.+++... ...+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467889999999999999999765 689999999876543 3446689999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||..+|.+++|+.... .+.......++.|+..|++|+|+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998653 3555888899999999999999999 99999999999999999999999999998875
Q ss_pred CCCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
+....+ ..|++.|.|||++.+.++ .++.|+||+|++||-|+.|..||+...-.+-. ++
T Consensus 208 ~~~lqt--~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------------~r 266 (596)
T KOG0586|consen 208 GLMLQT--FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------------PR 266 (596)
T ss_pred cccccc--cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------------ch
Confidence 443333 449999999999988765 57999999999999999999999844322110 00
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.+...- ..-...++.++++++|..+|.+|++++++.+.
T Consensus 267 vl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 01100000 00112235589999999999999999999754
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=297.01 Aligned_cols=267 Identities=21% Similarity=0.291 Sum_probs=194.7
Q ss_pred cEeccc--CcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSG--GFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
..||+| +||+||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999775 79999999986543 23456788999999999999999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc-
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV- 505 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~- 505 (646)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+............
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987643 235899999999999999999999999 9999999999999999999999998654332111100
Q ss_pred -----ccccCccccccCccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHH------------
Q 006402 506 -----STCAQGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ------------ 566 (646)
Q Consensus 506 -----~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~------------ 566 (646)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 0111246679999998763 578999999999999999999999864322110 0000000
Q ss_pred ----HhcC----------------CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHH
Q 006402 567 ----RASN----------------GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH--ELQR 624 (646)
Q Consensus 567 ----~~~~----------------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~--~L~~ 624 (646)
.... .......+..+. ..........+.+|+++||+.+|++|||+.|+++ .+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR----TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhhccchhhhhcccccchhcccccccccccccc----chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0000 000000000111 0012234567889999999999999999999984 3555
Q ss_pred HHHH
Q 006402 625 IIEI 628 (646)
Q Consensus 625 ~~~~ 628 (646)
+.+.
T Consensus 314 ~~~~ 317 (328)
T cd08226 314 VKEQ 317 (328)
T ss_pred HHHh
Confidence 5554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.81 Aligned_cols=266 Identities=27% Similarity=0.304 Sum_probs=193.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
.++|++.++||+|++|.||+|+.+ +++.+|+|++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999875 6899999988654322 2346789999999999999999999886544
Q ss_pred --cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 416 --QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 416 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
..++|+||+.+ +|...+... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999864 677666543 335899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCc----------cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH
Q 006402 494 LSRLAKPGLSH----------VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562 (646)
Q Consensus 494 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~ 562 (646)
+++........ ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 99765432211 11223468889999987653 57899999999999999999999986332211 111
Q ss_pred HHHHHhcC---C------ccccc----ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 563 YVSQRASN---G------AIMEV----VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 563 ~~~~~~~~---~------~~~~~----~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+...... . ..... ........ ...........+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCcc-HHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111000 0 00000 00000000 00000112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=289.93 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=199.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 420 (646)
++|...+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|+.++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999876 68999999886532 233567889999999998 99999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999753 25899999999999999999999999 99999999999999999999999999886643
Q ss_pred CCC-------------------ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHH
Q 006402 501 GLS-------------------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA 561 (646)
Q Consensus 501 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~ 561 (646)
... .......++..|+|||.+....++.++||||||++++++++|+.||..... . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~--~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---Y--L 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---H--H
Confidence 321 111233478899999999888899999999999999999999999874321 1 1
Q ss_pred HHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 006402 562 IYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM----TDVVH 620 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~----~evl~ 620 (646)
. ..... .. ...+.. ...+.+.+++.+||+.+|++|||+ .++++
T Consensus 230 ~-~~~~~-~~--~~~~~~------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 T-FQKIL-KL--EYSFPP------------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-HHHHH-hc--CCCCCC------------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 01111 00 000000 113446789999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.46 Aligned_cols=243 Identities=22% Similarity=0.238 Sum_probs=186.2
Q ss_pred cEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHH-hhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGIL-SQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
+.||+|++|.||+|... +++.||+|++..... .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999775 689999999865432 1223445555544 455899999999999999999999999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 9999998643 35889999999999999999999999 999999999999999999999999998765331
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
....++..|+|||.+.+..++.++||||||+++|||++|..||...... .. .......... .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~--~~~~~----- 216 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AV-FDNILSRRIN--WPEEV----- 216 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhcccC--CCCcc-----
Confidence 1234788999999998878899999999999999999999998632211 11 1111111100 00000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 587 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.......+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 ---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 011234577999999999999999876554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=290.95 Aligned_cols=263 Identities=26% Similarity=0.331 Sum_probs=198.0
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
|+..+.||+|.+|.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999876 58999999987653 334567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
+ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999997542 35899999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc---CCcc-------
Q 006402 505 VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS---NGAI------- 573 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~------- 573 (646)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+ ....+..... +...
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccc
Confidence 1223357789999998766 78999999999999999999998886433211 1111111000 0000
Q ss_pred -cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 -MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 -~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+..-+.................+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000001112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.76 Aligned_cols=244 Identities=29% Similarity=0.406 Sum_probs=191.0
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|...+.||+|+||+||+|+.. +++.|++|++..... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999765 688999998864332 2345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+. ++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 5777777543 235899999999999999999999999 999999999999999999999999998654322
Q ss_pred ccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
....++..|+|||++. ...++.++||||||+++|||++|+.||..... ..... ..... ... .
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~---~~~~~-~~~-----~ 239 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY---HIAQN-DSP-----T 239 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHH---HHHhc-CCC-----C
Confidence 1234788999999984 45688899999999999999999999863321 11111 11111 110 1
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
... ......+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~-------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQS-------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCc-------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0112346689999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=297.61 Aligned_cols=264 Identities=25% Similarity=0.290 Sum_probs=193.9
Q ss_pred cCCCc-ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCccc--------------HHHHHHHHHHHhhCCCCcccccce
Q 006402 346 NGFSK-ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKS--------------TQQVLNEVGILSQVNHKNLVRLLG 409 (646)
Q Consensus 346 ~~~~~-~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 409 (646)
++|.. .+.||+|+||+||+|... +++.||+|+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 477999999999999865 68999999886542221 125789999999999999999999
Q ss_pred eEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 410 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
++...+..++||||+. ++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 6899888643 35899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCC-------------CccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 006402 490 ADFGLSRLAKPGL-------------SHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555 (646)
Q Consensus 490 ~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~ 555 (646)
+|||++....... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654111 1111223468889999998654 4688999999999999999999998644321
Q ss_pred CCccHHHHHHHHhcCCc---ccccc--------cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 556 DDVNLAIYVSQRASNGA---IMEVV--------DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 556 ~~~~~~~~~~~~~~~~~---~~~~~--------d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+ ....+........ ..... ..... ............++.+++.+||+.+|++|||+.|++.
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP-KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCc-ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 1111111111000 00000 00000 0000000112355779999999999999999999985
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=297.67 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=197.6
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEe-CC
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-AE 415 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 415 (646)
++..++++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456789999999999999999999765 7899999987542 22345678899999999999999999999876 45
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++|+||+ +++|.++++.. .+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 788999998 56888887532 4788888999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh------
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA------ 568 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 568 (646)
....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .........
T Consensus 156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~ 228 (328)
T cd07856 156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN---QFSIITDLLGTPPDD 228 (328)
T ss_pred cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 7553321 12346889999998765 568999999999999999999999986432210 000000000
Q ss_pred -----cCCcccccccccccC-CchhH--HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 569 -----SNGAIMEVVDPRLQG-HEASV--NILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 569 -----~~~~~~~~~d~~l~~-~~~~~--~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+.. +.. ..... ........+.+++.+||+.+|++|||+.|++..
T Consensus 229 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 000 00000 001123567899999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.08 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=194.7
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCC----
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE---- 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 415 (646)
...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999754 78999999885432 223456889999999999999999999987654
Q ss_pred --cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 416 --QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 416 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999998 7789888753 25899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH-------
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS------- 565 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~------- 565 (646)
++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .+.....
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence 998654322 22347889999999875 458899999999999999999999986332110 0000000
Q ss_pred ---HHhcCCccccccc--ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 566 ---QRASNGAIMEVVD--PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 566 ---~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...........+. +.................+.+++.+|++.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 000000000000112345779999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.90 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=207.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc----C----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCC-CCcccccceeEEe
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ----D----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVN-HKNLVRLLGCCVE 413 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 413 (646)
..++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+. |+||+.++|+|.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3344556679999999999999653 1 4579999987543 345788999999999995 9999999999999
Q ss_pred CCcCeEEEEEccCCCccccccCCc-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKY-----SS--------FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNIL 480 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIl 480 (646)
.+..++|+||+..|+|.++|+.++ .. ..|+....+.++.|||.|++||++.. ++||||-.+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999998654 00 23889999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeecCCCccCCCCCCccccccC--ccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 006402 481 LDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDD 557 (646)
Q Consensus 481 l~~~~~~ki~DfGl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~ 557 (646)
+.++..+||+|||+++.............. -...|||||.+....|+.||||||||++||||+| |..|+.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---
Confidence 999999999999999976654443322222 2446999999999999999999999999999999 5666643111
Q ss_pred ccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 558 VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
... +...+.+|...+. .....+++.++++.||+.+|++||++.|+.+.|+.++.
T Consensus 528 --~~~-l~~~l~~G~r~~~-------------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 --TEE-LLEFLKEGNRMEQ-------------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHH-HHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111 1223333332221 11234567899999999999999999999999999643
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=293.67 Aligned_cols=244 Identities=28% Similarity=0.404 Sum_probs=191.3
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
|+..+.||+|++|.||+|+.. +++.+|+|.+... .....+++.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556678999999999999875 6789999987643 223356788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 169 (308)
T cd06634 97 CL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN- 169 (308)
T ss_pred cC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc-
Confidence 96 6787777533 235889999999999999999999998 9999999999999999999999999987654321
Q ss_pred ccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ....... .... +.
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~ 233 (308)
T cd06634 170 ----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNES-----PA 233 (308)
T ss_pred ----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHh-hcCC-----CC
Confidence 234788999999874 346788999999999999999999997532111 1111111 1111 01
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. .......+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 234 LQ-------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cC-------cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 10 01123456789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.20 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=185.1
Q ss_pred EecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---cHHHHHHHHH---HHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 353 ILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---STQQVLNEVG---ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
+||+|+||.||++... +++.||+|.+...... ....+.+|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 5889999988654221 1223444544 3444579999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 99999988643 35899999999999999999999999 99999999999999999999999999876543222
Q ss_pred ccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... ...... .+..+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~~~- 220 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVELPD- 220 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCCCC-
Confidence 123489999999998754 689999999999999999999999874422211111 111100 0111111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
.....+.+++.+||+.+|.+|| ++.++++
T Consensus 221 -------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 -------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1124567899999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.80 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=194.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC---------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--------- 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 414 (646)
..+|...+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999765 6899999998776666678899999999999999999999876654
Q ss_pred -----CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEE
Q 006402 415 -----EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSK 488 (646)
Q Consensus 415 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~k 488 (646)
...++|+||++ ++|.+++.+ ..+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 24689999996 588887753 24889999999999999999999999 99999999999997 566799
Q ss_pred EeecCCCccCCCCCCcc--ccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 489 VADFGLSRLAKPGLSHV--STCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
|+|||+++......... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+.. ....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM---QLIL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 99999997654322211 122347889999998654 46788999999999999999999999643221110 0000
Q ss_pred HHhcCC------ccccccccccc----CCchh--HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 566 QRASNG------AIMEVVDPRLQ----GHEAS--VNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 566 ~~~~~~------~~~~~~d~~l~----~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...... .....+...+. ..... ........++.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 00000000000 00000 000112345778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=275.56 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=203.6
Q ss_pred cHHHHHHHhcCCCcccEecccCcEEEEEE-EEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeC
Q 006402 337 HLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEA 414 (646)
Q Consensus 337 ~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 414 (646)
.++++-+.+. ++||+|+++.|-.. .+.+|..+|||++.+.......++.+|++++.+.+ |+||+.|+++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3567766665 78999999999887 45689999999998876667788999999999986 99999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CEEEee
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF---NSKVAD 491 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~---~~ki~D 491 (646)
...|||||.|.||+|..+|+++ ..+++..+.++..+||.||.|||.++ |.||||||+|||-.+.. -+||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999999854 35889999999999999999999999 99999999999986443 489999
Q ss_pred cCCCccCCCCC--C----ccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCc--
Q 006402 492 FGLSRLAKPGL--S----HVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV-- 558 (646)
Q Consensus 492 fGl~~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~-- 558 (646)
|.+........ + .......|+..|||||+.. ...|+.+.|.|||||+||-|++|..||...-..+-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 99876543211 1 1122346888999999753 336888999999999999999999999866543211
Q ss_pred -----cH-HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 559 -----NL-AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 559 -----~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. .......++++.. ++-|..+ .....+..+++...|..++.+|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY-eFPdkdW---------ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY-EFPDKDW---------AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC-cCChhhh---------HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00 1111122222221 1222211 123345678999999999999999988886
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=281.79 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=192.4
Q ss_pred CCCcccEecccCcEEEEEEEEcC-CcEEEEEEcccC-----CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVG-----NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999997653 444555655432 122344577899999999999999999999999999999
Q ss_pred EEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 421 YEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++|+||||+||+++++ .+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeecC-CEeecccCceeecC
Confidence 99999999999886422 3346899999999999999999999999 9999999999999864 69999999987764
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... .+. .+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~-----~~ 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGP-----TP 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCC-----CC
Confidence 3322 1223457889999999988888999999999999999999999985221 111111111 111 11
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SL--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 0122345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=298.80 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=196.8
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCc---
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ--- 416 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 416 (646)
...++|+..+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999876 5889999988643 22334667889999999999999999998876654
Q ss_pred ---CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 417 ---PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 417 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 6799998864 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc---
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS--- 569 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 569 (646)
++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+.....
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPD 236 (343)
T ss_pred ccccccccc----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCC
Confidence 998764331 22347889999998865 367889999999999999999999986332211 1111111000
Q ss_pred --------CCcccccccccccC--CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 --------NGAIMEVVDPRLQG--HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 --------~~~~~~~~d~~l~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+...... .............+.+++.+||+.+|++|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000 0000000112456789999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=293.46 Aligned_cols=264 Identities=24% Similarity=0.269 Sum_probs=189.6
Q ss_pred CCCcccEecccCcEEEEEEEEc-C--CcEEEEEEcccC--CcccHHHHHHHHHHHhhC-CCCcccccceeEEeC----Cc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-D--GTVVAVKSAKVG--NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA----EQ 416 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 416 (646)
+|++.+.||+|+||.||+++.. . +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999875 3 778999987643 222356788999999999 599999999976533 35
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++++||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 6898888643 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc---cccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC--
Q 006402 497 LAKPGLSH---VSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN-- 570 (646)
Q Consensus 497 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 570 (646)
........ ......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 65432211 1122358899999998765 468899999999999999999999986433111 00000000000
Q ss_pred -Cccccccccc-------c---cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 -GAIMEVVDPR-------L---QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 -~~~~~~~d~~-------l---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.++. + ...............+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0 000000000011345779999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=273.39 Aligned_cols=204 Identities=26% Similarity=0.366 Sum_probs=169.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc---C--CcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEe-CCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ---D--GTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVE-AEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 417 (646)
..|+....||+|.+|.|||+.-+ + ...+|+|+++..+.. -.....+|+.+++.++|||++.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45778889999999999999543 2 237999998765322 23567899999999999999999999998 6788
Q ss_pred eEEEEEccCCCccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CCEEEee
Q 006402 418 LLIYEYIANGTLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD----FNSKVAD 491 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~----~~~ki~D 491 (646)
++++||.+. +|...|+-+. ....++-..+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999865 7888775332 3357899999999999999999999998 9999999999999877 8999999
Q ss_pred cCCCccCCCCCCcc--ccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 492 FGLSRLAKPGLSHV--STCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 492 fGl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
||+++.+....... ...+.-|..|+|||.+.+. .||.+.|||+.||++.||+|-++-|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999887554332 2345679999999998765 69999999999999999999887776443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=322.76 Aligned_cols=254 Identities=28% Similarity=0.376 Sum_probs=197.9
Q ss_pred HHHhcCCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
...+-++....+||.|.||.||.+. ..+|+..|+|-++..+. +..+...+|+.+|..++|||+|+.+|+=...+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3345667778899999999999995 45799999997765433 33566789999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
|.|||+++|+|.+.+...+ .+++.....+-.|++.|++|||+++ ||||||||.||||+.+|.+|++|||.|...
T Consensus 1311 IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999996432 3566666778899999999999999 999999999999999999999999999887
Q ss_pred CCCCCc---cccccCccccccCccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 499 KPGLSH---VSTCAQGTLGYLDPEYYRNY---QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 499 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
...... ......||+.|||||++.+. ....+.||||+|||++||+||++||...+.. .. +..+...++
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~a--IMy~V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WA--IMYHVAAGH 1458 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hH--HHhHHhccC
Confidence 655322 22345699999999999654 3456899999999999999999999743322 11 111222222
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+ ..+ ...+=.+++.+||+.||++|-++.|+++
T Consensus 1459 ~Pq~-P~~------------ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 KPQI-PER------------LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCC-chh------------hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2211 111 2233458999999999999977765543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.16 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=190.6
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
||+|++|.||++... +++.+|+|.+...... ..+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 5899999988754332 456788999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 9999754 25899999999999999999999998 9999999999999999999999999998765432 112234
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
.++..|++||...+...+.++|+||||+++|||++|+.||..... .... .. ...... .++.
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~---~~-~~~~~~--~~~~---------- 214 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY---EK-ILKDPL--RFPE---------- 214 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HH-HhcCCC--CCCC----------
Confidence 578899999999888889999999999999999999999863322 1111 11 111100 0010
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPSMTD 617 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs~~e 617 (646)
.....+.+++.+||..+|++||++.+
T Consensus 215 --~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 --FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 01344678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=265.71 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=192.8
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
...||.|..|.|++.+.+ .|..+|||.+... +.+..++++..+.++.+-+ .|+||+.+|+|..+...++-||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 356999999999999776 5899999988765 3445677788888777665 8999999999999999999999884 4
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~ 507 (646)
.++..+++- ..++++..+-++..-+.+||.||.++.. |+|||+||+|||+|+.|++|++|||++-.+-+...+..
T Consensus 176 C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr- 250 (391)
T KOG0983|consen 176 CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR- 250 (391)
T ss_pred HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccccccc-
Confidence 556655542 3458888888999999999999998764 99999999999999999999999999987765544433
Q ss_pred ccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 508 CAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 508 ~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
..|-+.|||||.+. ..+|+.++||||||+.|+||.||+.||..-..+.+ . .....+ ...|.|.++
T Consensus 251 -sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~----ltkvln-----~ePP~L~~~ 318 (391)
T KOG0983|consen 251 -SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--V----LTKVLN-----EEPPLLPGH 318 (391)
T ss_pred -ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--H----HHHHHh-----cCCCCCCcc
Confidence 34899999999984 34689999999999999999999999975433211 1 111111 112334332
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .....+.+++..||+.|+.+||.-.++++
T Consensus 319 ~------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 M------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred c------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2 24566789999999999999999998875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=271.92 Aligned_cols=241 Identities=24% Similarity=0.289 Sum_probs=194.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|...++||+|.||+|.+.+-+ .++.+|+|++++.-.- ....-+.|-++|+..+||.+..|...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888899999999999999665 6999999999865433 344557799999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||..||.|.-+|.+. ..+++.....+-..|..||.|||+.+ |+.||||.+|.|||.+|++||+|||+++..-.
T Consensus 247 MeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999999754 34788888888999999999999999 99999999999999999999999999985433
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .......|||.|+|||++....|....|.|.+||++|||+.|+.||....... +...+. ..+-+.. .
T Consensus 321 ~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl--~ed~kFP----r- 389 (516)
T KOG0690|consen 321 YG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELIL--MEDLKFP----R- 389 (516)
T ss_pred cc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHH--hhhccCC----c-
Confidence 22 22334569999999999999999999999999999999999999997443321 111111 1111111 1
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERP 613 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 613 (646)
....+...|+...|..||.+|.
T Consensus 390 -----------~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 390 -----------TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----------cCCHHHHHHHHHHhhcChHhhc
Confidence 1123345788899999999994
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=270.18 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=194.0
Q ss_pred hcCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEe----CCcC
Q 006402 345 TNGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVE----AEQP 417 (646)
Q Consensus 345 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 417 (646)
+++|++. ++||-|-.|+|-....+ +++.+|+|++... ....+|+++--.. .|||||.+++++.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3445443 67999999999988655 7899999988532 4456888876666 59999999999875 3456
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeecCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGL 494 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~DfGl 494 (646)
++|||+|+||.|.+.++++ ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7999999999999999876 4456999999999999999999999999 99999999999996 455799999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
++........ .....||.|.|||++...+|+...|+||+||++|-|+.|.+||...-. ....-- ...++..+. .
T Consensus 211 AK~t~~~~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispg--Mk~rI~~gq-y 284 (400)
T KOG0604|consen 211 AKETQEPGDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPG--MKRRIRTGQ-Y 284 (400)
T ss_pred ccccCCCccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChh--HHhHhhccC-c
Confidence 9977643332 334589999999999999999999999999999999999999963322 111111 111111111 0
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
++-++. =....+...++|+.+|..+|++|.|+.|++.
T Consensus 285 ~FP~pE---------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 EFPEPE---------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCCChh---------HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111111 1234566789999999999999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.67 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=195.5
Q ss_pred hcCCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCC-cc------cHHHHHHHHHHHhhCCCCcccccceeEEe-CC
Q 006402 345 TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGN-IK------STQQVLNEVGILSQVNHKNLVRLLGCCVE-AE 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 415 (646)
.++|-...+||+|+|+.|||+. +...+.||+|+-.... +. -.+...+|..|-+.|.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3457778899999999999994 4568899999754332 11 13457889999999999999999999874 56
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeec
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADF 492 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~Df 492 (646)
.++-|+||++|.+|+-||+.++ .+++..+..|+.||..||.||.+.. +||||-||||.||||. .-|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 8889999999999999998653 5899999999999999999999987 7899999999999995 4578999999
Q ss_pred CCCccCCCCCCc------cccccCccccccCccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH
Q 006402 493 GLSRLAKPGLSH------VSTCAQGTLGYLDPEYYRNY----QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562 (646)
Q Consensus 493 Gl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~ 562 (646)
|+++.+..+... .+....||..|++||.+.-+ +++.|+||||.||++|..+.|++||.......+. .
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--L- 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--L- 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--H-
Confidence 999988754332 22334699999999988433 5788999999999999999999999754433211 1
Q ss_pred HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 563 YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+..+...-.-.... -.....+...+|++||+.-.++|....++..
T Consensus 695 ------qeNTIlkAtEVqFP~------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 ------QENTILKATEVQFPP------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------hhhchhcceeccCCC------CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111110000000 0112233557999999999999988777753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.90 Aligned_cols=258 Identities=24% Similarity=0.257 Sum_probs=207.0
Q ss_pred HHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEccc---CCcccHHHHHHHHHHHhhCCCCcccccceeEEe
Q 006402 338 LKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKV---GNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413 (646)
Q Consensus 338 ~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 413 (646)
..+++...++|.+.++||+|+||.|..++.+ ++++||+|++.+ .......-|..|..+|.--+.+.|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4556666788999999999999999999876 689999999876 334456779999999999999999999999999
Q ss_pred CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
..++|+|||||+||+|-..+.... .+++..+..++..|..||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999996532 5899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccc----c-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYR----N-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
.+..+..+..-.....+|||.|++||+++ + +.|+...|.||+||++|||+.|..||... .++.-..+.+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHh
Confidence 99888766666666778999999999984 2 56899999999999999999999999622 2222112111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS---MTDVV 619 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs---~~evl 619 (646)
.-.....+- ..........+||.+.+ -+|+.|-. +.++-
T Consensus 295 ~hk~~l~FP-----------~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 295 NHKESLSFP-----------DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred chhhhcCCC-----------cccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence 110000000 11223455668888877 56888877 66654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=304.36 Aligned_cols=145 Identities=30% Similarity=0.425 Sum_probs=130.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.++||+|+||+||+|... +++.||||+++... ....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999876 68999999986543 223467889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
||+.+++|.+++... ..+++..++.|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 24788999999999999999999998 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=288.02 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=180.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEE-----------------cCCcEEEEEEcccCCcccHHHH--------------HHH
Q 006402 344 ATNGFSKERILGSGGFGEVYKGEL-----------------QDGTVVAVKSAKVGNIKSTQQV--------------LNE 392 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 392 (646)
..++|++.++||+|+||+||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 2456899999875443333333 346
Q ss_pred HHHHhhCCCCcc-----cccceeEEe--------CCcCeEEEEEccCCCccccccCCcC---------------------
Q 006402 393 VGILSQVNHKNL-----VRLLGCCVE--------AEQPLLIYEYIANGTLHDHLHGKYS--------------------- 438 (646)
Q Consensus 393 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 438 (646)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677887753 3467999999999999999874311
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCc
Q 006402 439 SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518 (646)
Q Consensus 439 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aP 518 (646)
...++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567889999999999999999999 99999999999999999999999999976544322222223358899999
Q ss_pred cccccCC----------------------CCchhhHHHHHHHHHHHHcCCC-CCCCCCCCC------CccHHHHHHHHhc
Q 006402 519 EYYRNYQ----------------------LTDKSDVYSYGVVLLELLTSQK-AIDFSRDPD------DVNLAIYVSQRAS 569 (646)
Q Consensus 519 E~~~~~~----------------------~~~ksDv~s~G~ll~elltg~~-p~~~~~~~~------~~~~~~~~~~~~~ 569 (646)
|.+.... ...+.||||+||+++||++|.. |+....... +..+..|. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence 9875322 1235799999999999999875 553211000 00111111 111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKK---SERPSMTDVVH 620 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p---~~RPs~~evl~ 620 (646)
.... +-.. .........+|+.++|..+| .+|+|++|+++
T Consensus 458 ~~~~----~~~~--------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKY----DFSL--------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCC----Cccc--------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1110 0000 01122446689999999765 68999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=274.71 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=201.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-C-C----cccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-H-K----NLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 417 (646)
+++|.+..+||+|.||.|-....+ .+..||||+++.-+ +-.+..+-|+++|.++. + | -+|.+.+||.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 688999999999999999998654 47899999987543 23455677999999994 2 2 278888999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--------------
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-------------- 483 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-------------- 483 (646)
+||+|.+ |-|+.++|..+ +-.+.+..++..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 77999999875 4456899999999999999999999999 999999999999832
Q ss_pred ------CCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 006402 484 ------DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557 (646)
Q Consensus 484 ------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~ 557 (646)
+..+||+|||.|+...... +....|..|+|||++.+-.++.++||||+||+|+|+.||...|....+.+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3468999999998765543 334579999999999999999999999999999999999999987765443
Q ss_pred ccHHHHHHHHhcC--------------Ccc-----------cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCC
Q 006402 558 VNLAIYVSQRASN--------------GAI-----------MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSER 612 (646)
Q Consensus 558 ~~~~~~~~~~~~~--------------~~~-----------~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 612 (646)
..+...+...... +.+ ....++-..-............++.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 3222222111110 000 000000000000000012234568899999999999999
Q ss_pred CCHHHHHH
Q 006402 613 PSMTDVVH 620 (646)
Q Consensus 613 Ps~~evl~ 620 (646)
+|+.|+++
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=269.43 Aligned_cols=222 Identities=20% Similarity=0.165 Sum_probs=175.8
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCccccccC
Q 006402 357 GGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG 435 (646)
Q Consensus 357 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 435 (646)
|.+|+||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999765 68999999986543 234555666667799999999999999999999999999999999864
Q ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccc
Q 006402 436 KYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515 (646)
Q Consensus 436 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y 515 (646)
. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3 24899999999999999999999999 9999999999999999999999999876554321 122357789
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHH
Q 006402 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLK 595 (646)
Q Consensus 516 ~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 595 (646)
+|||.+.+..++.++||||+|+++|||++|+.|+....... ... ....+. .....
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~~~~--------~~~~~ 203 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTLNIP--------EWVSE 203 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cccCCc--------ccCCH
Confidence 99999988888999999999999999999998764221100 000 000000 01224
Q ss_pred HHHHHHHHhcccCCCCCCCHHHH
Q 006402 596 LFSELAVACLREKKSERPSMTDV 618 (646)
Q Consensus 596 ~~~~li~~cl~~~p~~RPs~~ev 618 (646)
.+.+++.+||+.||++||++.+.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCCcc
Confidence 46789999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=286.93 Aligned_cols=239 Identities=24% Similarity=0.281 Sum_probs=192.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++.|.....+|.|+|+.|-..... +++..++|++.... .+-.+|+.++... +||||+++.+.+.+....++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556777788999999999988654 67889999987552 2234677666665 69999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE-cCCCCEEEeecCCCccCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL-DDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll-~~~~~~ki~DfGl~~~~~~~ 501 (646)
.+.++-|.+.+..++ .....+..|+.+|+.|+.|||+++ |+||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998888876542 223677789999999999999999 9999999999999 58899999999999987765
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.....-|..|.|||++....|++++|+||||++||+|++|+.||...... ..+...+..+...+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~------ 533 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSE------ 533 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcccc------
Confidence 11223688999999999999999999999999999999999999755443 22233333332221
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+...+|+.+||+.+|.+||+|.++..
T Consensus 534 ----------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 ----------CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----------ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22344678999999999999999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=263.37 Aligned_cols=269 Identities=26% Similarity=0.375 Sum_probs=211.8
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeE
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCC 411 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 411 (646)
.||..-..+++...++-+|.||.||.|.|. +.+.|.+|.++.. +.-....++.|..++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 345555567888888999999999999664 3456778877644 333467789999999999999999999998
Q ss_pred EeC-CcCeEEEEEccCCCcccccc-----CCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 006402 412 VEA-EQPLLIYEYIANGTLHDHLH-----GKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485 (646)
Q Consensus 412 ~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~ 485 (646)
.++ +..+++|.++.-|+|..||. +......++-.+...++.|++.|++|||..+ |+|.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 875 47889999999999999997 3333445788889999999999999999999 99999999999999999
Q ss_pred CEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHH
Q 006402 486 NSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIY 563 (646)
Q Consensus 486 ~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~ 563 (646)
++||+|=.+++..-+...+ ..........||+||.+.+..|+.++|||||||+||||+| |+.|+...+. ...
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-----fEm- 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-----FEM- 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-----HHH-
Confidence 9999999999987655443 2233346778999999999999999999999999999998 6777652211 111
Q ss_pred HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 564 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
...+.+|. ++. +...+++++..++.-||...|++||++++++.-|...-.++.
T Consensus 508 -~~ylkdGy-------Rla------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 508 -EHYLKDGY-------RLA------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred -HHHHhccc-------eec------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 11111111 111 123456778899999999999999999999999988876654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=240.59 Aligned_cols=267 Identities=22% Similarity=0.296 Sum_probs=198.1
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+|...++||+|.+|+||||+.+ +++.||+|+++..+. .-....++|+-+|+.++|+|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566688999999999999765 689999998876543 3356788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+ ..+|..|...- ...++......++.|+++||.|.|+++ ++|||+||+|.||+.+|+.|++|||+++.+.....
T Consensus 83 c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9 55788877653 345888999999999999999999999 99999999999999999999999999998876554
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH-HHHHHhcCCc---cccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI-YVSQRASNGA---IMEVVD 578 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~d 578 (646)
..+ ...-|..|++|.++.+. -|+...|+||.||++.|+.....|.....+.++..... +..-...+.. +..+-|
T Consensus 157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 332 23468999999998766 47889999999999999998766654443333322222 1111111111 111112
Q ss_pred ccccC---Cc--hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQG---HE--ASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~---~~--~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..... .. ...........=++|+.+.+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11110 00 00001111122357888999999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=272.00 Aligned_cols=240 Identities=24% Similarity=0.315 Sum_probs=189.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 420 (646)
.+|....+||+|+||+|.++..+ +.+.+|||++++.-. .+.+--+.|-++|.... -|.++.++.+|+..+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888899999999999999765 468899999886532 23344567888888774 68899999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+.||+|.-++++- ..+.+..+..+|.+||-||-+||+++ |+.||||..|||||.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999998754 24677888999999999999999999 99999999999999999999999999985433
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
+.. .+....|||.|+|||.+...+|...+|.|||||+||||+.|+.||+...+.+- -..+..+ +.. ..
T Consensus 503 ~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~aI~eh--nvs----yP-- 570 (683)
T KOG0696|consen 503 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQAIMEH--NVS----YP-- 570 (683)
T ss_pred CCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHc--cCc----Cc--
Confidence 221 22334599999999999999999999999999999999999999985443221 1111100 000 01
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERP 613 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 613 (646)
....++..++....|..+|.+|.
T Consensus 571 ----------KslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 571 ----------KSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----------ccccHHHHHHHHHHhhcCCcccc
Confidence 11234455788888889998883
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-33 Score=281.40 Aligned_cols=243 Identities=28% Similarity=0.356 Sum_probs=191.3
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
.++||.|.||+||-|+++ +|+.||||++.+.. .+....+.+|+.||+++.||.||.+.-.|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999765 79999999986542 244577899999999999999999999999999999999999 55
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCCCccCCCCCCc
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl~~~~~~~~~~ 504 (646)
+..+.|-.. ....|++.....+..||+.||.|||.++ |+|+||||+||||.+ .-.+||+|||.++.+....-+
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 665555433 2335888888899999999999999999 999999999999963 357999999999998765433
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
..+.|||.|+|||+++++.|+..-|+||.||++|--++|..||....+- ...+ ++...+ ..+
T Consensus 724 --rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----ndQI----QNAaFM--yPp----- 785 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----NDQI----QNAAFM--YPP----- 785 (888)
T ss_pred --hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----hHHh----hccccc--cCC-----
Confidence 3456999999999999999999999999999999999999999743322 1111 111000 000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
.+ =.+......+||...|+..-.+|-|.+.-+
T Consensus 786 -~P--W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 -NP--WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -Cc--hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 00 012223456889999999999998887665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=265.13 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=192.1
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
+..||.|+||+|+|-.++ .|+..|||+++.... ++.++++.|.+...+- +.||||+++|.+..++..++-||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 466999999999998765 699999999987654 5677888888876665 6899999999999999999999999 44
Q ss_pred CccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 428 TLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 428 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|+.+-+.-. ....+++..+-.|..-...||.||...-. |+||||||+|||||..|.+||+|||++-.+.... .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 6655443111 23358888888898899999999998664 9999999999999999999999999987765432 2
Q ss_pred ccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 506 STCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.+...|-..|||||.+.. ..|+.+|||||||++|+|+.||+.|+..... ....+.+... +.. |.+..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gdp-----p~l~~ 292 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GDP-----PILLF 292 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CCC-----CeecC
Confidence 233458889999999853 3589999999999999999999999874432 2222222222 111 11111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. +.......+..++--||..|..+||...++.+.
T Consensus 293 ~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cc---cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 123344567889999999999999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=264.15 Aligned_cols=238 Identities=32% Similarity=0.441 Sum_probs=192.1
Q ss_pred CcEEEEEEEEc-CCcEEEEEEcccCCccc-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCccccccC
Q 006402 358 GFGEVYKGELQ-DGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG 435 (646)
Q Consensus 358 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 435 (646)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999887 48999999987665544 78899999999999999999999999999999999999999999999875
Q ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccc
Q 006402 436 KYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515 (646)
Q Consensus 436 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y 515 (646)
.. .+++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 42 2889999999999999999999998 9999999999999999999999999998775532 22234478899
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHH
Q 006402 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLK 595 (646)
Q Consensus 516 ~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 595 (646)
++||.+....++.++||||||+++++|++|..||...... ... ............ .. ......
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~----~~~~~~~~~~~~-~~----------~~~~~~ 215 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL----FKKIGKPKPPFP-PP----------EWKISP 215 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH----HHHHhccCCCCc-cc----------cccCCH
Confidence 9999998888899999999999999999999998642111 111 111111111000 00 000234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 596 LFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 596 ~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 5778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=292.69 Aligned_cols=264 Identities=25% Similarity=0.275 Sum_probs=169.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-C----CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCccccccee------EE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-D----GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC------CV 412 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 412 (646)
..++|...++||+|+||.||+|++. + +..||+|++..... .+.+.+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999875 4 68999998764321 1222222 1222223333333222 23
Q ss_pred eCCcCeEEEEEccCCCccccccCCcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 006402 413 EAEQPLLIYEYIANGTLHDHLHGKYSS-----------------FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVK 475 (646)
Q Consensus 413 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik 475 (646)
.....++||||+.+++|.++++..... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999999988653210 01123345679999999999999998 9999999
Q ss_pred CCCEEEcC-CCCEEEeecCCCccCCCCCCccccccCccccccCccccccC----------------------CCCchhhH
Q 006402 476 STNILLDD-DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY----------------------QLTDKSDV 532 (646)
Q Consensus 476 ~~NIll~~-~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDv 532 (646)
|+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 68999999999987654433333445689999999965321 24456799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC----cccccccccccCCch--hHHHHHHHHHHHHHHHHhcc
Q 006402 533 YSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG----AIMEVVDPRLQGHEA--SVNILMSLKLFSELAVACLR 606 (646)
Q Consensus 533 ~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l~~~~~--~~~~~~~~~~~~~li~~cl~ 606 (646)
|||||+||||+++..+++. .+..+.......+ .+...+++....... ............+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999987655321 1111111000000 000111111000000 00000011234589999999
Q ss_pred cCCCCCCCHHHHHHH
Q 006402 607 EKKSERPSMTDVVHE 621 (646)
Q Consensus 607 ~~p~~RPs~~evl~~ 621 (646)
.||++|||++|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=257.91 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=191.9
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeC--------Cc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEA--------EQ 416 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~ 416 (646)
|....+||+|.||.||+++.+ .|+.||+|+.-..+++ -....++|+.+|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 445578999999999999766 5788999876543332 245678999999999999999999998653 24
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++|+++++. +|.-.|... ...++..++.+++.++..||.|+|... |+|||+|++|+||+.++.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 7899999965 677777543 235888999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCC---ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 497 LAKPGLS---HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 497 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
.+..... ...+...-|..|++||.+.+ ..++++.|||..||++.||+||.+-+....+.....+.....-......
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6643221 12334456999999998765 4799999999999999999999887765443333322222111111111
Q ss_pred --------cccccccc-ccCCchhHHHHHH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 --------IMEVVDPR-LQGHEASVNILMS------LKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 --------~~~~~d~~-l~~~~~~~~~~~~------~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+...+... +....... .... .++..+|+.+++..||.+|+.+++++.
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rk-v~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRK-VKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhh-hhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111000 11100000 0111 125678999999999999999998874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=282.42 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=205.8
Q ss_pred HHHHHHHhcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEe--
Q 006402 338 LKELKKATNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVE-- 413 (646)
Q Consensus 338 ~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-- 413 (646)
++.+...+..|.+.++||+|.+|.||+++. ++++.+|+|+..... ...++...|.++|+.+. |||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344444567788999999999999999965 478999999876543 44466778999999984 9999999999874
Q ss_pred ---CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 414 ---AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 414 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
++.++||||||.+|+.-|++++-. +..+.|..+..|++.++.||.+||... ++|||||-.||||+.++.+|+.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998765 667999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCCccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 491 DFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 491 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
|||.+........... ...|||.|||||++.. ..|+..+|+||||++..||--|.+|+. ++.-.....
T Consensus 166 DFGvSaQldsT~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~------DmHPmraLF 238 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC------DMHPMRALF 238 (953)
T ss_pred eeeeeeeeeccccccc-CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc------Ccchhhhhc
Confidence 9999987654433322 3459999999999853 357789999999999999999999975 222111111
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...++ -.|.+.. ...-.+++.++|..||..|-++||++.++++
T Consensus 239 ~IpRN------PPPkLkr------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPRN------PPPKLKR------PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCCC------CCccccc------hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 1222221 2234567889999999999999999999984
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=252.56 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=197.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (646)
.+.|...++||+|++++|..++++ +.+.+|+|++++. +.++.+-+..|-.++.+. +||.+|.|+.+|+....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357889999999999999999776 5789999998753 334556667788888877 59999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|.||+++|+|.-++++. ..|+++.+..+..+|..||.|||+.+ |+.||||..|+|||..|++||.|+|+.+.--
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999888754 35899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CCCCccHHHHHHHHhcCCccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR-DPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.+. ..+....|||.|+|||.+++..|....|.|++||+++||+.|+.||+... ...+.+...+..+.+.+..+. +.
T Consensus 403 ~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--ip 479 (593)
T KOG0695|consen 403 GPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--IP 479 (593)
T ss_pred CCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--cc
Confidence 322 22334569999999999999999999999999999999999999998433 333444444444433222110 11
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERP 613 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 613 (646)
..+ ..+...+++.-|+.||.+|.
T Consensus 480 rsl------------svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSL------------SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cee------------ehhhHHHHHHhhcCCcHHhc
Confidence 111 12234677888899999884
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.73 Aligned_cols=212 Identities=26% Similarity=0.360 Sum_probs=175.9
Q ss_pred HHHHHHHh---cCCCcccEecccCcEEEEEE-EEcCCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCccccccee
Q 006402 338 LKELKKAT---NGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGC 410 (646)
Q Consensus 338 ~~el~~~~---~~~~~~~~Lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~ 410 (646)
|..|+++. .-|..++.||-|+||.|.++ +.++...+|+|.+++.+. .....+..|..||.....+.||+|+..
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44555543 44778899999999999999 455677899999876654 234567789999999999999999999
Q ss_pred EEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 411 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
|.+++.+|+||||++||++..+|-+. .-+++..+..++.++..|+++.|..| +|||||||+|||||.+|++||.
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence 99999999999999999999998753 34677888888999999999999999 9999999999999999999999
Q ss_pred ecCCCccCC---------CCCC--------------------------------ccccccCccccccCccccccCCCCch
Q 006402 491 DFGLSRLAK---------PGLS--------------------------------HVSTCAQGTLGYLDPEYYRNYQLTDK 529 (646)
Q Consensus 491 DfGl~~~~~---------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k 529 (646)
||||+.-+. .+.. .......||+.|+|||++....++..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 999985321 0000 00112349999999999999999999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCC
Q 006402 530 SDVYSYGVVLLELLTSQKAIDFSRDP 555 (646)
Q Consensus 530 sDv~s~G~ll~elltg~~p~~~~~~~ 555 (646)
.|.||.||+||||+.|+.||......
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCC
Confidence 99999999999999999999755443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=267.62 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=194.3
Q ss_pred CCcccEecccCcEEEEEEEEcCCc-EEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQDGT-VVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+.....||-|+||.|=++..+... .+|+|.+++. +.+..+.+..|-.+|.+.+.|.||+|+-.|.+.+..|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 444567999999999999876543 4888877654 344567789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+-||.|...|+++ ..++..+...++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||.++....+..
T Consensus 502 ClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 502 CLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999999864 35788888899999999999999999 99999999999999999999999999999877654
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.- ...|||.|.|||++.+...+.++|.||||+++|||++|.+||..... +.....+.+.+.... +..
T Consensus 576 Tw--TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid~i~----~Pr---- 642 (732)
T KOG0614|consen 576 TW--TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGIDKIE----FPR---- 642 (732)
T ss_pred ee--eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhhhhh----ccc----
Confidence 43 34599999999999998999999999999999999999999974432 222222222221111 111
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCC
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPS 614 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 614 (646)
...+...+|+++....+|.+|.-
T Consensus 643 --------~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 --------RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --------ccchhHHHHHHHHHhcCcHhhhc
Confidence 12233557899999999999965
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=282.85 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=193.3
Q ss_pred CCcccEecccCcEE-EEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEcc
Q 006402 348 FSKERILGSGGFGE-VYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
|...+++|.|+.|+ ||+|.. +|+.||||++-.. ..+...+|+..|+.-+ |||||+.++.-.+....||..|.+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45557899999986 799988 5789999987542 3345578999999884 999999998877888899999999
Q ss_pred CCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCCEEEeecCCCccCC
Q 006402 426 NGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-----DFNSKVADFGLSRLAK 499 (646)
Q Consensus 426 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-----~~~~ki~DfGl~~~~~ 499 (646)
..+|.+++.... ......-...+.+..|+++||++||+.+ |+||||||+||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 569999998641 1111111345678899999999999999 999999999999975 3579999999999987
Q ss_pred CCCCccc--cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 500 PGLSHVS--TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTS-QKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 500 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.+..... ....||.||+|||.+....-+.++||+|+||++|+.++| ..||......+ ......+..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------~NIl~~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------ANILTGNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------hhhhcCccceee-
Confidence 6655433 345699999999999888888899999999999999997 78886222111 111111111111
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH---------HHHHHHHHHHhhcccccc
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV---------HELQRIIEIVNQEKVSND 637 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl---------~~L~~~~~~~~~~~~~~~ 637 (646)
+.... +. +..+||.+|+.++|..||++.+|+ ++|+=+++.-+.-+.+++
T Consensus 735 ----L~~~~----d~----eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r 792 (903)
T KOG1027|consen 735 ----LEPLP----DC----EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENR 792 (903)
T ss_pred ----eccCc----hH----HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhc
Confidence 11000 00 466899999999999999999998 345555544444444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=238.39 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=195.7
Q ss_pred hcCCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCC--cCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAE--QPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lV 420 (646)
.++|++.+++|+|.++.||.|. ..+.+.++||+++.- ..+.+.+|+.||..|+ ||||++|+++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4578888999999999999995 557889999998764 4567889999999997 999999999998754 67899
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCccCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLAK 499 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~~ 499 (646)
+||+.+.+...... .|+...+...+.++++||.|.|++| |+|||+||.|++||. .-..+|+|+|+|....
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99998877665432 3777888999999999999999999 999999999999995 4569999999999887
Q ss_pred CCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC-------
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG------- 571 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 571 (646)
++..... ...+..|.-||.+-.. .|+..-|+|||||+|.+|+..+.||....+..+..... ...+...
T Consensus 185 p~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI--akVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI--AKVLGTDELYAYLN 260 (338)
T ss_pred CCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH--HHHhChHHHHHHHH
Confidence 7665432 2356778999998655 57788999999999999999999997655443332111 1111000
Q ss_pred cccccccccccC------------CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 AIMEVVDPRLQG------------HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 ~~~~~~d~~l~~------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...-.+||...+ ...+.+..-...+..+|+.+.|..|-++|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000012222111 0001111112356779999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=235.22 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=166.5
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
......||+|++|.|-+-++. +|+..|+|++... +.+..++.++|+.+..+- ..|.+|.++|...+....++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334466999999999887654 7999999998754 334567788888887665 5999999999999999999999999
Q ss_pred cCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 425 ANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 425 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
..+|+.+-++-. .+..+++..+-+||..+..||.|||++-. |+|||+||+||||+.+|++||+|||++-.+.+...
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 557777654322 34568999999999999999999999765 99999999999999999999999999987765433
Q ss_pred ccccccCccccccCccccc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006402 504 HVSTCAQGTLGYLDPEYYR----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~ 554 (646)
. +...|-..|||||.+. ...|+-||||||||+++.||.+++.|++....
T Consensus 205 k--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 205 K--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred H--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2 2234788899999874 33789999999999999999999999875544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-31 Score=246.99 Aligned_cols=265 Identities=26% Similarity=0.319 Sum_probs=195.4
Q ss_pred CcccEecccCcEEEEEEEE-cCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----cCeEE
Q 006402 349 SKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-----QPLLI 420 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 420 (646)
+..+-||-|+||.||.++. ++|+.||+|++..- +....+.+.+|+.+|.-.+|.|++..+++..-.. +.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457799999999999966 48999999987532 2345678999999999999999999999876543 56788
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+|.| ..+|+..|-. ...|+-..+.-+..||++||+|||+.+ |+||||||.|.|++.|-..||+|||+++....
T Consensus 136 TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 9988 4588888763 346888888889999999999999999 99999999999999999999999999999887
Q ss_pred CCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH--------HHHHhcCC
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY--------VSQRASNG 571 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 571 (646)
+.....+...-|..|+|||.+.+. .|+.+.||||.||++.||+.++-.|......+...+... .....-++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 777666666678999999998765 699999999999999999988877764433222211110 00111111
Q ss_pred cccccccccccCC-------chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 572 AIMEVVDPRLQGH-------EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 572 ~~~~~~d~~l~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
....++....+.. .... .....+...+..+++..+|++|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~--~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASP--DDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCC--cccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111100 0000 01112344688899999999999988877543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=236.16 Aligned_cols=210 Identities=38% Similarity=0.588 Sum_probs=182.8
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCccc
Q 006402 354 LGSGGFGEVYKGELQD-GTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHD 431 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 431 (646)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999998765433 35779999999999999999999999999999999999999999999
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCccCCCCCCccccccC
Q 006402 432 HLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLAKPGLSHVSTCAQ 510 (646)
Q Consensus 432 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~~~~~~~~~~~~~ 510 (646)
++.... ..+++..++.++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987532 35899999999999999999999998 999999999999999 89999999999987654321 122244
Q ss_pred ccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHH
Q 006402 511 GTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVN 589 (646)
Q Consensus 511 gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 589 (646)
+...|++||.+... ..+.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 590 ILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 590 ~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 235589999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=234.52 Aligned_cols=198 Identities=36% Similarity=0.525 Sum_probs=172.5
Q ss_pred CCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
|...+.||+|++|+||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998875 889999998866554 67789999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999875421 1789999999999999999999998 9999999999999999999999999998776543111
Q ss_pred ccccCccccccCcccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006402 506 STCAQGTLGYLDPEYY-RNYQLTDKSDVYSYGVVLLELLTSQKAID 550 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~ll~elltg~~p~~ 550 (646)
.....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2223477889999998 66678889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=254.33 Aligned_cols=196 Identities=24% Similarity=0.350 Sum_probs=167.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--------ccHHHHHHHHHHHhhCC---CCcccccceeEEe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--------KSTQQVLNEVGILSQVN---HKNLVRLLGCCVE 413 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 413 (646)
..|+..+.||.|+||.|+.+.++ +...|+||.+.+... ...-.+-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888899999999999999877 456789998765321 11123567999999997 9999999999999
Q ss_pred CCcCeEEEEEc-cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 414 AEQPLLIYEYI-ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 414 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
++.+||+||-. ++-+|.++|..+ ..+++....-|+.|++.|+++||+.+ |+|||||-+||.+|.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999966 467899999754 35899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCccccccCccccccCccccccCCCC-chhhHHHHHHHHHHHHcCCCCCC
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT-DKSDVYSYGVVLLELLTSQKAID 550 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~ll~elltg~~p~~ 550 (646)
|.+.+.+.+.-. ..+||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgpfd---~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGPFD---VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCCcc---eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999888765433 34599999999999988774 45799999999999999988874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=228.62 Aligned_cols=255 Identities=16% Similarity=0.245 Sum_probs=190.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCccccccee-EEeCCcCeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGC-CVEAEQPLLI 420 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lV 420 (646)
..+.|.+.+.||+|.||.+.++.++ ..+.+++|.+... ....++|.+|...--.|. |.||+.-+++ |+..+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467899999999999999999887 5778899977543 345788999998766675 8999998876 5556777899
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCEEEeecCCCccC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD--DDFNSKVADFGLSRLA 498 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~--~~~~~ki~DfGl~~~~ 498 (646)
+||++.|+|.+.+... .+.+....+++.|++.||.|||+++ ++|||||.+||||- +..++||+|||+++..
T Consensus 101 qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999988653 4778888999999999999999999 99999999999993 4558999999998765
Q ss_pred CCCCCccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
...... ..-+..|.+||.... ....+.+|||+||++++.++||+.||.... ..+..... +..+..+..
T Consensus 174 g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~--~~~w~~rk~ 246 (378)
T KOG1345|consen 174 GTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWE--WEQWLKRKN 246 (378)
T ss_pred Cceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHH--HHHHhcccC
Confidence 432221 235677999997632 245678999999999999999999998332 22333333 233333332
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
... .... ......+..+.++-|.+++++|-.+.++.++..
T Consensus 247 ~~~-P~~F---------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 PAL-PKKF---------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ccC-chhh---------cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 221 1111 112334557888999999999966666665543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=234.77 Aligned_cols=263 Identities=25% Similarity=0.292 Sum_probs=191.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeC------C
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA------E 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 415 (646)
..+|...+.+|.|.- .|-.+... .++.||+|+.... +....++..+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777778888888 55555332 5889999976432 334567788999999999999999999998754 3
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..|+|||+| ..+|...++. .++-..+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 678999999 5688888863 2677888899999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH---------HHHH
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI---------YVSQ 566 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~---------~~~~ 566 (646)
+..... ...+....|..|.|||++-+..+.+.+||||+||++.||++|+--|.....-+...... +..+
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 876654 34455668999999999988889999999999999999999998876332211110000 0000
Q ss_pred H-------hcC------Cccccccccc-ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 567 R-------ASN------GAIMEVVDPR-LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 567 ~-------~~~------~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. ... ....+.+... ....... .........+++.+||..+|++|.+++++|+.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~--~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG--SKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccC--CccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 000 0011111110 0000000 01123446789999999999999999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=247.68 Aligned_cols=269 Identities=21% Similarity=0.233 Sum_probs=206.5
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC------CCcccccceeEEeCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN------HKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~ 416 (646)
.-.+|.+....|+|-|++|-.|... .|..||||++.... .-.+.=+.|+++|++|+ --|+++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4467888888999999999999765 47899999997542 22344568999999995 3589999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecCCC
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFGLS 495 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfGl~ 495 (646)
++||+|-+ ..+|.+.|+.-.....|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+||+|||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 5689999987666677899999999999999999999999 9999999999999854 57899999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH-----hcC
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR-----ASN 570 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~ 570 (646)
........ +...-+..|.|||++.+..|+...|+||.||.||||.||+--|..........+.+.+.-. +..
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 87765432 2222455799999999999999999999999999999999988766554433332211100 000
Q ss_pred Cc---------------------------ccccccc------ccc-CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006402 571 GA---------------------------IMEVVDP------RLQ-GHEASVNILMSLKLFSELAVACLREKKSERPSMT 616 (646)
Q Consensus 571 ~~---------------------------~~~~~d~------~l~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 616 (646)
+. ++..+.| .|. ....+.++......+.+|+.+||..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 00 0001111 111 1123334566778899999999999999999999
Q ss_pred HHHH
Q 006402 617 DVVH 620 (646)
Q Consensus 617 evl~ 620 (646)
++|+
T Consensus 742 qAL~ 745 (752)
T KOG0670|consen 742 QALK 745 (752)
T ss_pred HHhc
Confidence 8875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.87 Aligned_cols=132 Identities=29% Similarity=0.372 Sum_probs=110.9
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-----C---CcccccceeEEe---
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-----H---KNLVRLLGCCVE--- 413 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 413 (646)
.+|.+.++||-|-|++||++.. .+.+.||+|+.+... .-.+..+.|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788999999999999999954 468899999986432 33566789999999984 2 369999999985
Q ss_pred -CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 414 -AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 414 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
+.+.++|+|++ |.+|..+|.... -..++...+.+|+.||+.||.|||.+.. |||-||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 34789999998 778888887542 3458999999999999999999999875 99999999999983
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=238.09 Aligned_cols=203 Identities=27% Similarity=0.411 Sum_probs=168.1
Q ss_pred HHHHhcCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCC
Q 006402 341 LKKATNGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAE 415 (646)
Q Consensus 341 l~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 415 (646)
+....+.|..+++||+|.|++||++++. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567888999999999999999654 36789999887653 4556889999999996 999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGL 494 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl 494 (646)
...+|+||++.....++... ++...+...++.+++||+++|..| |+||||||+|+|.+ ..++-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999888888753 678899999999999999999999 99999999999998 567889999999
Q ss_pred CccCC-----------------C-CC-------------------------CccccccCccccccCccccc-cCCCCchh
Q 006402 495 SRLAK-----------------P-GL-------------------------SHVSTCAQGTLGYLDPEYYR-NYQLTDKS 530 (646)
Q Consensus 495 ~~~~~-----------------~-~~-------------------------~~~~~~~~gt~~y~aPE~~~-~~~~~~ks 530 (646)
+.... + .. ........||+||+|||++. ....+.+.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87210 0 00 00001124999999999975 44678999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCC
Q 006402 531 DVYSYGVVLLELLTSQKAIDFSRD 554 (646)
Q Consensus 531 Dv~s~G~ll~elltg~~p~~~~~~ 554 (646)
||||.|++++.+++++.||....+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred ceeeccceeehhhccccccccCcc
Confidence 999999999999999999875544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=251.87 Aligned_cols=269 Identities=25% Similarity=0.398 Sum_probs=208.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+|.....+|.|.+|.|||++.. .++..|+|+++........-..+|+.+++.-+|+|||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 356888899999999999999765 6899999999887767777788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+.+|+|.+.-+. ..++++.++..+.+..++||+|||+.+ =+|||||-.|||+++.+.+|++|||.+-.+.....
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999998774 346899999999999999999999999 69999999999999999999999999876543221
Q ss_pred ccccccCccccccCcccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
......||+.|||||+. +.+.|..++|||+.|+...|+---+.|.. +..- +.+...+... ..-.+.
T Consensus 168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf------dlhp-mr~l~LmTkS---~~qpp~ 236 (829)
T KOG0576|consen 168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF------DLHP-MRALFLMTKS---GFQPPT 236 (829)
T ss_pred -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc------ccch-HHHHHHhhcc---CCCCCc
Confidence 12234699999999986 45679999999999999999987776632 1110 1111111111 111122
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--------HHHHHHHHhhccccc
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE--------LQRIIEIVNQEKVSN 636 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--------L~~~~~~~~~~~~~~ 636 (646)
++... .-.+.+-++++.++..+|.+|||++.+++. ..-.++.|++-.+.+
T Consensus 237 lkDk~------kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 237 LKDKT------KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred ccCCc------cchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 22111 122346689999999999999999988742 233445555555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=265.04 Aligned_cols=195 Identities=21% Similarity=0.264 Sum_probs=138.6
Q ss_pred hCCC-CcccccceeE-------EeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006402 398 QVNH-KNLVRLLGCC-------VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469 (646)
Q Consensus 398 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 469 (646)
.++| +||++++++| .+.+..++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4456 6888899887 3334667889987 66999999743 345899999999999999999999999 9
Q ss_pred eeccCCCCCEEEcC-------------------CCCEEEeecCCCccCCCCCC---------------ccccccCccccc
Q 006402 470 YHRDVKSTNILLDD-------------------DFNSKVADFGLSRLAKPGLS---------------HVSTCAQGTLGY 515 (646)
Q Consensus 470 ~H~Dik~~NIll~~-------------------~~~~ki~DfGl~~~~~~~~~---------------~~~~~~~gt~~y 515 (646)
+||||||+||||+. ++.+||+|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666666653211000 000113478899
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHH
Q 006402 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLK 595 (646)
Q Consensus 516 ~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 595 (646)
+|||++.+..++.++|||||||+||||++|..|+.... ......... ..++.. .....
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~--------~~~~~~---------~~~~~ 239 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR--------VLPPQI---------LLNWP 239 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh--------hcChhh---------hhcCH
Confidence 99999998899999999999999999999887754110 000000000 011111 01122
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 596 LFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 596 ~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....++.+||+.+|.+||+|.|+++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 3457889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=206.68 Aligned_cols=169 Identities=24% Similarity=0.297 Sum_probs=126.5
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
|+|.++++.. ...+++.+++.|+.|+++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888988753 335999999999999999999999976 999999999999999 99988765432
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCch
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 586 (646)
..||+.|+|||++.+..++.++||||||+++|||+||+.||....... ..+.... ...... ++... .
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~------~~~~~---~ 130 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILL-NGMPAD------DPRDR---S 130 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHH-HHhccC------Ccccc---c
Confidence 248999999999999999999999999999999999999986332211 1111111 111100 00000 0
Q ss_pred hHHHHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 587 SVNILMSL--KLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 587 ~~~~~~~~--~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
. ..... ..+.+++.+||+.+|++||++.|+++.+..+..
T Consensus 131 ~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 131 N--LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred c--HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0 11112 258899999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=218.11 Aligned_cols=165 Identities=21% Similarity=0.173 Sum_probs=129.3
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc--CCcEEEEEEcccC-----CcccHHHHHHHHHHHhhCCCCcccccceeEEeC
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ--DGTVVAVKSAKVG-----NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA 414 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 414 (646)
.....+|...+.||+|+||+||+|..+ +++.||||++... .....+.|.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 445678999999999999999999765 5788899986532 12235668999999999999999853322 2
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCEEEcCCCCEEEeecC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV-KSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Di-k~~NIll~~~~~~ki~DfG 493 (646)
+..++||||+++++|... .. .. ...++.|++++|+|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 468999999999999632 11 11 1467889999999999999 999999 9999999999999999999
Q ss_pred CCccCCCCCCc-------cccccCccccccCccccc
Q 006402 494 LSRLAKPGLSH-------VSTCAQGTLGYLDPEYYR 522 (646)
Q Consensus 494 l~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 522 (646)
+++........ ..+...+++.|+|||.+.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99876543211 113456888999999985
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=208.84 Aligned_cols=262 Identities=20% Similarity=0.226 Sum_probs=193.3
Q ss_pred CCCcccEecccCcEEEEEEEEcCC--cEEEEEEcccCCcccHHHHHHHHHHHhhCCC----CcccccceeE-EeCCcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGELQDG--TVVAVKSAKVGNIKSTQQVLNEVGILSQVNH----KNLVRLLGCC-VEAEQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 419 (646)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986543 5788887765433332367788999888873 6899999998 47778899
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-----CCEEEeecCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-----FNSKVADFGL 494 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-----~~~ki~DfGl 494 (646)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.+ ++||||||.|+++... -.+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999775543 456899999999999999999999999 9999999999999754 4699999999
Q ss_pred Cc--cCCCCC------Ccc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 495 SR--LAKPGL------SHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 495 ~~--~~~~~~------~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
++ ...... ... ....+||..|.++....+...+.+.|+||++.++.|++.|..||........... ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HH
Confidence 98 321111 111 1234599999999999999999999999999999999999999864433222111 11
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.......... .. ......+.++...+-..+...+|.-..+...|+......
T Consensus 251 ~~~~~~~~~~-----~~--------~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDR-----FG--------DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcccc-----cc--------CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111110000 00 001122334444444588999999999998887776654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=197.83 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=186.2
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
..+|.+...|..|+|+++.+ .+++|++..... ...++|..|.-.|+-..||||+.++|.|.....+.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45688889999999999754 455677654432 234678899999999999999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccc
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTC 508 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~ 508 (646)
|+..||+. ....++-.++.++|.++|+|++|||+.. +-|...-|.+..+++|++.+++|+- +-.+..-. ...
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsfq-----e~g 345 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ-----EVG 345 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeeee-----ccc
Confidence 99999976 4455788899999999999999999987 4455667999999999999888752 11111111 111
Q ss_pred cCccccccCccccccCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 509 AQGTLGYLDPEYYRNYQLT---DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~---~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
..-.|.|++||.++..+-+ .++|+|||.++||||.|+..||..-..-+ ...++.-+.+.--+.|.
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------cgmkialeglrv~ippg----- 413 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------CGMKIALEGLRVHIPPG----- 413 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------hhhhhhhccccccCCCC-----
Confidence 2357889999999876543 47899999999999999999986322211 11111111111122222
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
....+.+|+.-|.+.||.+||.++.++-.||+++
T Consensus 414 -------is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 -------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2334668999999999999999999999998864
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=175.33 Aligned_cols=101 Identities=30% Similarity=0.581 Sum_probs=78.1
Q ss_pred CCCCC-CCCCceeeccCCCCCCCCC-CCcceeecCCCCceeeccCCCceEEEEEEecCceEEEeecCcccCCCCCCCCcc
Q 006402 31 QKICP-SCGPIQVPYPLSTNPKCGD-PNYLLRCDLHSHKLYFDALNGSSYLVLRTMASSQRIVMQPASWINDSCVTHDMV 108 (646)
Q Consensus 31 ~~~C~-~CG~i~i~yPFg~~~~C~~-~~f~l~C~~~~~~~~l~~~~~~~~~V~~i~~~~~~~~~~~~~~~~~~c~~~~~~ 108 (646)
+++|+ +|||++||||||++++|++ |+|+|+|++++.++.|...++. |+|++|+|++++++|.++.. +.|......
T Consensus 1 ~~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~-~~V~~I~~~~~~i~v~~~~~--~~~~~~~~~ 77 (106)
T PF13947_consen 1 KPGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGN-YEVLSISYENGTIRVSDPIS--SNCYSSSSS 77 (106)
T ss_pred CCCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCc-EEEEEEecCCCEEEEEeccc--cceecCCCC
Confidence 46899 9999999999999999999 9999999998544545444444 99999999999999998653 355554432
Q ss_pred cc--cccccCCCCCccccCC-CeEEEEcCCc
Q 006402 109 TS--EGLWLNQSLPFNVTSS-NTIFLFNCSP 136 (646)
Q Consensus 109 ~~--~~~~~~~~~pf~~s~~-n~~~~~gC~~ 136 (646)
.. .+++++ .||.+++. |.|+++||++
T Consensus 78 ~~~~~~~~~~--~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 78 NSSNSNLSLN--GPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred cccccEEeec--CCceEccCCcEEEEECCCC
Confidence 22 234443 48888875 9999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-21 Score=196.96 Aligned_cols=260 Identities=30% Similarity=0.406 Sum_probs=195.2
Q ss_pred CCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc---cHHHHHHHHHHHhhCCCC-cccccceeEEeCCcCeEEEEE
Q 006402 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK---STQQVLNEVGILSQVNHK-NLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 423 (646)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 78899988755433 367899999999999988 799999999777778999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~~~~~ 502 (646)
+.++++.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977654321125888999999999999999999999 99999999999999888 79999999998655433
Q ss_pred Cc-----cccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-CCccHHHHHHHHhcCCcc
Q 006402 503 SH-----VSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 503 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 573 (646)
.. ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ........+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 22 2344569999999999987 57888999999999999999999996543321 001111111111100 00
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......... ......+.+++..++..+|..|.++.+....
T Consensus 236 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNP--------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcccc--------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 1122346689999999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=181.86 Aligned_cols=204 Identities=22% Similarity=0.281 Sum_probs=168.0
Q ss_pred hcCCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC-CcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH-KNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 422 (646)
...|...++||.|+||.+|.|. ..+|+.||||+-... ....++..|..+...|+| ..|..+.-+..+.+.-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3679999999999999999995 568999999975432 334567789999999975 678888888889999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl~~~~~ 499 (646)
.+ |.+|++...-. ...++..+.+.+|.|++.-++|+|.++ .+||||||+|.|+.- -..+.++|||+++...
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 88998877432 234788999999999999999999999 999999999999963 3468999999998765
Q ss_pred CCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 006402 500 PGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD 556 (646)
Q Consensus 500 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~ 556 (646)
+..+. ......||..|.+-....+...+.+.|+-|+|.+|.++..|..||..-....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 43322 1233459999999888888788999999999999999999999998655443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=221.92 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=189.6
Q ss_pred CcccEecccCcEEEEEEEEc-CCcEEEEEEccc----C-Cccc-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 349 SKERILGSGGFGEVYKGELQ-DGTVVAVKSAKV----G-NIKS-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~-~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
...+++|.|++|.|+..... ..+..+.|.... . .... ...+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777443 444455554331 1 1111 122667888888899999999998888877777779
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++ +|...+... ..+....+..++.|+..|+.|||+.+ |.|||||++|++++.++.+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998753 24778888999999999999999999 999999999999999999999999999876543
Q ss_pred CC---ccccccCccccccCccccccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 502 LS---HVSTCAQGTLGYLDPEYYRNYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 502 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.. .......|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......+... .........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~---- 544 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQR---- 544 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccc----
Confidence 33 3445667999999999999888876 6899999999999999999998665554332 000000000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. .................++.++|+.+|.+|.||++|++
T Consensus 545 --~~-~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 --NI-FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --cc-ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 01111113344556778999999999999999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=184.81 Aligned_cols=265 Identities=15% Similarity=0.204 Sum_probs=196.1
Q ss_pred cCCCcccEecccCcEEEEEEE-EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
-+|.+.++||+|.||..+.|+ +-+++.||||.-...+ +..++..|.+..+.|. .++|...+.+..++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999995 4589999999654332 3345667888888875 78999999999999899999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCCEEEeecCCCccC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-----DFNSKVADFGLSRLA 498 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-----~~~~ki~DfGl~~~~ 498 (646)
+ |-+|+|...-. +..++.++++.||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+++..
T Consensus 106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 88888876532 335899999999999999999999999 999999999999953 346899999999987
Q ss_pred CCCCCcc------ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 499 KPGLSHV------STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 499 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
.+..+.. .....||..||+-....+.+.+.+.|+-|+|-++.+.|.|..||..-...........+....+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 6544321 2344599999999999999999999999999999999999999986655432222222222111111
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
+.++ ....+.++..-++-.=..+-++-|.-+-+..-+..+++.+..
T Consensus 260 i~~L-------------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 260 IEVL-------------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred HHHH-------------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1111 222333444444444455666668877776666666655543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=182.29 Aligned_cols=140 Identities=17% Similarity=0.171 Sum_probs=109.6
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc--c-------HHH-----------------HHHHHHHHhhCCCCcc
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK--S-------TQQ-----------------VLNEVGILSQVNHKNL 404 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 404 (646)
...||+|++|.||+|...+|+.||||+++..... . ... ..+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999998888999999998754211 1 112 2349999999988887
Q ss_pred cccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCCCCCEEEcC
Q 006402 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL-HSAAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 405 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~Dik~~NIll~~ 483 (646)
.....+. ....+|||||++++++...+.. ...+++...+.++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 5444332 2334899999998877654322 23588999999999999999999 6888 999999999999984
Q ss_pred CCCEEEeecCCCccCC
Q 006402 484 DFNSKVADFGLSRLAK 499 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~~ 499 (646)
+.++|+|||++....
T Consensus 154 -~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 -GKLYIIDVSQSVEHD 168 (190)
T ss_pred -CcEEEEEccccccCC
Confidence 689999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=185.92 Aligned_cols=171 Identities=13% Similarity=0.106 Sum_probs=134.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHH---H------HHHHHHHHhhCCCCcccccceeEEeC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQ---Q------VLNEVGILSQVNHKNLVRLLGCCVEA 414 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~ 414 (646)
..++|+..++||.|+||.||.... ++..+|+|.++.......+ . +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 568899999999999999999766 5678999999755433322 2 67899999999999999999987643
Q ss_pred --------CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 415 --------EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 415 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
...++||||++|.+|.++.. ++. ....+++.+|..||..+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988732 222 24569999999999999 99999999999999888
Q ss_pred EEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHH
Q 006402 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ell 543 (646)
++|+|||.......+.... .+.....+..++|+|+||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999887653322111 1333445667999999999988765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-20 Score=175.04 Aligned_cols=141 Identities=18% Similarity=0.177 Sum_probs=112.0
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc--c------------------------HHHHHHHHHHHhhCCCCcc
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK--S------------------------TQQVLNEVGILSQVNHKNL 404 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 404 (646)
...||+|++|.||+|...+|+.||||+++..... . ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998878999999998754211 0 1123578999999999988
Q ss_pred cccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcC
Q 006402 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 405 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~ 483 (646)
.....+... ..++||||++++++...... ...++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655544333 35899999988865443221 2247788999999999999999999 88 99999999999999
Q ss_pred CCCEEEeecCCCccCCC
Q 006402 484 DFNSKVADFGLSRLAKP 500 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~~~ 500 (646)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=208.27 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=178.6
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC-cccHHHHHHHHHH--HhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN-IKSTQQVLNEVGI--LSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++...+.||.+.|=+|.+++++.|. |+||++-+.+ .-..+.|.++++- ...++|||.+++.-+-..++..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999998887 8899886554 3345555544433 4556899999999887778888999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC--CCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA--KPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~--~~~ 501 (646)
.. -+|+|.|.. +.-|...+...|+.|++.||.-.|..+ |+|||||.+||||+.-.-+.|+||..-+.. +.+
T Consensus 103 vk-hnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 489998864 334778888999999999999999999 999999999999998888999999876543 222
Q ss_pred CCc----cccccCccccccCccccccC----------C-CCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCCccHHHHHH
Q 006402 502 LSH----VSTCAQGTLGYLDPEYYRNY----------Q-LTDKSDVYSYGVVLLELLTS-QKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 502 ~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~ksDv~s~G~ll~elltg-~~p~~~~~~~~~~~~~~~~~ 565 (646)
... .....+.-..|+|||.+... . .+++.||||+||++.||++- +++|. +.....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHh
Confidence 211 11122345579999987431 2 67899999999999999985 55554 222111
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+-.+....+.+-..+ ....+++++..|++.||++|.++++.|+.
T Consensus 247 Yr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111000000000000 01236689999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=168.70 Aligned_cols=185 Identities=18% Similarity=0.117 Sum_probs=139.7
Q ss_pred CcccEecccCcEEEEEEEEcCCcEEEEEEcccCCccc----HHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEE
Q 006402 349 SKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS----TQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.....|++|+||+||.+.. ++.+++.+.+.....-. ...|.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997765 67788877776543311 225789999999995 5889999886 456999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV-KSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Di-k~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+.|.+|.+.+.. ....++.|++++|.++|..+ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999988654311 11357789999999999999 999999 7999999999999999999998655433
Q ss_pred Cc----c--------ccccCccccccCccccccC-CCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 006402 503 SH----V--------STCAQGTLGYLDPEYYRNY-QLT-DKSDVYSYGVVLLELLTSQKAIDF 551 (646)
Q Consensus 503 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDv~s~G~ll~elltg~~p~~~ 551 (646)
.. . ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 1112367888888854322 223 467888999999999999887543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=191.52 Aligned_cols=216 Identities=28% Similarity=0.461 Sum_probs=163.7
Q ss_pred HhhCCCCcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eeccC
Q 006402 396 LSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI-YHRDV 474 (646)
Q Consensus 396 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i-~H~Di 474 (646)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+... ...++|.....+.++|++||+|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 46789999999999999999999999999999999999763 456899999999999999999999977 5 99999
Q ss_pred CCCCEEEcCCCCEEEeecCCCccCCCC-CCccccccCccccccCccccccC---C----CCchhhHHHHHHHHHHHHcCC
Q 006402 475 KSTNILLDDDFNSKVADFGLSRLAKPG-LSHVSTCAQGTLGYLDPEYYRNY---Q----LTDKSDVYSYGVVLLELLTSQ 546 (646)
Q Consensus 475 k~~NIll~~~~~~ki~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~----~~~ksDv~s~G~ll~elltg~ 546 (646)
++.|.++|..+.+||+|||+....... ............-|.|||.+... . .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998877431 11111122245679999998653 1 467899999999999999999
Q ss_pred CCCCCCCCCCCc-cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 547 KAIDFSRDPDDV-NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 547 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.||+......+. .+..++.. .....+.|.+... .+...++..++.+||..+|.+||+++.|-..++.+
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999865444332 12222111 1111122222211 02333577899999999999999999998877665
Q ss_pred HH
Q 006402 626 IE 627 (646)
Q Consensus 626 ~~ 627 (646)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 44
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=166.62 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=107.1
Q ss_pred CcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhC-----CCCcccccceeEEeCC---c-CeE
Q 006402 349 SKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-----NHKNLVRLLGCCVEAE---Q-PLL 419 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 419 (646)
+..+.||+|+||.||. ...++.. +||++........+.+.+|+.+++++ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 3234444 69988766555667899999999999 5799999999999874 2 237
Q ss_pred EEEE--ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeccCCCCCEEEcC----CCCEEEeec
Q 006402 420 IYEY--IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL-AYLHSAAYTPIYHRDVKSTNILLDD----DFNSKVADF 492 (646)
Q Consensus 420 V~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~i~H~Dik~~NIll~~----~~~~ki~Df 492 (646)
|+|| ..+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999653 24544 35677888777 9999999 999999999999973 348999995
Q ss_pred CCC
Q 006402 493 GLS 495 (646)
Q Consensus 493 Gl~ 495 (646)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=174.93 Aligned_cols=232 Identities=21% Similarity=0.257 Sum_probs=148.9
Q ss_pred CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCC----------CcccccceeEE-
Q 006402 348 FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNH----------KNLVRLLGCCV- 412 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~- 412 (646)
+...+.||.|+++.||.+++. +++.+|||++..... ...+++.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345688999999999999886 589999998754432 345677777766555432 23333333322
Q ss_pred --------eCC--------cCeEEEEEccCCCccccccC---Cc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 006402 413 --------EAE--------QPLLIYEYIANGTLHDHLHG---KY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHR 472 (646)
Q Consensus 413 --------~~~--------~~~lV~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~ 472 (646)
... +.+++|+-+ -++|.+++.. .. ....+....++.+..|+.+.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 235677766 5688777642 11 1123455667778899999999999999 9999
Q ss_pred cCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCcccccc--------CCCCchhhHHHHHHHHHHHHc
Q 006402 473 DVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN--------YQLTDKSDVYSYGVVLLELLT 544 (646)
Q Consensus 473 Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~s~G~ll~ellt 544 (646)
||||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999877655432211 235678999997633 257889999999999999999
Q ss_pred CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCC
Q 006402 545 SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSER 612 (646)
Q Consensus 545 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 612 (646)
++.||........... .+.. ....++.+..||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f~~------C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DFSR------CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GGTT------SS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cchh------cCCcCHHHHHHHHHHccCCcccC
Confidence 9999975433221111 1110 11345667899999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.3e-20 Score=192.75 Aligned_cols=225 Identities=25% Similarity=0.263 Sum_probs=174.0
Q ss_pred EecccCcEEEEEEE----EcCCcEEEEEEcccCCccc--HHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEcc
Q 006402 353 ILGSGGFGEVYKGE----LQDGTVVAVKSAKVGNIKS--TQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|+|.+|.|+.+. .+.|..+|+|++++..... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999862 2347788999876543321 225567888888887 9999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|.|...+... ...+..........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99999988643 34566667777888999999999999 999999999999999999999999999876543322
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
.||..|||||++. .....+|.||||++++||+||..||.. .....+... .+..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~------------~~~~-- 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKA------------ELEM-- 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhh------------ccCC--
Confidence 4899999999998 456789999999999999999999874 111111100 0000
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
..+......+++.+++..+|.+|--.
T Consensus 207 ----p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 ----PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12233445678888888888888554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=188.74 Aligned_cols=202 Identities=21% Similarity=0.222 Sum_probs=161.3
Q ss_pred cHHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC---CCcccccceeEEe
Q 006402 337 HLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN---HKNLVRLLGCCVE 413 (646)
Q Consensus 337 ~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 413 (646)
...+++.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-. |.--.+++.+|+ -+-|..+...+.-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3445555667789999999999999999998889999999877654322 222223333443 3456666666677
Q ss_pred CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-------CCCC
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-------DDFN 486 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-------~~~~ 486 (646)
.+.-+||+||.+.|+|.+++. ....++|...+.++.|+++.++.||..+ |||+||||+|.||. ++..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 778899999999999999997 3446899999999999999999999999 99999999999994 3456
Q ss_pred EEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 006402 487 SKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~ 547 (646)
++|+|||-+..+..-.. .......+|-.+--+|...+..++...|-|.++.+++-||.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999999876542111 22344568889999999999999999999999999999999863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=161.00 Aligned_cols=134 Identities=22% Similarity=0.381 Sum_probs=114.2
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcc--------cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK--------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+.||+|++|.||+|.. +|..+++|+....... ....+.+|+.++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678889976533211 124578899999999999998888888888889999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988542 12 78899999999999999999 99999999999999 78999999998865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=162.64 Aligned_cols=143 Identities=17% Similarity=0.156 Sum_probs=111.5
Q ss_pred CCCcccEecccCcEEEEEEE--EcCCcEEEEEEcccCCcc------------------------cHHHHHHHHHHHhhCC
Q 006402 347 GFSKERILGSGGFGEVYKGE--LQDGTVVAVKSAKVGNIK------------------------STQQVLNEVGILSQVN 400 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 400 (646)
-|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999988754211 0123568999999997
Q ss_pred CCc--ccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 006402 401 HKN--LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTN 478 (646)
Q Consensus 401 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~N 478 (646)
+.+ +.+++++ ...++||||+++.+|....... ..+.......++.|++.+|++||+.+. |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhh
Confidence 633 3333432 3458999999998887765322 235566778999999999999999874 9999999999
Q ss_pred EEEcCCCCEEEeecCCCccCC
Q 006402 479 ILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 479 Ill~~~~~~ki~DfGl~~~~~ 499 (646)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 7899999999987554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=158.03 Aligned_cols=145 Identities=21% Similarity=0.194 Sum_probs=112.7
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc----------------------cHHHHHHHHHHHh
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK----------------------STQQVLNEVGILS 397 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 397 (646)
++.+....|...+.||+|+||.||++..++|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444447778999999999999998888999999986543210 1123667899999
Q ss_pred hCCCCc--ccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 006402 398 QVNHKN--LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVK 475 (646)
Q Consensus 398 ~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik 475 (646)
++.|++ ++..++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998774 444443 3456899999999998775421 234678899999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEeecCCCccCCC
Q 006402 476 STNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 476 ~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|+||++++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=158.30 Aligned_cols=131 Identities=21% Similarity=0.360 Sum_probs=108.3
Q ss_pred EecccCcEEEEEEEEcCCcEEEEEEcccCCcc--------cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 353 ILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK--------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.||+|++|.||+|.+ ++..+++|+....... ..+.+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5678999985432211 1356778999999999988766666666777889999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875321 0 78999999999999999 99999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-18 Score=179.54 Aligned_cols=123 Identities=33% Similarity=0.466 Sum_probs=108.9
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
.+++.|+++...+|.+||.++......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999877777778999999999999999999 66 899999999999999989999999998
Q ss_pred ccCCCCC-----CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc
Q 006402 496 RLAKPGL-----SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544 (646)
Q Consensus 496 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt 544 (646)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7765443 122344569999999999999999999999999999999997
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=163.21 Aligned_cols=196 Identities=26% Similarity=0.300 Sum_probs=133.4
Q ss_pred CCCcccccceeEEeC---------------------------CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHH
Q 006402 400 NHKNLVRLLGCCVEA---------------------------EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL 452 (646)
Q Consensus 400 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 452 (646)
+|||||+++++|.+. ..+|+||.-+ .-+|.+|+..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 589999988877532 3457888877 45888888643 356667778899
Q ss_pred HHHHHHHHHHhCCCCCeeeccCCCCCEEE--cCCC--CEEEeecCCCccCCCC-----CCccccccCccccccCcccccc
Q 006402 453 QTAEALAYLHSAAYTPIYHRDVKSTNILL--DDDF--NSKVADFGLSRLAKPG-----LSHVSTCAQGTLGYLDPEYYRN 523 (646)
Q Consensus 453 ~ia~~l~yLH~~~~~~i~H~Dik~~NIll--~~~~--~~ki~DfGl~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 523 (646)
|+++|+.|||.++ |.|||+|++|||| |++. ...|+|||.+--.... .........|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999998 3443 4789999987543221 1111112336778899999864
Q ss_pred CC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHH
Q 006402 524 YQ------LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLF 597 (646)
Q Consensus 524 ~~------~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~ 597 (646)
.+ --.|+|.|+.|.+.||+++...||.... +-......| + +.--|.+.+ .....+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y--q--------e~qLPalp~--------~vpp~~ 486 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY--Q--------ESQLPALPS--------RVPPVA 486 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh--h--------hhhCCCCcc--------cCChHH
Confidence 32 1248999999999999999999997411 111111111 1 111111211 122335
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 598 SELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 598 ~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
.+|+...|+.||.+|++..-....|
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHH
Confidence 6899999999999999976655544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=180.72 Aligned_cols=140 Identities=24% Similarity=0.357 Sum_probs=112.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccC-Cc------ccHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVG-NI------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
....|...++||+|+||+||+|.+.+...++.++.... .. ...+.+.+|++++.+++|++++....++.....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34455677899999999999998765443332222211 11 123568899999999999999988888888778
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998874 35678999999999999999 9999999999999 56799999999987
Q ss_pred cC
Q 006402 497 LA 498 (646)
Q Consensus 497 ~~ 498 (646)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 54
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=176.50 Aligned_cols=208 Identities=25% Similarity=0.297 Sum_probs=139.7
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
...+|..+++|..|++|.||.++++ ..+.+|+|. .+.+ .+++- ++.....|.+ |
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfv---------------v-- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFV---------------V-- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCcce---------------e--
Confidence 3467889999999999999999876 466788743 2211 11111 2222233333 2
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+=...++. ..+++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 ----gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 333333332 1233332 278999999999 9999999999999999999999999987532110
Q ss_pred ------------Cc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 503 ------------SH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 503 ------------~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
.+ ....+.||+.|+|||++..+.|...+|.|++|+++||.+.|..||+....++-. ...+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhh
Confidence 00 112346999999999999989999999999999999999999999755333211 1111
Q ss_pred cC-CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC
Q 006402 569 SN-GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP 613 (646)
Q Consensus 569 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 613 (646)
.. ..+.|- |. ....+..+++.+.|+.+|..|-
T Consensus 272 sd~i~wpE~-de------------a~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDDIEWPEE-DE------------ALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhcccccc-Cc------------CCCHHHHHHHHHHHHhChHhhc
Confidence 11 111111 11 1234566899999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.4e-15 Score=136.84 Aligned_cols=136 Identities=24% Similarity=0.251 Sum_probs=114.9
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC--CcccccceeEEeCCcCeEEEEEccCC
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH--KNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999998855 7899998865433 5678899999999986 58899998888778899999999887
Q ss_pred CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 428 TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.++++|||.+...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77654 45677888999999999999965445999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=144.35 Aligned_cols=137 Identities=21% Similarity=0.235 Sum_probs=98.3
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc--cHHHH----------------------HHHHHHHhhCCCCc--c
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK--STQQV----------------------LNEVGILSQVNHKN--L 404 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 404 (646)
.+.||+|+||+||+|...+++.||||+++..... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998888999999987653221 11111 24555566654432 3
Q ss_pred cccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcC
Q 006402 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 405 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~ 483 (646)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 344332 346899999998654322111100 11 5678899999999999999 88 99999999999999
Q ss_pred CCCEEEeecCCCccCC
Q 006402 484 DFNSKVADFGLSRLAK 499 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~~ 499 (646)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.4e-15 Score=144.63 Aligned_cols=135 Identities=24% Similarity=0.309 Sum_probs=105.7
Q ss_pred cEec-ccCcEEEEEEEEcCCcEEEEEEcccCC-------------cccHHHHHHHHHHHhhCCCCcc--cccceeEEeCC
Q 006402 352 RILG-SGGFGEVYKGELQDGTVVAVKSAKVGN-------------IKSTQQVLNEVGILSQVNHKNL--VRLLGCCVEAE 415 (646)
Q Consensus 352 ~~Lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 415 (646)
.+|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999875 6778888775321 1223567889999999998875 67777654432
Q ss_pred c----CeEEEEEccC-CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 416 Q----PLLIYEYIAN-GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 416 ~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
. .++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+.+ |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6898887542 34443 3578999999999999 9999999999999988899999
Q ss_pred ecCCCccC
Q 006402 491 DFGLSRLA 498 (646)
Q Consensus 491 DfGl~~~~ 498 (646)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-16 Score=173.28 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=187.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc--CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ--DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 419 (646)
...|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345777788999999999887553 34567777655443 223344556888888887 9999999999999999999
Q ss_pred EEEEccCCCccccc-cCCcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCc
Q 006402 420 IYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYLH-SAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSR 496 (646)
Q Consensus 420 V~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~ 496 (646)
+.||..++++.+-+ +.. ....+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999988 432 113555667788999999999999 888 99999999999999999 99999999998
Q ss_pred cCCC--CCCccccccCc-cccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 497 LAKP--GLSHVSTCAQG-TLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 497 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
.... +.........| ++.|+|||...+. ......|+||.|+++.-+++|..|+......... ...|.... ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~ 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GR 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---cc
Confidence 7765 33333344457 9999999998874 4466889999999999999999999866544321 11111110 00
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
..... + ........++..+++..+|..|.+.+++-
T Consensus 250 ~~~~~---~---------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLP---W---------NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCc---c---------ccCChhhhhcccccccCCchhcccccccc
Confidence 00000 0 01112234678888889999999998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.1e-14 Score=137.93 Aligned_cols=205 Identities=21% Similarity=0.289 Sum_probs=142.1
Q ss_pred HHHHhhCCCCcccccceeEEeCC-----cCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006402 393 VGILSQVNHKNLVRLLGCCVEAE-----QPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAY 466 (646)
Q Consensus 393 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 466 (646)
..-|-++.|.|||+++.|+.+.+ ...++.|||+.|+|..+|++.. ....+......+|..||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34456677999999999987543 4678999999999999997543 3445788888899999999999999987
Q ss_pred CCeeeccCCCCCEEEcCCCCEEEeecCCCccCC---CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHH
Q 006402 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK---PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543 (646)
Q Consensus 467 ~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ell 543 (646)
|||+|+++.-+-|++..++-+||.----...-. ...........+.++|.|||+-..-+.+..+|||+||+..+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999988884322111100 00011112234788999999877777888999999999999998
Q ss_pred cCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 544 TSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 544 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.---.. .+...... +.+...+.+.+.. .=+.++.+|++..|..||+|.+++..
T Consensus 277 ilEiq~tn---seS~~~~e------------e~ia~~i~~len~--------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTN---SESKVEVE------------ENIANVIIGLENG--------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCC---Ccceeehh------------hhhhhheeeccCc--------cccCcCcccccCCCCCCcchhhhhcC
Confidence 77532111 11110000 0011111111110 01257899999999999999998743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=146.34 Aligned_cols=145 Identities=23% Similarity=0.265 Sum_probs=104.2
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccH----------------------------------------
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST---------------------------------------- 386 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 386 (646)
.|. .+.||.|++|.||+|++++|+.||||+.+....+..
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 367999999999999999999999999865421110
Q ss_pred HHHHHHHHHHhhCC----CCcccccceeEEe-CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHH-HHHH
Q 006402 387 QQVLNEVGILSQVN----HKNLVRLLGCCVE-AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE-ALAY 460 (646)
Q Consensus 387 ~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~y 460 (646)
-+|.+|...+.+++ |.+-+.+-.++.+ ....+|||||++|++|.++...... .. .+.+++.+++. .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHH
Confidence 02455666666552 3333333333332 4467999999999999987643211 12 23456777666 4788
Q ss_pred HHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 461 LH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
+|..+ ++|+|++|.||+++++++++++|||++....+
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99988 99999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=7e-12 Score=117.64 Aligned_cols=130 Identities=22% Similarity=0.184 Sum_probs=97.2
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCccc-ccceeEEeCCcCeEEEEEccCCCcc
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLV-RLLGCCVEAEQPLLIYEYIANGTLH 430 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL~ 430 (646)
+.|+.|.++.||+++.. +..+++|....... ....+.+|+.+++.+.+.+++ +++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 56889999999999875 77899998754421 223467899999998765554 44433 334568999999998876
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 431 DHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA--YTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
+.. . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 531 0 11245678999999999987 22359999999999999 56899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.3e-11 Score=129.01 Aligned_cols=147 Identities=16% Similarity=0.222 Sum_probs=95.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCccc----------------------------------HH-
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKS----------------------------------TQ- 387 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~- 387 (646)
....|+. +-||.|++|.||+|++++ |+.||||+.++.-.+. .+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3455776 789999999999999987 9999999987542110 01
Q ss_pred -----HHHHHHHHHhhCC----CCcccccceeEEe-CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHH-H
Q 006402 388 -----QVLNEVGILSQVN----HKNLVRLLGCCVE-AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTA-E 456 (646)
Q Consensus 388 -----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia-~ 456 (646)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-... ..+... ++...+ .
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~~---la~~~v~~ 271 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMKL---LAERGVEV 271 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHHH---HHHHHHHH
Confidence 2344555555542 3444444444444 4567899999999999874211111 122111 221111 1
Q ss_pred HHHHHHhCCCCCeeeccCCCCCEEEcCCC----CEEEeecCCCccCC
Q 006402 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDF----NSKVADFGLSRLAK 499 (646)
Q Consensus 457 ~l~yLH~~~~~~i~H~Dik~~NIll~~~~----~~ki~DfGl~~~~~ 499 (646)
-+.-++..+ ++|+|+||.||+++.++ ++++.|||+.....
T Consensus 272 ~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 123334567 99999999999999887 99999999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.9e-12 Score=134.17 Aligned_cols=246 Identities=23% Similarity=0.226 Sum_probs=177.4
Q ss_pred CCCcccEecc--cCcEEEEEEEE---cCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCe
Q 006402 347 GFSKERILGS--GGFGEVYKGEL---QDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 347 ~~~~~~~Lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 418 (646)
.|.....+|. |.+|.||++.. .++..+|+|+-+.. .......=++|+...++++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455577899 99999999976 36888999975432 2233333356777777775 999999888888999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE----ALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFG 493 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfG 493 (646)
+-+|.+ +.+|.++.+... ..++....+.+..+..+ ||.++|+.. ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 999987 578888887543 23666777777777777 999999999 9999999999999988 889999999
Q ss_pred CCccCCCCCCc----cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 494 LSRLAKPGLSH----VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 494 l~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
+...+....-. ......|...|++||..++ -++.++|+|++|.+..|-.++..+........ |...+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccccc
Confidence 98877654311 1122357788999999876 67889999999999999999876654332111 11111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
.+- +..... ......+..++.++++.+|-.|++.+.+.
T Consensus 340 ~~~----ip~e~~--------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 340 QGY----IPLEFC--------EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccc----Cchhhh--------cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 110 111111 01112234588899999999999887765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-10 Score=109.91 Aligned_cols=136 Identities=15% Similarity=0.133 Sum_probs=99.0
Q ss_pred cEecccCcEEEEEEEEcC-------CcEEEEEEcccCCc----------------------ccHHHHH----HHHHHHhh
Q 006402 352 RILGSGGFGEVYKGELQD-------GTVVAVKSAKVGNI----------------------KSTQQVL----NEVGILSQ 398 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 398 (646)
..||.|.-+.||.|...+ +..+|||+.+.... ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47899997643210 0122233 79999999
Q ss_pred CCC--CcccccceeEEeCCcCeEEEEEccCCCccc-cccCCcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccC
Q 006402 399 VNH--KNLVRLLGCCVEAEQPLLIYEYIANGTLHD-HLHGKYSSFNLTWSTRLRIALQTAEALAYL-HSAAYTPIYHRDV 474 (646)
Q Consensus 399 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~Di 474 (646)
+.. -++.+++++ ...+|||||+.+..+.. .+++ ..++......+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 863 456666654 56789999997654422 2221 1245556677889999999999 8888 999999
Q ss_pred CCCCEEEcCCCCEEEeecCCCccCC
Q 006402 475 KSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 475 k~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
++.|||+++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999975 589999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.7e-10 Score=122.03 Aligned_cols=166 Identities=20% Similarity=0.188 Sum_probs=124.6
Q ss_pred EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHH
Q 006402 367 LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWST 446 (646)
Q Consensus 367 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 446 (646)
..++..|.|...+...........+-++.|+.++||||+++++.+.+.+..|||+|-+ ..|..++++ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 3468888888887666544556778899999999999999999999999999999976 356666653 23455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCC
Q 006402 447 RLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526 (646)
Q Consensus 447 ~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 526 (646)
....+.||+.||.|||+.+. ++|++|.-..|+++..|+.||++|.+......-.. ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66678999999999997664 99999999999999999999999988754322111 001111222456666543322
Q ss_pred CchhhHHHHHHHHHHHHcC
Q 006402 527 TDKSDVYSYGVVLLELLTS 545 (646)
Q Consensus 527 ~~ksDv~s~G~ll~elltg 545 (646)
-..|.|.||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 235999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-10 Score=111.88 Aligned_cols=143 Identities=24% Similarity=0.329 Sum_probs=112.5
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCC--cccccceeEEeCC---cCeEEEEEcc
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHK--NLVRLLGCCVEAE---QPLLIYEYIA 425 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~ 425 (646)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778899998765432 1356788999999999764 4577777766542 5689999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA---------------------------------------- 465 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 465 (646)
+.++.+.+.. ..++..++..++.+++++|+.||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988886642 24678888899999999999999632
Q ss_pred -------------CCCeeeccCCCCCEEEcC--CCCEEEeecCCCccC
Q 006402 466 -------------YTPIYHRDVKSTNILLDD--DFNSKVADFGLSRLA 498 (646)
Q Consensus 466 -------------~~~i~H~Dik~~NIll~~--~~~~ki~DfGl~~~~ 498 (646)
...++|+|+++.||+++. ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 124799999999999998 666899999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.5e-10 Score=102.56 Aligned_cols=132 Identities=22% Similarity=0.315 Sum_probs=102.2
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEE-cccCC--c-----ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKS-AKVGN--I-----KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+++|+-+.+|.+.+.+. .+++|. +.+.- + -..+.-.+|+.++.+++--.|.-..=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977543 355553 22210 0 1234567899999999766666666666788889999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
++|..|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888643 3567778888899999999 99999999999998874 999999998744
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-11 Score=128.92 Aligned_cols=261 Identities=23% Similarity=0.257 Sum_probs=182.3
Q ss_pred CcccccHHH-HHHHhcCCCcccEecccCcEEEEEEEEc--CCcEEEEEEcccCCcccHHHH--HHHHHHHhhC-CCCccc
Q 006402 332 PARIFHLKE-LKKATNGFSKERILGSGGFGEVYKGELQ--DGTVVAVKSAKVGNIKSTQQV--LNEVGILSQV-NHKNLV 405 (646)
Q Consensus 332 ~~~~~~~~e-l~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv 405 (646)
+..+|.-++ ......+|..+..||.|.|+.|++...+ ++..+++|.+...-.....+. +.|+.+...+ .|.+++
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 444455555 3445567888999999999999998543 678899998765543333322 4566666666 489999
Q ss_pred ccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-
Q 006402 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD- 484 (646)
Q Consensus 406 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~- 484 (646)
+....+...+..++=-||++++++...+. ....++...++++..|++.++.++|+.. ++|+|+||+||++..+
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 98888888888889999999998887662 2335778889999999999999999999 9999999999999875
Q ss_pred CCEEEeecCCCccCCCCCCccccccCccccc-cCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH
Q 006402 485 FNSKVADFGLSRLAKPGLSHVSTCAQGTLGY-LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563 (646)
Q Consensus 485 ~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~ 563 (646)
+.-++.|||.+....-.. ......+..| .+|+......+..+.|++|||.-+.|.+++..--.... .|
T Consensus 404 ~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~ 472 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS 472 (524)
T ss_pred hhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc
Confidence 889999999987532111 1111123334 36666677788899999999999999999864321000 00
Q ss_pred HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 564 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.....+.+ +.+. ....++..+...++..++..||.+.++....+-.
T Consensus 473 --~~i~~~~~-----p~~~---------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 473 --LTIRSGDT-----PNLP---------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --eeeecccc-----cCCC---------chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00111111 0111 1113345678888999999999998887655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.4e-10 Score=100.55 Aligned_cols=144 Identities=19% Similarity=0.272 Sum_probs=108.3
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEE-cccCC-------cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKS-AKVGN-------IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
...+|-+|+-+.|+++.+. |+...||. +.+.- .-..++..+|++.|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999885 66666663 32210 112456788999999987667766666777888889999
Q ss_pred EEccC-CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CEEEeecCCCcc
Q 006402 422 EYIAN-GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF---NSKVADFGLSRL 497 (646)
Q Consensus 422 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~---~~ki~DfGl~~~ 497 (646)
||+++ .++.+++...... .........++.+|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 5788888654322 2223334788999999999999999 99999999999996443 468999999865
Q ss_pred C
Q 006402 498 A 498 (646)
Q Consensus 498 ~ 498 (646)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.7e-09 Score=110.94 Aligned_cols=169 Identities=19% Similarity=0.255 Sum_probs=131.2
Q ss_pred cEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe----CCcCeEEEEEccC-CCcccc
Q 006402 359 FGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQPLLIYEYIAN-GTLHDH 432 (646)
Q Consensus 359 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~ 432 (646)
-.+.||+... ||..|++|+++............-++.++++.|+|+|++.+++.. +..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3678999655 899999999955444444445567889999999999999999883 3467899999986 566665
Q ss_pred ccCCc------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 433 LHGKY------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 433 l~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
-.... .+..+++..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43221 2234788999999999999999999999 88899999999999999999999998776654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKA 548 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p 548 (646)
+.. |.+.. -.+-|.=.||.+++.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 431 11111 2267889999999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.4e-09 Score=98.23 Aligned_cols=126 Identities=25% Similarity=0.309 Sum_probs=83.3
Q ss_pred EEEEEEEcCCcEEEEEEcccCCcc--------------------------cHHHHHHHHHHHhhCCCC--cccccceeEE
Q 006402 361 EVYKGELQDGTVVAVKSAKVGNIK--------------------------STQQVLNEVGILSQVNHK--NLVRLLGCCV 412 (646)
Q Consensus 361 ~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 412 (646)
.||.|...+|+.+|||..+..... ......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999889999999976532100 123457899999999865 45666644
Q ss_pred eCCcCeEEEEEcc--CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 413 EAEQPLLIYEYIA--NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY-LHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 413 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
....|||||++ +..+....... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 35689999998 55554433221 1123455677788886665 57888 9999999999999988 9999
Q ss_pred eecCCCccCC
Q 006402 490 ADFGLSRLAK 499 (646)
Q Consensus 490 ~DfGl~~~~~ 499 (646)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-08 Score=102.03 Aligned_cols=272 Identities=19% Similarity=0.215 Sum_probs=163.4
Q ss_pred CcccEecccCcEEEEEE-EEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeE------Ee-CCcCeE
Q 006402 349 SKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCC------VE-AEQPLL 419 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~-~~~~~l 419 (646)
...+-||+|+.+.+|.. ...| -+-|+.+........+ -+..|... .||-+-.=+.|= -+ ....-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34577999999999964 2222 2335554433222222 22333333 455433212211 11 122456
Q ss_pred EEEEccCCC-ccccc---cCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 420 IYEYIANGT-LHDHL---HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 420 V~e~~~~gs-L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
.|..+++.. ...++ +++.+-....|...++.++.+|.+.+-||..| .+-+|+.++|+|+++++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 777776542 12222 12223345799999999999999999999999 788999999999999999999886644
Q ss_pred ccCCCCCCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCCccHHHHHHHHhc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTS-QKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
..... .....+..|.+.|++||.-. +..-+..+|.|.+|+++++++.| +.||.......+..-... ..+-
T Consensus 165 qi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia 240 (637)
T COG4248 165 QINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIA 240 (637)
T ss_pred eeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhh
Confidence 33322 22334567999999999753 44567789999999999999887 899875432211100000 0000
Q ss_pred CCccccccc--ccccCCchhHHHHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHhhcc
Q 006402 570 NGAIMEVVD--PRLQGHEASVNILMSLKLFSELAVACLRE--KKSERPSMTDVVHELQRIIEIVNQEK 633 (646)
Q Consensus 570 ~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~li~~cl~~--~p~~RPs~~evl~~L~~~~~~~~~~~ 633 (646)
.+.....-| +.+........-......+..+..+|+.. ++.-|||.+-.+..|..+..++-+=-
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 111111111 01111111111223344566788888865 36789999999999999888776543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-08 Score=101.62 Aligned_cols=141 Identities=16% Similarity=0.108 Sum_probs=101.6
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCccc-----------HHHHHHHHHHHhhCCCCcc--cccceeEEeC----
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS-----------TQQVLNEVGILSQVNHKNL--VRLLGCCVEA---- 414 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~---- 414 (646)
+.+-.-....|.+..+ +|+.+.||+........ ...+.+|...+.++...+| +.++++....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667766 57789999764333111 1147899999988864444 4556666542
Q ss_pred -CcCeEEEEEccCC-CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------CC
Q 006402 415 -EQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-------DF 485 (646)
Q Consensus 415 -~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-------~~ 485 (646)
..-+||+|++++. +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 2467999999886 8888875321 223456677889999999999999999 999999999999975 56
Q ss_pred CEEEeecCCCcc
Q 006402 486 NSKVADFGLSRL 497 (646)
Q Consensus 486 ~~ki~DfGl~~~ 497 (646)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-08 Score=96.08 Aligned_cols=136 Identities=21% Similarity=0.201 Sum_probs=99.9
Q ss_pred CCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc----------------------ccHHHHHHHHHHHhhCCCC--c
Q 006402 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI----------------------KSTQQVLNEVGILSQVNHK--N 403 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 403 (646)
..+...||.|.-+.||.|....|.++|||.=+.... .......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455688999999999999999999999994321100 0123457899999999755 7
Q ss_pred ccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 006402 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 404 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~ 483 (646)
+.+.+++ +...+||||+++-.|...- ++....-.|+..|++-+.-+-..| |+|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777765 5678999999887666532 122333345555555555555777 999999999999999
Q ss_pred CCCEEEeecCCCccC
Q 006402 484 DFNSKVADFGLSRLA 498 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~ 498 (646)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999765543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-09 Score=121.77 Aligned_cols=249 Identities=20% Similarity=0.221 Sum_probs=163.0
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
..+.+.+.+-+-.|.++.++.+.-. .|...+.|+..... ..+.+....+-.++-..+||-++....-+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666667778999999877433 24333444332221 1222333334444444456777766655556678899
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|++|+.+++|..-|+... ..+.......+..+..+++|||... +.|+|++|.|+|+..++..++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999988543 3444444556667888999999987 8999999999999999999999998432110
Q ss_pred ---------------------C---------CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006402 500 ---------------------P---------GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAI 549 (646)
Q Consensus 500 ---------------------~---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~ 549 (646)
. +.........+|+.|.+||...+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0001122345899999999999988889999999999999999999998
Q ss_pred CCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006402 550 DFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMT 616 (646)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 616 (646)
......... ..+... +..+... ..+....+.+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~~f-------~ni~~~------~~~~p~g-----~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF-------ENILNR------DIPWPEG-----PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh-------hccccC------CCCCCCC-----ccccChhhhhhhhhhhccCchhccCcc
Confidence 743322111 001000 0001100 111223345788888889999997765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.3e-07 Score=86.28 Aligned_cols=139 Identities=16% Similarity=0.122 Sum_probs=103.5
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEcccCC------cccHHHHHHHHHHHhhCCCCc--ccccceeEE-eCC----cCeEE
Q 006402 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGN------IKSTQQVLNEVGILSQVNHKN--LVRLLGCCV-EAE----QPLLI 420 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~~~----~~~lV 420 (646)
-|+||.+.|+...+.+ ..+-+|+-...- +-....|.+|+..|.++...+ +.+++ ++. ... ..+||
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 3668999999987754 468888654111 235678999999999996433 45555 333 221 35799
Q ss_pred EEEccC-CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--EEEeecCCCcc
Q 006402 421 YEYIAN-GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN--SKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~--~ki~DfGl~~~ 497 (646)
+|-+++ -+|.+++.+. ...+.+...+..++.++++.++-||+.+ +.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997754 5888887543 2234677888899999999999999999 999999999999986666 99999987764
Q ss_pred C
Q 006402 498 A 498 (646)
Q Consensus 498 ~ 498 (646)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.8e-07 Score=89.26 Aligned_cols=108 Identities=25% Similarity=0.268 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHhhCCCC--cccccceeEEeCC----cCeEEEEEccCC-CccccccCCcCCCCCCHHHHHHHHHHHHHHH
Q 006402 386 TQQVLNEVGILSQVNHK--NLVRLLGCCVEAE----QPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458 (646)
Q Consensus 386 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 458 (646)
.....+|...+.++... ...+.+++..... ..++|+|++++. +|.+++.+.. .++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34577888888887543 3567777766643 347999999884 7999886532 155667788999999999
Q ss_pred HHHHhCCCCCeeeccCCCCCEEEcCCC---CEEEeecCCCccCC
Q 006402 459 AYLHSAAYTPIYHRDVKSTNILLDDDF---NSKVADFGLSRLAK 499 (646)
Q Consensus 459 ~yLH~~~~~~i~H~Dik~~NIll~~~~---~~ki~DfGl~~~~~ 499 (646)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 99999999999999876 89999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.7e-08 Score=108.89 Aligned_cols=151 Identities=22% Similarity=0.254 Sum_probs=101.1
Q ss_pred HHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc--------cccccCccccccCcccccc
Q 006402 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH--------VSTCAQGTLGYLDPEYYRN 523 (646)
Q Consensus 452 ~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 523 (646)
.+++.|+.|+|.... +||++|.|++|.++.++..||+.|+.+......... .....+....|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345599999998764 999999999999999999999999988765442211 1112235668999999988
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHH
Q 006402 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVA 603 (646)
Q Consensus 524 ~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~ 603 (646)
...+.++|+||+|+++|.+..|.++.......... ....... .+...... ......++.+=+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~~~~~~--------~~~~~~~~-----s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YSFSRNL--------LNAGAFGY-----SNNLPSELRESLKK 247 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch---hhhhhcc--------cccccccc-----cccCcHHHHHHHHH
Confidence 77889999999999999999665553322111100 0000000 00000000 01233456677889
Q ss_pred hcccCCCCCCCHHHHHH
Q 006402 604 CLREKKSERPSMTDVVH 620 (646)
Q Consensus 604 cl~~~p~~RPs~~evl~ 620 (646)
.+..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999998887764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5e-06 Score=80.18 Aligned_cols=152 Identities=20% Similarity=0.224 Sum_probs=103.9
Q ss_pred ccHHHHHHHhcCCCcccEec---ccCcEEEEEEEEcCCcEEEEEEcccCCccc-------------------HH-----H
Q 006402 336 FHLKELKKATNGFSKERILG---SGGFGEVYKGELQDGTVVAVKSAKVGNIKS-------------------TQ-----Q 388 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~ 388 (646)
.+.+.|....++..+....| .|.-+.||+|...++..+|||+.+...... .+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45667777777776665554 677788999988889999999876432211 11 1
Q ss_pred HHHHHHHHhhCC--CCcccccceeEEeCCcCeEEEEEccCC-CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 006402 389 VLNEVGILSQVN--HKNLVRLLGCCVEAEQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-A 464 (646)
Q Consensus 389 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~ 464 (646)
..+|+..|+++. +-.+.+.+++ ..-.|||||+... .-.-.|+ ..++.......+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 245777777764 3344455443 2347999999653 1112222 1123333567788889999988887 6
Q ss_pred CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 465 ~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
+ ++|+||+.-|||+. ++.+.|+|||-+....
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 6 99999999999999 7799999999876554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.7e-07 Score=96.63 Aligned_cols=147 Identities=22% Similarity=0.241 Sum_probs=97.8
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccH------------------------------H--------
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST------------------------------Q-------- 387 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~-------- 387 (646)
..|+. +-|+.++-|.||+|++++|+.||||+.++.-.+.. +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 56889999999999999999999998775422110 0
Q ss_pred --HHHHHHHHHhhCC----CCcccccceeEEe-CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHH-HH
Q 006402 388 --QVLNEVGILSQVN----HKNLVRLLGCCVE-AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEA-LA 459 (646)
Q Consensus 388 --~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~ 459 (646)
++.+|...+.+++ +.--+++=.++.+ .....|+|||++|-.+.+...-+. ..++... ++..++++ +.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHH
Confidence 2445666655552 2222333344443 567899999999999988853221 2244333 33333322 22
Q ss_pred HHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 460 yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
.+=..+ ++|.|..|.||+++.++++.+.|||+.....+.
T Consensus 280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 233355 899999999999999999999999998766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.6e-06 Score=80.35 Aligned_cols=138 Identities=18% Similarity=0.257 Sum_probs=93.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHH---------HHHHHHHhhCCCCccc---ccceeE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQV---------LNEVGILSQVNHKNLV---RLLGCC 411 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~niv---~l~~~~ 411 (646)
...+|...+++-......|.+-.. +|..+++|..+.......+.| .+++..+.+++..++. .++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788878887777777777666 568899998876543333322 2344444444433333 322222
Q ss_pred Ee-----CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 412 VE-----AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 412 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
.. ....+++|||++|..|.++.. ++. .++..+.+++.-||..| ++|+|..|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 22 234468999999988877642 222 35567888899999999 9999999999999966 4
Q ss_pred EEEeecCCCcc
Q 006402 487 SKVADFGLSRL 497 (646)
Q Consensus 487 ~ki~DfGl~~~ 497 (646)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.2e-06 Score=81.48 Aligned_cols=132 Identities=20% Similarity=0.156 Sum_probs=84.9
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--ccccceeEEeCCcCeEEEEEccCCC-
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRLLGCCVEAEQPLLIYEYIANGT- 428 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs- 428 (646)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24457788876432 3455788999999986443 4677777777777789999998863
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhC-CCCC
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEA---------------------------------------LAYLHSA-AYTP 468 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------l~yLH~~-~~~~ 468 (646)
+...+. .+......++.++++. ..+|... ..+.
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221111 0011111111122222 2222211 1234
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.5e-06 Score=78.63 Aligned_cols=105 Identities=27% Similarity=0.355 Sum_probs=83.8
Q ss_pred HHHHHHHhhCCC-CcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006402 390 LNEVGILSQVNH-KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468 (646)
Q Consensus 390 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 468 (646)
.+|..+++.+.+ +++++++|+| ..++|.||...+++...-..-..-..-+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888998876 6999999998 45789999987766432100001123689999999999999999999976666
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+.-.|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=79.24 Aligned_cols=143 Identities=23% Similarity=0.229 Sum_probs=83.8
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC--cccccceeEEeC---CcCeEEEEEcc
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK--NLVRLLGCCVEA---EQPLLIYEYIA 425 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~~ 425 (646)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3678999999999999877 58899986543 4556778899998888633 345666644332 24579999999
Q ss_pred CCCccc----------------cc---cCCc-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 006402 426 NGTLHD----------------HL---HGKY-SSFNLTWST---------RLRI------------ALQTAE-ALAYLHS 463 (646)
Q Consensus 426 ~gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~ 463 (646)
+..+.. .+ +... ......+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 1110 001111110 0000 111222 3333332
Q ss_pred C----CCCCeeeccCCCCCEEEc-CCCCEEEeecCCCc
Q 006402 464 A----AYTPIYHRDVKSTNILLD-DDFNSKVADFGLSR 496 (646)
Q Consensus 464 ~----~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~ 496 (646)
. ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234499999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.3e-05 Score=78.18 Aligned_cols=139 Identities=18% Similarity=0.143 Sum_probs=83.8
Q ss_pred ecccCc-EEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEccCCCccc
Q 006402 354 LGSGGF-GEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIANGTLHD 431 (646)
Q Consensus 354 Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 431 (646)
|-.|.. ..||+.... +..+.+|...... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 789998764 4678888775432 345668888888884 4445677777766667899999999987764
Q ss_pred cc-------------------cCCcC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 006402 432 HL-------------------HGKYS-SFNLT--WSTRLRIAL--------------------QTAEALAYLHS----AA 465 (646)
Q Consensus 432 ~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~l~yLH~----~~ 465 (646)
.. |.... ..+.. ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 00111 001110000 01111222211 11
Q ss_pred CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 466 ~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.1e-05 Score=85.24 Aligned_cols=146 Identities=20% Similarity=0.236 Sum_probs=94.0
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCccc-------------------------------------HHH
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS-------------------------------------TQQ 388 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~ 388 (646)
..|+ .+-|+.-+.|.||+|++++|+.||||+-+..-.+. .=+
T Consensus 162 ~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 162 SEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred HhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 3344 35699999999999999999999999876532210 003
Q ss_pred HHHHHHHHhhC----CCCc---ccccceeEEe-CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHH
Q 006402 389 VLNEVGILSQV----NHKN---LVRLLGCCVE-AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460 (646)
Q Consensus 389 ~~~E~~~l~~l----~h~n---iv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y 460 (646)
|.+|.+...+. +|-+ -|.+=.++.+ .....|+||||+|..+.+.-.-. ...++...+.. .+.++...
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~---~l~~~~~~ 315 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILN---KLVEAYLE 315 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHH---HHHHHHHH
Confidence 55565544443 3555 2223334443 34779999999998887754221 22355544333 33332221
Q ss_pred -HHhCCCCCeeeccCCCCCEEEc----CCCCEEEeecCCCccCCC
Q 006402 461 -LHSAAYTPIYHRDVKSTNILLD----DDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 461 -LH~~~~~~i~H~Dik~~NIll~----~~~~~ki~DfGl~~~~~~ 500 (646)
|=..| .+|.|=.|.||+++ .++.+.+.|||+......
T Consensus 316 qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 316 QIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 12234 89999999999998 367899999999876654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.2e-07 Score=95.46 Aligned_cols=181 Identities=19% Similarity=0.153 Sum_probs=131.1
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc-ccccceeEEeCCcCeEEEEEccCC-Cc
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN-LVRLLGCCVEAEQPLLIYEYIANG-TL 429 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~~~g-sL 429 (646)
.-+++|+.++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..++++++...+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 446889999999986554444445554332 34456899999999999 677777777777888999998776 22
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcccccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 509 (646)
..-.. .....+...+...+.+.-++++++||+.. =+|+| ||+..+ ...|..||+....+..... ....
T Consensus 323 ~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~--~~t~ 390 (829)
T KOG0576|consen 323 ALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK--PRTA 390 (829)
T ss_pred cccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccc--cccC
Confidence 21111 11222444555667777889999999975 48999 887776 4799999999887765432 2334
Q ss_pred CccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006402 510 QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAI 549 (646)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~ 549 (646)
.+|+.++|||+.....+..+.|+|+.|+--.+|--|-.|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 5899999999999989999999999998766776665553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.01 E-value=8.9e-05 Score=86.93 Aligned_cols=148 Identities=21% Similarity=0.326 Sum_probs=92.5
Q ss_pred ccEecccCcEEEEEEEEcCC---cEEEEEEcccCC-cccHHHHHHHHHHHhhCC-CCcc--cccceeEEeC---CcCeEE
Q 006402 351 ERILGSGGFGEVYKGELQDG---TVVAVKSAKVGN-IKSTQQVLNEVGILSQVN-HKNL--VRLLGCCVEA---EQPLLI 420 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 420 (646)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877654 367777754432 223457889999999996 6665 7777777654 467899
Q ss_pred EEEccCCCcccc-----------------------ccCCcC--------CCCCCH--HHHHHHH---------------H
Q 006402 421 YEYIANGTLHDH-----------------------LHGKYS--------SFNLTW--STRLRIA---------------L 452 (646)
Q Consensus 421 ~e~~~~gsL~~~-----------------------l~~~~~--------~~~l~~--~~~~~i~---------------~ 452 (646)
|||+++..+.+- ||.... ..+..+ .++.++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 111100 000011 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeeeccCCCCCEEEcC-CCC-EEEeecCCCccC
Q 006402 453 QTAEALAYLHSAAY--------TPIYHRDVKSTNILLDD-DFN-SKVADFGLSRLA 498 (646)
Q Consensus 453 ~ia~~l~yLH~~~~--------~~i~H~Dik~~NIll~~-~~~-~ki~DfGl~~~~ 498 (646)
.+.+.+.+|..+-. +.++|+|+++.|||++. +.+ +-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23334566654332 23999999999999984 333 579999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00016 Score=68.90 Aligned_cols=129 Identities=22% Similarity=0.258 Sum_probs=90.1
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEEcccCC----------------cccHHHHHHHHHHHhhCC------CCccccc
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKSAKVGN----------------IKSTQQVLNEVGILSQVN------HKNLVRL 407 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 407 (646)
....||+|+.=.||.- .+.....||+..... ....++..+|+.-..++. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999963 344556788776654 122455666766665555 8899999
Q ss_pred ceeEEeCCcCeEEEEEccC------CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 408 LGCCVEAEQPLLIYEYIAN------GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
+|+..++...-+|+|.+.+ -+|.+++... .++. . +...+-+-..||-+.+ |+.+|++|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998754 3566776432 2444 3 3333445556777888 9999999999999
Q ss_pred cCC--C--CEEEee
Q 006402 482 DDD--F--NSKVAD 491 (646)
Q Consensus 482 ~~~--~--~~ki~D 491 (646)
..+ + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=67.03 Aligned_cols=128 Identities=21% Similarity=0.238 Sum_probs=88.1
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccc-cceeEEeCCcCeEEEEEccCCC
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR-LLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gs 428 (646)
..+.|++|.+|.||+|.+.+ ..+|+|+-+.. .....+..|+++|..+.-.++-+ ++.+. ..++.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 45779999999999999964 47888875443 45677889999999998666643 44332 2345599998888
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC-CCCEEEcCCCCEEEeecCCCcc
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVK-STNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik-~~NIll~~~~~~ki~DfGl~~~ 497 (646)
|.+.-... +-.+. ..+++.---|...+ |-|+.|. |..++|-.+..+.|+||..|+.
T Consensus 99 L~~~~~~~------~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------DRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------cHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87764321 22333 34555545566677 9999987 4444444444999999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00019 Score=71.10 Aligned_cols=74 Identities=20% Similarity=0.275 Sum_probs=46.1
Q ss_pred cEecccCcE-EEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC---cccccceeEEeCC---cCeEEEEEc
Q 006402 352 RILGSGGFG-EVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK---NLVRLLGCCVEAE---QPLLIYEYI 424 (646)
Q Consensus 352 ~~Lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lV~e~~ 424 (646)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766666 58875 234677865432 2345788999999888632 2344444333222 348899999
Q ss_pred cCCCccc
Q 006402 425 ANGTLHD 431 (646)
Q Consensus 425 ~~gsL~~ 431 (646)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9977754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00025 Score=70.13 Aligned_cols=141 Identities=20% Similarity=0.246 Sum_probs=82.0
Q ss_pred cEecccCcEEEEEEEEcC--CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCccc-ccceeEEeCCcCeEEEEEccCCC
Q 006402 352 RILGSGGFGEVYKGELQD--GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLV-RLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
+.|..|-...+|+....+ ++.+++|+....... .-+..+|+.+++.+...+++ ++++.. + ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 567888889999987764 678889977543221 12334788888888644443 443332 2 248999999877
Q ss_pred cccc-----------------ccCCcCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 006402 429 LHDH-----------------LHGKYSS--------FNLT-WSTRLRIAL----------------------QTAEALAY 460 (646)
Q Consensus 429 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~l~y 460 (646)
+... +|..... .... +..+..+.. .+.+-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6421 1111111 0111 222112111 11111112
Q ss_pred H----HhC-CCCCeeeccCCCCCEEEcC-CCCEEEeecCCCcc
Q 006402 461 L----HSA-AYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRL 497 (646)
Q Consensus 461 L----H~~-~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~ 497 (646)
| ... ....++|+|+.+.|||+++ +..+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 211 1234899999999999997 57899999988754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00038 Score=71.40 Aligned_cols=76 Identities=11% Similarity=0.116 Sum_probs=56.1
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC---CcccccceeEEe---CCcCeEEEEEc
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH---KNLVRLLGCCVE---AEQPLLIYEYI 424 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lV~e~~ 424 (646)
.+-||+|..+.||.....+++ +.+|..+. ......|.+|.+.|+.+.- -.+.++++++.. .+..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 467999999999998766664 66676432 1133578899999998853 357788887754 35689999999
Q ss_pred cCCCc
Q 006402 425 ANGTL 429 (646)
Q Consensus 425 ~~gsL 429 (646)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00023 Score=67.31 Aligned_cols=125 Identities=26% Similarity=0.371 Sum_probs=90.2
Q ss_pred cCCCcccEecccCc-EEEEEEEEcCCcEEEEEEccc---CCc------------------ccHHHHHHHHHHHhhCC---
Q 006402 346 NGFSKERILGSGGF-GEVYKGELQDGTVVAVKSAKV---GNI------------------KSTQQVLNEVGILSQVN--- 400 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 400 (646)
..++..+.||.|.. |.|||++. +|+.+|+|.++. ... .-...|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999998 467999998322 100 01235788888888775
Q ss_pred CCcc--cccceeEEeCC------------------cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHH
Q 006402 401 HKNL--VRLLGCCVEAE------------------QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460 (646)
Q Consensus 401 h~ni--v~l~~~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y 460 (646)
+.++ |+.+||..-.. .+.||.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4566 89999874321 2357777765432 112 2345577788899
Q ss_pred HHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 461 LH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999986 4589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00026 Score=71.09 Aligned_cols=138 Identities=17% Similarity=0.153 Sum_probs=79.4
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEEccCCCcccc
Q 006402 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEYIANGTLHDH 432 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL~~~ 432 (646)
+..|-...+|+... +++.+++|........-.-+..+|..+++.+....+ .+++... ...+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 55677889998874 567788887654322211235678899998865444 3344332 24799999998776532
Q ss_pred -----------------ccCCc-CCCCCCHHHHH-HHHHH---------HHHHHHHHHhC-----CCCCeeeccCCCCCE
Q 006402 433 -----------------LHGKY-SSFNLTWSTRL-RIALQ---------TAEALAYLHSA-----AYTPIYHRDVKSTNI 479 (646)
Q Consensus 433 -----------------l~~~~-~~~~l~~~~~~-~i~~~---------ia~~l~yLH~~-----~~~~i~H~Dik~~NI 479 (646)
||... ...+++...++ ....+ +...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12211 11112222111 11111 11112222211 123489999999999
Q ss_pred EEcCCCCEEEeecCCCcc
Q 006402 480 LLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 480 ll~~~~~~ki~DfGl~~~ 497 (646)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00093 Score=68.64 Aligned_cols=143 Identities=20% Similarity=0.190 Sum_probs=85.6
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--cccccee------EEeCCcCeEEEE
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRLLGC------CVEAEQPLLIYE 422 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e 422 (646)
.+.|..|....+|+....++ .+++|+... ...+....|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 35577788889999876544 688888754 23455667888888775333 4444432 123445689999
Q ss_pred EccCCCcccc--------------ccCCc---C-----CCCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 006402 423 YIANGTLHDH--------------LHGKY---S-----SFNLTWSTRL----------RIALQTAEALAYLHSA----AY 466 (646)
Q Consensus 423 ~~~~gsL~~~--------------l~~~~---~-----~~~l~~~~~~----------~i~~~ia~~l~yLH~~----~~ 466 (646)
|++|..+... +|... . .....|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776430 01100 0 0111222211 0112233445555531 12
Q ss_pred CCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 467 ~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3489999999999999987778999997653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=68.11 Aligned_cols=141 Identities=22% Similarity=0.257 Sum_probs=84.2
Q ss_pred cEecccCcEEEEEEEEcC-------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQD-------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 423 (646)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+...++ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456677778999987765 5789999865543 223455688888888864334 34454443 2368999
Q ss_pred ccCCCcccc-----------------ccCCcCCC------CC--CHHHHHH--------------------------HHH
Q 006402 424 IANGTLHDH-----------------LHGKYSSF------NL--TWSTRLR--------------------------IAL 452 (646)
Q Consensus 424 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~ 452 (646)
++|..+... +|...... .. -|..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 11111110 00 0111111 111
Q ss_pred HHHHHHHHHHh------CCCCCeeeccCCCCCEEEcCC----CCEEEeecCCCcc
Q 006402 453 QTAEALAYLHS------AAYTPIYHRDVKSTNILLDDD----FNSKVADFGLSRL 497 (646)
Q Consensus 453 ~ia~~l~yLH~------~~~~~i~H~Dik~~NIll~~~----~~~ki~DfGl~~~ 497 (646)
.+...+.+|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233334432 123458999999999999974 7899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0017 Score=68.67 Aligned_cols=74 Identities=18% Similarity=0.201 Sum_probs=53.6
Q ss_pred cEecccCcEEEEEEEEcCC-cEEEEEEcccC-----C--cccHHHHHHHHHHHhhCC---CCcccccceeEEeCCcCeEE
Q 006402 352 RILGSGGFGEVYKGELQDG-TVVAVKSAKVG-----N--IKSTQQVLNEVGILSQVN---HKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 420 (646)
+.||.|.+..||++...+| +.|+||.-... . .-..+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998877 58999974321 1 124566778888888863 2456666665 44567899
Q ss_pred EEEccCC
Q 006402 421 YEYIANG 427 (646)
Q Consensus 421 ~e~~~~g 427 (646)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00052 Score=79.02 Aligned_cols=195 Identities=20% Similarity=0.180 Sum_probs=134.1
Q ss_pred HHHHHHHHhhCCCCcccccceeEEeCCcCe----EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 006402 389 VLNEVGILSQVNHKNLVRLLGCCVEAEQPL----LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464 (646)
Q Consensus 389 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~ 464 (646)
..-|...+.++.|+|++.++.|..+....- +..|+++.-++...+... ..++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677788889999999999987754332 345677777777776533 3578888889999999999999998
Q ss_pred CCCCeeeccCCCC---CEEEcCCCCEEEe--ecCCCccCCCCCCccccccCccccccCccccccCCCC--chhhHHHHHH
Q 006402 465 AYTPIYHRDVKST---NILLDDDFNSKVA--DFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT--DKSDVYSYGV 537 (646)
Q Consensus 465 ~~~~i~H~Dik~~---NIll~~~~~~ki~--DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~ksDv~s~G~ 537 (646)
. ..|.-+..+ +-..+..+.+.++ ||+.++.......... ..-+..+.+||.......+ ...|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 6 666666555 5555677778887 9998887765433222 2245567888887665444 4579999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006402 538 VLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTD 617 (646)
Q Consensus 538 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~e 617 (646)
++..+..|..+-..... ...+++.. ....+.+...+|+..++++|++..+
T Consensus 381 l~~~~~~~~~i~~~~~~------------------~~~~l~~~------------~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV------------------PVSLLDVL------------STSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHhhhhhcCcccccccc------------------hhhhhccc------------cchhhhhhhhhhcchhhhhccchhh
Confidence 99999987654221100 00011100 0012446788999999999999999
Q ss_pred HHHH
Q 006402 618 VVHE 621 (646)
Q Consensus 618 vl~~ 621 (646)
++..
T Consensus 431 ll~~ 434 (1351)
T KOG1035|consen 431 LLTH 434 (1351)
T ss_pred hhhc
Confidence 8854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0017 Score=67.08 Aligned_cols=144 Identities=15% Similarity=0.177 Sum_probs=82.3
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--ccccceeE------EeCCcCeEEEE
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRLLGCC------VEAEQPLLIYE 422 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~e 422 (646)
.+.++.|....+|+.+..+| .+++|+.+... ..+....|.+++..|...+ +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34567777789999876555 56778765421 2344556777777764222 34444321 12345689999
Q ss_pred EccCCCcccc--------------ccCCcCCC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 006402 423 YIANGTLHDH--------------LHGKYSSF---------NLTWSTRL------------RIALQTAEALAYLHS---- 463 (646)
Q Consensus 423 ~~~~gsL~~~--------------l~~~~~~~---------~l~~~~~~------------~i~~~ia~~l~yLH~---- 463 (646)
|++|..+... +|...... .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654311 12110000 01121110 011223345555543
Q ss_pred CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 464 ~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
.....++|+|+.+.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1224599999999999999887778999998653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0055 Score=63.68 Aligned_cols=142 Identities=16% Similarity=0.159 Sum_probs=76.5
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--ccccce------eEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRLLG------CCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~e~ 423 (646)
+.|+.|....+|+.+..+| .+++|+.... ..+....|..++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4466777789999887666 5788877522 2233344555555553222 333332 11224567899999
Q ss_pred ccCCCcccc--------------ccCCcC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 006402 424 IANGTLHDH--------------LHGKYS--------SFNLTW-STRLR------------IA-LQTAEALAYLHSA--- 464 (646)
Q Consensus 424 ~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~-~~ia~~l~yLH~~--- 464 (646)
++|..+... +|.... ...+.| ..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 988754321 111100 011212 11111 11 1111222333211
Q ss_pred -CCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 465 -AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 465 -~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
-...++|+|+.+.||+++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123499999999999999775568999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.008 Score=60.93 Aligned_cols=72 Identities=15% Similarity=0.121 Sum_probs=41.7
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC-cccccceeEEeCCcCeEEEEEccCCCc
Q 006402 354 LGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK-NLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 354 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
.++|-...|+.....+|+.+++|.-+.. .......+|.++|+.+... -+ ..-.+... +...++|++++|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~v-pvP~~~~~-~~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPV-QVPDWRVH-TPELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCC-CCCceeee-cCceEEEeccCCCcc
Confidence 3444445666655556888999976432 2345678899999988531 11 11111111 233577888777655
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.00083 Score=67.25 Aligned_cols=145 Identities=19% Similarity=0.228 Sum_probs=99.9
Q ss_pred ccHHHHHHHhcC---CCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC-----cc-----------------cHHHHH
Q 006402 336 FHLKELKKATNG---FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN-----IK-----------------STQQVL 390 (646)
Q Consensus 336 ~~~~el~~~~~~---~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~-----------------~~~~~~ 390 (646)
+.+--|+...++ ++..+.||-|.-+.+|.+-..+|+..++|.-+... .+ +.-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 344455554443 56788999999999999999899999998322110 00 011345
Q ss_pred HHHHHHhhCCC--CcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006402 391 NEVGILSQVNH--KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468 (646)
Q Consensus 391 ~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 468 (646)
+|+..|+.+.- --+.+.+++ +..++|||++.+-.|...-+- .+..+ +...+..-|.-|-.+|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC---
Confidence 78888888853 224455543 567899999988888765432 12223 3344445566677788
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
+||+|..-=||+++++..++++||--..
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999996543
|
|
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00061 Score=56.66 Aligned_cols=43 Identities=21% Similarity=0.730 Sum_probs=35.5
Q ss_pred cccccceEEEecCCCCCCCCCCccCCC-CceeccCCCCCceeeecCCC
Q 006402 213 NQWEEGLEIQWAPPPEPVCKTQLDCSG-ASKCLSAGRNGVYRCLCIKG 259 (646)
Q Consensus 213 ~~~~~g~~L~W~~~~~~~C~~~~~C~~-~~~C~~~~~~~~~~C~C~~g 259 (646)
..++.||+|+|.+ ....| .+|.. +|.|+++.....+.|+|++|
T Consensus 50 ~~L~~GF~L~w~~-~~~~C---~~C~~SgG~Cgy~~~~~~f~C~C~dg 93 (94)
T PF14380_consen 50 EVLKKGFELEWNA-DSGDC---RECEASGGRCGYDSNSEQFTCFCSDG 93 (94)
T ss_pred HHHhcCcEEEEeC-CCCcC---cChhcCCCEeCCCCCCceEEEECCCC
Confidence 3458999999986 33368 68977 99999998888899999876
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0081 Score=63.00 Aligned_cols=141 Identities=18% Similarity=0.212 Sum_probs=82.7
Q ss_pred cEecccCcEEEEEEEEcC-----CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEEcc
Q 006402 352 RILGSGGFGEVYKGELQD-----GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~ 425 (646)
+.|-.|-.-.+|+....+ ++.|++|..........+ ..+|..+++.+...++ .++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345567788899987532 367899987654433222 2678899888865444 3555654322 5899998
Q ss_pred CCCcccc-----------------ccCCc-C--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 006402 426 NGTLHDH-----------------LHGKY-S--SFNLTWSTRLRIALQT-----------------AEALAYL----HS- 463 (646)
Q Consensus 426 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i-----------------a~~l~yL----H~- 463 (646)
+.+|... +|+.. . .....|.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 12211 0 1111233333332211 1112222 21
Q ss_pred CCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCcc
Q 006402 464 AAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRL 497 (646)
Q Consensus 464 ~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~ 497 (646)
.....++|+|+++.|||+++ +..+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234899999999999986 46899999998764
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0023 Score=53.91 Aligned_cols=83 Identities=17% Similarity=0.384 Sum_probs=44.8
Q ss_pred CCCCCCCCceeeecCCCC-CceeEEec--------cCCcceeE----EeeecCCCCC---CcccccceEEEecCCCCCCC
Q 006402 168 QCASELEPCCTFIAGGMP-SAYKIRLH--------SSGCKAFR----SILHLDPNKP---ANQWEEGLEIQWAPPPEPVC 231 (646)
Q Consensus 168 ~C~~g~~gcC~~~~~~~~-~~~~~~~~--------~~~c~~~~----~~~~~~~~~~---~~~~~~g~~L~W~~~~~~~C 231 (646)
+|+ | .+|||+.+|..+ ..+.+... ..+|+.-+ .|+..+.+.+ ....+++++|+|.+......
T Consensus 3 ~Cs-G-~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~i~t~~~~ 80 (103)
T PF08488_consen 3 SCS-G-IGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWFIDTSDSS 80 (103)
T ss_pred ccC-C-cceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEEEecCCcC
Confidence 799 8 899998888753 44554432 24777321 2332222222 12236789999998533211
Q ss_pred -CCCccCCCCceeccCCCCCceeeecC
Q 006402 232 -KTQLDCSGASKCLSAGRNGVYRCLCI 257 (646)
Q Consensus 232 -~~~~~C~~~~~C~~~~~~~~~~C~C~ 257 (646)
...++|..... ++ ...+|.|.
T Consensus 81 ~~~s~~C~~~~~--y~---~~~~C~C~ 102 (103)
T PF08488_consen 81 FSNSLACKNNTE--YS---SSNRCSCS 102 (103)
T ss_pred cCcCccCCCcee--cc---CCCcEeCC
Confidence 12256665333 21 12278884
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0098 Score=60.40 Aligned_cols=73 Identities=16% Similarity=0.249 Sum_probs=48.1
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC---CCcccccceeEEeCCcCeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN---HKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
.+.|+.|....+|+.+ .+++.+.||+-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4668889999999987 567889999765 233456778888888883 455778899888888889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.028 Score=57.53 Aligned_cols=123 Identities=20% Similarity=0.338 Sum_probs=77.3
Q ss_pred CcEEEEEEcc-cCCcccHHHHHHHHHHHhhCCC--CcccccceeEEeCC--cCeEEEEEccCCCccccccCCcCCCCCCH
Q 006402 370 GTVVAVKSAK-VGNIKSTQQVLNEVGILSQVNH--KNLVRLLGCCVEAE--QPLLIYEYIANGTLHDHLHGKYSSFNLTW 444 (646)
Q Consensus 370 ~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~~l~~ 444 (646)
++.+++++.. ........+..+|+.+++.+.- --+.+.++.|.++. ..+.||+|++|..+.+.+.... ..
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~----~~- 122 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES----LG- 122 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc----ch-
Confidence 6777777321 1223445566788888888753 33455667777666 7799999998854444332110 00
Q ss_pred HHHHHHH-HHHHHHHH--------------------------------------------------HHHhCCC-----CC
Q 006402 445 STRLRIA-LQTAEALA--------------------------------------------------YLHSAAY-----TP 468 (646)
Q Consensus 445 ~~~~~i~-~~ia~~l~--------------------------------------------------yLH~~~~-----~~ 468 (646)
.+++ ..+++.|+ ||+.... +.
T Consensus 123 ---~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~ 199 (321)
T COG3173 123 ---RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV 199 (321)
T ss_pred ---HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence 0111 23333444 4443322 35
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
++|+|+.+.||+++.+.-+=|.||+++..-.+
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 89999999999999888899999999876543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.018 Score=58.95 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=95.2
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEEcccCC-----cc-----------------cHH----HHHHHHHHHhhCCCCc
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKSAKVGN-----IK-----------------STQ----QVLNEVGILSQVNHKN 403 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~-----------------~~~----~~~~E~~~l~~l~h~n 403 (646)
+...|..|.-+.||.+.-.+|+.+|||+.+..- .. ..+ -...|++-|++++.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345688899999999999999999999765321 00 000 1245777888876555
Q ss_pred ccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 006402 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 404 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~ 483 (646)
|.-.--+.. ....|||+|+.... |-.-+-....++...+..+-.|++.-+.-|.+.+. +||.||+--|+|+-+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC
Confidence 433222212 24579999995321 11111123356777778888888888888877664 999999999999976
Q ss_pred CCCEEEeecCCCccC
Q 006402 484 DFNSKVADFGLSRLA 498 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~ 498 (646)
+ .+.|+|.+-+...
T Consensus 301 G-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVEH 314 (520)
T ss_pred C-EEEEEEccccccC
Confidence 5 8999999876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.00085 Score=79.03 Aligned_cols=160 Identities=16% Similarity=0.067 Sum_probs=111.6
Q ss_pred HHHHHHHHhhCCCCcccccceeEEe--CCcCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 006402 389 VLNEVGILSQVNHKNLVRLLGCCVE--AEQPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAA 465 (646)
Q Consensus 389 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~ 465 (646)
.+.|...+++..|+++.....-... ....+.+++++..|.+.+.|-+.- ....++..-......+...+..-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445555666788888765544332 346688999999999999885432 2223333333333333355555555432
Q ss_pred --CCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHH
Q 006402 466 --YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543 (646)
Q Consensus 466 --~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ell 543 (646)
....+|+++|+-|.+|+.+.++|+.++|+.+...+.... .....+++-|++|+....-.++.++|+|..|..+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 345799999999999999999999999999954443322 22234788899999998888999999999999999987
Q ss_pred cCCCCC
Q 006402 544 TSQKAI 549 (646)
Q Consensus 544 tg~~p~ 549 (646)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776554
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.052 Score=56.63 Aligned_cols=142 Identities=16% Similarity=0.190 Sum_probs=80.8
Q ss_pred cEecccCcEEEEEEEEcC----CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQD----GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 426 (646)
+.|..|-.-.+|+....+ +..|++|+........ -+-.+|..+++.+...++ .++++++. .. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445567778899886543 2378899876543322 223578888888876555 45565542 22 58999977
Q ss_pred CCcccc-----------------ccCCc-CC--CCCCHHHHHHHHHHH----------------------HHHHHH----
Q 006402 427 GTLHDH-----------------LHGKY-SS--FNLTWSTRLRIALQT----------------------AEALAY---- 460 (646)
Q Consensus 427 gsL~~~-----------------l~~~~-~~--~~l~~~~~~~i~~~i----------------------a~~l~y---- 460 (646)
..|..- +|... .. ..-.|..+.++..++ .+-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665320 12211 00 011233322222211 111111
Q ss_pred HHhCC-CCCeeeccCCCCCEEEcC-CCCEEEeecCCCccC
Q 006402 461 LHSAA-YTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLA 498 (646)
Q Consensus 461 LH~~~-~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~ 498 (646)
+...+ ...++|.|+.+.|||+++ ++.++++||..+-..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11111 123799999999999974 578999999987543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.093 Score=55.59 Aligned_cols=73 Identities=14% Similarity=0.111 Sum_probs=49.2
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccC----Cc---ccHHHHHHHHHHHhhCC---CCcccccceeEEeCCcCeEE
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVG----NI---KSTQQVLNEVGILSQVN---HKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 420 (646)
.+.||.|....||+.... +..++||+-... .. -...+-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998764 456889975421 11 13344445667776654 246777887766 456889
Q ss_pred EEEccC
Q 006402 421 YEYIAN 426 (646)
Q Consensus 421 ~e~~~~ 426 (646)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.055 Score=55.88 Aligned_cols=29 Identities=34% Similarity=0.429 Sum_probs=25.1
Q ss_pred CCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 467 ~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999998 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.024 Score=54.94 Aligned_cols=29 Identities=31% Similarity=0.521 Sum_probs=20.7
Q ss_pred eeeccCCCCCEEE-cCCCCEEEeecCCCcc
Q 006402 469 IYHRDVKSTNILL-DDDFNSKVADFGLSRL 497 (646)
Q Consensus 469 i~H~Dik~~NIll-~~~~~~ki~DfGl~~~ 497 (646)
+.|+|+.+.|||+ +.++.++++||..+..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8888999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.042 Score=57.09 Aligned_cols=72 Identities=18% Similarity=0.193 Sum_probs=46.8
Q ss_pred EecccCcEEEEEEEEcCC-cEEEEEEcccC------C-cccHHHHHHHHHHHhhCC--CC-cccccceeEEeCCcCeEEE
Q 006402 353 ILGSGGFGEVYKGELQDG-TVVAVKSAKVG------N-IKSTQQVLNEVGILSQVN--HK-NLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV~ 421 (646)
.||.|....||++...+| +.|+||.-... + +-..++..-|.+.|+... -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 378999999999987654 57999954211 1 223455567777777653 34 3444443 3555667999
Q ss_pred EEccC
Q 006402 422 EYIAN 426 (646)
Q Consensus 422 e~~~~ 426 (646)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.13 Score=53.02 Aligned_cols=31 Identities=16% Similarity=0.289 Sum_probs=27.7
Q ss_pred CeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 468 ~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
.++|+|+.+.|||+++++.+.|+||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 4999999999999999989999999987643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.57 Score=48.74 Aligned_cols=94 Identities=16% Similarity=0.100 Sum_probs=54.0
Q ss_pred cccHHHHHHHhcCCCcc---c-EecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC--cccccc
Q 006402 335 IFHLKELKKATNGFSKE---R-ILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK--NLVRLL 408 (646)
Q Consensus 335 ~~~~~el~~~~~~~~~~---~-~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 408 (646)
.++.+.+..+...+... + ..-.+.-..||+....++..+++|+.+.. .....+...|.+.+..|... .++...
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34555555554444221 1 12234557799998888888999987533 23455666777777766321 122222
Q ss_pred ---e--eEEeCCcCeEEEEEccCCCc
Q 006402 409 ---G--CCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 409 ---~--~~~~~~~~~lV~e~~~~gsL 429 (646)
| ....++..+.|+++++|...
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 2 12224456789999987654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.29 Score=50.75 Aligned_cols=136 Identities=22% Similarity=0.321 Sum_probs=80.1
Q ss_pred CcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc------ccccceeEE--eCC--cCeEEEEEccCC
Q 006402 358 GFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN------LVRLLGCCV--EAE--QPLLIYEYIANG 427 (646)
Q Consensus 358 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~--~~~--~~~lV~e~~~~g 427 (646)
.-..+|+.+..+|+. ++|+.+.. ....+...|...+..|.-.. +..+-|-.. -.. ..+-|++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789998888777 88877665 44556667777777764222 222222111 123 667899999998
Q ss_pred Cccc-cc--------------cC--------CcC-CCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C
Q 006402 428 TLHD-HL--------------HG--------KYS-SFNLTWST-------------RLRIALQTAEALAYLHSAA----Y 466 (646)
Q Consensus 428 sL~~-~l--------------~~--------~~~-~~~l~~~~-------------~~~i~~~ia~~l~yLH~~~----~ 466 (646)
.+.. .. |. +.. .....|.. ......++...+..+.+.- .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 10 000 11133330 0112233444444444322 1
Q ss_pred ---CCeeeccCCCCCEEEcCCCC-EEEeecCCCc
Q 006402 467 ---TPIYHRDVKSTNILLDDDFN-SKVADFGLSR 496 (646)
Q Consensus 467 ---~~i~H~Dik~~NIll~~~~~-~ki~DfGl~~ 496 (646)
..+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22899999999999998875 8999999765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.078 Score=55.87 Aligned_cols=74 Identities=16% Similarity=0.153 Sum_probs=48.6
Q ss_pred ccEecccCcEEEEEEEEcC-CcEEEEEEccc----C-C-cccHHHHHHHHHHHhhCC--CC-cccccceeEEeCCcCeEE
Q 006402 351 ERILGSGGFGEVYKGELQD-GTVVAVKSAKV----G-N-IKSTQQVLNEVGILSQVN--HK-NLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~-~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV 420 (646)
.+.||.|.-..||++...+ ++.|+||.-.. . + .-..++..-|.+.|+... -| ++.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3568999999999998753 56799995321 1 1 223566677888888764 34 34445443 55566788
Q ss_pred EEEccC
Q 006402 421 YEYIAN 426 (646)
Q Consensus 421 ~e~~~~ 426 (646)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.078 Score=50.65 Aligned_cols=152 Identities=17% Similarity=0.143 Sum_probs=91.3
Q ss_pred cCcEEEEEEEEcCCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCccccccC
Q 006402 357 GGFGEVYKGELQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG 435 (646)
Q Consensus 357 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 435 (646)
++-++.-+++.+-|. ..+|++....-. ...-|.++.+++.+++ .|++|..- .....-++.|++-.-
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 334555555443333 455655544333 4456788999999875 47777622 233455888877221
Q ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccc
Q 006402 436 KYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515 (646)
Q Consensus 436 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y 515 (646)
+ . .. ..++.-=+++|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+..... +.-|
T Consensus 140 ---~--i--~~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~~ 197 (308)
T PF07387_consen 140 ---K--I--NF-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVNM 197 (308)
T ss_pred ---c--c--ch-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh-------------eeeE
Confidence 0 0 01 111111246788889654 34999999999999999999999998753211 1112
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHcCC
Q 006402 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546 (646)
Q Consensus 516 ~aPE~~~~~~~~~ksDv~s~G~ll~elltg~ 546 (646)
.--| ....|.++.+-+|=.-++++....
T Consensus 198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred Eeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 2211 124577888888888888877643
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.29 Score=51.95 Aligned_cols=74 Identities=20% Similarity=0.294 Sum_probs=45.6
Q ss_pred cEecccCcEEEEEEEEcCC--c-----EEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQDG--T-----VVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 423 (646)
+.|..|-...+|++...++ . .|.++......... -+-.+|+.+++.+...++ .++++.+. -.+|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4565688889999876532 1 24444432221111 123578999999976555 45555543 2699999
Q ss_pred ccCCCcc
Q 006402 424 IANGTLH 430 (646)
Q Consensus 424 ~~~gsL~ 430 (646)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.02 Score=60.96 Aligned_cols=49 Identities=22% Similarity=0.314 Sum_probs=38.4
Q ss_pred HHHHHHHHHHhhCCCCcccccceeEEeCC-cCeEEEEEccCCCccccccCC
Q 006402 387 QQVLNEVGILSQVNHKNLVRLLGCCVEAE-QPLLIYEYIANGTLHDHLHGK 436 (646)
Q Consensus 387 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~ 436 (646)
.+++-...+++.+.|+|.-..+++-.... ...+|+|++ +.+|++++..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 45667788999999999999888866544 456889988 77999988654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.36 Score=58.06 Aligned_cols=143 Identities=17% Similarity=0.234 Sum_probs=77.3
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-------CCcccccc-eeE----Ee-CC--c
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-------HKNLVRLL-GCC----VE-AE--Q 416 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~~~----~~-~~--~ 416 (646)
+.|+ |..-.+|+.+..+|..+++|+.+... .......|...|..|. -|.+++-. |-. .. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 45677899988888899999987542 2223334444554442 23333322 111 11 12 3
Q ss_pred CeEEEEEccCCCccccc-----------------cC---Cc----CCCCCCHHH-----------------HHHHHHHHH
Q 006402 417 PLLIYEYIANGTLHDHL-----------------HG---KY----SSFNLTWST-----------------RLRIALQTA 455 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l-----------------~~---~~----~~~~l~~~~-----------------~~~i~~~ia 455 (646)
.+.+++|++|..|.+.. +. .. ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 46789999997776511 00 00 011123321 112222332
Q ss_pred HHHH-----HHHhCCCCCeeeccCCCCCEEEcCCC--CEE-EeecCCCccC
Q 006402 456 EALA-----YLHSAAYTPIYHRDVKSTNILLDDDF--NSK-VADFGLSRLA 498 (646)
Q Consensus 456 ~~l~-----yLH~~~~~~i~H~Dik~~NIll~~~~--~~k-i~DfGl~~~~ 498 (646)
+... .|.. -...+||+|+.+.|||++.+. ++. |+|||.+...
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 2221 1212 123499999999999999775 555 9999987643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 646 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-28 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-26 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-26 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-26 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-26 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-26 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-26 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-26 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-25 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-25 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-25 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-25 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-20 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 411 bits (1060), Expect = e-140
Identities = 126/320 (39%), Positives = 188/320 (58%), Gaps = 9/320 (2%)
Query: 311 KQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDG 370
K +K D L SS + + L +L++ATN F + ++G G FG+VYKG L+DG
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 371 TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH 430
VA+K + + ++ E+ LS H +LV L+G C E + +LIY+Y+ NG L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 431 DHLHGKYS-SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489
HL+G + +++W RL I + A L YLH+ I HRDVKS NILLD++F K+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI 180
Query: 490 ADFGLSRLA-KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKA 548
DFG+S+ + +H+ST +GTLGY+DPEY+ +LT+KSDVYS+GVVL E+L ++ A
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 549 IDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREK 608
I S + VNLA + + +NG + ++VDP L SL+ F + AV CL
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE----SLRKFGDTAVKCLALS 296
Query: 609 KSERPSMTDVVHELQRIIEI 628
+RPSM DV+ +L+ + +
Sbjct: 297 SEDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-127
Identities = 121/294 (41%), Positives = 176/294 (59%), Gaps = 8/294 (2%)
Query: 333 ARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQ-QVLN 391
+ F L+EL+ A++ FS + ILG GGFG+VYKG L DGT+VAVK K + + Q
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 392 EVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSS-FNLTWSTRLRI 450
EV ++S H+NL+RL G C+ + LL+Y Y+ANG++ L + S L W R RI
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
AL +A LAYLH I HRDVK+ NILLD++F + V DFGL++L +HV+T +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP--DDVNLAIYVSQRA 568
GT+G++ PEY + ++K+DV+ YGV+LLEL+T Q+A D +R DDV L +V
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622
+ +VD LQG+ + ++ +A+ C + ERP M++VV L
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQ----VALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-121
Identities = 104/314 (33%), Positives = 165/314 (52%), Gaps = 24/314 (7%)
Query: 324 KSSNIAGKPARIFHLKELKKATNGFSKER------ILGSGGFGEVYKGELQDGTVVAVKS 377
KS ++ F ELK TN F + +G GGFG VYKG + + T VAVK
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 378 AKVG-NIKSTQ---QVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL 433
+I + + Q E+ ++++ H+NLV LLG + + L+Y Y+ NG+L D L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 434 HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493
+ L+W R +IA A + +LH HRD+KS NILLD+ F +K++DFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 178
Query: 494 LSRLAKPG-LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552
L+R ++ + +++ GT Y+ PE R ++T KSD+YS+GVVLLE++T A+D
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 553 RDPDDVNLAIYVSQR-ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSE 611
R+P L + I + +D ++ +++ S++ +A CL EKK++
Sbjct: 238 REPQ--LLLDIKEEIEDEEKTIEDYIDKKMNDADST-----SVEAMYSVASQCLHEKKNK 290
Query: 612 RPSMTDVVHELQRI 625
RP + V LQ +
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 6e-81
Identities = 78/314 (24%), Positives = 122/314 (38%), Gaps = 25/314 (7%)
Query: 336 FHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGI 395
+ L + + G FG V+K +L VAVK + + +S Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 396 LSQVNHKNLVRLLGCCVEAE----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIA 451
L + H+N+++ +G LI + G+L D L ++W+ IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127
Query: 452 LQTAEALAYLHSAAYT-------PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
A LAYLH I HRD+KS N+LL ++ + +ADFGL+ + G S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 505 VSTCAQ-GTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558
T Q GT Y+ PE + D+Y+ G+VL EL + A D D +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 559 NLAIYVSQRASNGAIMEVVDPRLQ--GHEASVNILMSLKLFSELAVACLREKKSERPSMT 616
+ Q S + EVV + + + + E C R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 617 DVVHELQRIIEIVN 630
V + ++ + N
Sbjct: 308 CVGERITQMQRLTN 321
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 7e-69
Identities = 72/280 (25%), Positives = 133/280 (47%), Gaps = 32/280 (11%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
E ++G G FG V K + + VA+K ++ + + + E+ LS+VNH N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 411 CVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
C+ P+ L+ EY G+L++ LHG T + + LQ ++ +AYLHS +
Sbjct: 70 CL---NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 470 YHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD 528
HRD+K N+LL K+ DFG + + T +G+ ++ PE + ++
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 529 KSDVYSYGVVLLELLTSQKA-IDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
K DV+S+G++L E++T +K + + A++ R +++ + +
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP---LIKNLPKPI------ 233
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
L C + S+RPSM ++V + ++
Sbjct: 234 ----------ESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-68
Identities = 84/283 (29%), Positives = 138/283 (48%), Gaps = 32/283 (11%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLL 408
+ +G+G FG V++ E G+ VAVK + + + L EV I+ ++ H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
G + ++ EY++ G+L+ LH + L RL +A A+ + YLH+ P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD 528
I HR++KS N+L+D + KV DFGLSRL K S A GT ++ PE R+ +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 529 KSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLAIYVSQRASNGA---IMEVVDPRLQGH 584
KSDVYS+GV+L EL T Q+ P ++N A V+ I ++P++
Sbjct: 219 KSDVYSFGVILWELATLQQ-------PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV--- 268
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ + C + +RPS ++ L+ +I+
Sbjct: 269 -------------AAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-64
Identities = 80/291 (27%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVR 406
E I+G GGFG+VY+ G VAVK+A+ ++ + V E + + + H N++
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L G C++ L+ E+ G L+ L GK + + A+Q A + YLH A
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 467 TPIYHRDVKSTNILLDDDFNS--------KVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
PI HRD+KS+NIL+ + K+ DFGL+R A G ++ P
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH---RTTKMSAAGAYAWMAP 183
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLAIYVSQRASNGAIMEV- 576
E R + SDV+SYGV+L ELLT + P ++ A N + +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE-------VPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 577 --VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
++L C RPS T+++ +L I
Sbjct: 237 STCPEPF----------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-63
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 53/296 (17%)
Query: 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKST-------QQVLNEVGILSQVNHK 402
E+ +G GGFG V+KG L D +VVA+KS +G+ + Q+ EV I+S +NH
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V+L G P ++ E++ G L+ L K + + WS +LR+ L A + Y+
Sbjct: 84 NIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 463 SAAYTPIYHRDVKSTNILLDD-----DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
+ PI HRD++S NI L +KVADFGLS+ H + G ++
Sbjct: 140 NQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMA 194
Query: 518 PE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNL--AIYVSQRASNGA 572
PE T+K+D YS+ ++L +LT + P D+ + +++ G
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG-------PFDEYSYGKIKFINMIREEGL 247
Query: 573 ---IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
I E PRL + C +RP + +V EL +
Sbjct: 248 RPTIPEDCPPRL----------------RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-62
Identities = 71/326 (21%), Positives = 122/326 (37%), Gaps = 40/326 (12%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGI--LS 397
E + ++G G +G VYKG L D VAVK V + + Q +NE I +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK---VFSFANRQNFINEKNIYRVP 62
Query: 398 QVNHKNLVRLLGCCVEAE-----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL 452
+ H N+ R + + LL+ EY NG+L +L W + R+A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAH 118
Query: 453 QTAEALAYLHSAAYT------PIYHRDVKSTNILLDDDFNSKVADFGLSRL-------AK 499
LAYLH+ I HRD+ S N+L+ +D ++DFGLS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 500 PGLSHVSTCAQGTLGYLDPEYYRN-------YQLTDKSDVYSYGVVLLELLTSQKAIDFS 552
+ + GT+ Y+ PE + D+Y+ G++ E+ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 553 RDPDDVNLAIY--VSQRASNGAIMEVV---DPRLQGHEASVNILMSLKLFSELAVACLRE 607
+ +A V + + +V R + EA ++++ E C +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 608 KKSERPSMTDVVHELQRIIEIVNQEK 633
R + + ++ I + K
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNK 324
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-62
Identities = 61/286 (21%), Positives = 120/286 (41%), Gaps = 43/286 (15%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLL 408
L GE++KG Q G + VK KV + + ++ E L +H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 409 GCCVEAEQPLL--IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
G C P I ++ G+L++ LH + ++F + S ++ AL A +A+LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
I + S ++++D+D ++++ + S S ++ PE +
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 527 ---TDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLAIYVSQRASNG---AIMEVVDP 579
+D++S+ V+L EL+T + P D++ + A G I + P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE-------VPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+ S+L C+ E ++RP +V L+++
Sbjct: 239 HV----------------SKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-61
Identities = 78/314 (24%), Positives = 121/314 (38%), Gaps = 50/314 (15%)
Query: 331 KPARIFHLKELKKATNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQV 389
P RIF +L +LG G FG+ K + G V+ +K + ++ +
Sbjct: 2 MPHRIFRPSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF 54
Query: 390 LNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR 449
L EV ++ + H N+++ +G + ++ I EYI GTL + WS R+
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVS 112
Query: 450 IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL------------ 497
A A +AYLHS I HRD+ S N L+ ++ N VADFGL+RL
Sbjct: 113 FAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 498 -AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD 556
K G ++ PE +K DV+S+G+VL E++ A DPD
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPD 224
Query: 557 DVNLAIYVSQRASNGAIMEV---VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP 613
+ + P F + V C +RP
Sbjct: 225 YLPRTMDFGLNVRGFLDRYCPPNCPPS----------------FFPITVRCCDLDPEKRP 268
Query: 614 SMTDVVHELQRIIE 627
S + H L+ +
Sbjct: 269 SFVKLEHWLETLRM 282
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-60
Identities = 83/284 (29%), Positives = 135/284 (47%), Gaps = 33/284 (11%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLL 408
+ +GSG FG VYKG+ G V AVK V + Q NEVG+L + H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 409 GCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G L ++ ++ +L+ HLH + F + IA QTA + YLH+
Sbjct: 87 GYSTA--PQLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQTARGMDYLHA---K 139
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRL-AKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
I HRD+KS NI L +D K+ DFGL+ ++ SH G++ ++ PE R
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 527 ---TDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ +SDVY++G+VL EL+T Q P ++N + + G++ +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQL-------PYSNINNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
+ LM+ CL++K+ ERPS ++ E++ +
Sbjct: 253 NCPKRMKRLMA---------ECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-59
Identities = 63/293 (21%), Positives = 117/293 (39%), Gaps = 42/293 (14%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLL 408
++G G FG+VY G G V A++ + + EV Q H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
G C+ +I TL+ + L + +IA + + + YLH+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL----SHVSTCAQGTLGYLDPEYYRNY 524
I H+D+KS N+ D+ + DFGL ++ G L +L PE R
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 525 QL---------TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
+ SDV++ G + EL + P + +Q AI+
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREW-------P-------FKTQ--PAEAIIW 253
Query: 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628
+ G + +++ + K S++ + C ++ ERP+ T ++ L+++ +
Sbjct: 254 QMG---TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-55
Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 45/304 (14%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+G G +GEV++G Q G VAVK + KS + E+ + H+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRET-ELYNTVMLRHENILGFIAS 70
Query: 411 CV----EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ + Q LI Y G+L+D+L L + LRI L A LA+LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 467 T-----PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTC---AQGTLGYLDP 518
I HRD+KS NIL+ + +AD GL+ + + + GT Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 519 E------YYRNYQLTDKSDVYSYGVVLLELLT---SQKAIDFSRDPDDVNLAIYVSQRAS 569
E + + D++++G+VL E+ S ++ + P + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP-------FYDVVPN 239
Query: 570 NGAIMEVVD--------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621
+ + ++ P + S L ++L C + S R + +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPT---LTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 622 LQRI 625
L +I
Sbjct: 297 LTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-55
Identities = 76/349 (21%), Positives = 136/349 (38%), Gaps = 44/349 (12%)
Query: 308 KLAKQAKLAKEREDMLKSSNIAGKPA---RIFHLKELKKATNGFSKERILGSGGFGEVYK 364
+ L E S + +G P R K+++ + +G G +GEV+
Sbjct: 4 YIPPGESLRDLIEQSQSSGSGSGLPLLVQRTI-AKQIQM-------VKQIGKGRYGEVWM 55
Query: 365 GELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----QPLLI 420
G+ + G VAVK S + E+ + H+N++ + ++ Q LI
Sbjct: 56 GKWR-GEKVAVKVFFTTEEASWFRET-EIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113
Query: 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT-----PIYHRDVK 475
+Y NG+L+D+L L + L++A + L +LH+ ++ I HRD+K
Sbjct: 114 TDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 476 STNILLDDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDPE------YYRNYQL 526
S NIL+ + +AD GL+ + V GT Y+ PE ++Q
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 527 TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRL 581
+D+YS+G++L E+ + + V S + E+V P
Sbjct: 230 YIMADMYSFGLILWEVARR-CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630
+S L+ +L C + R + V L ++ E +
Sbjct: 289 PNRWSSDEC---LRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 41/304 (13%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ +G G FGEV++G+ + G VAVK +S + E+ + H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 104
Query: 411 CVEAE----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ Q L+ +Y +G+L D+L+ +T +++AL TA LA+LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 467 T-----PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDP 518
I HRD+KS NIL+ + +AD GL+ + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 519 E------YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572
E ++++ ++D+Y+ G+V E+ + +I + + V S
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 573 IMEVV---------DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
+ +VV R Q EA L++ +++ C + R + + L
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEA-------LRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 624 RIIE 627
++ +
Sbjct: 333 QLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 45/289 (15%)
Query: 351 ERILGSGGFGEVYKGELQDGTV-VAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNLVRLL 408
+G G FGEV+ G L+ VAVKS + + L E IL Q +H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
G C + + ++ E + G L + + L T L++ A + YL S
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKCCI- 235
Query: 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL-----DPEYYRN 523
HRD+ + N L+ + K++DFG+SR G A G L + PE
Sbjct: 236 --HRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALNY 289
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD----- 578
+ + +SDV+S+G++L E + P Y SN E V+
Sbjct: 290 GRYSSESDVWSFGILLWETFS------LGASP-------Y--PNLSNQQTREFVEKGGRL 334
Query: 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
P + +V LM C + +RPS + + ELQ I +
Sbjct: 335 PCPELCPDAVFRLME---------QCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-44
Identities = 75/283 (26%), Positives = 131/283 (46%), Gaps = 35/283 (12%)
Query: 351 ERILGSGGFGEVYKGELQDGTV-VAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+ LG G +GEVY+G + ++ VAVK+ K + ++ L E ++ ++ H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
C +I E++ G L D+L + + ++ L +A Q + A+ YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKKNFI-- 340
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HR++ + N L+ ++ KVADFGLSRL A+ + + PE + + K
Sbjct: 341 -HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGH 584
SDV+++GV+L E+ T + P Y + E+++ R +G
Sbjct: 400 SDVWAFGVLLWEIAT------YGMSP-------Y--PGIDLSQVYELLEKDYRMERPEGC 444
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
V LM AC + S+RPS ++ + + +
Sbjct: 445 PEKVYELM---------RACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 66/319 (20%), Positives = 114/319 (35%), Gaps = 38/319 (11%)
Query: 324 KSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGN 382
+ +G+ F + + + LG GGF V E L DG A+K
Sbjct: 7 HHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE 66
Query: 383 IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP----LLIYEYIANGTLHDHL-HGKY 437
+ ++ E + NH N++RL+ C+ L+ + GTL + + K
Sbjct: 67 QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKD 126
Query: 438 SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497
LT L + L L +H+ HRD+K TNILL D+ + D G
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 498 AKPGLSHVSTCAQ--------GTLGYLDPE---YYRNYQLTDKSDVYSYGVVLLELLTSQ 546
A + T+ Y PE + + +++DV+S G VL ++ +
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 547 KAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLR 606
+ D V A + PR S L +L + +
Sbjct: 244 GP--Y----DMVFQKGDSVALAVQNQLSIPQSPR-----------HSSAL-WQLLNSMMT 285
Query: 607 EKKSERPSMTDVVHELQRI 625
+RP + ++ +L+ +
Sbjct: 286 VDPHQRPHIPLLLSQLEAL 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-44
Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 37/283 (13%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
E LG G FGEV+ G T VA+K+ K G + S + L E ++ ++ H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 411 CVEAEQPLLI-YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
E+P+ I EY++ G+L D L G+ + L + +A Q A +AY+ Y
Sbjct: 248 VS--EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV-- 302
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+++ NIL+ ++ KVADFGL+RL + A+ + + PE + T K
Sbjct: 303 -HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGH 584
SDV+S+G++L EL T R P Y N +++ V+ P
Sbjct: 362 SDVWSFGILLTELTT------KGRVP-------Y--PGMVNREVLDQVERGYRMPCPPEC 406
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
S++ LM C R++ ERP+ + L+
Sbjct: 407 PESLHDLM---------CQCWRKEPEERPTFEYLQAFLEDYFT 440
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 351 ERILGSGGFGEVYKGELQDGTV-VAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+ LG G +GEVY+G + ++ VAVK+ K + ++ L E ++ ++ H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
C +I E++ G L D+L ++ L +A Q + A+ YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI-- 133
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE--YYRNYQLT 527
HRD+ + N L+ ++ KVADFGLSRL A+ + + PE Y + +
Sbjct: 134 -HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF--S 190
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQ 582
KSDV+++GV+L E+ T + P Y + E+++ R +
Sbjct: 191 IKSDVWAFGVLLWEIAT------YGMSP-------Y--PGIDLSQVYELLEKDYRMERPE 235
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
G V LM AC + S+RPS ++ + + +
Sbjct: 236 GCPEKVYELMR---------ACWQWNPSDRPSFAEIHQAFETMFQ 271
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 62/302 (20%)
Query: 348 FSKERILGSGGFGEVYKGELQDG-----TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNH 401
F K ++LGSG FG VYKG VA+K + K+ +++L+E +++ V++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ RLLG C+ LI + + G L D++ + L +Q A+ + YL
Sbjct: 77 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYL 133
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST---------CAQGT 512
HRD+ + N+L+ + K+ DFGL++L A
Sbjct: 134 EDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--- 187
Query: 513 LGYLDPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
E +R Y T +SDV+SYGV + EL+T F P Y
Sbjct: 188 -----LESILHRIY--THQSDVWSYGVTVWELMT------FGSKP-------Y--DGIPA 225
Query: 571 GAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
I +++ P+ V ++M C RP +++ E ++
Sbjct: 226 SEISSILEKGERLPQPPICTIDVYMIM---------RKCWMIDADSRPKFRELIIEFSKM 276
Query: 626 IE 627
Sbjct: 277 AR 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 74/328 (22%), Positives = 125/328 (38%), Gaps = 67/328 (20%)
Query: 330 GKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIK 384
G F + LK + LG G FG V G VVAVK + +
Sbjct: 1 GSDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 53
Query: 385 STQQVLNEVGILSQVNHKNLVRLLGCCVEA-EQPL-LIYEYIANGTLHDHLHGKYSSFNL 442
+ E+ IL + H N+V+ G C A + L LI EY+ G+L D+L +
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
L+ Q + + YL + Y HRD+ + NIL++++ K+ DFGL+++
Sbjct: 114 --IKLLQYTSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLP--- 165
Query: 503 SHVSTCAQGTLGYLDPEYYR-----------------NYQL-TDKSDVYSYGVVLLELLT 544
D E+++ + SDV+S+GVVL EL T
Sbjct: 166 -------------QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
Query: 545 SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSE 599
+ + + ++E++ PR G + ++M+
Sbjct: 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE----- 267
Query: 600 LAVACLREKKSERPSMTDVVHELQRIIE 627
C ++RPS D+ + +I +
Sbjct: 268 ----CWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 45/287 (15%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ LGSG FG V G+ + VAVK K G++ S + E + +++H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
C + ++ EYI+NG L ++L + L + E +A+L S +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMAFLESHQFI--- 126
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL---GYLDPE--YYRNYQ 525
HRD+ + N L+D D KV+DFG++R + GT + PE +Y Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFHYFKY- 182
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PR 580
+ KSDV+++G+++ E+ + + P Y +N ++ V R
Sbjct: 183 -SSKSDVWAFGILMWEVFS------LGKMP-------Y--DLYTNSEVVLKVSQGHRLYR 226
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
++ +M +C E +RP+ ++ ++ + E
Sbjct: 227 PHLASDTIYQIMY---------SCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 45/287 (15%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ +GSG FG V+ G + VA+K+ + G + S + + E ++ +++H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
C+E L+ E++ +G L D+L + F T L + L E +AYL A
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI--- 126
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL---GYLDPE--YYRNYQ 525
HRD+ + N L+ ++ KV+DFG++R T + GT + PE + Y
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSRY- 182
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PR 580
+ KSDV+S+GV++ E+ + + P Y + SN ++E + +
Sbjct: 183 -SSKSDVWSFGVLMWEVFS------EGKIP-------Y--ENRSNSEVVEDISTGFRLYK 226
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ V +M C RE+ +RP+ + ++ +L I E
Sbjct: 227 PRLASTHVYQIM---------NHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-43
Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 37/283 (13%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
E LG G FGEV+ G T VA+K+ K G + S + L E ++ ++ H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 411 CVEAEQPLLI-YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
E+P+ I EY++ G+L D L G+ + L + +A Q A +AY+ Y
Sbjct: 331 VS--EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV-- 385
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+++ NIL+ ++ KVADFGL+RL + A+ + + PE + T K
Sbjct: 386 -HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGH 584
SDV+S+G++L EL T R P Y N +++ V+ P
Sbjct: 445 SDVWSFGILLTELTT------KGRVP-------Y--PGMVNREVLDQVERGYRMPCPPEC 489
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
S++ LM C R++ ERP+ + L+
Sbjct: 490 PESLHDLM---------CQCWRKEPEERPTFEYLQAFLEDYFT 523
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-43
Identities = 74/287 (25%), Positives = 128/287 (44%), Gaps = 45/287 (15%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ LG+G FG V G+ + VA+K K G++ S + + E ++ ++H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
C + +I EY+ANG L ++L F L + EA+ YL S +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESKQFL--- 142
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL---GYLDPE--YYRNYQ 525
HRD+ + N L++D KV+DFGLSR T + G+ + PE Y +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYSKF- 198
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PR 580
+ KSD++++GV++ E+ + + P Y +R +N E + R
Sbjct: 199 -SSKSDIWAFGVLMWEIYS------LGKMP-------Y--ERFTNSETAEHIAQGLRLYR 242
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
V +M +C EK ERP+ ++ + +++
Sbjct: 243 PHLASEKVYTIM---------YSCWHEKADERPTFKILLSNILDVMD 280
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 41/285 (14%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
LG+G FGEV+ G T VAVKS K G++ S L E ++ Q+ H+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 411 CVEAEQPLLI-YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
++P+ I EY+ NG+L D L LT + L +A Q AE +A++ Y
Sbjct: 77 VT--QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYI-- 131
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE--YYRNYQLT 527
HRD+++ NIL+ D + K+ADFGL+RL + A+ + + PE Y + T
Sbjct: 132 -HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF--T 188
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQ 582
KSDV+S+G++L E++T R P Y +N +++ ++ R
Sbjct: 189 IKSDVWSFGILLTEIVT------HGRIP-------Y--PGMTNPEVIQNLERGYRMVRPD 233
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ LM C +E+ +RP+ + L+
Sbjct: 234 NCPEELYQLMR---------LCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 47/286 (16%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ +G G FG+V G+ + G VAVK K + Q L E +++Q+ H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 411 CVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
VE + L ++ EY+A G+L D+L + S L L+ +L EA+ YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV-- 311
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT---LGYLDPEYYRNYQL 526
HRD+ + N+L+ +D +KV+DFGL++ S+ + + PE R +
Sbjct: 312 -HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 527 TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRL 581
+ KSDV+S+G++L E+ + F R P Y R ++ V+
Sbjct: 364 STKSDVWSFGILLWEIYS------FGRVP-------Y--PRIPLKDVVPRVEKGYKMDAP 408
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
G +V +M C + RP+ + +L+ I
Sbjct: 409 DGCPPAVYDVMK---------NCWHLDAATRPTFLQLREQLEHIRT 445
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 75/327 (22%), Positives = 124/327 (37%), Gaps = 67/327 (20%)
Query: 331 KPARIFHLKELKKATNGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKS 385
+ F + LK + LG G FG V G VVAVK + +
Sbjct: 33 RDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 85
Query: 386 TQQVLNEVGILSQVNHKNLVRLLGCCVEA-EQPL-LIYEYIANGTLHDHLHGKYSSFNLT 443
+ E+ IL + H N+V+ G C A + L LI EY+ G+L D+L +
Sbjct: 86 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH- 144
Query: 444 WSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503
L+ Q + + YL + Y HRD+ + NIL++++ K+ DFGL+++
Sbjct: 145 -IKLLQYTSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLP---- 196
Query: 504 HVSTCAQGTLGYLDPEYYR-----------------NYQL-TDKSDVYSYGVVLLELLTS 545
D EYY+ + SDV+S+GVVL EL T
Sbjct: 197 ------------QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244
Query: 546 QKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSEL 600
+ + + ++E++ PR G + ++M
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM-------- 296
Query: 601 AVACLREKKSERPSMTDVVHELQRIIE 627
C ++RPS D+ + +I +
Sbjct: 297 -TECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 74/301 (24%), Positives = 122/301 (40%), Gaps = 53/301 (17%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLV 405
+R++G G FG VY GE D A+KS ++ + L E ++ +NH N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 406 RLLGCCVEAE-QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
L+G + E P ++ Y+ +G L + + N T + LQ A + YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL------DP 518
+ HRD+ + N +LD+ F KVADFGL+R L Q
Sbjct: 144 KFV---HRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197
Query: 519 E--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
E + T KSDV+S+GV+L ELLT P Y + +
Sbjct: 198 ESLQTYRF--TTKSDVWSFGVLLWELLT------RGAPP-------Y--RHIDPFDLTHF 240
Query: 577 VD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631
+ P+ + S+ +M C + RP+ +V E+++I+ +
Sbjct: 241 LAQGRRLPQPEYCPDSLYQVMQ---------QCWEADPAVRPTFRVLVGEVEQIVSALLG 291
Query: 632 E 632
+
Sbjct: 292 D 292
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 69/317 (21%)
Query: 333 ARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDG-----TVVAVKSAKVG-NIKST 386
ARIF EL+K ++LGSG FG V+KG V +K + +S
Sbjct: 7 ARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 387 QQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWST 446
Q V + + + ++H ++VRLLG C L+ +Y+ G+L DH+ + L
Sbjct: 60 QAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQL 116
Query: 447 RLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506
L +Q A+ + YL HR++ + N+LL +VADFG++ L P +
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 507 T---------CAQGTLGYLDPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555
A E ++ Y T +SDV+SYGV + EL+T F +P
Sbjct: 174 YSEAKTPIKWMA--------LESIHFGKY--THQSDVWSYGVTVWELMT------FGAEP 217
Query: 556 DDVNLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKS 610
Y + ++++ + Q V ++M V C ++
Sbjct: 218 -------Y--AGLRLAEVPDLLEKGERLAQPQICTIDVYMVM---------VKCWMIDEN 259
Query: 611 ERPSMTDVVHELQRIIE 627
RP+ ++ +E R+
Sbjct: 260 IRPTFKELANEFTRMAR 276
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 9e-42
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 51/288 (17%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ +G G FG+V G+ + G VAVK K + Q L E +++Q+ H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 411 CVEAEQPLLI-YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
VE + L I EY+A G+L D+L + S L L+ +L EA+ YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV-- 139
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT---LGYLDPE--YYRNY 524
HRD+ + N+L+ +D +KV+DFGL++ S+ + + PE + +
Sbjct: 140 -HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 191
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----P 579
+ KSDV+S+G++L E+ + F R P Y R ++ V+
Sbjct: 192 --STKSDVWSFGILLWEIYS------FGRVP-------Y--PRIPLKDVVPRVEKGYKMD 234
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
G +V +M C + RPS + +L+ I
Sbjct: 235 APDGCPPAVYEVMK---------NCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-42
Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 53/301 (17%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLV 405
++G G FG VY G L D AVKS +I Q L E I+ +H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 406 RLLGCCVEAEQPLL-IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
LLG C+ +E L + Y+ +G L + + + + N T + LQ A+ + YL S
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL------DP 518
+ HRD+ + N +LD+ F KVADFGL+R G
Sbjct: 148 KFV---HRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMAL 201
Query: 519 E--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
E + + T KSDV+S+GV+L EL+T P Y + I
Sbjct: 202 ESLQTQKF--TTKSDVWSFGVLLWELMT------RGAPP-------Y--PDVNTFDITVY 244
Query: 577 VD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631
+ + + + +M C K RPS +++V + I
Sbjct: 245 LLQGRRLLQPEYCPDPLYEVML---------KCWHPKAEMRPSFSELVSRISAIFSTFIG 295
Query: 632 E 632
E
Sbjct: 296 E 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-41
Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 37/288 (12%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
E+ LG+G FGEV+ T VAVK+ K G++ S + L E ++ + H LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 411 CVEAEQPLLI-YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
++P+ I E++A G+L D L S + + Q AE +A++ Y
Sbjct: 252 VT--KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI-- 306
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDK 529
HRD+++ NIL+ K+ADFGL+R+ + A+ + + PE T K
Sbjct: 307 -HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGH 584
SDV+S+G++L+E++T + R P Y SN ++ ++ PR +
Sbjct: 366 SDVWSFGILLMEIVT------YGRIP-------Y--PGMSNPEVIRALERGYRMPRPENC 410
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632
+ +M C + + ERP+ + L +
Sbjct: 411 PEELYNIMM---------RCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 75/325 (23%), Positives = 124/325 (38%), Gaps = 69/325 (21%)
Query: 334 RIFHLKELKKATNGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKSTQQ 388
F + LK+ R LG G FG+V G VAVKS K + +
Sbjct: 16 THFEKRFLKR-------IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 389 -VLNEVGILSQVNHKNLVRLLGCCVEAE-QPL-LIYEYIANGTLHDHLHGKYSSFNLTWS 445
+ E+ IL + H+N+V+ G C E + LI E++ +G+L ++L + NL
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--K 126
Query: 446 TRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505
+L+ A+Q + + YL S Y HRD+ + N+L++ + K+ DFGL++
Sbjct: 127 QQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAI------- 176
Query: 506 STCAQGTLGYLDPEYYR-----------------NYQL-TDKSDVYSYGVVLLELLTSQK 547
D EYY SDV+S+GV L ELLT
Sbjct: 177 ---------ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227
Query: 548 AIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAV 602
+ + Q + ++ + P V LM
Sbjct: 228 SDSSPMALFLKMIGPTHGQM-TVTRLVNTLKEGKRLPCPPNCPDEVYQLM---------R 277
Query: 603 ACLREKKSERPSMTDVVHELQRIIE 627
C + S R S +++ + +++
Sbjct: 278 KCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 82/325 (25%), Positives = 128/325 (39%), Gaps = 63/325 (19%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNL 404
R+LG G FG V + +L+ VAVK K I S+ L E + + +H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 405 VRLLGCCVEAE------QPLLIYEYIANGTLHDHL---HGKYSSFNLTWSTRLRIALQTA 455
+L+G + + P++I ++ +G LH L + FNL T +R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515
+ YL S + HRD+ + N +L +D VADFGLSR + QG
Sbjct: 148 CGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRK----IYSGDYYRQGCASK 200
Query: 516 L-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568
L E Y T SDV+++GV + E++T + P Y
Sbjct: 201 LPVKWLALESLADNLY--TVHSDVWAFGVTMWEIMT------RGQTP-------Y--AGI 243
Query: 569 SNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
N I + + V LM C +RPS T + EL+
Sbjct: 244 ENAEIYNYLIGGNRLKQPPECMEEVYDLMY---------QCWSADPKQRPSFTCLRMELE 294
Query: 624 RIIEIVNQEKVSND---VNVETAPE 645
I+ ++ S D +N+E A
Sbjct: 295 NILGHLSVLSTSQDPLYINIERAHH 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 84/327 (25%), Positives = 132/327 (40%), Gaps = 73/327 (22%)
Query: 333 ARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQD-----GTVVAVKSAKVGNIKSTQ 387
+FH + LKK R LG G FG+V G +VAVK+ K +
Sbjct: 25 PTVFHKRYLKK-------IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77
Query: 388 Q-VLNEVGILSQVNHKNLVRLLGCCVEA-EQPL-LIYEYIANGTLHDHLHGKYSSFNLTW 444
E+ IL + H+++++ GCC +A L L+ EY+ G+L D+L ++
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGL 133
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
+ L A Q E +AYLH+ Y HRD+ + N+LLD+D K+ DFGL++
Sbjct: 134 AQLLLFAQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAV------ 184
Query: 505 VSTCAQGTLGYLDPEYYR-----------------NYQL-TDKSDVYSYGVVLLELLT-S 545
EYYR SDV+S+GV L ELLT
Sbjct: 185 ----------PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 546 QKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSEL 600
+ ++ + + + E+++ PR A V LM
Sbjct: 235 DSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERGERLPRPDKCPAEVYHLM-------- 284
Query: 601 AVACLREKKSERPSMTDVVHELQRIIE 627
C + S RP+ +++ L+ + E
Sbjct: 285 -KNCWETEASFRPTFENLIPILKTVHE 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 76/320 (23%), Positives = 127/320 (39%), Gaps = 50/320 (15%)
Query: 329 AGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNI 383
A + IF + LK LG G FG V G +VAVK +
Sbjct: 13 ACQDPTIFEERHLKY-------ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65
Query: 384 KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-EQPL-LIYEYIANGTLHDHLHGKYSSFN 441
+ E+ IL ++ +V+ G Q L L+ EY+ +G L D L + +
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
S L + Q + + YL S HRD+ + NIL++ + + K+ADFGL++L
Sbjct: 126 A--SRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLD 180
Query: 502 LSH--VSTCAQGTLGYLDPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-- 555
+ V Q + + PE + + +SDV+S+GVVL EL T +
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIF--SRQSDVWSFGVVLYELFT------YCDKSCS 232
Query: 556 ---DDVNLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLRE 607
+ + + + ++E+++ P A V+ LM L C
Sbjct: 233 PSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKL---------CWAP 283
Query: 608 KKSERPSMTDVVHELQRIIE 627
+RPS + + +L +
Sbjct: 284 SPQDRPSFSALGPQLDMLWS 303
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 81/313 (25%), Positives = 127/313 (40%), Gaps = 55/313 (17%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLV 405
++G G FG VY G L D AVKS +I Q L E I+ +H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 406 RLLGCCVEAEQPLL-IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
LLG C+ +E L + Y+ +G L + + + + N T + LQ A+ + +L S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL-----DPE 519
+ HRD+ + N +LD+ F KVADFGL+R T L E
Sbjct: 212 KFV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALE 266
Query: 520 --YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577
+ + T KSDV+S+GV+L EL+T P Y + I +
Sbjct: 267 SLQTQKF--TTKSDVWSFGVLLWELMT------RGAPP-------Y--PDVNTFDITVYL 309
Query: 578 D-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE-IVNQ 631
+ + + +M C K RPS +++V + I + +
Sbjct: 310 LQGRRLLQPEYCPDPLYEVML---------KCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
Query: 632 EKVSND---VNVE 641
V + VNV+
Sbjct: 361 HYVHVNATYVNVK 373
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 56/309 (18%), Positives = 113/309 (36%), Gaps = 78/309 (25%)
Query: 351 ERILGSGGFGEVYKGELQD--------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK 402
LG G F +++KG ++ T V +K + ++ ++S+++HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+LV G CV ++ +L+ E++ G+L +L + N+ W +L +A Q A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE 130
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNS--------KVADFGLSRLAKPGLSHVSTCAQGTLG 514
H +V + NILL + + K++D G+S
Sbjct: 131 ENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT----------------- 170
Query: 515 YLDPEYYR-------------NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA 561
L + + L +D +S+G L E+ + P
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS------GGDKP------ 218
Query: 562 IYVSQRASNGAIMEVVDP--RL-QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ ++ + +L A + L++ C+ + RPS +
Sbjct: 219 -L--SALDSQRKLQFYEDRHQLPAPKAAELANLIN---------NCMDYEPDHRPSFRAI 266
Query: 619 VHELQRIIE 627
+ +L +
Sbjct: 267 IRDLNSLFT 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 78/303 (25%), Positives = 133/303 (43%), Gaps = 61/303 (20%)
Query: 352 RILGSGGFGEVYKGELQDG------TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNL 404
R LG G FG VY+G + T VA+K+ +++ + LNE ++ + N ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL-------HGKYSSFNLTWSTRLRIALQTAEA 457
VRLLG + + L+I E + G L +L + S +++A + A+
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL- 516
+AYL++ + HRD+ + N ++ +DF K+ DFG++R + +G G L
Sbjct: 151 MAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRD----IYETDYYRKGGKGLLP 203
Query: 517 ----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
PE + T SDV+S+GVVL E+ T + P Y Q SN
Sbjct: 204 VRWMSPESLKDGVF--TTYSDVWSFGVVLWEIAT------LAEQP-------Y--QGLSN 246
Query: 571 GAIMEVVDPRLQGHEASVNILM------SLKLFSELAVACLREKKSERPSMTDVVHELQR 624
+V+ ++G L+ LF EL C + RPS +++ ++
Sbjct: 247 ---EQVLRFVMEGG------LLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKE 296
Query: 625 IIE 627
+E
Sbjct: 297 EME 299
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 74/311 (23%), Positives = 133/311 (42%), Gaps = 70/311 (22%)
Query: 351 ERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+R LG G FG+V+ E +D +VAVK+ K + + + E +L+ + H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL-------------HGKYSSFNLTWSTRLRIA 451
V+ G C + + ++++EY+ +G L+ L + + L S L IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQG 511
Q A + YL S + HRD+ + N L+ + K+ DFG+SR + G
Sbjct: 140 SQIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRD----VYSTDYYRVG 192
Query: 512 TLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV 564
L PE YR + T +SDV+S+GV+L E+ T + + P +
Sbjct: 193 GHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFT------YGKQP-------W- 236
Query: 565 SQRASNGAIMEVVDPRLQGHE--------ASVNILMSLKLFSELAVACLREKKSERPSMT 616
+ SN EV++ QG V +M + C + + +R ++
Sbjct: 237 -FQLSN---TEVIECITQGRVLERPRVCPKEVYDVM---------LGCWQREPQQRLNIK 283
Query: 617 DVVHELQRIIE 627
++ L + +
Sbjct: 284 EIYKILHALGK 294
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 62/302 (20%)
Query: 348 FSKERILGSGGFGEVYKGELQDG-----TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNH 401
F K ++LGSG FG VYKG VA+K + K+ +++L+E +++ V++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ RLLG C+ LI + + G L D++ + N+ L +Q A+ + YL
Sbjct: 77 PHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST---------CAQGT 512
HRD+ + N+L+ + K+ DFGL++L A
Sbjct: 134 EDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--- 187
Query: 513 LGYLDPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
E +R Y T +SDV+SYGV + EL+T F P Y
Sbjct: 188 -----LESILHRIY--THQSDVWSYGVTVWELMT------FGSKP-------Y--DGIPA 225
Query: 571 GAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
I +++ P+ V ++M V C RP +++ E ++
Sbjct: 226 SEISSILEKGERLPQPPICTIDVYMIM---------VKCWMIDADSRPKFRELIIEFSKM 276
Query: 626 IE 627
Sbjct: 277 AR 278
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 45/291 (15%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNLV 405
E+I+GSG GEV G L+ VA+K+ K G + ++ L+E I+ Q +H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
RL G +++ EY+ NG+L L + T + + + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL--DPE--YY 521
Y HRD+ + N+L+D + KV+DFGLSR+ + T G + PE +
Sbjct: 172 YV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD--- 578
R + + SDV+S+GVV+ E+L + P Y +N ++ V+
Sbjct: 229 RTF--SSASDVWSFGVVMWEVLA------YGERP-------Y--WNMTNRDVISSVEEGY 271
Query: 579 --PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
P G +++ LM + C + +++RP + +V L +I
Sbjct: 272 RLPAPMGCPHALHQLM---------LDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 74/304 (24%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLV 405
RILG G FGEVY+G + VAVK+ K + + ++ ++E I+ ++H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+L+G E E +I E G L +L +S + T + +LQ +A+AYL S
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESIN 133
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR--- 522
HRD+ NIL+ K+ DFGLSR + D +YY+
Sbjct: 134 CV---HRDIAVRNILVASPECVKLGDFGLSRYIE-----------------DEDYYKASV 173
Query: 523 -------------NYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568
N++ T SDV+ + V + E+L+ F + P +
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------FGKQP-------F--FWL 218
Query: 569 SNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
N ++ V++ P+ + LM C S+RP T++V L
Sbjct: 219 ENKDVIGVLEKGDRLPKPDLCPPVLYTLM---------TRCWDYDPSDRPRFTELVCSLS 269
Query: 624 RIIE 627
+ +
Sbjct: 270 DVYQ 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 72/306 (23%), Positives = 116/306 (37%), Gaps = 47/306 (15%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLV 405
R+L GGF VY+ + + G A+K + + ++ EV + ++ H N+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 406 RLLGCCVEAEQP-------LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
+ ++ L+ + G L + L S L+ T L+I QT A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ-------- 510
++H PI HRD+K N+LL + K+ DFG + + + +
Sbjct: 150 QHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 511 ---GTLGYLDPE---YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV 564
T Y PE Y N+ + +K D+++ G +L L Q + D L I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-----DGAKLRIV- 262
Query: 565 SQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
NG F L A L+ ER S+ +VVH+LQ
Sbjct: 263 -----NGKYSIPPHDT-----------QYTV-FHSLIRAMLQVNPEERLSIAEVVHQLQE 305
Query: 625 IIEIVN 630
I N
Sbjct: 306 IAAARN 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 9/209 (4%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNL 404
+ +G+G +G K DG ++ K G++ Q +++EV +L ++ H N+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 405 VRLLGCCVEAEQPLL--IYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYL 461
VR ++ L + EY G L + G L LR+ Q AL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 462 HS--AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
H + HRD+K N+ LD N K+ DFGL+R+ S T GT Y+ PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE 186
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKA 548
+KSD++S G +L EL
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 78/308 (25%), Positives = 129/308 (41%), Gaps = 65/308 (21%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+ LG G FG+V+ E + +VAVK+ K + + Q E +L+ + H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFN----------LTWSTRLRIAL 452
VR G C E L+++EY+ +G L+ L HG + L L +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
Q A + YL + HRD+ + N L+ K+ DFG+SR + G
Sbjct: 166 QVAAGMVYLAGLHFV---HRDLATRNCLVGQGLVVKIGDFGMSRD----IYSTDYYRVGG 218
Query: 513 LGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565
L PE YR + T +SDV+S+GVVL E+ T + + P +
Sbjct: 219 RTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFT------YGKQP-------W-- 261
Query: 566 QRASNGAIMEVVDPRLQGHEASVNILM------SLKLFSELAVACLREKKSERPSMTDVV 619
+ SN E +D QG + +++ + C + + +R S+ DV
Sbjct: 262 YQLSN---TEAIDCITQGR------ELERPRACPPEVY-AIMRGCWQREPQQRHSIKDVH 311
Query: 620 HELQRIIE 627
LQ + +
Sbjct: 312 ARLQALAQ 319
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 48/293 (16%)
Query: 351 ERILGSGGFGEVYKGELQDGTV-----VAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNL 404
++++G+G FGEVYKG L+ + VA+K+ K G + + L E GI+ Q +H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+RL G + + ++I EY+ NG L L + + + + A + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT---LGYLDPE-- 519
Y HRD+ + NIL++ + KV+DFGLSR+ + T G + + PE
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-TSGGKIPIRWTAPEAI 222
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD- 578
YR + T SDV+S+G+V+ E++T + P Y SN +M+ ++
Sbjct: 223 SYRKF--TSASDVWSFGIVMWEVMT------YGERP-------Y--WELSNHEVMKAIND 265
Query: 579 ----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
P +++ LM + C +++++ RP D+V L ++I
Sbjct: 266 GFRLPTPMDCPSAIYQLM---------MQCWQQERARRPKFADIVSILDKLIR 309
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-40
Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNLV 405
R +G G FG+V++G VA+K+ K S ++ L E + Q +H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+L+G E +I E G L L + S +L ++ + A Q + ALAYL S
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKR 136
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRL--------AKPGLSHVSTCAQGTLGYLD 517
+ HRD+ + N+L+ + K+ DFGLSR A G + A
Sbjct: 137 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA-------- 185
Query: 518 PE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
PE +R + T SDV+ +GV + E+L P + Q N ++
Sbjct: 186 PESINFRRF--TSASDVWMFGVCMWEILM------HGVKP-------F--QGVKNNDVIG 228
Query: 576 VVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
++ P ++ LM C S RP T++ +L I+E
Sbjct: 229 RIENGERLPMPPNCPPTLYSLM---------TKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 61/304 (20%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNL 404
+ILG G FG V +G L+ VAVK+ K+ N + L+E + +H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 405 VRLLGCCVEAE-----QPLLIYEYIANGTLHDHL---HGKYSSFNLTWSTRLRIALQTAE 456
+RLLG C+E +P++I ++ G LH +L + ++ T L+ + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
+ YL + + HRD+ + N +L DD VADFGLS+ + QG + +
Sbjct: 159 GMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKK----IYSGDYYRQGRIAKM 211
Query: 517 -----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569
E R Y T KSDV+++GV + E+ T P Y
Sbjct: 212 PVKWIAIESLADRVY--TSKSDVWAFGVTMWEIAT------RGMTP-------Y--PGVQ 254
Query: 570 NGAIMEVVDPRLQGHEASVNILM------SLKLFSELAVACLREKKSERPSMTDVVHELQ 623
N + + + GH + +L+ E+ +C R +RP+ + + +L+
Sbjct: 255 NHEMYDYLL---HGH------RLKQPEDCLDELY-EIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 624 RIIE 627
+++E
Sbjct: 305 KLLE 308
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKN 403
F E+ +G G F EVY+ L DG VA+K ++ ++ + E+ +L Q+NH N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 404 LVRLLGCCVEAEQPLLIY-EYIANGTLHDHL-HGKYSSFNLTWSTRLRIALQTAEALAYL 461
+++ +E + L I E G L + H K + T + +Q AL ++
Sbjct: 94 VIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
HS + HRD+K N+ + K+ D GL R + + GT Y+ PE
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 208
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKA 548
KSD++S G +L E+ Q
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-40
Identities = 73/296 (24%), Positives = 115/296 (38%), Gaps = 51/296 (17%)
Query: 348 FSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVN 400
LG G FG V +GE VAVK K + + + + EV + ++
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 401 HKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA 459
H+NL+RL G + P+ ++ E G+L D L F L T R A+Q AE +
Sbjct: 80 HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMG 135
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY--LD 517
YL S + HRD+ + N+LL K+ DFGL R H + +
Sbjct: 136 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 518 PE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
PE R + + SD + +GV L E+ T + ++P + + I+
Sbjct: 193 PESLKTRTF--SHASDTWMFGVTLWEMFT------YGQEP-------W--IGLNGSQILH 235
Query: 576 VVD------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+D PR + + +M V C K +RP+ + L
Sbjct: 236 KIDKEGERLPRPEDCPQDIYNVM---------VQCWAHKPEDRPTFVALRDFLLEA 282
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 45/291 (15%)
Query: 351 ERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNLV 405
++++G+G FGEV G L+ VA+K+ KVG + ++ L E I+ Q +H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
RL G +++ +++ EY+ NG+L L + T + + A + YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL--DPE--YY 521
Y HRD+ + NIL++ + KV+DFGL R+ + T G + PE Y
Sbjct: 168 YV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD--- 578
R + T SDV+SYG+VL E+++ + P Y SN +++ VD
Sbjct: 225 RKF--TSASDVWSYGIVLWEVMS------YGERP-------Y--WEMSNQDVIKAVDEGY 267
Query: 579 --PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
P A++ LM + C ++ ++ RP +V L ++I
Sbjct: 268 RLPPPMDCPAALYQLM---------LDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 8/206 (3%)
Query: 346 NGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHK 402
+ + + +G G FG+ + +DG +K + + K ++ EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N+V+ E ++ +Y G L ++ L +Q AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRD+KS NI L D ++ DFG++R+ + C GT YL PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKA 548
N +KSD+++ G VL EL T + A
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
F + ++GSGGFG+V+K + DG +K K + ++ EV L++++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVH 68
Query: 407 LLGCCVEAEQPL----------------LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI 450
GC + + E+ GTL + K L L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALEL 127
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
Q + + Y+HS + +RD+K +NI L D K+ DFGL K +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
GTL Y+ PE + + D+Y+ G++L ELL
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 47/298 (15%)
Query: 350 KERILGSGGFGEVYKGELQDG---TVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNL 404
+++ LGSG FG V KG Q VAVK K + L E ++ Q+++ +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
VR++G C EAE +L+ E G L+ +L + ++ + + Q + + YL +
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL--GYLDPE--Y 520
+ HRD+ + N+LL +K++DFGLS+ + ++ G + PE
Sbjct: 137 NFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 521 YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD-- 578
Y + + KSDV+S+GV++ E + + + P Y + + +++
Sbjct: 194 YYKF--SSKSDVWSFGVLMWEAFS------YGQKP-------Y--RGMKGSEVTAMLEKG 236
Query: 579 ---PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEK 633
G + LM C RP V L+ V E
Sbjct: 237 ERMGCPAGCPREMYDLM---------NLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLV 405
F + LG GGFG V++ + D A+K ++ N + ++V+ EV L+++ H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 406 RLLGCCVE---------AEQPLLIY---EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
R +E + + +Y + L D ++G+ + S L I LQ
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--- 510
AEA+ +LHS + HRD+K +NI D KV DFGL +
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 511 --------GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
GT Y+ PE + K D++S G++L ELL
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 45/290 (15%)
Query: 351 ERILGSGGFGEVYKGELQDG---TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVR 406
+ LG G FG V +G + VA+K K G T++++ E I+ Q+++ +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L+G C +AE +L+ E G LH L + S + Q + + YL +
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL--GYLDPE--YYR 522
HRD+ + N+LL + +K++DFGLS+ S+ + + G + PE +R
Sbjct: 132 V---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD---- 578
+ + +SDV+SYGV + E L+ + + P Y ++ +M ++
Sbjct: 189 KF--SSRSDVWSYGVTMWEALS------YGQKP-------Y--KKMKGPEVMAFIEQGKR 231
Query: 579 -PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ LM C K +RP V ++
Sbjct: 232 MECPPECPPELYALM---------SDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 77/315 (24%), Positives = 126/315 (40%), Gaps = 82/315 (26%)
Query: 351 ERILGSGGFGEVYKGELQDG---TVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKNLV 405
+ ++G G FG+V K ++ A+K K + + E+ +L ++ +H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHL-------------HGKYSSFNLTWSTRLRIAL 452
LLG C L EY +G L D L ++ L+ L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
A + YL + HRD+ + NIL+ +++ +K+ADFGLSR
Sbjct: 150 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSR---------------- 190
Query: 513 LGYLDPEYYR-----------------NYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRD 554
E Y NY + T SDV+SYGV+L E+++
Sbjct: 191 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGT 240
Query: 555 PDDVNLAIYVSQRASNGAIMEVVDPRLQGH--EASVNILMSLKLFSELAVACLREKKSER 612
P Y + + E + QG+ E +N +++ +L C REK ER
Sbjct: 241 P-------Y--CGMTCAELYEKLP---QGYRLEKPLNC--DDEVY-DLMRQCWREKPYER 285
Query: 613 PSMTDVVHELQRIIE 627
PS ++ L R++E
Sbjct: 286 PSFAQILVSLNRMLE 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 77/318 (24%), Positives = 130/318 (40%), Gaps = 70/318 (22%)
Query: 351 ERILGSGGFGEVYKGELQD--------GTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-N 400
+ LG G FG+V E VAVK K K +++E+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL-------------HGKYSSFNLTWSTR 447
HKN++ LLG C + +I EY + G L ++L + +T+
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
+ Q A + YL S HRD+ + N+L+ ++ K+ADFGL+R ++++
Sbjct: 206 VSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARD----INNIDY 258
Query: 508 CAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
+ T G L PE + R Y T +SDV+S+GV++ E+ T P
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT------LGGSP----- 305
Query: 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILM------SLKLFSELAVACLREKKSERPS 614
Y E+ +GH M + +L+ + C S+RP+
Sbjct: 306 --Y--PGIPV---EELFKLLKEGH------RMDKPANCTNELY-MMMRDCWHAVPSQRPT 351
Query: 615 MTDVVHELQRIIEIVNQE 632
+V +L RI+ + E
Sbjct: 352 FKQLVEDLDRILTLTTNE 369
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 73/305 (23%), Positives = 117/305 (38%), Gaps = 65/305 (21%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKN 403
LG FG+VYKG L VA+K+ K ++ +E + +++ H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLH-------------GKYSSFNLTWSTRLRI 450
+V LLG + + +I+ Y ++G LH+ L + L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
Q A + YL S H+D+ + N+L+ D N K++D GL R +
Sbjct: 134 VAQIAAGMEYLSSHHVV---HKDLATRNVLVYDKLNVKISDLGLFRE----VYAADYYKL 186
Query: 511 GTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563
L PE Y + + SD++SYGVVL E+ + + P Y
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVFS------YGLQP-------Y 231
Query: 564 VSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
SN ++E++ P A V LM + C E S RP D+
Sbjct: 232 --CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALM---------IECWNEFPSRRPRFKDI 280
Query: 619 VHELQ 623
L+
Sbjct: 281 HSRLR 285
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 69/199 (34%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
R LG G FG VY E Q ++A+K A++ Q+ EV I S + H N++RL
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
G +A + LI EY GT++ L K+ T + A AL+Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTA-TYITELANALSYCHSKR 129
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
+ HRD+K N+LL K+ADFG S A P C GTL YL PE
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDLC--GTLDYLPPEMIEGRM 183
Query: 526 LTDKSDVYSYGVVLLELLT 544
+K D++S GV+ E L
Sbjct: 184 HDEKVDLWSLGVLCYEFLV 202
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-38
Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNLV 405
R +G G FG+V++G VA+K+ K S ++ L E + Q +H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+L+G E +I E G L L + S +L ++ + A Q + ALAYL S
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKR 511
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRL--------AKPGLSHVSTCAQGTLGYLD 517
+ HRD+ + N+L+ + K+ DFGLSR A G + A
Sbjct: 512 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA-------- 560
Query: 518 PE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
PE +R + T SDV+ +GV + E+L P + Q N ++
Sbjct: 561 PESINFRRF--TSASDVWMFGVCMWEILM------HGVKP-------F--QGVKNNDVIG 603
Query: 576 VVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
++ P ++ LM C S RP T++ +L I+E
Sbjct: 604 RIENGERLPMPPNCPPTLYSLM---------TKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 72/320 (22%), Positives = 126/320 (39%), Gaps = 61/320 (19%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVGNIKSTQQ-VLNEVGILSQVNHKN 403
R LG G FGEVY+G++ VAVK+ + + L E I+S+ NH+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL----HGKYSSFNLTWSTRLRIALQTAEALA 459
+VR +G +++ ++ E +A G L L +L L +A A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 460 YLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
YL + HRD+ + N LL +K+ DFG++R + S +G L
Sbjct: 155 YLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 207
Query: 517 -----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569
PE + T K+D +S+GV+L E+ + P Y S
Sbjct: 208 PVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIFS------LGYMP-------Y--PSKS 250
Query: 570 NGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
N ++E V + V +M C + + +RP+ ++ ++
Sbjct: 251 NQEVLEFVTSGGRMDPPKNCPGPVYRIM---------TQCWQHQPEDRPNFAIILERIEY 301
Query: 625 IIEIVNQEKVSNDVNVETAP 644
+ + + ++ + +E P
Sbjct: 302 CTQ--DPDVINTALPIEYGP 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 77/322 (23%), Positives = 132/322 (40%), Gaps = 70/322 (21%)
Query: 351 ERILGSGGFGEVYKGELQD--------GTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-N 400
+ LG G FG+V E VAVK K K +++E+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL-------------HGKYSSFNLTWSTR 447
HKN++ LLG C + +I EY + G L ++L + +T+
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
+ Q A + YL S HRD+ + N+L+ ++ K+ADFGL+R ++++
Sbjct: 160 VSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARD----INNIDY 212
Query: 508 CAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
+ T G L PE + R Y T +SDV+S+GV++ E+ T P
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT------LGGSP----- 259
Query: 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILM------SLKLFSELAVACLREKKSERPS 614
Y E+ +GH M + +L+ + C S+RP+
Sbjct: 260 --Y--PGIPV---EELFKLLKEGH------RMDKPANCTNELY-MMMRDCWHAVPSQRPT 305
Query: 615 MTDVVHELQRIIEIVNQEKVSN 636
+V +L RI+ + E+ +
Sbjct: 306 FKQLVEDLDRILTLTTNEEYLD 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 353 ILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLG 409
+G G F VYKG + + VA + + Q+ E +L + H N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 410 CCV---EAEQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+ ++ +++ E + +GTL +L ++ Q + L +LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMK--IKVLRSWCRQILKGLQFLHTRT 149
Query: 466 YTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
PI HRD+K NI + S K+ D GL+ L + S GT ++ PE Y
Sbjct: 150 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAV-IGTPEFMAPEMYEE- 204
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584
+ + DVY++G+ +LE+ TS+ +S + + V+ + +V P ++
Sbjct: 205 KYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK-- 260
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPS 614
I+ C+R+ K ER S
Sbjct: 261 ----EIIEG----------CIRQNKDERYS 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 62/313 (19%)
Query: 352 RILGSGGFGEVYKGELQD------GTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKN 403
+ LG G FG+V + + VAVK K G + +++E+ IL + +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 404 LVRLLGCCVEAEQPL-LIYEYIANGTLHDHL-------------HGKYSSFNLTWSTRLR 449
+V LLG C + PL +I E+ G L +L LT +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 450 IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCA 509
+ Q A+ + +L S HRD+ + NILL + K+ DFGL+R +
Sbjct: 153 YSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYV 205
Query: 510 QGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP-DDVNLA 561
+ L PE + R Y T +SDV+S+GV+L E+ + P V +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS------LGASPYPGVKID 257
Query: 562 IYVSQRASNGAIMEVVDPRLQGHEASVNI--LMSLKLFSELAVACLREKKSERPSMTDVV 619
+R G M + + M C + S+RP+ +++V
Sbjct: 258 EEFCRRLKEGTRMR------APDYTTPEMYQTML---------DCWHGEPSQRPTFSELV 302
Query: 620 HELQRIIEIVNQE 632
L +++ Q+
Sbjct: 303 EHLGNLLQANAQQ 315
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 80/329 (24%), Positives = 135/329 (41%), Gaps = 68/329 (20%)
Query: 351 ERILGSGGFGEVYKGELQD--------GTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-N 400
+ LG G FG+V E T VAVK K K +++E+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL-----HGKYSSFN--------LTWSTR 447
HKN++ LLG C + +I EY + G L ++L G S+N L+
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
+ A Q A + YL S HRD+ + N+L+ +D K+ADFGL+R + H+
Sbjct: 194 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARD----IHHIDY 246
Query: 508 CAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
+ T G L PE + R Y T +SDV+S+GV+L E+ T P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT------LGGSP----- 293
Query: 561 AIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615
Y + +++ + + ++M C S+RP+
Sbjct: 294 --Y--PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---------DCWHAVPSQRPTF 340
Query: 616 TDVVHELQRIIEIVNQEKVSNDVNVETAP 644
+V +L RI+ + + +++ +
Sbjct: 341 KQLVEDLDRIVALTSNQEMGYYHHHHHHD 369
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 75/320 (23%), Positives = 124/320 (38%), Gaps = 79/320 (24%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKN 403
+ LG G FG+V K T VAVK K + + +L+E +L QVNH +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL---------------------HGKYSSFNL 442
+++L G C + LLI EY G+L L L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
T + A Q ++ + YL HRD+ + NIL+ + K++DFGLSR +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEGRKMKISDFGLSRD----V 200
Query: 503 SHVSTCAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555
+ + + G + E + Y T +SDV+S+GV+L E++T +P
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVT------LGGNP 252
Query: 556 DDVNLAIYVSQRASNGAIMEVVDPRLQGH------EASVNI--LMSLKLFSELAVACLRE 607
Y + + GH S + LM C ++
Sbjct: 253 -------Y--PGIPP---ERLFNLLKTGHRMERPDNCSEEMYRLML---------QCWKQ 291
Query: 608 KKSERPSMTDVVHELQRIIE 627
+ +RP D+ +L++++
Sbjct: 292 EPDKRPVFADISKDLEKMMV 311
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 21/213 (9%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLV 405
+ ILG G V++G + G + A+K + ++ + E +L ++NHKN+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 406 RLLGC--CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+L +LI E+ G+L+ L +++ L S L + + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 464 AAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
I HR++K NI+ D K+ DFG +R + VS GT YL P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185
Query: 520 YYRNYQLTD--------KSDVYSYGVVLLELLT 544
Y L D++S GV T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 48/232 (20%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
F + +LG G FG+V K D A+K + + +L+EV +L+ +NH+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVR 66
Query: 407 LLGCCVEAEQPLL----------IY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIA 451
+E + ++ EY NGTL+D + + W R+
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLF 122
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ- 510
Q EAL+Y+HS I HRD+K NI +D+ N K+ DFGL++ L + +Q
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 511 ------------GTLGYLDPE------YYRNYQLTDKSDVYSYGVVLLELLT 544
GT Y+ E +Y +K D+YS G++ E++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIY 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 71/321 (22%), Positives = 126/321 (39%), Gaps = 63/321 (19%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKN 403
R LG G FGEVY+G++ VAVK+ + + L E I+S+ NH+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL----HGKYSSFNLTWSTRLRIALQTAEALA 459
+VR +G +++ ++ E +A G L L +L L +A A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 460 YLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
YL + HRD+ + N LL +K+ DFG++R + +G L
Sbjct: 196 YLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAML 248
Query: 517 -----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569
PE + T K+D +S+GV+L E+ + P Y S
Sbjct: 249 PVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIFS------LGYMP-------Y--PSKS 291
Query: 570 NGAIMEVVDPRLQGHEASVNILM------SLKLFSELAVACLREKKSERPSMTDVVHELQ 623
N EV++ G M ++ + C + + +RP+ ++ ++
Sbjct: 292 N---QEVLEFVTSGG------RMDPPKNCPGPVY-RIMTQCWQHQPEDRPNFAIILERIE 341
Query: 624 RIIEIVNQEKVSNDVNVETAP 644
+ + + ++ + +E P
Sbjct: 342 YCTQ--DPDVINTALPIEYGP 360
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+LG G +G VY G +L + +A+K + + +Q + E+ + + HKN+V+ L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 409 GCCVEAEQPLLIY-EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G E + I+ E + G+L L K+ T Q E L YLH
Sbjct: 86 GSFSENGF-IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 468 PIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE----YYR 522
I HRD+K N+L++ K++DFG S+ T GTL Y+ PE R
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPR 200
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQ 546
Y +D++S G ++E+ T +
Sbjct: 201 GY--GKAADIWSLGCTIIEMATGK 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 77/328 (23%), Positives = 127/328 (38%), Gaps = 95/328 (28%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKN 403
R +G G FG V++ T+VAVK K + E ++++ ++ N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL---------------------HGKYSSFNL 442
+V+LLG C + L++EY+A G L++ L L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
+ + +L IA Q A +AYL + HRD+ + N L+ ++ K+ADFGLSR +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 503 SHVSTCAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLT----------S 545
+ PE +Y Y T +SDV++YGVVL E+ +
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 546 QKAIDFSRD------PDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSE 599
++ I + RD P++ L +Y +M
Sbjct: 283 EEVIYYVRDGNILACPENCPLELY--------NLM------------------------- 309
Query: 600 LAVACLREKKSERPSMTDVVHELQRIIE 627
C + ++RPS + LQR+ E
Sbjct: 310 --RLCWSKLPADRPSFCSIHRILQRMCE 335
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKN 403
F +LG G F VY+ + G VA+K + Q+V NEV I Q+ H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++ L ++ L+ E NG ++ +L + F+ R Q + YLHS
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLYLHS 130
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRD+ +N+LL + N K+ADFGL+ +L P H + C GT Y+ PE
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIAT 185
Query: 523 NYQLTDKSDVYSYGVVLLELLT 544
+SDV+S G + LL
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLI 207
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 21/213 (9%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLV 405
+ ILG G V++G + G + A+K + ++ + E +L ++NHKN+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 406 RLLGC--CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+L +LI E+ G+L+ L +++ L S L + + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 464 AAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
I HR++K NI+ D K+ DFG +R + VS GT YL P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185
Query: 520 YYRNYQLTD--------KSDVYSYGVVLLELLT 544
Y L D++S GV T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-36
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 45/290 (15%)
Query: 351 ERILGSGGFGEVYKGELQDG---TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVR 406
+ LG G FG V +G + VA+K K G T++++ E I+ Q+++ +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L+G C +AE +L+ E G LH L + S + Q + + YL +
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY--LDPE--YYR 522
HR++ + N+LL + +K++DFGLS+ S+ + + G PE +R
Sbjct: 458 V---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD---- 578
+ + +SDV+SYGV + E L+ + + P Y ++ +M ++
Sbjct: 515 KF--SSRSDVWSYGVTMWEALS------YGQKP-------Y--KKMKGPEVMAFIEQGKR 557
Query: 579 -PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ LMS C K +RP V ++
Sbjct: 558 MECPPECPPELYALMS---------DCWIYKWEDRPDFLTVEQRMRACYY 598
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 78/326 (23%), Positives = 124/326 (38%), Gaps = 87/326 (26%)
Query: 351 ERILGSGGFGEVYKGELQD------GTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHK 402
+ LG+G FG+V + VAVK K + + +++E+ I+S + H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGK-----------YSSFNLTWSTRLRIA 451
N+V LLG C L+I EY G L + L K ++ + L +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQG 511
Q A+ +A+L S HRDV + N+LL + +K+ DFGL+R
Sbjct: 171 SQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDI------------- 214
Query: 512 TLGYLDPEY-------------------YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552
D Y Y T +SDV+SYG++L E+ +
Sbjct: 215 ---MNDSNYIVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS------LG 263
Query: 553 RDP---DDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNI--LMSLKLFSELAVACLRE 607
+P VN Y + +G M Q A NI +M AC
Sbjct: 264 LNPYPGILVNSKFY--KLVKDGYQMA------QPAFAPKNIYSIMQ---------ACWAL 306
Query: 608 KKSERPSMTDVVHELQRIIEIVNQEK 633
+ + RP+ + LQ + +E+
Sbjct: 307 EPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
R LG G FG VY E Q+ ++A+K +++ Q+ E+ I S + H N++R+
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+ ++ L+ E+ G L+ L HG++ + + A+AL Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSA-TFMEELADALHYCHERK 134
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
+ HRD+K N+L+ K+ADFG S A P L + C GTL YL PE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRTMC--GTLDYLPPEMIEGKT 188
Query: 526 LTDKSDVYSYGVVLLELLT 544
+K D++ GV+ E L
Sbjct: 189 HDEKVDLWCAGVLCYEFLV 207
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 75/320 (23%), Positives = 121/320 (37%), Gaps = 73/320 (22%)
Query: 351 ERILGSGGFGEVYKGEL------QDGTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHK 402
+ LG+G FG+V + VAVK K ++ + +++E+ +LS + NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHL---------------HGKYSSFNLTWSTR 447
N+V LLG C L+I EY G L + L + L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
L + Q A+ +A+L S HRD+ + NILL +K+ DFGL+R K ++V
Sbjct: 148 LSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 508 CAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
L PE + Y T +SDV+SYG+ L EL + P
Sbjct: 205 ----GNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFS------LGSSP----- 247
Query: 561 AIYVSQRASNGAIMEVVDPRLQGH------EASVNI--LMSLKLFSELAVACLREKKSER 612
Y + +++ +G A + +M C +R
Sbjct: 248 --Y-PGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMK---------TCWDADPLKR 292
Query: 613 PSMTDVVHELQRIIEIVNQE 632
P+ +V +++ I
Sbjct: 293 PTFKQIVQLIEKQISESTNH 312
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 351 ERILGSGGFGEVYKGELQDG------TVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHK 402
++LGSG FG+V VAVK K + + +++E+ +++Q+ +H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN--------------------L 442
N+V LLG C + LI+EY G L ++L K F+ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 443 TWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502
T+ L A Q A+ + +L + HRD+ + N+L+ K+ DFGL+R
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 503 SHVSTCAQGTLGYL-----DPE--YYRNYQLTDKSDVYSYGVVLLELLT 544
++V L PE + Y T KSDV+SYG++L E+ +
Sbjct: 227 NYVVR----GNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFS 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKN 403
+ + R LG GGF + ++ + V A K + + +++ E+ I + H++
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
+V G + + ++ E +L + + R Q YL
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT----EPEAR-YYLRQIVLGCQYL 157
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEY 520
H + HRD+K N+ L++D K+ DFGL+ ++ G C GT Y+ PE
Sbjct: 158 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEV 212
Query: 521 YRNYQLTDKSDVYSYGVVLLELLT 544
+ + DV+S G ++ LL
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLV 236
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKN 403
+ + R LG GGF + ++ + V A K + + +++ E+ I + H++
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
+V G + + ++ E +L + + R Q YL
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT----EPEAR-YYLRQIVLGCQYL 131
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQGTLGYLDPEY 520
H + HRD+K N+ L++D K+ DFGL+ ++ G C GT Y+ PE
Sbjct: 132 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEV 186
Query: 521 YRNYQLTDKSDVYSYGVVLLELLT 544
+ + DV+S G ++ LL
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLV 210
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 58/206 (28%), Positives = 80/206 (38%), Gaps = 17/206 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQV-NHKN 403
F + LG G +GEV+K +DG + AVK + + L EVG +V H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
VRL E L E +L H G W T ALA+L
Sbjct: 119 CVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHL 173
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
HS + H DVK NI L K+ DFGL + G Y+ PE
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL 228
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQK 547
+ +DV+S G+ +LE+ + +
Sbjct: 229 QG-SYGTAADVFSLGLTILEVACNME 253
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 5e-34
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+ LG+GGFG V + G VA+K + + K+ ++ E+ I+ ++NH N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 409 ------GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+ PLL EY G L +L+ + L + + AL YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNS---KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
I HRD+K NI+L K+ D G ++ G GTL YL PE
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAPE 193
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLT 544
+ T D +S+G + E +T
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNL- 404
+S + +GSGG +V++ + + A+K + ++ NE+ L+++ +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 405 -VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+RL + + ++ E N L+ L K S + EA+ +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWER--KSYWKNMLEAVHTIHQ 145
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDPE- 519
I H D+K N L+ D K+ DFG++ +P + V S GT+ Y+ PE
Sbjct: 146 HG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEA 199
Query: 520 ----------YYRNYQLTDKSDVYSYGVVLLELLT 544
+++ KSDV+S G +L +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNL- 404
+S + +GSGG +V++ + + A+K + ++ NE+ L+++ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 405 -VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+RL + + ++ E N L+ L K S + R EA+ +H
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWE--RKSYWKNMLEAVHTIHQ 126
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDPE- 519
I H D+K N L+ D K+ DFG++ +P + V S GT+ Y+ PE
Sbjct: 127 HG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEA 180
Query: 520 ----------YYRNYQLTDKSDVYSYGVVLLELLT 544
+++ KSDV+S G +L +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 19/240 (7%)
Query: 312 QAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDG 370
AKL + + + + E ++ + + + +G G FGEV++ + Q G
Sbjct: 24 SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 371 TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY-EYIANGTL 429
AVK ++ + E+ + ++ +V L G E + I+ E + G+L
Sbjct: 84 FQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPW-VNIFMELLEGGSL 137
Query: 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS-K 488
+ + L Q E L YLH+ I H DVK+ N+LL D +
Sbjct: 138 GQLIK-QMGCLPE--DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAA 191
Query: 489 VADFGLS-RLAKPGLSHVSTCA---QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ DFG + L GL GT ++ PE K D++S ++L +L
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 24/246 (9%)
Query: 309 LAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-EL 367
+ + RE++ ++ P K+ + + + + LGSG +GEV +
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKK-GHLSEMYQRVKKLGSGAYGEVLLCRDK 59
Query: 368 QDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424
A+K V S ++L EV +L ++H N+++L + L+ E
Sbjct: 60 VTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 425 ANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL- 481
G L D + K++ I Q + YLH I HRD+K N+LL
Sbjct: 119 KGGELFDEIIHRMKFNE-----VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170
Query: 482 --DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YYRNYQLTDKSDVYSYGVV 538
+ D K+ DFGLS + + GT Y+ PE + Y +K DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRKKY--DEKCDVWSIGVI 226
Query: 539 LLELLT 544
L LL
Sbjct: 227 LFILLA 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 52/254 (20%), Positives = 103/254 (40%), Gaps = 34/254 (13%)
Query: 316 AKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAV 375
+D+L + + + ++KE K N + R L G F ++ E +D A+
Sbjct: 3 LGSMKDILSNYSNLIYLNK--YVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYAL 59
Query: 376 K-----------------SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418
K + K+ NE+ I++ + ++ + G ++
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRL------RIALQTAEALAYLHSAAYTPIYHR 472
+IYEY+ N ++ + + ++ + I + +Y+H+ I HR
Sbjct: 120 IIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHR 176
Query: 473 DVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD--KS 530
DVK +NIL+D + K++DFG S + GT ++ PE++ N + K
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSR--GTYEFMPPEFFSNESSYNGAKV 233
Query: 531 DVYSYGVVLLELLT 544
D++S G+ L +
Sbjct: 234 DIWSLGICLYVMFY 247
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 335 IFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKSTQQVL 390
+F ++ + +R+LG G FGEV + G AVK +V + +L
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 391 NEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRL 448
EV +L Q++H N+++L + L+ E G L D + ++S
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-----VDAA 129
Query: 449 RIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHV 505
RI Q + Y+H I HRD+K N+LL D N ++ DFGLS +
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 506 STCAQGTLGYLDPE-YYRNYQLTDKSDVYSYGVVLLELLT 544
GT Y+ PE + Y +K DV+S GV+L LL+
Sbjct: 187 DKI--GTAYYIAPEVLHGTY--DEKCDVWSTGVILYILLS 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 53/257 (20%), Positives = 98/257 (38%), Gaps = 28/257 (10%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
K AK ++ D A + + +S + +GSGG +V++
Sbjct: 16 GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75
Query: 366 ELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNL--VRLLGCCVEAEQPLLIY 421
+ + A+K + ++ NE+ L+++ + +RL + + ++
Sbjct: 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135
Query: 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481
E N L+ L K S + R EA+ +H I H D+K N L+
Sbjct: 136 EC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188
Query: 482 DDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDPE-----------YYRNYQLT 527
D K+ DFG++ +P + V S G + Y+ PE +++
Sbjct: 189 VDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 528 DKSDVYSYGVVLLELLT 544
KSDV+S G +L +
Sbjct: 246 PKSDVWSLGCILYYMTY 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVR 406
F + +LG G G + + D VAVK + EV +L + + H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ + + E A TL +++ K F + + QT LA+LHS
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 467 TPIYHRDVKSTNILLDDDFNS-----KVADFGLSRLAKPGLS--HVSTCAQGTLGYLDPE 519
I HRD+K NIL+ ++DFGL + G + GT G++ PE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 520 YYR---NYQLTDKSDVYSYGVVLLELLT 544
T D++S G V +++
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 66/254 (25%), Positives = 99/254 (38%), Gaps = 33/254 (12%)
Query: 311 KQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQD 369
+ L IA P KE K + K R LGSG +GEV E
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKE-GKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 370 GTVVAVKS-------------AKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416
+ A+K K +++ NE+ +L ++H N+++L + +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 417 PLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV 474
L+ E+ G L + + K+ + I Q + YLH I HRD+
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAA-----NIMKQILSGICYLHKHN---IVHRDI 172
Query: 475 KSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YYRNYQLTDKS 530
K NILL + N K+ DFGLS GT Y+ PE + Y +K
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPEVLKKKY--NEKC 228
Query: 531 DVYSYGVVLLELLT 544
DV+S GV++ LL
Sbjct: 229 DVWSCGVIMYILLC 242
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-31
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+LG G FGEV K + AVK A N K T +L EV +L +++H N+++
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMK 85
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
L ++ ++ E G L D + ++S RI Q + Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMHKH 140
Query: 465 AYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-Y 520
I HRD+K NILL + D + K+ DFGLS + GT Y+ PE
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL 195
Query: 521 YRNYQLTDKSDVYSYGVVLLELLT 544
Y +K DV+S GV+L LL+
Sbjct: 196 RGTY--DEKCDVWSAGVILYILLS 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 35/223 (15%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQV-NHKN 403
F + +GSG FG V+K + DG + A+K +K S Q L EV + + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 404 LVRLLGCCVEAEQPLLIY-EYIANGTLHDHLHGKYSSFN-LTWSTRLRIALQTAEALAYL 461
+VR E + +LI EY G+L D + Y + + + LQ L Y+
Sbjct: 73 VVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 462 HSAAYTPIYHRDVKSTNILLDDD-------------------FNSKVADFGLSRLAKPGL 502
HS + + H D+K +NI + K+ D G +
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR----I 184
Query: 503 SHVSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLT 544
S +G +L E + NY K+D+++ + ++
Sbjct: 185 SSPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
LG GG VY E VA+K ++ ++ EV SQ++H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
++ E + L+ EYI TL +++ L+ T + Q + + + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMR- 131
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
I HRD+K NIL+D + K+ DFG+++ L++ L+ + GT+ Y PE +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEA 188
Query: 526 LTDKSDVYSYGVVLLELLT 544
+ +D+YS G+VL E+L
Sbjct: 189 TDECTDIYSIGIVLYEMLV 207
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 37/228 (16%), Positives = 72/228 (31%), Gaps = 27/228 (11%)
Query: 339 KELKKATNGFSKERILGSGGFGEVYKGE------LQDGTVVAVKSAKVGNIKSTQQVLNE 392
E + + +LG G F +VY+ ++ +K K N
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 393 VGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRI 450
+ L ++ + +L+ E + GTL + + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS-----------KVADFGLS---R 496
A++ + +H I H D+K N +L + F + D G S +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
L G + C T G+ E N + D + + +L
Sbjct: 235 LFPKGTIFTAKC--ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKS--------AKVGNIKSTQQVLNEVGILSQVNHK 402
+ LGSG GEV E + VA++ V E+ IL ++NH
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAY 460
++++ +AE ++ E + G L D + + + +T Q A+ Y
Sbjct: 201 CIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKE-----ATCKLYFYQMLLAVQY 254
Query: 461 LHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
LH I HRD+K N+LL ++D K+ DFG S++ + C GT YL
Sbjct: 255 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 518 PE-----YYRNYQLTDKSDVYSYGVVLLELLT 544
PE Y D +S GV+L L+
Sbjct: 310 PEVLVSVGTAGY--NRAVDCWSLGVILFICLS 339
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 36/211 (17%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLN---------------EVG 394
R++G GG G+VY+ E +VA+K +++ E
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALK------------LMSETLSSDPVFRTRMQREAR 86
Query: 395 ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQT 454
++ ++V + Q + I L L + L + I Q
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQI 143
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTL 513
AL H+A HRDVK NIL+ D + + DFG++ L+ + GTL
Sbjct: 144 GSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTL 199
Query: 514 GYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
Y+ PE + T ++D+Y+ VL E LT
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLT 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
LGSG FG V++ E G V K V NE+ I++Q++H L+ L
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
+ + +LI E+++ G L D + + + ++ + + Q E L ++H + I
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 470 YHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
H D+K NI+ + S K+ DFGL+ P T T + PE +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVG 228
Query: 528 DKSDVYSYGVVLLELLT 544
+D+++ GV+ LL+
Sbjct: 229 FYTDMWAIGVLGYVLLS 245
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
SK ILG G FG+V+K E G +A K K +K ++V NE+ +++Q++H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L +L+ EY+ G L D + + S+NLT + Q E + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY- 207
Query: 467 TPIYHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I H D+K NIL + K+ DFGL+R KP GT +L PE
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNYD 263
Query: 525 QLTDKSDVYSYGVVLLELLT 544
++ +D++S GV+ LL+
Sbjct: 264 FVSFPTDMWSVGVIAYMLLS 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+LG G FGEV K + AVK A N K T +L EV +L +++H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKL 86
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
++ ++ E G L D + ++S RI Q + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMHKHN 141
Query: 466 YTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YY 521
I HRD+K NILL + D + K+ DFGLS + GT Y+ PE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR 196
Query: 522 RNYQLTDKSDVYSYGVVLLELL 543
Y +K DV+S GV+L LL
Sbjct: 197 GTY--DEKCDVWSAGVILYILL 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 56/226 (24%), Positives = 83/226 (36%), Gaps = 35/226 (15%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVR 406
E+ILG G G V G VAVK I L E+ +L++ +H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTR--LRIALQTAEALAYLH 462
+ E N L D + + + Q A +A+LH
Sbjct: 74 YYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 463 SAAYTPIYHRDVKSTNILLD-------------DDFNSKVADFGLSRLAKPGLSHVSTCA 509
S I HRD+K NIL+ ++ ++DFGL + G S T
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 510 Q---GTLGYLDPE-------YYRNYQLTDKSDVYSYGVVLLELLTS 545
GT G+ PE +LT D++S G V +L+
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 24/240 (10%), Positives = 56/240 (23%), Gaps = 42/240 (17%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVK---SAKVGNIKSTQQVLNEVGI 395
L + L G V+ +++ A+K + +++
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 396 LSQVNHKNLVRLLGCC-------------------------VEAEQPLLIYEYIANGTLH 430
+++ ++ A L+ A+ L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 431 DHL----HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486
+ + Q A L S + H N+ + D
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232
Query: 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY--RNYQLTDKSDVYSYGVVLLELLT 544
+ D K G ++ + Y E+ T + + G+ + +
Sbjct: 233 LMLGDVSALW--KVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 19/200 (9%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
E +G G +GEV + A K ++ + E+ I+ ++H N++RL
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 410 CCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
+ L+ E G L + + + S RI A+AY H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRE-----SDAARIMKDVLSAVAYCHKLN-- 126
Query: 468 PIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YYRN 523
+ HRD+K N L D K+ DFGL+ KPG + GT Y+ P+
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGL 183
Query: 524 YQLTDKSDVYSYGVVLLELL 543
Y + D +S GV++ LL
Sbjct: 184 Y--GPECDEWSAGVMMYVLL 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 51/242 (21%), Positives = 94/242 (38%), Gaps = 11/242 (4%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
K+ + D + +K + + LG+G FG V++
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH-DHVLDHYDIHEELGTGAFGVVHRV 176
Query: 366 -ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424
E G A K + + V E+ +S + H LV L + + ++IYE++
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD 484
+ G L + + + ++ + Q + L ++H H D+K NI+
Sbjct: 237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 291
Query: 485 FNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLEL 542
++ K+ DFGL+ P S T GT + PE + +D++S GV+ L
Sbjct: 292 RSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349
Query: 543 LT 544
L+
Sbjct: 350 LS 351
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 48/267 (17%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+R LGSG FG+V+ E G +K+ K + +Q+ E+ +L ++H N++++
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF-NLTWSTRLRIALQTAEALAYLHSAAYT 467
+ ++ E G L + + + L+ + Q ALAY HS
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-- 144
Query: 468 PIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE-YYRN 523
+ H+D+K NIL K+ DFGL+ L K + GT Y+ PE + R+
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFKRD 201
Query: 524 YQLTDKSDVYSYGVVLLELLT--------SQKAI---------DFSRDPDDVNLAIYVSQ 566
T K D++S GVV+ LLT S + + +++ + +
Sbjct: 202 V--TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL-------- 251
Query: 567 RASNGAI-----MEVVDP--RLQGHEA 586
+ A+ M DP R +
Sbjct: 252 --TPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 23/202 (11%)
Query: 351 ERILGSGGFGEVYKGE--LQDGTVVAVKSAKVGNIKSTQQV-LNEVGILSQVNHKNLVRL 407
+ + GG G +Y +G V +K Q + + E L++V H ++V++
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 408 L--GCCVEAEQPLLIY---EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+ + Y EY+ +L K L + + L+ AL+YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH 199
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
S + + D+K NI+L ++ K+ D G ++ GT G+ PE R
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEIVR 250
Query: 523 NYQLTDKSDVYSYGVVLLELLT 544
T +D+Y+ G L L
Sbjct: 251 T-GPTVATDIYTVGRTLAALTL 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKS--------AKVGNIKSTQQVLNEVGILSQVNHK 402
+ LGSG GEV E + VA+K V E+ IL ++NH
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAY 460
++++ +AE ++ E + G L D + + + +T Q A+ Y
Sbjct: 76 CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE-----ATCKLYFYQMLLAVQY 129
Query: 461 LHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
LH I HRD+K N+LL ++D K+ DFG S++ + C GT YL
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 518 PE-----YYRNYQLTDKSDVYSYGVVLLELL 543
PE Y D +S GV+L L
Sbjct: 185 PEVLVSVGTAGY--NRAVDCWSLGVILFICL 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/204 (29%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
ILG GG EV+ L+D VAVK + + + E + +NH +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 407 LLGCCVEAEQPLLIY----EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+ + EY+ TL D +H + +T + + +AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEY 520
I HRDVK NI++ KV DFG++R + V+ A GT YL PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 521 YRNYQLTDKSDVYSYGVVLLELLT 544
R + +SDVYS G VL E+LT
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 67/227 (29%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 342 KKATNGFSKE----RILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKST------Q 387
+T+GF + ILG G V + AVK G+ + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 388 QVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTW 444
L EV IL +V+ H N+++L L+++ + G L D+L S
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE--- 125
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
TR +I E + LH I HRD+K NILLDDD N K+ DFG S PG
Sbjct: 126 -TR-KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 505 VSTCAQGTLGYLDPE--------YYRNYQLTDKSDVYSYGVVLLELL 543
C GT YL PE + Y + D++S GV++ LL
Sbjct: 181 REVC--GTPSYLAPEIIECSMNDNHPGY--GKEVDMWSTGVIMYTLL 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+LGSG F EV+ + G + A+K K + NE+ +L ++ H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 410 CCVEAEQPLLIYEYIANGTLHDHL--HGKYS----SFNLTWSTRLRIALQTAEALAYLHS 463
L+ + ++ G L D + G Y+ S + Q A+ YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------LVIQQVLSAVKYLHE 124
Query: 464 AAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
I HRD+K N+L +++ + DFGLS++ + G+ + C GT GY+ PE
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TAC--GTPGYVAPEV 178
Query: 521 YRNYQLTDKSDVYSYGVVLLELL 543
+ D +S GV+ LL
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILL 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST------QQVLNEVGILSQVNHKN 403
LGSG F V K E G A K K +++ +++ EV IL QV H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ L +LI E ++ G L D L S T + Q + + YL
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QILDGVNYL 131
Query: 462 HSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
H+ I H D+K NI+L + K+ DFGL+ + G+ + GT ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVA 186
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLT 544
PE L ++D++S GV+ LL+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 27/241 (11%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
S + + + + L ++ +P +F + E LG G +G VYK
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK------------LGEGSYGSVYKA 48
Query: 366 -ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424
+ G +VA+K +V Q+++ E+ I+ Q + ++V+ G + ++ EY
Sbjct: 49 IHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 425 ANGTLHDHLHGKYSSFNLTWSTRLRIAL---QTAEALAYLHSAAYTPIYHRDVKSTNILL 481
G++ D + + + IA T + L YLH HRD+K+ NILL
Sbjct: 107 GAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLEYLHF---MRKIHRDIKAGNILL 158
Query: 482 DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLE 541
+ + ++K+ADFG++ ++ +T GT ++ PE + +D++S G+ +E
Sbjct: 159 NTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
Query: 542 L 542
+
Sbjct: 218 M 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
LG G FG+V GE G VAVK K+ ++ ++ E+ L H ++++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 407 LLGCCVE-AEQPLLIY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAY 460
L + P + EY++ G L D++ HG+ + R+ Q A+ Y
Sbjct: 76 LY----QVISTPTDFFMVMEYVSGGELFDYICKHGR-----VEEMEARRLFQQILSAVDY 126
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
H + HRD+K N+LLD N+K+ADFGLS + G ++C G+ Y PE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEV 181
Query: 521 YRNYQLTD--KSDVYSYGVVLLELLT 544
+L + D++S GV+L LL
Sbjct: 182 ISG-RLYAGPEVDIWSCGVILYALLC 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
LG G FG V++ E K KV V E+ IL+ H+N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIY 470
E+ ++I+E+I+ + + ++ +F L + Q EAL +LHS I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 471 HRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTD 528
H D++ NI+ +S K+ +FG +R KPG Y PE +++ ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 529 KSDVYSYGVVLLELLT 544
+D++S G ++ LL+
Sbjct: 183 ATDMWSLGTLVYVLLS 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST------QQVLNEVGILSQVNHKN 403
LGSG F V K + G A K K + S+ +++ EV IL ++ H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ L +LI E ++ G L D L + T + Q + + YL
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QILDGVHYL 124
Query: 462 HSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
HS I H D+K NI+L + K+ DFG++ + G + GT ++
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVA 179
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLT 544
PE L ++D++S GV+ LL+
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST------QQVLNEVGILSQVNHKNL 404
LGSG F V K E G A K K +++ +++ EV IL QV H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLH 462
+ L +LI E ++ G L D L S T + Q + + YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QILDGVNYLH 132
Query: 463 SAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
+ I H D+K NI+L + K+ DFGL+ + G+ + GT ++ P
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAP 187
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLT 544
E L ++D++S GV+ LL+
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLVRL 407
+ +G G F +V + G VA+K + T Q++ EV I+ +NH N+V+L
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 408 LGCCVEAEQPL-LIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+E E+ L LI EY + G + D+L HG+ + Q A+ Y H
Sbjct: 80 FEV-IETEKTLYLIMEYASGGEVFDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQK 133
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I HRD+K+ N+LLD D N K+ADFG S G + G Y PE ++
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPELFQG- 187
Query: 525 QLTD--KSDVYSYGVVLLELLT 544
+ D + DV+S GV+L L++
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVS 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-27
Identities = 29/236 (12%), Positives = 62/236 (26%), Gaps = 42/236 (17%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVK----------------------SAKVGNIK 384
+ +LG + + G V + IK
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 385 STQQVLNEVGILSQ---VNHKNLVRLLGCCVEAEQPLLIYEYIA-------NGTLHDHLH 434
+ +Q + + V +++ ++ ++ + T + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 435 GKYSSFN-LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493
S+ L RL++ LQ LA LH + H ++ +I+LD + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ-----LTDKSDVYSYGVVLLELLT 544
Q +T D ++ G+ + +
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 28/205 (13%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
LG G F V + G A K K+ + Q++ E I ++ H N+VRL
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRL 70
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHL--HGKYS----SFNLTWSTRLRIALQTAEALAYL 461
E L+++ + G L + + YS S Q E++AY
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQILESIAYC 121
Query: 462 HSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
HS I HR++K N+LL K+ADFGL+ + GT GYL P
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSP 176
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELL 543
E + + D+++ GV+L LL
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILL 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+ LG G +GEV VAVK + + + E+ I +NH+N+V+
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 409 GCCVEAEQPLLIY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
G + + Y EY + G L D + + R Q + YLH
Sbjct: 72 GH---RREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG 123
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDPEY 520
I HRD+K N+LLD+ N K++DFGL+ + + C GTL Y+ PE
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPEL 178
Query: 521 Y--RNYQLTDKSDVYSYGVVLLELLT 544
R + + DV+S G+VL +L
Sbjct: 179 LKRREFH-AEPVDVWSCGIVLTAMLA 203
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 60/273 (21%), Positives = 98/273 (35%), Gaps = 57/273 (20%)
Query: 324 KSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKS----- 377
+ +G+ F L + + + +G G +G V E Q + A+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 378 AKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKY 437
+ N K +++ EV ++ +++H N+ RL + + L+ E G L D L+
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 438 SSFNLTWSTRL-------------------------------------RIALQTAEALAY 460
+ + I Q AL Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNS--KVADFGLSRL---AKPGLSHVSTCAQGTLGY 515
LH+ I HRD+K N L + + K+ DFGLS+ G + T GT +
Sbjct: 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 516 LDPE----YYRNYQLTDKSDVYSYGVVLLELLT 544
+ PE +Y K D +S GV+L LL
Sbjct: 241 VAPEVLNTTNESY--GPKCDAWSAGVLLHLLLM 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 30/235 (12%)
Query: 325 SSNIAGKPARIFHLKELKKATNGFSKE----RILGSGGFGEVYKG-ELQDGTVVAVKSAK 379
+++ G + + A+ FS LG G F V + G A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 380 VGNIKS--TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HG 435
+ + Q++ E I ++ H N+VRL E L+++ + G L + +
Sbjct: 64 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123
Query: 436 KYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSK 488
YS S Q E++AY HS I HR++K N+LL K
Sbjct: 124 FYSEADAS---------HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVK 171
Query: 489 VADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
+ADFGL+ + GT GYL PE + + D+++ GV+L LL
Sbjct: 172 LADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+++ +G G G VY ++ G VA++ + + ++NE+ ++ + + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR------IALQTAEALAY 460
L + ++ ++ EY+A G+L D + T + + + +AL +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTD----------VVTETCMDEGQIAAVCRECLQALEF 131
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
LHS + HRD+KS NILL D + K+ DFG P S ST GT ++ PE
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 187
Query: 521 YRNYQLTDKSDVYSYGVVLLEL 542
K D++S G++ +E+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEM 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
+ LG G +GEV VAVK + + + E+ I +NH+N+V+
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 409 GCCVEAEQPLLIY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
G + + Y EY + G L D + + R Q + YLH
Sbjct: 72 GH---RREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG 123
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV---STCAQGTLGYLDPE- 519
I HRD+K N+LLD+ N K++DFGL+ + + C GTL Y+ PE
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPEL 178
Query: 520 -YYRNYQLTDKSDVYSYGVVLLELLT 544
R + + DV+S G+VL +L
Sbjct: 179 LKRREFH-AEPVDVWSCGIVLTAMLA 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 62/262 (23%), Positives = 101/262 (38%), Gaps = 40/262 (15%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
AK+ A+ + G + K+ + + ++G G V +
Sbjct: 54 LLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC 113
Query: 366 -ELQDGTVVAVKS--------AKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415
G AVK + + + E IL QV H +++ L+ +
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 416 QPLLIYEYIANGTLHDHL--HGKYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469
L+++ + G L D+L S I EA+++LH+ I
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETR---------SIMRSLLEAVSFLHANN---I 221
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE--------YY 521
HRD+K NILLDD+ +++DFG S +PG C GT GYL PE +
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPEILKCSMDETH 279
Query: 522 RNYQLTDKSDVYSYGVVLLELL 543
Y + D+++ GV+L LL
Sbjct: 280 PGY--GKEVDLWACGVILFTLL 299
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/207 (28%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST------QQVLNEVGILSQVNHKN 403
LGSG F V K E G A K K KS+ + + EV IL ++ H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ L +LI E +A G L D L + T + Q + YL
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QILNGVYYL 130
Query: 462 HSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
HS I H D+K NI+L K+ DFGL+ G + GT ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVA 185
Query: 518 PEYYRNYQLTDKSDVYSYGVVLLELLT 544
PE L ++D++S GV+ LL+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 36/250 (14%), Positives = 68/250 (27%), Gaps = 53/250 (21%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVK---------------------- 376
EL + + +LG + + + G V
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 377 ------SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCC-VEAEQPLLIYEYIANGTL 429
K + + ++ K ++R+ L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 430 HDHLHGKYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485
S +L RL++ LQ LA LH + H ++ +I+LD
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRG 243
Query: 486 NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY-----------YRNYQLTDKSDVYS 534
+ F + G VS+ + G+ PE R +T D ++
Sbjct: 244 GVFLTGFEHLV--RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 535 YGVVLLELLT 544
G+V+ +
Sbjct: 299 LGLVIYWIWC 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 21/202 (10%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+G G G V E G VAVK + + + + NEV I+ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLR------IALQTAEALAY 460
+ + E+ ++ E++ G L D + RL + +ALAY
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD----------IVSQVRLNEEQIATVCEAVLQALAY 156
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
LH+ + HRD+KS +ILL D K++DFG + + GT ++ PE
Sbjct: 157 LHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 212
Query: 521 YRNYQLTDKSDVYSYGVVLLEL 542
+ D++S G++++E+
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEM 234
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 25/209 (11%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKST-QQVLNEVGILSQVNHKNLV 405
+LG G +G+V + + AVK K+ I + V E+ +L ++ HKN++
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 406 RLLGCCVEAEQPLLIY---EYIANGT--LHDHL-HGKYSSFNLTWSTRLRIALQTAEALA 459
+L+ + E+ +Y EY G + D + + Q + L
Sbjct: 70 QLVDV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQLIDGLE 123
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL--SHVSTCAQGTLGYLD 517
YLHS I H+D+K N+LL K++ G++ P T QG+ +
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQP 179
Query: 518 PEYYRNYQLTD--KSDVYSYGVVLLELLT 544
PE K D++S GV L + T
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 36/250 (14%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKS------AKVGNIKSTQQVLNEVGILSQVNHK- 402
+LGSGGFG VY G + D VA+K + G + + +V EV +L +V+
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 403 -NLVRLLGCCVEAEQPLLIYEYIAN-GTLHDHL--HGKYSSFNLTWSTRLRIALQTAEAL 458
++RLL + +LI E L D + G L Q EA+
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAV 162
Query: 459 AYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
+ H+ + HRD+K NIL+D + K+ DFG L K + GT Y
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-D--GTRVYSP 216
Query: 518 PEY--YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY-VSQRASNGAI- 573
PE+ Y Y + V+S G++L +++ I F +++ QR S+
Sbjct: 217 PEWIRYHRYHGR-SAAVWSLGILLYDMVC--GDIPF-EHDEEIIRGQVFFRQRVSSECQH 272
Query: 574 ----MEVVDP 579
+ P
Sbjct: 273 LIRWCLALRP 282
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 61/269 (22%), Positives = 97/269 (36%), Gaps = 48/269 (17%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNH-KNLV 405
+ LG G F V + G A K K ++L+E+ +L ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
L + +LI EY A G + + + ++ + +R+ Q E + YLH
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQILEGVYYLHQNN 151
Query: 466 YTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I H D+K NILL + K+ DFG+SR GT YL PE
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILN 206
Query: 523 NYQLTDKSDVYSYGVVLLELLT-----------------SQKAIDFSRDP-DDVNLAIYV 564
+T +D+++ G++ LLT SQ +D+S + V
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV------ 260
Query: 565 SQRASNGAI-----MEVVDP--RLQGHEA 586
S A + V +P R
Sbjct: 261 ----SQLATDFIQSLLVKNPEKRPTAEIC 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ LG G FG+VYK + G + A K + + + + + E+ IL+ +H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL---QTAEALAYLHS 463
LLG + ++ E+ G + + I + Q EAL +LHS
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNFLHS 135
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE---- 519
I HRD+K+ N+L+ + + ++ADFG+S L + GT ++ PE
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191
Query: 520 -YYRNYQLTDKSDVYSYGVVLLEL 542
++ K+D++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKS-----TQQVLNEVGILSQVNHKNLV 405
++G G F V + + G AVK V S T+ + E I + H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSS-FNLTWSTRLRIALQTAEALAYLHSA 464
LL +++E++ L + + + F + + Q EAL Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 465 AYTPIYHRDVKSTNILL---DDDFNSKVADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEY 520
I HRDVK +LL ++ K+ FG++ L + GL GT ++ PE
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEV 204
Query: 521 YRNYQLTDKSDVYSYGVVLLELL 543
+ DV+ GV+L LL
Sbjct: 205 VKREPYGKPVDVWGCGVILFILL 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 25/204 (12%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKS--AKVGNIKSTQQVLNEVGILSQVNHKNLVRLL 408
LG G F V + ++ G A K + + Q++ E I + H N+VRL
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHL--HGKYS----SFNLTWSTRLRIALQTAEALAYLH 462
E LI++ + G L + + YS S Q EA+ + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------HCIQQILEAVLHCH 127
Query: 463 SAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
+ HR++K N+LL K+ADFGL+ + A GT GYL PE
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
Query: 520 YYRNYQLTDKSDVYSYGVVLLELL 543
R D+++ GV+L LL
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILL 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/211 (26%), Positives = 82/211 (38%), Gaps = 29/211 (13%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKS------AKVGNIKSTQQVLNEVGILSQVN--- 400
+LG GGFG V+ G L D VA+K + + EV +L +V
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 401 -HKNLVRLLGCCVEAEQPLLIYEYIANGT-LHDHL--HGKYSSFNLTWSTRLRIALQTAE 456
H ++RLL E +L+ E L D++ G L Q
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----LGEGPSRCFFGQVVA 150
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGY 515
A+ + HS + HRD+K NIL+D K+ DFG L GT Y
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-D--GTRVY 204
Query: 516 LDPEYYRN--YQLTDKSDVYSYGVVLLELLT 544
PE+ Y + V+S G++L +++
Sbjct: 205 SPPEWISRHQYHAL-PATVWSLGILLYDMVC 234
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 32/235 (13%)
Query: 324 KSSNIAGKPARIFHLKELKKATNGFSKE----RILGSGGFGEVYKG-ELQDGTVVAVKS- 377
+S G + + + S LG G VY+ + A+K
Sbjct: 27 TASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL 86
Query: 378 AKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HG 435
K + V E+G+L +++H N+++L + L+ E + G L D + G
Sbjct: 87 KKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG 143
Query: 436 KYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSK 488
YS + Q EA+AYLH I HRD+K N+L D K
Sbjct: 144 YYSERDAA---------DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLK 191
Query: 489 VADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELL 543
+ADFGLS++ + + + C GT GY PE R + D++S G++ LL
Sbjct: 192 IADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLV 405
F+K +G G FGEV+KG + + VVA+K + + + + E+ +LSQ + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+ G ++ + +I EY+ G+ D L L + I + + L YLHS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK 139
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
HRD+K+ N+LL + K+ADFG++ +T GT ++ PE +
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 195
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585
K+D++S G+ +EL + P V I N P L+G+
Sbjct: 196 YDSKADIWSLGITAIELARGE-PPHSELHPMKVLFLI-----PKNNP------PTLEGN- 242
Query: 586 ASVNILMSLKLFSELAVACLREKKSERPSMTD 617
S K E ACL ++ S RP+ +
Sbjct: 243 ------YS-KPLKEFVEACLNKEPSFRPTAKE 267
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 27/209 (12%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVK--------SAKVGNIKSTQQVLNEVGILSQVNH 401
LGSG FG V+ + V VK +V E+ ILS+V H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 402 KNLVRLLGCCVEAEQPL-LIYEYIANGT-LHDHL--HGKYSSFNLTWSTRLRIALQTAEA 457
N++++L E + L+ E +G L + H + L I Q A
Sbjct: 89 ANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-----LDEPLASYIFRQLVSA 142
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
+ YL I HRD+K NI++ +DF K+ DFG + + G T GT+ Y
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFC-GTIEYCA 197
Query: 518 PEYYRN--YQLTDKSDVYSYGVVLLELLT 544
PE Y+ + +++S GV L L+
Sbjct: 198 PEVLMGNPYR-GPELEMWSLGVTLYTLVF 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
LG G FG+V + VA+K + +V E+ L + H ++++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 407 LLGCCVEA-EQPLLIY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAY 460
L + P I EY A G L D++ + +T R Q A+ Y
Sbjct: 74 LY----DVITTPTDIVMVIEY-AGGELFDYIVEKKR-----MTEDEGRRFFQQIICAIEY 123
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
H I HRD+K N+LLDD+ N K+ADFGLS + G ++C G+ Y PE
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPEV 178
Query: 521 YRN--YQLTDKSDVYSYGVVLLELLT 544
Y + DV+S G+VL +L
Sbjct: 179 INGKLYA-GPEVDVWSCGIVLYVMLV 203
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
LG G FG+V G+ G VAVK K+ ++ ++ E+ L H ++++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 407 LLGCCVEA-EQPLLIY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAY 460
L + P I+ EY++ G L D++ +G+ L R+ Q + Y
Sbjct: 81 LY----QVISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRLFQQILSGVDY 131
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
H + HRD+K N+LLD N+K+ADFGLS + G ++C G+ Y PE
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEV 186
Query: 521 YRNYQLTD--KSDVYSYGVVLLELLT 544
+L + D++S GV+L LL
Sbjct: 187 ISG-RLYAGPEVDIWSSGVILYALLC 211
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLV 405
F ++G+G +G+VYKG ++ G + A+K V +++ E+ +L + +H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 406 RLLGCCVEAEQPL------LIYEYIANGTLHDHLHG-KYSSFNLTWSTRLRIAL---QTA 455
G ++ P L+ E+ G++ D + K ++ W IA +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREIL 139
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515
L++LH + HRD+K N+LL ++ K+ DFG+S + +T GT +
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 195
Query: 516 LDPEYYRNYQLTD-----KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
+ PE + D KSD++S G+ +E+ + P I N
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-CDMHPMRALFLI-----PRN 249
Query: 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTD 617
A PRL+ + S K F +CL + S+RP+
Sbjct: 250 PA------PRLKSKKWS-------KKFQSFIESCLVKNHSQRPATEQ 283
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 340 ELKKAT-NGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVG 394
E + + F R+LG GGFGEV+ +++ G + A K +K + + E
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 395 ILSQVNHKNLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-AL 452
IL++V+ + +V L E + L L+ + G + H++ R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQG 511
Q L +LH I +RD+K N+LLDDD N +++D GL+ K G + G
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--G 351
Query: 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
T G++ PE + D ++ GV L E++ ++
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 340 ELKKAT-NGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVG 394
E + T N F + R+LG GGFGEV +++ G + A K + IK + LNE
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 395 ILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLH-GKYSSFNLTWSTRLRIALQ 453
IL +VN + +V L + L+ + G L H++ + F R
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFY 291
Query: 454 TAE---ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
AE L LH I +RD+K NILLDD + +++D GL+ G +
Sbjct: 292 AAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-- 346
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
GT+GY+ PE +N + T D ++ G +L E++ Q
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/219 (25%), Positives = 86/219 (39%), Gaps = 40/219 (18%)
Query: 350 KERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRL 407
+E +LG G V L AVK + +V EV +L Q H+N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLH--GKYS----SFNLTWSTRLRIALQTAEALAYL 461
+ E ++ L++E + G++ H+H ++ S + A AL +L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---------VVVQDVASALDFL 127
Query: 462 HSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQ------GT 512
H+ I HRD+K NIL + K+ DF L K G+
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 513 LGYLDPE-------YYRNYQLTDKS-DVYSYGVVLLELL 543
Y+ PE Y DK D++S GV+L LL
Sbjct: 185 AEYMAPEVVEAFSEEASIY---DKRCDLWSLGVILYILL 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 53/300 (17%), Positives = 96/300 (32%), Gaps = 48/300 (16%)
Query: 355 GSGGFGEVYKG-ELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCC 411
G V G V V+ + + + E+ + NH N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 412 VEAEQPLLIYEYIANGTLHDHL-HGKYSSFNLTW-STRLRIALQTAEALAYLHSAAYTPI 469
+ + ++ ++A G+ D + N + L+ L+ AL Y+H Y +
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK---ALDYIHHMGY--V 150
Query: 470 YHRDVKSTNILLDDDFNSKVADFGLS------RLAKPGLSHVSTCAQGTLGYLDPE---- 519
HR VK+++IL+ D ++ + + + + L +L PE
Sbjct: 151 -HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQ---------KAI------------DFSRDPDDV 558
+ Y KSD+YS G+ EL + + D S P +
Sbjct: 210 NLQGY--DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFS----ELAVACLREKKSERPS 614
A++G + + + FS CL+ RPS
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 66/336 (19%), Positives = 125/336 (37%), Gaps = 52/336 (15%)
Query: 314 KLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGEL-QDGTV 372
+L + + + + ++ LK+ + F K LG+G G V+K G V
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 373 VAVKSAKV-GNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHD 431
+A K + Q++ E+ +L + N +V G + + E++ G+L
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 432 HL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489
L G+ L ++++ + L YL I HRDVK +NIL++ K+
Sbjct: 121 VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 490 ADFGLSR-----LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
DFG+S +A S V GT Y+ PE + + +SD++S G+ L+E+
Sbjct: 174 CDFGVSGQLIDSMAN---SFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 545 SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAV-- 602
+ I + + + + P ++ ++ + +F L
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285
Query: 603 ---------------------ACLREKKSERPSMTD 617
CL + +ER +
Sbjct: 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 40/284 (14%), Positives = 85/284 (29%), Gaps = 59/284 (20%)
Query: 351 ERILGSGGFGEVYKGELQD---GTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNL 404
G + ++ D VA+ V Q+ L+ LS+++ +
Sbjct: 36 LIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
R+L L++ E+I G+L + + + +R A A H A
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
+ + + + D + +A T+ +P+
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ----- 182
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584
D+ G L LL ++ LA A + ++P
Sbjct: 183 -----DDIRGIGASLYALLVNRWP--LPEAGVRSGLAP-----AERDTAGQPIEPADIDR 230
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628
+ I S +A ++ R + T +++ +Q+ +
Sbjct: 231 DIPFQI-------SAVAARSVQGDGGIRSAST-LLNLMQQATAV 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 342 KKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI---KSTQQVLNEVGILS 397
KK F +ILG G F V EL A+K + +I V E ++S
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 398 QVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEA 457
+++H V+L + E+ Y NG L ++ K SF+ T TR A + A
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDET-CTRFYTA-EIVSA 142
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST---CAQGTLG 514
L YLH I HRD+K NILL++D + ++ DFG +++ P GT
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV--GTAQ 197
Query: 515 YLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
Y+ PE SD+++ G ++ +L+
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 34/283 (12%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQ----VLNEVGILSQVNHK 402
+ + ++GSG V VA+K N++ Q +L E+ +SQ +H
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWS--TRLRIAL---QTAEA 457
N+V V ++ L+ + ++ G++ D + + IA + E
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQ---GTL 513
L YLH HRDVK+ NILL +D + ++ADFG+S LA G + + GT
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 514 GYLDPEYYRNYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572
++ PE + D K+D++S+G+ +EL T A P V + N
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA-APYHKYPPMKVLMLT-----LQNDP 244
Query: 573 IMEVVDPRLQGHEASVNILMSL-KLFSELAVACLREKKSERPS 614
P L+ +L K F ++ CL++ +RP+
Sbjct: 245 ------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKS---AKVGNIKSTQQVLNEVGILSQVNHKN 403
F R +G G FG+V + D + A+K K + V E+ I+ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
LV L + E ++ + + G L HL + F + +L I + AL YL +
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEE-TVKLFIC-ELVMALDYLQN 133
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
I HRD+K NILLD+ + + DF ++ + + GT Y+ PE + +
Sbjct: 134 QR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSS 188
Query: 524 YQLT--DKS-DVYSYGVVLLELLT 544
+ + D +S GV ELL
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLR 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 75/292 (25%), Positives = 112/292 (38%), Gaps = 67/292 (22%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKN 403
FS R +G G FG VY ++++ VVA+K +S Q ++ EV L ++ H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL---QTAEALAY 460
++ GC + L+ EY G+ D L IA + LAY
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAY 169
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--------GT 512
LHS + HRDVK+ NILL + K+ DFG + GT
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS-------------ASIMAPANSFVGT 213
Query: 513 LGYLDPEYYRNYQLTD---KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL----AIYVS 565
++ PE K DV+S G+ +EL + P N+ A+Y
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK--------PPLFNMNAMSALYHI 265
Query: 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTD 617
A N + P LQ S + F +CL++ +RP+
Sbjct: 266 --AQNES------PALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEV 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 52/231 (22%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVK--------------------------SAKVGNIK 384
+G G +G V D T A+K +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 385 STQQVLNEVGILSQVNHKNLVRLLGCCVE-----AEQPL-LIYEYIANGTLHDHL-HGKY 437
+QV E+ IL +++H N+V+L VE E L +++E + G + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 438 SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497
S + + YLH I HRD+K +N+L+ +D + K+ADFG+S
Sbjct: 135 SE-----DQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 498 AKPGLSHVSTCAQGTLGYLDPE----YYRNYQLTDKSDVYSYGVVLLELLT 544
K + +S GT ++ PE + + DV++ GV L +
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVF 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 29/207 (14%)
Query: 349 SKERILGSGGFGEVYKG-ELQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQV-NHKNLV 405
K++ LG G F K + AVK +K + E+ L H N+V
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIV 69
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYS----SFNLTWSTRLRIALQTAEALA 459
+L + L+ E + G L + + +S S I + A++
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---------YIMRKLVSAVS 120
Query: 460 YLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
++H + HRD+K N+L +D+ K+ DFG +RL P + T TL Y
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYA 176
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELL 543
PE + D++S GV+L +L
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTML 203
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 56/204 (27%), Positives = 81/204 (39%), Gaps = 25/204 (12%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+ +GSG FG +VAVK + G + V E+ + H N+VR
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKE 83
Query: 410 CCVEAEQPLLIY---EYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
P + EY + G L++ + G+ + Q ++Y HS
Sbjct: 84 VI---LTPTHLAIIMEYASGGELYERICNAGR-----FSEDEARFFFQQLLSGVSYCHSM 135
Query: 465 AYTPIYHRDVKSTNILLDDDF--NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRD+K N LLD K+ DFG S+ + ST GT Y+ PE
Sbjct: 136 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLL 190
Query: 523 NYQLTD--KSDVYSYGVVLLELLT 544
Q D +DV+S GV L +L
Sbjct: 191 R-QEYDGKIADVWSCGVTLYVMLV 213
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKN 403
FS RI+G GGFGEVY D G + A+K IK Q LNE +LS V+ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 404 ---LVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE--- 456
+V + L I + + G LH HL ++ F+ + AE
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEA-----DMRFYAAEIIL 303
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
L ++H+ + +RD+K NILLD+ + +++D GL+ H ++ GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYM 357
Query: 517 DPEYYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
PE + D S D +S G +L +LL
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 46/224 (20%), Positives = 89/224 (39%), Gaps = 39/224 (17%)
Query: 339 KELKKATNGFSKE----RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEV 393
++L + + F+ +G G + + AVK KS + E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEI 66
Query: 394 GILSQ-VNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYS----SFNLTWST 446
IL + H N++ L + + ++ E + G L D + +S S
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS------- 119
Query: 447 RLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRLAKPGL 502
+ + + YLH+ + HRD+K +NIL + + ++ DFG ++ +
Sbjct: 120 --AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 503 SHVSTCAQGTLGYLDPE--YYRNYQLTDKS-DVYSYGVVLLELL 543
+ T T ++ PE + Y D + D++S GV+L +L
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGY---DAACDIWSLGVLLYTML 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 44/174 (25%), Positives = 67/174 (38%), Gaps = 14/174 (8%)
Query: 382 NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN 441
+ ++ + + KN V L + + L D ++ + S +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR----- 496
L I +Q AEA+ +LHS + HRD+K +NI D KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 497 ------LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
L T GT Y+ PE + K D++S G++L ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 22/100 (22%), Positives = 42/100 (42%), Gaps = 2/100 (2%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLV 405
F + +G GGFG V++ + D A+K ++ N + ++V+ EV L+++ H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWS 445
R +E E + SS + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA 107
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 38/242 (15%)
Query: 316 AKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVA 374
++ S + K I ++ ++LG G G+V + + A
Sbjct: 40 PQQFPQFHVKSGLQIKKNAIIDDYKVTS--------QVLGLGINGKVLQIFNKRTQEKFA 91
Query: 375 VKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQP----LLIYEYIANGTL 429
+K ++ + EV + + ++VR++ L++ E + G L
Sbjct: 92 LKM-----LQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146
Query: 430 HDHLHGKYSSFNLTWSTR--LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDD 484
+ + ++ R I EA+ YLHS I HRDVK N+L +
Sbjct: 147 FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPN 200
Query: 485 FNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE--YYRNYQLTDKS-DVYSYGVVLLE 541
K+ DFG ++ S + C T Y+ PE Y DKS D++S GV++
Sbjct: 201 AILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYI 255
Query: 542 LL 543
LL
Sbjct: 256 LL 257
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 28/208 (13%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLV 405
SK+ +LG G G+V + + G A+K + + + EV Q ++V
Sbjct: 32 LSKQ-VLGLGVNGKVLECFHRRTGQKCALKL-----LYDSPKARQEVDHHWQASGGPHIV 85
Query: 406 RLLGCCVEAEQP----LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
+L L+I E + G L + + T I A+ +L
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFL 144
Query: 462 HSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
HS I HRDVK N+L + D K+ DFG ++ + C T Y+ P
Sbjct: 145 HSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPC--YTPYYVAP 198
Query: 519 E--YYRNYQLTDKS-DVYSYGVVLLELL 543
E Y DKS D++S GV++ LL
Sbjct: 199 EVLGPEKY---DKSCDMWSLGVIMYILL 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKV-GNIKSTQQVLNEVGI-LSQVNHKNL 404
+G G +G V K G ++AVK + + K +Q+L ++ + + + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEALAYLH 462
V+ G + E ++ + YS + + +I L T +AL +L
Sbjct: 84 VQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQ----GTLGYLD 517
I HRD+K +NILLD N K+ DFG+S +L V + A+ G Y+
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-------VDSIAKTRDAGCRPYMA 193
Query: 518 PE------YYRNYQLTDKSDVYSYGVVLLEL 542
PE + Y +SDV+S G+ L EL
Sbjct: 194 PERIDPSASRQGY--DVRSDVWSLGITLYEL 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 31/247 (12%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
S + + + LAK +ED LK + + F + + LG+G FG V
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQN---------TAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 366 ELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421
+ ++ G A+K + +Q+ LNE IL VN LV+L + ++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481
EY+A G + HL + F+ R A Q YLHS + +RD+K N+L+
Sbjct: 121 EYVAGGEMFSHLR-RIGRFSEPH-ARFYAA-QIVLTFEYLHSLD---LIYRDLKPENLLI 174
Query: 482 DDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYRN--YQLTDKS-DVYSYGV 537
D +V DFG AK T C GT L PE + Y +K+ D ++ GV
Sbjct: 175 DQQGYIQVTDFG---FAKRVKGRTWTLC--GTPEALAPEIILSKGY---NKAVDWWALGV 226
Query: 538 VLLELLT 544
++ E+
Sbjct: 227 LIYEMAA 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 65/282 (23%), Positives = 111/282 (39%), Gaps = 45/282 (15%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKV-GNIKSTQQVLNEVGI-LSQVNHKNL 404
LG G +G V K + G ++AVK + N + +++L ++ I + V+
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRL-RIALQTAEALAYLHS 463
V G + E + + +L L +IA+ +AL +LHS
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLAKPGLSHVSTCAQ----GTLGYLDP 518
+ HRDVK +N+L++ K+ DFG+S L V A+ G Y+ P
Sbjct: 128 K--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL-------VDDVAKDIDAGCKPYMAP 178
Query: 519 E------YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572
E + Y + KSD++S G+ ++EL + D P
Sbjct: 179 ERINPELNQKGY--SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-----------Q 225
Query: 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS 614
++E P+L + S F + CL++ ERP+
Sbjct: 226 VVEEPSPQLPADKFS-------AEFVDFTSQCLKKNSKERPT 260
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 18/248 (7%)
Query: 309 LAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQ 368
+ ++ ++ +D + + + LKE++ + F +++G G F EV +++
Sbjct: 24 VHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK 83
Query: 369 D-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLGCCVEAEQPL-LIYEY 423
G V A+K ++ +V E +L + + + +L + E L L+ EY
Sbjct: 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142
Query: 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD 483
G L L + R +A + A+ +H HRD+K NILLD
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMA-RFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDR 197
Query: 484 DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVY-------SYG 536
+ ++ADFG + + S A GT YL PE + + Y + G
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 537 VVLLELLT 544
V E+
Sbjct: 258 VFAYEMFY 265
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKN 403
F + LG+G + VYKG G VA+K K+ + ST + E+ ++ ++ H+N
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST--AIREISLMKELKHEN 64
Query: 404 LVRLLGCCVEAEQPLLIYEYIAN--GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
+VRL + L++E++ N D + L + Q + LA+
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
H I HRD+K N+L++ K+ DFGL+R
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 16/155 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK----STQQVLNEVGILSQVNHKN 403
+ K +G G +G VYK + G +VA+K ++ ST + E+ +L +++H N
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST--AIREISLLKELHHPN 80
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG--KYSSFNLTWSTRLRIALQTAEALAYL 461
+V L+ L++E++ D L + L S Q +A+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
H I HRD+K N+L++ D K+ADFGL+R
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIK----STQQVLNEVGILSQVNHK 402
+ K +G G +G V+K + +VA+K ++ + S+ L E+ +L ++ HK
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--ALREICLLKELKHK 61
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG--KYSSFNLTWSTRLRIALQTAEALAY 460
N+VRL ++ L++E+ D L + +L Q + L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL-AKPG--LSH--VSTCAQGTLGY 515
HS + HRD+K N+L++ + K+A+FGL+R P S V TL Y
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV------TLWY 167
Query: 516 LDPEY---YRNYQLTDKSDVYSYGVVLLELLTSQKAI 549
P+ + Y + D++S G + EL + + +
Sbjct: 168 RPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPL 202
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
F K +G G +G VYK G VVA+K ++ + ST + E+ +L ++NH
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST--AIREISLLKELNHP 62
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG---KYSSFNLTWSTRLRIALQTAEALA 459
N+V+LL + L++E++ D L + + Q + LA
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLH----QD-LKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
+ HS + HRD+K N+L++ + K+ADFGL+R
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 70/250 (28%), Positives = 104/250 (41%), Gaps = 19/250 (7%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKAT-NGFSKERILGSGGFGEVYK 364
+ L KQA + S N + + K + T N F ++LG G FG+V
Sbjct: 107 ADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVIL 166
Query: 365 GELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRLLGCCVEAEQPL-L 419
+ + G A+K K I + +V L E +L H L L + L
Sbjct: 167 VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCF 225
Query: 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAAYTPIYHRDVKSTN 478
+ EY G L HL + F+ R R + AL YLHS + +RD+K N
Sbjct: 226 VMEYANGGELFFHLS-RERVFSED---RARFYGAEIVSALDYLHSE--KNVVYRDLKLEN 279
Query: 479 ILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYLDPEYYRNYQLTDKSDVYSYG 536
++LD D + K+ DFGL K G+ +T GT YL PE + D + G
Sbjct: 280 LMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 336
Query: 537 VVLLELLTSQ 546
VV+ E++ +
Sbjct: 337 VVMYEMMCGR 346
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 13/154 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
+ K +G G +G V+K G +VA+K IK L E+ +L Q+ H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHP 62
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
NLV LL + L++EY + T+ L + I QT +A+ + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
HRDVK NIL+ K+ DFG +R
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
++ +++G+G FG V++ +L + VA+K KV K + E+ I+ V H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFK--NRELQIMRIVKHPNVVDL 97
Query: 408 LGCCVEAEQPL------LIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEALA 459
L+ EY+ T++ Y+ T L Q +LA
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYV-PETVYRASR-HYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
Y+HS I HRD+K N+LLD K+ DFG +++ G +VS Y+
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS--------YICS 204
Query: 519 EYYR---------NYQLTDKSDVYSYGVVLLELLTSQ 546
YYR NY T D++S G V+ EL+ Q
Sbjct: 205 RYYRAPELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 352 RILGSGGFGEVY----KGELQDGTVVAVKSAKVGNIKSTQQV--LNEVGILSQVNHKNLV 405
++LG G FG+V+ + A+K K +K +V E IL +VNH +V
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 406 RLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+L + E L LI +++ G L L K F + +A + A AL +LHS
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEED-VKFYLA-ELALALDHLHSL 145
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDPE- 519
I +RD+K NILLD++ + K+ DFGLS K + H C GT+ Y+ PE
Sbjct: 146 G---IIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFC--GTVEYMAPEV 197
Query: 520 -YYRNYQLTDKS-DVYSYGVVLLELLT 544
R + +S D +S+GV++ E+LT
Sbjct: 198 VNRRGH---TQSADWWSFGVLMFEMLT 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKNLVRL 407
++LG G FG+V + G A+K + I + +V + E +L H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 408 LGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
+ L + EY G L HL + F R R + AL YLHS
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEE---RARFYGAEIVSALEYLHSRD 125
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDPE-- 519
+ +RD+K N++LD D + K+ DFGL K G+S +T C GT YL PE
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFC--GTPEYLAPEVL 177
Query: 520 YYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
+Y ++ D + GVV+ E++ +
Sbjct: 178 EDNDY---GRAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 14/217 (6%)
Query: 337 HLKELKKATNGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNE 392
+K+++ F +++G G FGEV +L++ V A+K + + E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 393 VGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL 452
+L + K + L + L+ +Y G L L + R +A
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLA- 182
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
+ A+ +H HRD+K NIL+D + + ++ADFG + S+ A GT
Sbjct: 183 EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 513 LGYLDPEYYRNYQLTDKS-----DVYSYGVVLLELLT 544
Y+ PE + + D +S GV + E+L
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 38/218 (17%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
++ +++G+G FG VY+ +L D G +VA+K KV ++ + E+ I+ +++H N+VR
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KV--LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 407 LLGCCVEAEQPL------LIYEYIANGTLHDHLHGKYSSFNLTWSTRL--RIALQTAEAL 458
L + + L+ +Y+ T++ YS T Q +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
AY+HS I HRD+K N+LLD D K+ DFG ++ G +VS Y+
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YIC 218
Query: 518 PEYYR---------NYQLTDKSDVYSYGVVLLELLTSQ 546
YYR +Y T DV+S G VL ELL Q
Sbjct: 219 SRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
+ ++G G +G V K G +VA+K + +K + E+ +L Q+ H+
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHE 84
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
NLV LL C + ++ L++E++ + T+ D L + L + + Q + + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
S I HRD+K NIL+ K+ DFG +R
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 1e-19
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK----STQQVLNEVGILSQVNHKN 403
+ +G G +G VYK + G A+K ++ ST + E+ IL ++ H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST--TIREISILKELKHSN 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG--KYSSFNLTWSTRLRIALQTAEALAYL 461
+V+L ++ +L++E++ D L L T LQ +AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
H + HRD+K N+L++ + K+ADFGL+R
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHK 402
+ K +G G FGEV+K + G VA+K + N T L E+ IL + H+
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--ALREIKILQLLKHE 76
Query: 403 NLVRLLGCCVEAEQPL--------LIYEYIANGTLHDHLHG--KYSSFNLTWSTRLRIAL 452
N+V L+ C P L++++ HD L G T S R+
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HD-LAGLLSNVLVKFTLSEIKRVMQ 131
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS---TCA 509
L Y+H I HRD+K+ N+L+ D K+ADFGL+R + T
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 510 QGTLGYLDPEY---YRNYQLTDKSDVYSYGVVLLELLT 544
TL Y PE R+Y D++ G ++ E+ T
Sbjct: 189 VVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWT 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNHKN 403
F R LG+G FG V+ + G A+K K + +QV +E +LS V H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++R+ G +A+Q +I +YI G L L K F + A + AL YLHS
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNP-VAKFYAA-EVCLALEYLHS 124
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST-CAQGTLGYLDPEYYR 522
I +RD+K NILLD + + K+ DFG AK T C GT Y+ PE
Sbjct: 125 KD---IIYRDLKPENILLDKNGHIKITDFG---FAKYVPDVTYTLC--GTPDYIAPEVVS 176
Query: 523 N--YQLTDKS-DVYSYGVVLLELLT 544
Y +KS D +S+G+++ E+L
Sbjct: 177 TKPY---NKSIDWWSFGILIYEMLA 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 25/196 (12%)
Query: 315 LAKEREDMLKSSNIAGKPARIFHLKELKKATN--GFSKERILGSGGFGEVYKG-ELQDGT 371
+A + + + + AT+ + + LG G +GEVYK +
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 372 VVAVKSAKVGNIK----STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427
VA+K ++ + + T + EV +L ++ H+N++ L + LI+EY
Sbjct: 61 TVAIKRIRLEHEEEGVPGT--AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-- 116
Query: 428 TLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485
+D L KY + +++ Q + + HS HRD+K N+LL
Sbjct: 117 --ND-LK-KYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSD 169
Query: 486 NS-----KVADFGLSR 496
S K+ DFGL+R
Sbjct: 170 ASETPVLKIGDFGLAR 185
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 27/233 (11%)
Query: 325 SSNIAGKPARIFHL--KELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKV- 380
SS +GK + + + N +GSG G+V+K + G V+AVK +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 381 GNIKSTQQVLNEVGIL-SQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSS 439
GN + +++L ++ ++ + +V+ G + + E +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP 120
Query: 440 FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS-RLA 498
+ + + +AL YL + HRDVK +NILLD+ K+ DFG+S RL
Sbjct: 121 IPERILGK--MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL- 175
Query: 499 KPGLSHVSTCAQ----GTLGYLDPEYYRNYQLTD-----KSDVYSYGVVLLEL 542
V A+ G Y+ PE T ++DV+S G+ L+EL
Sbjct: 176 ------VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN-------IKSTQQVLN 391
++K + K LG G F VYK + +VA+K K+G+ I T L
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT--ALR 61
Query: 392 EVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG--KYSSFNLTWSTRLR 449
E+ +L +++H N++ LL L+++++ D L K +S LT S
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM----ETD-LEVIIKDNSLVLTPSHIKA 116
Query: 450 IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
L T + L YLH I HRD+K N+LLD++ K+ADFGL++
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 22/219 (10%)
Query: 342 KKATNGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQ-VLNEVGILSQV 399
+K + F ER+ G G FG V G+ + G VA+K KV + L + L+ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQDPRFRNRELQIMQDLAVL 76
Query: 400 NHKNLVRLLGC--CVEAEQP-----LLIYEYIANGTLHDHL-HGKYSSFNLTWSTRLRIA 451
+H N+V+L + ++ EY+ TLH +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
Q ++ LH + + HRD+K N+L++ D K+ DFG ++ P +V+
Sbjct: 136 FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193
Query: 511 GTLGYLDPEY---YRNYQLTDKSDVYSYGVVLLELLTSQ 546
+ Y PE ++Y T D++S G + E++ +
Sbjct: 194 -SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 352 RILGSGGFGEVY---KGELQD-GTVVAVKSAK----VGNIKSTQQVLNEVGILSQVNHKN 403
R+LG GG+G+V+ K + G + A+K K V N K T E IL +V H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 404 LVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALA 459
+V L+ + L LI EY++ G L L + F AE AL
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMED-----TACFYLAEISMALG 135
Query: 460 YLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGY 515
+LH I +RD+K NI+L+ + K+ DFGL K + + C GT+ Y
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC---KESIHDGTVTHTFC--GTIEY 187
Query: 516 LDPE--YYRNYQLTDKS-DVYSYGVVLLELLT 544
+ PE + +++ D +S G ++ ++LT
Sbjct: 188 MAPEILMRSGH---NRAVDWWSLGALMYDMLT 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 16/155 (10%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKN 403
+ K LG G + VYKG +VA+K ++ + T + EV +L + H N
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--AIREVSLLKDLKHAN 61
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHG--KYSSFNLTWSTRLRIALQTAEALAYL 461
+V L + L++EY+ D L + Q LAY
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
H + HRD+K N+L+++ K+ADFGL+R
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
R++G G + +V L+ + A+K K + + + E + Q NH LV
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 407 LLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLH 462
L C + E L + EY+ G L H+ + +AE AL YLH
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEE-----HARFYSAEISLALNYLH 127
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDP 518
I +RD+K N+LLD + + K+ D+G+ K GL T C GT Y+ P
Sbjct: 128 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFC--GTPNYIAP 179
Query: 519 EYYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
E R + S D ++ GV++ E++ +
Sbjct: 180 EILR-GEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 339 KELKKATNGFSKERI-LGSGGFGEVYKG---ELQDGTVVAVKSAKVGNIKSTQQVLNEVG 394
E ++ + F E +G G +G VYK + +D A+K + I + E+
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS--ACREIA 70
Query: 395 ILSQVNHKNLVRLLGCCVE-AEQPL-LIYEYIAN---GTLHDHLHGKYSSFNLTWSTRLR 449
+L ++ H N++ L + A++ + L+++Y + + H K + + +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 450 --IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS----KVADFGLSRL-AKP-- 500
+ Q + + YLH+ + HRD+K NIL+ + K+AD G +RL P
Sbjct: 131 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 501 GLSHVSTCAQGTLGYLDPEY---YRNYQLTDKSDVYSYGVVLLELLTSQ 546
L+ + T Y PE R+Y T D+++ G + ELLTS+
Sbjct: 188 PLADLDPVVV-TFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSE 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 34/210 (16%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLV 405
+ R LG G + EV++ + + V VK + +K +++ E+ IL + N++
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVK--ILKPVK-KKKIKREIKILENLRGGPNII 94
Query: 406 RLLGCCVEAEQ---PLLIYEYIANGTLHDHL------HGKYSSFNLTWSTRLRIALQTAE 456
L V+ P L++E++ N ++ + + +
Sbjct: 95 TLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY------------EILK 141
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGY 515
AL Y HS I HRDVK N+++D + ++ D+GL+ PG + + +
Sbjct: 142 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYF 196
Query: 516 LDPEYYRNYQLTDKS-DVYSYGVVLLELLT 544
PE +YQ+ D S D++S G +L ++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
R+LG G FG+V +++ G + AVK K I V + E ILS NH L +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLHS 463
L C ++ + E++ G L H+ K F+ R AE AL +LH
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEA-----RARFYAAEIISALMFLHD 142
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDPE 519
I +RD+K N+LLD + + K+ADFG+ K G+ + T C GT Y+ PE
Sbjct: 143 KG---IIYRDLKLDNVLLDHEGHCKLADFGMC---KEGICNGVTTATFC--GTPDYIAPE 194
Query: 520 YYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
+ L + D ++ GV+L E+L
Sbjct: 195 ILQ-EMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 15/215 (6%)
Query: 338 LKELKKATNGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEV 393
+++L+ + +++G G FGEV + V A+K + E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
I++ N +V+L + ++ EY+ G L + + W+ R A +
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWA-RFYTA-E 176
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
AL +HS HRDVK N+LLD + K+ADFG A GT
Sbjct: 177 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 514 GYLDPEYYRNYQLT---DKS-DVYSYGVVLLELLT 544
Y+ PE ++ + D +S GV L E+L
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
R++G G + +V L+ + A++ K + + + E + Q NH LV
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 407 LLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLH 462
L C + E L + EY+ G L H+ + +AE AL YLH
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEE-----HARFYSAEISLALNYLH 170
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDP 518
I +RD+K N+LLD + + K+ D+G+ K GL T C GT Y+ P
Sbjct: 171 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFC--GTPNYIAP 222
Query: 519 EYYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
E R + S D ++ GV++ E++ +
Sbjct: 223 EILR-GEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 71/250 (28%), Positives = 107/250 (42%), Gaps = 33/250 (13%)
Query: 315 LAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKE-----RILGSGGFGEVYKGELQD 369
+++ +E L ++N A PA + + +++G G FG+V +
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 370 -GTVVAVKSAKVGNIKSTQQV---LNEVGILSQ-VNHKNLVRLLGCCVEAEQPL-LIYEY 423
AVK + I ++ ++E +L + V H LV L + L + +Y
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDY 120
Query: 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD 483
I G L HL + F R A + A AL YLHS I +RD+K NILLD
Sbjct: 121 INGGELFYHLQ-RERCFLEPR-ARFYAA-EIASALGYLHSLN---IVYRDLKPENILLDS 174
Query: 484 DFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDPE--YYRNYQLTDKS-DVYSYG 536
+ + DFGL K + H ST C GT YL PE + + Y D++ D + G
Sbjct: 175 QGHIVLTDFGLC---KENIEHNSTTSTFC--GTPEYLAPEVLHKQPY---DRTVDWWCLG 226
Query: 537 VVLLELLTSQ 546
VL E+L
Sbjct: 227 AVLYEMLYGL 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHK 402
+ + +GSG G V + VA+K K+ ++ E+ ++ VNHK
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 403 NLVRLL-----GCCVEAEQPLLIYEYIANGTLH-------DHLHGKYSSFNLTWSTRLRI 450
N++ LL +E Q + I + + L DH Y +
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY------------L 132
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
Q + +LHSA I HRD+K +NI++ D K+ DFGL+R A S + T
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 187
Query: 511 GTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
T Y PE + D++S G ++ E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 49/166 (29%), Positives = 70/166 (42%), Gaps = 25/166 (15%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLN-----EVGIL---SQ 398
+ +G G +G VYK + G VA+KS +V N L EV +L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 399 VNHKNLVRLLGCCVEAEQPL-----LIYEYIANGTLHDHLHG---KYSSFNLTWSTRLRI 450
H N+VRL+ C + L++E++ D L K L T +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDL 125
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
Q L +LH+ I HRD+K NIL+ K+ADFGL+R
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
++LG G FG+V+ E + A+K+ K + V + E +LS H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLHS 463
+ E + EY+ G L H+ F+L+ R AE L +LHS
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLS-----RATFYAAEIILGLQFLHS 136
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDPE 519
I +RD+K NILLD D + K+ADFG+ K + + C GT Y+ PE
Sbjct: 137 KG---IVYRDLKLDNILLDKDGHIKIADFGMC---KENMLGDAKTNTFC--GTPDYIAPE 188
Query: 520 YYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
Q + S D +S+GV+L E+L Q
Sbjct: 189 ILL-GQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQV-NHKNLVR 406
+LG G FG+V E + + AVK K + V + E +L+ L +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 407 LLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE---ALAYLH 462
L C + L + EY+ G L H+ + F AE L +L
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP-----HAVFYAAEIAIGLFFLQ 138
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDP 518
S I +RD+K N++LD + + K+ADFG+ K + T C GT Y+ P
Sbjct: 139 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMC---KENIWDGVTTKTFC--GTPDYIAP 190
Query: 519 EYYRNYQLTDKS-DVYSYGVVLLELLTSQ 546
E YQ KS D +++GV+L E+L Q
Sbjct: 191 EIIA-YQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 55/248 (22%), Positives = 91/248 (36%), Gaps = 66/248 (26%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+S + LG+G FG V + + G A+K KV + E+ I+ ++H N+++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQDPRYK--NRELDIMKVLDHVNIIK 64
Query: 407 LLGC-----------------------------CVEAEQPL---------LIYEYIANGT 428
L+ + +I EY+ T
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDT 123
Query: 429 LHDHLHGKYSSFNLTWSTRLRIAL------QTAEALAYLHSAAYTPIYHRDVKSTNILLD 482
LH L S + + L Q A+ ++HS I HRD+K N+L++
Sbjct: 124 LHKVLKSFIRS-----GRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVN 175
Query: 483 -DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY---YRNYQLTDKSDVYSYGVV 538
D K+ DFG ++ P V+ + Y PE Y T D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEY--TPSIDLWSIGCV 231
Query: 539 LLELLTSQ 546
EL+ +
Sbjct: 232 FGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 55/225 (24%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHK 402
+ +GSG +G V + + G VA+K K+ ++ E+ +L + H+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 403 NLVRLLGCCVEAEQPL-------LIYEYIANGTLH-------DHLHGKYSSFNLTWSTRL 448
N++ LL L L+ ++ L +Y
Sbjct: 84 NVIGLLDV-FTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQY----------- 130
Query: 449 RIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTC 508
+ Q + L Y+HSA + HRD+K N+ +++D K+ DFGL+R A ++
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----- 181
Query: 509 AQGTLGYLDPEYYR------NYQLTDKS-DVYSYGVVLLELLTSQ 546
GY+ +YR ++ +++ D++S G ++ E+LT +
Sbjct: 182 -----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVR 406
+ +GSG +G V + + G VA+K K+ ++ E+ +L + H+N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 407 LLGCCVEAEQPLLIYE--YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
LL ++ L + Y+ + L L + Q + L Y+H+A
Sbjct: 89 LLDV-FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-- 522
I HRD+K N+ +++D K+ DFGL+R A ++ GY+ +YR
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----------GYVVTRWYRAP 194
Query: 523 ----NYQLTDKS-DVYSYGVVLLELLTSQ 546
N+ ++ D++S G ++ E++T +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 352 RILGSGGFGEVY---KGELQD-GTVVAVKSAK----VGNIKSTQQVLNEVGILSQVNHKN 403
++LG+G +G+V+ K D G + A+K K V K+T+ E +L +
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 404 -LVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
LV L + E L LI +YI G L HL + F ++ + + AL +L
Sbjct: 120 FLVTLH-YAFQTETKLHLILDYINGGELFTHLS-QRERFTEHE-VQIYVG-EIVLALEHL 175
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ---GTLGYLDP 518
H I +RD+K NILLD + + + DFGLS K ++ + A GT+ Y+ P
Sbjct: 176 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLS---KEFVADETERAYDFCGTIEYMAP 229
Query: 519 EYYR-NYQLTDKS-DVYSYGVVLLELLTSQ 546
+ R DK+ D +S GV++ ELLT
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQV---LNEVGILSQVN-HKNLVR 406
+LG G FG+V E + + AVK K + V + E +L+ L +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRI-ALQTAEALAYLHSAA 465
L C ++ + EY+ G L H+ + F A + A L +L S
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP---HAVFYAAEIAIGLFFLQSKG 462
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST----CAQGTLGYLDPEYY 521
I +RD+K N++LD + + K+ADFG+ K + T C GT Y+ PE
Sbjct: 463 ---IIYRDLKLDNVMLDSEGHIKIADFGMC---KENIWDGVTTKTFC--GTPDYIAPEII 514
Query: 522 RNYQLTDKS-DVYSYGVVLLELLTSQ 546
YQ KS D +++GV+L E+L Q
Sbjct: 515 A-YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 27/166 (16%)
Query: 348 FSKERILGSGGFGEVYKG--ELQDGTVVAVKSAKVGNIK----STQQVLNEVGIL---SQ 398
+ +G G +G+V+K G VA+K +V + + + EV +L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAVLRHLET 70
Query: 399 VNHKNLVRLLGCCVEAEQPL-----LIYEYIANGTLHDHLHG---KYSSFNLTWSTRLRI 450
H N+VRL C + L++E++ D L K + T +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKDM 125
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
Q L +LHS + HRD+K NIL+ K+ADFGL+R
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 51/242 (21%), Positives = 84/242 (34%), Gaps = 67/242 (27%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVR 406
++G G +G VY + VA+K KV + +++L E+ IL+++ ++R
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIR 89
Query: 407 LLGCCVEAEQPL------LIYEYIANGT-LH---------DHLHGKYSSFNLTWSTRLRI 450
L + + L ++ E + L H K I
Sbjct: 90 LYDL-IIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKT------------I 134
Query: 451 ALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ 510
++H + I HRD+K N LL+ D + KV DFGL+R
Sbjct: 135 LYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 511 GTLGYLDPE---------------YYR---------NYQLTDKSDVYSYGVVLLELLTSQ 546
P +YR NY T D++S G + ELL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAELLNML 249
Query: 547 KA 548
++
Sbjct: 250 QS 251
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 47/223 (21%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKV---GNIKSTQQVLNEVGILSQVNHKNLVRL 407
+LG G +G V G +VA+K K+ + L E+ IL H+N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 408 LGCCVEAEQPL------LIYEY--------IANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
+ +I E I+ L D H +Y Q
Sbjct: 75 FNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD-HIQY------------FIYQ 120
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
T A+ LH + + HRD+K +N+L++ + + KV DFGL+R+ + S
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 514 ---GYLDPEYYR------NYQLTDKS-DVYSYGVVLLELLTSQ 546
++ +YR ++ DV+S G +L EL +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ LG GG G V+ + VA+K + + +S + L E+ I+ +++H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 411 CVEAEQPLLIYEYIANGTLHD----------HLHGKYSSFNLTWSTRLRIALQTAEALAY 460
+ L + + L+ L L Q L Y
Sbjct: 77 -LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKY 135
Query: 461 LHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQGTL-GYLDP 518
+HSA + HRD+K N+ ++ +D K+ DFGL+R+ P SH +G L L
Sbjct: 136 IHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH-----KGHLSEGLVT 187
Query: 519 EYYR---------NYQLTDKSDVYSYGVVLLELLTSQ 546
++YR NY T D+++ G + E+LT +
Sbjct: 188 KWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGK 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVR 406
+ +GSG G V + VA+K K+ ++ E+ ++ VNHKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 407 LLGCCVEAEQPLLIYE--YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
LL ++ L ++ Y+ + +L + L + Q + +LHSA
Sbjct: 126 LLNV-FTPQKTLEEFQDVYLVMELMDANLC-QVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I HRD+K +NI++ D K+ DFGL+R A S + T T Y PE
Sbjct: 184 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 238
Query: 525 QLTDKSDVYSYGVVLLELLTSQ 546
+ D++S G ++ E++ +
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHK 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 31/223 (13%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHK 402
+ ++G+G +G V + + + VVA+K K+ + +++L E+ IL+++NH
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 403 NLVRLLGCCVEAEQPL-----LIYEYIANGT-LHDHLHGKYSSFNLTWSTRLRIALQTAE 456
++V++L + + ++ E + + LT +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFR---TPVYLTELHIKTLLYNLLV 167
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
+ Y+HSA I HRD+K N L++ D + KV DFGL+R + S
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLL-----ELLTSQ----KAID 550
+ K + + VV EL+ Q +AID
Sbjct: 225 MNLVTFPHTKNLKRQLTGH-VVTRWYRAPELILLQENYTEAID 266
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 59/227 (25%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST-------------QQVLNEVGILSQ 398
R + SG +G V G +G VA+K +V N S ++VL E+ +L+
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 399 VNHKNLVRLLGCCVEAEQPL-----LIYEYI---------ANGTLHDHLHGKYSSFNLTW 444
+H N++ L V E+P L+ E + + H +Y
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY------- 138
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
L LH A + HRD+ NILL D+ + + DF L+R
Sbjct: 139 -----FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA--DA 188
Query: 505 VSTCAQGTLGYLDPEYYR------NYQLTDKS-DVYSYGVVLLELLT 544
T Y+ +YR ++ K D++S G V+ E+
Sbjct: 189 NKT------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 35/161 (21%), Positives = 60/161 (37%), Gaps = 34/161 (21%)
Query: 351 ERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLL 408
++LG G G+V + + A+K ++ + EV + + ++VR++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIV 77
Query: 409 GCCVEAEQP----LLIYEYIANGTLHDHL----HGKYS----SFNLTWSTRLRIALQTAE 456
L++ E + G L + ++ S I E
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---------EIMKSIGE 128
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGL 494
A+ YLHS I HRDVK N+L + K+ DFG
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVR 406
+GSG +G V + + G VAVK K+ ++ E+ +L + H+N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 407 LLGCCVEAEQPLLIYE-----YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
LL + P E Y+ + L+ LT + Q L Y+
Sbjct: 93 LL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
HSA I HRD+K +N+ +++D K+ DFGL+R ++ GY+ +Y
Sbjct: 149 HSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWY 195
Query: 522 R------NYQLTDKS-DVYSYGVVLLELLTSQ 546
R N+ +++ D++S G ++ ELLT +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 50/221 (22%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKNLVRL 407
+G G +G V + + VA+K K+ + Q+ L E+ IL + H+N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 408 LGCCVEAEQPL------LIYEY--------IANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
+ A ++ + + L + H Y Q
Sbjct: 91 NDI-IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-HICY------------FLYQ 136
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTL 513
L Y+HSA + HRD+K +N+LL+ + K+ DFGL+R+A P H G L
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-----TGFL 188
Query: 514 -GYLDPEYYR------NYQLTDKS-DVYSYGVVLLELLTSQ 546
Y+ +YR N + KS D++S G +L E+L+++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 6e-15
Identities = 35/212 (16%), Positives = 67/212 (31%), Gaps = 54/212 (25%)
Query: 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVK--------SAKVGNIKSTQQVLNEVGI 395
T + +G G FGEV++ D T VA+K + K+ +++L E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 396 LSQV---------NHKNLVRLLGCCV------------------------------EAEQ 416
++ + + L + +Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKS 476
++ E+ G + + K SS +T I Q +LA ++ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASL--RFEHRDLHW 190
Query: 477 TNILLDDDFNSKVADFGLSRLAKPGLSHVSTC 508
N+LL K+ + + +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVS 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 34/193 (17%)
Query: 352 RILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVN-HKNLV 405
+ LG G +G V+K + + G VVAVK K+ + Q+ E+ IL++++ H+N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 406 RLLGCCV-EAEQPL-LIYEY--------IANGTLHDHLHGKYSSFNLTWSTRLRIALQTA 455
LL + ++ + L+++Y I L H +Y + Q
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-HKQY------------VVYQLI 119
Query: 456 EALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGY 515
+ + YLHS + HRD+K +NILL+ + + KVADFGLSR +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 516 LDPEYYRNYQLTD 528
+ LTD
Sbjct: 177 TENFDDDQPILTD 189
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 61/213 (28%), Positives = 87/213 (40%), Gaps = 41/213 (19%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHK------N 403
+++G G FG+V K + VA+K + N K +Q E+ IL + + N
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 404 LVRLLGC-------CVEAEQPLL---IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
++ +L C+ E LL +YE I K+ F+L R + A
Sbjct: 161 VIHMLENFTFRNHICMTFE--LLSMNLYELIKK--------NKFQGFSLP-LVR-KFAHS 208
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQG 511
+ L LH I H D+K NILL S KV DFG S V T Q
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQ- 261
Query: 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ Y PE + D++S G +L ELLT
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 12/108 (11%)
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
LT + + Q A+ + +L S HRD+ + NILL + K+ DFGL+R
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD---- 242
Query: 502 LSHVSTCAQGTLGYLD-----PEYYRNYQLTDKSDVYSYGVVLLELLT 544
+ + L PE + T +SDV+S+GV+L E+ +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 9/104 (8%)
Query: 351 ERILGSGGFGEVYKGEL------QDGTVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHK 402
+ LG G FG+V + + VAVK K G + +++E+ IL + +H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 403 NLVRLLGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWS 445
N+V LLG C + PL +I E+ G L +L K + F +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 38/175 (21%), Positives = 65/175 (37%), Gaps = 26/175 (14%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLG 409
+ +GSGGFG +Y A KV + + +E+ +V K+ ++
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKW- 99
Query: 410 CCVEAEQPLLIYEYIANGTLHDHLHGKY-------------SSFN----LTWSTRLRIAL 452
+ L I + +G + Y ST L++ +
Sbjct: 100 IERKQLDYLGIPLFYGSGL-TEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV--ADFGLSRLAKPGLSHV 505
+ + L Y+H Y H D+K+ N+LL +V AD+GLS P +H
Sbjct: 159 RMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 55/221 (24%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNH------KN 403
++G G FG+V K + VA+K K N K+ Q EV +L +N
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 404 LVRLLGC-------CVEAEQPLL---IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
+V L C+ E +L +Y+ + N + +L TR + A Q
Sbjct: 118 IVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNT--------NFRGVSLN-LTR-KFAQQ 165
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQG 511
AL +L + + I H D+K NILL + S K+ DFG S +
Sbjct: 166 MCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQ---- 217
Query: 512 TLGYLDPEYYR--------NYQLTDKSDVYSYGVVLLELLT 544
Y+ +YR Y D++S G +L+E+ T
Sbjct: 218 ---YIQSRFYRSPEVLLGMPY--DLAIDMWSLGCILVEMHT 253
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 5e-12
Identities = 99/661 (14%), Positives = 185/661 (27%), Gaps = 228/661 (34%)
Query: 5 TNPNNKPELF----LYINISFLLI-LHYCYSQKICPSCGPIQVPYPLSTNPKCGDPNYLL 59
+ + F L IN FL+ + Q PS + Y + D
Sbjct: 73 SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ---PS--MMTRMYIEQRDRLYNDNQVFA 127
Query: 60 RCDLHSHKLYFDALNGSSYLVLRTMASSQRIVMQPASWINDSCVTHDM-------VTSEG 112
+ ++ + Y L LR ++PA + + + V +
Sbjct: 128 KYNVSRLQPY---------LKLRQALLE----LRPAKNV----LIDGVLGSGKTWVALDV 170
Query: 113 LWLNQSLPFNVTSSNTIF---LFNC-SPRLLISPLNCSSSSLCH----NFLESPEHV--- 161
S IF L NC SP ++ L L + N+ +H
Sbjct: 171 C---LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ----KLLYQIDPNWTSRSDHSSNI 223
Query: 162 --------DKKRALQCASELEPCCTFIAGGMPSAYKIRLHSSGCK--------------- 198
+ R L S+ C + + +A + CK
Sbjct: 224 KLRIHSIQAELRRLL-KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 199 -AFRSILHLDPNKPANQWEEGLEI--QWAP------PPEPVCKTQ-LDCS--GASKCLSA 246
A + + LD + +E + ++ P E V T S S
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-VLTTNPRRLSIIAESI---- 337
Query: 247 GRNGVYRCLCIKGYYWDHVLGTCQRKRRNRRSGL--------------------SLKISI 286
R+G+ W HV C + S L S I
Sbjct: 338 -RDGLAT---WD--NWKHV--NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
Query: 287 GVISVLSLAIAVAAIKIICSRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATN 346
++S++ + + + ++ + KL K + + K+ ++ S I +L+ K N
Sbjct: 390 ILLSLIWFDVIKSDVMVVVN-KLHKYSLVEKQPKESTIS--IPS-----IYLELKVKLEN 441
Query: 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
++ R + V+H N+ +
Sbjct: 442 EYALHRSI--------------------------------------------VDHYNIPK 457
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHL--HGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ P + +Y + H+ H L+ E
Sbjct: 458 TF--DSDDLIPPYLDQYFYS-----HIGHH-----------------LKNIEH------- 486
Query: 465 AYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
R + LD F K+ + A + + TL ++Y+
Sbjct: 487 -----PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-------TL--QQLKFYKP 532
Query: 524 YQLTDKSDVYSYGVVLLE--LLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
Y + D Y V + L ++ + S+ D + +A+ A + AI E ++
Sbjct: 533 Y-ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM----AEDEAIFEEAHKQV 587
Query: 582 Q 582
Q
Sbjct: 588 Q 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 1e-07
Identities = 63/393 (16%), Positives = 122/393 (31%), Gaps = 110/393 (27%)
Query: 263 DHVLGTCQRKRRNRR--SGLSLKISIGVISVLSLAIA------VAAIKIICSRKLAKQAK 314
DH++ + R L K V + + ++ IK +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 315 LAKEREDMLKSSNIAGKP--ARIFHLKELKKATNGFSKERIL---GSGGFGEVYKGELQD 369
++R+ + + + K +R+ +L++A + + G G G K
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K----- 163
Query: 370 GTVVAVKSAKVGNIKSTQQVLNEVGI--LSQVNHKNLVRLLGCCVEAEQPLLIYEYIANG 427
T VA+ Q + I L+ L C E L + +
Sbjct: 164 -TWVALDVCL----SYKVQCKMDFKIFWLN----------LKNCNSPETVLEMLQ----- 203
Query: 428 TLHDHLHGKYSSF-NLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486
L + ++S + + + +LRI L L + + ++ ++L + N
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIH-SIQAELRRL-------LKSKPYENCLLVLLNVQN 255
Query: 487 SKVAD-FGLS-RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLE--- 541
+K + F LS ++ L ++T R Q+TD + + L+
Sbjct: 256 AKAWNAFNLSCKI----L--LTT--------------RFKQVTDFLSAATTTHISLDHHS 295
Query: 542 -LLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSEL 600
LT + L Y+ R + PR E L + +E
Sbjct: 296 MTLTPDEVKSL--------LLKYLDCRPQD-------LPR----EVLTTNPRRLSIIAES 336
Query: 601 AVACLREKKSERPSMTD-----VVHELQRIIEI 628
+R + + D +L IIE
Sbjct: 337 ----IR----DGLATWDNWKHVNCDKLTTIIES 361
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLV-RLL 408
R +GSG FG++Y G + G VA+K V Q+ E I + + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIR 71
Query: 409 GCCVEAEQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
C E + +++ E + G +L D + F+L T L +A Q + Y+HS +
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKNFI 127
Query: 468 PIYHRDVKSTNILLDDDFNSK---VADFGLSR 496
HRDVK N L+ + DFGL++
Sbjct: 128 ---HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 32/154 (20%), Positives = 60/154 (38%), Gaps = 17/154 (11%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLL 408
R +G G FG +++G L + VA+K + Q+ +E + + +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVY 72
Query: 409 GCCVEAEQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
E +L+ + + G +L D L F++ T A Q + +H +
Sbjct: 73 YFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKSLV 128
Query: 468 PIYHRDVKSTNILLDDDFNSK-----VADFGLSR 496
+RD+K N L+ + V DFG+ +
Sbjct: 129 ---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 36/178 (20%), Positives = 66/178 (37%), Gaps = 29/178 (16%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+G GGFG +Y ++ V KV + + E+ + ++
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQK 98
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKY-------------SSFN-----LTWSTRLR 449
+ L + +Y +G LHD Y + + T L+
Sbjct: 99 W-IRTRKLKYLGVPKYWGSG-LHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156
Query: 450 IALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV--ADFGLSRLAKPGLSHV 505
++L+ + L Y+H Y H D+K++N+LL+ +V D+GL+ P H
Sbjct: 157 LSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLV-RLL 408
R +GSG FGE+Y G +Q VA+K V Q+L E I + + +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVR 69
Query: 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468
VE + +L+ + + +L D + +L T L +A Q + ++HS ++
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFL- 125
Query: 469 IYHRDVKSTNILLDDDFNSK---VADFGLSR 496
HRD+K N L+ + + DFGL++
Sbjct: 126 --HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLN-EVGILSQV-NHKNLVRL 407
+ +G G FGE+ G+ L VA+ K+ +KS L+ E Q+ + + ++
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAI---KLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 408 LGCCVEAEQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ ++ E + G +L D +F+L T L IA+Q + Y+HS
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHSKNL 126
Query: 467 TPIYHRDVKSTNILLDDDFNSK-----VADFGLSR 496
+RDVK N L+ N + DF L++
Sbjct: 127 I---YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 45/233 (19%), Positives = 83/233 (35%), Gaps = 67/233 (28%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVN--------- 400
R LG G F V+ + + + T VA+K + K T+ +E+ +L +VN
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 401 --HKNLVRLLG------------CCVEAEQPLL---IYEYIANGTLHDHLHGKYSSFNLT 443
++++LL V +L + I ++ L
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMV---FEVLGENLLALIKKY--------EHRGIPLI 131
Query: 444 WSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS------KVADFGLSRL 497
+ +I+ Q L Y+H I H D+K N+L++ + K+AD G +
Sbjct: 132 -YVK-QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 498 AKPGLSHVSTCAQGTLGYLDPEYYR------NYQLTDKSDVYSYGVVLLELLT 544
H + + YR +D++S ++ EL+T
Sbjct: 188 YD---EHYTN-------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 33/180 (18%), Positives = 59/180 (32%), Gaps = 33/180 (18%)
Query: 351 ERILGSGGFGEVYKGE---------LQDGTVVAVK-SAKVGNIKSTQQVLNEVGILSQVN 400
+ G +Y+ ++K AK G + + Q QVN
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 401 H-KNLVRLLGCCVEAEQPLLIYEYIANGTLH------------DHLHGKYSSFNLTWSTR 447
K L + P + + + + L+ +
Sbjct: 107 KWKKLYSTPLLAI----PTCMG-FGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV--ADFGLSRLAKPGLSHV 505
L++A + +AL +LH Y H +V + NI +D + S+V A +G + P HV
Sbjct: 162 LQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 45/234 (19%), Positives = 77/234 (32%), Gaps = 65/234 (27%)
Query: 352 RILGSGGFGEVYKG--ELQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHK------ 402
LG G FG+V + + + VA+K + N+ + E+ +L ++ K
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 403 NLVRLLGC-------CVEAEQPLL---IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIAL 452
V + C+ E LL +E++ + + L R +A
Sbjct: 83 LCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKEN--------NFQPYPLP-HVR-HMAY 130
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS--------- 503
Q AL +LH + H D+K NIL + + + S K +
Sbjct: 131 QLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 504 -------HVSTCAQGTLGYLDPEYYR------NYQLTDKSDVYSYGVVLLELLT 544
H +T + +YR DV+S G +L E
Sbjct: 188 SATFDHEHHTT-------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 53/231 (22%), Positives = 84/231 (36%), Gaps = 55/231 (23%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNH-----KNL 404
R +G G FG V + + + AVK + NIK T+ E IL ++ + N+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 405 VRLLGC-------CVEAEQPLL---IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQT 454
V+ G C+ E L +YE I Y+ F++ + ++
Sbjct: 99 VKYHGKFMYYDHMCLIFE--PLGPSLYEIITR--------NNYNGFHIE-DIK-LYCIEI 146
Query: 455 AEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV--------- 505
+AL YL + + H D+K NILLDD + K +
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 506 ----STC--AQGTLGYLDPEYYR------NYQLTDKSDVYSYGVVLLELLT 544
+ ++ YR N SD++S+G VL EL T
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 67/235 (28%)
Query: 352 RILGSGGFGEVYKG--ELQDGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHK------ 402
LG G FG+V + G VAVK K N+ + +E+ +L +N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVK--NVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 403 NLVRLLGC-------CVEAEQPLL---IYEYI-ANGTLHDHLHGKYSSFNLTWSTRLRIA 451
V++L C+ E LL Y++I NG + F L R ++A
Sbjct: 78 RCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG---------FLPFRLD-HIR-KMA 124
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS-------- 503
Q +++ +LHS + H D+K NIL ++ + + R + ++
Sbjct: 125 YQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 504 --------HVSTCAQGTLGYLDPEYYR------NYQLTDKSDVYSYGVVLLELLT 544
H ST + +YR + DV+S G +L+E
Sbjct: 182 GSATYDDEHHST-------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 53/264 (20%), Positives = 81/264 (30%), Gaps = 85/264 (32%)
Query: 352 RILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV--------NHK 402
R LG G F V+ +Q VA+K K T+ L+E+ +L V N +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 403 NLVRLLGC-----------CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIA 451
+V+LL C +++E + L + K + L +I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-------MVFE-VLGHHLLKWII-KSNYQGLPLPCVKKII 152
Query: 452 LQTAEALAYLHSAAYTPIYHRDVKSTNILL------------------------------ 481
Q + L YLH+ I H D+K NILL
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 482 -------------------DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
+ K+AD G + H + Q T Y E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQ-TRQYRSLEVLI 266
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQ 546
+D++S + EL T
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 39/254 (15%), Positives = 65/254 (25%), Gaps = 66/254 (25%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV 399
ELKK + + +VYK ++ + +K +T V E ++ +
Sbjct: 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLY-LKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 400 NHKNLV-RLLGCCVEAEQPLLIYEYIANGTLHD--------------------HLHG-KY 437
K V ++L L+ + H
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDI 126
Query: 438 SSFNLTWSTRLRIA------------------------LQTAEALAYLHSAAYTP---IY 470
S T S R+A E +L +
Sbjct: 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFS 186
Query: 471 HRDVKSTNILLDDDFNSKVADFGLSRLAKPG--LSHVSTCAQGTLG-----------Y-- 515
H D+ +NI + D S D G S A ++ + +G
Sbjct: 187 HGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELFFDLLGI 246
Query: 516 -LDPEYYRNYQLTD 528
D E + Y L D
Sbjct: 247 KPDWEKIKYYILLD 260
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 646 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.61 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.61 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 86.82 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 85.91 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.13 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 83.98 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 83.73 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 81.79 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.08 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=445.71 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=207.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|.+.++||+|+||+||+|+++ +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 478999999988777778899999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 420 IYEYIANGTLHDHLHGKY------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
||||+++|+|.++|+... ...+++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997542 1245999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHH
Q 006402 488 KVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 565 (646)
||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH-
Confidence 9999999987654332 22334569999999999999999999999999999999999 8999863321 1111111
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
..+...+ ... ...+++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 274 ---~~g~~~~-----~p~--------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 ---TQGRELE-----RPR--------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHTCCCC-----CCT--------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HcCCCCC-----Ccc--------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 000 1234577899999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=443.18 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=212.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|.+.+.||+|+||+||+|++. +++.||||+++..+.+..++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 478899999987777778899999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 420 IYEYIANGTLHDHLHGKY----------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
||||+++|+|.++|+... ....++|.+++.|+.|||+||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2346999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHH
Q 006402 490 ADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
+|||+|+........ ......||+.|||||++.+..++.|+|||||||+||||+| |+.||..... ..+.. .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~----~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE----C 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH----H
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----H
Confidence 999999876543322 2233458999999999999999999999999999999999 8999863321 11111 1
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+..... ++ ...+++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 243 i~~~~~~~~-p~------------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRVLQR-PR------------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCCCCC-CT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCC-Cc------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111211110 00 1234577899999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=434.39 Aligned_cols=261 Identities=29% Similarity=0.463 Sum_probs=203.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
+++.+.++||+|+||+||+|++++ .||||+++... .+..+.|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999998754 59999987543 3456789999999999999999999998764 578999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC-
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL- 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~- 502 (646)
+++|+|.++|+.. ...++|.+++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999754 235999999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
........||+.|||||++.+ ..++.|+|||||||+||||+||+.||...... . .+......+.. .+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~---~~~~~~~~~~~----~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---D---QIIFMVGRGYA----SP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H---HHHHHHHTTCC----CC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcCCC----CC
Confidence 223344569999999999863 36899999999999999999999999633211 1 11111111111 11
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.+.... ....+.+.+|+.+||+.+|++||||.||++.|+.+...+
T Consensus 258 ~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 258 DLSKLY-----KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CSTTSC-----TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred Cccccc-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111000 012345778999999999999999999999999886544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=436.66 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=207.3
Q ss_pred CCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
+++..++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455688999999999999863 46889999997543 3346789999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 420 IYEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
||||+++|+|.++|+... ....++|..+++|+.|||+||+|||+.+ |+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996532 1245999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCC-CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHH
Q 006402 487 SKVADFGLSRLAKPGL-SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYV 564 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 564 (646)
+||+|||+++...... ........||+.|||||++.+..++.|+|||||||+||||+| |+.||..... ..+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~--- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV--- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH---
Confidence 9999999998764332 222344569999999999999999999999999999999999 8899863321 1111
Q ss_pred HHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 565 SQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 565 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.....+..... . ......+.+|+.+||+.||++||||+||++.|+..
T Consensus 258 -~~i~~~~~~~~-----p--------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 -EMIRNRQVLPC-----P--------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHHTTCCCCC-----C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHHcCCCCCC-----c--------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12222221111 0 01234577899999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=424.69 Aligned_cols=249 Identities=20% Similarity=0.363 Sum_probs=207.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+.|+..++||+|+||+||+|+.+ +|+.||||++...+....+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999876 69999999997766666677899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999643 4899999999999999999999999 999999999999999999999999999877544332
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.+...||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+. .. ..+.+..
T Consensus 227 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~----~~-----~~~~~~~- 292 (346)
T 4fih_A 227 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR----DN-----LPPRLKN- 292 (346)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HS-----SCCCCSC-
T ss_pred -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH----cC-----CCCCCCc-
Confidence 2345699999999999999999999999999999999999999963211 11111111 11 1111110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......++.+|+.+||+.||++|||+.|+++
T Consensus 293 -----~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 -----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112345678999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=423.97 Aligned_cols=268 Identities=23% Similarity=0.348 Sum_probs=201.0
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC----cCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----QPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 421 (646)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567789999999999999988 589999999865322 1222334666667889999999999998764 468999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA-----YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
||+++|+|.++|+.. .++|..+++++.|+|+||+|||++. .++|+||||||+|||||+++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999753 4899999999999999999999871 2349999999999999999999999999998
Q ss_pred cCCCCCCcc---ccccCccccccCccccccC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC---------Cc
Q 006402 497 LAKPGLSHV---STCAQGTLGYLDPEYYRNY------QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD---------DV 558 (646)
Q Consensus 497 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~---------~~ 558 (646)
......... .....||+.|+|||++.+. .++.|+|||||||+||||+||+.|+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433221 2234699999999998653 46789999999999999999988875433211 01
Q ss_pred cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
... .......... +++.+..... .....+.+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 237 ~~~-~~~~~~~~~~----~rp~~p~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVE-EMRKVVCEQK----LRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHH-HHHHHHTTSC----CCCCCCGGGG---SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHH-HHHHHHhccc----CCCCCCcccc---chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111 1111111111 1222211111 22345668899999999999999999999999998864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=421.07 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=209.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+.|...++||+|+||+||+|+.+ +|+.||||+++.... +.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999875 699999999975432 247999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccCCCCCC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~~~~~~ 503 (646)
++|+|.++|++. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+|+....+..
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999753 35999999999999999999999999 99999999999999887 699999999997754322
Q ss_pred c----cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 504 H----VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 504 ~----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
. ......||+.|||||++.+..++.++|||||||+||||+||+.||......+ +...+... .....+ +.+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~--~~~~~~-~~~ 280 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIASE--PPPIRE-IPP 280 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHHS--CCGGGG-SCT
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHcC--CCCchh-cCc
Confidence 1 1123469999999999999999999999999999999999999997443222 11111110 001111 111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKV 634 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~ 634 (646)
.....+.+|+.+||+.||++|||+.|+++.|...+..+...++
T Consensus 281 ------------~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 281 ------------SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp ------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred ------------cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 1224567899999999999999999999999998887766554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=431.33 Aligned_cols=268 Identities=26% Similarity=0.401 Sum_probs=214.8
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEcC------CcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCC-Cccccccee
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQD------GTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNH-KNLVRLLGC 410 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~ 410 (646)
++++...++|++.+.||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+.+|++++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444456789999999999999999998653 36899999876543 346789999999999975 899999999
Q ss_pred EEeC-CcCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 006402 411 CVEA-EQPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKS 476 (646)
Q Consensus 411 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~ 476 (646)
|.+. +..+|||||+++|+|.++|+.... ...++|..++.++.|||+||+|||+++ |+||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9775 568999999999999999975421 245899999999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 006402 477 TNILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRD 554 (646)
Q Consensus 477 ~NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~ 554 (646)
+||||++++.+||+|||+|+....+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999977554333 2334568999999999999999999999999999999998 8999864332
Q ss_pred CCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 555 PDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
.+ .+. .....+.... ... ....++.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 294 ~~--~~~----~~i~~g~~~~-----~p~--------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 DE--EFC----RRLKEGTRMR-----APD--------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SH--HHH----HHHHHTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH--HHH----HHHHcCCCCC-----CCc--------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 21 111 1111111111 110 1124567899999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=427.98 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=200.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 69999999987543 3446789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.++|... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999754 2345799999999999999999999999 9999999999999999999999999998765322
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
. ..+...||+.|||||++.+..|+.++|||||||+||||+||+.||.... .......... +.... +.
T Consensus 180 ~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~-~~~~~-----~~ 246 (350)
T 4b9d_A 180 E-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIIS-GSFPP-----VS 246 (350)
T ss_dssp H-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH-TCCCC-----CC
T ss_pred c-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHc-CCCCC-----CC
Confidence 1 2233459999999999999999999999999999999999999996321 1111111111 11110 10
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ....++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~--------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 L--------HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c--------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 12244678999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=410.72 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=196.7
Q ss_pred CcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEe----CCcCeEEE
Q 006402 349 SKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQPLLIY 421 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 421 (646)
+..++||+|+||+||+|... +++.||+|++... .....+.|.+|+.+|++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45578999999999999876 6899999998643 33446789999999999999999999999876 24578999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~~~ 500 (646)
||+++|+|.+++++. ..+++..+..|+.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999753 35899999999999999999999987 4699999999999998 479999999999986543
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
. ......||+.|||||++.+ .++.++|||||||+||||+||+.||..... .. .+......+.....++..
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~-~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AA-QIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HH-HHHHHHTTTCCCGGGGGC
T ss_pred C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HH-HHHHHHHcCCCCCCCCcc
Confidence 2 2234569999999999875 699999999999999999999999963221 11 112222222111111111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...++.+|+.+||+.||++|||++|+++
T Consensus 255 ------------~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 ------------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1234678999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=425.94 Aligned_cols=249 Identities=20% Similarity=0.357 Sum_probs=207.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+.|+..+.||+|+||+||+|+.+ +|+.||||++...+....+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999876 69999999998776667778999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.++++.. .+++..+..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999643 4899999999999999999999999 999999999999999999999999999877544332
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||.... .......+. .. ..+.+...
T Consensus 304 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~----~~-----~~~~~~~~ 370 (423)
T 4fie_A 304 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIR----DN-----LPPRLKNL 370 (423)
T ss_dssp -BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHH----HS-----CCCCCSCT
T ss_pred -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHH----cC-----CCCCCccc
Confidence 234569999999999999999999999999999999999999996321 111111111 11 11111110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+|+.+||+.||++|||+.|+++
T Consensus 371 ------~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 ------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 012245678999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=414.58 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=205.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||+||+++.+ +|+.||||++... +....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999875 6999999998643 2345678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999987543
Q ss_pred CC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .......||+.|||||++.+..++.++||||+||+||||++|+.||.... ...+...+ . .+.. + ++..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i---~-~~~~-~-~p~~ 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKI---I-KLEY-D-FPEK 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---H-HTCC-C-CCTT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---H-cCCC-C-CCcc
Confidence 32 23344569999999999999999999999999999999999999996321 11111111 1 1111 0 1111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
...++.+|+.+||+.||++|||++|++
T Consensus 257 ------------~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 ------------FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------------CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------------cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 123467899999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=402.21 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=188.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999865 69999999986542 234567999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+ +|+|.+++.++ ..+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999998753 35999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....||+.|+|||++.+..+ +.++||||+||+||||+||+.||.... ..... .....+... ++..
T Consensus 166 ~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~-~~i~~~~~~--~p~~ 234 (275)
T 3hyh_A 166 NF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLF-KNISNGVYT--LPKF 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHHHTCCC--CCTT
T ss_pred Cc--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHH-HHHHcCCCC--CCCC
Confidence 32 233469999999999988776 579999999999999999999996321 11111 111111110 1111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+.+.+|+.+||+.||++|||++|+++
T Consensus 235 ------------~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 ------------LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1234668999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=401.54 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=190.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-------
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ------- 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 416 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||+++..+. ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999875 689999999875543 345779999999999999999999999986553
Q ss_pred -----CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 417 -----PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 417 -----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
.++||||+++|+|.+++.........++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999987644445677889999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCCc-----------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccH
Q 006402 492 FGLSRLAKPGLSH-----------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560 (646)
Q Consensus 492 fGl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~ 560 (646)
||+|+........ ..+...||+.|||||++.+..|+.++|||||||+||||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876543221 1123459999999999999999999999999999999996 65411 111
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ............ ...........+|+.+||+.||++|||+.|+++
T Consensus 234 ~-~~~~~~~~~~~p-------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V-RTLTDVRNLKFP-------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-HHHHHHHTTCCC-------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHhcCCCC-------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111111111 111222344568999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=406.46 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=193.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+.+|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999762 47899999986542 2234568899999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999753 35899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..... .....||+.|+|||++.+..++.++|||||||+||||+||+.||..... ..+...+ .. .... +..
T Consensus 178 ~~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i---~~-~~~~--~p~ 247 (304)
T 3ubd_A 178 DHEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMI---LK-AKLG--MPQ 247 (304)
T ss_dssp ---CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HH-CCCC--CCT
T ss_pred CCCcc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHH---Hc-CCCC--CCC
Confidence 43222 2335699999999999999999999999999999999999999963211 1111111 11 1110 011
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSM-----TDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~-----~evl~ 620 (646)
. ...++.+|+.+||+.||++|||+ +|+++
T Consensus 248 ~------------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 F------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp T------------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred c------------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 12346789999999999999984 56653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=391.02 Aligned_cols=287 Identities=42% Similarity=0.702 Sum_probs=243.6
Q ss_pred cccHHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC
Q 006402 335 IFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA 414 (646)
Q Consensus 335 ~~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 414 (646)
.+.+.++..++++|+..+.||+|+||+||+|++++++.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 35556677788999999999999999999999888999999998877767788899999999999999999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
+..++||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997653 2345899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCC-CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 494 LSRLAKPGL-SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 494 l~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998654322 2222334589999999999888999999999999999999999999987666666666666655555566
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
+...+++.+..... ......+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 265 ~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSC----HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccC----HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 66666665543322 24566788999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=396.07 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=199.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC------Cc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA------EQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 416 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999875 79999999986543 23456789999999999999999999987643 56
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+|||||++ |+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 799999995 7899999753 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCC---CccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 497 LAKPGL---SHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 497 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence 764321 1223345699999999998765 5699999999999999999999999743221 11111111111100
Q ss_pred ccccccc-----------cccC---CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 IMEVVDP-----------RLQG---HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ~~~~~d~-----------~l~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.... .+.. ............++.+|+.+||+.||++|||+.|+++
T Consensus 284 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 -PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 0000000012345779999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=388.42 Aligned_cols=199 Identities=24% Similarity=0.362 Sum_probs=171.2
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcC
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (646)
...++|++.++||+|+||+||+|+.+ .++.||||++... .....+.+|+++|+++ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999753 4688999988654 3456788999999998 699999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecCCCc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFGLSR 496 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfGl~~ 496 (646)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999984 3899999999999999999999999 9999999999999876 799999999998
Q ss_pred cCCCCCCc---------------------------cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCC
Q 006402 497 LAKPGLSH---------------------------VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKA 548 (646)
Q Consensus 497 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p 548 (646)
........ ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432211 11234599999999998765 589999999999999999999999
Q ss_pred CCCC
Q 006402 549 IDFS 552 (646)
Q Consensus 549 ~~~~ 552 (646)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=385.00 Aligned_cols=289 Identities=42% Similarity=0.689 Sum_probs=240.9
Q ss_pred CcccccHHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCccccccee
Q 006402 332 PARIFHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGC 410 (646)
Q Consensus 332 ~~~~~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~ 410 (646)
..+.+++.++....++|+..++||+|+||+||+|+.++++.||||++...... ....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45678999999999999999999999999999999888999999998754322 23468999999999999999999999
Q ss_pred EEeCCcCeEEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 411 CVEAEQPLLIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 411 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
+.+.+..++||||+++++|.++++... ....+++..++.++.|++.||+|||+...+.|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997654 3345999999999999999999999992122999999999999999999999
Q ss_pred eecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCCCccHHHHHHHH
Q 006402 490 ADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR--DPDDVNLAIYVSQR 567 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~--~~~~~~~~~~~~~~ 567 (646)
+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998776554444555569999999999988889999999999999999999999996322 22344455555555
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
..........+..+..... ....+.+.+++.+||+.+|.+|||+.||++.|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCC----HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccC----HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 5555666666665554332 2455678899999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=403.01 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=207.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+++.+ +|+.||+|++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999876 6999999999877766778899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCCEEEeecCCCccCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD--DFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~--~~~~ki~DfGl~~~~~~~ 501 (646)
+++|+|.++|..+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999653 235899999999999999999999999 999999999999985 489999999999987654
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
... ....||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .... ........ . ++...
T Consensus 311 ~~~--~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~----~~i~~~~~-~-~~~~~ 379 (573)
T 3uto_A 311 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETL----RNVKSCDW-N-MDDSA 379 (573)
T ss_dssp SEE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH----HHHHTTCC-C-CCSGG
T ss_pred Cce--eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH----HHHHhCCC-C-CCccc
Confidence 332 334599999999999999999999999999999999999999963321 1111 11111110 0 00000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ....+.+.+|+.+||+.||.+|||+.|+++
T Consensus 380 ~--------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 F--------SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp G--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c--------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 012244678999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=362.23 Aligned_cols=285 Identities=35% Similarity=0.573 Sum_probs=230.4
Q ss_pred CcccccHHHHHHHhcCCCcc------cEecccCcEEEEEEEEcCCcEEEEEEcccC----CcccHHHHHHHHHHHhhCCC
Q 006402 332 PARIFHLKELKKATNGFSKE------RILGSGGFGEVYKGELQDGTVVAVKSAKVG----NIKSTQQVLNEVGILSQVNH 401 (646)
Q Consensus 332 ~~~~~~~~el~~~~~~~~~~------~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 401 (646)
+...|++.++.+++++|... +.||+|+||+||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999887 8999999999999987 5789999988643 22346789999999999999
Q ss_pred CcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 402 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976544557999999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccH
Q 006402 482 DDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~ 560 (646)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999876543222 2233468999999998875 588999999999999999999999975543322211
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
.. .........+.+.+++.+... .......+.+++.+||+.+|.+|||+.||++.|+++..
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IK-EEIEDEEKTIEDYIDKKMNDA-----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HH-HHHHTTSCCHHHHSCSSCSCC-----CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HH-HHhhhhhhhhhhhcccccccc-----chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11 111111223344444444322 12345668899999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=398.50 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=197.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHH---HHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVL---NEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.++||+|+||+||+++.+ +|+.||||++++.. ......+. +++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56899999999999999999876 69999999986431 12223333 4466777889999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
|||||++||+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+|+..
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999753 35899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... ....||+.|||||++.+ ..|+.++|+|||||+||||++|+.||......+...+...+ ........
T Consensus 343 ~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p--- 414 (689)
T 3v5w_A 343 SKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELP--- 414 (689)
T ss_dssp SSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCC---
T ss_pred CCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCC---
Confidence 54432 23469999999999964 57999999999999999999999999743322211111111 11111111
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
.. ...++.+|+.+||+.||.+|++ ++||++
T Consensus 415 -~~------------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 -DS------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -TT------------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -cc------------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 1234678999999999999998 577764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.96 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=215.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|...++||+|+||+||++... +++.||+|++...+....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888899999999999999875 68999999987777777889999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999753 345899999999999999999999999 999999999999999999999999999876433221
Q ss_pred c-------------ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC---ccHHHHHHHHh
Q 006402 505 V-------------STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD---VNLAIYVSQRA 568 (646)
Q Consensus 505 ~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~---~~~~~~~~~~~ 568 (646)
. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+........ ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY- 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-
Confidence 1 1134699999999999999999999999999999999999998864332211 1111111100
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
..+. ....+.+++.+||+.||++|||+.|+++.|+++...+...
T Consensus 244 --------~~~~------------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 244 --------CPPN------------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp --------CCTT------------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred --------CCCC------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 0010 1123668999999999999999999999999999877653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.91 Aligned_cols=266 Identities=30% Similarity=0.462 Sum_probs=204.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..++|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346788999999999999999987 58899999987553 234568999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++........+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999976543334899999999999999999999987 45999999999999999999999999999865433
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..............+ +..
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~~~~-~~~-- 262 (309)
T 3p86_A 193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCKRLE-IPR-- 262 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCCCCC-CCT--
T ss_pred cc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCCCC-CCc--
Confidence 21 12334589999999999998999999999999999999999999863321 111111111111000 000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.....+.+|+.+||+.+|++|||+.|+++.|+.+.+....
T Consensus 263 ----------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 263 ----------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ----------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 1123467899999999999999999999999998765433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=371.87 Aligned_cols=269 Identities=27% Similarity=0.360 Sum_probs=210.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCc----CeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ----PLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lV 420 (646)
.++|++.++||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367899999999999999999875 7899999986543 334456679999999999999999999988654 5899
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA----------AYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
|||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999653 489999999999999999999998 7 9999999999999999999999
Q ss_pred ecCCCccCCCCCCc-cccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH-
Q 006402 491 DFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY- 563 (646)
Q Consensus 491 DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~- 563 (646)
|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||+||+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 2233569999999999876 3566789999999999999999999976544332222211
Q ss_pred --------HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 564 --------VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 564 --------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.............+..... .....+.+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQ-------KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGG-------SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCchhhhhhhhhcccCCCCcccccc-------ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111111111111 1234456889999999999999999999999999997653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=371.17 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=213.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 414 (646)
.++|.+.+.||+|+||+||+|+.. ++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888999999999999999763 356799999976533 3467899999999999 899999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975421 235899999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVN 559 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~ 559 (646)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986654322 22233457889999999999899999999999999999999 99998643221 1
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
+... ...+.... .. ......+.+++.+||+.+|++|||+.|+++.|++++....++
T Consensus 314 ~~~~----~~~~~~~~-----~~--------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~~ 369 (370)
T 2psq_A 314 LFKL----LKEGHRMD-----KP--------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369 (370)
T ss_dssp HHHH----HHTTCCCC-----CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHH----HhcCCCCC-----CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhccC
Confidence 1111 11111110 00 012245778999999999999999999999999999877654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.38 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=206.7
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999976 47899999998776666678899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999653 4899999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ...... .+..
T Consensus 172 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~---~~~~~~------~~~~ 238 (297)
T 3fxz_A 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLI---ATNGTP------ELQN 238 (297)
T ss_dssp C-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HHHCSC------CCSC
T ss_pred c-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCCC------CCCC
Confidence 2 23346999999999999999999999999999999999999998632211 111111 111100 0000
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+|+.+||+.||++|||+.|+++
T Consensus 239 ------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 ------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112344678999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=365.23 Aligned_cols=265 Identities=25% Similarity=0.448 Sum_probs=209.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|.+.++||+|+||+||+|.+. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999874 3456999998764 334567899999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999654 235899999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~----~~~~~~~~~~-- 274 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVI----SSVEEGYRLP-- 274 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTCCCC--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHcCCCCC--
Confidence 3322 2223346788999999998899999999999999999999 99998632211 111 1111111000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcccc
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVS 635 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~ 635 (646)
.. ......+.+|+.+||+.+|++|||+.||++.|+++.+..+..+..
T Consensus 275 ---~~--------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~ 321 (325)
T 3kul_A 275 ---AP--------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321 (325)
T ss_dssp ---CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred ---CC--------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence 00 012245778999999999999999999999999998776655443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.22 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=214.0
Q ss_pred ccccHHHHHHHhcC----------CCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC
Q 006402 334 RIFHLKELKKATNG----------FSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK 402 (646)
Q Consensus 334 ~~~~~~el~~~~~~----------~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 402 (646)
..++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34778888887765 666789999999999999886 7999999999877767788899999999999999
Q ss_pred cccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 403 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
||+++++++...+..++||||+++++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 9999999999999999999999999999998643 5899999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~ 562 (646)
.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH
T ss_pred CCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence 9999999999999876543322 2334699999999999988999999999999999999999999863321 11111
Q ss_pred HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 563 YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...... .+.+... ......+.+++.+||+.||++|||+.|+++
T Consensus 252 ----~~~~~~-----~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 ----RLRDSP-----PPKLKNS------HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ----HHHHSS-----CCCCTTG------GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHhcCC-----CCCcCcc------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111110 1111100 112244678999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=353.25 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=211.4
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|+..+.||+|+||+||++...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5688889999999999999999889999999987543 345779999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999754 235899999999999999999999999 9999999999999999999999999998765433333
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... ....+. ....+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~-~~~~~~--~~~~~~---- 230 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVE-DISTGF--RLYKPR---- 230 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-HHHTTC--CCCCCT----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHH-HHhcCc--cCCCCC----
Confidence 334457889999999998899999999999999999999 8989863221 11111 111110 000111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
.....+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 231 -------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 -------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 012346789999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=357.36 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=207.3
Q ss_pred cCCCcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 418 (646)
++|++.+.||+|+||+||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788899999999999999984 26889999999877767778899999999999999999999998654 4689
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999997542 34899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CCCccHHHHHHHH
Q 006402 499 KPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD---------PDDVNLAIYVSQR 567 (646)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~---------~~~~~~~~~~~~~ 567 (646)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543321 22234477889999999998999999999999999999999988753211 0000011111111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
........ . .....+.+.+|+.+||+.+|++|||+.|+++.|+++++.+
T Consensus 245 ~~~~~~~~-----~--------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 245 LKNNGRLP-----R--------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHTTCCCC-----C--------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhccCcCC-----C--------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111000 0 0112345778999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.23 Aligned_cols=263 Identities=27% Similarity=0.487 Sum_probs=201.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.++||+|+||+||+|+++ ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999875 5778999998765 334567899999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.++++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999754 335899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+. .....+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~----~~i~~~~~~--- 269 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVI----KAVDEGYRL--- 269 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHH----HHHHTTEEC---
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCC---
Confidence 33221 122235778999999998899999999999999999998 9999863321 1111 111111100
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEK 633 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~ 633 (646)
.. . ......+.+++.+||+.+|++||++.||++.|+++.......+
T Consensus 270 ~~--~--------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~~ 315 (373)
T 2qol_A 270 PP--P--------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLK 315 (373)
T ss_dssp CC--C--------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGGG
T ss_pred CC--C--------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccccc
Confidence 00 0 0122457789999999999999999999999999987655443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.10 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=212.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++|++.+.||+|+||+||+++.+++..||+|+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35788899999999999999999888899999987654 34577999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999753 234899999999999999999999999 999999999999999999999999999877655444
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+.. ...+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-~~~~~~--~~~~~~-- 229 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLK-VSQGHR--LYRPHL-- 229 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-HHTTCC--CCCCTT--
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHH-HHcCCC--CCCCCc--
Confidence 3444557788999999998889999999999999999999 99998633211 11111 111110 001110
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
..+.+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 230 ---------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 230 ---------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 12346789999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=383.85 Aligned_cols=265 Identities=25% Similarity=0.411 Sum_probs=213.6
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
+++....++|.+.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 33444557788999999999999999999888999999997644 45788999999999999999999999986 66789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999997542 235889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
............+++.|+|||++....++.++||||||++||||+| |+.||...... .....+. ..... .
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~---~~~~~-~-- 405 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE---RGYRM-P-- 405 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---HTCCC-C--
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---cCCCC-C--
Confidence 5432222233446889999999998899999999999999999999 99998632211 1111111 11110 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.+ ....+.+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus 406 ~~-----------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 RP-----------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CC-----------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 00 012345778999999999999999999999998876443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=351.20 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=209.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++|++.+.||+|+||+||+++.+++..||+|+++... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46788899999999999999999988899999987543 34577999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999763 235899999999999999999999999 999999999999999999999999999876543322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ...+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~--~~~~~--- 244 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE----HIAQGLR--LYRPH--- 244 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH----HHHTTCC--CCCCT---
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHH----HHhcccC--CCCCC---
Confidence 2333457889999999998899999999999999999998 99998633211 1111 1111100 00010
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+.+.+++.+||+.+|++|||++|+++.|+++.+.
T Consensus 245 --------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 --------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0123467899999999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=358.16 Aligned_cols=248 Identities=27% Similarity=0.361 Sum_probs=203.8
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|++.+.||+|+||+||+|+. .+|+.||||++... +....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999987 47999999998654 3345677899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999653 35899999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccCccccccCccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLT-DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....||+.|+|||++.+..+. .++||||||+++|||++|+.||.... .......... +.. .
T Consensus 168 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~-~~~------~ 232 (328)
T 3fe3_A 168 GK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLR-GKY------R 232 (328)
T ss_dssp CG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CCC------C
T ss_pred Cc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHh-CCC------C
Confidence 32 2344699999999999887765 79999999999999999999996332 1111111111 110 0
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.. .....+.+|+.+||+.||.+|||++|+++.
T Consensus 233 ~p~--------~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 IPF--------YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCT--------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCC--------CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 012346689999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.93 Aligned_cols=272 Identities=25% Similarity=0.393 Sum_probs=215.2
Q ss_pred ccHHHHHHHhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCccccc
Q 006402 336 FHLKELKKATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRL 407 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l 407 (646)
+...++....++|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555566788999999999999999999742 468999999976433 3456799999999999 79999999
Q ss_pred ceeEEeCCc-CeEEEEEccCCCccccccCCcC------------------------------------------------
Q 006402 408 LGCCVEAEQ-PLLIYEYIANGTLHDHLHGKYS------------------------------------------------ 438 (646)
Q Consensus 408 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------ 438 (646)
++++.+.+. .++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 8999999999999999976432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 439 ---------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 439 ---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112899999999999999999999999 99999999999999999999999999987644332
Q ss_pred c-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 504 H-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
. ......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .+.. ....+.... .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~~~-----~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMR-----A 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCCCC-----C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCCCC-----C
Confidence 2 2334558999999999998899999999999999999998 999986433221 1111 111111100 0
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.. .....+.+++.+||+.+|++|||+.|+++.|+++++..
T Consensus 318 ~~--------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 PD--------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC--------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00 01234678999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.21 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=209.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|.+.+.||+|+||+||+|++. +++.||||+++... ....+.|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888999999999999999886 78999999987543 2334678999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.++++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999753 234899999999999999999999999 9999999999999999999999999998654332
Q ss_pred Cccc-cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 503 SHVS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 503 ~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~----- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QT----REFVEKGGRLP----- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HH----HHHHHTTCCCC-----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCCC-----
Confidence 1111 11235778999999998889999999999999999998 99988633211 11 11111111100
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
... .....+.+|+.+||+.+|++|||+.++++.|+++.+.
T Consensus 336 ~~~--------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPE--------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 000 1223567899999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=351.35 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=201.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhh--CCCCcccccceeEEeC----CcCe
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQ--VNHKNLVRLLGCCVEA----EQPL 418 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 418 (646)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 6899999998643 44566677777776 7899999999997653 3578
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH--------SAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
+||||+++|+|.++++.. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999543 5899999999999999999999 777 9999999999999999999999
Q ss_pred ecCCCccCCCCCCcc---ccccCccccccCccccccC------CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 006402 491 DFGLSRLAKPGLSHV---STCAQGTLGYLDPEYYRNY------QLTDKSDVYSYGVVLLELLTS----------QKAIDF 551 (646)
Q Consensus 491 DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~ll~elltg----------~~p~~~ 551 (646)
|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654433221 1233699999999999776 455799999999999999999 777754
Q ss_pred CCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 552 SRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
....... ............. .+.+.... ........+.+|+.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPS-FEDMRKVVCVDQQ-----RPNIPNRW---FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCC-HHHHHHHHTTSCC-----CCCCCGGG---GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcc-hhhhhHHHhccCC-----CCCCChhh---ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3332221 1111111111111 11111000 0123456788999999999999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=350.75 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=204.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999865 68999999885432 23457889999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .... ...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~-~~~ 235 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNV-TTD 235 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCH-HHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCc-chh
Confidence 433333445699999999999998999999999999999999999999963321 11111111111 1000 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERP-SMTDVVHELQRII 626 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-s~~evl~~L~~~~ 626 (646)
+. ....+.+.+++.+||+.+|.+|| +++++.+.|+++.
T Consensus 236 ~~--------~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 236 VR--------KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp SC--------TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cc--------cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 00 11234577899999999999998 8999998888764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.68 Aligned_cols=273 Identities=22% Similarity=0.298 Sum_probs=212.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCC--cCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE--QPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 421 (646)
++|.+.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999876 58999999987543 344677889999999999999999999998765 668999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCEEEeecCCCcc
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRL 497 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll----~~~~~~ki~DfGl~~~ 497 (646)
||+++++|.+++........+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999987655555999999999999999999999999 9999999999999 7888899999999987
Q ss_pred CCCCCCccccccCccccccCccccc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHH-HHHHHHh
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYR--------NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA-IYVSQRA 568 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~-~~~~~~~ 568 (646)
....... ....||+.|+|||++. +..++.++||||||+++|||++|+.||............ ..+....
T Consensus 166 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 7554332 2345899999999986 467899999999999999999999999754433322222 1122111
Q ss_pred cCCccccccc---------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 569 SNGAIMEVVD---------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 569 ~~~~~~~~~d---------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
.......... ..+..... ........+.+++.+||+.||++|||++|+++.....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCS--SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccc--cchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111100 01110000 0134456688999999999999999999999877643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=363.24 Aligned_cols=269 Identities=26% Similarity=0.402 Sum_probs=215.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 414 (646)
.++|.+.+.||+|+||+||+|+.. .+..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467889999999999999999763 23579999987543 34457899999999999 899999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
+..++||||+++|+|.+++..... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999975431 235899999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVN 559 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~ 559 (646)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999987654322 22334457899999999999899999999999999999999 9999863321
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccccc
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSN 636 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~ 636 (646)
.. .......+..... .. .....+.+|+.+||+.+|++|||+.||++.|+++.......+...
T Consensus 300 -~~-~~~~~~~~~~~~~-----~~--------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 300 -EE-LFKLLKEGHRMDK-----PS--------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp -HH-HHHHHHTTCCCCC-----CS--------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred -HH-HHHHHHcCCCCCC-----Cc--------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 11 1111211111110 00 112447789999999999999999999999999998776665444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.49 Aligned_cols=263 Identities=20% Similarity=0.233 Sum_probs=208.5
Q ss_pred cHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEE
Q 006402 337 HLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCV 412 (646)
Q Consensus 337 ~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 412 (646)
.+.+++...++|++.++||+|+||+||+|+.+ +++.||+|+++.... ...+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667789999999999999999999887 488999999864221 22334889999999999999999999999
Q ss_pred eCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 413 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999753 235899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
|+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||..... ......+...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~ 296 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNH 296 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhhc
Confidence 999877655444444457999999999986 45789999999999999999999999963221 1111111110
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVH 620 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~ 620 (646)
...... ..... .....+.+|+.+||+.+|++ ||+++|+++
T Consensus 297 ~~~~~~----p~~~~---------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KERFQF----PTQVT---------DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHCCC----CSSCC---------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccC----Ccccc---------cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000000 00000 01234668999999888888 999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.54 Aligned_cols=267 Identities=15% Similarity=0.195 Sum_probs=213.8
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36799999999999999999986 478999999886442 334578899999999 79999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-----EEEeecCCCcc
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN-----SKVADFGLSRL 497 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~-----~ki~DfGl~~~ 497 (646)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999753 235899999999999999999999999 999999999999987766 99999999987
Q ss_pred CCCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 498 AKPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 498 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 1234569999999999999899999999999999999999999997544332222222111111111
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
...+. .....+.+.+++.+||+.+|++|||+++|++.|+++.+.++..
T Consensus 241 ~~~~~-------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 241 PLREL-------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp CHHHH-------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cHHHH-------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 11100 0012345779999999999999999999999999998876544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.52 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=202.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..++|++.++||+|+||+||+|+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3478999999999999999999998899999999865432 23567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9997 4788887653 335899999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---cccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---AIMEVV 577 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 577 (646)
... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..+....... ......
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGT
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhh
Confidence 222 223458999999999876 56899999999999999999999999754433221 1111111110 000000
Q ss_pred c------cc---ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 D------PR---LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d------~~---l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+ .. ..............+++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00 0000000000112345779999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=359.25 Aligned_cols=272 Identities=27% Similarity=0.439 Sum_probs=196.5
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcC-C---cEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQD-G---TVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
..++|++.+.||+|+||+||+|+... + ..||||+++.. .....+.+.+|+.++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999997653 3 27999998754 334567899999999999999999999999887655
Q ss_pred ------eEEEEEccCCCccccccCCc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEE
Q 006402 418 ------LLIYEYIANGTLHDHLHGKY---SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSK 488 (646)
Q Consensus 418 ------~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~k 488 (646)
++||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 89999999999999996432 2225899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHH
Q 006402 489 VADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 566 (646)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~- 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLI- 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH-
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHh-
Confidence 9999999876543322 2233447889999999999899999999999999999999 89988643221 1111111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccccccc
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSNDV 638 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 638 (646)
.+.... ..+ .....+.+|+.+||+.||++|||+.|+++.|+++++.+.-...++++
T Consensus 254 ---~~~~~~-~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 254 ---GGNRLK-QPP------------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp ---TTCCCC-CCT------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred ---cCCCCC-CCC------------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 111000 000 12245778999999999999999999999999999888777766663
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.02 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=198.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.++|++.+.||+|+||+||+|.... +..||+|+++... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 3678889999999999999998742 4579999987543 33467799999999999999999999997 4567899
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999753 335899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+. .+.... +.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~----~~~~~~-~~ 239 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----NGERLP-MP 239 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCCC-CC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHH----cCCCCC-CC
Confidence 543333334457889999999998899999999999999999997 88898643222 1111111 111000 01
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
+ .....+.+++.+||+.+|++|||+.|+++.|+++.+...
T Consensus 240 ~------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 240 P------------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp T------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 122446789999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=354.37 Aligned_cols=252 Identities=25% Similarity=0.308 Sum_probs=204.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc------cHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
..++|.+.+.||+|+||+||+++.+ +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999876 6899999998754322 35789999999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CEEEeec
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF----NSKVADF 492 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~----~~ki~Df 492 (646)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999653 35899999999999999999999999 99999999999998776 7999999
Q ss_pred CCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
|+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..||..... . ... .......
T Consensus 164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~---~~~-~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---Q---ETL-ANITAVS 234 (361)
T ss_dssp SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---H---HHH-HHHHTTC
T ss_pred CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---H---HHH-HHHHhcC
Confidence 99987755332 2234599999999999988999999999999999999999999963211 1 111 1111111
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. +++.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~--~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDEEF--------FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCchh--------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 01000 0112345778999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=348.33 Aligned_cols=263 Identities=30% Similarity=0.442 Sum_probs=211.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..++|++.+.||+|+||+||+|..++++.||+|+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346788899999999999999998888899999987543 35678999999999999999999999976 4568999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999997542 235899999999999999999999999 99999999999999999999999999987765433
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... .....+... ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~-~~~~~~~~~-----~~~ 232 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVI-QNLERGYRM-----VRP 232 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHH-HHHHTTCCC-----CCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHH-HHHhcccCC-----CCc
Confidence 33334457889999999988889999999999999999999 8888863221 1111 111111100 000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
. .....+.+++.+||+.+|++|||+.++++.|+++......+
T Consensus 233 ~--------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 233 D--------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred c--------cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 0 12245778999999999999999999999999998776544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=375.56 Aligned_cols=261 Identities=29% Similarity=0.431 Sum_probs=205.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..++|++.+.||+|+||+||+|.++++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999999888889999997654 346789999999999999999999999876 678999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.++++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999753 2235899999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.......+++.|+|||.+.+..++.++||||||++||||++ |+.||..... .. +......+.... ..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~-~~~~i~~~~~~~-----~~ 403 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------RE-VLDQVERGYRMP-----CP 403 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHHHHTTCCCC-----CC
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCC-----CC
Confidence 33333457889999999998899999999999999999999 8999863221 11 111111111000 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
....+.+.+|+.+||+.+|++|||+.++++.|+.+....+
T Consensus 404 --------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 404 --------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0123456789999999999999999999999998865443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.21 Aligned_cols=265 Identities=17% Similarity=0.175 Sum_probs=211.5
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36789999999999999999986 478999999986543 234688999999999 89999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-----EEEeecCCCcc
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN-----SKVADFGLSRL 497 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~-----~ki~DfGl~~~ 497 (646)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999753 346899999999999999999999999 999999999999998887 99999999987
Q ss_pred CCCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 498 AKPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 498 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6433221 1234569999999999999999999999999999999999999997543332211111111111000
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.. + .+. .... .+.+++.+||+.+|.+||++.+|++.|+++.+....
T Consensus 240 ~~-~----~~~--------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 240 PI-E----VLC--------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp CH-H----HHT--------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CH-H----HHh--------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 0 000 0012 577999999999999999999999999998877643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=343.96 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=210.5
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5688889999999999999999888999999987654 345789999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999753 235899999999999999999999999 9999999999999999999999999998765432222
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... ....+.. . ..+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~-~i~~~~~-~-~~~~---- 228 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVE-DISTGFR-L-YKPR---- 228 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-HHHTTCC-C-CCCT----
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHH-HHhcCCc-C-CCCc----
Confidence 233457889999999998889999999999999999999 8888863221 11111 1111110 0 0010
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
.....+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 229 -------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 -------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 012346789999999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=363.88 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=209.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|++.+.||+|+||+||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999853 4678999998654 334556789999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CEEEe
Q 006402 418 LLIYEYIANGTLHDHLHGKY----SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF---NSKVA 490 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~---~~ki~ 490 (646)
++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997542 2235899999999999999999999999 99999999999999544 59999
Q ss_pred ecCCCccCCCC-CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHh
Q 006402 491 DFGLSRLAKPG-LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 491 DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
|||+++..... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~-~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEV-LEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHH-HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHH
Confidence 99999754221 1122233457999999999998899999999999999999998 9999863321 111 1111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
..+..... . ......+.+|+.+||+.+|++|||+.||++.|+.+.+..+..
T Consensus 300 ~~~~~~~~-----~--------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 300 TSGGRMDP-----P--------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp HTTCCCCC-----C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred HcCCCCCC-----C--------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 11111000 0 011234678999999999999999999999999988765543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=376.10 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=211.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..+|++.++||+|+||+||+|+++. +..||||+++... ...++|.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999998874 8899999997543 4578899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.++++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999754 2345899999999999999999999999 99999999999999999999999999987754433
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.......+++.|+|||++.+..++.++||||||++||||++ |+.||...... .+... ...+.... ..
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~~-----~~ 441 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYRME-----RP 441 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCCCC-----CC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCCC-----CC
Confidence 33334457789999999998899999999999999999999 88888643221 11111 11111000 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
......+.+|+.+||+.+|++|||+.||++.|+.+.
T Consensus 442 --------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 --------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 012245778999999999999999999999998874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=367.88 Aligned_cols=253 Identities=28% Similarity=0.450 Sum_probs=206.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-cCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE-QPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+|+++ ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456888899999999999999885 7899999987543 5578999999999999999999999988765 78999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.++++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999999754 2334799999999999999999999999 9999999999999999999999999998654321
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
....+++.|+|||.+.+..++.++||||||++||||+| |+.||......+ .... ...+.... ..
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~~~-----~p 408 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMD-----AP 408 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCCCC-----CC
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCCC-----CC
Confidence 12247889999999999999999999999999999999 999987443221 1111 11111100 00
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
......+.+|+.+||+.+|++|||+.++++.|+.+...
T Consensus 409 --------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 --------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01234577899999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.93 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=201.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|+..++||+|+||+||+|++. +++ .||+|.++.. .....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999864 344 3688887543 2345678999999999999999999999998754 789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|+||+.+|+|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999764 245899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+. .+.... .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~----~~~~~~-~ 240 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGERLP-Q 240 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCCC-C
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHHH----cCCCCC-C
Confidence 43322 2233457889999999999999999999999999999999 99998643222 1111111 111000 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.+ .....+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 241 ~~------------~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 241 PP------------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp CT------------TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred Cc------------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 00 112346789999999999999999999999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.90 Aligned_cols=253 Identities=31% Similarity=0.491 Sum_probs=194.9
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc----ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI----KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|+..++||+|+||+||+|... ++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888999999999999999875 88999999865432 23577899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--------CCCEEEeecC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD--------DFNSKVADFG 493 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~--------~~~~ki~DfG 493 (646)
||+++++|.+++.. ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999854 35899999999999999999999998666899999999999986 7789999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-~~ 231 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMN-KL 231 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTS-CC
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcC-CC
Confidence 9986654322 233589999999999988999999999999999999999999863221 1111111111 11
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
...+.. ...+.+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 232 ~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 ALPIPS------------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCc------------ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 100110 1124577899999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.78 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=200.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ------ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 416 (646)
.++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457889999999999999999886 79999999987543 3356789999999999999999999999876542
Q ss_pred ---------------------------------------------------CeEEEEEccCCCccccccCCcCCCCCCHH
Q 006402 417 ---------------------------------------------------PLLIYEYIANGTLHDHLHGKYSSFNLTWS 445 (646)
Q Consensus 417 ---------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~ 445 (646)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 68999999999999999876555567888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC-----------ccccccCcccc
Q 006402 446 TRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS-----------HVSTCAQGTLG 514 (646)
Q Consensus 446 ~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~-----------~~~~~~~gt~~ 514 (646)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987754421 11223459999
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHH
Q 006402 515 YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSL 594 (646)
Q Consensus 515 y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 594 (646)
|+|||.+.+..++.++||||||+++|||++|..|+. ... ........... +.......
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~-~~~~~~~~~~~-------------~~~~~~~~ 299 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERV-RIITDVRNLKF-------------PLLFTQKY 299 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHH-HHHHHHHTTCC-------------CHHHHHHC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHH-HHHHHhhccCC-------------CcccccCC
Confidence 999999999899999999999999999999876532 001 11111111111 11122334
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 595 KLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 595 ~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+.+|+.+||+.||++|||+.|+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 55678999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.10 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=205.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|.+.+.||+|+||+||+++.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999876 68899999987543 4456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCCEEEeecCCCccCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD--DFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~--~~~~ki~DfGl~~~~~~~ 501 (646)
+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999753 235899999999999999999999999 999999999999987 789999999999877654
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... . ........ .... .+.
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~i~~-~~~~--~~~-- 224 (321)
T 1tki_A 158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---Q---QIIENIMN-AEYT--FDE-- 224 (321)
T ss_dssp CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHH-TCCC--CCH--
T ss_pred Cc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---H---HHHHHHHc-CCCC--CCh--
Confidence 32 2334589999999999988899999999999999999999999963221 1 11111111 1000 000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.........+.+|+.+||+.||++|||+.|+++.
T Consensus 225 ------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 ------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011223457799999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.01 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=202.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+++.+ +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999876 6899999998653 2235677899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998743 35899999999999999999999999 999999999999999999999999999864332
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+. ..... ... .+
T Consensus 159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~---~~i~~-~~~------~~ 224 (337)
T 1o6l_A 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF---ELILM-EEI------RF 224 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHH-CCC------CC
T ss_pred CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHH---HHHHc-CCC------CC
Confidence 22 22334599999999999998999999999999999999999999863211 1111 11111 110 01
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
.. .....+.+|+.+||+.||++|| +++|+++.
T Consensus 225 p~--------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PR--------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CT--------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC--------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00 1123467899999999999999 89998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.68 Aligned_cols=261 Identities=28% Similarity=0.407 Sum_probs=211.4
Q ss_pred hcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|.+.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788999999999999999976 245889999987543 34467899999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYS---------------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKS 476 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~ 476 (646)
++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999975432 124899999999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 006402 477 TNILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRD 554 (646)
Q Consensus 477 ~NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~ 554 (646)
+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2233457889999999998889999999999999999999 9999864322
Q ss_pred CCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 555 PDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
. .+... ...+.... ... .....+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 259 ~---~~~~~----~~~~~~~~-----~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 E---RLFNL----LKTGHRME-----RPD--------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G---GHHHH----HHTTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H---HHHHH----hhcCCcCC-----CCc--------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1 11111 11111100 000 1224577899999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.67 Aligned_cols=269 Identities=26% Similarity=0.364 Sum_probs=208.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
..++|.+.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456789999999999999999986 245689999987542 23457899999999999 8999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSS--------------------FNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVK 475 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik 475 (646)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999764321 24899999999999999999999999 9999999
Q ss_pred CCCEEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 006402 476 STNILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSR 553 (646)
Q Consensus 476 ~~NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~ 553 (646)
|+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866543322 2233457889999999988899999999999999999998 999986443
Q ss_pred CCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 006402 554 DPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEK 633 (646)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~ 633 (646)
... ... .....+.... ... .....+.+|+.+||+.+|.+|||+.|+++.|+.+.....++.
T Consensus 280 ~~~--~~~----~~~~~~~~~~-~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 280 VDA--NFY----KLIQNGFKMD-QPF------------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp CSH--HHH----HHHHTTCCCC-CCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred cHH--HHH----HHHhcCCCCC-CCC------------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 221 111 1111111000 000 112446789999999999999999999999999987766554
Q ss_pred c
Q 006402 634 V 634 (646)
Q Consensus 634 ~ 634 (646)
.
T Consensus 341 ~ 341 (344)
T 1rjb_A 341 Y 341 (344)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.26 Aligned_cols=265 Identities=28% Similarity=0.405 Sum_probs=210.9
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCC
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE 415 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 415 (646)
...++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999875 34889999997653 334678999999999999999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYS---------------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV 474 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Di 474 (646)
..++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999975321 146899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCCEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 006402 475 KSTNILLDDDFNSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFS 552 (646)
Q Consensus 475 k~~NIll~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~ 552 (646)
||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543221 12233458899999999998899999999999999999999 99998632
Q ss_pred CCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 553 RDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.. .. .......+..... .. .....+.+|+.+||+.+|++|||+.|+++.|+++.+...
T Consensus 281 ~~------~~-~~~~~~~~~~~~~-~~------------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 281 AH------EE-VIYYVRDGNILAC-PE------------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CH------HH-HHHHHHTTCCCCC-CT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred Ch------HH-HHHHHhCCCcCCC-CC------------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 21 11 1111112211110 00 122357789999999999999999999999999876554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.92 Aligned_cols=263 Identities=28% Similarity=0.404 Sum_probs=212.7
Q ss_pred hcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46789999999999999999975 2468999999875543 3467899999999999 89999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 417 PLLIYEYIANGTLHDHLHGKYS---------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 124899999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVN 559 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~ 559 (646)
+.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 999999999999998776543322 223457889999999988899999999999999999999 999986433221 1
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
.......... ..... .....+.+++.+||+.+|.+|||+.|+++.|+++....
T Consensus 257 ~~~~~~~~~~-----~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMIKEGFR-----MLSPE------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHTCC-----CCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHhccCCC-----CCCcc------------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111111100 00000 11244678999999999999999999999999988754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.56 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=216.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
..++|++.+.||+|+||+||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567889999999999999999887 4889999998754 3456789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999754 3346899999999999999999999999 9999999999999999999999999998776554
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
........+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ....... ..... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~----~~~~~-----~~ 233 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE----KDYRM-----ER 233 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH----TTCCC-----CC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----ccCCC-----CC
Confidence 444444557889999999998899999999999999999999 88888643221 1111111 11000 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
. ....+.+.+|+.+||+.+|.+|||+.|+++.|+++......
T Consensus 234 ~--------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 234 P--------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred C--------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0 01224577899999999999999999999999998876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.37 Aligned_cols=250 Identities=27% Similarity=0.309 Sum_probs=203.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc------cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|.+.+.||+|+||+||++... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888999999999999999876 6899999998754322 4678999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CEEEeecCC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF----NSKVADFGL 494 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~----~~ki~DfGl 494 (646)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999643 35899999999999999999999999 99999999999999877 899999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. ......
T Consensus 165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~--~~~~~~ 237 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSA--VNYEFE 237 (326)
T ss_dssp CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHH--TCCCCC
T ss_pred CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHh--cCCCcC
Confidence 987754322 22345999999999999889999999999999999999999998632211 11111110 000000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... .......+.+|+.+||+.||++|||+.|+++
T Consensus 238 ----~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 ----DEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----HHH--------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----ccc--------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 1112345678999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=361.95 Aligned_cols=273 Identities=16% Similarity=0.242 Sum_probs=210.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcC------CcEEEEEEcccCCccc-----------HHHHHHHHHHHhhCCCCcccc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQD------GTVVAVKSAKVGNIKS-----------TQQVLNEVGILSQVNHKNLVR 406 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 406 (646)
..++|.+.+.||+|+||+||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998764 4789999987654221 123456677788889999999
Q ss_pred cceeEEeC----CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 407 LLGCCVEA----EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 407 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
+++++... ...++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 3479999999 99999999753 346999999999999999999999999 99999999999999
Q ss_pred --CCCCEEEeecCCCccCCCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006402 483 --DDFNSKVADFGLSRLAKPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554 (646)
Q Consensus 483 --~~~~~ki~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~ 554 (646)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432211 11234499999999999998999999999999999999999999974322
Q ss_pred CCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 555 PDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
. ........... ...+.+++++.+... .....+.+++.+||+.+|++||++.++++.|+++.+.....
T Consensus 267 ~--~~~~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 267 D--PKYVRDSKIRY-RENIASLMDKCFPAA-------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp C--HHHHHHHHHHH-HHCHHHHHHHHSCTT-------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred C--HHHHHHHHHHh-hhhHHHHHHHhcccc-------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 2 11111111111 112223333322211 12345778999999999999999999999999998876544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.76 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=204.3
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+|+.+ ++.||||+++... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999985 8899999987653 34456799999999999999999999999887 6789999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.++++.. ....+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 999999999999864 2335899999999999999999999976 55999999999999999999999999987654322
Q ss_pred CCccccccCccccccCccccccCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLT---DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
...||+.|+|||.+.+..++ .++||||||+++|||++|+.||..... .............
T Consensus 167 ------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~----- 229 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLR----- 229 (271)
T ss_dssp ------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCC-----
T ss_pred ------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCC-----
Confidence 23489999999999765444 489999999999999999999863221 1111111111111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
+.+.. .....+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 230 ~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 PTIPP--------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111 122346789999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=348.20 Aligned_cols=260 Identities=29% Similarity=0.475 Sum_probs=201.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.+.||+|+||+||+++.. ++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46888899999999999999875 788999998643 45678999999999999999999999876 45899999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-EEEeecCCCccCCCCCCc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN-SKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~-~ki~DfGl~~~~~~~~~~ 504 (646)
+++|.++++.......+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999986544445889999999999999999999932222999999999999998876 7999999997654322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..... ...+.... +..
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~-~~~~~-~~~~~~~~-----~~~- 227 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---AF-RIMWA-VHNGTRPP-----LIK- 227 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---HH-HHHHH-HHTTCCCC-----CBT-
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---HH-HHHHH-HhcCCCCC-----ccc-
Confidence 2234899999999999989999999999999999999999998643221 11 11111 11111111 110
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
.....+.+++.+||+.+|++|||+.|+++.|+++...+...
T Consensus 228 -------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 228 -------NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp -------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred -------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 11234678999999999999999999999999997766443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=350.74 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=212.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc--------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEA 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 414 (646)
.++|.+.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467899999999999999999863 46789999987543 34467899999999999 899999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999976431 234899999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVN 559 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~ 559 (646)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 99999999999999876543322 2233457889999999988889999999999999999999 9999863211
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKV 634 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~ 634 (646)
..... ....+.... ... .....+.+++.+||+.+|.+|||+.|+++.|+++.....+.+.
T Consensus 266 -~~~~~-~~~~~~~~~-----~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~ 325 (334)
T 2pvf_A 266 -EELFK-LLKEGHRMD-----KPA--------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325 (334)
T ss_dssp -HHHHH-HHHHTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred -HHHHH-HHhcCCCCC-----CCc--------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcc
Confidence 11111 111111000 000 1223467899999999999999999999999999988776543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=350.52 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=201.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999876 789999999865433 234678899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999743 35899999999999999999999999 9999999999999999999999999998654322
Q ss_pred C-ccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 503 S-HVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 503 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .....+. ..... .++
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~----~~~~~---~~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKTY---LNP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHH----TTCTT---STT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----ccccc---CCc-
Confidence 1 22234569999999999987765 779999999999999999999997443321 1111111 00000 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ---------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01122446689999999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.54 Aligned_cols=268 Identities=25% Similarity=0.357 Sum_probs=203.6
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhC--CCCcccccceeEEeC----C
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV--NHKNLVRLLGCCVEA----E 415 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 415 (646)
....++|++.+.||+|+||+||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 345578999999999999999999885 899999998643 334555666666655 899999999999887 6
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeccCCCCCEEEcCCCCE
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA--------AYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
..++||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 789999999999999999643 489999999999999999999998 6 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcc---ccccCccccccCccccccCCCCch------hhHHHHHHHHHHHHcC----------CCC
Q 006402 488 KVADFGLSRLAKPGLSHV---STCAQGTLGYLDPEYYRNYQLTDK------SDVYSYGVVLLELLTS----------QKA 548 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDv~s~G~ll~elltg----------~~p 548 (646)
||+|||+++......... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997665433221 123459999999999977655554 9999999999999999 555
Q ss_pred CCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 549 IDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
|......... .... ............+..... .....+.+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 262 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 262 YHDLVPSDPS-YEDM-REIVCIKKLRPSFPNRWS-------SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTTSCSSCC-HHHH-HHHHTTSCCCCCCCGGGG-------GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HhhhcCCCCc-hhhh-HHHHhhhccCccccccch-------hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 5432222211 1111 111111111111111111 124566788999999999999999999999999999875
Q ss_pred H
Q 006402 629 V 629 (646)
Q Consensus 629 ~ 629 (646)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.05 Aligned_cols=277 Identities=24% Similarity=0.382 Sum_probs=202.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHH--HhhCCCCcccccceeEEe-----CCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGI--LSQVNHKNLVRLLGCCVE-----AEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 417 (646)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36788999999999999999977 6899999998643 33445555555 445899999999986553 2256
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeccCCCCCEEEcCCCCEE
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA---------AYTPIYHRDVKSTNILLDDDFNSK 488 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------~~~~i~H~Dik~~NIll~~~~~~k 488 (646)
++||||+++|+|.+++... ..++..++.++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999999654 358999999999999999999999 7 99999999999999999999
Q ss_pred EeecCCCccCCCCC-------CccccccCccccccCcccccc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006402 489 VADFGLSRLAKPGL-------SHVSTCAQGTLGYLDPEYYRN-------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRD 554 (646)
Q Consensus 489 i~DfGl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~ 554 (646)
|+|||+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998764321 111223459999999999876 3567799999999999999999888754333
Q ss_pred CCCccHHH-----------HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 555 PDDVNLAI-----------YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 555 ~~~~~~~~-----------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
........ ..............+...... .....+.+.+|+.+||+.||++|||++|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE------NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC------CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc------ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 22111100 000111111111111111111 1224556889999999999999999999999999
Q ss_pred HHHHHHhhccccccc
Q 006402 624 RIIEIVNQEKVSNDV 638 (646)
Q Consensus 624 ~~~~~~~~~~~~~~~ 638 (646)
++++.+++.+...+.
T Consensus 315 ~ll~~~~~~~~~~~~ 329 (336)
T 3g2f_A 315 ELMMIWERNKSVSPT 329 (336)
T ss_dssp HHHHCCCC-------
T ss_pred HHHHHHHhcccCCCc
Confidence 999999888776653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.21 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=206.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999876 6899999999876656667899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCEEEeecCCCccCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD--DDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~--~~~~~ki~DfGl~~~~~~~ 501 (646)
+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999753 235899999999999999999999999 99999999999997 4578999999999877554
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..... .... .... .++..
T Consensus 205 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~i~~-~~~~--~~~~~ 273 (387)
T 1kob_A 205 EIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQ---NVKR-CDWE--FDEDA 273 (387)
T ss_dssp SCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHH-CCCC--CCSST
T ss_pred cce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-CCCC--CCccc
Confidence 322 233599999999999988999999999999999999999999863221 11111 1111 1000 01111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. ......+.+|+.+||+.||++|||+.|+++.
T Consensus 274 ~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 F--------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 0122456789999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=352.60 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=205.7
Q ss_pred cCCCcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcC
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (646)
++|++.+.||+|+||.||++++ .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 368999999987543 34567899999999999999999999999876 567
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 8999999999999999643 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------CCCccHHHHHHHH
Q 006402 498 AKPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD--------PDDVNLAIYVSQR 567 (646)
Q Consensus 498 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~--------~~~~~~~~~~~~~ 567 (646)
....... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... .............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7654332 22334588899999999988899999999999999999999988642210 0000001111111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
...+.... .. ....+.+.+|+.+||+.||.+|||+.|+++.|++++
T Consensus 256 ~~~~~~~~-----~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLP-----CP--------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCC-----CC--------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCC-----CC--------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111000 00 012345779999999999999999999999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.24 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=203.0
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-C-------cEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-G-------TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
++|.+.+.||+|+||+||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568889999999999999997653 3 57999999776667788899999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--------EEE
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN--------SKV 489 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~--------~ki 489 (646)
++||||+++++|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999997542 34899999999999999999999999 999999999999998877 999
Q ss_pred eecCCCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 490 ADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+...... ........
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~ 232 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQFYE 232 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHHHhh
Confidence 999998755332 12347899999999987 67899999999999999999976554322111 11111111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
......... ...+.+|+.+||+.||++|||+.|+++.|+++...-
T Consensus 233 ~~~~~~~~~----------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 DRHQLPAPK----------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TTCCCCCCS----------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccCCCCCCC----------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111111111 122568999999999999999999999999886643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=341.41 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=206.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.++|.+.+.||+|+||+||+|+..+ +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999997653 346999998765 33456789999999999999999999999764 46789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999753 335899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.... ....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~~-~~~~----- 235 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKGD-RLPK----- 235 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHTC-CCCC-----
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcCC-CCCC-----
Confidence 543333344457889999999998899999999999999999998 99998643222 1111111110 0000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
+ . .....+.+++.+||+.+|++|||+.|+++.|+++.+...+
T Consensus 236 ~---~--------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 236 P---D--------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp C---T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred C---C--------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 0 0 0123467899999999999999999999999999876443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=349.98 Aligned_cols=270 Identities=27% Similarity=0.472 Sum_probs=208.5
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|+..++||+|+||+||+|.... +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999997653 2469999987543 3345679999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999753 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 500 PGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 500 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. +......+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~-~~~~~~~~~~~~- 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HE-VMKAINDGFRLP- 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHHHHHTTCCCC-
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HH-HHHHHHCCCcCC-
Confidence 43221 1222346889999999998899999999999999999999 9999853221 11 111111111000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccccccccc
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSNDVNV 640 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 640 (646)
.. ......+.+++.+||+.+|++||++.|+++.|+++....+..+.-.+.+.
T Consensus 271 ----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~p 322 (333)
T 1mqb_A 271 ----TP--------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322 (333)
T ss_dssp ----CC--------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCCC--
T ss_pred ----Cc--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhcCCCc
Confidence 00 01224467899999999999999999999999999988777666555443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=343.08 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=194.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--------------------------cHHHHHHHHHHHhh
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--------------------------STQQVLNEVGILSQ 398 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~ 398 (646)
++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67999999999999999999875 6899999998654321 23568899999999
Q ss_pred CCCCcccccceeEEe--CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 006402 399 VNHKNLVRLLGCCVE--AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKS 476 (646)
Q Consensus 399 l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~ 476 (646)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999987 5578999999999999997643 35899999999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 477 TNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ---LTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 477 ~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
+|||++.++.+||+|||+++........ .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999876543222 23346999999999997654 4789999999999999999999986321
Q ss_pred CCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 554 DPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....... ........ +.. ....+.+.+|+.+||+.||++|||+.|+++
T Consensus 245 ------~~~~~~~-~~~~~~~~---~~~---------~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ------IMCLHSK-IKSQALEF---PDQ---------PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HHHHHHH-HHHCCCCC---CSS---------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HHHHHHH-HhcccCCC---CCc---------cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111111 11111000 000 011234678999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.53 Aligned_cols=275 Identities=22% Similarity=0.312 Sum_probs=213.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCC--cCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE--QPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 421 (646)
++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56889999999999999999876 58999999987543 234677889999999999999999999998765 668999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCEEEeecCCCcc
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL----DDDFNSKVADFGLSRL 497 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll----~~~~~~ki~DfGl~~~ 497 (646)
||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999987654555999999999999999999999999 9999999999999 7788899999999987
Q ss_pred CCCCCCccccccCccccccCcccccc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH-HHHHh
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRN--------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY-VSQRA 568 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~-~~~~~ 568 (646)
...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. +....
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 654322 223459999999999864 4678899999999999999999999975444332222211 11111
Q ss_pred cCCcccccc---------cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 569 SNGAIMEVV---------DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 569 ~~~~~~~~~---------d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
......... ...+..... ........+.+++.+||+.||++|||+.|+++.++.+++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCS--SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccc--cchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111111000 000110000 013455667899999999999999999999999988765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=357.66 Aligned_cols=270 Identities=28% Similarity=0.407 Sum_probs=214.0
Q ss_pred HHHHhcCCCcccEecccCcEEEEEEEEcC-C-----cEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEE
Q 006402 341 LKKATNGFSKERILGSGGFGEVYKGELQD-G-----TVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCV 412 (646)
Q Consensus 341 l~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 412 (646)
+....++|.+.+.||+|+||+||+|.... + ..||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34445789999999999999999998642 2 479999987553 23467799999999999 8999999999999
Q ss_pred eCCcCeEEEEEccCCCccccccCCc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 413 EAEQPLLIYEYIANGTLHDHLHGKY-----------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 413 ~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999997532 1335899999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVN 559 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~ 559 (646)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H
Confidence 99999999999999866433222 2223447889999999988899999999999999999999 888886432221 1
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
....... .... ..+. .....+.+++.+||+.+|.+|||+.|+++.|+++.....++
T Consensus 276 ~~~~~~~----~~~~--~~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 276 FYKLVKD----GYQM--AQPA-----------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp HHHHHHH----TCCC--CCCT-----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhc----CCCC--CCCC-----------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 1111111 1000 0000 01234678999999999999999999999999998776554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.38 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=203.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
..++|.+.+.||+|+||.||++..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999876 68999999987543 23457789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCEEEeecCCCcc
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD---FNSKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~---~~~ki~DfGl~~~ 497 (646)
|||+++|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999998753 35899999999999999999999999 9999999999999864 4599999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+... ...+... ..
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~----i~~~~~~-~~ 250 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQ----IKAGAYD-YP 250 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHTCCC-CC
T ss_pred ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH----HHhCCCC-CC
Confidence 654332 2234599999999999988999999999999999999999999863211 111111 1111100 00
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGG---------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccc---------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 1123456789999999999999999998853
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.88 Aligned_cols=267 Identities=21% Similarity=0.261 Sum_probs=207.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeE-EeCCcCeEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCC-VEAEQPLLIY 421 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 421 (646)
..++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 478999999865432 223578899999999988887777766 4566779999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCccC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLA 498 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~~ 498 (646)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998743 235899999999999999999999999 9999999999999 78899999999999876
Q ss_pred CCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 499 KPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 499 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221 12234689999999999998999999999999999999999999986544433333222221111111
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
... . .....+.+.+++.+||+.+|++|||+.++++.|+++.+....
T Consensus 239 ~~~-~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 IEV-L------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHH-H------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhh-h------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 000 0 001134577999999999999999999999999999887654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=351.61 Aligned_cols=254 Identities=23% Similarity=0.293 Sum_probs=203.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-----cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-----IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
.++|++.+.||+|+||+||++..+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356899999999999999999875 68999999885421 224678999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---EEEeecCC
Q 006402 419 LIYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN---SKVADFGL 494 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~---~ki~DfGl 494 (646)
+||||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886432 3345899999999999999999999999 999999999999986554 99999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+ ......+...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~----~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL----FEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH----HHHHHHTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH----HHHHHcCCCC
Confidence 987754322 2233459999999999998899999999999999999999999996421 111 1111111100
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.++. ........+.+|+.+||+.||++|||+.|+++
T Consensus 251 --~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00112345778999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.31 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=203.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcE----EEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTV----VAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|++.++||+|+||+||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888999999999999999865 4443 7888775432 233456789999999999999999999886 557889
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999764 235889999999999999999999999 9999999999999999999999999998875
Q ss_pred CCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+ ..+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~~-- 237 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLL----EKGERLA-- 237 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHH----HTTCBCC--
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHH----HcCCCCC--
Confidence 54332 2234557889999999998899999999999999999999 99998743322 111111 1111000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.+.. ....+.+++.+||+.+|.+|||+.|+++.|+++.....
T Consensus 238 ~~~~-----------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 238 QPQI-----------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp CCTT-----------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred CCCc-----------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0000 11124579999999999999999999999999875443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=342.24 Aligned_cols=254 Identities=31% Similarity=0.528 Sum_probs=201.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCccc-------HHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKS-------TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
++|++.+.||+|+||+||+|+.. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67889999999999999999875 78999999986543321 167899999999999999999999986544
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-----EEEeec
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN-----SKVADF 492 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~-----~ki~Df 492 (646)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999988654 346899999999999999999999987 45999999999999987776 999999
Q ss_pred CCCccCCCCCCccccccCccccccCcccc--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYY--RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
|+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||....... . .........
T Consensus 174 g~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~~~ 245 (287)
T 4f0f_A 174 GLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I-KFINMIREE 245 (287)
T ss_dssp TTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---H-HHHHHHHHS
T ss_pred Ccccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---H-HHHHHHhcc
Confidence 999854332 2334589999999998 34567899999999999999999999997433221 1 111111111
Q ss_pred CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 571 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
. .. +.+.. .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 246 ~-~~----~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 G-LR----PTIPE--------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C-CC----CCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C-CC----CCCCc--------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 11 11111 1124577899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.36 Aligned_cols=266 Identities=28% Similarity=0.416 Sum_probs=209.0
Q ss_pred CCcccEecccCcEEEEEEEEc-----CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeC--CcCeE
Q 006402 348 FSKERILGSGGFGEVYKGELQ-----DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA--EQPLL 419 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 419 (646)
|++.+.||+|+||+||++.++ +++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 388899999999999988653 68899999987653 34467799999999999999999999999884 46789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999653 3899999999999999999999999 9999999999999999999999999998776
Q ss_pred CCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--------CccHHHHHHHHhc
Q 006402 500 PGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPD--------DVNLAIYVSQRAS 569 (646)
Q Consensus 500 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~ 569 (646)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... .............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 54332 2233457888999999998889999999999999999999999986321100 0000000111111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEK 633 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~ 633 (646)
...... . .......+.+|+.+||+.+|++|||+.|+++.|+++.+.+..+.
T Consensus 266 ~~~~~~-----~--------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 266 RGERLP-----R--------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp TTCCCC-----C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred cccCCC-----C--------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 110000 0 01123457799999999999999999999999999998887553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=379.44 Aligned_cols=261 Identities=30% Similarity=0.445 Sum_probs=210.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
..++|++.++||+|+||+||+|+++++..||||+++... ...++|.+|+.+|++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788899999999999999999888889999997654 346789999999999999999999999876 678999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.++++.. ....+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999753 2235899999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.......++..|+|||.+.+..++.++||||||++||||++ |+.||..... .. +......+.... ...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~-~~~~i~~~~~~~-~~~--- 487 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------RE-VLDQVERGYRMP-CPP--- 487 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HH-HHHHHHTTCCCC-CCT---
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCC-CCC---
Confidence 22223447889999999998899999999999999999999 8999863221 11 111111111100 000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.....+.+|+.+||+.+|++|||+.+|++.|+.+....+
T Consensus 488 ---------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 488 ---------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 122456789999999999999999999999998765443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=345.36 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=199.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|.+.+.||+|+||+||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999876 689999999875432 2357789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC-cccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG-AIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~ 579 (646)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . ......... .......+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-~~~~~~~~~~~~~~~~~~ 259 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------S-VMGAHINQAIPRPSTVRP 259 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------H-HHHHHHHSCCCCGGGTST
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------H-HHHHHhccCCCCccccCC
Confidence 433333345589999999999988899999999999999999999999863211 1 111111111 11111111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHHhhcccc
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERP-SMTDVVHELQRIIEIVNQEKVS 635 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-s~~evl~~L~~~~~~~~~~~~~ 635 (646)
.....+.+++.+||+.+|++|| |++++++.|+++..........
T Consensus 260 ------------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~ 304 (309)
T 2h34_A 260 ------------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304 (309)
T ss_dssp ------------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--------
T ss_pred ------------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchh
Confidence 1123466899999999999999 9999999999887766655443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=339.50 Aligned_cols=265 Identities=28% Similarity=0.425 Sum_probs=209.7
Q ss_pred CCCcccEecccCcEEEEEEEEcC-C---cEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC-eEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQD-G---TVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP-LLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 420 (646)
.|...++||+|+||+||+|++.+ + ..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999997642 2 3799999875433 4467899999999999999999999999876655 999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+.+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999763 345899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCC---ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLS---HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
... .......+++.|+|||.+.+..++.++||||||+++|||++|..|+...... ......+.. .....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~----~~~~~-- 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQ----GRRLP-- 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHT----TCCCC--
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhc----CCCCC--
Confidence 221 1223345789999999999999999999999999999999977665433222 122221111 11000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcccc
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVS 635 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~ 635 (646)
... .....+.+++.+||+.+|.+|||+.|+++.|+++.+.+......
T Consensus 249 ---~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~ 295 (298)
T 3pls_A 249 ---QPE--------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYV 295 (298)
T ss_dssp ---CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBC
T ss_pred ---CCc--------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchh
Confidence 000 11234678999999999999999999999999999988766543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=355.81 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=196.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.++||+|+||+||+++.+ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 56889999999999999999876 58899999987542 22345678999999887 899999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC--ccHHHHHHHHhcCCccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD--VNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d 578 (646)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ................
T Consensus 206 ~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp TTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred CCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 221 23345699999999999999999999999999999999999999964432211 1111111111111110
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.+.. .....+.+|+.+||+.||.+||++
T Consensus 280 -~~p~--------~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -RIPR--------SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCT--------TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -CCCC--------cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000 112346689999999999999995
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=346.89 Aligned_cols=273 Identities=25% Similarity=0.385 Sum_probs=215.2
Q ss_pred cHHHHHHHhcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccc
Q 006402 337 HLKELKKATNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLL 408 (646)
Q Consensus 337 ~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 408 (646)
...++....++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444555567899999999999999999974 2468999999876433 3456789999999999 699999999
Q ss_pred eeEEeCC-cCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 006402 409 GCCVEAE-QPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDV 474 (646)
Q Consensus 409 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Di 474 (646)
+++...+ ..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988755 58999999999999999976532 123789999999999999999999999 999999
Q ss_pred CCCCEEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 006402 475 KSTNILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFS 552 (646)
Q Consensus 475 k~~NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~ 552 (646)
||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876543322 2233457889999999998899999999999999999998 99998643
Q ss_pred CCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 553 RDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.... ..... ...+.... ... .....+.+++.+||+.+|.+|||+.|+++.|+++++...+
T Consensus 255 ~~~~--~~~~~----~~~~~~~~-----~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 255 KIDE--EFCRR----LKEGTRMR-----APD--------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp CCSH--HHHHH----HHHTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred chhH--HHHHH----hccCccCC-----CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 3221 11111 11111000 000 0123467899999999999999999999999999876544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=338.40 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=211.0
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeE-EeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCC-VEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+.++++++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999987 4799999998865432 34688999999999998877777666 45667799999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~~~ 499 (646)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999999643 235899999999999999999999999 9999999999999 488899999999998765
Q ss_pred CCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 500 PGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 500 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43321 123446999999999999989999999999999999999999999865443333222222211111100
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
.. +. ....+.+.+++.+||+.+|++|||+.++++.|+++.+.....
T Consensus 240 ~~-~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 240 EV-LC------------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HH-HT------------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HH-HH------------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00 00 112345778999999999999999999999999998776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=365.05 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=206.5
Q ss_pred HHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEe
Q 006402 338 LKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413 (646)
Q Consensus 338 ~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 413 (646)
+.+++...++|.+.++||+|+||+||+++.+ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455556788999999999999999999876 58999999986421 1223457899999999999999999999999
Q ss_pred CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
.+..++||||+++|+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999998643 4899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ----LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
+++..............||+.|+|||++.+.. ++.++||||||++||||++|+.||..... ......+.....
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~ 290 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKN 290 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHHH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhccc
Confidence 99877654433334556999999999997654 78899999999999999999999963221 111111111000
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSE--RPSMTDVVHE 621 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--RPs~~evl~~ 621 (646)
.... +.. ......+.+|+.+||+.+|.+ ||+++||++.
T Consensus 291 ~~~~-----p~~---------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLTF-----PDD---------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCCC-----CTT---------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccC-----CCc---------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 000 011244678999999999988 9999999854
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=355.49 Aligned_cols=270 Identities=25% Similarity=0.330 Sum_probs=209.7
Q ss_pred cCCCcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 418 (646)
++|++.+.||+|+||+||++++ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 3688999999987776777889999999999999999999999874 45678
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999997532 24899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------CCccHHHHHHHHh
Q 006402 499 KPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDP--------DDVNLAIYVSQRA 568 (646)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~--------~~~~~~~~~~~~~ 568 (646)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 544332 223345888999999999888999999999999999999999998532110 0000001111111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEK 633 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~ 633 (646)
..+.... . .....+.+.+|+.+||+.+|++|||+.|+++.|+.+........
T Consensus 258 ~~~~~~~-----~--------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 258 EEGQRLP-----A--------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HTTCCCC-----C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred hcccCCC-----C--------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 1111000 0 01123457799999999999999999999999999977665444
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.93 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=201.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56889999999999999999876 58899999986432 234678899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.. .....||+.|+|||++.. ..++.++||||||+++|||++|+.||................. ..... .
T Consensus 169 ~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~----p 240 (384)
T 4fr4_A 169 TQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTY----P 240 (384)
T ss_dssp CC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCC----C
T ss_pred Cc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCC----C
Confidence 32 234559999999999864 4589999999999999999999999974433221111111111 00000 0
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-MTDVVH 620 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-~~evl~ 620 (646)
. .....+.+|+.+||+.+|.+||+ +.++.+
T Consensus 241 ~------------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 S------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp T------------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred C------------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 11244678999999999999999 666653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.83 Aligned_cols=265 Identities=21% Similarity=0.285 Sum_probs=199.1
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||+||+|+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999988899999999865432 2346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++ +|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 899888653 245899999999999999999999999 99999999999999999999999999986643222
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---cccc----
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---AIME---- 575 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 575 (646)
. .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+....... ....
T Consensus 156 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhcc
Confidence 1 2233589999999998654 5899999999999999999999998643211 1111111111110 0000
Q ss_pred -cccccccCCc---hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 -VVDPRLQGHE---ASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 -~~d~~l~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..++...... .........+.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111110000 00000112345678999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=353.63 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=198.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (646)
.++|++.++||+|+||+||+++.+ +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999876 6899999998753 223456788999999998 69999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999753 35899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .... +..
T Consensus 176 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~~--~p~ 245 (353)
T 3txo_A 176 CNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN-DEVV--YPT 245 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCCC--CCT
T ss_pred cCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHc-CCCC--CCC
Confidence 3222 22334599999999999988899999999999999999999999963321 111111111 1100 010
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSM------TDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~------~evl~ 620 (646)
. ....+.+|+.+||+.+|++||++ .|+++
T Consensus 246 ~------------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 W------------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp T------------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C------------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 12346689999999999999998 66664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=342.77 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=205.0
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe---------
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--------- 413 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 413 (646)
...+|++.+.||+|+||.||+|+.. +++.||+|+++... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467899999999999999999886 79999999987543 356789999999999999999998864
Q ss_pred -------CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 006402 414 -------AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN 486 (646)
Q Consensus 414 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~ 486 (646)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999999754 2346899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHH
Q 006402 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 566 (646)
+||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+... .. ...
T Consensus 161 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~-~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK-FFT 229 (284)
T ss_dssp EEECCCTTCEESSCCSCC--CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-HHH
T ss_pred EEECcchhheeccccccc--cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-HHH
Confidence 999999999877544322 2345899999999999888999999999999999999998876311 11 111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
.......... ....+.+++.+||+.||++|||+.|+++.|+.+.+...+.
T Consensus 230 ~~~~~~~~~~----------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 230 DLRDGIISDI----------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHTTCCCTT----------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred Hhhccccccc----------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 1111111111 1233568999999999999999999999999887665554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=356.99 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=202.8
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
..++|++.+.||+|+||+||++... +|+.+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999765 789999999875432 3456789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeecCCCcc
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~DfGl~~~ 497 (646)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998753 35899999999999999999999999 99999999999998 567899999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ...+.. ....+.. ...
T Consensus 163 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~----~i~~~~~-~~~ 233 (444)
T 3soa_A 163 VEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQ----QIKAGAY-DFP 233 (444)
T ss_dssp CCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH----HHHHTCC-CCC
T ss_pred ecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHH----HHHhCCC-CCC
Confidence 6544322 233569999999999998899999999999999999999999986321 111111 1111111 000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+... .....+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~---------~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEWD---------TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccc---------cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11110 12245678999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=364.99 Aligned_cols=263 Identities=21% Similarity=0.221 Sum_probs=207.1
Q ss_pred ccHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeE
Q 006402 336 FHLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCC 411 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 411 (646)
+.+++++...++|++.++||+|+||+||+++.+ +|+.||||+++... ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566666789999999999999999999886 69999999986432 12234578999999999999999999999
Q ss_pred EeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 412 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
.+.+..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999753 235899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCCccccccCccccccCccccc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHH
Q 006402 492 FGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-------NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV 564 (646)
Q Consensus 492 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~ 564 (646)
||+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||...... .....+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i 282 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKI 282 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 9999877654443334456999999999987 356899999999999999999999999633211 111111
Q ss_pred HHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 006402 565 SQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSER---PSMTDVVH 620 (646)
Q Consensus 565 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---Ps~~evl~ 620 (646)
......... +.+. .....++.+|+.+||+ +|.+| |+++|+++
T Consensus 283 ~~~~~~~~~-----p~~~--------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYKEHLSL-----PLVD--------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHHHHCCC-----C------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhcccCcCC-----Cccc--------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 110000000 0000 0122456789999999 99998 68988874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.83 Aligned_cols=246 Identities=28% Similarity=0.382 Sum_probs=196.3
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
.++||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999875 6899999999877666778899999999999999999999999999999999999999999
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE--cCCCCEEEeecCCCccCCCCCCcccc
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL--DDDFNSKVADFGLSRLAKPGLSHVST 507 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll--~~~~~~ki~DfGl~~~~~~~~~~~~~ 507 (646)
.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++........ .
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--~ 246 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--K 246 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--C
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--c
Confidence 9988653 235899999999999999999999999 9999999999999 56789999999999877544322 2
Q ss_pred ccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchh
Q 006402 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587 (646)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 587 (646)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ......... ...+...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~---~~~i~~~~~--~~~~~~~------ 312 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ET---LNNILACRW--DLEDEEF------ 312 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHHTCC--CSCSGGG------
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhccC--CCChhhh------
Confidence 345999999999999888999999999999999999999998633211 11 111111100 0000000
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 588 ~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......+.+|+.+||+.+|.+|||+.|+++
T Consensus 313 ---~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 ---QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112345778999999999999999999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=341.81 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=194.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.++||+|+||+||+|+.. ..||+|+++... ....+.+.+|+.++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 359999987543 34467899999999999999999999964 5567899999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999999654 345899999999999999999999999 9999999999999999999999999998654321
Q ss_pred -CccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 503 -SHVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 503 -~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ .+.. ....+.....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----HhcccccCcchh
Confidence 12223345899999999986 5678899999999999999999999996432211 1111 111111111110
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
. +. ....+.+.+|+.+||+.+|++|||+.|+++.|+++.
T Consensus 249 ~-~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 K-VR--------SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp S-SC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-cc--------ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 00 012345778999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.80 Aligned_cols=263 Identities=31% Similarity=0.473 Sum_probs=204.5
Q ss_pred cCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEe-CCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-AEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 419 (646)
.+|.+.++||+|+||+||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457888999999999999998642 2368999887543 3446789999999999999999999998654 557899
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999999753 345899999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCC---ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 500 PGLS---HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 500 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... ........ +.. .
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~----~~~-~- 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ----GRR-L- 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHT----TCC-C-
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhc----CCC-C-
Confidence 4321 11233457889999999998899999999999999999999555433222221 11111111 110 0
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
..+. .....+.+++.+||+.+|++|||+.|+++.|+++...+..+
T Consensus 252 ~~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 252 LQPE-----------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp CCCT-----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CCCc-----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 0000 01234678999999999999999999999999998866543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.81 Aligned_cols=244 Identities=26% Similarity=0.290 Sum_probs=193.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999886 799999998765432 3344566666666665 8999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 77999988654 345999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. .....||+.|+|||++.+ .++.++||||||+++|||++|..|+.... . ......+.... .+
T Consensus 211 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~--~~~~~~~~~~~----~~ 273 (311)
T 3p1a_A 211 GA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------G--WQQLRQGYLPP----EF 273 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------H--HHHHTTTCCCH----HH
T ss_pred CC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------H--HHHHhccCCCc----cc
Confidence 22 233459999999999876 78999999999999999999977654210 0 11111111111 11
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+|+.+||+.+|++|||+.|+++
T Consensus 274 --------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 --------TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112355779999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.57 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=199.7
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999987 478999999986431 123457889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+ +|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 78999988643 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
... ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ..... ...
T Consensus 162 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~------~~~ 226 (336)
T 3h4j_B 162 NFL--KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSC------VYV 226 (336)
T ss_dssp BTT--CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSS------CCC
T ss_pred ccc--ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcC------CCC
Confidence 322 23459999999999988765 789999999999999999999997433221110 00000 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.. .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 227 ~p~--------~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 MPD--------FLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCT--------TSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred Ccc--------cCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 112346789999999999999999999853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.27 Aligned_cols=268 Identities=15% Similarity=0.201 Sum_probs=207.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEcC---------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccc---------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQD---------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR--------- 406 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 406 (646)
.++|.+.+.||+|+||+||+|+... ++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999998763 789999998644 46789999999999999998
Q ss_pred ------cceeEEe-CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 006402 407 ------LLGCCVE-AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNI 479 (646)
Q Consensus 407 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NI 479 (646)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667766 66789999999 99999999754 2346999999999999999999999999 99999999999
Q ss_pred EEcCCC--CEEEeecCCCccCCCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006402 480 LLDDDF--NSKVADFGLSRLAKPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDF 551 (646)
Q Consensus 480 ll~~~~--~~ki~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~ 551 (646)
|++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876532211 11234699999999999998999999999999999999999999975
Q ss_pred CCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 552 SRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
...... .+......... ......+...... .....+.+|+.+||+.+|++|||+.|+++.|+++.+....
T Consensus 271 ~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVD--KPGPFVGPCGHWI-------RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GTTCHH-HHHHHHHHHHH--SCCCEECTTSCEE-------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCcCHH-HHHHHHHhccC--ChhhhhhhccccC-------CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 432211 11111111111 1111111111000 1124577899999999999999999999999999877654
Q ss_pred c
Q 006402 632 E 632 (646)
Q Consensus 632 ~ 632 (646)
.
T Consensus 341 ~ 341 (352)
T 2jii_A 341 S 341 (352)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.20 Aligned_cols=267 Identities=24% Similarity=0.368 Sum_probs=211.7
Q ss_pred cCCCcccEecccCcEEEEEEEE-----cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC--cCe
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-----QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE--QPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 418 (646)
++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5688889999999999999984 368999999998776667788999999999999999999999987654 789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999754 235899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CCCccHHHHHHHH
Q 006402 499 KPGLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRD---------PDDVNLAIYVSQR 567 (646)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~---------~~~~~~~~~~~~~ 567 (646)
....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... .............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 6543321 2234477889999999888899999999999999999999988753210 0000001111111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
........ .. ......+.+++.+||+.+|++|||+.|+++.|+++++.+.
T Consensus 276 ~~~~~~~~-----~~--------~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 276 LKNNGRLP-----RP--------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHTTCCCC-----CC--------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhcCCCCC-----CC--------CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11110000 00 0123457789999999999999999999999999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.16 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=211.5
Q ss_pred cCCCccc-EecccCcEEEEEEEEc---CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKER-ILGSGGFGEVYKGELQ---DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|.+.+ .||+|+||+||+|... ++..||||+++... ....+.+.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999754 57889999997653 34567899999999999999999999998 55678999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999999753 345899999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+.... +
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~~~~-~ 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRME-C 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCCC-C
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCCcCC-C
Confidence 43321 223346899999999988889999999999999999999 99998643221 11111 11111110 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKV 634 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~ 634 (646)
++ .....+.+++.+||+.+|++|||+.|+++.|+++.........
T Consensus 235 ~~------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 235 PP------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp CT------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CC------------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 11 1224577899999999999999999999999999888776543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=342.34 Aligned_cols=266 Identities=20% Similarity=0.281 Sum_probs=199.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.++||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999876 689999999875432 335778999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 555555432 345899999999999999999999999 9999999999999999999999999998765332
Q ss_pred CccccccCccccccCccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---cccccc-
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---AIMEVV- 577 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 577 (646)
.. .....||+.|+|||.+.+.. ++.++||||||+++|||++|..|+....... .....+....... ......
T Consensus 156 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred cc-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcc
Confidence 22 23345899999999987765 7999999999999999999998865332211 1111111111110 000000
Q ss_pred --cc---cc-c-CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 --DP---RL-Q-GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 --d~---~l-~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+. .. . ..............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00 0 00000000112345678999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.31 Aligned_cols=271 Identities=25% Similarity=0.401 Sum_probs=215.1
Q ss_pred cccHHHHHHHhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCccccc
Q 006402 335 IFHLKELKKATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRL 407 (646)
Q Consensus 335 ~~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 407 (646)
.+..+++....++|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3455566667788999999999999999999764 367899999875432 345678999999999999999999
Q ss_pred ceeEEeCCcCeEEEEEccCCCccccccCCc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 006402 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKY-------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNIL 480 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIl 480 (646)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999999999999999999999999997532 1245799999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCc
Q 006402 481 LDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDV 558 (646)
Q Consensus 481 l~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~ 558 (646)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 246 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---- 246 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----
Confidence 999999999999999865432221 1223346889999999998899999999999999999999 7888753211
Q ss_pred cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
... ......+..... . ......+.+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 247 --~~~-~~~~~~~~~~~~-----~--------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 --EQV-LRFVMEGGLLDK-----P--------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp --HHH-HHHHHTTCCCCC-----C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred --HHH-HHHHHcCCcCCC-----C--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111 111111111110 0 01224467899999999999999999999999887543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.56 Aligned_cols=244 Identities=27% Similarity=0.361 Sum_probs=201.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+++.+ +|+.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999876 68999999986532 234677889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... ... .+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~------~~ 222 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-AEL------RF 222 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-CCC------CC
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC------CC
Confidence 2234599999999999998999999999999999999999999863211 111111111 110 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
.. .....+.+++.+||+.+|++|| +++|+++
T Consensus 223 p~--------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PP--------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CT--------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 0123467899999999999999 8888874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.29 Aligned_cols=266 Identities=23% Similarity=0.350 Sum_probs=202.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|++.+.||+|+||.||+|... +++.||+|+++.. +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999874 7899999998753 234467789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 421 YEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986422 2345899999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... .............
T Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 188 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEQCDYPPLPS- 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHH-HHHHTTCSCCCCT-
T ss_pred CCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHH-HHhhcccCCCCcc-
Confidence 43221 2234589999999999988999999999999999999999999863321 111111 1111111111100
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
. .....+.+++.+||+.||++|||+.||++.|+++......
T Consensus 261 ----~-------~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 261 ----D-------HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ----T-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----c-------ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0 1223567899999999999999999999999999876644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=345.40 Aligned_cols=271 Identities=24% Similarity=0.362 Sum_probs=210.8
Q ss_pred HHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhh--CCCCcccccceeEEeCC
Q 006402 338 LKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQ--VNHKNLVRLLGCCVEAE 415 (646)
Q Consensus 338 ~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 415 (646)
+..-....++|.+.+.||+|+||+||+|+. +++.||||++.. ...+.+.+|.+++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445667899999999999999999988 589999999864 345678889999888 78999999999998876
Q ss_pred ----cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCEEEcC
Q 006402 416 ----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH--------SAAYTPIYHRDVKSTNILLDD 483 (646)
Q Consensus 416 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~i~H~Dik~~NIll~~ 483 (646)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 789999999999999999643 4899999999999999999999 777 999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCCc---cccccCccccccCccccccC------CCCchhhHHHHHHHHHHHHcC---------
Q 006402 484 DFNSKVADFGLSRLAKPGLSH---VSTCAQGTLGYLDPEYYRNY------QLTDKSDVYSYGVVLLELLTS--------- 545 (646)
Q Consensus 484 ~~~~ki~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~ll~elltg--------- 545 (646)
++.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876543322 12334589999999998765 234789999999999999999
Q ss_pred -CCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 546 -QKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 546 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
+.||....... ........ ..........+..... .....+.+.+|+.+||+.+|++|||+.||++.|++
T Consensus 263 ~~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 263 YQLPYYDLVPSD-PSVEEMRK-VVCEQKLRPNIPNRWQ-------SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCTTTTTSCSS-CCHHHHHH-HHTTSCCCCCCCGGGG-------TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCccccCcCc-ccHHHHHH-HHHHHHhCCCCccccc-------chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 66765332221 11222111 1111111111111111 22455678899999999999999999999999999
Q ss_pred HHHH
Q 006402 625 IIEI 628 (646)
Q Consensus 625 ~~~~ 628 (646)
+.+.
T Consensus 334 i~~~ 337 (342)
T 1b6c_B 334 LSQQ 337 (342)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 8764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.83 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=188.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
..++|++.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4577999999999999999999886 58899999987542 44678899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl~~~~~ 499 (646)
|+++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999753 35899999999999999999999999 999999999999975 8899999999998765
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ ....+
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~-~~~~~ 273 (349)
T 2w4o_A 203 HQVL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEY-YFISP 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCC-CCCTT
T ss_pred cccc--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCC-ccCCc
Confidence 4321 22345899999999999889999999999999999999999998633221 111111111111 00111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. ......+.+|+.+||+.||++|||+.|+++
T Consensus 274 ~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 WW---------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TT---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hh---------hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 012245678999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.35 Aligned_cols=263 Identities=30% Similarity=0.485 Sum_probs=198.9
Q ss_pred CCCcccEecccCcEEEEEEEEc--CC--cEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEe-CCcCeEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ--DG--TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE-AEQPLLI 420 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 420 (646)
.|...++||+|+||+||+|++. ++ ..||+|.++.. +....+.|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999764 22 46899988653 33456789999999999999999999998765 4578999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.++++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999754 335889999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCc---cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 501 GLSH---VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 501 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+. .+...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~----~~~~~-- 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL----QGRRL-- 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHH----TTCCC--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHH----cCCCC--
Confidence 3211 1233457889999999999899999999999999999999 56666533222 1222111 11100
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKV 634 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~ 634 (646)
..+. .....+.+++.+||+.+|++|||+.|+++.|+++...+..+..
T Consensus 316 ~~p~-----------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 316 LQPE-----------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp CCCT-----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred CCCC-----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 0110 1123467899999999999999999999999999988776543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=346.10 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=198.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.+.||+|+||+||+++.+ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999876 58999999987542 23456788999999988 899999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999743 35899999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCc--cHHHHHHHHhcCCccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV--NLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d 578 (646)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...............
T Consensus 163 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 236 (345)
T 3a8x_A 163 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 236 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred CCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence 221 223346999999999999989999999999999999999999999643222111 111111111111110
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.+.. .....+.+|+.+||+.||.+||++
T Consensus 237 -~~p~--------~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -RIPR--------SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCCT--------TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCC--------CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0110 112346789999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.42 Aligned_cols=204 Identities=19% Similarity=0.253 Sum_probs=176.6
Q ss_pred hcCCCcccEeccc--CcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSG--GFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.++|++.++||+| +||+||+++.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3679999999999 99999999886 69999999987543 3345678899999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999997542 345899999999999999999999999 9999999999999999999999999886542
Q ss_pred CCCC------ccccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 500 PGLS------HVSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 500 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 2111 11122358999999999987 57899999999999999999999999743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.01 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=199.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ- 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 416 (646)
..++|.+.+.||+|+||+||+|+.. .++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567888999999999999999764 34589999987543 3345779999999999999999999999987653
Q ss_pred ----CeEEEEEccCCCccccccCCc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 417 ----PLLIYEYIANGTLHDHLHGKY---SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 417 ----~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
.++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 489999999999999984321 3346999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHH
Q 006402 490 ADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 490 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .......
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~-- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYLL-- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHH--
Confidence 99999987654322 12233457889999999999899999999999999999999 88888643221 1111111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
.+.... ... .....+.+++.+||+.+|.+|||+.++++.|+++.+.+.
T Consensus 264 --~~~~~~-----~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 264 --HGHRLK-----QPE--------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --TTCCCC-----CBT--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --cCCCCC-----CCc--------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111000 000 122457789999999999999999999999999988764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.30 Aligned_cols=267 Identities=24% Similarity=0.292 Sum_probs=198.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-----ccHHHHHHHHHHHhhCC---CCcccccceeEEeC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-----KSTQQVLNEVGILSQVN---HKNLVRLLGCCVEA 414 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 414 (646)
..++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999864 689999999864321 12345667777777664 99999999999876
Q ss_pred C-----cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 415 E-----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 415 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
. ..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999996 69999997653 334899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 490 ADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
+|||+++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 162 ~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQMAL--TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCCCS--GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred eeCccccccCCCccc--CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhC
Confidence 999999876543322 3345899999999999889999999999999999999999998643221 11111111111
Q ss_pred C---Ccccccc---cccccC---CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 N---GAIMEVV---DPRLQG---HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 ~---~~~~~~~---d~~l~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ....... ...+.. ...........+.+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1 0000000 000000 0000000112345778999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.91 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=200.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcE----EEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTV----VAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
++|++.++||+|+||+||+|... +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57899999999999999999864 4443 577776543 3346788999999999999999999999998764 789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999754 335899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+. .+.... .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~~-~ 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGERLP-Q 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCCC-C
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCCCCC-C
Confidence 43222 2233447889999999999999999999999999999999 99998643222 1111111 111000 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.+ .....+.+++.+||+.+|.+|||+.|+++.|+++......
T Consensus 241 ~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 282 (327)
T 3lzb_A 241 PP------------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282 (327)
T ss_dssp CT------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred Cc------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence 00 1123467899999999999999999999999999865443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=350.30 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=201.3
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
....++|.+.++||+|+||+||+|+.+ +++.||||+++... ....+.+.+|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344578999999999999999999886 68999999987532 23456788999999987 89999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999999743 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+.. ......
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~----~i~~~~---- 234 (345)
T 1xjd_A 167 ENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFH----SIRMDN---- 234 (345)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCC----
T ss_pred hcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHhCC----
Confidence 6543222 22345699999999999998999999999999999999999999963221 11111 111111
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMT-DVV 619 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-evl 619 (646)
+.+.. .....+.+|+.+||+.+|++||++. |++
T Consensus 235 --~~~p~--------~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 --PFYPR--------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CCCCT--------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCCCc--------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00100 0123467899999999999999997 665
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.74 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=196.4
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC---
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP--- 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 417 (646)
.++|++.+.||+|+||+||+++. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999986 4789999999876432 3356789999999999999999999999877655
Q ss_pred -eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 418 -LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 418 -~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
++||||+++++|.++++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999743 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 497 LAKPGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 497 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 76543222 22234589999999999998999999999999999999999999863221 11111111111110
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV-HELQRI 625 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl-~~L~~~ 625 (646)
+... .......+.+|+.+||+.||++||+..+++ +.|.++
T Consensus 239 ----~~~~-------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ----PSAR-------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----HHHH-------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----cccc-------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 011234577899999999999999766554 445444
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.41 Aligned_cols=261 Identities=25% Similarity=0.279 Sum_probs=200.6
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-----CcccHHHHHHHHHHHhhCCCCcccccceeEEe
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-----NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 413 (646)
++....++|.+.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35566788999999999999999999875 6889999988643 33456789999999999999999999999999
Q ss_pred CCcCeEEEEEccCCCccccccCCc-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKY-------------------------------------SSFNLTWSTRLRIALQTAE 456 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~ 456 (646)
.+..++||||+++|+|.+++.... ....+++..++.++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999985210 0112467788899999999
Q ss_pred HHHHHHhCCCCCeeeccCCCCCEEEcCCC--CEEEeecCCCccCCCC---CCccccccCccccccCcccccc--CCCCch
Q 006402 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDF--NSKVADFGLSRLAKPG---LSHVSTCAQGTLGYLDPEYYRN--YQLTDK 529 (646)
Q Consensus 457 ~l~yLH~~~~~~i~H~Dik~~NIll~~~~--~~ki~DfGl~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~k 529 (646)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++..... .........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998766 8999999999865321 1112234569999999999865 578999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCC
Q 006402 530 SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKK 609 (646)
Q Consensus 530 sDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p 609 (646)
+||||||+++|||++|+.||...... ............. ..+. .......+.+|+.+||+.+|
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--ENPN---------YNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--TSGG---------GGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--CCcc---------cccCCHHHHHHHHHHcCCCh
Confidence 99999999999999999998633211 1111111111000 0000 01123457789999999999
Q ss_pred CCCCCHHHHHH
Q 006402 610 SERPSMTDVVH 620 (646)
Q Consensus 610 ~~RPs~~evl~ 620 (646)
.+|||+.|+++
T Consensus 320 ~~Rps~~~~l~ 330 (345)
T 3hko_A 320 DERFDAMRALQ 330 (345)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCCCHHHHhc
Confidence 99999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=360.73 Aligned_cols=262 Identities=23% Similarity=0.253 Sum_probs=195.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
.++|++.++||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999765 6899999998754 3345678899999999999999999999997654
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 45999999975 46666643 3899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC----
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---- 571 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 571 (646)
+...... ..+...||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+.......
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEF 286 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHH
Confidence 8765432 2234569999999999999999999999999999999999999996432111 111111110000
Q ss_pred ---------------------cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 572 ---------------------AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 572 ---------------------~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.....+...+... ...........+.+|+.+||+.||++|||++|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC-SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCccccccc-ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001111111100 111122235668899999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.60 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=204.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
..++|++.+.||+|+||+||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467899999999999999999876 578999999887666677889999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~~~ 499 (646)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999988643 34899999999999999999999999 9999999999999 788999999999998765
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..... ....||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... ... . ....+.... +
T Consensus 161 ~~~~~--~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~-~~~~~~~~~---~ 227 (277)
T 3f3z_A 161 PGKMM--RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVM---L-KIREGTFTF---P 227 (277)
T ss_dssp TTSCB--CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---H-HHHHCCCCC---C
T ss_pred Cccch--hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHH---H-HHHhCCCCC---C
Confidence 44322 234589999999998764 899999999999999999999998633211 111 1 111111000 0
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..........+.+|+.+||+.+|++|||+.|+++
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 -------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001122345778999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.44 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=193.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|.+.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999876 78999999987543 2346688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--EEEeecCCCccCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN--SKVADFGLSRLAKPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~--~ki~DfGl~~~~~~~ 501 (646)
+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999998643 35899999999999999999999999 999999999999987765 999999999754332
Q ss_pred CCccccccCccccccCccccccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDK-SDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....||+.|+|||++.+..++.+ +||||||+++|||++|+.||......... ......... .... +...
T Consensus 172 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~-~~~~--~~~~ 244 (361)
T 3uc3_A 172 SQ--PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILS-VKYS--IPDD 244 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHT-TCCC--CCTT
T ss_pred CC--CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhc-CCCC--CCCc
Confidence 22 223459999999999988877665 89999999999999999999754433322 111111111 1000 0000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+.+|+.+||+.+|++|||+.|+++.
T Consensus 245 ----------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 ----------IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0112346789999999999999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.86 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=180.9
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEccCCC
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
.+.||+|+||+||++..+ +++.||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999876 689999999864 34567789999999997 9999999999999999999999999999
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CEEEeecCCCccCCCCCCcc
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF---NSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~---~~ki~DfGl~~~~~~~~~~~ 505 (646)
|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 99999753 35899999999999999999999999 99999999999997665 8999999999876543322
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+... ..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~--- 236 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FE--- 236 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CC---
Confidence 223458999999999999899999999999999999999999997544322211122222222222110 00
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
........+.+.+|+.+||+.||++|||+.|+++
T Consensus 237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0001123456779999999999999999999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=369.90 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=202.2
Q ss_pred EecccCcEEEEEEEEc---CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccCCC
Q 006402 353 ILGSGGFGEVYKGELQ---DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 353 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
.||+|+||+||+|.++ ++..||||+++... ....++|.+|+.+|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999775 46679999997653 3457889999999999999999999999876 56899999999999
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc--c
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV--S 506 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~--~ 506 (646)
|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999754 345899999999999999999999999 9999999999999999999999999998765433221 1
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
....+++.|+|||++.+..++.++||||||++||||++ |+.||...... .+. .....+..... .+
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~~~~-p~------ 562 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRMEC-PP------ 562 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH----HHHHTTCCCCC-CT------
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCCCCCC-CC------
Confidence 22346789999999998899999999999999999998 99998743321 111 11111211110 00
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.....+.+|+.+||+.+|++||++.+|++.|+.+...+..
T Consensus 563 ------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 563 ------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ------TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 1234577899999999999999999999999999877644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=346.18 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=189.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|..+ +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999875 689999999875432 345778899999999999999999999999999999999
Q ss_pred EccCCCccccccCCc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKY---SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|++ ++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886432 2235899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Ccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GAIME 575 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 575 (646)
..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+...... .....
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence 33221 223458999999999876 46899999999999999999999999643221 111111111110 00000
Q ss_pred c-----ccccccCC---chhH-----HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 V-----VDPRLQGH---EASV-----NILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~-----~d~~l~~~---~~~~-----~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ..+.+... .... ........+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000000 0000 00012345789999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=339.80 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=204.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc------cHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|.+.+.||+|+||.||+++.. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456889999999999999999876 6899999998754322 367899999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CEEEeecC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF----NSKVADFG 493 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~----~~ki~DfG 493 (646)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999753 35899999999999999999999999 99999999999999887 79999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
+++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ......
T Consensus 165 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~-i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLAN-ITSVSY 235 (321)
T ss_dssp TCEECCTTCCC--CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHH-HHTTCC
T ss_pred cceecCccccc--cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHhccc
Confidence 99876543322 234589999999999988999999999999999999999999863211 111111 111100
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..++.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001100 0112345778999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.01 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=201.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+++.+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999876 68999999986432 234678899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ......+.. .+
T Consensus 195 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~-~~~i~~~~~------~~ 257 (350)
T 1rdq_E 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQI-YEKIVSGKV------RF 257 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCC------CC
T ss_pred c----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHH-HHHHHcCCC------CC
Confidence 2 234589999999999988999999999999999999999999963211 111 111111111 01
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
.. .....+.+|+.+||+.||.+||+ ++|+++
T Consensus 258 p~--------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PS--------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CT--------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 00 11234678999999999999998 788874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=335.65 Aligned_cols=251 Identities=27% Similarity=0.350 Sum_probs=196.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|.+.+.||+|+||+||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888999999999999999875 68999999986543 34568899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCccCC
Q 006402 424 IANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 424 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~~~ 499 (646)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986432 2346899999999999999999999999 9999999999999 456789999999998765
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||..... ................
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~--- 246 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNYAV--- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCCC---
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCccccc---
Confidence 4322 22345899999999986 4689999999999999999999999863221 1111111111100000
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .....+.+.+|+.+||+.||++|||+.|+++
T Consensus 247 --~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0001234668999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=352.56 Aligned_cols=209 Identities=27% Similarity=0.315 Sum_probs=181.1
Q ss_pred ccccHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-----CCccccc
Q 006402 334 RIFHLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-----HKNLVRL 407 (646)
Q Consensus 334 ~~~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 407 (646)
..+++++.....++|.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|+.++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 33455555566789999999999999999999875 6899999998642 344567788999999996 9999999
Q ss_pred ceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC----
Q 006402 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---- 483 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---- 483 (646)
++++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 999999997642 335899999999999999999999999 999999999999975
Q ss_pred ---------------------CCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHH
Q 006402 484 ---------------------DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLEL 542 (646)
Q Consensus 484 ---------------------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~el 542 (646)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7899999999998654322 234589999999999999999999999999999999
Q ss_pred HcCCCCCCCC
Q 006402 543 LTSQKAIDFS 552 (646)
Q Consensus 543 ltg~~p~~~~ 552 (646)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999743
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=340.97 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=198.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC-CcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-EQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+++.+ |+.||||+++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 367889999999999999999874 889999998754 3567899999999999999999999997655 478999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999999997542 223789999999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ....
T Consensus 173 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~~ 236 (278)
T 1byg_A 173 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGYK-----MDAP 236 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTCC-----CCCC
T ss_pred ----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCCC-----CCCc
Confidence 2347889999999998899999999999999999998 99998643221 1111 1111110 0011
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
. .....+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 237 ~--------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 D--------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c--------cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0 1224567899999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.56 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=191.4
Q ss_pred hcCCCcccEecccCcEEEEEEEE----cCCcEEEEEEcccCC----cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL----QDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
.++|++.++||+|+||+||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35789999999999999999987 478999999987542 2345668899999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999743 35889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ..... ... .
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~---~~i~~-~~~--~ 239 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTI---DKILK-CKL--N 239 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHH-TCC--C
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHh-CCC--C
Confidence 6433221 12234589999999999988899999999999999999999999963221 1111 11111 100 0
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
+.+ .....+.+|+.+||+.+|++|| ++.|+++
T Consensus 240 ~p~------------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 LPP------------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCT------------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCC------------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011 1123467899999999999999 7778765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.41 Aligned_cols=266 Identities=18% Similarity=0.190 Sum_probs=199.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCCcc-----------cHHHHHHHHHHHhhCCCCcccccce
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGNIK-----------STQQVLNEVGILSQVNHKNLVRLLG 409 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 409 (646)
.++|.+.+.||+|+||+||+|... ++..+|+|+....... ..+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 5788999998755322 1234678899999999999999999
Q ss_pred eEEe----CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 006402 410 CCVE----AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF 485 (646)
Q Consensus 410 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~ 485 (646)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999997542 6899999999999999999999999 99999999999999877
Q ss_pred --CEEEeecCCCccCCCCCC------ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 006402 486 --NSKVADFGLSRLAKPGLS------HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557 (646)
Q Consensus 486 --~~ki~DfGl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~ 557 (646)
.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 999999999987643211 11134469999999999999899999999999999999999999996322211
Q ss_pred ccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 558 VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
............ .....+...... ......+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 268 -~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 -VAVQTAKTNLLD-ELPQSVLKWAPS-------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHHHH-TTTHHHHHHSCT-------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHHHhhcc-cccHHHHhhccc-------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111110 000100000000 0123457799999999999999999999999987644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=345.32 Aligned_cols=263 Identities=27% Similarity=0.382 Sum_probs=194.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEe--------C
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVE--------A 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~ 414 (646)
..+|++.++||+|+||+||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457899999999999999999875 68999999987776667788999999999996 9999999999853 3
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
...++||||+. |+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 34789999995 799998875434456999999999999999999999986 4599999999999999999999999999
Q ss_pred CccCCCCCCcc-----------ccccCccccccCcccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccH
Q 006402 495 SRLAKPGLSHV-----------STCAQGTLGYLDPEYY---RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560 (646)
Q Consensus 495 ~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~ 560 (646)
++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1123489999999998 56678999999999999999999999986322111
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
... .... ..+ ... ....+.+|+.+||+.+|++|||+.|+++.|+.+.......
T Consensus 261 --~~~-----~~~~--~~~--~~~--------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 --IVN-----GKYS--IPP--HDT--------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ------------CC--CCT--TCC--------SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred --hhc-----Cccc--CCc--ccc--------cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 000 0000 000 000 1122568999999999999999999999999998765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.72 Aligned_cols=259 Identities=22% Similarity=0.270 Sum_probs=198.1
Q ss_pred cCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 422 (646)
+.|.+. ++||+|+||+||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 78999999999999765 7899999999876666678899999999995 79999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---EEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN---SKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~---~ki~DfGl~~~~~ 499 (646)
|+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999753 35899999999999999999999999 999999999999997765 9999999987654
Q ss_pred CCCC------ccccccCccccccCcccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccH--------
Q 006402 500 PGLS------HVSTCAQGTLGYLDPEYYRN-----YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL-------- 560 (646)
Q Consensus 500 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~-------- 560 (646)
.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11123458999999999865 4578999999999999999999999975443221100
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..........+.. . + . ..........+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~i~~~~~-~-----~--~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKY-E-----F--P--DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCC-C-----C--C--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCc-c-----c--C--chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011111111110 0 0 0 0000112345779999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=336.42 Aligned_cols=263 Identities=27% Similarity=0.386 Sum_probs=208.1
Q ss_pred hcCCCccc-EecccCcEEEEEEEEc---CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 345 TNGFSKER-ILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 345 ~~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
.++|.+.+ .||+|+||+||+|.+. +++.||||+++.... ...+.+.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999653 468899999875432 2367899999999999999999999998 667789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999753 35899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 499 KPGLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGERMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCCC
Confidence 5543322 122346789999999988889999999999999999999 99998633211 11 11111111111
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKV 634 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~ 634 (646)
... .....+.+++.+||+.+|++|||+.|+++.|+++....-....
T Consensus 241 -----~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 241 -----CPA--------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp -----CCT--------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred -----CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 100 1224577899999999999999999999999999887765543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=349.57 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=204.5
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe----CCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 419 (646)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999987 4789999999877766777889999999999999999999999873 346789
Q ss_pred EEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 420 IYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
||||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997532 2346899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCcc--------ccccCccccccCccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 006402 499 KPGLSHV--------STCAQGTLGYLDPEYYRNYQ---LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 499 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
....... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh---
Confidence 4221110 11234799999999987543 688999999999999999999998532111111 11111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
.... . .... ......+.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 261 -~~~~--~-----~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 -QNQL--S-----IPQS------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -HCC---------CCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -hccC--C-----CCcc------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0000 0 0000 012245778999999999999999999999998874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.38 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=205.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcE--EEEEEcccC-CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTV--VAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.+.||+|+||.||+|+.. ++.. +|+|+++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56889999999999999999765 5664 499988653 233456789999999999 899999999999999999999
Q ss_pred EEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 421 YEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997542 2246899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHH
Q 006402 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 566 (646)
||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ..
T Consensus 182 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~-~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AEL-YE 252 (327)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH-HH
T ss_pred EEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHH-HH
Confidence 9999999875432211 122347889999999988889999999999999999998 9999863321 111 11
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
....+... .... .....+.+|+.+||+.+|.+|||+.|+++.|+++.+...
T Consensus 253 ~~~~~~~~-----~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KLPQGYRL-----EKPL--------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HGGGTCCC-----CCCT--------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HhhcCCCC-----CCCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111100 0000 122457789999999999999999999999999887544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.72 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=202.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999876 5899999998654 3334577889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---EEEeecCCCccC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN---SKVADFGLSRLA 498 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~---~ki~DfGl~~~~ 498 (646)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999988643 35899999999999999999999999 999999999999986555 999999999876
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+ ..+... ...
T Consensus 159 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~----~~~~~~-~~~ 228 (284)
T 3kk8_A 159 NDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQI----KAGAYD-YPS 228 (284)
T ss_dssp CSSCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCCC-CCT
T ss_pred ccCccc--cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHH----Hhcccc-CCc
Confidence 543322 234589999999999998999999999999999999999999863211 1111111 111100 000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.. ......+.+|+.+||+.+|++|||+.|+++
T Consensus 229 ~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTT---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhh---------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 012244678999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=350.65 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=190.9
Q ss_pred cCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhh-CCCCcccccceeEEe----CCcCe
Q 006402 346 NGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQ-VNHKNLVRLLGCCVE----AEQPL 418 (646)
Q Consensus 346 ~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 418 (646)
++|.+. ++||+|+||+||++..+ +++.||||+++. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999876 689999999863 2456788888754 589999999999876 55789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCCC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLS 495 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl~ 495 (646)
+||||+++|+|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999764 2345899999999999999999999999 999999999999997 789999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCcc-HHHHHHHHhcCCccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVN-LAIYVSQRASNGAIM 574 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 574 (646)
+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....+.. +..
T Consensus 212 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~- 284 (400)
T 1nxk_A 212 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY- 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC-
T ss_pred cccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc-
Confidence 87654322 223458999999999998899999999999999999999999997543322111 1111111 110
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....+.. ......+.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~~~~~~~---------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPNPEW---------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCTTTT---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 0123456789999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=363.81 Aligned_cols=253 Identities=26% Similarity=0.331 Sum_probs=205.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|...++||+|+||+||+++.+ +|+.||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456889999999999999999876 69999999986432 23456789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999997642 345899999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... ....||+.|+|||++.+..++.++||||||+++|||++|+.||........... +........ ..
T Consensus 339 ~~~~--~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~~------~~ 407 (576)
T 2acx_A 339 GQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVP------EE 407 (576)
T ss_dssp TCCE--ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHCC------CC
T ss_pred Cccc--cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhccc------cc
Confidence 4322 234699999999999988899999999999999999999999975432211111 111111110 00
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
+.. .....+.+|+.+||+.||.+|| ++.|+++
T Consensus 408 ~p~--------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 YSE--------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCT--------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCc--------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 100 1123467899999999999999 7888875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.71 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=194.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCC--CcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNH--KNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 420 (646)
.++|++.+.||+|+||+||++...+++.||||++.... ....+.+.+|+.++.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688999999999999999998889999999987543 3345788999999999986 9999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999999753 35899999999999999999999999 99999999999997 56899999999987754
Q ss_pred CCCc-cccccCccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 501 GLSH-VSTCAQGTLGYLDPEYYRN-----------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 4322 2234569999999999864 6789999999999999999999999863211 111111111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......+ .... ....+.+|+.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~-----~~~~--------~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIE-----FPDI--------PEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCC-----CCCC--------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccC-----Cccc--------CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111000 0000 11346689999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.98 Aligned_cols=248 Identities=23% Similarity=0.279 Sum_probs=192.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|++.++||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999875 6899999998653 334456788999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999643 358999999999999999999998 88 9999999999999999999999999998644
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... ......||+.|+|||++.+..++.++||||||++||||++|+.||..... ..+...+. ....... .
T Consensus 301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~--~~~~~~p----~ 370 (446)
T 4ejn_A 301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELIL--MEEIRFP----R 370 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH--HCCCCCC----T
T ss_pred CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHH--hCCCCCC----c
Confidence 3322 22335699999999999999999999999999999999999999963221 11111111 1111110 0
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
. ....+.+|+.+||+.||.+|| |++|+++
T Consensus 371 ~------------~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 371 T------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp T------------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred c------------CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 123467899999999999999 9999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=345.23 Aligned_cols=248 Identities=22% Similarity=0.286 Sum_probs=200.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (646)
.++|++.++||+|+||+||+++.+ +++.||||+++... ....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999886 47899999987532 23467788999999988 79999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999743 35899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+. ..... .... +..
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~---~~i~~-~~~~--~p~ 242 (353)
T 2i0e_A 173 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF---QSIME-HNVA--YPK 242 (353)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHH-CCCC--CCT
T ss_pred cCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHH---HHHHh-CCCC--CCC
Confidence 3221 22334699999999999988999999999999999999999999963211 1111 11111 1100 011
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
.....+.+|+.+||+.+|++||+ +.|+++
T Consensus 243 ------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 ------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11234678999999999999996 466653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=356.71 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=202.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999876 79999999986432 233567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999877543
Q ss_pred CCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..+. .....+... .+.
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~----~~i~~~~~~---~p~ 237 (476)
T 2y94_A 170 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLF----KKICDGIFY---TPQ 237 (476)
T ss_dssp CC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHH----HHHHTTCCC---CCT
T ss_pred cc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHH----HHHhcCCcC---CCc
Confidence 32 223459999999999988765 6899999999999999999999963321 1111 111111110 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+|+.+||+.||++|||+.|+++
T Consensus 238 -----------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 238 -----------YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01234678999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=339.31 Aligned_cols=266 Identities=25% Similarity=0.323 Sum_probs=198.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367899999999999999999876 589999998865432 23567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999987643 35899999999999999999999999 999999999999999999999999999876533
Q ss_pred CCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC----------
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---------- 570 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 570 (646)
... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+......
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHH
T ss_pred ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhcccccccccccc
Confidence 222 223458999999999875 57899999999999999999999998643322111 111111100
Q ss_pred -Cccc---ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 571 -GAIM---EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 571 -~~~~---~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.... ...++.-. .............+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDM-EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSC-CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCcccc-chhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000000 00000001223457789999999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.54 Aligned_cols=243 Identities=25% Similarity=0.339 Sum_probs=200.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--------ccHHHHHHHHHHHhhCCCCcccccceeEEeC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA 414 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 414 (646)
..++|++.+.||+|+||+||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4568999999999999999999865 689999999875432 1334677899999999999999999999999
Q ss_pred CcCeEEEEEccCC-CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 415 EQPLLIYEYIANG-TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 415 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
+..++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 999998753 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
+++........ ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 176 SAAYLERGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp TCEECCTTCCB--CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred cceECCCCCce--eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 99877654332 23458999999999988776 78999999999999999999998631110
Q ss_pred ccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 573 ~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
......... .....+.+|+.+||+.+|++|||+.|+++.
T Consensus 237 ----~~~~~~~~~------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VEAAIHPPY------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTTCCCCSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HhhccCCCc------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 012346789999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.04 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=192.3
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--------ccHHHHHHHHHHHhhCCCCcccccceeEEe
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--------KSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 413 (646)
...++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 35678999999999999999999775 689999999865321 12235789999999999999999999975
Q ss_pred CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCEEEe
Q 006402 414 AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD---FNSKVA 490 (646)
Q Consensus 414 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~---~~~ki~ 490 (646)
.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 44579999999999999998753 35899999999999999999999999 9999999999999754 459999
Q ss_pred ecCCCccCCCCCCccccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 006402 491 DFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 491 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+...+.
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~-- 358 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT-- 358 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH--
T ss_pred ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh--
Confidence 999998765432 2233459999999999853 568889999999999999999999997433222 1221111
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+... .. +. ........+.+|+.+||+.||++|||+.|+++
T Consensus 359 --~~~~~-~~-~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 --SGKYN-FI-PE--------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --TTCCC-CC-HH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --cCCCC-CC-ch--------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11100 00 00 01112345779999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.47 Aligned_cols=245 Identities=29% Similarity=0.414 Sum_probs=197.3
Q ss_pred cCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
+.|+..+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 4789999999875432 23467899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+. |+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9996 6888877542 346899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
. ...||+.|+|||++. ...++.++||||||+++|||++|+.||..... ........... .
T Consensus 208 ~-----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~-~----- 270 (348)
T 1u5q_A 208 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-S----- 270 (348)
T ss_dssp C-----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-C-----
T ss_pred C-----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-C-----
Confidence 2 235899999999984 56789999999999999999999999863221 11111111111 1
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.+... .....+.+|+.+||+.+|++|||+.++++
T Consensus 271 ~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 PALQSG-------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC-------CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111 11234678999999999999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.53 Aligned_cols=202 Identities=31% Similarity=0.434 Sum_probs=163.8
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCC-CCcccccceeEEeCC--c
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAE--Q 416 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 416 (646)
...++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999875 6899999988543 3345677889999999997 999999999998654 6
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 6899988643 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCC--------------------CccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 497 LAKPGL--------------------SHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 497 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
...... ....+...||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 653211 111233469999999999876 57899999999999999999999999743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.37 Aligned_cols=250 Identities=25% Similarity=0.309 Sum_probs=200.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc------ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.+.||+|+||+||+++.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999886 689999998865422 23678999999999999999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CEEEeecCC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF----NSKVADFGL 494 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~----~~ki~DfGl 494 (646)
+||||+++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999643 35899999999999999999999999 99999999999998876 899999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+......... ....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ..........
T Consensus 159 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~ 229 (283)
T 3bhy_A 159 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QET-LTNISAVNYD 229 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHTTCCC
T ss_pred ceeccCCCcc--cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHH-HHHhHhcccC
Confidence 9876543222 234589999999999988999999999999999999999999863221 111 1111111000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+... .......+.+++.+||+.+|++|||+.|+++
T Consensus 230 --~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 --FDEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCHHH--------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --Ccchh--------cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000 1112345778999999999999999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=333.64 Aligned_cols=247 Identities=29% Similarity=0.381 Sum_probs=198.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467889999999999999999776 57899999985432 22356789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998643 35899999999999999999999999 99999999999999999999999999865543
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ..... ..
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~------~~ 225 (279)
T 3fdn_A 162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKR-ISRVE------FT 225 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH-HHHTC------CC
T ss_pred cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHH-HHhCC------CC
Confidence 32 2234589999999999988899999999999999999999999863211 111111 11000 00
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.. .....+.+|+.+||+.+|++|||+.|+++.
T Consensus 226 ~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 FPD--------FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCT--------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCC--------cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 012346689999999999999999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=347.78 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=194.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCccc-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKS-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|.+.+.||+|+||+||+|+.. +++.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999876 78999999986543222 22456899999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 96 5898888754 335899999999999999999999999 99999999999999999999999999986543322
Q ss_pred ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Cccccccc-
Q 006402 504 HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GAIMEVVD- 578 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d- 578 (646)
. .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+...... ........
T Consensus 156 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 T-YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred c-cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcc
Confidence 2 223458999999999876 568999999999999999999999997432211 11111111111 11111100
Q ss_pred --------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 --------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 --------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.................+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000001112345779999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=341.22 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=206.3
Q ss_pred hcCCCcccEecccCcEEEEEEEE------cCCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|.+.+.||+|+||+||+|++ .+++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999974 25778999998644 334567899999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEe
Q 006402 418 LLIYEYIANGTLHDHLHGKYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVA 490 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~ 490 (646)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975431 135899999999999999999999999 99999999999998 44569999
Q ss_pred ecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHh
Q 006402 491 DFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 491 DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL----EFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH----HHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHH----HHH
Confidence 9999875432221 12233457899999999988899999999999999999998 8888863221 1111 111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
..+.... ... .....+.+++.+||+.+|.+|||+.|+++.|+.+....+..
T Consensus 259 ~~~~~~~-~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 259 TSGGRMD-PPK------------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp HTTCCCC-CCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred hcCCCCC-CCC------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 1111100 000 11234678999999999999999999999999987755544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.37 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=199.0
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
+|....+||+|+||+||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555679999999999999865 688999999987766667889999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCCCccCCCCCCc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl~~~~~~~~~~ 504 (646)
+++|.+++........+++..+..++.|++.||+|||+.+ |+|+||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999976544456789999999999999999999999 999999999999987 89999999999987653321
Q ss_pred cccccCccccccCccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
......|++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ........... ..+.+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~-------~~~~~~ 248 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFK-------VHPEIP 248 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHHC-------CCCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhcccc-------cccccc
Confidence 12234589999999998764 3889999999999999999999998632211 11111110000 011111
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .....+.+++.+||+.+|++|||+.|+++
T Consensus 249 ~--------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 E--------SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp T--------TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c--------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11234678999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=347.35 Aligned_cols=259 Identities=15% Similarity=0.193 Sum_probs=207.4
Q ss_pred HHHHhcCCCcccEecccCcEEEEEEE------EcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC---CCcccccceeE
Q 006402 341 LKKATNGFSKERILGSGGFGEVYKGE------LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN---HKNLVRLLGCC 411 (646)
Q Consensus 341 l~~~~~~~~~~~~Lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 411 (646)
+....++|.+.++||+|+||+||+|. ..+++.||||+++.. ...++.+|+.++.+++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 33445779999999999999999993 446889999998754 3556778888888886 99999999999
Q ss_pred EeCCcCeEEEEEccCCCccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC------
Q 006402 412 VEAEQPLLIYEYIANGTLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD------ 483 (646)
Q Consensus 412 ~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~------ 483 (646)
...+..++||||+++|+|.++++... ....+++..++.|+.||++||+|||+.+ |+||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999997422 2346999999999999999999999999 999999999999998
Q ss_pred -----CCCEEEeecCCCccCCCC-CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 006402 484 -----DFNSKVADFGLSRLAKPG-LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557 (646)
Q Consensus 484 -----~~~~ki~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~ 557 (646)
++.+||+|||+++..... .........||+.|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 899999999999765321 22233445699999999999998999999999999999999999999853322100
Q ss_pred ccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHh
Q 006402 558 VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSER-PSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R-Ps~~evl~~L~~~~~~~~ 630 (646)
. +...+.... ..+.+.+++..|++.+|.+| |+++++.+.|+++.+...
T Consensus 294 --------------~----~~~~~~~~~-------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 --------------K----PEGLFRRLP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp --------------E----ECSCCTTCS-------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred --------------e----echhccccC-------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 111111110 12345679999999999999 779999999988877643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=333.98 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=182.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357889999999999999999874 78999999986432 12357789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999999753 246899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .... .. +..
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~---~~---~~~ 230 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVV---LA---DYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC---SS---CCC
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHh---hc---ccC
Confidence 3221 12345899999999999888999999999999999999999998744322110 0000 00 001
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.. .....+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPS--------FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCT--------TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccc--------ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 110 11234678999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=349.25 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=195.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCC--CCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVN--HKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 421 (646)
.+|++.+.||+|+||+||++...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4589999999999999999998889999999986543 345678999999999996 599999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
| +.+++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 5689999999754 35899999999999999999999999 99999999999996 479999999999877544
Q ss_pred CCc-cccccCccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 502 LSH-VSTCAQGTLGYLDPEYYRN-----------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 502 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ..........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~ 282 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhC
Confidence 322 2234569999999999865 3688999999999999999999999963221 1111111111
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
...... .... ....+.+|+.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~-----~~~~--------~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEIE-----FPDI--------PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCCC-----CCCC--------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCC-----CCcc--------chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 110000 0000 12346789999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.37 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCC-CCcccccceeEE
Q 006402 338 LKELKKATNGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVN-HKNLVRLLGCCV 412 (646)
Q Consensus 338 ~~el~~~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 412 (646)
+.......+.|.+. +.||+|+||+||++... +++.||+|+++.. .......+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556677776 88999999999999876 6899999988653 2344678999999999995 699999999999
Q ss_pred eCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEE
Q 006402 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKV 489 (646)
Q Consensus 413 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki 489 (646)
+.+..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998654 2346899999999999999999999999 999999999999987 789999
Q ss_pred eecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc
Q 006402 490 ADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS 569 (646)
Q Consensus 490 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 569 (646)
+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. .
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~-~- 248 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQ-V- 248 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH-T-
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHh-c-
Confidence 99999987654322 22345999999999999889999999999999999999999998633211 11111111 0
Q ss_pred CCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 570 NGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 570 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
...... +.. ....+.+.+|+.+||+.+|++|||++|+++.
T Consensus 249 ~~~~~~---~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSE---ETF---------SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCT---TTT---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCc---hhh---------cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 000 1123446789999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.34 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=200.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|.+.+.||+|+||+||+++.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457889999999999999999876 6899999999866555567789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCccCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~~~~ 500 (646)
+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998643 35899999999999999999999999 9999999999999 7889999999999976543
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.. ....+.. .. +..
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~----~i~~~~~-~~-~~~ 229 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFE----KIKEGYY-EF-ESP 229 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHCCC-CC-CTT
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCCC-CC-Ccc
Confidence 22 2223489999999999998999999999999999999999999863221 11111 1111110 00 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. ......+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FW--------DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TT--------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 012245678999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=368.25 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=199.4
Q ss_pred cEecccCcEEEEEEEEc---CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQ---DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
+.||+|+||+||+|.+. .++.||||+++... ....+++.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46789999987543 334688999999999999999999999986 4568899999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc--
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH-- 504 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~-- 504 (646)
|+|.++++.. ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999643 35899999999999999999999999 999999999999999999999999999876543322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
......+|+.|+|||++.+..++.++||||||++||||++ |+.||...... . +......+..... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~----~~~~i~~~~~~~~-----p~ 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMGC-----PA 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCCC-----CT
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCCC-----CC
Confidence 2233447889999999999899999999999999999998 99998633221 1 1111211111110 00
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
...+.+.+|+.+||+.+|++|||+.+|++.|+++...+
T Consensus 596 --------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 --------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp --------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 12345778999999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.65 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=202.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457889999999999999999876 68999999986443 3446788999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999743 35899999999999999999999999 9999999999999999999999999998654322
Q ss_pred C-ccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 503 S-HVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 503 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+. .... ...+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----~~~~--~~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK-----EKKT--YLNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH-----TTCT--TSTT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh-----hccc--ccCc-
Confidence 1 12233458999999999987665 779999999999999999999997543221 1111111 1100 0000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 W---------KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp G---------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h---------hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 012234668999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.38 Aligned_cols=252 Identities=15% Similarity=0.177 Sum_probs=194.4
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccC---CcccHHHHHHHH---HHHhhCCCCcccccc-------ee
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVG---NIKSTQQVLNEV---GILSQVNHKNLVRLL-------GC 410 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 410 (646)
.++|.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 46999999998743 334567899999 555566899999999 55
Q ss_pred EEeCC-----------------cCeEEEEEccCCCccccccCCcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006402 411 CVEAE-----------------QPLLIYEYIANGTLHDHLHGKYS----SFNLTWSTRLRIALQTAEALAYLHSAAYTPI 469 (646)
Q Consensus 411 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 469 (646)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.|+.||++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 6899999975321 122456888999999999999999999 9
Q ss_pred eeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccC-----------CCCchhhHHHHHHH
Q 006402 470 YHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-----------QLTDKSDVYSYGVV 538 (646)
Q Consensus 470 ~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~s~G~l 538 (646)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2233457 999999999877 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006402 539 LLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618 (646)
Q Consensus 539 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ev 618 (646)
||||++|+.||......... ..+.. ... .....+.+|+.+||+.||++|||+.|+
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~-~~~---------~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFR-SCK---------NIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGS-SCC---------CCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhh-hcc---------CCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999998643222111 00100 000 112446789999999999999999999
Q ss_pred HH--HHHHHHHHHh
Q 006402 619 VH--ELQRIIEIVN 630 (646)
Q Consensus 619 l~--~L~~~~~~~~ 630 (646)
++ .++++.+.+.
T Consensus 358 l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 358 METPEYEQLRTELS 371 (377)
T ss_dssp HTSHHHHHHHHHHH
T ss_pred hhChHHHHHHHHHH
Confidence 96 5666655543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.93 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=201.5
Q ss_pred cCCCcccEecccCcEEEEEEEE----cCCcEEEEEEcccCC----cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCc
Q 006402 346 NGFSKERILGSGGFGEVYKGEL----QDGTVVAVKSAKVGN----IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 416 (646)
++|.+.++||+|+||+||+++. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 368999999986532 22345677899999999 69999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999753 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
..............||+.|+|||++.+ ..++.++||||||++||||++|+.||......... ...........
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC---
Confidence 765443333344569999999999975 35789999999999999999999999744332221 11111111110
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVHE 621 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~~ 621 (646)
+.... .....+.+|+.+||+.||.+|| |++|+++.
T Consensus 283 ----~~~~~--------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ----PPYPQ--------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----CCCCT--------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----CCCCc--------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 00100 1123466899999999999999 99999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.33 Aligned_cols=249 Identities=27% Similarity=0.343 Sum_probs=191.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHH-HhhCCCCcccccceeEEeCCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGI-LSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.++|++.++||+|+||+||+++.+ +++.||||+++.... ...+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999876 588999999875432 234566777776 577899999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999753 35889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... ... .+.+
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~--~~~~ 260 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-KPL--QLKP 260 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH-SCC--CCCS
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-ccc--CCCC
Confidence 2221 22334599999999999998999999999999999999999999963211 111111111 110 0111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. ....+.+|+.+||+.||.+||++.+.++.
T Consensus 261 ~------------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 261 N------------ITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp S------------SCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred C------------CCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 1 12346689999999999999998644433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=344.14 Aligned_cols=270 Identities=24% Similarity=0.304 Sum_probs=196.3
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCccc-----HHHHHHHHHHHhhCCCCcccccceeEEeCC
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKS-----TQQVLNEVGILSQVNHKNLVRLLGCCVEAE 415 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 415 (646)
....++|.+.+.||+|+||+||+|+.. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 445678999999999999999999876 58999999987543221 246889999999999999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||+++ +|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999975 888888653 235888999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG--- 571 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 571 (646)
+........ .....+|+.|+|||.+.+. .++.++||||||+++|||++|..||..... ......+.......
T Consensus 160 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE 235 (346)
T ss_dssp STTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred eeccCCccc-CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence 876543222 2334589999999998654 589999999999999999999988864321 11111111111110
Q ss_pred cccccc---cc----cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 572 AIMEVV---DP----RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 572 ~~~~~~---d~----~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
...+.. +. .................+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00 000000000001123567899999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.68 Aligned_cols=274 Identities=22% Similarity=0.262 Sum_probs=200.2
Q ss_pred cHHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc-----------ccHHHHHHHHHHHhhCCCCccc
Q 006402 337 HLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI-----------KSTQQVLNEVGILSQVNHKNLV 405 (646)
Q Consensus 337 ~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 405 (646)
...++....++|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 46678888999999999999999999999988899999998854321 1237899999999999999999
Q ss_pred ccceeEEeCC-----cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 006402 406 RLLGCCVEAE-----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNIL 480 (646)
Q Consensus 406 ~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIl 480 (646)
++++++...+ ..++||||++ |+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999986533 4689999997 6888888753 346899999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeecCCCccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCcc
Q 006402 481 LDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVN 559 (646)
Q Consensus 481 l~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~ 559 (646)
++.++.+||+|||+++....... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---N 241 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred EcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---H
Confidence 99999999999999986543322 223458999999999876 67899999999999999999999999743211 1
Q ss_pred HHHHHHHHhcCCccc-----------cccccccc---CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 560 LAIYVSQRASNGAIM-----------EVVDPRLQ---GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~-----------~~~d~~l~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....+.......... +.+...+. ..............+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111110000 00000000 000000011123457799999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.90 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=197.1
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeC----CcCeE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA----EQPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~l 419 (646)
.|.+.+.||+|+||+||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++... ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3677789999999999999775 6889999988643 334567899999999999999999999998763 45789
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLA 498 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~ 498 (646)
||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++|+||||||+|||++ +++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999743 35899999999999999999999987 4599999999999998 7899999999999765
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .. .......+......+
T Consensus 183 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 183 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPASFD 252 (290)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCGGGG
T ss_pred cccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HH-HHHHHhccCCccccC
Confidence 4432 223458999999998875 5899999999999999999999998632211 11 111111111111111
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .....+.+++.+||+.+|.+|||+.|+++
T Consensus 253 ~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 K------------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G------------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C------------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11234778999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.67 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=203.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|.+.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999876 5889999988654 233467789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988643 35899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ...... .
T Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~~~------~ 233 (294)
T 2rku_A 168 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLR-IKKNEY------S 233 (294)
T ss_dssp TTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH-HHTTCC------C
T ss_pred Cccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhhccC------C
Confidence 3222 2234589999999999988899999999999999999999999863321 111111 111110 0
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.. .....+.+++.+||+.+|++|||+.|+++.
T Consensus 234 ~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 IPK--------HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCT--------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Ccc--------ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 112346689999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.60 Aligned_cols=197 Identities=26% Similarity=0.393 Sum_probs=174.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888999999999999999876 6899999998765 334467899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999753 2589999999999999999999996 8 9999999999999999999999999987543211
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDF 551 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~ 551 (646)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1234589999999999998999999999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.29 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=208.3
Q ss_pred hcCCCcccEecccCcEEEEEEEE-cCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC-CcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH-KNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|.+.++||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999986 4689999998765432 3457899999999987 555556666667778899999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~~~ 499 (646)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999743 235899999999999999999999999 9999999999999 688999999999998765
Q ss_pred CCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 500 PGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 500 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
..... ......||+.|+|||.+.+..++.++||||||++||||++|+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 112456999999999999999999999999999999999999999755443322222211111111111
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
..+ ......++.+|+.+||+.+|++||++.+|++.|+++.....
T Consensus 238 ~~l-------------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 238 EAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHH-------------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHH-------------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 000 01123567899999999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=342.43 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=198.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..++|++.+.||+|+||+||++..+ +++.||||+++..... +.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999876 6899999998765432 34688888888 7999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CCEEEeecCCCcc
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD----FNSKVADFGLSRL 497 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~----~~~ki~DfGl~~~ 497 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999753 35899999999999999999999999 9999999999998533 3599999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........+. .....+... ..
T Consensus 170 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~-~~ 243 (342)
T 2qr7_A 170 LRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS-LS 243 (342)
T ss_dssp CBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC-CC
T ss_pred CcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc-cC
Confidence 6543222 22345899999999998878899999999999999999999999743322111111 111111111 00
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.... ....+.+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 GGYW---------NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp STTT---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 012245678999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.19 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=203.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999999999999876 5889999988654 234467789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988643 35899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... ... .
T Consensus 194 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~-~~~------~ 259 (335)
T 2owb_A 194 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKK-NEY------S 259 (335)
T ss_dssp TTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-TCC------C
T ss_pred Cccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhc-CCC------C
Confidence 3222 2334589999999999988899999999999999999999999863221 111111111 100 0
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
+.. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~--------~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 IPK--------HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCT--------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCc--------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 012346689999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=345.40 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=193.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
.++|...+.||+|+||+||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999875 6999999998543 2234567899999999999999999999998764
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999864 25899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+..... .+...+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+...... ...
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~-~~~ 247 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGT-PPA 247 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCC-CCH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC-CCH
Confidence 876432 223458999999999876 67999999999999999999999999743221 111111111100 000
Q ss_pred cccc--------------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVD--------------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d--------------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.+. +.................+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 000000000000112345779999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=334.97 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=196.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc--CCc--EEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ--DGT--VVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.+.||+|+||+||+|++. +++ .||||+++.. .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57899999999999999999864 333 6899988654 2345678999999999999999999999988764 89
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+|+||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999999753 234899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 499 KPGLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCCC
Confidence 5443321 223457889999999988889999999999999999999 9999863321 111111111111000
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
.. ......+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 246 -----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 -----RP--------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----CC--------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00 01224577899999999999999999999999887543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=338.31 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=204.7
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--------ccHHHHHHHHHHHhhC-CCCcccccc
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--------KSTQQVLNEVGILSQV-NHKNLVRLL 408 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~ 408 (646)
.......++|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556678999999999999999999886 799999999865432 1145678999999999 799999999
Q ss_pred eeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEE
Q 006402 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSK 488 (646)
Q Consensus 409 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~k 488 (646)
+++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999743 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCccccccCccccccCcccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH
Q 006402 489 VADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~ 562 (646)
|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 241 l~DfG~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLR 315 (365)
T ss_dssp ECCCTTCEECCTTCCB--CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred EEecCcccccCCCccc--ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHH
Confidence 9999999876544322 23459999999999863 3578899999999999999999999863211 11111
Q ss_pred HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 563 YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+. .+... ...+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 316 ~i~----~~~~~-~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIM----EGQYQ-FSSPE---------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH----HTCCC-CCHHH---------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH----hCCCC-CCCcc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11100 00000 0112245778999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.02 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=193.6
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc--cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK--STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
...++|++.++||+|+||+||++... +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999765 7899999998754332 34568899999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-----CCCCEEEeecCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-----DDFNSKVADFGL 494 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-----~~~~~ki~DfGl 494 (646)
||||++ ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 5999998753 35899999999999999999999999 99999999999994 555699999999
Q ss_pred CccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN--- 570 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 570 (646)
++........ .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+......
T Consensus 184 a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCT
T ss_pred ccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCch
Confidence 9876533222 2234579999999998764 5899999999999999999999998643221 111111111110
Q ss_pred Cccccc--------ccccccCCchhH-HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 GAIMEV--------VDPRLQGHEASV-NILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 ~~~~~~--------~d~~l~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...... ..+......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 000001110000 00112356789999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.92 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=204.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.+.|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999765 68999999987553 3456889999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999864 35899999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+ . ... .+.+.
T Consensus 174 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~-~~~-----~~~~~ 240 (303)
T 3a7i_A 174 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLI---P-KNN-----PPTLE 240 (303)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH---H-HSC-----CCCCC
T ss_pred cc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHh---h-cCC-----CCCCc
Confidence 21 2234589999999999988999999999999999999999999863211 1111111 1 111 01111
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. ....+.+|+.+||+.+|++|||+.|+++.
T Consensus 241 ~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GN--------YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SS--------CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cc--------cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 12346789999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=329.54 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=198.3
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (646)
..++|++.+.||+|+||+||+|... +++.||+|+++.. .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999876 7999999998754 233467788999999999 89999999999999999999
Q ss_pred EEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---------------
Q 006402 420 IYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD--------------- 483 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~--------------- 483 (646)
||||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997542 1245899999999999999999999999 999999999999984
Q ss_pred ----CCCEEEeecCCCccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 006402 484 ----DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558 (646)
Q Consensus 484 ----~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~ 558 (646)
...+||+|||++........ ..||+.|+|||.+.+. .++.++||||||+++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 44899999999987654322 2389999999998765 5678999999999999999998765311
Q ss_pred cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... .....+.... +... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~----~~~~~~~~~~-----~~~~--------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQW----HEIRQGRLPR-----IPQV--------LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHH----HHHHTTCCCC-----CSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH----HHHHcCCCCC-----CCcc--------cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 1111111111 1111 1234678999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=355.31 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=201.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|...++||+|+||+||+++.+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999886 69999999986432 234577899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987543 2346999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......... .... +.+
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~-~~~~--~p~- 414 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE-QAVT--YPD- 414 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH-CCCC--CCT-
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh-cccC--CCc-
Confidence 4322 2234699999999999998999999999999999999999999975432211 1111111111 1100 000
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
.....+.+|+.+||+.||++||++
T Consensus 415 -----------~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 415 -----------KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----------TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----------ccCHHHHHHHHHhccCCHhHCCCC
Confidence 112346689999999999999976
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.43 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=198.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeC--------
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-------- 414 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 414 (646)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57999999999999999999874 789999998865432 2356788999999999999999999999874
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
+..++||||+++ +|.+.+... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457899999975 777777543 235899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCC---ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 495 SRLAKPGLS---HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 495 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence 987643221 12234458999999998875 46899999999999999999999998743221 111111111110
Q ss_pred ---Cccccccccc-------ccCCch-hHHH---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 ---GAIMEVVDPR-------LQGHEA-SVNI---LMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 ---~~~~~~~d~~-------l~~~~~-~~~~---~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......-... ...... .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000000 000000 0000 011345789999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.34 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=193.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999886 78999999986432 234567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999653 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
... ....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ... ......+.. .
T Consensus 165 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~~~~------~ 229 (276)
T 2h6d_A 165 EFL--RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTL-FKKIRGGVF------Y 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCC------C
T ss_pred cce--ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHH-HHHhhcCcc------c
Confidence 222 23358999999999987765 6899999999999999999999863211 111 111111110 0
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.. .....+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IPE--------YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch--------hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000 01234678999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.08 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=197.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999886 5899999999877667788999999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999998643 235899999999999999999999999 9999999999999999999999999875322110
Q ss_pred ccccccCccccccCcccc-----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 504 HVSTCAQGTLGYLDPEYY-----RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||..... ............ .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~~ 244 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP-PTLLT 244 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCCSS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC-cccCC
Confidence 011223489999999998 356789999999999999999999999863321 111111111111 00000
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+ ......+.+++.+||+.+|++|||+.++++
T Consensus 245 ~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 P-----------SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp G-----------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c-----------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 112244678999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=329.27 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=200.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999876 57899999986432 223567899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....... ..+
T Consensus 168 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~~~~~~------~~~ 231 (284)
T 2vgo_A 168 RR---RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETH-RRIVNVD------LKF 231 (284)
T ss_dssp CB---CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHTTC------CCC
T ss_pred cc---ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHH-HHHhccc------cCC
Confidence 21 2345899999999999888999999999999999999999998633211 111 1111111 011
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. .....+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 PP--------FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CT--------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC--------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 10 11234678999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.81 Aligned_cols=194 Identities=26% Similarity=0.415 Sum_probs=155.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeC-----Cc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-----EQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 416 (646)
.++|.+.++||+|+||+||+|... +++.||||++... +....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999765 6899999998653 334467899999999999999999999998543 46
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+ +++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 67899988643 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCC--------------------------ccccccCccccccCcccc-ccCCCCchhhHHHHHHHHHHHHcC
Q 006402 497 LAKPGLS--------------------------HVSTCAQGTLGYLDPEYY-RNYQLTDKSDVYSYGVVLLELLTS 545 (646)
Q Consensus 497 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~ll~elltg 545 (646)
....... ...+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 112334589999999976 566799999999999999999994
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.65 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=199.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|++.++||+|+||+||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999876 589999998865433 23566889999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999999886533 35899999999999999999999999 999999999999999999999999999866443
Q ss_pred CCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc-----------
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS----------- 569 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 569 (646)
... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 178 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GEV-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHH
T ss_pred ccc-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhhhHhh
Confidence 221 2234589999999998765 78999999999999999999999986433211 1111110000
Q ss_pred -CCcccccccccccCCch-hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 570 -NGAIMEVVDPRLQGHEA-SVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 570 -~~~~~~~~d~~l~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.........+.+..... ........+.+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000011111111110 00011234568899999999999999999999853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.70 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=203.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCccc-----------------HHHHHHHHHHHhhCCCCccccc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKS-----------------TQQVLNEVGILSQVNHKNLVRL 407 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 407 (646)
.++|.+.+.||+|+||.||+++. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 89999999986432211 2789999999999999999999
Q ss_pred ceeEEeCCcCeEEEEEccCCCcccc------ccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEE
Q 006402 408 LGCCVEAEQPLLIYEYIANGTLHDH------LHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNIL 480 (646)
Q Consensus 408 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIl 480 (646)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 5432 24569999999999999999999999 88 999999999999
Q ss_pred EcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 006402 481 LDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558 (646)
Q Consensus 481 l~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDv~s~G~ll~elltg~~p~~~~~~~~~~ 558 (646)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--V 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--H
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--H
Confidence 999999999999999876443 22334589999999999877 6666 999999999999999999999743321 1
Q ss_pred cHHHHHHHHhcCCccccccc-----ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 559 NLAIYVSQRASNGAIMEVVD-----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~d-----~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... .....+......+ ..+...............+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111111100000 000000000000122355779999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.99 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=197.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEe--CCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVE--AEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+|... +++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57889999999999999999764 7899999998643 4577899999999997 9999999999998 55789999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~~~ 500 (646)
||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999884 2789999999999999999999999 99999999999999766 899999999987654
Q ss_pred CCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc--
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV-- 577 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 577 (646)
.... ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.......+. +. ............+.+
T Consensus 184 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~-~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LV-RIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCCC--CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HH-HHHHHHCHHHHHHHHHH
T ss_pred CCcc--ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HH-HHHHhcCCchhhhHHHH
Confidence 4332 23458999999999876 57899999999999999999999998533221111 11 000000000000000
Q ss_pred -----cc------------cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 -----DP------------RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 -----d~------------~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
++ .+...............+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00000000001113456789999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.13 Aligned_cols=262 Identities=23% Similarity=0.260 Sum_probs=192.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
.++|.+.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999765 6899999998653 2334567899999999999999999999998765
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 5799999996 578887753 3889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhc------
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRAS------ 569 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 569 (646)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHH
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 8664332 1223458999999999998899999999999999999999999996432110 0000000000
Q ss_pred -------------C-C-----cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 570 -------------N-G-----AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 570 -------------~-~-----~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. . .....+...+. .............+.+|+.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF-PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccC-cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0 00000000000 00111122335668899999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.53 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=185.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-cc-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KS-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|++.+.||+|+||+||+++.. +++.||+|+++.... .. .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999999999999874 789999999875422 22 233445555688889999999999999999999999
Q ss_pred EEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 422 EYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||++ ++|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 58888775421 334699999999999999999999998 8 9999999999999999999999999998765
Q ss_pred CCCCccccccCccccccCcccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYY----RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
..... ....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... .. .......... .
T Consensus 162 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~-~- 232 (290)
T 3fme_A 162 DDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQ-QLKQVVEEPS-P- 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HH-HHHHHHHSCC-C-
T ss_pred ccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HH-HHHHHhccCC-C-
Confidence 43322 223589999999996 5567899999999999999999999998632211 11 1111111111 0
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..... .....+.+++.+||+.+|++|||+.|+++
T Consensus 233 ----~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 ----QLPAD-------KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCTT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----Ccccc-------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01100 12244678999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.12 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=183.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeC------
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA------ 414 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 414 (646)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999764 6899999998653 233467789999999999999999999998754
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
...++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999998 7899998864 35899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
++..... .+...||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+....... .
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p-~ 250 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTP-G 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSC-C
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-C
Confidence 9875432 223458999999999876 67899999999999999999999999643221 1111111111100 0
Q ss_pred cccccc-----------cc---cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 574 MEVVDP-----------RL---QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 574 ~~~~d~-----------~l---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.+.. .+ ...............+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 00 0000000001123457799999999999999999999853
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.55 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=201.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPLL 419 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 419 (646)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999876 68999999987543 3446779999999999999999999998865 557899
Q ss_pred EEEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 420 IYEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAA--YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997543 2345899999999999999999999977 2349999999999999999999999999998
Q ss_pred cCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+. .....+....
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----~~i~~~~~~~- 235 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA----GKIREGKFRR- 235 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCCC-
T ss_pred eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHH----HHHhhccccc-
Confidence 76543221 2233589999999999988899999999999999999999999863321 1111 1111111111
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHEL 622 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L 622 (646)
+.. .....+.+++.+||+.+|++|||+.|+++.+
T Consensus 236 ~~~------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 236 IPY------------RYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CCc------------ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 110 1224567899999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=363.44 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=204.4
Q ss_pred HhcCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
..++|.+.+.||+|+||+||+|.+.. +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999998742 4679999987543 334578999999999999999999999985 45789
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999753 335899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ . .+.... +
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i---~-~~~~~~-~ 613 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---E-NGERLP-M 613 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---H-HTCCCC-C
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH---H-cCCCCC-C
Confidence 5544333334457889999999998899999999999999999997 88898633211 111111 1 111000 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
.+ .....+.+|+.+||+.||++|||+.|+++.|+++.+.
T Consensus 614 ~~------------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 614 PP------------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Cc------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 1224567899999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.82 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=196.1
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--------ccHHHHHHHHHHHhhCCCCcccccceeEEeC
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA 414 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 414 (646)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999875 589999999864321 2234588999999999999999999998765
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---EEEee
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN---SKVAD 491 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~---~ki~D 491 (646)
+ .++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 89999999999999998743 35899999999999999999999999 999999999999987654 99999
Q ss_pred cCCCccCCCCCCccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 492 FGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 492 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+...+..
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-- 234 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-- 234 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence 99998765322 122345899999999974 4578999999999999999999999997443322 12221111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+... . .+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 235 --~~~~-~-~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYN-F-IPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCC-C-CHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Cccc-c-Cchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 0 0000 1112345779999999999999999999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.01 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=198.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
..++|++.+.||+|+||.||+|... +|+.||+|++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999876 5899999998754 345678999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998632 345899999999999999999999999 9999999999999999999999999997665432
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... . +.+.
T Consensus 180 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~-----~~~~ 246 (314)
T 3com_A 180 AK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNP-P-----PTFR 246 (314)
T ss_dssp SC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-C-----CCCS
T ss_pred cc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCC-C-----cccC
Confidence 21 2234589999999999988999999999999999999999999863211 11111111110 0 0000
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .......+.+|+.+||+.+|.+|||+.++++
T Consensus 247 ~------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 K------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp S------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 0012245678999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.97 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=203.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
.++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357899999999999999999876 78999999986543 34577899999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCEEEeecCCCcc
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL---DDDFNSKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll---~~~~~~ki~DfGl~~~ 497 (646)
|||+.+++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999998753 35899999999999999999999999 9999999999999 5678999999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ..... ....+.....
T Consensus 179 ~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~----~i~~~~~~~~- 247 (484)
T 3nyv_A 179 FEASKKM--KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILK----KVEKGKYTFE- 247 (484)
T ss_dssp BCCCCSH--HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCCCCC-
T ss_pred ccccccc--ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCCCCCC-
Confidence 7554332 23459999999999876 689999999999999999999999963321 11111 1111111100
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.. ......+.+|+.+||+.+|.+|||+.|+++
T Consensus 248 ~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQW---------KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGG---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000 112345678999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.90 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=185.4
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
..++|.+.+.||+|+||+||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999764 68999999886543 234567889999999999999999999999999999999
Q ss_pred EEccCCCccccccCC-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 422 EYIANGTLHDHLHGK-----YSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 422 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
||+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 12345899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC----ccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 497 LAKPGLS----HVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 497 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLMLTLQNDPPS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHTSSCCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHHHHhccCCCc
Confidence 6643221 11223458999999999865 56899999999999999999999998743221 1111111100000
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......++.+.. .....+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLK--------KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhh--------hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000001111111 11235678999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=352.39 Aligned_cols=252 Identities=27% Similarity=0.368 Sum_probs=201.1
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
..++|.+.++||+|+||+||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999876 7899999998543 223567899999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeecCCCcc
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~DfGl~~~ 497 (646)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988643 35899999999999999999999999 99999999999995 566899999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... .... .....+.....
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~----~~i~~~~~~~~- 242 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL----KRVETGKYAFD- 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCCSC-
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCCCCCC-
Confidence 654332 223459999999999876 589999999999999999999999963321 1111 11111111100
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.+ ......+.+|+.+||+.+|.+|||+.|+++.
T Consensus 243 ~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQW---------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGG---------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred Cccc---------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 1123456789999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=352.79 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=200.1
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-------------ccHHHHHHHHHHHhhCCCCcccccc
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-------------KSTQQVLNEVGILSQVNHKNLVRLL 408 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~ 408 (646)
...++|.+.++||+|+||+||+++.+ +++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999876 588999999865431 2356789999999999999999999
Q ss_pred eeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---
Q 006402 409 GCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF--- 485 (646)
Q Consensus 409 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~--- 485 (646)
+++.+....++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999998643 35899999999999999999999999 99999999999998765
Q ss_pred CEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 486 NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 486 ~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
.+||+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---- 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII---- 256 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----
Confidence 699999999987755432 223459999999999874 6899999999999999999999999633211 111
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.... + ..........+.+|+.+||+.+|.+|||+.|+++
T Consensus 257 ~~i~~~~~~~--~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYF--D--------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCC--C--------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCC--C--------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111100 0 0000112345779999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=337.36 Aligned_cols=260 Identities=22% Similarity=0.382 Sum_probs=198.9
Q ss_pred ccHHHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEe
Q 006402 336 FHLKELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVE 413 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 413 (646)
+.+.++....++|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444555667789999999999999999999875 78999999987543 3457789999999999 79999999999987
Q ss_pred ------CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 414 ------AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 414 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 457899999999999999997542 346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH
Q 006402 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~ 562 (646)
||+|||++......... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||..... ..
T Consensus 169 kl~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~ 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MR 241 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HH
T ss_pred EEeeCcCceecCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HH
Confidence 99999999876432211 22345899999999986 55789999999999999999999999853211 11
Q ss_pred HHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 563 YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....... ......... . ....+.+|+.+||+.+|.+|||+.|+++
T Consensus 242 ~~~~~~~-~~~~~~~~~-----~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ALFLIPR-NPAPRLKSK-----K-------WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHH-SCCCCCSCS-----C-------SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhhc-CccccCCcc-----c-------cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111 111111111 1 1234678999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=325.34 Aligned_cols=252 Identities=26% Similarity=0.336 Sum_probs=202.0
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---------ccHHHHHHHHHHHhhCC-CCcccccceeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---------KSTQQVLNEVGILSQVN-HKNLVRLLGCCV 412 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 412 (646)
..++|.+.+.||+|+||.||++..+ +++.||||++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999876 689999999875431 22467889999999996 999999999999
Q ss_pred eCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 413 EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 413 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
+.+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999999753 35899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCccccccCccccccCccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHH
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYR------NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 566 (646)
|++......... ....+++.|+|||.+. ...++.++||||||+++|||++|+.||..... .....
T Consensus 169 g~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~---- 239 (298)
T 1phk_A 169 GFSCQLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR---- 239 (298)
T ss_dssp TTCEECCTTCCB--CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----
T ss_pred cchhhcCCCccc--ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHH----
Confidence 999876543322 2345899999999985 44688999999999999999999999863211 11111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....+... ...+. .......+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~-~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQ-FGSPE---------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCC-CCTTT---------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcc-cCccc---------ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111100 00000 0112345778999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.11 Aligned_cols=198 Identities=24% Similarity=0.284 Sum_probs=171.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC------CCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV------NHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 417 (646)
..+|++.++||+|+||+||+|... +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999776 5899999998643 33456778888888887 577999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--EEEeecCCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN--SKVADFGLS 495 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~--~ki~DfGl~ 495 (646)
++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999995 68999887542 335899999999999999999999999 999999999999999887 999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
....... ....||+.|+|||++.+..++.++||||||++||||++|+.||...
T Consensus 250 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7654332 2345899999999999989999999999999999999999998744
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.97 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=197.5
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
..++|++.+.||+|+||+||+++.+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999876 68899999987543 23457789999999999999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCCCcc
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl~~~ 497 (646)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999988643 35899999999999999999999999 999999999999975 45599999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ..+. .....+... ..
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~----~~i~~~~~~-~~ 257 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEIL----RKVEKGKYT-FD 257 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCC-CC
T ss_pred CCCCcc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCCCC-CC
Confidence 654322 233459999999999864 689999999999999999999999963321 1111 111111110 00
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+.+. .....+.+|+.+||+.+|.+|||+.|+++.
T Consensus 258 ~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEWK---------NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGGT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhcc---------cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111 122446789999999999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.24 Aligned_cols=198 Identities=24% Similarity=0.369 Sum_probs=167.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeC-----Cc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-----EQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 416 (646)
.++|.+.++||+|+||+||+|... +++.||||++... .....+.+.+|+.+|++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999875 6889999998653 333457899999999999999999999999876 56
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999985 6999999743 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc---------------------cccccCccccccCcccc-ccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006402 497 LAKPGLSH---------------------VSTCAQGTLGYLDPEYY-RNYQLTDKSDVYSYGVVLLELLTSQKAI 549 (646)
Q Consensus 497 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~ll~elltg~~p~ 549 (646)
........ ..+...||+.|+|||++ ....++.++|||||||+||||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543211 12445689999999986 5667999999999999999999865554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=339.64 Aligned_cols=266 Identities=21% Similarity=0.259 Sum_probs=200.4
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeC-----Cc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-----EQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 416 (646)
..++|++.++||+|+||+||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999875 688999999875432 3457889999999999999999999998765 36
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+. ++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 789999996 5899988643 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc--ccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 497 LAKPGLSHV--STCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 497 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+.........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 765432221 233469999999998754 458999999999999999999999996443222 11111111111000
Q ss_pred c---ccccc-------ccc---CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 M---EVVDP-------RLQ---GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~---~~~d~-------~l~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. ...+. .+. ..............+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000 000 00000000112345779999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.89 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=196.2
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC----cccHHHHHHHHHHHhhCCCCcccccceeEE--eCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNHKNLVRLLGCCV--EAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 416 (646)
..++|.+.+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999875 68899999986532 234678999999999999999999999985 4457
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||++++ |.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 77766543 2346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCC-ccccccCccccccCccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 497 LAKPGLS-HVSTCAQGTLGYLDPEYYRNYQ--LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
....... .......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.... ..... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~-~~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLF-ENIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHH-HHHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHH-HHHhcCCC
Confidence 7653322 2223455899999999987643 4789999999999999999999986321 11111 11111110
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ------~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------AIPGD--------CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCSS--------SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCc--------cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 12346689999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=342.48 Aligned_cols=266 Identities=20% Similarity=0.216 Sum_probs=200.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC--------CCcccccceeEE---
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN--------HKNLVRLLGCCV--- 412 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 412 (646)
.++|.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999765 6899999998643 345677899999999985 788999999988
Q ss_pred -eCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCC-----
Q 006402 413 -EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDF----- 485 (646)
Q Consensus 413 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~----- 485 (646)
.....++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 56666666543 234589999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------CEEEeecCCCccCCCCCCccccccCccccccCcccc
Q 006402 486 --------------------------------------------NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521 (646)
Q Consensus 486 --------------------------------------------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~ 521 (646)
.+||+|||+++...... ....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCChhh
Confidence 89999999998765332 234589999999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHH---HHHHHhcCC--------c-cccccccc--cc-----
Q 006402 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI---YVSQRASNG--------A-IMEVVDPR--LQ----- 582 (646)
Q Consensus 522 ~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~--------~-~~~~~d~~--l~----- 582 (646)
.+..++.++||||||++||||++|+.||......+...... .+....... . ..+.+... +.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99899999999999999999999999997554433221111 111111100 0 00000000 00
Q ss_pred -CCch-------hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 -GHEA-------SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 -~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 0001234566889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=342.80 Aligned_cols=273 Identities=22% Similarity=0.252 Sum_probs=197.2
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC-----
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----- 415 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 415 (646)
....++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999764 789999998865432 2237999999999999999999985432
Q ss_pred ---------------------------------cCeEEEEEccCCCccccccCC-cCCCCCCHHHHHHHHHHHHHHHHHH
Q 006402 416 ---------------------------------QPLLIYEYIANGTLHDHLHGK-YSSFNLTWSTRLRIALQTAEALAYL 461 (646)
Q Consensus 416 ---------------------------------~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yL 461 (646)
..++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3779999997 5877777532 1344699999999999999999999
Q ss_pred HhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHH
Q 006402 462 HSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVL 539 (646)
Q Consensus 462 H~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll 539 (646)
|+.+ |+||||||+|||++ .++.+||+|||+++........ ....+|+.|+|||.+.+. .++.++||||||+++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999 99999999999998 6889999999999876544332 234589999999998764 589999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC----------cccccccccccCCchhH-HHHHHHHHHHHHHHHhcccC
Q 006402 540 LELLTSQKAIDFSRDPDDVNLAIYVSQRASNG----------AIMEVVDPRLQGHEASV-NILMSLKLFSELAVACLREK 608 (646)
Q Consensus 540 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~~~~~~~-~~~~~~~~~~~li~~cl~~~ 608 (646)
|||++|+.||......+ ....+....... ...+..-+.+....... ........+.+|+.+||+.+
T Consensus 233 ~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999997432211 111111111100 00010001111110000 00012345779999999999
Q ss_pred CCCCCCHHHHHH--HHHHHHH
Q 006402 609 KSERPSMTDVVH--ELQRIIE 627 (646)
Q Consensus 609 p~~RPs~~evl~--~L~~~~~ 627 (646)
|++|||+.|+++ .++.+.+
T Consensus 310 P~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHHHH
T ss_pred hhhCCCHHHHhcCHHHHHHHh
Confidence 999999999994 3555544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.08 Aligned_cols=265 Identities=10% Similarity=0.016 Sum_probs=186.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhC--CCCcccccc-------eeE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQV--NHKNLVRLL-------GCC 411 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 411 (646)
..+|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999876 789999999987543 3355677785444444 699988755 444
Q ss_pred EeC-----------------CcCeEEEEEccCCCccccccCCcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 006402 412 VEA-----------------EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTR------LRIALQTAEALAYLHSAAYTP 468 (646)
Q Consensus 412 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~ 468 (646)
... ...++||||++ ++|.+++..... .+++..+ +.++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23699999998 899999975422 3455566 788899999999999999
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCC
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQ 546 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~ 546 (646)
|+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998664321 13347799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHH
Q 006402 547 KAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH--ELQR 624 (646)
Q Consensus 547 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~--~L~~ 624 (646)
.||.......... .............+.... .......+.+|+.+||+.||++|||+.|+++ .+++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGS----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTT----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhh----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9997543221110 000000000000000000 0012345778999999999999999999985 4555
Q ss_pred HHHHHhh
Q 006402 625 IIEIVNQ 631 (646)
Q Consensus 625 ~~~~~~~ 631 (646)
+.+....
T Consensus 359 ~~~~~~~ 365 (371)
T 3q60_A 359 LQNEISS 365 (371)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 5554443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=363.31 Aligned_cols=244 Identities=22% Similarity=0.285 Sum_probs=198.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCe
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 418 (646)
..++|++.++||+|+||+||+|+.+ +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567999999999999999999876 6889999998743 223456788999999988 6999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++|+|.++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999753 35899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||..... ..... .+...... +.
T Consensus 493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~-~i~~~~~~--~p 562 (674)
T 3pfq_A 493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQ-SIMEHNVA--YP 562 (674)
T ss_dssp CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHSSCCC--CC
T ss_pred ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHH-HHHhCCCC--CC
Confidence 33222 23345699999999999999999999999999999999999999963211 11111 11111100 01
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
. ....++.+|+.+||+.||++||++
T Consensus 563 ~------------~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 563 K------------SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp T------------TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred c------------cCCHHHHHHHHHHccCCHHHCCCC
Confidence 1 122446789999999999999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.31 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=200.9
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
++.....++|++.+.||+|+||+||+|+.++ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3333445789999999999999999998754 49999886542 2334567899999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999999754 335899999999999999999999999 99999999999998 5799999999987
Q ss_pred cCCCCC----CccccccCccccccCcccccc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHH
Q 006402 497 LAKPGL----SHVSTCAQGTLGYLDPEYYRN---------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563 (646)
Q Consensus 497 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~ 563 (646)
...... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||..... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~ 251 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAI 251 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH
Confidence 653211 112233458999999999864 3578899999999999999999999863221 111
Q ss_pred HHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 564 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
.. ....+......... ....+.+++.+||+.+|++|||+.++++.|+++.+.....
T Consensus 252 ~~-~~~~~~~~~~~~~~------------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 252 IW-QMGTGMKPNLSQIG------------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HH-HHHTTCCCCCCCSS------------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred HH-HhccCCCCCCCcCC------------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 11 11111111111111 1123668999999999999999999999999988765443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.26 Aligned_cols=263 Identities=23% Similarity=0.269 Sum_probs=192.5
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCc------CeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ------PLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l 419 (646)
.+|+..++||+|+||+||+|+...+..||+|++..... ...+|+.++++++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46899999999999999999988777799998754322 12369999999999999999999976543 779
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLA 498 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~ 498 (646)
||||++++.+....+.......+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999977544443322223446899999999999999999999999 99999999999999 7999999999999876
Q ss_pred CCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC------
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG------ 571 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 571 (646)
...... ....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ....+.......
T Consensus 193 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHH
T ss_pred cCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence 544332 234589999999998654 58999999999999999999999997432211 111111111000
Q ss_pred ----cccccccccccCCchhHH-HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 ----AIMEVVDPRLQGHEASVN-ILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 ----~~~~~~d~~l~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+..-+.......... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000001110000000 0012346789999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.49 Aligned_cols=273 Identities=22% Similarity=0.290 Sum_probs=189.8
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ- 416 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 416 (646)
.+.....++|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677789999999999999999999875 68999999886533 334567788899999999999999999976543
Q ss_pred ------CeEEEEEccCCCccccccC-CcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeccCCCCCEEEcC-CCC
Q 006402 417 ------PLLIYEYIANGTLHDHLHG-KYSSFNLTWSTRLRIALQTAEALAYLH--SAAYTPIYHRDVKSTNILLDD-DFN 486 (646)
Q Consensus 417 ------~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~i~H~Dik~~NIll~~-~~~ 486 (646)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999976 44443332 113446899999999999999999999 888 999999999999996 899
Q ss_pred EEEeecCCCccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
+||+|||+++........ ....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ....+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EEEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHH
Confidence 999999999877544332 234589999999998654 48999999999999999999999997432211 111111
Q ss_pred HHhcCCc--cccccccc-----c---cCCchhH----HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 566 QRASNGA--IMEVVDPR-----L---QGHEASV----NILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 566 ~~~~~~~--~~~~~d~~-----l---~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
....... ....+++. . ....... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110000 00000000 0 0000000 000124567899999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=338.82 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=195.6
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC---
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP--- 417 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 417 (646)
..++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999875 68999999987543 23357889999999999999999999999887655
Q ss_pred ---eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 418 ---LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 418 ---~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688887742 3899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+...... ..
T Consensus 191 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~-~~ 262 (371)
T 4exu_A 191 ARHADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGV-PG 262 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC-CC
T ss_pred ccccccCc----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC-Cc
Confidence 98654332 23458999999999876 67899999999999999999999999643211 111111111100 00
Q ss_pred cccccc-----------cc---cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 574 MEVVDP-----------RL---QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 574 ~~~~d~-----------~l---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.+..+. .+ ...............+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00 0000000001123567899999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.70 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=201.0
Q ss_pred hcCCCcccEecccCcEEEEEEEE-c-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc------ccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGEL-Q-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN------LVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 416 (646)
.++|++.+.||+|+||+||++.. + +++.||||+++.. ....+.+.+|+.++++++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999986 3 6889999998643 344577889999999987654 9999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD------------- 483 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~------------- 483 (646)
.++||||+ +++|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999999754 2346899999999999999999999999 999999999999987
Q ss_pred ------CCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 006402 484 ------DFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557 (646)
Q Consensus 484 ------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~ 557 (646)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 6789999999998754332 234589999999999988999999999999999999999999974332111
Q ss_pred ccHHHHHHHHhcCCc--------cccccc-c--cccCCch---------------hHHHHHHHHHHHHHHHHhcccCCCC
Q 006402 558 VNLAIYVSQRASNGA--------IMEVVD-P--RLQGHEA---------------SVNILMSLKLFSELAVACLREKKSE 611 (646)
Q Consensus 558 ~~~~~~~~~~~~~~~--------~~~~~d-~--~l~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~ 611 (646)
...+........ ...... . .+..... ........+.+.+|+.+||+.||.+
T Consensus 243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111111110000 000000 0 0000000 0001123466889999999999999
Q ss_pred CCCHHHHHH
Q 006402 612 RPSMTDVVH 620 (646)
Q Consensus 612 RPs~~evl~ 620 (646)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=344.75 Aligned_cols=262 Identities=25% Similarity=0.292 Sum_probs=191.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC------cCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------QPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 418 (646)
.+|+..++||+|+||+||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999886 58999999986432 22347999999999999999999986532 356
Q ss_pred EEEEEccCCCccccccCC-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCEEEeecCCCc
Q 006402 419 LIYEYIANGTLHDHLHGK-YSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFGLSR 496 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-~~~ki~DfGl~~ 496 (646)
+||||+++ +|.+.+... .....+++..++.++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 566555421 13456999999999999999999999999 9999999999999954 578999999998
Q ss_pred cCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC-----
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN----- 570 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 570 (646)
........ ....+|+.|+|||++.+. .++.++||||||++||||++|+.||......+ .+.. +......
T Consensus 206 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~-i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCSCCHHH
T ss_pred hcccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHH
Confidence 76543322 234589999999998664 78999999999999999999999997432211 1111 1111100
Q ss_pred -----CcccccccccccCCchhHH-HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 -----GAIMEVVDPRLQGHEASVN-ILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 -----~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....+...+.+........ ......++.+|+.+||+.||.+|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0111111111111110000 0012345779999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.10 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=193.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEE-----------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCV----------- 412 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 412 (646)
.++|.+.+.||+|+||+||+|... +++.||+|++...+....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367899999999999999999886 48999999998777677788999999999999999999999874
Q ss_pred ---eCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEE
Q 006402 413 ---EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSK 488 (646)
Q Consensus 413 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~k 488 (646)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999997 699999864 35899999999999999999999999 99999999999997 677999
Q ss_pred EeecCCCccCCCCCCc--cccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 489 VADFGLSRLAKPGLSH--VSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
|+|||+++........ ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+.
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 9999999876533221 1223447999999998865 67899999999999999999999998743221 1111111
Q ss_pred HHhcCC----------cccccccccccCCch--hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 566 QRASNG----------AIMEVVDPRLQGHEA--SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 566 ~~~~~~----------~~~~~~d~~l~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...... .....+...+..... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 110000 000000000000000 0000112356789999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=333.59 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=198.4
Q ss_pred HhcCCCcccEecccCcEEEEEEEE--cCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhC---CCCcccccceeEE----
Q 006402 344 ATNGFSKERILGSGGFGEVYKGEL--QDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQV---NHKNLVRLLGCCV---- 412 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 412 (646)
+.++|++.+.||+|+||+||+|+. .+++.||+|+++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 3688999998864321 2233566777777666 8999999999987
Q ss_pred -eCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 413 -EAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 413 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
.....++||||++ ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567889999997 69999987542 335899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 492 FGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 492 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.......
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCC
Confidence 99998664322 223345899999999999889999999999999999999999998743221 1111111111100
Q ss_pred ---ccccccc-c--ccc---CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 572 ---AIMEVVD-P--RLQ---GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 572 ---~~~~~~d-~--~l~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
....... + ... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0 000 00000000112345678999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.82 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=191.0
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe---------
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--------- 413 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 413 (646)
..++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467899999999999999999875 7899999998643 3456788999999999999999999998865
Q ss_pred ----CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEE
Q 006402 414 ----AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKV 489 (646)
Q Consensus 414 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki 489 (646)
.+..++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 34678999999999999999753 234788999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCC-------------CccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 006402 490 ADFGLSRLAKPGL-------------SHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDP 555 (646)
Q Consensus 490 ~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~ 555 (646)
+|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999998764321 1112334589999999998754 68999999999999999998 44311
Q ss_pred CCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 556 DDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..... ......... ..+.+.+.. .....+.+++.+||+.||.+|||+.|+++
T Consensus 232 --~~~~~-~~~~~~~~~--~~~~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 --MERVN-ILKKLRSVS--IEFPPDFDD--------NKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHH-HHHHHHSTT--CCCCTTCCT--------TTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hhHHH-HHHhccccc--cccCccccc--------cchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 01111 111111110 001111111 12234678999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.01 Aligned_cols=265 Identities=21% Similarity=0.274 Sum_probs=197.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeC-----CcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-----EQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 417 (646)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999876 68999999986543 23456788999999999999999999988764 577
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||+. ++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 6899988642 5899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCc---------cccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 006402 498 AKPGLSH---------VSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 498 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence 6532211 1122358999999998754 678999999999999999999999987432111 11111111
Q ss_pred hcCCcccc----cccc-------cc---cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 568 ASNGAIME----VVDP-------RL---QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 568 ~~~~~~~~----~~d~-------~l---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
........ ...+ .+ ...............+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11000000 0000 00 000000000122355779999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.24 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=194.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-----
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ----- 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 416 (646)
.++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999875 68999999986542 2335678999999999999999999999987654
Q ss_pred -CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 417 -PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 417 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
.++||||+. ++|.+++.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 688888743 3899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc--
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA-- 572 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 572 (646)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+........
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 865432 223458999999999876 67899999999999999999999999743221 11111111100000
Q ss_pred -ccc--------c---ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 -IME--------V---VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 -~~~--------~---~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... . +...... ............+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRK-DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSC-CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCc-cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0 0000000 000000112345779999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.98 Aligned_cols=200 Identities=25% Similarity=0.384 Sum_probs=154.4
Q ss_pred CCc-ccEecccCcEEEEEEEEc---CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCeEEE
Q 006402 348 FSK-ERILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPLLIY 421 (646)
Q Consensus 348 ~~~-~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 421 (646)
|.+ .++||+|+||+||+|+.+ +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 457999999999999875 57899999987543 33568899999999999999999999965 56789999
Q ss_pred EEccCCCccccccCCc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCEEEee
Q 006402 422 EYIANGTLHDHLHGKY------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL----DDDFNSKVAD 491 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll----~~~~~~ki~D 491 (646)
||+. ++|.+++.... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 57888775321 2234899999999999999999999999 9999999999999 7788999999
Q ss_pred cCCCccCCCCCC--ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 492 FGLSRLAKPGLS--HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 492 fGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
||+++....... .......||+.|+|||++.+. .++.++||||||++||||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999987654322 122335689999999998774 58999999999999999999999996443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.55 Aligned_cols=252 Identities=27% Similarity=0.370 Sum_probs=201.3
Q ss_pred HHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 343 KATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 343 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
...++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999876 68999999986432 3457789999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCEEEeecCCCc
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD---FNSKVADFGLSR 496 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~---~~~ki~DfGl~~ 496 (646)
|+||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999988643 25899999999999999999999999 9999999999999754 479999999998
Q ss_pred cCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
........ ....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .... .....+.....
T Consensus 173 ~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~~~ 242 (287)
T 2wei_A 173 CFQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL----KRVETGKYAFD 242 (287)
T ss_dssp TBCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCCCCC
T ss_pred eecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHcCCCCCC
Confidence 76543322 22348999999999876 489999999999999999999999863321 1111 11111111100
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. +.. ......+.+++.+||+.+|++|||+.|+++
T Consensus 243 ~-~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-PQW---------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-GGG---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hhh---------hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 000 112345778999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.06 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=197.8
Q ss_pred ccHHHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--cccHHHHHHHHHHHhhCC--CCcccccceeE
Q 006402 336 FHLKELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVN--HKNLVRLLGCC 411 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 411 (646)
+.+..+....++|++.+.||+|+||+||++...+++.||||++.... ....+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33344444557799999999999999999998889999999986543 345678999999999997 59999999999
Q ss_pred EeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEee
Q 006402 412 VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVAD 491 (646)
Q Consensus 412 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~D 491 (646)
.+.+..++||| +.+++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 5688999999753 35899999999999999999999999 999999999999975 7999999
Q ss_pred cCCCccCCCCCCc-cccccCccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCcc
Q 006402 492 FGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRN-----------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVN 559 (646)
Q Consensus 492 fGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~ 559 (646)
||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 245 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence 9999876543322 1223458999999999865 46888999999999999999999998632211
Q ss_pred HHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 560 LAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
............... .... ....+.+++.+||+.+|++|||+.|+++.
T Consensus 246 -~~~~~~~~~~~~~~~-----~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 -ISKLHAIIDPNHEIE-----FPDI--------PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHHHCTTSCCC-----CCCC--------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHhcccccC-----Cccc--------chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111111111000 0000 12346789999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.55 Aligned_cols=201 Identities=25% Similarity=0.296 Sum_probs=171.5
Q ss_pred HHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CC-----cccccceeEEeC
Q 006402 342 KKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HK-----NLVRLLGCCVEA 414 (646)
Q Consensus 342 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 414 (646)
....++|.+.++||+|+||+||+|... +++.||||+++.. ....+.+.+|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345678999999999999999999876 6889999998743 234567788999988885 44 499999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeccCCCCCEEEc--CCCCEEEe
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS--AAYTPIYHRDVKSTNILLD--DDFNSKVA 490 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~--~~~~~i~H~Dik~~NIll~--~~~~~ki~ 490 (646)
+..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+ .+ |+||||||+||||+ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 59999997642 2358999999999999999999995 45 99999999999994 57889999
Q ss_pred ecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006402 491 DFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFS 552 (646)
Q Consensus 491 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~ 552 (646)
|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 204 DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998765432 2345899999999999989999999999999999999999999743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.23 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=171.7
Q ss_pred hcCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEe----CCcCe
Q 006402 345 TNGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQPL 418 (646)
Q Consensus 345 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 418 (646)
.++|.+. ++||+|+||+||++..+ +++.||||++... .+...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678885 46999999999999876 6899999998643 1222223334667789999999999986 34578
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCCC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGLS 495 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl~ 495 (646)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999765 2346999999999999999999999999 999999999999975 456999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||........... .......... .
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~-~ 251 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQY-G 251 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcccc-c
Confidence 8665332 2234589999999999888899999999999999999999999864332211000 0000000000 0
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+.. ......+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 FPNPEW---------SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCTTTS---------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCchhh---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 012345678999999999999999999996
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=331.46 Aligned_cols=265 Identities=18% Similarity=0.212 Sum_probs=196.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-----------CCcccccceeEEe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-----------HKNLVRLLGCCVE 413 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 413 (646)
++|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57999999999999999999874 7899999998643 344567889999999886 8999999999987
Q ss_pred CC----cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEc------
Q 006402 414 AE----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLD------ 482 (646)
Q Consensus 414 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~------ 482 (646)
.+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 678999999 899999997542 33589999999999999999999998 8 99999999999994
Q ss_pred CCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHH-
Q 006402 483 DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA- 561 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~- 561 (646)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 44589999999998765332 2235899999999999989999999999999999999999999754322111111
Q ss_pred --HHHHHHhcCCc---------ccccccc-----cccC-Cchh---------HHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 006402 562 --IYVSQRASNGA---------IMEVVDP-----RLQG-HEAS---------VNILMSLKLFSELAVACLREKKSERPSM 615 (646)
Q Consensus 562 --~~~~~~~~~~~---------~~~~~d~-----~l~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RPs~ 615 (646)
..+........ ....+.. .+.. .... .........+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111110000 0000000 0000 0000 0012345678899999999999999999
Q ss_pred HHHHH
Q 006402 616 TDVVH 620 (646)
Q Consensus 616 ~evl~ 620 (646)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=326.69 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=177.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHH-HHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVG-ILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|...+.||+|+||.||++..+ +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888999999999999999875 68999999987653 233455666666 777789999999999999999999999
Q ss_pred EEccCCCccccccCCc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 422 EYIANGTLHDHLHGKY--SSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
||+++ +|.+++.... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 7877775311 234689999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCCCccccccCccccccCcccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYY----RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
...... ....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .. .....+.
T Consensus 177 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~-- 246 (327)
T 3aln_A 177 VDSIAK--TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGD-- 246 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC--
T ss_pred cccccc--ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCC--
Confidence 543222 223589999999998 456789999999999999999999999864321100 00 0000000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ---~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 ---PPQLSNSEE----REFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCCCCCSS----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCccc----ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 011111000 012345778999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.62 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=185.1
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEcc
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556889999999998776668999999988643 345678999999986 89999999999999999999999995
Q ss_pred CCCccccccCCcCCC-C---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-------------CCEE
Q 006402 426 NGTLHDHLHGKYSSF-N---LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD-------------FNSK 488 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~-~---l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~-------------~~~k 488 (646)
|+|.+++....... . .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997653211 1 133456789999999999999999 9999999999999754 4899
Q ss_pred EeecCCCccCCCCCCc---cccccCccccccCcccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 006402 489 VADFGLSRLAKPGLSH---VSTCAQGTLGYLDPEYYRN-------YQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDD 557 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~ 557 (646)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-- 246 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-- 246 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence 9999999877654322 1223469999999999865 568999999999999999999 89998532211
Q ss_pred ccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 558 VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+.... ...... +.+. ......++.+|+.+||+.||.+|||+.||++
T Consensus 247 ---~~~i~~~~--~~~~~~--~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---ESNIIRGI--FSLDEM--KCLH-------DRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHHTC--CCCCCC--TTCC-------CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHhcCC--CCcccc--cccc-------cccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111100 000000 0000 1234466789999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.21 Aligned_cols=263 Identities=19% Similarity=0.232 Sum_probs=198.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CC-cEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc------ccccceeEEeCCc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DG-TVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN------LVRLLGCCVEAEQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 416 (646)
.++|++.+.||+|+||+||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999875 34 78999998643 344577889999999997766 8999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---------------
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL--------------- 481 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll--------------- 481 (646)
.++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66777777543 2345899999999999999999999999 9999999999999
Q ss_pred ----cCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 006402 482 ----DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557 (646)
Q Consensus 482 ----~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~ 557 (646)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 568899999999998754332 23458999999999998899999999999999999999999997432211
Q ss_pred ccHHHHHHHHhcCC--------cccc-cccccc--cCCchh---------------HHHHHHHHHHHHHHHHhcccCCCC
Q 006402 558 VNLAIYVSQRASNG--------AIME-VVDPRL--QGHEAS---------------VNILMSLKLFSELAVACLREKKSE 611 (646)
Q Consensus 558 ~~~~~~~~~~~~~~--------~~~~-~~d~~l--~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~ 611 (646)
....+....... .... ...... ...... .........+.+|+.+||+.||++
T Consensus 247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111111111000 0000 000000 000000 001122446789999999999999
Q ss_pred CCCHHHHHH
Q 006402 612 RPSMTDVVH 620 (646)
Q Consensus 612 RPs~~evl~ 620 (646)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=324.14 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=189.4
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc------cHHHHHHHHHHHhhC----CCCcccccc
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK------STQQVLNEVGILSQV----NHKNLVRLL 408 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~ 408 (646)
+.....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456688999999999999999999764 6899999998754332 233456799999998 899999999
Q ss_pred eeEEeCCcCeEEEEE-ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCC
Q 006402 409 GCCVEAEQPLLIYEY-IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFN 486 (646)
Q Consensus 409 ~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~ 486 (646)
+++.+.+..++|+|+ +.+++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 7899999999753 35899999999999999999999999 99999999999999 8899
Q ss_pred EEEeecCCCccCCCCCCccccccCccccccCccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH
Q 006402 487 SKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT-DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS 565 (646)
Q Consensus 487 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~ 565 (646)
+||+|||+++...... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||.... . ..
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~-~~ 246 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E-IL 246 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-HH
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H-Hh
Confidence 9999999998765432 2234589999999998776664 58999999999999999999985210 0 00
Q ss_pred HHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 566 QRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 566 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .... +.. .....+.+++.+||+.+|++|||+.|+++
T Consensus 247 ~--~~~~--------~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 E--AELH--------FPA--------HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H--TCCC--------CCT--------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h--hccC--------Ccc--------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000 000 11234678999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=327.11 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=197.2
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc------cHHHHHHHHHHHhhCC--CCccccccee
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK------STQQVLNEVGILSQVN--HKNLVRLLGC 410 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~ 410 (646)
+.....++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999764 6899999998654321 2245678999999996 5999999999
Q ss_pred EEeCCcCeEEEEEccC-CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEE
Q 006402 411 CVEAEQPLLIYEYIAN-GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSK 488 (646)
Q Consensus 411 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~k 488 (646)
+.+.+..++|+|++.+ ++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999976 8999998753 35899999999999999999999999 99999999999999 788999
Q ss_pred EeecCCCccCCCCCCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHH
Q 006402 489 VADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567 (646)
Q Consensus 489 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 567 (646)
|+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... . .
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~-~--- 255 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E-I--- 255 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-H---
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h-h---
Confidence 99999998765432 223458999999999977665 678999999999999999999985221 0 0
Q ss_pred hcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... .. ..... ....+.+|+.+||+.+|++|||+.|+++
T Consensus 256 ~~~-~~--~~~~~------------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRG-QV--FFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHC-CC--CCSSC------------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcc-cc--ccccc------------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 00111 1234678999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=317.39 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=177.8
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc-c-HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK-S-TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.++|+..+.||+|+||+||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999886 6899999998755332 2 233445556788889999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
||+ ++.+..+... ....+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455444432 234689999999999999999999995 8 99999999999999999999999999976654
Q ss_pred CCCccccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
.... ....+|+.|+|||.+. ...++.++||||||+++|||++|+.||...... . ...........
T Consensus 178 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~~~--- 247 (318)
T 2dyl_A 178 DKAK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--F---EVLTKVLQEEP--- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--H---HHHHHHHHSCC---
T ss_pred Cccc--cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--H---HHHHHHhccCC---
Confidence 3222 2335899999999984 456889999999999999999999998632211 1 11111111110
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+.+.... .....+.+++.+||+.||.+|||+.|+++
T Consensus 248 ---~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ---PLLPGHM------GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCCCSSS------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCCCccC------CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0010000 11234678999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=330.13 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=185.1
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.+|...++||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +|||||++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 468888999999999976655668899999998654332 356899999999 7999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-----CCCCEEEeecCCCccCC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-----DDFNSKVADFGLSRLAK 499 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-----~~~~~ki~DfGl~~~~~ 499 (646)
. |+|.+++.... ..+.+..++.++.||++||+|||+.+ |+||||||+|||++ ....+||+|||+++...
T Consensus 101 ~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 5 69999997643 23445567789999999999999999 99999999999994 33468899999998775
Q ss_pred CCCC--ccccccCccccccCccccc---cCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 500 PGLS--HVSTCAQGTLGYLDPEYYR---NYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 500 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
.... .......||+.|+|||++. ...++.++||||||+++|||++ |..||...... . .........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~---~~~~~~~~~- 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----Q---ANILLGACS- 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----H---HHHHTTCCC-
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----H---HHHHhccCC-
Confidence 4322 1223456999999999997 4567889999999999999999 88887522111 0 111111111
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+ .......+.+|+.+||+.||.+|||+.||++
T Consensus 247 ~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LDCLHP----------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTSCT----------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCc----------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 1122344678999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=348.74 Aligned_cols=242 Identities=20% Similarity=0.322 Sum_probs=196.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc--CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCc-----C
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ--DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ-----P 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 417 (646)
++|++.+.||+|+||+||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999875 68999999986543 3445678999999999999999999999998765 6
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++||||+++++|.+++.. .+++..++.|+.||++||.|||+.+ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999998753 5899999999999999999999999 9999999999999986 999999999987
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
.... ....||+.|+|||++.+. ++.++||||||++||||++|..|+.......
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------- 283 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------- 283 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------------------
Confidence 6543 234599999999998765 4899999999999999999988875211100
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-MTDVVHELQRIIEIV 629 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-~~evl~~L~~~~~~~ 629 (646)
+.... ........+.+|+.+||+.||++||+ ++++.+.|..+....
T Consensus 284 ---~~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 284 ---LPEDD---PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp ---CCTTC---HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ---ccccc---cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 00000 01223355778999999999999995 777778888776544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.61 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEe------CCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE------AEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 417 (646)
++|.+.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999774 6899999988754 33456779999999999999999999998765 6678
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---EEEeecCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFN---SKVADFGL 494 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~---~ki~DfGl 494 (646)
++||||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999987554456899999999999999999999999 999999999999997665 99999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC----
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---- 570 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 570 (646)
+......... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..|.......
T Consensus 171 a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGELC--TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCCC--CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred cccccccccc--ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence 9876544322 3345899999999999999999999999999999999999998643111 0000000000
Q ss_pred Cccccccc------ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006402 571 GAIMEVVD------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 571 ~~~~~~~d------~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl 619 (646)
....+... ..+..... ........+.+++.+||+.||++|||+.|++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~--l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCC--CCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhccccccccccCCchh--hchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000000 00000000 0112445678999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.27 Aligned_cols=234 Identities=14% Similarity=0.086 Sum_probs=183.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999876 589999999976533 33578999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++++|.+++... ....++.+|+.|++.||+|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999542 355678899999999999999999 9999999999999999999998443
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
|++ .++.++||||||+++|||+||+.||......+..... ...+....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~~ 222 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQP 222 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSCB
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccCC
Confidence 333 3688999999999999999999999754332211000 00000000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
. ............+.+|+.+||+.||++| |+.|+++.|+++.....
T Consensus 223 ~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 223 I--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp C--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred C--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0 0000001123457799999999999999 99999999999875543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=328.31 Aligned_cols=253 Identities=15% Similarity=0.141 Sum_probs=185.0
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCC-Cccccccee--------
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNH-KNLVRLLGC-------- 410 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~-------- 410 (646)
...+|...++||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.+++.++| +|...+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445777899999999999999865 699999999874433 235789999999999987 322211111
Q ss_pred -------------EEe-----CCcCeEEEEEccCCCccccccCC----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006402 411 -------------CVE-----AEQPLLIYEYIANGTLHDHLHGK----YSSFNLTWSTRLRIALQTAEALAYLHSAAYTP 468 (646)
Q Consensus 411 -------------~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 468 (646)
+.. ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 111 12345666654 78999988411 12335788999999999999999999999
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCcccc----------ccCCCCchhhHHHHHHH
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY----------RNYQLTDKSDVYSYGVV 538 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDv~s~G~l 538 (646)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998865432 233457 999999998 55568899999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006402 539 LLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618 (646)
Q Consensus 539 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ev 618 (646)
+|||++|+.||......+.. ..++. ... ...+.+.+|+.+||+.+|++|||+.|+
T Consensus 307 l~elltg~~Pf~~~~~~~~~---------------~~~~~----~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS---------------EWIFR----SCK------NIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS---------------GGGGS----SCC------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCcchhhhH---------------HHHHh----hcc------cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999643221110 11111 000 112457789999999999999999998
Q ss_pred HHH--HHHHHHHHh
Q 006402 619 VHE--LQRIIEIVN 630 (646)
Q Consensus 619 l~~--L~~~~~~~~ 630 (646)
++. ++++.+.+.
T Consensus 362 l~~~~~~~~~~~~~ 375 (413)
T 3dzo_A 362 METPEYEQLRTELS 375 (413)
T ss_dssp TTSHHHHHHHHHHH
T ss_pred HhCHHHHHHHHHHH
Confidence 753 444444443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=300.83 Aligned_cols=231 Identities=20% Similarity=0.268 Sum_probs=178.1
Q ss_pred hcCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHH-hhCCCCcccccceeEEe----CCcC
Q 006402 345 TNGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGIL-SQVNHKNLVRLLGCCVE----AEQP 417 (646)
Q Consensus 345 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 417 (646)
.++|.+. ++||+|+||.||++... +++.||+|+++. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567766 78999999999999874 689999999853 24567888888 55689999999999987 6678
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGL 494 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl 494 (646)
++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999764 2346899999999999999999999999 999999999999997 78999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+..... ..++.++||||||+++|||++|+.||........ ......
T Consensus 167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 865421 3467799999999999999999999863322110 000000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
........ ............+.+|+.+||+.||++|||+.|+++
T Consensus 213 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQYE--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCCS--SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhcccc--CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 000001123456789999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=313.06 Aligned_cols=240 Identities=20% Similarity=0.209 Sum_probs=181.8
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCC--------cccHHHHHHHHHHHhhCC-----------------
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGN--------IKSTQQVLNEVGILSQVN----------------- 400 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~----------------- 400 (646)
++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5688889999999999999987 68999999987653 233578899999999886
Q ss_pred ---------CCcccccceeEEe-------------CCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHH
Q 006402 401 ---------HKNLVRLLGCCVE-------------AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458 (646)
Q Consensus 401 ---------h~niv~l~~~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 458 (646)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 4555555555554 6788999999999987777743 3489999999999999999
Q ss_pred HHHH-hCCCCCeeeccCCCCCEEEcCCC--------------------CEEEeecCCCccCCCCCCccccccCccccccC
Q 006402 459 AYLH-SAAYTPIYHRDVKSTNILLDDDF--------------------NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517 (646)
Q Consensus 459 ~yLH-~~~~~~i~H~Dik~~NIll~~~~--------------------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~a 517 (646)
+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|+|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 899 99999999999999886 8999999999876532 2359999999
Q ss_pred ccccccCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCCCCccHHHHHHHHhc-CCcccccccccccCCchhHHHHHHHH
Q 006402 518 PEYYRNYQLTDKSDVYSYGVV-LLELLTSQKAIDFSRDPDDVNLAIYVSQRAS-NGAIMEVVDPRLQGHEASVNILMSLK 595 (646)
Q Consensus 518 PE~~~~~~~~~ksDv~s~G~l-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~ 595 (646)
||++.+.. +.++||||++.+ .+++++|..||.. ............ ..... ............+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFK--------TKCNTPAMKQIKR 310 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCS--------SCCCSHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccC--------cccchhhhhhcCH
Confidence 99998766 889999998777 7788889888741 000011111111 00000 0011111334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 006402 596 LFSELAVACLREKKSERPSMTDVV 619 (646)
Q Consensus 596 ~~~~li~~cl~~~p~~RPs~~evl 619 (646)
++.+|+.+||+.+ |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 7889999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-30 Score=283.25 Aligned_cols=184 Identities=17% Similarity=0.107 Sum_probs=129.4
Q ss_pred ecccCcEEEEEEE-EcCCcEEEEEEcccCC----------cccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEEE
Q 006402 354 LGSGGFGEVYKGE-LQDGTVVAVKSAKVGN----------IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 354 Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 421 (646)
.+.|+.|.+..++ .-.|+.+|+|++.... ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666665553 3358889999986542 12346799999999999 6999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||++|++|.++|... .+++.. +|+.||+.||+|||+++ |+||||||+||||++++++||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999754 346654 58899999999999999 999999999999999999999999999877654
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKA 548 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p 548 (646)
.... ....||++|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~~~-~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWP-TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCS-HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cccc-cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 3322 33459999999999976 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=256.99 Aligned_cols=184 Identities=16% Similarity=0.230 Sum_probs=146.6
Q ss_pred CcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc--------cHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 349 SKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK--------STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
...++||+|+||+||+++. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 5678888876433211 135589999999999999999877777788889999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++++|.++++. ++.++.|+++||+|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999864 4589999999999999999 999999999999999 999999999998765
Q ss_pred CCCcc------ccccCccccccCcccccc--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 006402 501 GLSHV------STCAQGTLGYLDPEYYRN--YQLTDKSDVYSYGVVLLELLTSQKAI 549 (646)
Q Consensus 501 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~ll~elltg~~p~ 549 (646)
..... .....||+.|+|||++.. ..|+.++|+||..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 124469999999999976 56788899999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-24 Score=214.95 Aligned_cols=152 Identities=18% Similarity=0.125 Sum_probs=123.0
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc------------------ccHHHHHHHHHHHhhCCC
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI------------------KSTQQVLNEVGILSQVNH 401 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 401 (646)
.+......|.+.+.||+|+||.||+|...+|+.||+|+++.... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444556677799999999999999887799999999864321 13457899999999999
Q ss_pred CcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 006402 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481 (646)
Q Consensus 402 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll 481 (646)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 5 77777654 467799999999999998 532 123469999999999999999 9999999999999
Q ss_pred cCCCCEEEeecCCCccCCCCCCccccccCccccccCcccccc
Q 006402 482 DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523 (646)
Q Consensus 482 ~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 523 (646)
+ ++.+||+|||+++. +..+.|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9 99999999999863 445788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=180.33 Aligned_cols=136 Identities=19% Similarity=0.181 Sum_probs=105.9
Q ss_pred CCcccEecccCcEEEEEEEE-cCCcE--EEEEEcccCCcc------------------------cHHHHHHHHHHHhhCC
Q 006402 348 FSKERILGSGGFGEVYKGEL-QDGTV--VAVKSAKVGNIK------------------------STQQVLNEVGILSQVN 400 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 400 (646)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 68888 999986543111 1136789999999999
Q ss_pred CCcc--cccceeEEeCCcCeEEEEEccC-C----CccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeec
Q 006402 401 HKNL--VRLLGCCVEAEQPLLIYEYIAN-G----TLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH-SAAYTPIYHR 472 (646)
Q Consensus 401 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~i~H~ 472 (646)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8864 333332 467999999942 4 45444321 234467789999999999999 888 9999
Q ss_pred cCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 473 DVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 473 Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.1e-17 Score=169.67 Aligned_cols=138 Identities=12% Similarity=0.151 Sum_probs=98.9
Q ss_pred CCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc--------------ccHHHHH--------HHHHHHhhCCCCcc
Q 006402 347 GFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--------------KSTQQVL--------NEVGILSQVNHKNL 404 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~--------~E~~~l~~l~h~ni 404 (646)
-|++.+.||+|++|.||+|...+|+.||||+++.... ......+ +|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999988999999998753210 0111222 34455555543332
Q ss_pred cccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC
Q 006402 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDD 484 (646)
Q Consensus 405 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~ 484 (646)
.-..-+ .....+|||||+++++|.++... .....++.|++.+|.|||..+ |+||||||.||||+++
T Consensus 176 ~vp~p~--~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPI--AQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEE--EEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCeee--eccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 211111 12245799999999888776431 123568899999999999999 9999999999999877
Q ss_pred C----------CEEEeecCCCccC
Q 006402 485 F----------NSKVADFGLSRLA 498 (646)
Q Consensus 485 ~----------~~ki~DfGl~~~~ 498 (646)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999976643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=128.21 Aligned_cols=148 Identities=18% Similarity=0.113 Sum_probs=114.7
Q ss_pred HHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCe
Q 006402 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 340 el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 418 (646)
.+......|+....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455567888888888999999998754 6789999886532223345888999999885 677889999998888899
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA--------------------------------- 465 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------- 465 (646)
+||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 87 lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999998876421 1223478889999999999811
Q ss_pred -----------------------CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 466 -----------------------YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 466 -----------------------~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=2.7e-11 Score=120.48 Aligned_cols=138 Identities=20% Similarity=0.174 Sum_probs=101.9
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--ccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e 422 (646)
...+....+.+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445543333456669999998777888999987543 2245778999999886544 4568888887778899999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA------------------------------------- 465 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------- 465 (646)
|++|.+|. ... .+ ...++.++++.|+.||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 211 11 2357788888889888753
Q ss_pred ------------------CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 466 ------------------YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 466 ------------------~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=4.5e-10 Score=117.49 Aligned_cols=143 Identities=16% Similarity=0.262 Sum_probs=107.1
Q ss_pred cccEecccCcEEEEEEEEcCCcEEEEEEcc--cCC-cccHHHHHHHHHHHhhCC--CCcccccceeEEeC---CcCeEEE
Q 006402 350 KERILGSGGFGEVYKGELQDGTVVAVKSAK--VGN-IKSTQQVLNEVGILSQVN--HKNLVRLLGCCVEA---EQPLLIY 421 (646)
Q Consensus 350 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 421 (646)
..+.|+.|.++.||+.+..+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 577888765 322 123456788999999997 45578888888766 3589999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA------------------------------------ 465 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------ 465 (646)
||++|..+.+... ..++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988865321 23678888999999999999999831
Q ss_pred -------------------CCCeeeccCCCCCEEEcCCCC--EEEeecCCCccC
Q 006402 466 -------------------YTPIYHRDVKSTNILLDDDFN--SKVADFGLSRLA 498 (646)
Q Consensus 466 -------------------~~~i~H~Dik~~NIll~~~~~--~ki~DfGl~~~~ 498 (646)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 234999999999999997653 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=4.8e-10 Score=114.43 Aligned_cols=186 Identities=21% Similarity=0.237 Sum_probs=122.4
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCc--ccccceeEEeCC---cCeEEEEEc
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKN--LVRLLGCCVEAE---QPLLIYEYI 424 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~ 424 (646)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 45888875422 34567889999998884 333 334444433332 357899999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA--------------------------------------- 465 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------- 465 (646)
+|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988875432 13677888899999999999999621
Q ss_pred ----------------CCCeeeccCCCCCEEEcC--CCCEEEeecCCCccCCCCCCcccccc----C---------cccc
Q 006402 466 ----------------YTPIYHRDVKSTNILLDD--DFNSKVADFGLSRLAKPGLSHVSTCA----Q---------GTLG 514 (646)
Q Consensus 466 ----------------~~~i~H~Dik~~NIll~~--~~~~ki~DfGl~~~~~~~~~~~~~~~----~---------gt~~ 514 (646)
.+.++|+|++|.||++++ +..+.|+||+.+....+......... . ...+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134799999999999998 55688999999875432110000000 0 0001
Q ss_pred ccC-ccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006402 515 YLD-PEYYRNYQLTDKSDVYSYGVVLLELLTSQKAI 549 (646)
Q Consensus 515 y~a-PE~~~~~~~~~ksDv~s~G~ll~elltg~~p~ 549 (646)
... |+.... .....+.|+++.+++.+.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 222111 112368999999999999997654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.8e-06 Score=87.87 Aligned_cols=136 Identities=18% Similarity=0.165 Sum_probs=96.8
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC---cccccceeEE-eCCcCeEEEEEccC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK---NLVRLLGCCV-EAEQPLLIYEYIAN 426 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~ 426 (646)
.+.++.|....||+. +..+++|+.. .......+.+|..+|..+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888999987 4567888742 223456788999999999753 3556666664 34467899999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA----------------------------------------- 465 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------- 465 (646)
.+|.+.... .++...+..++.++++.|+.||+..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 2455666667777777777777532
Q ss_pred ----------------CCCeeeccCCCCCEEEcC---CCCE-EEeecCCCcc
Q 006402 466 ----------------YTPIYHRDVKSTNILLDD---DFNS-KVADFGLSRL 497 (646)
Q Consensus 466 ----------------~~~i~H~Dik~~NIll~~---~~~~-ki~DfGl~~~ 497 (646)
.+.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 4554 8999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.4e-06 Score=90.67 Aligned_cols=81 Identities=11% Similarity=0.096 Sum_probs=56.5
Q ss_pred cEe-cccCcEEEEEEEEc-------CCcEEEEEEcccCC---cccHHHHHHHHHHHhhCC-C--CcccccceeEEeC---
Q 006402 352 RIL-GSGGFGEVYKGELQ-------DGTVVAVKSAKVGN---IKSTQQVLNEVGILSQVN-H--KNLVRLLGCCVEA--- 414 (646)
Q Consensus 352 ~~L-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 414 (646)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998764 26678888765322 111245678888888875 3 3467777776654
Q ss_pred CcCeEEEEEccCCCcccc
Q 006402 415 EQPLLIYEYIANGTLHDH 432 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~ 432 (646)
+..++||||++|..+.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 356899999999887653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=4e-06 Score=83.41 Aligned_cols=135 Identities=19% Similarity=0.144 Sum_probs=97.0
Q ss_pred EecccCcE-EEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 353 ILGSGGFG-EVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 353 ~Lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455554 68987665 466788897543 23456788999998885 33467888998888899999999999887
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-------------------------------------------
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY------------------------------------------- 466 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~------------------------------------------- 466 (646)
.+..... ......+..++++.|+-||....
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654321 12234566677777777775321
Q ss_pred ------------CCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 467 ------------TPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 467 ------------~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999887777999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.2e-05 Score=79.57 Aligned_cols=140 Identities=14% Similarity=0.177 Sum_probs=79.8
Q ss_pred cEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC--Ccccccce------eEEeCCcCeEEEEE
Q 006402 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH--KNLVRLLG------CCVEAEQPLLIYEY 423 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~e~ 423 (646)
+.|+.|..+.||+....+| .+++|+.... .+.+..|..++..+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 4889987642 2333445555555431 12334433 12345667899999
Q ss_pred ccCCCccc--------------cccCCcC----C-------CCCCHHHHH------------------------------
Q 006402 424 IANGTLHD--------------HLHGKYS----S-------FNLTWSTRL------------------------------ 448 (646)
Q Consensus 424 ~~~gsL~~--------------~l~~~~~----~-------~~l~~~~~~------------------------------ 448 (646)
++|..+.. .+|.... . ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 1121100 0 011332211
Q ss_pred -HHHHHHHHHHHHHHh--------C--CCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 449 -RIALQTAEALAYLHS--------A--AYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 449 -~i~~~ia~~l~yLH~--------~--~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+...+.+++++|+. . ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224446677763 1 23459999999999999878899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=3e-05 Score=81.81 Aligned_cols=75 Identities=16% Similarity=0.150 Sum_probs=49.5
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-------ccHHHHHHHHHHHhhCCC--Ccc-cccceeEEeCCcCeE
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-------KSTQQVLNEVGILSQVNH--KNL-VRLLGCCVEAEQPLL 419 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~ni-v~l~~~~~~~~~~~l 419 (646)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.++++.+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899997543211 123456789999888742 333 345433 4556789
Q ss_pred EEEEccCC
Q 006402 420 IYEYIANG 427 (646)
Q Consensus 420 V~e~~~~g 427 (646)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=8.4e-05 Score=74.58 Aligned_cols=78 Identities=18% Similarity=0.137 Sum_probs=57.3
Q ss_pred CCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCC---cccccceeEEeCCcCeEEEEEc
Q 006402 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHK---NLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 348 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~~ 424 (646)
....+.+|.|..+.||+.++.||+.|++|+...........|..|+..|+.+.-. -+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 3445779999999999999999999999987655444445678899999988522 23444443 3458999999
Q ss_pred cCCCc
Q 006402 425 ANGTL 429 (646)
Q Consensus 425 ~~gsL 429 (646)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=6.4e-05 Score=79.94 Aligned_cols=79 Identities=13% Similarity=0.123 Sum_probs=48.8
Q ss_pred CCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccC---CCCchhhHHHHHHHHHHHH
Q 006402 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY---QLTDKSDVYSYGVVLLELL 543 (646)
Q Consensus 467 ~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~ll~ell 543 (646)
+.++|+|+++.|||++.++ ++|+||+.+....+...-......-...|.+|+..... .-....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4499999999999999876 99999998875432211100000012346666654311 1122456668888888887
Q ss_pred cCC
Q 006402 544 TSQ 546 (646)
Q Consensus 544 tg~ 546 (646)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00031 Score=71.10 Aligned_cols=138 Identities=18% Similarity=0.179 Sum_probs=91.7
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC---CCcccccceeEEeCCcCeEEEEEccCC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN---HKNLVRLLGCCVEAEQPLLIYEYIANG 427 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~g 427 (646)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999876 4667888976532 3567889999998884 356888888888778899999999987
Q ss_pred Cccc-----------cccCCcC--C-----------------CCCCHHHHH---HHH----------------HHHHHH-
Q 006402 428 TLHD-----------HLHGKYS--S-----------------FNLTWSTRL---RIA----------------LQTAEA- 457 (646)
Q Consensus 428 sL~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~----------------~~ia~~- 457 (646)
.+.. .||.... . ..-+|.... ++. ..+.+.
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6532 1222111 0 012454321 111 111111
Q ss_pred HHHHHh-CCCCCeeeccCCCCCEEEcCCCCEEEeecC
Q 006402 458 LAYLHS-AAYTPIYHRDVKSTNILLDDDFNSKVADFG 493 (646)
Q Consensus 458 l~yLH~-~~~~~i~H~Dik~~NIll~~~~~~ki~DfG 493 (646)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2245699999999999999887 8899974
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00062 Score=72.38 Aligned_cols=73 Identities=16% Similarity=0.213 Sum_probs=50.6
Q ss_pred cEecccCcEEEEEEEEcC--------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEE
Q 006402 352 RILGSGGFGEVYKGELQD--------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 422 (646)
+.|+.|....+|+....+ ++.+++|+.... ...+.+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568888899999998753 478999987432 122566689999988864444 566665432 38999
Q ss_pred EccCCCcc
Q 006402 423 YIANGTLH 430 (646)
Q Consensus 423 ~~~~gsL~ 430 (646)
|++|.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0021 Score=65.27 Aligned_cols=158 Identities=13% Similarity=0.124 Sum_probs=87.5
Q ss_pred ccHHHHHHHhcCCCc-----ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--ccccc
Q 006402 336 FHLKELKKATNGFSK-----ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRLL 408 (646)
Q Consensus 336 ~~~~el~~~~~~~~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 408 (646)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... ...+.+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455666666666654 24466788899999987666 5778887642 11234456777776664222 23333
Q ss_pred ee------EEeCCcCeEEEEEccCCCcccc--------------ccCCc---CCC---CC---CHHHHHH----------
Q 006402 409 GC------CVEAEQPLLIYEYIANGTLHDH--------------LHGKY---SSF---NL---TWSTRLR---------- 449 (646)
Q Consensus 409 ~~------~~~~~~~~lV~e~~~~gsL~~~--------------l~~~~---~~~---~l---~~~~~~~---------- 449 (646)
.. ....+..+++++|++|..+... +|... ... .. .|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1223456899999998765321 12110 000 01 1322111
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 450 --IALQTAEALAYLHSA----AYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 450 --i~~~ia~~l~yLH~~----~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
+...+.+.++.++.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244555666532 12348999999999999987556899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.003 Score=64.28 Aligned_cols=159 Identities=15% Similarity=0.115 Sum_probs=89.7
Q ss_pred cccHHHHHHHhcCCCc-----ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc--cccc
Q 006402 335 IFHLKELKKATNGFSK-----ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN--LVRL 407 (646)
Q Consensus 335 ~~~~~el~~~~~~~~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 407 (646)
..+.+++..+...|.. .+.|+ |....||+....+|+.+++|...... ...+.+..|..++..+.... ++++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence 3455555554444432 34566 88889999877777789999876332 23456677888887774222 4445
Q ss_pred cee-----EEeCCcCeEEEEEccCCCccc----c----------ccCCc------CCCCCCHHHH----HHH--------
Q 006402 408 LGC-----CVEAEQPLLIYEYIANGTLHD----H----------LHGKY------SSFNLTWSTR----LRI-------- 450 (646)
Q Consensus 408 ~~~-----~~~~~~~~lV~e~~~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i-------- 450 (646)
+.. ....+..++||||++|..+.. . +|... ....+++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 443 112344578999998865431 0 11100 0111222211 000
Q ss_pred -------HHHHHHHHHHHHhC----CCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 451 -------ALQTAEALAYLHSA----AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 451 -------~~~ia~~l~yLH~~----~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
...+.+.++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 223489999999999999 4 899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0014 Score=66.01 Aligned_cols=129 Identities=17% Similarity=0.164 Sum_probs=76.0
Q ss_pred ccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEEc-cCCC
Q 006402 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEYI-ANGT 428 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gs 428 (646)
.+.|+.|....+|+. +.+++|+........ -+..+|+.+++.+...++ .+++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 457888765432111 122467777777753333 355543 344567999999 6655
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 006402 429 LHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-------------------------------------------- 464 (646)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-------------------------------------------- 464 (646)
|...... .+..++.++++.|+-||+.
T Consensus 95 l~~~~~~----------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFK----------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHH----------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHh----------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 5321000 0001222233333333321
Q ss_pred ------CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 465 ------AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 465 ------~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
....++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 1233899999999999 55668899999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0012 Score=68.74 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=83.3
Q ss_pred cEecccCcEEEEEEEEc--------CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc-ccccceeEEeCCcCeEEEE
Q 006402 352 RILGSGGFGEVYKGELQ--------DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN-LVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e 422 (646)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+.-.+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889998764 2478999986332 234566779999998885323 3566665443 39999
Q ss_pred EccCCCcccc-----------------ccCCc--CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 006402 423 YIANGTLHDH-----------------LHGKY--SSFNLT--WSTRLRIALQTAE-------------------ALAYL- 461 (646)
Q Consensus 423 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~l~yL- 461 (646)
|++|.+|..- ||... ...... |.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 11110 011122 4455555444321 22333
Q ss_pred ---HhCC-CCCeeeccCCCCCEEEcCC----CCEEEeecCCCcc
Q 006402 462 ---HSAA-YTPIYHRDVKSTNILLDDD----FNSKVADFGLSRL 497 (646)
Q Consensus 462 ---H~~~-~~~i~H~Dik~~NIll~~~----~~~ki~DfGl~~~ 497 (646)
.... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 2348999999999999876 7899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0026 Score=67.92 Aligned_cols=75 Identities=13% Similarity=0.014 Sum_probs=48.6
Q ss_pred ccEecccCcEEEEEEEEcC-CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEEEccCCC
Q 006402 351 ERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYEYIANGT 428 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gs 428 (646)
.+.|+.|-...+|+....+ +..+++|+........ -+..+|..++..+...++ .++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568889899999998765 4788899764332111 112478888988875555 56666652 2 36999998866
Q ss_pred cc
Q 006402 429 LH 430 (646)
Q Consensus 429 L~ 430 (646)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.002 Score=65.86 Aligned_cols=33 Identities=27% Similarity=0.372 Sum_probs=27.8
Q ss_pred CCeeeccCCCCCEEEcCC----CCEEEeecCCCccCC
Q 006402 467 TPIYHRDVKSTNILLDDD----FNSKVADFGLSRLAK 499 (646)
Q Consensus 467 ~~i~H~Dik~~NIll~~~----~~~ki~DfGl~~~~~ 499 (646)
..++|+|+.+.|||++.+ ..+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 459999999999999874 689999999887543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0022 Score=66.56 Aligned_cols=73 Identities=15% Similarity=0.129 Sum_probs=44.2
Q ss_pred cEecccCcEEEEEEEEcC---------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc-ccccceeEEeCCcCeEEE
Q 006402 352 RILGSGGFGEVYKGELQD---------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN-LVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 421 (646)
+.|+.|..-.+|+....+ ++.+++|+...... ...+...|..+++.+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 457788888999997754 26788888654321 1112357888888775334 34566543 247899
Q ss_pred EEccCCCc
Q 006402 422 EYIANGTL 429 (646)
Q Consensus 422 e~~~~gsL 429 (646)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.016 Score=59.30 Aligned_cols=32 Identities=22% Similarity=0.383 Sum_probs=27.6
Q ss_pred CCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 467 ~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 34999999999999998888999999876543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.037 Score=51.94 Aligned_cols=103 Identities=14% Similarity=0.047 Sum_probs=67.1
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCccc
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVS 506 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~~ 506 (646)
-+|.+.|... +.++++.++|.++.|.+++|.-+-....+ ..+=+.|..|+|..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence 4788888653 45799999999999999998776321111 1233457999999999988764 1111
Q ss_pred cccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 006402 507 TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKA 548 (646)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p 548 (646)
.....+.+||... ...+.+.-|||+|++||.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0223466888764 3557899999999999999865443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.35 E-value=0.028 Score=59.20 Aligned_cols=141 Identities=14% Similarity=0.118 Sum_probs=83.8
Q ss_pred ccEecccCcEEEEEEEEcC--------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCc-ccccceeEEeCCcCeEEE
Q 006402 351 ERILGSGGFGEVYKGELQD--------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKN-LVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 421 (646)
.+.|..|-...+|+....+ ++.+++|+...... ..-+..+|..+++.+.-.+ ..++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567778888999998753 57899998654321 1112347888888775333 34555432 247899
Q ss_pred EEccCCCcccc-c----------------cCCc----------CCCCCCHHHHHHHHHHH-------------------H
Q 006402 422 EYIANGTLHDH-L----------------HGKY----------SSFNLTWSTRLRIALQT-------------------A 455 (646)
Q Consensus 422 e~~~~gsL~~~-l----------------~~~~----------~~~~l~~~~~~~i~~~i-------------------a 455 (646)
||++|.+|..- + |... ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 1 1100 11111244444443322 2
Q ss_pred HHHHHHHh---------------------CCCCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 456 EALAYLHS---------------------AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 456 ~~l~yLH~---------------------~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
..+.+|.. .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11234899999999999 7788999999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.61 E-value=0.57 Score=48.78 Aligned_cols=29 Identities=31% Similarity=0.463 Sum_probs=24.5
Q ss_pred eeeccCCCCCEEE------cCCCCEEEeecCCCcc
Q 006402 469 IYHRDVKSTNILL------DDDFNSKVADFGLSRL 497 (646)
Q Consensus 469 i~H~Dik~~NIll------~~~~~~ki~DfGl~~~ 497 (646)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.61 E-value=1.2 Score=41.61 Aligned_cols=116 Identities=11% Similarity=0.137 Sum_probs=77.2
Q ss_pred CCCcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 006402 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNI 479 (646)
Q Consensus 400 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NI 479 (646)
.||+++.. .+-.+.+...+.|+- ..+..+|-. -..++...+++++..|+....+++. =+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEc--CcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888866 454555555555543 333333322 1236889999999999988855544 37889999999
Q ss_pred EEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006402 480 LLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAID 550 (646)
Q Consensus 480 ll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~ 550 (646)
+++.++.++|.-.|+-....+ . ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999988876443322 1 12222333467788899999987764
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=86.82 E-value=0.38 Score=32.62 Aligned_cols=28 Identities=25% Similarity=0.533 Sum_probs=21.8
Q ss_pred cCCCCceeccCCCCCceeeecCCCcccC
Q 006402 236 DCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 236 ~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|..+|.|......++|.|.|+.||.|.
T Consensus 10 pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 37 (45)
T 1a3p_A 10 YCLNGGVXMHIESLDSYTCNCVIGYSGD 37 (45)
T ss_dssp CCSSSCEEEECTTTSSEEEECCTTEETT
T ss_pred CCCCCCEEEeecCCCCEEEEcCCCCcCC
Confidence 5777899975334568999999999863
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=85.91 E-value=0.68 Score=32.65 Aligned_cols=28 Identities=29% Similarity=0.672 Sum_probs=22.0
Q ss_pred cCCCCceeccCCCCCceeeecCCCcccC
Q 006402 236 DCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 236 ~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|..+|.|......++|.|.|+.||.|.
T Consensus 13 pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 40 (53)
T 1egf_A 13 YCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp SSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred cCCCCcEEEeeCCCCCEEEECCCCCcCC
Confidence 5888899985334568999999999863
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.67 E-value=0.55 Score=31.58 Aligned_cols=7 Identities=29% Similarity=0.771 Sum_probs=2.8
Q ss_pred eeehHHH
Q 006402 284 ISIGVIS 290 (646)
Q Consensus 284 iiigi~~ 290 (646)
+..++++
T Consensus 13 IA~gVVg 19 (44)
T 2ks1_B 13 IATGMVG 19 (44)
T ss_dssp STHHHHH
T ss_pred EEeehhH
Confidence 3344433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.13 E-value=1.5 Score=41.12 Aligned_cols=114 Identities=11% Similarity=0.101 Sum_probs=73.3
Q ss_pred CCCcccccceeEEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeccCCCCC
Q 006402 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALA-YLHSAAYTPIYHRDVKSTN 478 (646)
Q Consensus 400 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~i~H~Dik~~N 478 (646)
.||++ -..+-.+.+...+.|+--+++.-...++ .++...+++++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 3333355556556665433332223332 3688999999999887766 5544 4788899999
Q ss_pred EEEcCCCCEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006402 479 ILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAI 549 (646)
Q Consensus 479 Ill~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~ 549 (646)
|++|.++.++|.-.|+-... +|. ..+...=.-++=+++..++.++..|
T Consensus 115 L~f~~~~~p~i~hRGi~~~l------------------pP~-----e~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL------------------PPD-----EWDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp EEECTTCCEEESCCEETTTB------------------SSC-----SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCCCcEEEEEcCCcccC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999888764333 222 1122222336677888888877655
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=83.98 E-value=0.45 Score=33.64 Aligned_cols=29 Identities=24% Similarity=0.527 Sum_probs=22.3
Q ss_pred ccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 235 LDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 235 ~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
..|..+|.|......++|.|.|+.||.|.
T Consensus 12 ~pC~nGG~C~~~~~~~~~~C~C~~GytG~ 40 (53)
T 1nql_B 12 GYCLHDGVCMYIEALDKYACNCVVGYIGE 40 (53)
T ss_dssp CEECTTCEEEEETTTTEEEEEECTTEEST
T ss_pred CCCCCCeEEeeecCCCCEEEecCCCCcCC
Confidence 35777899975334567999999999873
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.73 E-value=0.84 Score=32.49 Aligned_cols=33 Identities=18% Similarity=0.425 Sum_probs=23.8
Q ss_pred CCCCCccCCCCceeccC---CCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSA---GRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~---~~~~~~~C~C~~g~~~~ 263 (646)
.|.. .-|..+|.|... ....+|.|.|+.||.|.
T Consensus 10 eC~s-~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~ 45 (55)
T 3u7u_G 10 EKEK-TFCVNGGECFMVKDLSNPSRYLCKCPNEFTGD 45 (55)
T ss_dssp STTT-TTSCTTCEEEEECCC--CCCEEEEECTTEEST
T ss_pred CCcC-CCCCCCCCcCCCCccCCCCCEeEeCCCCCcCC
Confidence 4654 478889999643 23468999999999873
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=81.79 E-value=0.88 Score=29.56 Aligned_cols=31 Identities=23% Similarity=0.604 Sum_probs=23.6
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. ..|..++.|.+. .++|.|.|+.||.|.
T Consensus 5 ~C~~-~pC~ngg~C~~~--~~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 5 QCES-NPCLNGGSCKDD--INSYECWCPFGFEGK 35 (39)
T ss_dssp TTTT-CCCCTTCEEEEE--TTEEEEECCTTCCST
T ss_pred cCCC-CCCCCCCEeEcC--CCceEeECCCCCcCC
Confidence 3643 468888999765 467999999999863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.08 E-value=0.18 Score=53.65 Aligned_cols=60 Identities=8% Similarity=0.049 Sum_probs=17.7
Q ss_pred ccEecccCcEEEEEEEEcC-CcEEEE------EEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEe
Q 006402 351 ERILGSGGFGEVYKGELQD-GTVVAV------KSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVE 413 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 413 (646)
.+.|| ||.||+|.+.. ...||| |..+... .+....|.+|..++++++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 34566 99999998864 367888 7655422 2334578899999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 646 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 7e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-68
Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 25/284 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + +GSG FG VYKG+ V + + + Q NEVG+L + H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
+G Q ++ ++ +L+ HLH + F + IA QTA+ + YLH
Sbjct: 70 MGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLH---AK 123
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRL-AKPGLSHVSTCAQGTLGYLDPEYYRNYQ- 525
I HRD+KS NI L +D K+ DFGL+ + ++ SH G++ ++ PE R
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 526 --LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
+ +SDVY++G+VL EL+T Q + D + + + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------RGYLSPDLSK 233
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
++ K L CL++K+ ERP ++ ++ +
Sbjct: 234 VRSNC-----PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-66
Identities = 73/280 (26%), Positives = 134/280 (47%), Gaps = 25/280 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + +GSG FG V+ G + VA+K+ + G + S + + E ++ +++H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQL 65
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G C+E L++E++ +G L D+L + F T L + L E +AYL A
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEA--- 120
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
+ HRD+ + N L+ ++ KV+DFG++R ST + + + PE + + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
KSDV+S+GV++ E+ + K +R +V I R + PRL
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYKPRLASTHV- 231
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
++ C +E+ +RP+ + ++ +L I E
Sbjct: 232 ----------YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-66
Identities = 80/278 (28%), Positives = 126/278 (45%), Gaps = 25/278 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
LG+G FGEV+ G T VAVKS K G++ S L E ++ Q+ H+ LVRL
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRL 73
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
+ E +I EY+ NG+L D L S LT + L +A Q AE +A++
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
HRD+++ NIL+ D + K+ADFGL+RL + A+ + + PE T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
KSDV+S+G++L E++T + +V + +R + L
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---ERGYRMVRPDNCPEELY----- 240
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+L C +E+ +RP+ + L+
Sbjct: 241 -----------QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-63
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 25/278 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ + LG+G FG V G+ + VA+K K G++ S + + E ++ ++H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 64
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
G C + +I EY+ANG L ++L F L + EA+ YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE---SK 119
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
HRD+ + N L++D KV+DFGLSR S ++ + + PE + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
KSD++++GV++ E+ + K + I QG
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------------AQGLRLY 221
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
L S K++ + +C EK ERP+ ++ + +
Sbjct: 222 RPHLASEKVY-TIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 1e-63
Identities = 79/310 (25%), Positives = 141/310 (45%), Gaps = 42/310 (13%)
Query: 336 FHLKELKKATNGFSKE---------RILGSGGFGEVYKGEL----QDGTVVAVKSAKVGN 382
F ++ +A F+KE +++G+G FGEV G L + VA+K+ K G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 383 I-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN 441
K + L+E I+ Q +H N++ L G ++ ++I E++ NG+L L F
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 442 LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501
T + + A + YL HRD+ + NIL++ + KV+DFGLSR +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 502 LSHVSTCA----QGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDD 557
S + + + + + PE + + T SDV+SYG+V+ E+++ + + D
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 558 VNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTD 617
V AI D RL ++ +L +L + C ++ ++ RP
Sbjct: 242 VINAI-------------EQDYRL---PPPMDCPSALH---QLMLDCWQKDRNHRPKFGQ 282
Query: 618 VVHELQRIIE 627
+V+ L ++I
Sbjct: 283 IVNTLDKMIR 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-63
Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 31/279 (11%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
+ +G G FG+V G+ G VAVK + N + Q L E +++Q+ H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 408 LGCCVEAEQPL-LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
LG VE + L ++ EY+A G+L D+L + S L L+ +L EA+ YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
HRD+ + N+L+ +D +KV+DFGL++ S + + + PE R +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 527 TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586
+ KSDV+S+G++L E+ + + DV + + + P +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVY---- 230
Query: 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
E+ C + RPS + +L+ I
Sbjct: 231 ------------EVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-61
Identities = 63/299 (21%), Positives = 121/299 (40%), Gaps = 31/299 (10%)
Query: 351 ERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGC 410
+ +G G FGEV++G+ G VAVK +S + E+ + H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 65
Query: 411 CVEAE----QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ Q L+ +Y +G+L D+L+ +T +++AL TA LA+LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 467 T-----PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ---GTLGYLDP 518
I HRD+KS NIL+ + +AD GL+ + GT Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 519 EYY------RNYQLTDKSDVYSYGVVLLELLT----SQKAIDFSRDPDDVNLAIYVSQRA 568
E ++++ ++D+Y+ G+V E+ D+ D+ + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ + P + S L + ++ C + R + + L ++ +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMA---KIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 2e-60
Identities = 78/320 (24%), Positives = 131/320 (40%), Gaps = 51/320 (15%)
Query: 337 HLKELKKATNGFSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVGNIKSTQ-QV 389
L L+ N R +G G FG V++ + T+VAVK K Q
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 390 LNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN-------- 441
E ++++ ++ N+V+LLG C + L++EY+A G L++ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 442 -------------LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSK 488
L+ + +L IA Q A +AYL HRD+ + N L+ ++ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 489 VADFGLSR-LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK 547
+ADFGLSR + + ++ PE + T +SDV++YGVVL E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 548 AIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLRE 607
+ ++V + +G I+ + N + L L C +
Sbjct: 241 QPYYGMAHEEVIYYV------RDGNILACPE----------NCPLELY---NLMRLCWSK 281
Query: 608 KKSERPSMTDVVHELQRIIE 627
++RPS + LQR+ E
Sbjct: 282 LPADRPSFCSIHRILQRMCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-60
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 25/279 (8%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL 407
E LG G FGEV+ G T VA+K+ K G + S + L E ++ ++ H+ LV+L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQL 77
Query: 408 LGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT 467
E ++ EY++ G+L D L G+ + + +A Q A +AY+
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE---RM 132
Query: 468 PIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLT 527
HRD+++ NIL+ ++ KVADFGL+RL + A+ + + PE + T
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 528 DKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEAS 587
KSDV+S+G++L EL T + +V + +R L
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERGYRMPCPPECPESLH----- 244
Query: 588 VNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626
+L C R++ ERP+ + L+
Sbjct: 245 -----------DLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 6e-60
Identities = 71/288 (24%), Positives = 140/288 (48%), Gaps = 32/288 (11%)
Query: 348 FSKERILGSGGFGEVYKGELQDGT-----VVAVKSAKVGNI-KSTQQVLNEVGILSQVNH 401
++++++G+G FGEVYKG L+ + VA+K+ K G K L E GI+ Q +H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
N++RL G + + ++I EY+ NG L L K + + + A + YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL 126
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG--LSHVSTCAQGTLGYLDPE 519
+ HRD+ + NIL++ + KV+DFGLSR+ + ++ ++ + + + PE
Sbjct: 127 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579
+ T SDV+S+G+V+ E++T + + + +M+ ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAIND 228
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ ++ ++ +L + C +++++ RP D+V L ++I
Sbjct: 229 GFRL-PTPMDCPSAIY---QLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (508), Expect = 7e-60
Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 28/293 (9%)
Query: 348 FSKERILGSGGFGEVYKGELQD-GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ + LG G +GEVY+G + VAVK+ K ++ ++ L E ++ ++ H NLV+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 77
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
LLG C +I E++ G L D+L + ++ L +A Q + A+ YL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK-- 134
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
HRD+ + N L+ ++ KVADFGLSRL A+ + + PE +
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 527 TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586
+ KSDV+++GV+L E+ T + D + E+++ + E
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRM-ER 237
Query: 587 SVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSNDVN 639
+ EL AC + S+RPS ++ + + + + +S++V
Sbjct: 238 PEGCPEKVY---ELMRACWQWNPSDRPSFAEIHQAFETMFQ---ESSISDEVE 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 33/303 (10%)
Query: 341 LKKATNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST-QQVLNEVGILSQ 398
++ + F K LG+G G V+K G V+A K + + Q++ E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 399 VNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
N +V G + + E++ G+L L + ++++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
YL I HRDVK +NIL++ K+ DFG+S ++ GT Y+ P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI---------------- 562
E + + +SD++S G+ L+E+ + I + +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 563 -------YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSM 615
Y AI E++D + + + F + CL + +ER +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 616 TDV 618
+
Sbjct: 293 KQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 65/291 (22%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 350 KERILGSGGFGEVYKGELQD---GTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+++ LGSG FG V KG Q VAVK + + ++L E ++ Q+++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
VR++G C EAE +L+ E G L+ +L + + + Q + + YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST--CAQGTLGYLDPEYYR 522
+ HRD+ + N+LL +K++DFGLS+ + ++ + + + PE
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
Y+ + KSDV+S+GV++ E + + +V + +R +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMY 240
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII-EIVNQE 632
+L C RP V L+ ++VN+
Sbjct: 241 ----------------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-58
Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 37/304 (12%)
Query: 351 ERILGSGGFGEVYKGELQD----GTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHKNLV 405
++G G FG VY G L D AVKS ++ +I Q L E I+ +H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 406 RLLGCCVEAE-QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
LLG C+ +E PL++ Y+ +G L + + + N T + LQ A+ + +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLA-- 147
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG---LSHVSTCAQGTLGYLDPEYY 521
HRD+ + N +LD+ F KVADFGL+R H T A+ + ++ E
Sbjct: 148 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
+ + T KSDV+S+GV+L EL+T + D+ + + +R ++ P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------LLQPEY 258
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE-IVNQEKVSND--- 637
E+ + C K RPS +++V + I + + V +
Sbjct: 259 CPDP-----------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATY 307
Query: 638 VNVE 641
VNV+
Sbjct: 308 VNVK 311
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-58
Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 32/294 (10%)
Query: 339 KELKKATNGFS-KERILGSGGFGEVYKGELQ---DGTVVAVKSAKVGNIKS-TQQVLNEV 393
K+L + + LG G FG V +G + VA+K K G K+ T++++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 394 GILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
I+ Q+++ +VRL+G C +AE +L+ E G LH L GK + S + Q
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG--LSHVSTCAQG 511
+ + YL HRD+ + N+LL + +K++DFGLS+ + +
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571
L + PE + + +SDV+SYGV + E L+ + +V I +R
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-- 232
Query: 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
P L L C K +RP V ++
Sbjct: 233 -CPPECPPELY----------------ALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 45/304 (14%)
Query: 348 FSKERILGSGGFGEVYKGEL------QDGTVVAVKSAKVG-NIKSTQQVLNEVGILSQV- 399
S + LG+G FG+V + VAVK K ++ + +++E+ +LS +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF---------------NLTW 444
NH N+V LLG C L+I EY G L + L K SF L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
L + Q A+ +A+L S HRD+ + NILL +K+ DFGL+R K ++
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 505 -VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563
V A+ + ++ PE N T +SDV+SYG+ L EL + + D
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256
Query: 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
+++ + + + + ++ C +RP+ +V ++
Sbjct: 257 ---------FYKMIKEGFR-MLSPEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 624 RIIE 627
+ I
Sbjct: 304 KQIS 307
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-56
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 30/285 (10%)
Query: 348 FSKERILGSGGFGEVYKGEL----QDGTVVAVKSAKVGNIKST-QQVLNEVGILSQVNHK 402
R +G G FG+V++G VA+K+ K S ++ L E + Q +H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
++V+L+G E +I E G L L + S L ++ + A Q + ALAYL
Sbjct: 69 HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE 125
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
S HRD+ + N+L+ + K+ DFGLSR + + ++ + + ++ PE
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ T SDV+ +GV + E+L +DV I +R + P L
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLY 239
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
L C S RP T++ +L I+E
Sbjct: 240 ----------------SLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 9e-56
Identities = 71/279 (25%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVNHKN 403
FS R +G G FG VY +++ VVA+K +S Q ++ EV L ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++ GC + L+ EY K L + + LAYLHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+ HRDVK+ NILL + K+ DFG + + P S V GT ++ PE
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185
Query: 524 Y---QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580
Q K DV+S G+ +EL + + + I + P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPA 233
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619
LQ S + F +CL++ +RP+ ++
Sbjct: 234 LQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-55
Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 29/280 (10%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
+ +G+G +G K DG ++ K G++ Q +++EV +L ++ H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 405 VRLLGCCVEAE--QPLLIYEYIANGTLHDHLH-GKYSSFNLTWSTRLRIALQTAEALAYL 461
VR ++ ++ EY G L + G L LR+ Q AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 462 H--SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPE 519
H S + HRD+K N+ LD N K+ DFGL+R+ S GT Y+ PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPE 184
Query: 520 YYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579
+KSD++S G +L EL + ++ I + I
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGKFRR---IPYRYSD 240
Query: 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619
L E+ L K RPS+ +++
Sbjct: 241 ELN----------------EIITRMLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 42/300 (14%)
Query: 346 NGFSKERILGSGGFGEVYKGELQDG---TVVAVKS-AKVGNIKSTQQVLNEVGILSQV-N 400
N + ++G G FG+V K ++ A+K + + + E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKY-------------SSFNLTWSTR 447
H N++ LLG C L EY +G L D L ++ L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
L A A + YL HRD+ + NIL+ +++ +K+ADFGLSR + + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567
+ + ++ E T SDV+SYGV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------------ 232
Query: 568 ASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
E+ + QG+ + +++ +L C REK ERPS ++ L R++E
Sbjct: 233 ------AELYEKLPQGYRLEKPLNCDDEVY-DLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-54
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 34/278 (12%)
Query: 351 ERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRL 407
+ +G G F VYKG + VA + + Q+ E +L + H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 408 LGCCVEA----EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
+ +L+ E + +GTL +L + Q + L +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT 130
Query: 464 AAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
PI HRD+K NI + S K+ D GL+ L + + + GT ++ PE Y
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ + DVY++G+ +LE+ TS+ +S + + V+ + +V P ++
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620
E+ C+R+ K ER S+ D+++
Sbjct: 244 ----------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-54
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 50/305 (16%)
Query: 348 FSKERILGSGGFGEVYKGELQD------GTVVAVKSAKVGNIKST-QQVLNEVGILSQV- 399
++LGSG FG+V VAVK K S + +++E+ +++Q+
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 400 NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN------------------ 441
+H+N+V LLG C + LI+EY G L ++L K F+
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 442 --LTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499
LT+ L A Q A+ + +L HRD+ + N+L+ K+ DFGL+R
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 500 PGLSHVS-TCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV 558
++V A+ + ++ PE T KSDV+SYG++L E+ + D
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 559 NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+++ + + + + +C +RPS ++
Sbjct: 276 --------------FYKLIQNGFKM-DQPFYATEEIY---IIMQSCWAFDSRKRPSFPNL 317
Query: 619 VHELQ 623
L
Sbjct: 318 TSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 63/287 (21%), Positives = 124/287 (43%), Gaps = 32/287 (11%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSA-----KVGNIKSTQQVLNEVGILSQVNH 401
F K ++LGSG FG VYKG + +G V + A + + K+ +++L+E +++ V++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ RLLG C+ LI + + G L D++ + L +Q A+ + YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG-LSHVSTCAQGTLGYLDPEY 520
+ HRD+ + N+L+ + K+ DFGL++L + + + + ++ E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 521 YRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580
+ T +SDV+SYGV + EL+T +++ + +R +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTID 241
Query: 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ + V C RP +++ E ++
Sbjct: 242 VY----------------MIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 7e-54
Identities = 74/276 (26%), Positives = 107/276 (38%), Gaps = 34/276 (12%)
Query: 348 FSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQ---QVLNEVGILSQVNHKN 403
F R LG G FG VY Q ++A+K ++ Q+ EV I S + H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++RL G +A + LI EY GT++ L + A AL+Y HS
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS 124
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
+ HRD+K N+LL K+ADFG S A S T GTL YL PE
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEG 178
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
+K D++S GV+ E L + + Y + V +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDFVTEGAR- 232
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVV 619
+L L+ S+RP + +V+
Sbjct: 233 ---------------DLISRLLKHNPSQRPMLREVL 253
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-53
Identities = 66/287 (22%), Positives = 104/287 (36%), Gaps = 33/287 (11%)
Query: 348 FSKERILGSGGFGEVYKGEL----QDGTVVAVKSAKVGNIKSTQ---QVLNEVGILSQVN 400
LG G FG V +GE VAVK K + + + EV + ++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
H+NL+RL G + ++ E G+L D L F T R A+Q AE + Y
Sbjct: 70 HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHF--LLGTLSRYAVQVAEGMGY 126
Query: 461 LHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH--VSTCAQGTLGYLDP 518
L S HRD+ + N+LL K+ DFGL R H + + + P
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578
E + + SD + +GV L E+ T + + I+ +D
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------------ILHKID 228
Query: 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625
+ + + + V C K +RP+ + L
Sbjct: 229 KEGERLPRPEDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 1e-52
Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 27/272 (9%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+++ +G G G VY ++ G VA++ + + ++NE+ ++ + + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L + ++ ++ EY+A G+L D + + + +AL +LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHSN-- 135
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
+ HRD+KS NILL D + K+ DFG P S ST GT ++ PE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 527 TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEA 586
K D++S G++ +E++ + + + L + + E + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKLSAIFR---- 247
Query: 587 SVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ CL +R S ++
Sbjct: 248 ------------DFLNRCLDMDVEKRGSAKEL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 28/275 (10%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLV 405
+ + LG G +GEV VAVK + + + + E+ I +NH+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+ G E L EY + G L D + + R Q + YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI- 122
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG-LSHVSTCAQGTLGYLDPEYYRNY 524
I HRD+K N+LLD+ N K++DFGL+ + + + GTL Y+ PE +
Sbjct: 123 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 525 QL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583
+ + DV+S G+VL +L + D D + + ++ ++P +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKK-------TYLNPWKKI 232
Query: 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
A + +L L E S R ++ D+
Sbjct: 233 DSAPLALLHK----------ILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 30/277 (10%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ LG G FG+VYK + + + A K + + + + E+ IL+ +H N+V+
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
LL ++ E+ A G + + LT S + QT +AL YLH
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN-- 129
Query: 467 TPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL 526
I HRD+K+ NIL D + K+ADFG+S + + GT ++ PE
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETS 187
Query: 527 TD-----KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
D K+DV+S G+ L+E+ + +P V L I A
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKI-AKSEPPTLAQPSRWSSNF 245
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ + CL + R + + +
Sbjct: 246 K----------------DFLKKCLEKNVDARWTTSQL 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 6e-51
Identities = 51/276 (18%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 346 NGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+ + LG+G FG V++ E G A K + + V E+ +S + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
V L + + ++IYE+++ G L + + +++ ++ + Q + L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 143
Query: 465 AYTPIYHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
H D+K NI+ ++ K+ DFGL+ P S T GT + PE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ +D++S GV+ LL+ + D+ + + + + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ L + R ++
Sbjct: 258 ----------------DFIRKLLLADPNTRMTIHQA 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 68/295 (23%), Positives = 130/295 (44%), Gaps = 37/295 (12%)
Query: 348 FSKERILGSGGFGEVYKGEL------QDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVN 400
+ R LG G FG VY+G + T VA+K+ + +++ + LNE ++ + N
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN-------LTWSTRLRIALQ 453
++VRLLG + + L+I E + G L +L + + S +++A +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR-LAKPGLSHVSTCAQGT 512
A+ +AYL++ HRD+ + N ++ +DF K+ DFG++R + +
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 513 LGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572
+ ++ PE ++ T SDV+S+GVVL E+ T + + V + G
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------EGG 252
Query: 573 IMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+++ D + EL C + RPS +++ ++ +E
Sbjct: 253 LLDKPDN-------------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-49
Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 46/305 (15%)
Query: 348 FSKERILGSGGFGEVYKGEL--------QDGTVVAVKSAKVGNI-KSTQQVLNEVGILSQ 398
+ LG G FG+V E T VAVK K K +++E+ ++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 399 V-NHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSF-------------NLTW 444
+ HKN++ LLG C + +I EY + G L ++L + L+
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 445 STRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504
+ A Q A + YL S HRD+ + N+L+ +D K+ADFGL+R +
Sbjct: 135 KDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 505 VST-CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIY 563
T + + ++ PE + T +SDV+S+GV+L E+ T + +++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL- 250
Query: 564 VSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623
+GH + +L+ + C S+RP+ +V +L
Sbjct: 251 -----------------KEGHRMDKPSNCTNELY-MMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 624 RIIEI 628
RI+ +
Sbjct: 293 RIVAL 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (434), Expect = 2e-48
Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 27/274 (9%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ LGSG FG V++ E G V K V NE+ I++Q++H L+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L + + +LI E+++ G L D + + + ++ + + Q E L ++H
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH-- 146
Query: 467 TPIYHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I H D+K NI+ + S K+ DFGL+ P T T + PE
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDRE 203
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584
+ +D+++ GV+ LL+ D + + + V P +
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSVSPEAK-- 260
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ L+++ +R ++ D
Sbjct: 261 --------------DFIKNLLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-48
Identities = 75/303 (24%), Positives = 128/303 (42%), Gaps = 44/303 (14%)
Query: 348 FSKERILGSGGFGEVYKG------ELQDGTVVAVKSAKVGNIKSTQQ-VLNEVGILSQVN 400
+ LG G FG+V + + VAVK K G S + +++E+ IL +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 401 H-KNLVRLLGCCVEAEQPLLI-YEYIANGTLHDHLHGKYSSFN-------------LTWS 445
H N+V LLG C + PL++ E+ G L +L K + F LT
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 446 TRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505
+ + Q A+ + +L S HRD+ + NILL + K+ DFGL+R +V
Sbjct: 135 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 506 -STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV 564
A+ L ++ PE + T +SDV+S+GV+L E+ + + D+
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----F 246
Query: 565 SQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624
+R G M D + + + C + S+RP+ +++V L
Sbjct: 247 CRRLKEGTRMRAPDY-------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 625 IIE 627
+++
Sbjct: 294 LLQ 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 4e-47
Identities = 57/282 (20%), Positives = 107/282 (37%), Gaps = 24/282 (8%)
Query: 339 KELKKATNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQ-VLNEVGIL 396
K+ + + + +LG+G F EV E + +VA+K ++ + + NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 397 SQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE 456
++ H N+V L LI + ++ G L D + K T R+ Q +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLD 118
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
A+ YLH + LD+D ++DFGLS++ PG V + A GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYV 176
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
PE + D +S GV+ LL + + + I ++ + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ + + + + +R +
Sbjct: 236 ISDSAK----------------DFIRHLMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 6e-47
Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 34/292 (11%)
Query: 345 TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST---QQVLNEVGILSQVN 400
++ + ILG GG EV+ L+ VAVK + + + E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 401 HKNLVRLLGCCVE----AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE 456
H +V + P ++ EY+ TL D +H + +T + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV--STCAQGTLG 514
AL + H I HRDVK NI++ KV DFG++R + V + GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 515 YLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574
YL PE R + +SDVYS G VL E+LT + P V A
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARH 238
Query: 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-SMTDVVHELQRI 625
E + L + + L + R + ++ +L R+
Sbjct: 239 EGLSADLD----------------AVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 8e-47
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 11/208 (5%)
Query: 342 KKATNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQV---LNEVGILS 397
KK F +ILG G F V EL A+K + +I +V E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 398 QVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEA 457
+++H V+L + E+ Y NG L ++ S + + A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 120
Query: 458 LAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP-GLSHVSTCAQGTLGYL 516
L YLH I HRD+K NILL++D + ++ DFG +++ P + GT Y+
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLT 544
PE SD+++ G ++ +L+
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVA 205
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 4e-45
Identities = 67/288 (23%), Positives = 100/288 (34%), Gaps = 42/288 (14%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST---------QQVLNEVGILS 397
+ + ILG G V + AVK V S + L EV IL
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 398 QVN-HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE 456
+V+ H N+++L L+++ + G L D+L K L+ +I E
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLE 121
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
+ LH I HRD+K NILLDDD N K+ DFG S PG GT YL
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYL 176
Query: 517 DPEYYRNYQL------TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570
PE + D++S GV++ LL R + I
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFG 235
Query: 571 GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ ++ +L L + +R + +
Sbjct: 236 SPEWDDYSDTVK----------------DLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 5e-45
Identities = 61/294 (20%), Positives = 121/294 (41%), Gaps = 30/294 (10%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ LG G FG V++ E K KV V E+ IL+ H+N++
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILH 65
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
L E+ ++I+E+I+ + + ++ +F L + Q EAL +LHS
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 467 TPIYHRDVKSTNILLDDDFNS--KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I H D++ NI+ +S K+ +FG +R KPG + Y PE +++
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHD 178
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584
++ +D++S G ++ LL+ + N I + + E +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPF-----LAETNQQIIENIMNAEYTFDEEAFKEI--S 231
Query: 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVV-HE-LQRIIEIVNQEKVSN 636
+++ + L +++ R + ++ + H L++ IE V+ + +
Sbjct: 232 IEAMDFVDR----------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 65/275 (23%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQV---LNEVGILS-QVNHK 402
F ++LG G FG+V+ E + A+K+ K + V + E +LS H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
L + E + EY+ G L H+ + S A + L +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH 120
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
S I +RD+K NILLD D + K+ADFG+ + G + +T GT Y+ PE
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176
Query: 523 NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582
+ D +S+GV+L E+L Q ++ S R N ++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPF-----HGQDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTD 617
+L V + +R +
Sbjct: 232 ----------------DLLVKLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 21/292 (7%)
Query: 343 KATNGFSKERILGSGGFGEVYKGE--LQDGTVVAVKSAKVGNIKST--QQVLNEVGI--- 395
+A + +G G +G+V+K G VA+K +V + + EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 396 LSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLH---DHLHGKYSSFNLTWSTRLRIAL 452
L H N+VRL C + + + K + T +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 453 QTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGT 512
Q L +LHS + HRD+K NIL+ K+ADFGL+R+ ++ S T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VT 178
Query: 513 LGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572
L Y PE D++S G + E+ + S D D + + V
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 573 IMEVVD-PRLQGHEASVNILMSL-----KLFSELAVACLREKKSERPSMTDV 618
V PR H S + +L +L + CL ++R S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (392), Expect = 1e-42
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 17/223 (7%)
Query: 346 NGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQV------LNEVGILSQ 398
N FS RI+G GGFGEVY G + A+K IK Q + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 399 VNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
+ +V + ++ I + + G LH HL + A + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP 518
++H+ + +RD+K NILLD+ + +++D GL+ H + GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 519 EYYRNYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNL 560
E + D +D +S G +L +LL + D +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (385), Expect = 5e-42
Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 27/282 (9%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKN 403
F R LG+G FG V+ +G A+K V +K + +E +LS V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 404 LVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS 463
++R+ G +A+Q +I +YI G L L A + AL YLHS
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS 122
Query: 464 AAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRN 523
I +RD+K NILLD + + K+ DFG ++ + V+ GT Y+ PE
Sbjct: 123 K---DIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVST 175
Query: 524 YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI---------YVSQRASNG-AI 573
D +S+G+++ E+L + I + ++ + +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234
Query: 574 MEVVDP--RLQGHEASVNILMSLKLFSELAVACLREKKSERP 613
+ D RL + + + F E+ L + E P
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 26/288 (9%)
Query: 348 FSKERILGSGGFGEVYKGEL-QDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
++ +++G+G FG VY+ +L G +VA+K + + E+ I+ +++H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 407 LLGCCVEAEQP------LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
L + + L+ +Y+ H + L Q +LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 461 LHSAAYTPIYHRDVKSTNILLDDD-FNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDP- 518
+HS I HRD+K N+LLD D K+ DFG ++ G +VS Y P
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRAPE 192
Query: 519 EYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578
+ T DV+S G VL ELL Q D + I V + I E+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 579 PRLQGHEASVNILMSLKLFS--------ELAVACLREKKSERPSMTDV 618
+ + K+F L L + R + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 61/296 (20%), Positives = 116/296 (39%), Gaps = 32/296 (10%)
Query: 345 TNGFSKERILGSGGFGEVYKG-ELQDGTVVAVKS-AKVGNIKSTQQVLNEVGILSQVNHK 402
++ +G G +G V + + VA+K + + Q+ L E+ IL + H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 403 NLVRLLGCC----VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
N++ + +E + + + ++ L+ L ++ L+ Q L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGL 122
Query: 459 AYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ--GTLGYL 516
Y+HSA + HRD+K +N+LL+ + K+ DFGL+R+A P H + T Y
Sbjct: 123 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 517 DPEYYRNYQLTDKS-DVYSYGVVLLELLT-------------SQKAIDFSRDPDDVNLAI 562
PE N + KS D++S G +L E+L+ + P +L
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 563 YVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
++ +A N + ++ + N +L L +R +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKAL---DLLDKMLTFNPHKRIEVEQA 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 64/284 (22%), Positives = 107/284 (37%), Gaps = 23/284 (8%)
Query: 351 ERI--LGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST-----QQVLNEVGILSQVNHK 402
E++ LG G F VYK +VA+K K+G+ + L E+ +L +++H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 403 NLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLH 462
N++ LL L+++++ LT S L T + L YLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLH 117
Query: 463 SAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYR 522
I HRD+K N+LLD++ K+ADFGL++ + T T Y PE
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLF 173
Query: 523 NYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
++ D+++ G +L ELL + D D + + ++
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 582 QGHEASVNILMSLKLFS-------ELAVACLREKKSERPSMTDV 618
S + +FS +L R + T
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (374), Expect = 6e-41
Identities = 49/281 (17%), Positives = 103/281 (36%), Gaps = 16/281 (5%)
Query: 348 FSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNLV 405
+ +G G +G VYK + G A+K ++ + E+ IL ++ H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 406 RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA 465
+L ++ +L++E++ + L T LQ +AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 466 YTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQ 525
+ HRD+K N+L++ + K+ADFGL+R + + + +
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 526 LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585
+ D++S G + E++ + D + + ++ V +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 586 ASVNILMSLKLFS--------ELAVACLREKKSERPSMTDV 618
+V + + F +L L+ ++R +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 54/282 (19%), Positives = 100/282 (35%), Gaps = 16/282 (5%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
F K +G G +G VYK G VVA+K ++ + E+ +L ++NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
V+LL + L++E++ + + Q + LA+ HS
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
+ HRD+K N+L++ + K+ADFGL+R + +
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD------ 578
+ D++S G + E++T + + D + V
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 579 --PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
P+ + S + + L L ++R S
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-40
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 46/282 (16%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK------SAKVGNIKSTQQVLNEVGILSQVN 400
+ +LGSGGFG VY G + D VA+K + G + + +V EV +L +V+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 401 --HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
++RLL + +LI E + + L Q EA+
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAV 123
Query: 459 AYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLD 517
+ H+ + HRD+K NIL+D + K+ DFG L K V T GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSP 177
Query: 518 PEYYRNYQLTDKS-DVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
PE+ R ++ +S V+S G++L +++ F D + + ++ QR S+
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVSSECQ--- 232
Query: 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
L CL + S+RP+ ++
Sbjct: 233 ----------------------HLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 6e-40
Identities = 51/292 (17%), Positives = 97/292 (33%), Gaps = 30/292 (10%)
Query: 346 NGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL 404
N + R +GSG FG++Y G + G VA+K V Q+ E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ + C ++ + +L D + + S + T L +A Q + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 465 AYTPIYHRDVKSTNIL---LDDDFNSKVADFGLSRLAKPGLSHVSTCAQ------GTLGY 515
HRDVK N L + DFGL++ + +H + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
+ + + + D+ S G VL+ +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------------YER 227
Query: 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ + ++ + F+ C + ++P + + + +
Sbjct: 228 ISEKKMSTPIEVLCKGYP-SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 33/277 (11%)
Query: 351 ERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLL 408
++LG G G+V + + A+K ++ + EV + + ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIV 71
Query: 409 GCC----VEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ L++ E + G L + T I EA+ YLHS
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 465 AYTPIYHRDVKSTNILLDDDFNS---KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
I HRDVK N+L + K+ DFG ++ S + C T Y+ PE
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVL 185
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581
+ D++S GV++ LL +S ++ + R + + P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIR-----MGQYEFPNP 239
Query: 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ E S + L L+ + ++R ++T+
Sbjct: 240 EWSEVS-------EEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 53/283 (18%), Positives = 103/283 (36%), Gaps = 18/283 (6%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
+ K +G G +G V+K + + +VA+K ++ + L E+ +L ++ HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
VRL ++ L++E+ Q + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH-- 118
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
+ HRD+K N+L++ + K+A+FGL+R + S +
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 525 QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD------ 578
+ D++S G + EL + + + D DD I+ +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 579 --PRLQGHEASVNILMSL-KLFSELAVACLREKKSERPSMTDV 618
P + VN++ L +L L+ +R S +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (360), Expect = 6e-39
Identities = 40/292 (13%), Positives = 93/292 (31%), Gaps = 32/292 (10%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ R +G G FG +++G L + VA+K Q+ +E + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 407 LLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAY 466
+ + ++ + +L D L F + T A Q + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHEK-- 120
Query: 467 TPIYHRDVKSTNILLDDDFNS-----KVADFGLSRLAKPGLSHVSTCAQ------GTLGY 515
+ +RD+K N L+ + V DFG+ + + ++ + GT Y
Sbjct: 121 -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 516 LDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575
+ + + + + D+ + G V + L + + + ++ + + E
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627
+ + F + P + +++E
Sbjct: 240 LCAG-------------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-39
Identities = 66/282 (23%), Positives = 98/282 (34%), Gaps = 36/282 (12%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVKSAKVGNIKST------QQVLNEVGILSQVN 400
+ LGSG F V K E G A K K KS+ + + EV IL ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 401 HKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAY 460
H N++ L +LI E +A G L D L K S LT Q + Y
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 128
Query: 461 LHSAAYTPIYHRDVKSTNILLDDD----FNSKVADFGLSRLAKPGLSHVSTCAQGTLGYL 516
LHS I H D+K NI+L D K+ DFGL+ G + GT ++
Sbjct: 129 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFV 183
Query: 517 DPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576
PE L ++D++S GV+ LL+ + +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSN 242
Query: 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDV 618
+ + L + +R ++ D
Sbjct: 243 TSALAK----------------DFIRRLLVKDPKKRMTIQDS 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 3e-37
Identities = 76/323 (23%), Positives = 123/323 (38%), Gaps = 34/323 (10%)
Query: 306 SRKLAKQAKLAKEREDMLKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKG 365
S + + + LAK +ED LK + + + F + + LG+G FG V
Sbjct: 10 SEQESVKEFLAKAKEDFLK---------KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 366 E-LQDGTVVAVK---SAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421
+ + G A+K KV +K + LNE IL VN LV+L + ++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILL 481
EY+A G + HL + A Q YLHS + +RD+K N+L+
Sbjct: 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLI 174
Query: 482 DDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLE 541
D +V DFG ++ K + GT L PE + D ++ GV++ E
Sbjct: 175 DQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 542 LLT--------SQKAIDFSRDPDDVNLAIYVSQRASNG-AIMEVVDP--RLQGHEASVNI 590
+ I V + S + + VD R + VN
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 591 LMSLKLFSELAVACLREKKSERP 613
+ + K F+ + ++K E P
Sbjct: 291 IKNHKWFATTDWIAIYQRKVEAP 313
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 11/205 (5%)
Query: 346 NGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQV---LNEVGILSQVNH 401
N F ++LG G FG+V G A+K + I + +V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
L L ++ + EY G L HL + T + AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYL 121
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYY 521
HS + +RD+K N++LD D + K+ DFGL + + GT YL PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVL 177
Query: 522 RNYQLTDKSDVYSYGVVLLELLTSQ 546
+ D + GVV+ E++ +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 57/302 (18%), Positives = 110/302 (36%), Gaps = 26/302 (8%)
Query: 336 FHLKELKKAT----NGFSKERILGSGGFGEVYKG-ELQDGTVVAVK--SAKVGNIKSTQQ 388
F+ +E+ K + + +GSG +G V + + G VA+K + ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 389 VLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFN-LTWSTR 447
E+ +L + H+N++ LL E ++ GK L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 448 LRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVST 507
+ Q + L Y+H+A HRD+K N+ +++D K+ DFGL+R A S ++
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTG 177
Query: 508 CAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQR 567
+ T D++S G ++ E++T K + D D I
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMKVTG 236
Query: 568 ASNGAIMEVVD-----------PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMT 616
++ + P L+ + + + + L L L +R +
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 617 DV 618
+
Sbjct: 297 EA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 8e-37
Identities = 64/297 (21%), Positives = 110/297 (37%), Gaps = 32/297 (10%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKST--QQVLNEVGILSQVNHKNL 404
+ K +G G FGEV+K + G VA+K + N K L E+ IL + H+N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 405 VRLLGCCVEAEQP--------LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAE 456
V L+ C P L++++ + + T S R+
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLN 128
Query: 457 ALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQ---GTL 513
L Y+H I HRD+K+ N+L+ D K+ADFGL+R + TL
Sbjct: 129 GLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 514 GYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572
Y PE + D++ G ++ E+ T + + + + L + +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 573 IMEVVDPRL-------QGHEASVNILMSLKLFSELAV----ACLREKKSERPSMTDV 618
V + L +G + V + + A+ L ++R D
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 4e-34
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 20/223 (8%)
Query: 346 NGFSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKN 403
+ + R LG G + EV++ + + V VK K +++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPN 91
Query: 404 LVRLLGCCVE--AEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
++ L + + P L++E++ N LT + +AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNS-KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEY 520
HS I HRDVK N+++D + ++ D+GL+ PG + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPEL 200
Query: 521 YRNYQLTD-KSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAI 562
+YQ+ D D++S G +L ++ ++ D D + I
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 25/233 (10%)
Query: 323 LKSSNIAGKPARIFHLKELKKATNGFSKERILGSGGFGEVYKGEL----QDGTVVAVKSA 378
L+++N+ G ++ F ++LG+G +G+V+ G + A+K
Sbjct: 9 LRTANLTGHAEKV--------GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60
Query: 379 KVGNI----KSTQQVLNEVGILSQVNHK-NLVRLLGCCVEAEQPLLIYEYIANGTLHDHL 433
K I K+T+ E +L + LV L + LI +YI G L HL
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 434 HGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFG 493
+ T + AL +LH I +RD+K NILLD + + + DFG
Sbjct: 121 SQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 174
Query: 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYR--NYQLTDKSDVYSYGVVLLELLT 544
LS+ + + GT+ Y+ P+ R + D +S GV++ ELLT
Sbjct: 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 9e-32
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 8/202 (3%)
Query: 348 FSKERILGSGGFGEVYKG-ELQDGTVVAVK--SAKVGNIKSTQQVLNEVGILSQVNHKNL 404
+ + +GSG G V + VA+K S N ++ E+ ++ VNHKN+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 405 VRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA 464
+ LL + + L D + L + Q + +LHS
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 137
Query: 465 AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNY 524
I HRD+K +NI++ D K+ DFGL+R A S + T T Y PE
Sbjct: 138 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 525 QLTDKSDVYSYGVVLLELLTSQ 546
+ D++S G ++ E++ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 22/221 (9%)
Query: 336 FHLKELKKA----TNGFSKERILGSGGFGEVYKGE-LQDGTVVAVK--SAKVGNIKSTQQ 388
F+ +EL K + +GSG +G V + G VAVK S +I ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 389 VLNEVGILSQVNHKNLVRLLGCCVEAE-----QPLLIYEYIANGTLHDHLHGKYSSFNLT 443
E+ +L + H+N++ LL A + + ++ L++ + + LT
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 444 WSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503
+ Q L Y+HSA HRD+K +N+ +++D K+ DFGL+R
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173
Query: 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT 544
++ D++S G ++ ELLT
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (268), Expect = 5e-26
Identities = 44/215 (20%), Positives = 78/215 (36%), Gaps = 19/215 (8%)
Query: 348 FSKERILGSGGFGEVYKGE-LQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVR 406
+ R LG G F V+ + + + T VA+K + + T+ +E+ +L +VN + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTK 73
Query: 407 LLGCCVEAEQPLLIYEYIA-------------NGTLHDHLHGKYSSFNLTWSTRLRIALQ 453
LL + G L KY + +I+ Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 454 TAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKPGLSHVS-TCAQG 511
L Y+H I H D+K N+L++ D + ++ L T +
Sbjct: 134 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 512 TLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ 546
T Y PE +D++S ++ EL+T
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 8e-21
Identities = 26/155 (16%), Positives = 50/155 (32%), Gaps = 20/155 (12%)
Query: 352 RILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQ----------QVLNEVGILSQVNH 401
+++G G V+ + VK KVG+ + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 402 KNLVRLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYL 461
+ L +L G V +Y + N L + + K + + E +A
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 462 HSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496
+ I H D+ N+L+ + + DF S
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 45.8 bits (107), Expect = 7e-06
Identities = 20/135 (14%), Positives = 41/135 (30%), Gaps = 10/135 (7%)
Query: 340 ELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQV 399
ELKK + + +VYK ++ + +K +T V E ++ +
Sbjct: 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLY-LKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 400 NHKNLV-RLLGCCVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEAL 458
K V ++L L+ + + +I AE +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 459 AYLHSAAYTPIYHRD 473
HS + + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 646 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.39 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 93.07 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 92.94 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 91.79 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.88 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.5 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 89.36 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 89.3 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.28 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 88.75 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.15 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 88.09 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.98 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 87.69 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 87.01 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.37 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 86.21 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.81 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.32 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 84.7 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 82.35 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 81.23 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=416.92 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=202.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688889999999999999999889999999987543 456789999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|+|.+++... ...+++..++.|+.|||+||+|||+.+ |+||||||+|||||+++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999998754 345899999999999999999999999 9999999999999999999999999998776554444
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
.....||+.|+|||++.+..++.|+||||||++||||+|+..|+..... ...+...+. .+.. ...+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~----~~~~--~~~p~~---- 226 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDIS----TGFR--LYKPRL---- 226 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHH----HTCC--CCCCTT----
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHH----hcCC--CCCccc----
Confidence 4445689999999999999999999999999999999996655432211 111111111 1110 111111
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
..+++.+|+.+||+.||++||||+||++.|++++++
T Consensus 227 -------~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 227 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 123567899999999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=412.18 Aligned_cols=262 Identities=30% Similarity=0.487 Sum_probs=204.0
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.+.||+|+||+||+|++++ .||||+++.. +.+..+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 3678999999999999999998653 5999998654 34557889999999999999999999998754 56899999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|.++++.. ...+++..++.|+.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999754 235899999999999999999999999 9999999999999999999999999998765432
Q ss_pred C-ccccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccc
Q 006402 503 S-HVSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVD 578 (646)
Q Consensus 503 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 578 (646)
. .......||+.|+|||++.+ ..++.++|||||||+||||+||+.||....... .+. .....+.. .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~----~~~~~~~~----~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----FMVGRGYL----S 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHHTSC----C
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHH----HHHhcCCC----C
Confidence 2 23344569999999999864 358999999999999999999999986332211 111 11111111 1
Q ss_pred ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 006402 579 PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIV 629 (646)
Q Consensus 579 ~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~ 629 (646)
+.+... .....+.+.+|+.+||+.+|++||||+||++.|+.+.+.+
T Consensus 229 p~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 PDLSKV-----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCGGGS-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred Ccchhc-----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 111000 0112345778999999999999999999999999988654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=414.02 Aligned_cols=259 Identities=31% Similarity=0.450 Sum_probs=211.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35788889999999999999999888999999987543 456789999999999999999999998754 5679999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.+++... ....+++..+++|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999988654 2335899999999999999999999999 999999999999999999999999999987665544
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
......||+.|+|||++.+..++.++||||||++||||+||..|+...... .. +......+... ....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~----~~~~i~~~~~~-----~~p~- 233 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PE----VIQNLERGYRM-----VRPD- 233 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTCCC-----CCCT-
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HH----HHHHHHhcCCC-----CCcc-
Confidence 445567999999999999889999999999999999999977665422211 11 11112111110 0000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+.+.+|+.+||+.+|++||||+||++.|+.+..+
T Consensus 234 -------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 -------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1224577899999999999999999999999987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=418.48 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=198.9
Q ss_pred CCCcccEecccCcEEEEEEEEc-CC---cEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DG---TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
+|++.++||+|+||+||+|+++ ++ ..||||++... .....+.|.+|+.+|++++|||||+++|++.+.+..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4556789999999999999875 23 36899988654 3345678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ...++|.+++.|+.|||+||+|||+++ |+||||||+||||+.++++||+|||+++.....
T Consensus 107 Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999988754 335899999999999999999999999 999999999999999999999999999877544
Q ss_pred CCcc----ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCccccc
Q 006402 502 LSHV----STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEV 576 (646)
Q Consensus 502 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (646)
.... .....||+.|+|||.+.+..++.++|||||||+||||+| |+.||..... ..+.. ....+....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~----~i~~~~~~~- 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVIN----AIEQDYRLP- 253 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----HHHTTCCCC-
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCCCC-
Confidence 3221 122457999999999999999999999999999999998 8989863221 11111 111111000
Q ss_pred ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhh
Q 006402 577 VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQ 631 (646)
Q Consensus 577 ~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 631 (646)
.. ....+.+.+|+.+||+.+|++||||.||++.|+++++..+.
T Consensus 254 ----~~--------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 254 ----PP--------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp ----CC--------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ----CC--------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence 00 11234577899999999999999999999999998875544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-51 Score=412.29 Aligned_cols=258 Identities=29% Similarity=0.418 Sum_probs=213.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457888899999999999999886 58899999987543 4567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.+++... ....+++..++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999999754 3456999999999999999999999999 99999999999999999999999999998766555
Q ss_pred ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 504 HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.......|++.|+|||++.+..++.|+||||||+++|||++|..|+...... .. +......+...+ ...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~~-~~~~i~~~~~~~-----~~~ 239 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ-VYELLEKDYRME-----RPE 239 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HH-HHHHHHTTCCCC-----CCT
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----HH-HHHHHhcCCCCC-----CCc
Confidence 4445556899999999999999999999999999999999988776432221 11 111121111111 100
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
...+++.+|+.+||+.||++||||.||++.|+.+.
T Consensus 240 --------~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 240 --------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12245778999999999999999999999888763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=400.11 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=211.9
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6789999999999999999999989999999997654 456789999999999999999999999999999999999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|+|.+++... ...+++..+++++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999998654 335899999999999999999999999 9999999999999999999999999998776554444
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....||+.|+|||.+.+..++.|+||||||+++|||+| |+.||...... . +......+.. ...+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~--~~~p~~--- 225 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLR--LYRPHL--- 225 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCC--CCCCTT---
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHhCCC--CCCccc---
Confidence 445669999999999999999999999999999999998 78888633211 1 1122222211 111111
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQR 624 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~ 624 (646)
..+.+.+|+.+||+.||++|||++|+++.|..
T Consensus 226 --------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 --------ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 12457799999999999999999999998854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=405.31 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=206.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|++.+.||+|+||+||+|... +|+.||||+++..+....+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999864 69999999998766667788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.+++.++ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++........
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999987643 4899999999999999999999999 999999999999999999999999999877544322
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGH 584 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 584 (646)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ........... .+..
T Consensus 173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~---~~~~~~~~~~~------~~~~- 238 (293)
T d1yhwa1 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LR---ALYLIATNGTP------ELQN- 238 (293)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HH---HHHHHHHHCSC------CCSS-
T ss_pred -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HH---HHHHHHhCCCC------CCCC-
Confidence 2344699999999999999999999999999999999999999963221 11 11111111110 0000
Q ss_pred chhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 585 EASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 585 ~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+.+|+.+||+.||++|||+.|+++
T Consensus 239 -----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 -----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0012345678999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=404.75 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=201.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... +..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56889999999999999999875 689999999875432 3356789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+++|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||+++++++||+|||+++.......
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999999743 35899999999999999999999999 99999999999999999999999999987654322
Q ss_pred -ccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 504 -HVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
...+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||....... ..... ......... +
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~----~~~~~~~~~---~-- 228 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSD----WKEKKTYLN---P-- 228 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHH----HHTTCTTST---T--
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHH----HhcCCCCCC---c--
Confidence 22344569999999999988776 578999999999999999999997443321 11111 111110000 0
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+++.+|+.+||+.||++|||++|+++
T Consensus 229 --------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0012244668999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=406.49 Aligned_cols=267 Identities=27% Similarity=0.463 Sum_probs=206.9
Q ss_pred cCCCcccEecccCcEEEEEEEEcCC-----cEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDG-----TVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
+.|+..++||+|+||+||+|.+++. ..||||+++... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987642 479999986543 3445679999999999999999999999999999999
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
||||+.+++|.+++... ...++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999987653 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCc--cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSH--VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... ......||+.|+|||++.+..++.++||||||++||||+++..|+...... ..+ ......+....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~----~~~i~~~~~~~-- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV----MKAINDGFRLP-- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH----HHHHHTTCCCC--
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHH----HHHHhccCCCC--
Confidence 43322 223345899999999999999999999999999999999987776532221 111 11122211110
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhccccc
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQEKVSN 636 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~~~ 636 (646)
... .....+.+|+.+||+.+|++||||.||++.|+++++..+..+.-+
T Consensus 234 ---~~~--------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~l~ 281 (283)
T d1mqba_ 234 ---TPM--------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281 (283)
T ss_dssp ---CCT--------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBC
T ss_pred ---Cch--------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccccccc
Confidence 100 122457789999999999999999999999999988766555443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=399.14 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=203.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+|+.+ +++.||+|++... +....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999886 6899999998643 2234677899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999743 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
.. ....||+.|+|||++.+..++.++|||||||+||||++|+.||.... ... .......... .+
T Consensus 160 ~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~-~~~~i~~~~~------~~ 223 (263)
T d2j4za1 160 RR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQE-TYKRISRVEF------TF 223 (263)
T ss_dssp CC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHH-HHHHHHTTCC------CC
T ss_pred cc---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHH-HHHHHHcCCC------CC
Confidence 32 33469999999999999999999999999999999999999996321 111 1111111111 01
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. ...+++.+|+.+||+.||++|||++|+++
T Consensus 224 p~--------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PD--------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc--------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 10 11234678999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=401.67 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=209.1
Q ss_pred cCCCcccE-ecccCcEEEEEEEEc---CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERI-LGSGGFGEVYKGELQ---DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~-Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|.+.++ ||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999764 35579999987553 3446789999999999999999999999864 568999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++... +..+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999998653 346899999999999999999999999 99999999999999999999999999987765
Q ss_pred CCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 501 GLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 501 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+.. ....+...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~~~~~- 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRMEC- 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCCCC-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCCC-
Confidence 43322 233458999999999998899999999999999999998 89998643221 1111 1222221111
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
.+ ...+++.+|+.+||+.+|++||||.+|++.|+.+...+...
T Consensus 234 p~------------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 234 PP------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp CT------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CC------------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 11 12245778999999999999999999999999887665443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=404.17 Aligned_cols=258 Identities=29% Similarity=0.433 Sum_probs=203.9
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEcc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIA 425 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 425 (646)
++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 5789999999999999999999988899999997543 45678999999999999999999999985 456899999999
Q ss_pred CCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc
Q 006402 426 NGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV 505 (646)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~ 505 (646)
+|+|.+++.... ...++|.+++.|+.||+.||+|||+.+ |+||||||+|||||+++++||+|||+++.........
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999987542 335999999999999999999999999 9999999999999999999999999998876554444
Q ss_pred ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccCCc
Q 006402 506 STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQGHE 585 (646)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 585 (646)
.....||+.|+|||++.+..++.++||||||++||||++|..|+...... .... .....+.... +++
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~-~~i~~~~~~~-~~~------ 237 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVL-DQVERGYRMP-CPP------ 237 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHH-HHHHTTCCCC-CCT------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHH-HHHHhcCCCC-CCc------
Confidence 44556999999999999999999999999999999999987776533221 1111 1111111111 111
Q ss_pred hhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 586 ASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 586 ~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+++.+|+.+||+.||++||||++|+++|+.....
T Consensus 238 ------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 ------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ------ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1224577899999999999999999999988886543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=401.19 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=193.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEe--CCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVE--AEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 420 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999875 68999999987653 3345779999999999999999999999875 4467899
Q ss_pred EEEccCCCccccccCCc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 421 YEYIANGTLHDHLHGKY-SSFNLTWSTRLRIALQTAEALAYLHSAA--YTPIYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 3456999999999999999999999965 23599999999999999999999999999988
Q ss_pred CCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 498 AKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
....... .....||+.|+|||++.+..++.++||||||++||||+||+.||..... ..+ ......+.... +
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~----~~~i~~~~~~~-~ 234 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL----AGKIREGKFRR-I 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----HHHHHHTCCCC-C
T ss_pred cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHH----HHHHHcCCCCC-C
Confidence 7544322 2345699999999999999999999999999999999999999863211 111 11111121111 1
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. ...+++.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~------------~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 PY------------RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc------------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 12235778999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=397.80 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=199.6
Q ss_pred cEecccCcEEEEEEEEcC---CcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEccC
Q 006402 352 RILGSGGFGEVYKGELQD---GTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYIAN 426 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 426 (646)
++||+|+||+||+|.+++ ++.||||+++.. +....++|.+|+.+|++++|||||+++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 468999998643 23345789999999999999999999999854 567899999999
Q ss_pred CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCcc-
Q 006402 427 GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSHV- 505 (646)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~~- 505 (646)
|+|.++++.. ..+++..++.|+.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999999743 35999999999999999999999999 9999999999999999999999999998776543332
Q ss_pred -ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 506 -STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... ..+ ......+...+ ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~----~~~i~~~~~~~-----~p~ 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV----TAMLEKGERMG-----CPA 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH----HHHHHTTCCCC-----CCT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHH----HHHHHcCCCCC-----CCc
Confidence 234568999999999999899999999999999999998 8999863221 111 11122221111 100
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+++.+|+.+||+.||++|||+++|++.|+.....
T Consensus 234 --------~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 234 --------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1234577899999999999999999999999887543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=402.40 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=204.5
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
+.|++.+.||+|+||+||+|+.+ +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35888899999999999999875 68999999998777777788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.+++.+. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 999999998643 235999999999999999999999999 99999999999999999999999999976532211
Q ss_pred cccccCccccccCccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 505 VSTCAQGTLGYLDPEYYR-----NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
......||+.|+|||++. +..++.++|||||||+||||+||+.||...... .....+. ... ..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~---~~~-~~----- 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIA---KSE-PP----- 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHH---HSC-CC-----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHH---cCC-CC-----
Confidence 122356999999999983 456899999999999999999999998643221 1111111 111 00
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.. .....+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQ------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSS------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0112345778999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=392.32 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=196.2
Q ss_pred CcccEecccCcEEEEEEEEc-CCcEEEEEEcccC--CcccHHHHHHHHHHHhhCCCCcccccceeEEe----CCcCeEEE
Q 006402 349 SKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG--NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVE----AEQPLLIY 421 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 421 (646)
+..++||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999876 6889999988654 33446789999999999999999999999875 23578999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD-DDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~-~~~~~ki~DfGl~~~~~~ 500 (646)
||+++|+|.+++.+. ..+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999753 35899999999999999999999987 5599999999999996 578999999999986544
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .....||+.|+|||++.+ .++.++|||||||+||||++|+.||...... ..+......+.....++.
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~~- 236 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDK- 236 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGG-
T ss_pred Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccCc-
Confidence 32 234569999999999876 6999999999999999999999999632211 111222222211111111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+++.+|+.+||+.||++|||++|+++
T Consensus 237 -----------~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 -----------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11234678999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=412.67 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=177.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.++||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999875 68999999987543 3445789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSA-AYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
|+++|+|.+++.+. ..+++..+..++.|+++||.|||++ + |+||||||+||||++++++||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999753 3589999999999999999999984 7 999999999999999999999999999865432
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSR 553 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~ 553 (646)
. .+...||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 159 ~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp T---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred c---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 223469999999999999999999999999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=404.20 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=203.4
Q ss_pred cCCCcccEecccCcEEEEEEEEcC-C-----cEEEEEEcccC-CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD-G-----TVVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (646)
++|++.++||+|+||+||+|++.. + ..||+|++... +....+.+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999998753 2 36999988643 334456799999999998 899999999999999999
Q ss_pred eEEEEEccCCCccccccCCcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYS--------------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKST 477 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~ 477 (646)
++||||+++|+|.++|+.+.. ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999976431 135899999999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 006402 478 NILLDDDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDP 555 (646)
Q Consensus 478 NIll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~ 555 (646)
|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544332 2234458999999999999999999999999999999998 89998643222
Q ss_pred CCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 006402 556 DDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQ 623 (646)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~ 623 (646)
..+.. ....+... .... ...+.+.+|+.+||+.+|++|||++||++.|.
T Consensus 274 --~~~~~----~~~~~~~~-----~~p~--------~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 --ANFYK----LIQNGFKM-----DQPF--------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --HHHHH----HHHTTCCC-----CCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHH----HHhcCCCC-----CCCC--------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11111 11111100 0000 12245778999999999999999999999885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-48 Score=400.71 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=207.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|++.+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999875 6999999999877666778899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCEEEeecCCCccCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD--DDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~--~~~~~ki~DfGl~~~~~~~ 501 (646)
+++|+|.+++... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999653 235899999999999999999999999 99999999999995 4678999999999887654
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ....... ..
T Consensus 180 ~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~--~~~~~~~----~~ 248 (350)
T d1koaa2 180 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKS--CDWNMDD----SA 248 (350)
T ss_dssp SCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH--TCCCSCC----GG
T ss_pred ccc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHh--CCCCCCc----cc
Confidence 332 334599999999999999999999999999999999999999963211 111111111 1111110 00
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....+.+.+|+.+||+.||++|||++|+++
T Consensus 249 --------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 --------FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112245678999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-49 Score=400.80 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=208.9
Q ss_pred HhcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCcc-cHHHHHHHHHHHhhCCCCcccccceeEEeCCc
Q 006402 344 ATNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNIK-STQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 344 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 416 (646)
..++|++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|+.+|++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4567999999999999999999864 3578999998765433 45679999999999999999999999999999
Q ss_pred CeEEEEEccCCCccccccCCc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 006402 417 PLLIYEYIANGTLHDHLHGKY---------------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVK 475 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik 475 (646)
.++||||+++|+|.++++... ....+++..++.|+.|++.||+|||+.+ |+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999996421 1234899999999999999999999999 9999999
Q ss_pred CCCEEEcCCCCEEEeecCCCccCCCCCC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCC-CCCCCC
Q 006402 476 STNILLDDDFNSKVADFGLSRLAKPGLS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK-AIDFSR 553 (646)
Q Consensus 476 ~~NIll~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~-p~~~~~ 553 (646)
|+|||||.++.+||+|||+++....... .......||+.|+|||.+.+..++.|+||||||++||||++|.. ||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986644322 22334568999999999999999999999999999999999965 554221
Q ss_pred CCCCccHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 006402 554 DPDDVNLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRII 626 (646)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~ 626 (646)
. ..+. .....+...+. +. ....++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 248 ~---~e~~----~~v~~~~~~~~-p~------------~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 H---EEVI----YYVRDGNILAC-PE------------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp H---HHHH----HHHHTTCCCCC-CT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H---HHHH----HHHHcCCCCCC-Cc------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 1111 12222222111 11 12235778999999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=396.28 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=201.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. +....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999875 6899999998643 2344678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998743 35899999999999999999999999 999999999999999999999999999877543
Q ss_pred CC-ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 502 LS-HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 502 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||.... ...+ ......... . ++..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~----~~~i~~~~~-~-~p~~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLI----FQKIIKLEY-D-FPEK 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHTTCC-C-CCTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHH----HHHHHcCCC-C-CCcc
Confidence 32 22334569999999999999999999999999999999999999996321 1111 111111111 0 1111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+++.+|+.+||+.||++|||++|+++
T Consensus 233 ------------~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 233 ------------FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ------------CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ------------CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1234678999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=389.76 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=197.6
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeC-CcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-EQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 424 (646)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++||||++++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45777899999999999999985 788999998643 4567899999999999999999999998664 5689999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.++|+.+ ....++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 999999999754 2235899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccccC
Q 006402 505 VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQG 583 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 583 (646)
....+|+.|+|||++.+..++.++||||||+++|||+| |+.||..... ..+...+ ..+...+. ++
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~~~~~-~~---- 223 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMDA-PD---- 223 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTCCCCC-CT----
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCCCC-Cc----
Confidence 22347899999999998999999999999999999999 5666553211 1222222 12211111 11
Q ss_pred CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 584 HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 584 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
.....+.+|+.+||+.||.+||||.|++++|++++..
T Consensus 224 --------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 224 --------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1124567899999999999999999999999998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=390.49 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=197.1
Q ss_pred cCCCcccEecccCcEEEEEEEEcC----CcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD----GTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.+.||+|+||+||+|++.. +..||||+++.... ...+.|.+|+.++++++|||||+++|++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 568889999999999999998742 35789998865433 34577999999999999999999999985 4678999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999987643 346899999999999999999999999 99999999999999999999999999987765
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
......+...||+.|+|||++.+..++.++||||||+++|||+| |..||...... .+...+ ..+.... +++
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i----~~~~~~~-~~~ 232 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGERLP-MPP 232 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTCCCC-CCT
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCCCC-CCC
Confidence 54444455668999999999999999999999999999999998 78887643221 222211 1111111 111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
...+.+.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 233 ------------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 233 ------------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1224577899999999999999999999999988755
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-48 Score=395.55 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=188.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.+.|++.+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999876 689999999875432 334568899999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeecCCCccCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRLAK 499 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~DfGl~~~~~ 499 (646)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999753 35999999999999999999999999 99999999999994 57899999999998765
Q ss_pred CCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 500 PGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
..... ....||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+.. ........ .+.
T Consensus 162 ~~~~~--~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~----~i~~~~~~--~~~ 230 (307)
T d1a06a_ 162 PGSVL--STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFE----QILKAEYE--FDS 230 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH----HHHTTCCC--CCT
T ss_pred CCCee--eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHH----HHhccCCC--CCC
Confidence 43322 234599999999999999999999999999999999999999963211 11111 11111110 000
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... ....+.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYW--------DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTT--------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccc--------cCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 112245678999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-47 Score=398.30 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=206.9
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999875 79999999998766666778899999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCEEEeecCCCccCCCCC
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD--DDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~--~~~~~ki~DfGl~~~~~~~~ 502 (646)
++|+|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++......
T Consensus 109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999987653 335899999999999999999999999 99999999999998 67899999999999876543
Q ss_pred CccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRLQ 582 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 582 (646)
.. ....||+.|+|||++.+..++.++|||||||+||||+||+.||..... ......+.. ..... +....
T Consensus 184 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~--~~~~~----~~~~~ 252 (352)
T d1koba_ 184 IV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKR--CDWEF----DEDAF 252 (352)
T ss_dssp CE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH--CCCCC----CSSTT
T ss_pred ce--eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh--CCCCC----Ccccc
Confidence 32 334599999999999999999999999999999999999999963211 111111111 01111 11110
Q ss_pred CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 583 GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 583 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.....++.+|+.+||+.||.+|||+.|+++
T Consensus 253 --------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 --------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012244678999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-48 Score=395.97 Aligned_cols=244 Identities=26% Similarity=0.356 Sum_probs=198.8
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
.|+..+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999865 789999999876543 234678999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+++|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||++++++||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999876653 246999999999999999999999999 999999999999999999999999999876432
Q ss_pred CccccccCccccccCcccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccc
Q 006402 503 SHVSTCAQGTLGYLDPEYYRN---YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDP 579 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 579 (646)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......... +......+.
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~-~~~~~~~~~ 237 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESPALQSG 237 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCSCT
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCCCCCCCC
Confidence 23459999999999853 4689999999999999999999999863211 111111111 111111111
Q ss_pred cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 580 RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 580 ~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
...+.+.+|+.+||+.||++|||+.|+++
T Consensus 238 ------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 ------------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11235678999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=387.78 Aligned_cols=251 Identities=26% Similarity=0.297 Sum_probs=204.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc------ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI------KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999875 799999999864321 2367899999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CEEEeecC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF----NSKVADFG 493 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~----~~ki~DfG 493 (646)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999753 35999999999999999999999999 99999999999998766 59999999
Q ss_pred CCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 494 LSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 494 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
+++........ ....||+.|+|||++.+..++.++|||||||+||||++|+.||..... .... ........
T Consensus 163 ~a~~~~~~~~~--~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~-~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETL-ANVSAVNY 233 (293)
T ss_dssp TCEECTTSCBC--SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHTTCC
T ss_pred hhhhcCCCccc--cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHH-HHHHhcCC
Confidence 99877544332 234589999999999998999999999999999999999999963221 1111 11111110
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
. .. ..........+.+|+.+||+.||++|||++|+++
T Consensus 234 ~--~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FE--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CC--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CC--------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 0001112345778999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=393.31 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=203.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc----EEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT----VVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (646)
.+|++.++||+|+||+||+|++. +|+ .||+|+++.. +.+..++|.+|+.++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999875 444 6899988643 345578899999999999999999999999865 5678
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAK 499 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~ 499 (646)
++||+.+++|.+++... ...+++..+++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988754 346899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 500 PGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
...... .....||+.|+|||++.+..++.++||||||++||||+| |+.||...... .+...+.. +.... .
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~----~~~~~-~ 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK----GERLP-Q 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHH----TCCCC-C
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CCCCC-C
Confidence 544332 334568999999999999999999999999999999999 67777633221 12221111 11000 0
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
++ .....+.+|+.+||+.+|++|||+.|+++.|+++.....
T Consensus 235 p~------------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 235 PP------------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp CT------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred Cc------------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence 00 122446789999999999999999999999998876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=389.29 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=205.7
Q ss_pred ccEecccCcEEEEEEEEcCC----cEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeC-CcCeEEEEEc
Q 006402 351 ERILGSGGFGEVYKGELQDG----TVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-EQPLLIYEYI 424 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 424 (646)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|+++|++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999987532 36899998743 445568899999999999999999999998764 5789999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
++|+|.++++.. ...+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999998764 335789999999999999999999999 999999999999999999999999999876543322
Q ss_pred ---cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 505 ---VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 505 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
......||+.|+|||.+.+..++.++||||||++||||+||+.||....... .+...+. .+... ..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~~~--~~p~- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGRRL--LQPE- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCCC--CCCT-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCCCC--CCcc-
Confidence 2233568999999999999999999999999999999999988876433221 1122211 11111 0110
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVNQE 632 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 632 (646)
...+.+.+|+.+||+.||++||||.||++.|+++++....+
T Consensus 258 ----------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 258 ----------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 11235678999999999999999999999999998765554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=390.48 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=198.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCC-cccHHHHHHHHHHHhhC-CCCcccccceeEEeCC-
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE- 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 415 (646)
.++|++.++||+|+||+||+|++. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367899999999999999999764 34689999987543 34456788888888887 6899999999987654
Q ss_pred cCeEEEEEccCCCccccccCCcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYS-------------SFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
..++||||+++|+|.++++.... ...+++..++.++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975421 235899999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCCCccH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQK-AIDFSRDPDDVNL 560 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~-p~~~~~~~~~~~~ 560 (646)
+++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+||.. ||...... ..+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 9999999999999876544332 2334569999999999999999999999999999999999765 55432221 111
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
.. ....+...+ ... ...+++.+|+.+||+.||++|||++||++.|++++++
T Consensus 247 ~~----~~~~~~~~~-----~~~--------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 CR----RLKEGTRMR-----APD--------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HHHHTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHhcCCCCC-----CCc--------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 111111111 110 1123467899999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=392.50 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=204.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCc--EEEEEEcccC-CcccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGT--VVAVKSAKVG-NIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 420 (646)
++|++.++||+|+||+||+|+++ ++. .||||+++.. ..+..+.|.+|+++|+++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888899999999999999876 444 5788887543 334567899999999999 799999999999999999999
Q ss_pred EEEccCCCccccccCC-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCE
Q 006402 421 YEYIANGTLHDHLHGK-------------YSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNS 487 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ 487 (646)
|||+++|+|.++|+.. .....+++..++.++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 12356999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCCCccHHHHHHH
Q 006402 488 KVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKA-IDFSRDPDDVNLAIYVSQ 566 (646)
Q Consensus 488 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p-~~~~~~~~~~~~~~~~~~ 566 (646)
||+|||+++........ ....||+.|+|||.+.+..++.++||||||+++|||++|..| |... . ... +..
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~-----~~~-~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T-----CAE-LYE 237 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-C-----HHH-HHH
T ss_pred EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-C-----HHH-HHH
Confidence 99999999866543322 233489999999999999999999999999999999998764 4321 1 111 111
Q ss_pred HhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 567 RASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 567 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
....+...+ .. ....+++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 238 ~i~~~~~~~-----~~--------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQGYRLE-----KP--------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGTCCCC-----CC--------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcCCCC-----CC--------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222211111 10 01224577899999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.4e-47 Score=382.05 Aligned_cols=258 Identities=25% Similarity=0.322 Sum_probs=202.2
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc---ccHHHHHHHHHHHhhCCCCcccccceeEEeCCc----
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI---KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQ---- 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 416 (646)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.|.+|+.++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999864 799999999875432 345679999999999999999999999987543
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+||||+.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988643 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC--ccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 497 LAKPGLS--HVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 497 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
....... .......||+.|+|||++.+..++.++||||||++||||+||+.||.... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC
Confidence 6543322 22334569999999999999899999999999999999999999996321 111122222222111
Q ss_pred -ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 006402 575 -EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERP-SMTDVVHELQRII 626 (646)
Q Consensus 575 -~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-s~~evl~~L~~~~ 626 (646)
....+ ...+.+.+|+.+||+.||++|| |++++++.|.++.
T Consensus 234 ~~~~~~------------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHE------------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSS------------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Cchhcc------------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111 1224567899999999999999 8999999998875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=389.02 Aligned_cols=268 Identities=22% Similarity=0.338 Sum_probs=200.8
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHH--HHHHHhhCCCCcccccceeEEeCC----cCeE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLN--EVGILSQVNHKNLVRLLGCCVEAE----QPLL 419 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 419 (646)
+.|...+.||+|+||+||+|++ +|+.||||+++.. ..+++.+ |+..+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567778999999999999987 5889999998643 2334444 555556789999999999998764 4689
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA-----YTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
||||+++|+|.++|++. .++|..+++++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999753 4899999999999999999999741 12399999999999999999999999999
Q ss_pred CccCCCCCCc---cccccCccccccCccccccC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCc-------
Q 006402 495 SRLAKPGLSH---VSTCAQGTLGYLDPEYYRNY------QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDV------- 558 (646)
Q Consensus 495 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~------- 558 (646)
++........ ......||+.|+|||++.+. .++.|+||||||++||||+||..|+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 22345699999999998654 2577999999999999999998887543321110
Q ss_pred -cHHHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 559 -NLAIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 559 -~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
.............. .++.+.... ......+.+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~----~~p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK----LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----cCCCCCccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 11111111121111 122221111 1223556688999999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=382.38 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=195.2
Q ss_pred cCCCcccEecccCcEEEEEEEEcC--C--cEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD--G--TVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.+.||+|+||+||+|+++. + ..||||+++.. +.+..++|.+|+.+|++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468888999999999999997642 2 37899988654 23446789999999999999999999999965 4678
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999988654 235899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc--ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 499 KPGLSHV--STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 499 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
....... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||.... ...........+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCCCCC
Confidence 6544332 233457889999999999999999999999999999998 899986221 1111122222211111
Q ss_pred cccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 006402 576 VVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRI 625 (646)
Q Consensus 576 ~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~ 625 (646)
. .+ .....+.+|+.+||+.||++||||.||++.|+++
T Consensus 236 ~-~~------------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 R-PE------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-CT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-cc------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 00 1124477899999999999999999999888765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=387.18 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=203.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.++||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56899999999999999999875 7999999998643 2335678899999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998753 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
... .....||+.|+|||++.+..++.++||||+||+||||++|+.||..... ..+. .....+.. . +...
T Consensus 159 ~~~-~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~----~~i~~~~~-~-~p~~- 227 (337)
T d1o6la_ 159 GAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF----ELILMEEI-R-FPRT- 227 (337)
T ss_dssp TCC-BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCC-C-CCTT-
T ss_pred Ccc-cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHH----HHHhcCCC-C-CCcc-
Confidence 222 2334599999999999999999999999999999999999999974321 1111 11111111 0 0111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
...++.+|+.+||+.||.+||+ +.|+++
T Consensus 228 -----------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 -----------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----------CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1234668999999999999995 778775
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=384.91 Aligned_cols=262 Identities=29% Similarity=0.404 Sum_probs=210.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeCCcC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (646)
++|++.++||+|+||.||+|++. +++.||||+++.... .....|.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888899999999999999763 457899999976443 4456799999999999 699999999999999999
Q ss_pred eEEEEEccCCCccccccCCc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 418 LLIYEYIANGTLHDHLHGKY---------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
++||||+++|+|.++++... ....+++..++.++.||++||+|||+++ |+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999997542 1235899999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLA 561 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~ 561 (646)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+|+..|+....... ..+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 9999999999999977654332 3344568999999999999999999999999999999999665554232221 1111
Q ss_pred HHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 562 IYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
..+.. +.. +.... .....+.+|+.+||+.||++||||.||+++|++++..
T Consensus 259 ~~i~~----~~~-----~~~~~--------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKE----GFR-----MLSPE--------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHH----TCC-----CCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhc----CCC-----CCCcc--------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11111 110 00000 1124477899999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-46 Score=384.34 Aligned_cols=244 Identities=27% Similarity=0.355 Sum_probs=202.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999875 6999999998643 2345678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999988743 35788999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
. ....||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......... +.. .+.+.
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~-~~~--~~p~~- 223 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-AEL--RFPPF- 223 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-CCC--CCCTT-
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHc-CCC--CCCCC-
Confidence 2 235699999999999998999999999999999999999999963211 111111111 110 01111
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
..+.+.+++.+||+.||.+|| |++|+++
T Consensus 224 -----------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 224 -----------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -----------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 123466899999999999996 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-46 Score=374.09 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=202.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcc---------cHHHHHHHHHHHhhCC-CCcccccceeEEeC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIK---------STQQVLNEVGILSQVN-HKNLVRLLGCCVEA 414 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 414 (646)
++|++.+.||+|+||+||+++.. +|+.||||+++..... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67899999999999999999875 7899999998654321 2346889999999997 99999999999999
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
+..++||||+++|+|.++|+.+ ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999743 35999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCccccccCccccccCcccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRN------YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
++........ +...||+.|+|||++.+ ..++.++||||+|++||||++|+.||..... .... ...
T Consensus 157 a~~~~~~~~~--~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~----~~i 227 (277)
T d1phka_ 157 SCQLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLML----RMI 227 (277)
T ss_dssp CEECCTTCCB--CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHH
T ss_pred eeEccCCCce--eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHH----HHH
Confidence 9887654332 33569999999999853 3578899999999999999999999973321 1111 111
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+... ...+. .....+++.+|+.+||+.+|++|||+.||++
T Consensus 228 ~~~~~~-~~~~~---------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQ-FGSPE---------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCC-CCTTT---------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCC-CCCcc---------cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111110 00000 0112345779999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=380.70 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=204.8
Q ss_pred cCCCcccEecccCcEEEEEEEEcC--------CcEEEEEEcccCCc-ccHHHHHHHHHHHhhC-CCCcccccceeEEeCC
Q 006402 346 NGFSKERILGSGGFGEVYKGELQD--------GTVVAVKSAKVGNI-KSTQQVLNEVGILSQV-NHKNLVRLLGCCVEAE 415 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 415 (646)
++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 568888999999999999997642 24799999876543 3457889999999988 7999999999999999
Q ss_pred cCeEEEEEccCCCccccccCCc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 006402 416 QPLLIYEYIANGTLHDHLHGKY-------------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD 482 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~ 482 (646)
..++||||+++|+|.++|.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 9999999999999999997543 1245899999999999999999999999 99999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCCc-cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCCccH
Q 006402 483 DDFNSKVADFGLSRLAKPGLSH-VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLT-SQKAIDFSRDPDDVNL 560 (646)
Q Consensus 483 ~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~ellt-g~~p~~~~~~~~~~~~ 560 (646)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.|+||||||+++|||++ |+.||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 9999999999999877544332 2334568999999999999999999999999999999998 5777642211
Q ss_pred HHHHHHHhcCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 006402 561 AIYVSQRASNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEI 628 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~ 628 (646)
. .+......+...+. ++ ...+.+.+|+.+||+.+|++|||+.||++.|+++...
T Consensus 244 ~-~~~~~i~~~~~~~~-p~------------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 E-ELFKLLKEGHRMDK-PS------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp H-HHHHHHHTTCCCCC-CS------------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-HHHHHHHcCCCCCC-Cc------------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1 11222222211111 11 1123477899999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=382.51 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=204.1
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
.++|.+.+.||+|+||+||+|..+ +++.||||+++... .....+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999876 68999999997654 3345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCCEEEeecCCCccCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD--DFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~--~~~~ki~DfGl~~~~~~~ 501 (646)
+++|+|.+++... ...+++.++..|+.||++||+|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999754 335899999999999999999999999 999999999999984 458999999999877554
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
... ....+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... ......+.. .........
T Consensus 158 ~~~--~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~--~~~~~~~~~---- 226 (321)
T d1tkia_ 158 DNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMN--AEYTFDEEA---- 226 (321)
T ss_dssp CEE--EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH--TCCCCCHHH----
T ss_pred Ccc--cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh--CCCCCChhh----
Confidence 332 234589999999999999999999999999999999999999963321 111111111 000000000
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
......++.+|+.+||+.||++|||++|+++
T Consensus 227 --------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 --------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112345679999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=383.13 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=208.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc------CCcEEEEEEcccC-CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcC
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ------DGTVVAVKSAKVG-NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 417 (646)
.++|.+.+.||+|+||+||+|.++ +++.||||+++.. ..+....|.+|+.++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999764 3578999999754 334456799999999999999999999999999999
Q ss_pred eEEEEEccCCCccccccCCc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 418 LLIYEYIANGTLHDHLHGKY-------SSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
++||||+++|+|.++++... ....+++..+++++.|+|+||.|||+++ |+||||||+|||||+++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986431 2234799999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCCcc-ccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCCccHHHHHHHHh
Q 006402 491 DFGLSRLAKPGLSHV-STCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQ-KAIDFSRDPDDVNLAIYVSQRA 568 (646)
Q Consensus 491 DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 568 (646)
|||+++......... .....||+.|+|||.+.+..++.++||||||++||||+||. .||... ....... ..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~-~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLR-FV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHH-HH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHH-HH
Confidence 999998765433322 23345899999999999999999999999999999999986 455321 1111111 11
Q ss_pred cCCcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 569 SNGAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 569 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
..+...+.. + .....+.+|+.+||+.+|++||||+||+++|++.++
T Consensus 249 ~~~~~~~~p-~------------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDKP-D------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCCC-T------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCCc-c------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 122211110 0 122457799999999999999999999999887654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-46 Score=384.83 Aligned_cols=244 Identities=24% Similarity=0.320 Sum_probs=202.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 421 (646)
++|++.+.||+|+||+||+|+.+ +|+.||||++... +....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999875 7999999998643 2244678999999999999999999999999999999999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPG 501 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~ 501 (646)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999877543
Q ss_pred CCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccccccc
Q 006402 502 LSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPRL 581 (646)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 581 (646)
. ....||+.|+|||++.+..++.++|||||||+||||+||+.||.... ..... .... .+... ...
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~---~~i~-~~~~~--~p~-- 259 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIY---EKIV-SGKVR--FPS-- 259 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHH-HCCCC--CCT--
T ss_pred c----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHH---HHHh-cCCCC--CCc--
Confidence 2 23459999999999999999999999999999999999999996321 11111 1111 11100 001
Q ss_pred cCCchhHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006402 582 QGHEASVNILMSLKLFSELAVACLREKKSERP-----SMTDVVH 620 (646)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~evl~ 620 (646)
....++.+|+.+||+.||.+|+ |++|+++
T Consensus 260 ----------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 ----------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1123467899999999999994 8999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=380.84 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=197.5
Q ss_pred hcCCCcc-cEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhC-CCCcccccceeEEe----CCcC
Q 006402 345 TNGFSKE-RILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQV-NHKNLVRLLGCCVE----AEQP 417 (646)
Q Consensus 345 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 417 (646)
.++|.+. ++||+|+||+||+|+.. +++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578876 46999999999999874 789999999853 34577899987655 89999999999876 3568
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCEEEeecCC
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD---DFNSKVADFGL 494 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~---~~~~ki~DfGl 494 (646)
++||||+++|+|.++|..+ ....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999764 2346999999999999999999999999 999999999999985 56799999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
++........ ....||+.|+|||++.+..++.++|||||||+||||+||+.||......... ............
T Consensus 161 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~- 234 (335)
T d2ozaa1 161 AKETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQY- 234 (335)
T ss_dssp CEECCCCCCC--CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred eeeccCCCcc--ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCC-
Confidence 9877654332 3345999999999999999999999999999999999999999644322111 000111100000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+. ........+++.+|+.+||+.||++|||+.|+++
T Consensus 235 -----~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 -----EFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----SCC----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 0011233456889999999999999999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=378.18 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=193.6
Q ss_pred ccEecccCcEEEEEEEEc-CCcEEEEEEcccCCccc-----HHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEEc
Q 006402 351 ERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKS-----TQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEYI 424 (646)
Q Consensus 351 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 424 (646)
.++||+|+||+||+|+.+ +|+.||||+++...... .+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999875 68999999986543222 246889999999999999999999999999999999999
Q ss_pred cCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCCc
Q 006402 425 ANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLSH 504 (646)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~~ 504 (646)
.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 98877766643 345888999999999999999999999 999999999999999999999999999876544322
Q ss_pred cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc---ccc--
Q 006402 505 VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME---VVD-- 578 (646)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d-- 578 (646)
.....||+.|+|||++... .++.++|||||||++|||++|+.||...... .....+........... ...
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhccc
Confidence 2234589999999998654 6799999999999999999999998643221 11111111111100000 000
Q ss_pred -----ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 579 -----PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 579 -----~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
................+.+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000000112346789999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-45 Score=383.78 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=196.8
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC---cccHHHHH---HHHHHHhhCCCCcccccceeEEeCCcCe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN---IKSTQQVL---NEVGILSQVNHKNLVRLLGCCVEAEQPL 418 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (646)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+. +|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999876 69999999985321 12223333 4577778888999999999999999999
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
+||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999753 35789999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccccc
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVV 577 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (646)
..... ....||+.|+|||++.. ..++.++|||||||+||||+||+.||......+. . .+........ ..+
T Consensus 158 ~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~-~~~~~~~~~~--~~~ 228 (364)
T d1omwa3 158 SKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---H-EIDRMTLTMA--VEL 228 (364)
T ss_dssp SSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---H-HHHHHSSSCC--CCC
T ss_pred CCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHhcccCC--CCC
Confidence 54432 23459999999999864 5689999999999999999999999975433221 1 1111111110 000
Q ss_pred cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 578 DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 578 d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
... ..+++.+|+.+||+.||++||| ++|+++
T Consensus 229 ~~~------------~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 PDS------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CSS------------SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC------------CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111 1234678999999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=380.15 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=200.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccC---CcccHHHHHHHHHHHh-hCCCCcccccceeEEeCCcCeEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVG---NIKSTQQVLNEVGILS-QVNHKNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 420 (646)
++|.+.+.||+|+||+||+|+.+ +++.||||+++.. .....+.+.+|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999876 6999999998643 2234567778877765 68999999999999999999999
Q ss_pred EEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCC
Q 006402 421 YEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~ 500 (646)
|||+++|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999986654
Q ss_pred CCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccccccccc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIMEVVDPR 580 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 580 (646)
.... .+...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......+.. .+++.
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~----~~~i~~~~~--~~p~~ 225 (320)
T d1xjda_ 156 GDAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EEL----FHSIRMDNP--FYPRW 225 (320)
T ss_dssp TTCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHCCC--CCCTT
T ss_pred cccc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHH----HHHHHcCCC--CCCcc
Confidence 3322 2335699999999999999999999999999999999999999963221 111 111111110 01111
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 006402 581 LQGHEASVNILMSLKLFSELAVACLREKKSERPSMT-DVVH 620 (646)
Q Consensus 581 l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-evl~ 620 (646)
..+++.+|+.+||+.||++|||+. |+++
T Consensus 226 ------------~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 ------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------------SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------------CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 123467899999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=376.14 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=198.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999874 799999999865432 235789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
|+.++ +.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99654 44444332 2345999999999999999999999999 9999999999999999999999999998765433
Q ss_pred CccccccCccccccCccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC---Ccccccc-
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN---GAIMEVV- 577 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 577 (646)
.. .....||+.|+|||.+.... ++.++|||||||++|||++|+.||...... .....+...... .......
T Consensus 157 ~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp BC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhcccccc
Confidence 22 23345999999999876654 578999999999999999999999643211 111111111100 0000000
Q ss_pred --c--c---cccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 578 --D--P---RLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 578 --d--~---~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
+ . ...............+++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 0 00000000001112356789999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-45 Score=369.02 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=199.4
Q ss_pred cCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCc--ccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNI--KSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 423 (646)
++|++.++||+|+||+||+|+.++|+.||||+++.... ...+.+.+|+.+|++++|||||++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999999999999999999999999865432 3357899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGLS 503 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~~ 503 (646)
+.++.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 988777766543 346999999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---ccccc---
Q 006402 504 HVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---AIMEV--- 576 (646)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 576 (646)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+....... .....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhh
Confidence 2 2233589999999998654 5789999999999999999999999633211 1111111111100 00000
Q ss_pred --ccccccC---CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 577 --VDPRLQG---HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 577 --~d~~l~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+..... ...........+.+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0000000112345779999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=365.33 Aligned_cols=239 Identities=28% Similarity=0.402 Sum_probs=193.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCc------ccHHHHHHHHHHHhhCC--CCcccccceeEEeCCc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNI------KSTQQVLNEVGILSQVN--HKNLVRLLGCCVEAEQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 416 (646)
++|++.++||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999875 789999999864321 11234678999999997 8999999999999999
Q ss_pred CeEEEEEccC-CCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCEEEeecCC
Q 006402 417 PLLIYEYIAN-GTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-DFNSKVADFGL 494 (646)
Q Consensus 417 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-~~~~ki~DfGl 494 (646)
.++||||+.+ +++.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777543 35899999999999999999999999 999999999999984 57999999999
Q ss_pred CccCCCCCCccccccCccccccCccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcc
Q 006402 495 SRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQL-TDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAI 573 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (646)
++...... .+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... .+ .. ...
T Consensus 158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i---~~-~~~ 221 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EI---IR-GQV 221 (273)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH---HH-CCC
T ss_pred ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HH---hh-ccc
Confidence 98764432 233569999999999987665 567899999999999999999986321 00 00 000
Q ss_pred cccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 574 MEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 574 ~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.+.+. ...++.+|+.+||+.||++|||++|+++
T Consensus 222 --~~~~~------------~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 --FFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --CCSSC------------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCC------------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111 1234678999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=369.57 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=194.5
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-C-CcEEEEEEcccCC--cccHHHHHHHHHHHhhC---CCCcccccceeEEeC---
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-D-GTVVAVKSAKVGN--IKSTQQVLNEVGILSQV---NHKNLVRLLGCCVEA--- 414 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~--- 414 (646)
.++|++.++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999874 4 6789999986432 22233466777776665 799999999998642
Q ss_pred --CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeec
Q 006402 415 --EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADF 492 (646)
Q Consensus 415 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~Df 492 (646)
...+++|||+.++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 367899999988877655443 2345899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCc
Q 006402 493 GLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGA 572 (646)
Q Consensus 493 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 572 (646)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+........
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCc
Confidence 9988654332 233456999999999999999999999999999999999999999643211 11111111111000
Q ss_pred ---cc------ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 573 ---IM------EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 573 ---~~------~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. ....................+.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000000000000112345678999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.7e-43 Score=354.20 Aligned_cols=265 Identities=15% Similarity=0.190 Sum_probs=208.3
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC-CcccccceeEEeCCcCeEEEE
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH-KNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 422 (646)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ..+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999875 68999999876442 23456788999999975 899999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCCEEEeecCCCcc
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDD-----DFNSKVADFGLSRL 497 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~-----~~~~ki~DfGl~~~ 497 (646)
|+ +++|.++++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 78999988653 335899999999999999999999999 999999999999974 57899999999987
Q ss_pred CCCCCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC
Q 006402 498 AKPGLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG 571 (646)
Q Consensus 498 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 571 (646)
....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6433211 2234569999999999999999999999999999999999999997544433222221111111111
Q ss_pred cccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHh
Q 006402 572 AIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIEIVN 630 (646)
Q Consensus 572 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 630 (646)
...++ . ...++++.+++..|+..+|++||+.+.+.+.|+++.+..+
T Consensus 236 ~~~~l-----~--------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PLREL-----C--------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CHHHH-----T--------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ChHHh-----c--------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 11110 0 0123457789999999999999999999988888876554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=369.24 Aligned_cols=262 Identities=26% Similarity=0.305 Sum_probs=190.9
Q ss_pred CCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcccccceeEEeCC------cCeE
Q 006402 347 GFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------QPLL 419 (646)
Q Consensus 347 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 419 (646)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+.+|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999876 699999999875432 2347999999999999999999986532 3679
Q ss_pred EEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccC
Q 006402 420 IYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLA 498 (646)
Q Consensus 420 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~ 498 (646)
||||++++.+....+.......+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444332224456999999999999999999999999 99999999999999764 8999999999877
Q ss_pred CCCCCccccccCccccccCcccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHH----------HH
Q 006402 499 KPGLSHVSTCAQGTLGYLDPEYYRN-YQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVS----------QR 567 (646)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~----------~~ 567 (646)
....... ...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+..... ..
T Consensus 174 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCCC--SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcccc--cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhh
Confidence 5543332 2459999999998764 578999999999999999999999996433211 1111000 00
Q ss_pred hcCCcccccccccccCCch-hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 568 ASNGAIMEVVDPRLQGHEA-SVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 568 ~~~~~~~~~~d~~l~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.... ..+..-+....... .........++.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000000000 0000112345778999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=361.61 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=194.6
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC--------
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-------- 414 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 414 (646)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+.+|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999875 79999999986542 23457789999999999999999999998653
Q ss_pred CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCC
Q 006402 415 EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGL 494 (646)
Q Consensus 415 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl 494 (646)
+..++||||+.++.+..+... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 357899999988777655442 335889999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCc---cccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcC
Q 006402 495 SRLAKPGLSH---VSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASN 570 (646)
Q Consensus 495 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 570 (646)
++........ ......||+.|+|||++.+. .++.|+||||||+++|||++|+.||..... ......+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 9766533221 12234599999999998654 689999999999999999999999863321 1111111111111
Q ss_pred --Cccccccc-c----c---ccCCc-hhH---HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 571 --GAIMEVVD-P----R---LQGHE-ASV---NILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 571 --~~~~~~~d-~----~---l~~~~-~~~---~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.......+ . . ..... ... ........+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000 0 0 00000 000 01112345678999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-42 Score=354.48 Aligned_cols=261 Identities=21% Similarity=0.260 Sum_probs=197.7
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCccccc-ceeEEeCCcCeEEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNLVRL-LGCCVEAEQPLLIYEY 423 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lV~e~ 423 (646)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .+++.+|++++++++|+|++.. .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999875 689999998765432 3457889999999987776555 4555667788899999
Q ss_pred ccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCEEEeecCCCccCCC
Q 006402 424 IANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLD---DDFNSKVADFGLSRLAKP 500 (646)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~---~~~~~ki~DfGl~~~~~~ 500 (646)
+ +++|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++....
T Consensus 85 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 8 55666665432 345899999999999999999999999 99999999999985 456799999999987654
Q ss_pred CCCc------cccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 501 GLSH------VSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 501 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3321 2234569999999999999999999999999999999999999997544332222111111111000000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHELQRIIE 627 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~L~~~~~ 627 (646)
. +. ...++++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus 239 ~-----~~--------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 V-----LC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp H-----HT--------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred H-----hc--------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 00 1123457789999999999999999999998888754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=366.89 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=196.4
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC-cccHHHHHHHHHHHhhCCCCcccccceeEEeCC----cCe
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN-IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE----QPL 418 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 418 (646)
+.+|++.++||+|+||+||+|+.+ +|+.||||++.... ....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999764 79999999987543 334678999999999999999999999987654 345
Q ss_pred EEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccC
Q 006402 419 LIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLA 498 (646)
Q Consensus 419 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~ 498 (646)
++++++.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999999643 5899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCc--cccccCccccccCccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 499 KPGLSH--VSTCAQGTLGYLDPEYYR-NYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 499 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
...... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||......+. ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 543222 223456999999999984 44678999999999999999999999964322111 111111110000000
Q ss_pred c-------------ccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 576 V-------------VDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 576 ~-------------~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
. ..+................++.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000000000000112357799999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=365.89 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=194.6
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCC------
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAE------ 415 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 415 (646)
.++|++.++||+|+||+||+|..+ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999875 69999999987542 234567899999999999999999999998765
Q ss_pred cCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCC
Q 006402 416 QPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLS 495 (646)
Q Consensus 416 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~ 495 (646)
..++||||+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 6677776643 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 496 RLAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
+...... +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ +.. ....... ...
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~-~~~~~~~-~~~ 240 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKE-IMKVTGT-PPA 240 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCC-CCH
T ss_pred eccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHH-HHhccCC-CcH
Confidence 8765432 335599999999998764 578999999999999999999999964322111 111 0000000 000
Q ss_pred ccc--------------cccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 006402 575 EVV--------------DPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE--LQRII 626 (646)
Q Consensus 575 ~~~--------------d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~--L~~~~ 626 (646)
+.+ .+.................+.+|+.+||+.||++|||++|+++. ++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 00000000000001112346789999999999999999999974 55543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=352.70 Aligned_cols=266 Identities=20% Similarity=0.260 Sum_probs=203.0
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeCCcCeEEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 422 (646)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999875 78999999986543 2346789999999999999999999999999999999999
Q ss_pred EccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCccCCCCC
Q 006402 423 YIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSRLAKPGL 502 (646)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~~~~~~~ 502 (646)
++.+++|..++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999998887643 45889999999999999999999999 9999999999999999999999999998775443
Q ss_pred CccccccCccccccCccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCC---ccc---c
Q 006402 503 SHVSTCAQGTLGYLDPEYYRNYQ-LTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNG---AIM---E 575 (646)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~ 575 (646)
.. .....+++.|+|||.+.... ++.++|||||||++|||++|+.||....... .....+....... ... .
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred cc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhh
Confidence 22 22344788999999987654 6899999999999999999999975332211 1111111111110 000 0
Q ss_pred cccc---c-cc-CCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VVDP---R-LQ-GHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~d~---~-l~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
..+. . .. ............+.+.+|+.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 00 00000001112345778999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-42 Score=355.74 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=196.1
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeC--CcCeEEE
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEA--EQPLLIY 421 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 421 (646)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999874 7999999998653 3567889999999996 99999999999854 4688999
Q ss_pred EEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CEEEeecCCCccCCC
Q 006402 422 EYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDF-NSKVADFGLSRLAKP 500 (646)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~-~~ki~DfGl~~~~~~ 500 (646)
||+++++|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999987642 4899999999999999999999999 99999999999998654 699999999987765
Q ss_pred CCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHH----------HHHhc
Q 006402 501 GLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV----------SQRAS 569 (646)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~ 569 (646)
.... ....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||.......+....... .....
T Consensus 183 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCCC--CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCcc--cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 4332 234589999999998765 4799999999999999999999998744332211111000 00000
Q ss_pred CCc---ccccccccccC----CchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 570 NGA---IMEVVDPRLQG----HEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 570 ~~~---~~~~~d~~l~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
... ........... ...........+++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000000 0000001122345779999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=357.15 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=200.2
Q ss_pred cCCCcccEecccCcEEEEEEEEc----CCcEEEEEEcccCC----cccHHHHHHHHHHHhhCCC-CcccccceeEEeCCc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ----DGTVVAVKSAKVGN----IKSTQQVLNEVGILSQVNH-KNLVRLLGCCVEAEQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 416 (646)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999752 47899999986432 2345678899999999976 899999999999999
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+.+|+|.+++... ..++...+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999754 24788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccCccccccCccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNY--QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIM 574 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (646)
..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+.... +........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~-- 252 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSE-- 252 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCC--
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCC--
Confidence 7755444444455699999999998654 478899999999999999999999975543322111 111111000
Q ss_pred ccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006402 575 EVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPS-----MTDVVH 620 (646)
Q Consensus 575 ~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-----~~evl~ 620 (646)
+.+.. ....++.+|+.+||+.||++||| ++|+++
T Consensus 253 ----~~~~~--------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----PPYPQ--------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCT--------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCcc--------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00100 12245678999999999999995 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=355.18 Aligned_cols=261 Identities=22% Similarity=0.238 Sum_probs=190.4
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC------Cc
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA------EQ 416 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 416 (646)
++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999876 69999999987543 33456789999999999999999999999743 56
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++||||+.++.+. .+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 79999999765544 4432 4799999999999999999999999 9999999999999999999999999988
Q ss_pred cCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHh--------
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRA-------- 568 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 568 (646)
........ +...+|+.|+|||++.+..++.++||||+||+++||++|+.||...... .....+....
T Consensus 168 ~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 168 TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred cccccccc--ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCCCHHHH
Confidence 76543322 3345899999999999989999999999999999999999998633211 0000000000
Q ss_pred -----------cC------CcccccccccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006402 569 -----------SN------GAIMEVVDPRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVHE 621 (646)
Q Consensus 569 -----------~~------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~~ 621 (646)
.. ......+........ ..........+.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD-SEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCS-SHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCcccccccccccccccccccc-ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000011111111111 11233456678899999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=351.84 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=194.7
Q ss_pred hcCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCC--cccHHHHHHHHHHHhhCCCCcccccceeEEeC-----Cc
Q 006402 345 TNGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGN--IKSTQQVLNEVGILSQVNHKNLVRLLGCCVEA-----EQ 416 (646)
Q Consensus 345 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 416 (646)
+++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999864 79999999987543 23456789999999999999999999998743 34
Q ss_pred CeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 417 PLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 417 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+++++|+.+|+|.++++.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 57778888999999999643 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCccccccCccccccCccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHHHHHhcCCcccc
Q 006402 497 LAKPGLSHVSTCAQGTLGYLDPEYYRNY-QLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYVSQRASNGAIME 575 (646)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (646)
..... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+...... ...+
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~-~~~~ 241 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGT-PGAE 241 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC-CCHH
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC-CChH
Confidence 65322 2334589999999987665 5688999999999999999999999643211 111111111110 0000
Q ss_pred cc------------c--ccccCCchhHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006402 576 VV------------D--PRLQGHEASVNILMSLKLFSELAVACLREKKSERPSMTDVVH 620 (646)
Q Consensus 576 ~~------------d--~~l~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~evl~ 620 (646)
.. . ..................+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 0 000000000000112345779999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=318.58 Aligned_cols=267 Identities=19% Similarity=0.198 Sum_probs=188.3
Q ss_pred cCCCcccEecccCcEEEEEEEEc-CCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-----------CCcccccceeEEe
Q 006402 346 NGFSKERILGSGGFGEVYKGELQ-DGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-----------HKNLVRLLGCCVE 413 (646)
Q Consensus 346 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 413 (646)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999875 79999999987542 33467788999988875 5789999998875
Q ss_pred C--CcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCC-----
Q 006402 414 A--EQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHS-AAYTPIYHRDVKSTNILLDDDF----- 485 (646)
Q Consensus 414 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~Dik~~NIll~~~~----- 485 (646)
. ...++++++...+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 3556677776555443333323344568999999999999999999998 77 99999999999998654
Q ss_pred -CEEEeecCCCccCCCCCCccccccCccccccCccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCCccHHHHH
Q 006402 486 -NSKVADFGLSRLAKPGLSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSYGVVLLELLTSQKAIDFSRDPDDVNLAIYV 564 (646)
Q Consensus 486 -~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ll~elltg~~p~~~~~~~~~~~~~~~~ 564 (646)
.+|++|||.+....... ....||+.|+|||.+....++.++||||+|++++||++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 39999999998654322 2345999999999999889999999999999999999999998754332211111111
Q ss_pred H---HHhcC---------Ccccccccc-----cccCC---chh-------HHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006402 565 S---QRASN---------GAIMEVVDP-----RLQGH---EAS-------VNILMSLKLFSELAVACLREKKSERPSMTD 617 (646)
Q Consensus 565 ~---~~~~~---------~~~~~~~d~-----~l~~~---~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~e 617 (646)
. ..... .......+. .+... ... .......+++.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1 00000 000000000 00000 000 001234567889999999999999999999
Q ss_pred HHH
Q 006402 618 VVH 620 (646)
Q Consensus 618 vl~ 620 (646)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.6e-23 Score=197.56 Aligned_cols=163 Identities=18% Similarity=0.189 Sum_probs=120.9
Q ss_pred CcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcc------------------cHHHHHHHHHHHhhCCCCccccccee
Q 006402 349 SKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIK------------------STQQVLNEVGILSQVNHKNLVRLLGC 410 (646)
Q Consensus 349 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~~ 410 (646)
.+.++||+|+||+||+|+..+|+.||||+++..... ....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999889999999986532110 12334578899999999999888765
Q ss_pred EEeCCcCeEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCEEEe
Q 006402 411 CVEAEQPLLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYTPIYHRDVKSTNILLDDDFNSKVA 490 (646)
Q Consensus 411 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~Dik~~NIll~~~~~~ki~ 490 (646)
...+++|||+++..+.+ ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ----~~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 ----EGNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----ETTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred ----cCCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 23589999998765543 233445679999999999999999 9999999999999976 59999
Q ss_pred ecCCCccCCCCCCccccccCccccccC------ccccccCCCCchhhHHHHHHHH
Q 006402 491 DFGLSRLAKPGLSHVSTCAQGTLGYLD------PEYYRNYQLTDKSDVYSYGVVL 539 (646)
Q Consensus 491 DfGl~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDv~s~G~ll 539 (646)
|||+++........ .|.. .|.+ .+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999766433211 1111 1222 34678899999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=7.9e-08 Score=93.05 Aligned_cols=149 Identities=18% Similarity=0.136 Sum_probs=104.9
Q ss_pred HHHHHHhcCCCcccEecccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCC-CCcccccceeEEeCCcC
Q 006402 339 KELKKATNGFSKERILGSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVN-HKNLVRLLGCCVEAEQP 417 (646)
Q Consensus 339 ~el~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 417 (646)
.|+++..++|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777778887666544455578998865 45567788765544344445678888887774 43467788888888889
Q ss_pred eEEEEEccCCCccccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC------------------------------
Q 006402 418 LLIYEYIANGTLHDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAAYT------------------------------ 467 (646)
Q Consensus 418 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~------------------------------ 467 (646)
++||+++++.++.+..... .....++.++++.++.||+...+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998876644211 12234566777777777754210
Q ss_pred --------------------------CeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 468 --------------------------PIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 468 --------------------------~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 17899999999999987666799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.5e-05 Score=76.04 Aligned_cols=130 Identities=21% Similarity=0.187 Sum_probs=87.1
Q ss_pred EecccCc-EEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCC--CcccccceeEEeCCcCeEEEEEccCCCc
Q 006402 353 ILGSGGF-GEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNH--KNLVRLLGCCVEAEQPLLIYEYIANGTL 429 (646)
Q Consensus 353 ~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL 429 (646)
.+..|.. +.||+...+++..+++|........ .+..|...++.+.. -.+.+++.+..+.+..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 6799998888888999986654333 35567777776642 3356778887888888999999988776
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 006402 430 HDHLHGKYSSFNLTWSTRLRIALQTAEALAYLHSAA-------------------------------------------- 465 (646)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------------- 465 (646)
.+.. +.. ..++.++++.|+-||+..
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 5421 111 122334444444444321
Q ss_pred -----------CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 466 -----------YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 466 -----------~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
.+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0127999999999999987667899999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00034 Score=71.00 Aligned_cols=76 Identities=16% Similarity=0.182 Sum_probs=48.0
Q ss_pred cEecccCcEEEEEEEEcC-CcEEEEEEcccC----C---cccHHHHHHHHHHHhhCC-C--CcccccceeEEeCCcCeEE
Q 006402 352 RILGSGGFGEVYKGELQD-GTVVAVKSAKVG----N---IKSTQQVLNEVGILSQVN-H--KNLVRLLGCCVEAEQPLLI 420 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 420 (646)
+.||.|....||+....+ ++.++||..... . ....++...|.+.|+.+. + ..+.+++. .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468999999999997654 678899964321 1 112334556888877663 2 33445543 356677899
Q ss_pred EEEccCCCc
Q 006402 421 YEYIANGTL 429 (646)
Q Consensus 421 ~e~~~~gsL 429 (646)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0021 Score=63.07 Aligned_cols=136 Identities=15% Similarity=0.137 Sum_probs=77.9
Q ss_pred cEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc--cccc-----eeEEeCCcCeEEEEEccCCCccc
Q 006402 359 FGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL--VRLL-----GCCVEAEQPLLIYEYIANGTLHD 431 (646)
Q Consensus 359 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~gsL~~ 431 (646)
--.||+++.++|+.+++|+.+.. ....+++..|...+..|...++ +..+ ..+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999987654 2345667788888877743222 1111 12234456778999987754422
Q ss_pred c--------------cc----CC--cCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCCC
Q 006402 432 H--------------LH----GK--YSSFNLTWST-------------------RLRIALQTAEALAYLHS----AAYTP 468 (646)
Q Consensus 432 ~--------------l~----~~--~~~~~l~~~~-------------------~~~i~~~ia~~l~yLH~----~~~~~ 468 (646)
. +| .. ..+..+++.. +..+...+.+.++.+.. .....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 01 00 0111122211 11122222233333332 22234
Q ss_pred eeeccCCCCCEEEcCCCCEEEeecCCCcc
Q 006402 469 IYHRDVKSTNILLDDDFNSKVADFGLSRL 497 (646)
Q Consensus 469 i~H~Dik~~NIll~~~~~~ki~DfGl~~~ 497 (646)
++|+|+.+.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 46899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.72 E-value=0.0035 Score=63.26 Aligned_cols=73 Identities=16% Similarity=0.205 Sum_probs=50.0
Q ss_pred cEecccCcEEEEEEEEcC--------CcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc-cccceeEEeCCcCeEEEE
Q 006402 352 RILGSGGFGEVYKGELQD--------GTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL-VRLLGCCVEAEQPLLIYE 422 (646)
Q Consensus 352 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 422 (646)
+.|+.|-.=.+|+....+ .+.|.+++... .....+..+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 568888889999998754 35677776542 2233455689999998863344 46666653 268999
Q ss_pred EccCCCcc
Q 006402 423 YIANGTLH 430 (646)
Q Consensus 423 ~~~~gsL~ 430 (646)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.39 E-value=0.0056 Score=59.47 Aligned_cols=158 Identities=13% Similarity=0.061 Sum_probs=81.5
Q ss_pred ccHHHHHHHhcCCCcccEe-----cccCcEEEEEEEEcCCcEEEEEEcccCCcccHHHHHHHHHHHhhCCCCcc--cccc
Q 006402 336 FHLKELKKATNGFSKERIL-----GSGGFGEVYKGELQDGTVVAVKSAKVGNIKSTQQVLNEVGILSQVNHKNL--VRLL 408 (646)
Q Consensus 336 ~~~~el~~~~~~~~~~~~L-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~ 408 (646)
.+.+|+.....+|.+.++. ..|---+.|+.+.++|+ +++|+..... ..++...|+.++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567888888888775443 35666788999887665 7889875431 22334445666666542222 1111
Q ss_pred e------eEEeCCcCeEEEEEccCCCccccc--------------c----CC--c-CCCCCCH-----------------
Q 006402 409 G------CCVEAEQPLLIYEYIANGTLHDHL--------------H----GK--Y-SSFNLTW----------------- 444 (646)
Q Consensus 409 ~------~~~~~~~~~lV~e~~~~gsL~~~l--------------~----~~--~-~~~~l~~----------------- 444 (646)
- +.........++.++.+......- + .. . ......+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 111233455666666554332211 0 00 0 0000000
Q ss_pred HHHHHHHHHHHHHHHHHHhCC-CCCeeeccCCCCCEEEcCCCCEEEeecCCCc
Q 006402 445 STRLRIALQTAEALAYLHSAA-YTPIYHRDVKSTNILLDDDFNSKVADFGLSR 496 (646)
Q Consensus 445 ~~~~~i~~~ia~~l~yLH~~~-~~~i~H~Dik~~NIll~~~~~~ki~DfGl~~ 496 (646)
......+..+...+.-.+... ...++|+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222233322211 2348999999999999988777899999875
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.07 E-value=0.039 Score=35.21 Aligned_cols=29 Identities=21% Similarity=0.430 Sum_probs=24.5
Q ss_pred ccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 235 LDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 235 ~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.-|..+|.|.......+|.|.|..||.|.
T Consensus 4 nPC~ngG~C~~~~~~~~y~C~C~~g~~G~ 32 (41)
T d1tpga1 4 PRCFNGGTCQQALYFSDFVCQCPEGFAGK 32 (41)
T ss_dssp CCSCTTCEEEEESSSSCEEEECCTTCBSS
T ss_pred CCCCCCCEEecCCCCCCeEECCCCCCCCC
Confidence 35788999998877788999999999874
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.94 E-value=0.027 Score=35.70 Aligned_cols=28 Identities=21% Similarity=0.515 Sum_probs=23.1
Q ss_pred cCCCCceeccCCCCCceeeecCCCcccCCC
Q 006402 236 DCSGASKCLSAGRNGVYRCLCIKGYYWDHV 265 (646)
Q Consensus 236 ~C~~~~~C~~~~~~~~~~C~C~~g~~~~~~ 265 (646)
.|..++.|.+. .++|.|.|++||.||..
T Consensus 8 ~C~~~A~C~Nt--~Gsy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 8 QCSVHAECRDY--ATGFCCRCVANYTGNGR 35 (40)
T ss_dssp GSCTTEEEEEC--SSCEEEEECTTEEECSS
T ss_pred CCCCCCEeecC--CCCeEeECCCCCcCCCC
Confidence 57778999865 46899999999999864
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.79 E-value=0.079 Score=33.28 Aligned_cols=31 Identities=23% Similarity=0.604 Sum_probs=24.6
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. ..|..+|.|.+. .++|.|.|..||.|.
T Consensus 5 ~C~~-~PC~ngg~C~~~--~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 5 QCES-NPCLNGGSCKDD--INSYECWCPFGFEGK 35 (39)
T ss_dssp TTTT-CCCCTTCEEEEE--TTEEEEECCTTCCST
T ss_pred cCCC-CCCCCCcEEEcC--CCCEEEECCCCCCCC
Confidence 4754 479889999865 468999999999873
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.88 E-value=0.12 Score=32.36 Aligned_cols=31 Identities=29% Similarity=0.811 Sum_probs=24.1
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. ..|..+|.|.+. .++|.|.|..||.|.
T Consensus 3 ~C~~-~PC~n~g~C~~~--~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 3 ECVS-NPCQNDATCLDQ--IGEFQCICMPGYEGV 33 (39)
T ss_dssp TTTT-CCCCSSCEEEEC--SSCEEEECCTTEESS
T ss_pred CCcC-CCCCCCCEEECC--CCCEEEeCCCCCccC
Confidence 3644 468889999864 468999999999873
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.50 E-value=0.096 Score=33.51 Aligned_cols=27 Identities=33% Similarity=0.864 Sum_probs=22.2
Q ss_pred ccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 235 LDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 235 ~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
..|..+|.|.+. .++|.|.|+.||.|.
T Consensus 11 ~pC~n~g~C~n~--~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 11 NPCEHAGKCINT--LGSFECQCLQGYTGP 37 (42)
T ss_dssp CSSSTTCEEEEC--SSSEEEECCTTEEST
T ss_pred CCCCCCcEeECC--CCCEEeECCCCCcCC
Confidence 468889999875 467999999999874
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.36 E-value=0.1 Score=35.30 Aligned_cols=29 Identities=28% Similarity=0.598 Sum_probs=24.1
Q ss_pred ccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 235 LDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 235 ~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.-|..+|.|.......+|.|.|..||.|.
T Consensus 12 ~~C~NgG~C~~~~~~~~~~C~C~~gy~G~ 40 (53)
T d3egfa_ 12 GYCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp CCSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred CCCCCCcEeeccCCCCCeEeECCCCCcCC
Confidence 35888999987666678999999999874
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.30 E-value=0.12 Score=32.36 Aligned_cols=30 Identities=33% Similarity=0.875 Sum_probs=23.6
Q ss_pred CCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 231 CKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 231 C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
|.. ..|..+|.|.+. .++|.|.|+.||.|.
T Consensus 3 C~~-~PC~ngg~C~~~--~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 3 CET-SPCQNQGKCKDG--LGEYTCTCLEGFEGK 32 (39)
T ss_dssp TTT-CCCCSSCEECCC--SSSCCEECCTTEETT
T ss_pred CCC-CCCCCCcEEECC--CCCEEEECCCCCCcC
Confidence 644 468889999764 467999999999873
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.28 E-value=0.1 Score=33.50 Aligned_cols=29 Identities=21% Similarity=0.567 Sum_probs=22.6
Q ss_pred CceeccCCCCCceeeecCCCcccCCCCCCcc
Q 006402 240 ASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQ 270 (646)
Q Consensus 240 ~~~C~~~~~~~~~~C~C~~g~~~~~~~~~C~ 270 (646)
++.|.+. .++|.|.|+.||..++....|.
T Consensus 14 ~~~C~Nt--~G~y~C~C~~Gy~l~~d~~~C~ 42 (43)
T d1uzka1 14 SGNCVNT--PGSYICDCPPDFELNPTRVGCV 42 (43)
T ss_dssp TSEEEEE--TTEEEEECCTTCEECTTSSBEE
T ss_pred CCEeECC--CCCEEEecCCCCEECCCCCccc
Confidence 5789876 4789999999998876655554
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.75 E-value=0.09 Score=34.73 Aligned_cols=29 Identities=24% Similarity=0.527 Sum_probs=24.0
Q ss_pred ccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 235 LDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 235 ~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.-|..+|.|.......+|.|.|..||.|.
T Consensus 10 ~~C~ngG~C~~~~~~~~~~C~C~~gy~G~ 38 (48)
T d1nqlb_ 10 GYCLHDGVCMYIEALDKYACNCVVGYIGE 38 (48)
T ss_dssp CEECTTCEEEEETTTTEEEEEECTTEEST
T ss_pred CCCCCCcEEeeeCCCCCeEEeCCCCcccC
Confidence 35888899988766678999999999873
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.15 E-value=0.18 Score=32.35 Aligned_cols=28 Identities=32% Similarity=0.924 Sum_probs=21.6
Q ss_pred CceeccCCCCCceeeecCCCcccCCCCCCc
Q 006402 240 ASKCLSAGRNGVYRCLCIKGYYWDHVLGTC 269 (646)
Q Consensus 240 ~~~C~~~~~~~~~~C~C~~g~~~~~~~~~C 269 (646)
++.|.+. .++|+|.|+.||..+.....|
T Consensus 15 ~~~C~Nt--~Gsy~C~C~~Gy~l~~~~~~C 42 (43)
T d1uzka2 15 GGKCINT--FGSFQCRCPTGYYLNEDTRVC 42 (43)
T ss_dssp TSEEEEC--SSCEEEECCTTCCBCTTTCBB
T ss_pred CCEEECC--CCCeEeECCCCCeECcCCCcc
Confidence 4689776 478999999999877655555
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.09 E-value=0.12 Score=32.40 Aligned_cols=31 Identities=29% Similarity=0.730 Sum_probs=24.1
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. ..|..+|.|... .++|.|.|..||.|.
T Consensus 3 ~C~~-~pC~ngg~C~~~--~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 3 ACTN-TSCSGHGECVET--INNYTCKCDPGFSGL 33 (39)
T ss_dssp CCCT-TGGGGSEEEEEE--TTEEEEEECTTEEST
T ss_pred cccC-CcCCCCcEEECC--CCCEEEeCCCCCcCc
Confidence 3644 468889999865 368999999999874
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.98 E-value=0.21 Score=30.39 Aligned_cols=30 Identities=23% Similarity=0.693 Sum_probs=23.3
Q ss_pred CCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 231 CKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 231 C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
|.. ..|..+|.|.+. ..+|.|.|..||.|.
T Consensus 3 C~~-~PC~ngg~C~~~--~~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 3 CAS-SPCLHNGRCLDK--INEFQCECPTGFTGH 32 (35)
T ss_dssp TTT-CCSTTTCEEEEC--SSCEEEECCTTEESS
T ss_pred CCC-CCCCCCcEEECC--CCCeEEECCCCCCCC
Confidence 543 468889999764 357999999999873
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.69 E-value=0.14 Score=32.35 Aligned_cols=31 Identities=35% Similarity=0.940 Sum_probs=23.9
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. ..|..+|.|.... ++|.|.|..||.|.
T Consensus 3 ~C~~-~pC~ngg~C~~~~--~~y~C~C~~g~~G~ 33 (40)
T d1g1sa2 3 SCQD-MSCSKQGECLETI--GNYTCSCYPGFYGP 33 (40)
T ss_dssp CCCT-TGGGGSEEEEECS--SSEEEEECTTEEST
T ss_pred cccC-CcCCCCcEEECCC--CCeEEeCCCCccCC
Confidence 3644 3688899997653 58999999999873
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=87.01 E-value=0.15 Score=31.56 Aligned_cols=31 Identities=19% Similarity=0.616 Sum_probs=23.9
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. ..|..+|.|.+. ..+|.|.|..||.|.
T Consensus 4 ~C~~-~PC~ngg~C~~~--~~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 4 QCAS-SPCQNGGSCKDQ--LQSYICFCLPAFEGR 34 (37)
T ss_dssp GGGG-CCCCTTCEEEEE--TTEEEEECCTTEEST
T ss_pred cCCC-CCCCCCCEEECC--CCCeEEECCCCCcCC
Confidence 3643 468889999864 468999999999873
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.37 E-value=0.25 Score=31.75 Aligned_cols=31 Identities=26% Similarity=0.740 Sum_probs=22.1
Q ss_pred CCCC-ccCCCCceeccCCCCCceeeecCCCcccCC
Q 006402 231 CKTQ-LDCSGASKCLSAGRNGVYRCLCIKGYYWDH 264 (646)
Q Consensus 231 C~~~-~~C~~~~~C~~~~~~~~~~C~C~~g~~~~~ 264 (646)
|... ..|. ++.|.+. .++|.|.|+.||.++.
T Consensus 6 C~~~~~~C~-~~~C~Nt--~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 6 CRISPDLCG-RGQCVNT--PGDFECKCDEGYESGF 37 (44)
T ss_dssp TTTCSSTTT-TSCEEEE--TTEEEECCCSSEEECT
T ss_pred cCCCCCCCC-CCEeEcC--CCCeEEeCCCCCccCC
Confidence 5432 2343 5789776 4789999999998764
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.21 E-value=0.33 Score=32.61 Aligned_cols=29 Identities=31% Similarity=0.586 Sum_probs=22.0
Q ss_pred CceeccCCCCCceeeecCCCcccCCCCCCcc
Q 006402 240 ASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQ 270 (646)
Q Consensus 240 ~~~C~~~~~~~~~~C~C~~g~~~~~~~~~C~ 270 (646)
...|.+. .++|+|.|+.||..+....+|+
T Consensus 23 ~~~C~Nt--~GsY~C~C~~Gy~l~~d~~tC~ 51 (53)
T d1apqa_ 23 QHLCHNY--VGGYFCSCRPGYELQEDRHSCQ 51 (53)
T ss_dssp SSEEEEE--TTEEEEECSTTCEECTTSSCEE
T ss_pred cCEeEcC--CCCeEeECCCCCeECCCCCcee
Confidence 3478776 4789999999998766555564
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.81 E-value=0.25 Score=31.40 Aligned_cols=28 Identities=29% Similarity=0.724 Sum_probs=21.0
Q ss_pred CceeccCCCCCceeeecCCCcccCCCCCCc
Q 006402 240 ASKCLSAGRNGVYRCLCIKGYYWDHVLGTC 269 (646)
Q Consensus 240 ~~~C~~~~~~~~~~C~C~~g~~~~~~~~~C 269 (646)
++.|.+. .++|+|.|+.||..++....|
T Consensus 14 ~~~C~Nt--~Gsy~C~C~~Gy~l~~d~~~C 41 (42)
T d1lmja2 14 GGVCHNT--EGSYRCECPPGHQLSPNISAC 41 (42)
T ss_dssp TSEEEEE--TTEEEEESCTTSCCCSSSCCC
T ss_pred CCEeECC--CCCeEEeCCCCCeECcCCCcc
Confidence 6789876 478999999999866543333
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.32 E-value=0.34 Score=28.85 Aligned_cols=31 Identities=23% Similarity=0.631 Sum_probs=21.5
Q ss_pred CCCCccCCCCceeccCCCCCceeeecCCCcccCC
Q 006402 231 CKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDH 264 (646)
Q Consensus 231 C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~~ 264 (646)
|+....|+ +|.|.+. .+++.|.|.+||..-|
T Consensus 4 CsignpCG-nGTCtNv--iGgFec~C~~GFepgp 34 (39)
T d1emoa2 4 CSVGNPCG-NGTCKNV--IGGFECTCEEGFEPGP 34 (39)
T ss_dssp GGTTCSSS-SSCEEEC--SSSEEECCSSSSCCCS
T ss_pred cccCCccC-Cceeeec--ccceEEeecCCcCCCc
Confidence 44434455 5888654 5789999999997543
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.70 E-value=0.29 Score=30.91 Aligned_cols=36 Identities=31% Similarity=0.836 Sum_probs=24.4
Q ss_pred CCCCccCCCCceeccCCCCCceeeecCCCcccCCCCCCcc
Q 006402 231 CKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWDHVLGTCQ 270 (646)
Q Consensus 231 C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~~~~~~C~ 270 (646)
|.....|. ..|.+. .++|+|.|+.||..++....|+
T Consensus 4 C~~~~~C~--~~C~n~--~Gsy~C~C~~Gy~L~~d~~~C~ 39 (41)
T d1i0ua2 4 CQDPDTCS--QLCVNL--EGGYKCQCEEGFQLDPHTKACK 39 (41)
T ss_dssp TTTTTSCS--SCEECS--SSCCEECCCTTEEECTTTCCEE
T ss_pred CCCCCCCC--CEeECC--CCCEEeECCCCCeECCCCCccc
Confidence 54333443 478665 4789999999998776655564
|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (urokinase-type) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.35 E-value=0.62 Score=27.92 Aligned_cols=29 Identities=28% Similarity=0.581 Sum_probs=21.4
Q ss_pred cCCCCceeccCC-CCCceeeecCCCcccCC
Q 006402 236 DCSGASKCLSAG-RNGVYRCLCIKGYYWDH 264 (646)
Q Consensus 236 ~C~~~~~C~~~~-~~~~~~C~C~~g~~~~~ 264 (646)
.|..+|.|+... -++-.+|.|+++|.|.+
T Consensus 3 ~ClNGG~Cvsyk~FS~I~rC~CPk~f~G~H 32 (40)
T d2i9aa1 3 DCLNGGTCVSNKYFSNIHWCNCPKKFGGQH 32 (40)
T ss_dssp CCCTTCEEEECSSSTTCEEEECCTTEESTT
T ss_pred ccccCCEEEEEehhcCCEEecCCcccCcee
Confidence 577799997553 23456899999998754
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.23 E-value=0.63 Score=30.39 Aligned_cols=30 Identities=27% Similarity=0.721 Sum_probs=22.5
Q ss_pred CCCCCccCCCCceeccCCCCCceeeecCCCcccC
Q 006402 230 VCKTQLDCSGASKCLSAGRNGVYRCLCIKGYYWD 263 (646)
Q Consensus 230 ~C~~~~~C~~~~~C~~~~~~~~~~C~C~~g~~~~ 263 (646)
.|.. .-|. ||.|.+.. ++|+|.|+.||.|.
T Consensus 10 ~C~~-~PC~-nG~C~~~~--~~y~C~C~~G~~G~ 39 (48)
T d1autl1 10 PCAS-LCCG-HGTCIDGI--GSFSCDCRSGWEGR 39 (48)
T ss_dssp SSSS-TTTT-SEEECCCS--SCCCEEECTTEEST
T ss_pred cccC-CCCC-CCEEECCC--CCCeEeCCCCCcCC
Confidence 5754 4676 48998653 57999999999863
|